cell_line_id,drug_id,response,predictions
MOLP-8,11612883,2.388158793316403,1.9838022599181528
MDST8,654092,-1.4293910300938224,-0.24103126697209196
RKO,52947716,-6.611161073849914,-1.964790139919177
RKO,56963564,0.5825206420774123,-0.06897772817774102
Granta-519,107970,1.5911312599666134,1.9111837436562615
HEL,12003241,-0.3954740832299299,-1.6221911391476775
SK-HEP-1,445091,4.514173662724111,4.558461221718077
SK-CO-1,vorinostat-carboplatin (1-1 mol-mol),2.626947191906058,3.2368584322794165
SU-DHL-1,JQ-1-vorinostat (2-1 mol-mol),1.047000957100153,0.6815163752191341
PaTu 8902,selumetinib-navitoclax (8-1 mol-mol),2.7909772109313677,1.9138050891535239
HCC15,24775005,4.257174534281358,3.775265330350693
HuP-T3,6450551,3.7588607556856006,2.889498166257618
SaOS-2,72376,-1.862865015628177,-1.9006189437341185
HARA [Human squamous cell lung carcinoma],9911830,2.811378702432749,2.7644666022087265
Panc 02.03,3062316,2.5231792980774,0.768214396945234
MOLP-8,6918837,-6.2821371699611515,-4.361550907045941
SW48,1242560,3.5610164041067645,3.296892531869163
RCC10RGB,3062316,3.7206614033239833,0.553536511844277
IA-LM,25262965,-3.1838216959830796,-1.514510631174179
BICR 22,3038522,1.9324211832044784,2.967157804856433
SW1573,4096211,3.236722527011662,2.412097721103467
LS180,navitoclax-pluripotin (1-1 mol-mol),-0.4771322903655018,-0.9406422756481205
NCI-H2452,2733526,3.4563089712221,3.7099226297072505
WM115,44197249,3.814304480361476,4.125028138839355
HARA [Human squamous cell lung carcinoma],ISOX-bortezomib (250-1 mol-mol),0.5382016887520487,0.8678852170624137
Granta-519,JQ-1-UNC0638 (2-1 mol-mol),-1.2323689665878552,-0.0881551869883057
SW948,216345,3.8478701746280506,3.287289280332579
RKN,2858523,3.2318364946727653,3.111089359484254
HARA [Human squamous cell lung carcinoma],11507802,1.3937860028408913,1.6926785565158442
LCLC-97TM1,17759555,4.8791087487812606,3.5724149304166186
ALL-SIL,24771867,-3.516684419884963,-1.7741656189890949
WM115,11455910,0.9860510612095932,1.2541850214425547
MOLP-8,11485656,1.8270206697288176,1.6160667879673682
MOLM-13,9866186,-0.4750218873797177,0.00926976329987515
Daudi,445091,3.707432883595851,3.7819315658641393
RERF-LC-MS,9907093,3.840365222907794,4.241038853852462
LCLC-97TM1,selumetinib-decitabine (4-1 mol-mol),4.710076676704391,2.5462042873590973
IA-LM,49836020,4.225846480888235,2.847002247290054
IA-LM,JQ-1-navitoclax (2-1 mol-mol),0.4623829149690596,0.5125438319356478
HuP-T3,445643,4.0158423100173986,4.029730511413175
RKO,5351362,1.5688417029382893,1.2299773475192508
SU-DHL-1,25262965,-0.1887460090186497,-2.300395340608695
MOLP-8,3552672,2.5417747800161483,2.505273171100029
Daudi,selumetinib-UNC0638 (4-1 mol-mol),2.5339399670169827,2.768085929797534
HCC15,24771867,-1.1106317715549263,2.9934055730343876
HARA [Human squamous cell lung carcinoma],16115403,-4.2638303939611335,-3.8333348889857013
COR-L95,25161177,5.647598761093448,3.832342735225034
BFTC-909,16219061,3.736019824418232,3.5718702201443424
LCLC-97TM1,3503,2.904492448420953,2.4453532988349465
RKN,5287620,-2.679516494579474,-2.054649086593081
IA-LM,5281321,-0.2514769440259956,-2.175672218592911
SK-HEP-1,24964624,3.121305411780932,2.7258170762604874
SaOS-2,9884685,-0.6485333929619777,0.49443987012803114
MOLP-8,44566777,0.3680572795114795,-0.13136139170662622
K-562,3081361,1.217245739162405,1.9991882113542128
HuP-T3,53392493,2.0684681956337654,2.7420156864281187
SW48,11404337,-1.6842588085779022,-0.4869846706241626
RKO,24771867,6.323343540042099,-0.4500859075824537
MDST8,11497983,4.366208744407351,4.102251997827362
Daudi,6918638,-1.8107043721369585,-0.83583620764937
RERF-LC-MS,107970,3.001301355490032,2.5109768766439786
NCI-H2452,56963564,2.315469414243469,0.7887051999580592
MOLP-8,JQ-1-UNC0638 (2-1 mol-mol),-1.954296009625891,0.1910589441348508
MOLM-13,4259181,-1.5110532495146267,-0.449037234708616
RERF-LC-MS,5566,3.05978093065268,3.1414676744445234
HEL,44607531,1.529117499700861,0.8782733446909361
BFTC-909,25262965,-1.7887871070762158,-1.1370518638757943
ML-1 [Human thyroid carcinoma],26596,-0.6105391992480588,-0.9179336143514338
BICR 31,46191454,1.7584497327325264,1.7841989963783556
UACC-812,426756,4.999419351863596,4.191683541667936
SW1271,9911463,3.695583497273472,3.9387523399176674
COR-L105,219104,4.205860409291191,3.96578073611961
MOLP-8,46943432,-0.8980695552897974,0.7831284128158464
MOLM-13,11626560,-0.3289224093786886,0.6573974727891246
SU-DHL-1,73707398,0.2992121771474305,1.0298747440061802
HCC15,doxorubicin-navitoclax (2-1 mol-mol),-1.4188615279170478,-0.6814830052400059
HCC1500,9907093,4.182225492860836,4.207554577012926
SW1573,JQ-1-vorinostat (2-1 mol-mol),2.32143209708559,1.2826291843472253
LS180,serdemetan-SCH-529074 (1-1 mol-mol),1.4143670518957836,2.0406378124774283
NCI-H1568,5746,-0.0019321539800122,1.2446046999787979
SW1271,navitoclax-birinapant (1-1 mol-mol),0.1602834101021188,1.4607947305188054
HEL,10385095,1.0320529067741009,0.8045396157049024
P31/FUJ,374536,-2.654779926412406,1.0510407182873671
KU-19-19,119607,4.136898976237774,5.318234637956129
HCC1500,11656518,1.3375266797474916,1.7061068535793467
NCI-H1568,44819697,-2.651253194329211,-0.8347178910547616
COR-L105,6918328,0.8369476830507139,0.2366825772325256
PaTu 8988t,1750826,2.46453979570572,-1.236576903668262
NCI-H1568,vorinostat-navitoclax (4-1 mol-mol),0.9474025116898376,1.2687472943071256
HCC1500,6438330,2.8683818740810088,2.0778560371133596
HEL,11214940,0.9295508638766669,1.33271962257389
HCC15,104842,-2.640027553911029,-2.44565373032928
BICR 22,53495165,-1.022289455565369,0.11182672340597194
SK-HEP-1,JQ-1-vorinostat (2-1 mol-mol),1.4434630535263555,1.4602168873306822
SW948,11167602,-0.1815305116238505,2.211674241086796
SaOS-2,119607,5.401113896800015,5.255421972941599
SW1271,444795,4.935671262335122,4.771101195689821
LS411N,107970,2.4864618038552724,2.1362904246048
RERF-LC-MS,3025944,4.157794890121567,4.264347936176051
IGROV-1,5282054,3.614574021382022,3.728084570775175
MOLP-8,5284373,1.9803114216772224,2.191689135798364
SW1271,46907787,1.639327018501732,2.2185734713881384
K-562,tretinoin-carboplatin (2-1 mol-mol),5.512334561910439,3.6252250772131025
IA-LM,carboplatin-UNC0638 (2-1 mol-mol),4.065848381548882,3.3204296977089762
ALL-SIL,5351362,0.9273092220520184,0.9860551702871159
MDST8,docetaxel-tanespimycin (2-1 mol-mol),-2.250770682375198,-2.207315653656416
LCLC-97TM1,54618164,4.1848187977728,3.958004046435079
SK-HEP-1,123631,3.617013696107864,2.6287922669146555
LS180,1641662,3.031869457755623,3.4231642555264363
LCLC-97TM1,46199207,3.402623883365983,3.2575429653129326
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384,-0.5912558766204625
ALL-SIL,168312962,1.491579787235829,0.3761600276258978
IGROV-1,135398516,1.9751898057484376,1.972987049213949
SK-OV-3,4261,3.2658157069367615,2.0793224111013298
Panc 02.03,11707110,-0.717341284128793,-0.09764767750082204
P31/FUJ,4261,-0.12536828191131,0.3781635763667054
Daudi,53481919,2.490259403593742,2.94910311450475
MDST8,navitoclax-birinapant (1-1 mol-mol),-0.9553214738186762,1.20199236993035
ML-1 [Human thyroid carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),2.9053104812744186,1.9185936969446533
SW1573,12003241,-0.6702221198842615,-1.2839706857884934
COR-L95,11238147,1.8523673489534709,2.4261858707939523
SW48,452548,-3.152923699933953,0.3311877954942631
ALL-SIL,46224516,1.508509192124363,1.9675322313654229
COR-L105,selumetinib-MK-2206 (8-1 mol-mol),1.6265269022274589,2.0656748004187584
HARA [Human squamous cell lung carcinoma],46199207,3.289640650109998,3.2311725639562754
UACC-812,docetaxel-tanespimycin (2-1 mol-mol),-4.467025086254145,-2.7941349220592344
ML-1 [Human thyroid carcinoma],24856436,-1.6469735215058778,0.7616190298401732
Daudi,6918837,-6.333799665630375,-4.38987593452517
K-562,57330099,5.557476297558147,3.8327673906976116
MOLM-13,3038522,-2.559283473550591,1.6796394193884183
BICR 31,tanespimycin-bortezomib (250-1 mol-mol),0.0232172753211841,-0.40043780825447256
SU-DHL-6,9903786,1.8029536633965553,1.9500721409299526
Daudi,151289,0.3893937359913983,0.4512407664382775
MOLP-8,51037431,3.96461280344528,2.911511469511727
BICR 31,11152667,-0.7818812516610519,-0.4987329064347529
LS180,46907787,-0.2837252988913812,1.738933640789692
PaTu 8902,16725315,5.393152185048805,4.2233743702995135
Panc 02.03,6914657,-4.005158687469553,-3.675502869289336
HuP-T3,54613361,5.307179038572215,0.358319131889282
PaTu 8902,107970,2.826401466277882,2.3589266613955022
RKO,25183872,-1.1635703485572924,-1.0483485484362758
RCC10RGB,135659046,5.776465120313546,3.8307316051827116
BICR 31,16725315,5.360398456728244,4.159951903764956
IA-LM,216239,1.6797579071033788,1.7781099381196026
LCLC-97TM1,selumetinib-navitoclax (8-1 mol-mol),3.8256626967827385,1.5624884254646423
COR-L105,6610216,4.21117605455994,4.317415059181105
COR-L105,10427712,4.508625829006449,4.461153323383463
NCI-H2452,6610355,4.992583267176856,4.75918182147709
PaTu 8988t,11364421,0.0778741703331701,-2.0106803134972706
RKN,3552672,1.948192158503618,2.8904675979834025
Granta-519,46174525,4.2506809125564615,3.1759827589604286
SW1271,44819697,-0.8585090240358869,-1.0035501851236517
WM115,44486219,4.206639028474801,4.367481610907501
MOLP-8,6918736,-3.613498069188207,-2.1768111305201425
LS411N,navitoclax-pluripotin (1-1 mol-mol),0.0808011312818899,-0.6494237503863538
LS411N,49836020,4.501659667614969,2.8322631787039683
WM115,9927531,5.125567810288171,4.9304317322109235
SW1271,24797083,1.5469513987685792,1.2853765840336848
HCC1500,1566236,1.5057997400762737,2.112448856006192
SK-OV-3,serdemetan-SCH-529074 (1-1 mol-mol),2.3877296872918334,2.2024695711484283
LCLC-97TM1,5566,3.3253657103683976,2.989484471640243
NCI-H1568,1242560,2.6554382745340046,3.5291606256874077
RKO,11717001,3.92417498432234,3.7357081660929907
SW1271,11612883,2.3755529899406604,2.826577140781333
Daudi,11396600,1.6595042173405945,2.742403153770673
P31/FUJ,60700,-1.8341903870446763,-1.8264896573062017
MOLM-13,JQ-1-MK-0752 (1-1 mol-mol),-1.5133138249776965,-0.2230843852482176
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649,0.6492651134523644
ML-1 [Human thyroid carcinoma],2858523,3.273643216387516,3.149638034576036
IGROV-1,3552672,2.134472496867482,3.1161889649456254
Granta-519,637858,1.0013506713179747,0.8886751323617906
RERF-LC-MS,24753719,5.208830602571573,4.44002294769804
BICR 22,10385095,0.7738978245677988,1.6551065386488824
IA-LM,216468,5.467489395679956,1.2033446250280002
HARA [Human squamous cell lung carcinoma],46398810,2.9743064800682912,2.71700043019685
ML-1 [Human thyroid carcinoma],JQ-1-navitoclax (2-1 mol-mol),0.5559974390910295,1.0100700526760178
SK-HEP-1,5738263,4.7811273930471065,3.5973930614171667
SU-DHL-1,44632017,-0.1440136540504316,0.845385954904485
HEL,selumetinib-navitoclax (8-1 mol-mol),-0.2593426680751931,0.3625711562183943
PaTu 8902,11152667,1.2355675895718252,-0.5175939003089227
RCC10RGB,53245473,3.741106102916085,3.485329814105605
RERF-LC-MS,637858,3.156110522031532,2.362504443116622
IGROV-1,crizotinib-PLX-4032 (2-1 mol-mol),2.0296160065449858,2.027106144327899
HuP-T3,selumetinib-MK-2206 (8-1 mol-mol),2.743935040601299,1.8652393570910317
MOLP-8,23635314,-4.658988245687028,-2.9943635587148947
HCC1500,241158,4.347158152842418,3.9310710992313265
NCI-H1568,16065773,2.3280951044534923,2.469898004253066
COR-L105,24771867,3.297975412837562,3.2601526009102453
COR-L105,11625818,4.2515796910784385,4.538983203257907
RERF-LC-MS,JQ-1-MK-0752 (1-1 mol-mol),3.600892214686445,1.7571051174774632
IGROV-1,2841722,3.834853118277962,4.402824331350065
SaOS-2,51039095,1.985897726070115,2.62361529152779
LS180,navitoclax-sorafenib (1-1 mol-mol),3.51212583776398,1.7941657529304564
COR-L105,44589607,3.154557065472522,3.1257899507114293
HARA [Human squamous cell lung carcinoma],54626689,4.600126869473187,4.587452439056259
LS411N,9911463,4.267700407985282,3.245845228655727
IGROV-1,4378219,2.016502068118561,2.6115568885069553
Daudi,135659046,3.1156448500687923,3.1612499591612364
KU-19-19,16722836,2.3762239171314894,1.8663611880527207
IGROV-1,10410894,3.2660402181528263,3.340238906212299
Panc 02.03,49793307,-1.288996397670963,-2.561589438959187
HuP-T3,SNX-2112-bortezomib (250-1 mol-mol),0.0780901353743998,-1.1846033939591942
MOLM-13,3136844,3.815118683612459,3.5147414720783803
MOLP-8,6914657,-3.275680842626438,-4.628132180016238
K-562,9887053,4.062685534067952,3.067244830189907
ML-1 [Human thyroid carcinoma],16038120,1.3266996549374028,1.2379539175256034
NCI-H1568,52947716,-4.502411459776945,-0.730897091656289
BFTC-909,11178236,-2.4757289909406683,-3.166868164909735
Daudi,6610355,3.6984054922795906,3.8250392628333536
HuP-T3,10184653,2.026243337908569,1.243370181356066
IA-LM,36462,3.5803800151684384,2.046898762481039
SU-DHL-6,46907787,-0.6700724490980451,-0.6710517598680455
HCC15,10231331,4.227224330005602,2.1522043392189203
LS180,135398516,1.9815935031047112,2.094510602538606
MDST8,53495165,-1.6914230136545845,0.5290695836918453
SW48,135411,0.1882785626851766,0.8239936953108129
COR-L105,11485656,1.8131666015075352,2.400999162222868
HCC15,1239801,5.074899811919598,4.171720302292278
SK-CO-1,11497983,-2.036472499029009,3.780144791691916
Granta-519,2742550,3.255820788990773,3.13424335171601
ALL-SIL,16720766,-0.6951675656481376,-0.4420931243186985
COR-L105,11175137,3.2551565890936165,2.866878260824407
RCC10RGB,decitabine-navitoclax (2-1 mol-mol),2.143538063867694,1.9799161582887674
BICR 22,ISOX-bortezomib (250-1 mol-mol),1.660291867951594,0.7294611068142521
IGROV-1,409805,5.990596261907717,5.16137303049135
Panc 02.03,11485656,5.602754460209725,2.4806210827480526
Granta-519,54619267,3.910643053444693,3.271600478029061
COR-L95,navitoclax-gemcitabine (1-1 mol-mol),-4.597005855092225,-1.6056884524187516
BICR 22,6252,-0.1324642168432157,1.3171470155195402
MDST8,11404337,0.5498361952050128,-0.301227545705117
SaOS-2,60750,-3.1697993298632183,-1.9601467352210304
SW948,11717001,4.275182691709766,4.0520215294181705
MDST8,11175137,2.5746086097463974,2.6315313719264264
IGROV-1,322968,4.140599241163106,3.877148528872593
HCC1500,1242560,3.704354238917139,3.5917155756819854
MOLM-13,9911830,-0.5537570191991712,1.5025093485926506
COR-L105,16038120,1.5247864010803889,1.2734903202455845
COR-L105,45279963,3.905008730311125,3.708109976299422
WM115,148198,-2.543343591950365,-3.1700325120104913
IGROV-1,2749,2.0319044408234954,2.058794945926493
K-562,4477,-0.1635303329058878,0.3890006201387196
SK-HEP-1,25227462,1.4628952719758763,0.9618075011838348
Panc 02.03,23582824,1.3457270338170706,0.786789287623252
SK-HEP-1,241158,4.116654148222159,4.128765156806293
SK-CO-1,168313047,0.9150038640573646,2.4175474278764666
Granta-519,9823820,3.571742016367909,2.70159513813584
SK-CO-1,159324,2.1120355222347738,3.1368582239494973
SK-CO-1,10385095,1.4661007046294967,1.2903159137489393
NCI-H2452,71304818,2.7948147605911218,2.6988960830525683
MOLP-8,4578,4.125075782233611,4.071189572151291
NCI-H2452,11455910,0.7111396076654327,1.3712435746555258
HARA [Human squamous cell lung carcinoma],6917907,-4.425737266076785,-5.084738138007194
LS180,10074640,3.3464344717087333,2.9829116863569096
MDST8,71466578,3.80352554053155,4.36341220024826
LS411N,6184667,3.0967158778150465,2.5314542841656116
SW948,11317348,1.1175502037929408,1.9539998477835092
MDST8,119607,4.705186592802013,5.326402878514209
SW48,11507802,0.6466338181730511,1.3801358208903836
IA-LM,alisertib-navitoclax (2-1 mol-mol),-2.012462769104639,0.23828210912844278
WM115,5702613,3.6693021536028367,3.003784709749758
SK-CO-1,23725625,2.337747507524157,5.040164825844688
K-562,2749,1.8349792189296796,1.3888380789301644
IA-LM,3825829,4.571991496451351,3.5661524252318837
KU-19-19,104842,-1.861779032385676,-2.474626085094928
SK-HEP-1,12001922,2.448252559355595,2.0530646492100706
HEL,135440466,1.1488755358131115,1.5928749562607303
Panc 02.03,6918328,1.3018368822202735,0.2710253633437906
SaOS-2,72734382,4.901362762899978,4.706820830842407
HuP-T3,135421197,1.625440100707307,2.0635099742262932
HCC1500,3384730,2.626558190955656,2.937516531530424
IGROV-1,51037431,5.669320749085174,3.0676948197966
BFTC-909,4917,2.929839520827846,3.222524109305603
WM115,637858,1.77843641117838,2.1230674224896884
MDST8,44589607,2.007770745404649,2.98588097587332
LCLC-97TM1,5282054,3.1900504557345664,3.425585046479364
HuP-T3,46199207,3.4499209547515433,3.2314080961758402
BICR 31,25262965,-3.4333038857773093,-1.464795222912602
LCLC-97TM1,6914657,-1.7973267784986633,-3.7431304736731636
MOLM-13,9823820,-0.5140029045699521,2.7940079921748624
RCC10RGB,327653,3.228661308812885,3.136333342355588
NCI-H1568,4705,2.022283964907955,3.212298939459737
SW948,selumetinib-MK-2206 (8-1 mol-mol),-0.5060345185709773,2.276984200788504
RKO,6914657,-2.9196237708628505,-3.9180119229142605
WM115,72734382,5.455243998512052,4.853530207259945
SW48,46398810,2.2376864399879,2.749498249996449
LS411N,2945648,3.381909997555915,2.404238889524956
LS411N,JQ-1-UNC0638 (2-1 mol-mol),1.029472619372517,1.1019195918956144
SaOS-2,selumetinib-PLX-4032 (8-1 mol-mol),4.990111037976576,3.3622764998059496
ALL-SIL,421610,2.937759224643201,2.538537798212744
COR-L95,11404337,0.1032061359669597,-0.7915375116723987
WM115,11427553,3.734660617826416,2.909030820591868
HCC15,122327,4.313110702061898,4.69834011586471
Daudi,9444,3.424690286905087,3.715136926622339
Granta-519,4521392,4.382822475618979,3.9034380383725544
SW48,31703,-4.626106549902408,-0.986794401056082
RKN,10127622,5.371150210721622,4.040176645557656
ALL-SIL,71466445,2.2002248480614925,2.0734691539300893
MDST8,656346,0.9697505348816438,0.8537349177959264
Daudi,71680916,3.7291665773697,3.8276372923200266
HEL,135398516,1.4688857829361923,1.39202205864412
HARA [Human squamous cell lung carcinoma],168312962,2.6720428895447412,1.6925949985776823
P31/FUJ,9936388,-7.166815071220185,-4.956839798474339
HARA [Human squamous cell lung carcinoma],42611257,3.5357302300548716,3.568484665867729
HCC15,11625818,4.624206979967606,4.532224431571457
LCLC-97TM1,42611257,3.4642891468760957,3.5095922904332677
LCLC-97TM1,5311,1.9621633752287055,1.1567982665771321
RERF-LC-MS,52912189,3.970931922009392,2.2937368373449796
BICR 22,9915743,0.3047863731286212,-0.6671390138191914
Granta-519,11612883,3.2575401906490895,1.7923442887563092
LCLC-97TM1,vorinostat-carboplatin (1-1 mol-mol),3.53516680468747,2.7679838590445907
NCI-H2452,3543504,4.306818718463235,4.646185504138504
SK-CO-1,676352,2.6575015884388704,2.2113344296528354
COR-L105,docetaxel-tanespimycin (2-1 mol-mol),0.3286281168811693,-2.190466220029639
RKN,71304818,2.008207131108322,2.6941408393402555
IGROV-1,67156097,0.1763939852409119,-0.6219122782993197
IGROV-1,51039095,1.7163430299301403,2.8854198320339504
P31/FUJ,JQ-1-MK-0752 (1-1 mol-mol),-0.1535880671922636,-0.0024553013086886645
IGROV-1,72193861,2.0623829231433293,1.5194263716725789
Daudi,tretinoin-navitoclax (4-1 mol-mol),3.599991807714322,0.9341001077605441
NCI-H1568,11167602,1.5259281753697294,2.5685126609075373
NCI-H1568,52912189,3.4016367932827563,2.6867237994610425
SU-DHL-1,107985,-3.306496987383706,-3.9530251995778283
P31/FUJ,73707386,2.311695228129917,2.4223469596571743
WM115,9884685,-1.925323313513864,0.773187589984043
SaOS-2,16722836,0.8662367041162377,1.4513047289916585
PaTu 8902,46843906,4.340257675131653,3.191614477031805
BFTC-909,656346,-0.1018552101429806,1.0537765219474924
COR-L95,54618305,4.5292428127427575,4.2278477414097795
PaTu 8988t,selumetinib-MK-2206 (8-1 mol-mol),3.0176221561167096,2.5582424521184772
Daudi,24772860,-3.9771177154169304,-2.899248439089572
BFTC-909,9911463,4.114346930944119,4.039213957860266
LCLC-97TM1,44197249,3.7483906325702545,3.1210640743924762
BFTC-909,6918837,-1.9878509916437357,-2.4806890020534
RERF-LC-MS,24797083,0.2985814331764478,1.4493998727978221
P31/FUJ,135928012,4.893710575363991,3.9038568422710807
P31/FUJ,53232,3.343897726239282,2.5527457846716235
K-562,navitoclax-MST-312 (1-1 mol-mol),0.8745280332695038,0.42845225272511706
MOLP-8,25062766,1.6722099464266416,1.7175381826203724
PaTu 8902,JQ-1-vorinostat (2-1 mol-mol),2.024407809701968,1.1025811424828942
ALL-SIL,tanespimycin-bortezomib (250-1 mol-mol),0.6461816419253308,-0.5706189745971233
SK-CO-1,262093,3.1807391377127376,2.9527013100701747
LS180,72376,-2.8322202153843703,-2.3141307434222496
SK-CO-1,carboplatin-etoposide (40-17 mol-mol),1.570074747334896,2.9827545490270433
KU-19-19,6918328,0.0154884073180988,0.16146985452606422
SK-HEP-1,107985,-2.2891993358893856,-3.282634970495817
PaTu 8988t,216239,1.832862266271042,2.379321779846387
SW1573,vorinostat-navitoclax (4-1 mol-mol),1.892054443323453,1.4979303136905944
PaTu 8902,156414,2.7243668654536206,1.1877978765330917
Daudi,16659841,2.946181230411034,2.5775555980713953
LS180,123631,2.1427319304120624,2.0759134174192875
BFTC-909,10385095,0.9839595624316404,1.2927563107566247
NCI-H1568,241158,1.943489424131273,3.920376363624837
UACC-812,44589607,1.3537953197929582,2.9441668175571376
Granta-519,11960529,3.2261057296158593,3.4524057835141133
LCLC-97TM1,25062766,2.2139494005881293,2.0196087049999956
LCLC-97TM1,5291,3.6350350305332424,3.6843225638218
MOLM-13,44491742,3.7695621371445975,3.746353406966223
P31/FUJ,3025986,-2.3655111331800067,-1.8080330843624355
PaTu 8988t,2749,1.558615062570056,2.0582879787971287
IGROV-1,2113511,5.982902824257526,5.620563129665174
Daudi,54639126,5.221444108043,2.6154564243893286
HuP-T3,selumetinib-PLX-4032 (8-1 mol-mol),4.085577653340594,3.0283795140576246
HCC15,9868037,2.5640614102548556,3.382272476922722
PaTu 8902,6918837,-2.118913626513807,-2.791926739691241
ALL-SIL,23725625,2.2136327630148736,3.3697327513549977
COR-L105,11455910,0.425998653780944,1.4485131059884961
K-562,16013152,3.768503882504226,3.608448444529383
Daudi,67156097,-2.7448600083467163,-2.186396625408959
SW48,6610216,4.461301788418361,4.306760839837255
BICR 22,11977753,-1.1105881150796446,-1.0773008150540229
Daudi,753704,2.787779434331829,3.9484746118953638
COR-L105,46943432,2.471907312248233,2.858457826031702
IA-LM,16736978,1.926640001137528,1.7709300085693431
IGROV-1,176870,1.8349827429681411,3.3951507358346373
SK-CO-1,148198,-1.1611262776602205,-2.8703499203693332
HARA [Human squamous cell lung carcinoma],219104,4.732621852676119,4.0631990621039975
IGROV-1,46943432,4.105714883822214,2.543944378732092
LS411N,168312962,3.224541058203402,1.492732966336323
LS411N,1641662,3.6634193785306337,3.2205591597736367
HEL,vorinostat-navitoclax (4-1 mol-mol),-0.226382947191329,-0.2270576508576701
LCLC-97TM1,26596,-2.266692800551727,-1.5495220259244211
HEL,151289,0.2321343459174182,0.5188943146278389
Daudi,1285940,3.7558538743643792,2.8349645193162574
MOLP-8,2749,1.3302247490678565,1.0924272729976114
RERF-LC-MS,10427712,4.250983789220692,4.342405037741463
WM115,16725315,4.630500047502962,4.090686339115821
Granta-519,9840324,5.864872193260208,5.382355317936473
HuP-T3,25262965,3.989652761156405,-1.4198847922387252
NCI-H2452,11719255,2.41462187851326,3.5869881694437606
COR-L105,1641662,3.72017777917812,3.6885036661887836
SaOS-2,89928392,1.2892186505806515,1.1945311425264429
LS411N,969516,3.2917111714105647,2.4017426584348467
Panc 02.03,carboplatin-etoposide (40-17 mol-mol),3.971241945633474,3.0599640143579507
NCI-H2452,327653,3.049758242791241,3.3317818568588327
LS180,4521392,3.9983682640735094,4.094814137446835
IA-LM,2113511,5.955012720035456,5.298719023186147
HCC15,11167602,2.587200682435675,2.7144206471962598
RCC10RGB,9911830,4.5526597563763795,2.7195833663052196
P31/FUJ,168312962,2.530788243280419,0.38982798037380084
ML-1 [Human thyroid carcinoma],136227331,5.904689393841422,4.2255891948068305
ML-1 [Human thyroid carcinoma],11609586,2.006327876020203,2.999454869281296
Granta-519,9933475,1.54115480203428,1.458969626288249
HuP-T3,73707398,1.153693297692098,1.2558041107474265
SaOS-2,409805,5.764413924489168,4.857871884667315
KU-19-19,984333,-0.867877464903324,0.8748014237550477
HARA [Human squamous cell lung carcinoma],5351362,1.123570314509272,1.5385376421456036
LCLC-97TM1,selumetinib-PLX-4032 (8-1 mol-mol),3.0304859741823944,3.213874515287344
P31/FUJ,navitoclax-pluripotin (1-1 mol-mol),-1.7547710657643,-2.051894321166118
SW48,6918837,-4.354568378072889,-2.993161124922064
LCLC-97TM1,16741245,5.12826814210941,3.819990283851274
NCI-H2452,11507802,3.578778888517491,1.7888581973284774
HEL,11175137,3.15338888234114,1.7724940109483098
BICR 22,60750,-4.532323865382038,-1.0752904812785904
Granta-519,44491742,4.018752292224149,3.5272785036213365
SK-HEP-1,12003241,-1.7510835313415607,-1.1666222008655682
SU-DHL-6,36314,1.1358641594844867,-2.866507416336935
HuP-T3,11152667,0.3145958176635,-0.3223040123712844
Granta-519,15547703,2.599412791530534,2.493082889902163
IA-LM,25126798,4.097105087874825,3.6996350465471153
MOLP-8,119182,-1.11255726511749,-1.9483971688538275
BICR 31,65064,5.259646525120305,5.066472826176455
COR-L105,6917907,-5.504495586582428,-5.068247979910028
LCLC-97TM1,11238147,1.840896458617422,2.776641282869639
HEL,51039095,2.698396554100347,2.1653078568387993
PaTu 8902,44185566,2.9137350944736653,2.4932855565368492
Daudi,53495165,-3.885820769064659,-1.886576868089597
BICR 31,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7385932494474976,3.984098344633228
MOLP-8,439501,-2.9296652389863267,-2.342132352865822
Panc 02.03,4259181,2.0313571914007604,0.6496621844753521
PaTu 8902,126941,-2.2828817630557228,-2.6726891908678345
RKN,5328940,2.201806852003849,1.8137675244899156
PaTu 8988t,SNX-2112-bortezomib (250-1 mol-mol),-1.5745385961478635,-0.9071445943150809
HARA [Human squamous cell lung carcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.5629845870291592,1.9880590175283817
COR-L95,246676,4.317733637680926,4.0902527964879205
K-562,135928012,4.4390204871751004,3.8871183716641142
MOLP-8,56946209,-6.528820954061854,-5.094043730307464
SW948,selumetinib-decitabine (4-1 mol-mol),0.3455932815007744,1.2191569979841994
COR-L105,135421197,1.9442341701951136,2.095080953605391
HARA [Human squamous cell lung carcinoma],374536,3.8012573814376567,2.7150745639637033
IA-LM,selumetinib-MK-2206 (8-1 mol-mol),3.1087327611966185,2.213373429196073
ML-1 [Human thyroid carcinoma],56649450,4.029501942502391,3.224653664508622
RCC10RGB,5280436,4.525748645562069,3.5122660832938224
NCI-H1568,31703,-1.6950574450364193,-0.6309791475888067
SW1271,148198,-2.630785543453804,-3.4577192679360924
Granta-519,11964036,1.5223427206827596,0.11545641523386782
MOLM-13,16725315,3.788691115651132,3.602039214452804
Panc 02.03,1716436,3.766168811644757,3.1348566649981193
SaOS-2,JQ-1-UNC0638 (2-1 mol-mol),1.2943206739427773,1.4213992188341373
K-562,1566236,1.8179642124055264,1.6123517902552738
RCC10RGB,409805,6.020159348453613,5.3936581221360145
HuP-T3,navitoclax-MST-312 (1-1 mol-mol),0.8342028342455182,0.979533223491541
HCC1500,11175137,2.755904594476177,2.566071395747343
HCC1500,11494412,1.8019649514762912,2.591964281657999
HCC15,10127622,3.735977541508184,4.077560407890532
HARA [Human squamous cell lung carcinoma],4096211,1.410240196225579,2.1754734917519998
SK-HEP-1,168312962,-1.3309808369359073,1.5149551796794543
COR-L105,24180719,3.693037976394381,3.5227900269717662
Daudi,46943432,0.8866201698678313,1.0258214489547592
HCC15,BRD-K27188169-navitoclax (2-1 mol-mol),-0.2430288225821102,2.1949378876489174
Granta-519,24180125,1.2477770260094014,2.195056001885045
RKN,9967941,2.6996754619948065,3.834243439790314
RKN,135398516,1.9656218312143572,2.3051429118832365
KU-19-19,16115403,-3.194116920729502,-4.048778648584588
SW948,56949517,5.5880132005349505,4.14788407954099
NCI-H1568,44632017,0.9967277604489184,1.431362320552901
COR-L95,11175137,2.52315362607855,2.108029317729372
NCI-H1568,676352,1.7505105304855018,2.2708541041704073
NCI-H2452,126941,-2.0674603287446964,-2.7384243854039254
NCI-H2452,4477,0.2060981637085811,0.8267839227640204
SaOS-2,vorinostat-navitoclax (4-1 mol-mol),1.3300754000959574,1.0934964612684241
LS411N,vorinostat-carboplatin (1-1 mol-mol),2.115093899053651,2.353755232105304
BICR 31,11647372,2.8607835505972035,1.181316981151015
WM115,52912189,2.2242444616857417,2.612739811114263
COR-L105,2729026,3.0417945234466863,2.8412088048745674
COR-L95,65064,3.24172080303354,4.400746064489226
IGROV-1,54613361,1.0826132998561049,0.04411500100798021
NCI-H1568,53232,2.5527200815554587,2.9544225657551744
IGROV-1,9884685,-0.088911709267569,0.5773181567430125
HARA [Human squamous cell lung carcinoma],104842,-3.702627319243614,-2.6237363697214193
SW948,16720766,3.3510678765666517,0.39359202493636153
ALL-SIL,135928012,2.5698772014589992,3.5544323365358133
IGROV-1,ISOX-bortezomib (250-1 mol-mol),0.8859012184952701,0.7598490112315838
COR-L95,56946209,-6.902335125637694,-4.130115763118726
IA-LM,49867926,4.185996432673056,3.490112214868029
SW948,11625818,3.962309646097391,3.8884668482764466
IA-LM,4259181,2.3536383664390734,0.020284824554893933
NCI-H1568,4259181,0.5766231269303183,0.18929114981612055
SW948,6438330,3.286047925562068,2.20519142369028
P31/FUJ,15547703,2.950164329068843,2.446930446099448
COR-L95,1750826,-0.7485912803642704,-1.9071731930718852
HEL,51037431,1.91843497941606,2.651314701289812
BICR 22,vorinostat-navitoclax (4-1 mol-mol),0.9224898382798205,0.9156283180559339
Granta-519,462382,0.1364457210972633,0.17317643989047413
LCLC-97TM1,11719255,2.8064116850649774,3.174335745523656
IGROV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0361645465839266,-1.0970599541983097
MOLP-8,1242560,2.9421278446513393,3.1053544697428235
WM115,9911463,2.5241618652619007,3.902043394615235
RKO,3025986,-0.6013959236761957,-1.0776837962933983
PaTu 8902,5335621,4.440333682211631,4.574860444114912
NCI-H2452,19582717,3.9299005055458793,4.636405153326167
NCI-H2452,171352865,2.832902682703541,3.158950757501058
COR-L105,5566,3.258554573596101,3.067392900031269
BFTC-909,11647372,1.2423847125416496,1.147329304740126
Daudi,3503,0.8148417795144576,1.8183435333927245
COR-L105,25183872,-0.7403581245059931,-0.6504225608744878
ALL-SIL,375860,-1.552794194023853,-0.614024329476118
HuP-T3,72193861,3.3106720937076233,1.7735470902023391
NCI-H1568,ISOX-bortezomib (250-1 mol-mol),0.1016439372832729,0.7794722733379276
SW1271,6438330,2.1351654373433764,2.0935699414721434
SU-DHL-6,25262965,-2.983432395440536,-2.5404478760917617
SU-DHL-1,serdemetan-SCH-529074 (1-1 mol-mol),1.762662031403703,1.561368144693627
BICR 22,JQ-1-UNC0638 (2-1 mol-mol),1.3883099593452988,1.700515275850436
SU-DHL-1,44489367,4.533806271256096,4.29375387933235
MDST8,31703,-1.4422735490012837,-0.47212034818228565
ML-1 [Human thyroid carcinoma],568763,0.2556406277244685,0.6383434079520629
IA-LM,10302451,4.177351274859187,2.815065828799338
SW48,11214940,3.1705360221414134,2.087274374483988
RCC10RGB,10074640,3.4095283906874956,3.2531084433376867
HCC1500,carboplatin-UNC0638 (2-1 mol-mol),3.485346920824326,3.472145555857592
COR-L105,25227462,0.5095099099095757,1.1362123434951357
COR-L95,66577038,3.0490878420221934,2.908779777191492
LS180,46191454,1.5509574675684803,1.6122375741056783
RCC10RGB,65064,5.251967206688168,4.940693428414592
IGROV-1,72376,-2.111352545322758,-1.9602596944051651
MOLM-13,89183176,2.661461024404157,3.037233912422859
LCLC-97TM1,doxorubicin-navitoclax (2-1 mol-mol),-1.1891183752031609,-0.9240144931075315
RKO,3384730,1.0492755436091918,1.8866109225168473
SW948,11656518,-0.9054812480406104,1.802004177416859
ALL-SIL,2949965,1.286096946783907,2.220211449591647
ML-1 [Human thyroid carcinoma],selumetinib-tretinoin (2-1 mol-mol),1.8296865613090936,3.414724683309549
RERF-LC-MS,selumetinib-BRD-A02303741 (4-1 mol-mol),3.278081284431068,4.043368456458871
K-562,5287620,-0.244838249137823,-2.17756651332749
Granta-519,3825829,3.4773445434270243,3.3186780503278834
MOLP-8,10385095,0.909191851453096,0.9656046356054087
COR-L95,135928012,3.4969711227856397,3.774489441363333
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251,1.6112591376227328
UACC-812,25161177,3.457735095549926,3.9859002477950196
SK-HEP-1,11178236,-5.847785565222589,-3.3136128981335253
SW1573,16741245,2.047879460545898,3.7845600874813075
K-562,vorinostat-navitoclax (4-1 mol-mol),0.9167311998987592,0.8592595631554844
K-562,89183176,3.981701702250952,2.8977907652340313
P31/FUJ,9915743,-0.8907797257006451,0.12598170286190705
WM115,3503,1.3325075362119865,2.3849993698841896
PaTu 8988t,44202524,3.9754310935930968,2.2742617799961775
SW948,9952709,2.6604018004594514,2.578810707603089
Granta-519,56946209,-6.359988120178517,-4.956650102538233
NCI-H1568,navitoclax-piperlongumine (1-1 mol-mol),1.526760839095053,1.7105965136451855
Daudi,613000,1.9882519691431488,2.32046803058922
RERF-LC-MS,374536,3.716253113618047,2.478905903695649
LS180,72734382,4.032476699930466,4.62941912953375
Daudi,1566236,1.0534301581716357,1.6748486566181533
BFTC-909,9868037,3.24226767674478,3.6405941406244176
HuP-T3,107985,-4.90392348596967,-3.4107684503250932
BICR 22,crizotinib-PLX-4032 (2-1 mol-mol),2.04605335326416,1.9402043329739038
IGROV-1,168312962,3.022863957843741,1.71023733404168
IGROV-1,3081361,0.99973562532788,2.4002194488001196
BFTC-909,5311,1.6846521587280363,1.75223663947813
NCI-H2452,2841722,4.2339337769073175,4.57849239653897
NCI-H1568,navitoclax-gemcitabine (1-1 mol-mol),-4.7036832419339865,-0.4011552010592698
RERF-LC-MS,5278396,3.382202757419261,3.6089144026810187
COR-L95,44607531,1.1147625805359247,1.5586143648392146
SaOS-2,135440466,1.1747227113697256,2.269725603517442
RCC10RGB,285033,2.114091727684993,-0.9126196119166271
SW1573,448949,2.6434946381292703,2.293210567420674
SK-CO-1,11964036,1.41955554287601,1.3811102692231103
SK-HEP-1,24901704,5.545234809796251,3.3968237128728513
RERF-LC-MS,71751553,4.213964581210796,4.5492681390221446
SW1573,11178236,-2.507507612037206,-3.569534392834788
HCC15,6450551,1.6627728253820353,3.0092335497376554
SU-DHL-1,54619267,3.144461009217004,3.822427178977805
P31/FUJ,11626560,0.2148563033664798,0.5109757162012639
COR-L105,119607,5.370152891195211,5.502551442995812
NCI-H2452,11427553,2.818972077820031,2.805947293606677
HuP-T3,2871966,0.5817483683031975,0.7760876147358776
Granta-519,439501,-6.00499370561019,-2.6882587630044528
RCC10RGB,JQ-1-UNC0638 (2-1 mol-mol),2.5689754136574425,1.8145189989305626
SW948,navitoclax-sorafenib (1-1 mol-mol),1.76041571963915,1.2933176397241863
BICR 22,2945648,3.5832925483527625,2.5885096182580707
NCI-H1568,11228183,4.140816994678141,2.73958048355392
COR-L95,89928392,1.3878824566143364,0.9807948107195671
BICR 22,2871966,0.0284401826322965,0.8384104901424985
HEL,46199207,2.3973871372245372,2.7813069436941107
HCC1500,52912189,2.5783780690097857,1.992949559029942
KU-19-19,52947716,-4.518413756843173,0.07872945626485929
ML-1 [Human thyroid carcinoma],5280436,5.01828711367565,3.520189117925363
NCI-H1568,7326481,2.864470016727109,2.8969981769549884
RKN,53232,2.2291100881655037,2.404521775265119
KU-19-19,4477,-0.0533500132034658,0.573049740388391
SK-OV-3,107970,2.5604111984812152,2.3880748585599507
BICR 22,1242560,3.7933374150058015,3.273450203128404
ALL-SIL,5738263,2.854339564213428,2.6072522658898056
HEL,5329102,1.6539669706420914,1.46793367841292
LS411N,selumetinib-BRD-A02303741 (4-1 mol-mol),3.2423717644429577,3.1807176044068286
SaOS-2,3854666,0.6354016080385003,1.9853898203933777
P31/FUJ,107985,-4.114404549725097,-3.8476411193221223
SK-HEP-1,54619267,4.307302877095537,4.149287621123491
MOLP-8,11213558,1.2108381509164672,1.1792091218681962
LS180,6914657,-4.58065814502937,-4.101610996640101
HEL,71466380,3.121887792191312,3.8417879235991474
COR-L105,25154868,4.769445801979145,4.52269873338728
LCLC-97TM1,25105715,3.527934306265534,3.346097561582624
SW1271,16013152,5.485365595141675,4.269470960111509
ALL-SIL,1750826,-2.8707446972397483,-3.1336856603085637
SW48,44632017,-0.021210675828241,1.3761364155448748
NCI-H1568,4578,4.166510450069308,4.505284870823358
SW948,24180125,1.460789729891403,2.6819856498965517
COR-L105,25161177,3.712985248467103,4.085399331863882
P31/FUJ,57519531,1.451496749892495,1.5245684703641325
ALL-SIL,6918837,-4.772645295536399,-4.696813715098892
RKO,16720766,-1.2722083569090707,0.32696829580125636
Daudi,11707110,2.6257952816009498,1.488051575537425
PaTu 8988t,24785538,3.127280515757933,2.0238764588058826
PaTu 8988t,selumetinib-vorinostat (8-1 mol-mol),4.764605515620316,2.883570332278769
HEL,46174525,3.393297616528365,3.0438953623587155
MDST8,17759555,5.018522859633252,3.5882859537665945
SW1271,53392493,2.79081275696651,2.7533750736327467
COR-L95,carboplatin-UNC0638 (2-1 mol-mol),3.064030034312791,3.3790861255597218
SU-DHL-1,9927531,2.969590320438058,4.287236709541445
Daudi,445455,3.7530002864178416,4.086076611047554
SW948,24951314,0.7675285489701543,0.6591194640404738
IA-LM,JQ-1-carboplatin (1-1 mol-mol),4.993034474620053,0.5264926791715957
SK-CO-1,9866186,-0.7388742913087788,0.9946758301739842
RERF-LC-MS,60700,0.497286081450591,-0.05207154730184988
BFTC-909,11364421,-5.034674750215906,-1.6358293191404538
SW1573,49766530,-2.79322841384178,-0.46951665909099544
COR-L105,vorinostat-carboplatin (1-1 mol-mol),4.069993227019241,3.370618067377018
MDST8,25126798,3.890491738661291,3.7667391531103207
HCC1500,3543504,4.272332537756205,4.524838102616326
COR-L95,25062766,3.209944577871265,2.0311659864945613
ML-1 [Human thyroid carcinoma],5351362,1.4214743835970418,1.6356722982288172
SK-CO-1,44632017,0.9847861620501556,1.3526193388619305
NCI-H2452,navitoclax-piperlongumine (1-1 mol-mol),2.2697751233857058,1.9866123226180963
NCI-H2452,445455,4.8000860101003235,4.792384430659566
ML-1 [Human thyroid carcinoma],446155,2.0206180645356766,2.8880438297781432
HuP-T3,439501,-2.469428626730465,-2.0146369373351694
RERF-LC-MS,9884685,0.4531053665233772,0.76322085017561
RKO,5281321,1.9988379902215376,-1.8598999597803072
NCI-H2452,10410894,4.350169635958685,3.4306227285206563
HuP-T3,24951314,1.4235135044150102,1.4820649095191747
SaOS-2,71466445,4.363709574185696,4.1395607708660815
BICR 31,44185566,3.0664042381745946,2.7664230120547586
NCI-H1568,11625818,3.359978935972883,4.36536326209403
BICR 31,3552672,2.13577451695998,2.9711906977912417
P31/FUJ,decitabine-carboplatin (1-1 mol-mol),1.8939659397992608,-0.026500563717277763
HARA [Human squamous cell lung carcinoma],11640390,3.0925981241806983,3.5792363032270464
ML-1 [Human thyroid carcinoma],55283,2.9349831464401936,2.8320842654378713
LCLC-97TM1,119182,-0.294501899208461,-1.011394519975623
ALL-SIL,52947716,-0.7216046839402591,-4.055153522628055
RKO,11640390,5.295981617059328,2.466178878340517
RKO,25150857,2.5785304193211247,1.5575167087919135
RKO,erlotinib-PLX-4032 (2-1 mol-mol),3.5689359084165124,2.9359043380196517
ALL-SIL,1716436,3.0252724323132374,2.5114305893902684
RCC10RGB,262093,2.8343922904091134,2.858087483557261
HARA [Human squamous cell lung carcinoma],135411,-0.5831763791629045,0.6602915464638849
SK-HEP-1,439501,-2.4482777943885856,-2.151436863690288
RKN,71466380,6.199959456698308,4.393546053457973
HARA [Human squamous cell lung carcinoma],19582717,3.08314824082211,4.540642156315179
RERF-LC-MS,1242560,3.610791422912421,3.5820130781237913
SK-CO-1,ISOX-bortezomib (250-1 mol-mol),-0.2509608033573304,0.705418464255002
Panc 02.03,66577038,3.3089612685646985,3.1703807134792212
LCLC-97TM1,52947716,-3.0616129604635565,-0.4654125925206776
SU-DHL-1,20959075,-3.3128713931491087,-2.3593463327824167
BICR 22,2113511,7.552062733189383,5.496712885482445
SW948,25126798,3.357341035223679,3.7811780940732422
HEL,3854666,0.8085723321900852,0.744317568233324
HCC15,168313047,3.1265794948701338,2.482802380867607
WM115,107985,-2.5041726579949857,-3.3469850768458786
WM115,42611257,-0.3600732192588895,2.950036688163999
HCC15,60700,-1.3823438115431317,-0.6096281261989982
COR-L95,alisertib-navitoclax (2-1 mol-mol),-1.2067075871406427,-0.7324397614290663
PaTu 8902,navitoclax-MST-312 (1-1 mol-mol),2.8235677032410873,1.1219001731381666
SW48,60750,-4.2221568193195225,-1.6810644323400936
NCI-H1568,262093,2.8880881470868585,3.0740055936785033
PaTu 8902,53392493,3.316041661234319,2.9070922137900457
Granta-519,11647372,1.7523915142224398,0.05274871823421348
SK-HEP-1,8515,5.0523689066797495,4.109419748822521
SW1271,decitabine-navitoclax (2-1 mol-mol),4.244493551272361,2.0121359151645435
LS180,702558,5.586038369213652,5.250976610097997
IGROV-1,15983966,1.7101486625531308,-1.0802482622533212
SK-CO-1,6505803,-2.970063061644963,-1.0138290794018496
SaOS-2,navitoclax-piperlongumine (1-1 mol-mol),1.6017048786640289,1.692524923122306
PaTu 8988t,11485656,1.82057121616084,2.605401197162962
KU-19-19,2874250,6.302627434426347,4.71143066429129
MOLM-13,11175137,0.3158641445144168,1.5736822170657907
WM115,644241,2.021542714802758,2.1435782092855287
SW48,52947716,1.8444935422046616,-0.859415668898253
NCI-H1568,10302451,3.040030486332468,3.299681516707756
COR-L95,44185566,2.2555949878605484,1.9840050030263285
LS411N,16725315,5.1123164266785714,3.7517260789806586
BICR 22,25195348,4.085059979970886,3.151436525392079
SaOS-2,5311281,0.944453452900516,2.12828125815553
SW1271,613753,3.197731710568041,3.4539493501952148
IA-LM,9840324,5.344700856558617,5.611095576965635
LCLC-97TM1,439501,-2.367039612081251,-1.9870263883812138
LS180,9825149,2.508714096118433,1.9514586704637258
COR-L105,9911830,1.908645944756667,2.5074170514603598
Granta-519,25126798,3.857539921377872,3.5057112222758984
K-562,11238147,1.4367734907149323,2.2881985073061943
SK-CO-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6721111669479054,-1.423680516840333
IGROV-1,4705,3.3098412390054603,3.2888610235200817
RERF-LC-MS,1716436,4.437154842045929,3.147853555233192
COR-L95,6918638,0.5429028056483723,-0.12580451816229818
BICR 22,11507802,1.0844954054416946,2.3117625032960896
Daudi,54626689,2.8292455243221264,4.053364051880502
COR-L105,148124,3.589067174421039,-0.9651916981113086
HEL,selumetinib-JQ-1 (4-1 mol-mol),-0.6322408734916383,-0.4930129164351768
IGROV-1,9825149,2.5588021380929553,2.3373954854021637
LS180,2113511,7.0742493322433955,5.688265253079663
MOLP-8,16038120,-1.6086793301450355,-0.3073981009418905
KU-19-19,67291369,2.2261044123877656,2.905760875552912
COR-L105,carboplatin-etoposide (40-17 mol-mol),5.23047829437091,3.11420704633508
HARA [Human squamous cell lung carcinoma],6505803,-0.6058988133854029,-0.49979615551167006
MDST8,navitoclax-gemcitabine (1-1 mol-mol),0.2783653553106409,-1.4445171983927807
Granta-519,44462760,4.300929542453815,2.46873688737668
MDST8,tretinoin-navitoclax (4-1 mol-mol),1.0614057430446846,2.6029887208678972
KU-19-19,17755052,6.06318579738538,1.8278252238658304
MDST8,11214940,-0.3312007430689519,1.9175244830746818
SaOS-2,57519531,1.7793183342968584,2.6382970897081064
BFTC-909,erlotinib-PLX-4032 (2-1 mol-mol),4.45664321306644,3.1306093635340755
LCLC-97TM1,44493528,4.18527882332477,4.318095417337052
LS180,decitabine-navitoclax (2-1 mol-mol),3.265284502098727,2.2565733634389935
SW48,10231331,-2.95597966611556,2.0140586991492544
SW948,24797083,1.9027092264791332,1.5175180106334565
IGROV-1,11238147,2.1723642292765084,2.9638426560769027
COR-L95,17755052,2.817022282186957,1.3590711450805757
LS180,25126798,3.79328534931886,3.8986200373622553
IGROV-1,71304818,2.4878074097553378,2.5520112760564713
SK-HEP-1,10302451,4.165168773877425,3.4437986777505682
HCC15,25102847,1.68346873279249,2.5081658400950975
SK-OV-3,15983966,-3.6834707194333927,-1.2699823704267643
HCC1500,54143018,1.195335139641603,1.0045320956630963
COR-L105,11364421,-0.5536252833264237,-0.5477443322703924
RKN,148198,-1.0178445286580065,-3.3562284701426717
KU-19-19,400769,-0.482585358097733,-0.6042362972312835
COR-L105,7326481,3.3886978035876547,3.0392073545693052
COR-L105,44819697,1.466179589978979,-0.08120522272712848
SW1271,5281672,5.179464513143849,4.524636785369153
PaTu 8988t,3634881,3.651211463421112,3.3783624635226452
IA-LM,11404337,0.4340662777154989,-0.21235497477596926
NCI-H1568,5287969,-2.4053225408736405,-1.6037769754180007
ML-1 [Human thyroid carcinoma],60750,0.2716917716617745,-1.4588242366982866
COR-L105,54619267,4.07987987500145,4.05530169395967
SK-OV-3,9907093,4.994966956142975,4.258381514197704
ALL-SIL,11167602,0.1759872916057691,1.9224813316851226
MOLM-13,49836020,-0.1965532240483963,2.5241629053071724
HCC15,52947716,3.127529556956005,0.3377085354310956
SW1573,4261,3.544037815747042,1.765786914963984
MOLM-13,6184667,1.666374934082413,2.393293866062618
SK-HEP-1,3854666,3.0622551399292264,2.430359120532421
Granta-519,241158,3.1692083740262373,2.2741107950721773
MOLP-8,5978,-7.284134927472065,-3.1168789131522754
LS180,10302451,1.4669812473297774,2.584293305005403
RKO,16065773,3.3120716405166615,2.281356589361214
MOLM-13,24964624,0.892926396159225,1.1605891623032636
KU-19-19,11427553,3.4053411651543035,3.0793096224029473
SK-CO-1,44137675,3.0714779264964074,3.5530473207616637
P31/FUJ,6852167,1.016015239887951,1.6403559567023263
HCC1500,5351362,1.2955308259083285,1.605720800294505
ML-1 [Human thyroid carcinoma],11964036,2.920411614995081,1.6131191491596142
MOLM-13,252682,7.80657372951634,6.4055375440077285
HARA [Human squamous cell lung carcinoma],57330099,4.527264318285619,4.35278596447545
HCC1500,44607530,1.2894809747133489,1.6033706138384503
SW1271,3025944,4.184087558749553,4.29047042297747
HCC15,44493528,4.34604946513687,4.386617740810529
P31/FUJ,6918736,-1.9353169891324984,-2.387077559795563
ML-1 [Human thyroid carcinoma],168313016,5.516575315061805,5.024974060190996
K-562,24856436,0.0017034666231649,-0.4840850284877738
LS180,216468,-0.2416288368660945,3.102742473834203
SU-DHL-6,11507802,0.7208159532280615,0.6346182889070268
SW948,5291,4.046310039203204,3.571382530398726
ML-1 [Human thyroid carcinoma],46398810,2.1486791434985344,2.672824992985923
HCC15,11152667,0.1037945221143532,-0.40522318466420537
K-562,selumetinib-GDC-0941 (4-1 mol-mol),2.3648746020483284,0.7570571432102211
Daudi,piperlongumine-MST-312 (1-1 mol-mol),0.9306925214047892,1.1889032258572063
SaOS-2,49766530,0.3706728408995327,-0.807600535388577
SU-DHL-1,168313016,5.361416197440646,4.317762163743779
HCC15,168312962,2.4994502868710677,2.277676109338275
IGROV-1,24797083,1.5319862293819655,1.2043321730741277
WM115,71751553,4.133313051647094,4.611031430980841
SW1271,24951314,2.0404240106098723,1.4199145880676207
Granta-519,SNX-2112-bortezomib (250-1 mol-mol),-3.1352941908416243,-2.8246929070485476
SaOS-2,676352,2.2074841133021432,1.7522119691588756
P31/FUJ,322968,1.4419696378870497,2.2683592854456065
SU-DHL-1,10127622,2.7675483211751466,2.9846287860495697
COR-L105,44137675,1.808161252080405,3.9204720755488904
PaTu 8988t,11625818,4.482422780967983,4.507771798907504
HARA [Human squamous cell lung carcinoma],156414,2.353598180094054,1.1406385432381787
Panc 02.03,16038120,1.606654693103348,1.2657401925655973
BICR 22,3854666,0.9977305103930704,2.1015317108378473
Daudi,46398810,1.6020476162665716,1.9600617864679588
COR-L95,984333,1.162546188419483,0.13540451988123378
WM115,1317464,3.7806694387813753,3.159174299865376
K-562,71680916,4.727537128358906,3.874170930623196
BICR 31,25183872,-0.4870171412848909,-0.5689939704006708
COR-L105,11626560,2.2911739511823503,2.0513440453445266
SW1271,9936388,2.2656701786136315,-1.5952729077925818
MOLM-13,135421197,0.945680487717708,1.1962386278199026
SK-HEP-1,136227924,3.6301481247272287,3.1065386714977397
K-562,375860,-0.3542925626582329,-0.4879725961101476
SK-OV-3,9887053,4.42879128381072,4.269665891856708
LS180,9936388,-5.017955750811216,-2.0408797480322054
SW48,9935249,1.3330175828473068,2.8067391062444034
SW1271,11214940,1.5931636594582963,1.7271693989091486
BICR 31,serdemetan-SCH-529074 (1-1 mol-mol),3.0027631707479467,2.1255226737307327
RKO,67156097,-1.3338800856316015,-1.8947994165757274
LCLC-97TM1,51039095,2.799665973949055,2.7199832034269322
MOLM-13,54143018,-1.3895840664016086,-0.3799155744414247
Granta-519,5738263,2.4520737989935246,2.5175228902055253
SW1271,2828334,6.430891789984985,6.2678755553868
COR-L105,salermide-PLX-4032 (12-1 mol-mol),5.562133960836907,4.782614111295167
HCC15,3136844,4.306118753112888,4.450830425508051
IGROV-1,54454,2.453541831966438,2.8424551272422875
BICR 22,9935249,5.2884064452137585,2.735964377336006
BICR 22,72376,-2.4643814155147634,-1.587669403496179
HARA [Human squamous cell lung carcinoma],71304818,2.9544117211144147,2.5952569280992486
ML-1 [Human thyroid carcinoma],selumetinib-MK-2206 (8-1 mol-mol),-0.7620404937141786,2.3149275101546745
SK-OV-3,25022340,0.9085118587340768,2.854348501470048
HARA [Human squamous cell lung carcinoma],11167602,3.2969276962649823,2.3692184580428
P31/FUJ,11238147,2.0504580426090286,1.9603136613167012
NCI-H2452,44607531,1.7526351480007742,1.6802579715227335
SW48,selumetinib-navitoclax (8-1 mol-mol),-2.7874089121789662,1.9818166795479444
WM115,119607,3.834781850796951,5.500753543449775
IGROV-1,71466445,2.3758001916617797,4.0089789708597205
SaOS-2,54618164,4.337585482929099,4.166045788933286
SaOS-2,46843906,2.56299568717197,2.962951537360217
SW1573,navitoclax-sorafenib (1-1 mol-mol),1.0822173392973782,1.9696075283695313
LCLC-97TM1,2841722,4.284298549740087,4.1598861834481236
LS411N,36462,3.380504085081747,1.6998535747115262
COR-L95,637858,1.3348673917451612,1.5433131066178802
HuP-T3,10113978,4.191114511390656,3.489520580711302
Daudi,selumetinib-vorinostat (8-1 mol-mol),1.8930359660265372,1.73086553878817
MOLM-13,24772860,-4.1681928866236415,-3.127856325290532
WM115,9823820,4.472944540337913,4.109150509800394
MOLM-13,3676137,4.483658238026924,4.135526297409036
MOLP-8,49766530,-0.668776240648524,-1.3934259252682184
SW1271,107970,2.3235168881670285,2.3181945965367547
PaTu 8988t,16065773,3.154821962511545,2.4914576989182278
Daudi,tretinoin-carboplatin (2-1 mol-mol),4.019264736178175,3.324217164877669
SK-OV-3,JQ-1-UNC0638 (2-1 mol-mol),4.235651526458717,1.7685348726313632
Panc 02.03,selumetinib-UNC0638 (4-1 mol-mol),4.3993780952510955,2.856672357984144
RERF-LC-MS,selumetinib-PLX-4032 (8-1 mol-mol),2.4830780225250413,3.546817400820775
NCI-H2452,11364421,-0.8742390414707,-1.8038338914431344
NCI-H2452,4788,5.30317679490816,5.787544384264151
P31/FUJ,11396600,3.188193103342261,2.628612500294434
SW48,2130404,2.4705566813277215,3.330670934577461
SU-DHL-6,322968,0.8712022459195665,2.182121181149155
BICR 22,107985,-3.867593954539223,-3.2658986223973994
COR-L105,46215462,2.588599789838095,2.074703337634324
PaTu 8988t,5287969,-2.0890298278516513,-1.871412772492294
SaOS-2,9866186,1.0217998308229927,0.6791312206200333
SW948,16065773,2.2305150921307653,2.2171097795233377
RERF-LC-MS,tretinoin-carboplatin (2-1 mol-mol),4.86238533641819,5.073421143036742
WM115,10127622,-0.9383410403940764,2.9346861568546467
WM115,2733526,4.043531113233861,3.7138269522502743
PaTu 8902,49850262,5.593248228762752,3.7143315216571735
HCC1500,54613361,2.498230028210423,0.5107456350299174
SaOS-2,ISOX-bortezomib (250-1 mol-mol),1.126416426166952,0.6983128200215039
Daudi,5746,-2.3170879531966273,-0.2635439549491124
MDST8,6610355,3.7892287954147457,4.39235734759115
SK-OV-3,219104,6.736269406359778,3.795088197321581
MOLP-8,49793307,-5.094504062696007,-4.116908764701321
NCI-H1568,54626689,4.298451601405369,4.729990222346478
IGROV-1,156414,1.4212019235656712,1.5312627368550193
Daudi,4477,-0.8111056564008632,0.39753928747352973
K-562,135398738,1.706304792848783,2.7348782183766662
MOLM-13,57330099,4.105312173478173,3.487846184927559
SW1271,42642645,0.8738549597199083,1.148619409581093
SK-CO-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8128298123800823,-0.593678980415913
NCI-H1568,decitabine-carboplatin (1-1 mol-mol),4.2821372470380545,4.5456858313844535
ML-1 [Human thyroid carcinoma],selumetinib-vorinostat (8-1 mol-mol),1.7610539005616883,2.8312002310270894
Granta-519,16725315,3.130545070245978,3.4421034239127857
ML-1 [Human thyroid carcinoma],73707386,3.645367416812384,3.0568359785766033
RKO,3854666,1.2691133577357363,1.1339982512212243
SaOS-2,119182,-1.602754826097209,-0.12043742537865619
ML-1 [Human thyroid carcinoma],49793307,-2.0238665574613024,-1.7962006648733457
Granta-519,9843750,4.294258272153345,3.113240733731613
MDST8,5329102,2.639161266907228,2.163507425921936
Daudi,selumetinib-JQ-1 (4-1 mol-mol),0.1373274073902578,0.0766148844339321
SW48,36314,-6.6979677874770065,-1.295344598296614
RKO,9825149,2.459088339864112,2.0846061691442346
MOLM-13,9911463,2.5287579203643986,2.902528009402228
RERF-LC-MS,44566777,0.4059341966526995,0.7432222453293494
SK-OV-3,10184653,1.9718742380811307,0.9528314520124067
HCC1500,16219061,2.7461663809715375,3.202718958959963
SK-HEP-1,9926054,1.934364320328667,2.0947356985853403
IGROV-1,24901704,3.0789156375765936,3.2189541140905016
BICR 31,9933475,1.7480026685414405,1.7811917116763147
COR-L95,3552672,1.407232830890507,2.5438174049834004
NCI-H2452,ISOX-bortezomib (250-1 mol-mol),1.6045376494936,0.5889406473707108
COR-L105,66577038,3.4359280481345755,3.102570981293299
COR-L105,24753719,4.356648297258706,4.411728599528601
ALL-SIL,24978538,-2.389127379896269,-1.2583167218438573
SU-DHL-1,3025986,-2.176216514163443,-1.307031362456148
IA-LM,3062316,1.9598487648076035,0.6779833279061367
MOLP-8,448949,2.0087568721459146,1.4614993135776642
HCC15,89928392,2.045660123087396,1.9978728266359764
SK-CO-1,16720766,-0.9325558438762483,0.9936652983903123
IGROV-1,11485656,1.900409616013456,2.405844444552459
HCC15,44137675,4.493981948720765,3.610551121262896
SaOS-2,5284373,3.659507244236858,2.5894509723022416
COR-L95,44589607,1.7004659608333377,2.200604826598598
PaTu 8988t,16659841,4.413190590676007,4.190308111537941
MDST8,5311,1.1196330054843209,1.4497803897163277
HARA [Human squamous cell lung carcinoma],3825829,3.0637384073868787,4.088200461572524
K-562,168313200,4.769830643466651,2.7138720452099263
SU-DHL-1,36314,4.070517798024083,-2.162683732942772
COR-L95,219104,2.3748233222255144,3.2134153838212667
Granta-519,44566777,1.2837383493022634,-0.43346911648065684
WM115,45279963,3.6868070952026506,3.819581423750646
HuP-T3,10127622,4.169685865232827,3.2421153217071943
SaOS-2,54454,3.299905279612609,2.2693091749055516
COR-L105,71466445,5.452991683251573,4.27121632996632
SK-HEP-1,crizotinib-PLX-4032 (2-1 mol-mol),2.841663753001873,1.9392365121934423
COR-L105,19582717,3.403236730524823,4.472207692241911
K-562,11625818,4.129982389727392,3.745759560469048
LCLC-97TM1,3384730,2.793888789676347,2.313913590027073
BICR 31,4917,3.733916426719056,3.201434254910572
PaTu 8902,54619267,4.2510877724746585,4.159431937801672
ALL-SIL,25102847,-0.1309610459144975,1.7119766854417906
MOLM-13,23939,5.7894293981406,3.4469959822358254
COR-L95,2828334,5.963676169995917,5.830406450222142
PaTu 8988t,44137675,4.243997881661858,3.675442548511276
HARA [Human squamous cell lung carcinoma],675434,4.319126364052166,4.410242557442536
SW948,5978,-3.22198817122066,-1.5185362448471447
RKN,375860,0.0559819210079563,-0.25969772231206767
NCI-H1568,49836020,3.1231470101883336,2.9750917704913418
NCI-H1568,12001922,1.1909466973303815,1.899826529254756
HuP-T3,135411,0.8125735513868637,0.717457683275268
NCI-H1568,119607,3.825066299684422,5.309352327967369
WM115,9825149,1.8328544820090609,2.2643818877540904
WM115,104842,-0.2362637011987665,-1.9802944072133064
P31/FUJ,327653,2.543614095842417,2.4816015043880886
RKO,11396600,3.504834935214814,2.8650664632675835
SK-CO-1,135440466,-1.3303352220830715,2.237588591576686
HCC1500,sirolimus-bortezomib (250-1 mol-mol),0.0140631270051885,0.6159959121064668
P31/FUJ,23635314,-1.6494447832357666,-2.7699621418782834
RERF-LC-MS,carboplatin-etoposide (40-17 mol-mol),1.469978322286411,2.876572682575412
SW1271,46215462,2.0233113088179406,2.0150542810909324
MOLP-8,969516,1.8716619229833695,2.1983480079240794
K-562,135999136,3.657737204061429,2.56532516994044
SW1271,9866186,1.0057234740027048,0.972660526773745
BICR 31,5278396,4.450921628721945,3.780706123908276
HuP-T3,462382,0.4397112913332706,0.6949675912840948
SW48,44202524,0.7134579720144102,2.32902960920362
IGROV-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6574753619864233,-1.249883240287894
HARA [Human squamous cell lung carcinoma],6610216,4.810637550807952,4.203619360538255
LCLC-97TM1,3025944,4.079230434060959,4.259777292517976
SW48,46174525,4.111785915347283,4.436008279696654
HCC15,11396600,3.725702968544969,3.8784807782185062
SaOS-2,2949965,2.5764816921436067,2.9425430151688143
COR-L95,selumetinib-navitoclax (8-1 mol-mol),1.0752689694736437,1.5562835935881132
NCI-H1568,10296883,3.9462373745058863,4.09479445905521
COR-L105,SNX-2112-bortezomib (250-1 mol-mol),-1.6644703388391169,-1.0882197754343823
Panc 02.03,216345,4.682043945218969,4.297601970411288
Daudi,26596,-3.612902475241139,-2.7622599838727293
NCI-H2452,262093,3.2163720661137942,3.0567316850146
PaTu 8902,9936388,2.1491039356268966,-0.37537415732354584
SaOS-2,4477,0.5134457679146515,0.3782545833318999
RERF-LC-MS,4096211,1.8582313750529689,2.1265811492133646
SK-HEP-1,53232,2.505434368946379,2.5203400461894523
SaOS-2,crizotinib-PLX-4032 (2-1 mol-mol),1.6526017036303646,1.7232151056006384
KU-19-19,439501,-2.2192304341921205,-2.097454448280963
SW48,11222830,1.1015320686905217,1.662489915581218
P31/FUJ,71680916,4.420716560192731,3.768241507986258
IGROV-1,73707398,0.8848064516600974,1.2346201404199644
BICR 31,176870,3.2718013899021607,3.2699501033734752
PaTu 8902,72193861,3.6637635590803384,1.97996376492259
SW48,10427712,4.323791553226545,4.15778894317228
HuP-T3,5470400,-0.4965810223867313,-0.32049595668787867
BFTC-909,3385,6.578023483143935,4.431528286905312
LS411N,5278396,4.113687735714835,3.295599800042035
WM115,carboplatin-etoposide (40-17 mol-mol),5.807621476943687,2.96649341538299
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404,0.41847899942055994
P31/FUJ,36462,-0.6599401629031103,0.1513015633515044
IA-LM,24964624,2.660053298461781,1.7437072497408785
Granta-519,4477,0.7960263088071861,0.5737226068344268
WM115,675434,4.127717546006753,4.476459155916925
SW48,2708,3.1864056833879726,4.958561601727861
P31/FUJ,11964036,1.0580497047985076,0.08625591898662124
SK-CO-1,4096211,1.2314360568652074,2.00063293355999
Granta-519,24748573,3.0643863299071668,1.2084698857141023
HCC1500,salermide-PLX-4032 (12-1 mol-mol),5.277831355050616,4.748786336258245
MDST8,6918736,-3.3936356144084066,-0.9827420688611201
IGROV-1,3062316,-2.2361832227909075,1.0538766918908529
Daudi,136227331,3.813653547789358,3.533085779742961
MDST8,3385,6.506797592159471,4.172769991840354
MOLP-8,3101542,4.39402228569031,2.4549936263780476
PaTu 8988t,19582717,5.440280671607156,4.3153159612067595
ALL-SIL,54618771,-0.3818526805852408,-0.1997513293602516
SW948,9911463,3.099005262739027,3.0992540674066515
NCI-H1568,navitoclax-pluripotin (1-1 mol-mol),-0.6791877741589081,-0.7125729722733367
HEL,4259181,-1.3539346499127438,-0.47132329071143103
Panc 02.03,702558,5.477624163348055,5.400139308169356
RCC10RGB,9911463,4.415558893727306,3.9589657776642526
P31/FUJ,2828334,6.241721397046506,5.619086199213973
BFTC-909,53232,2.9810373365160316,2.756495178246015
KU-19-19,1750826,-1.6748688873644846,-1.159901299347127
WM115,54454,3.1744679186495963,2.908018070147091
LS180,5329102,2.7428602070947266,1.997390155275126
K-562,25102847,1.0686863962440132,2.2372965412011396
NCI-H2452,51039095,3.311280338748592,2.9319353075897867
SaOS-2,107985,-4.209612864808627,-3.344803633534062
RERF-LC-MS,24180719,3.6010609924552455,3.709650081392603
P31/FUJ,9967941,3.859476565836545,3.13302362964804
ALL-SIL,19582717,3.9660864037028793,2.914128331693263
BICR 31,448949,3.395825088667814,2.0818861570656413
IGROV-1,9926054,1.8111808945519428,2.061281477065468
MOLM-13,44632017,0.3571286974750209,0.7662044584852843
RKO,984333,1.1849980625737155,0.49662065821170365
BICR 31,tretinoin-carboplatin (2-1 mol-mol),5.271330190091957,5.040895735275458
LS180,5311281,2.3621140012684014,2.3717976440421014
IGROV-1,5328940,0.347812751869877,1.7834206777630226
SU-DHL-1,126941,-4.504729002827146,-2.8585961609380366
LS180,49850262,4.041689005821524,3.4794674554895897
RKO,selumetinib-GDC-0941 (4-1 mol-mol),1.3988498652301435,1.4579898606400243
SW48,10113978,2.97157913395206,3.3345284495447465
COR-L95,227681,2.232633220711044,3.0474024536703364
P31/FUJ,carboplatin-etoposide (40-17 mol-mol),0.2579285765316561,0.6547320408100668
SW1271,65064,3.2018268639765908,4.559292210247718
Daudi,2733487,3.89488184101632,5.398795674608762
MDST8,4096211,1.945430248625456,2.1567820791810535
MOLM-13,56963564,-0.6687647359934185,-0.3818660523181601
HEL,navitoclax-birinapant (1-1 mol-mol),-0.6071790485634636,-0.21858270431936677
Daudi,216468,0.1519487612341026,0.9456461496731323
COR-L105,11494412,3.277457630260471,2.425343899161493
BICR 31,31703,-0.4867862372580436,-0.517646233391419
P31/FUJ,49793307,-4.015617000908982,-4.226306502498959
ALL-SIL,6450551,-1.4599471288533186,1.063219775344851
LS411N,selumetinib-JQ-1 (4-1 mol-mol),-0.8055713738039206,0.33897009514046433
SW1271,36462,1.4389686814792042,2.172678452125282
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251,1.6112591376227328
SW1271,17755052,4.188603356762487,2.0277748389639685
HARA [Human squamous cell lung carcinoma],9444,4.21141613858085,4.3358518222300475
Granta-519,9967941,4.009641048767512,3.0059622148905696
HCC1500,25105715,3.368057340132644,3.483556736600205
Daudi,ISOX-bortezomib (250-1 mol-mol),-0.1612683603405773,0.14123067168540696
HEL,2858523,2.985624119180162,2.58658834130941
SaOS-2,3543504,4.845259948636094,4.460542914942891
HEL,71466578,3.2881122758034413,2.7457069277808857
MOLM-13,44185566,-0.1979234147827578,1.5457229522833822
RKO,46215462,1.869666408515056,1.2820117909043742
PaTu 8988t,16720766,0.7633491404380248,0.891726915471143
MDST8,17755052,0.7758841708349149,2.0400492573270883
SW948,doxorubicin-navitoclax (2-1 mol-mol),-0.3830277458226139,-0.5843819924552585
Granta-519,16741245,4.459375532286075,3.40169657692234
LCLC-97TM1,36462,0.8347023875377979,1.6791246735776386
HEL,24785538,4.025400084811953,-0.002867730482769968
SU-DHL-1,piperlongumine-MST-312 (1-1 mol-mol),0.8193437205412945,1.6446637775912185
SK-CO-1,54613361,-1.1953747905350511,0.18414715014005614
HCC1500,selumetinib-GDC-0941 (4-1 mol-mol),3.80127350150034,1.338386588663719
Daudi,25105715,2.455657378323054,3.1160884979123544
SK-CO-1,3038522,3.74499401693701,3.3352019794966594
LS411N,11625818,4.428513603720294,3.6365793545442933
SW948,445643,4.022773961540602,3.9703106498547203
COR-L105,135984461,4.336047626093702,4.08201633513121
NCI-H1568,71466578,4.264938806787537,4.608426005873567
HuP-T3,11364421,1.6783982807514195,-1.0064789617044851
Daudi,49867926,3.659415180241599,3.4230486330429795
HARA [Human squamous cell lung carcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.7875744304636512,-0.7479337969610664
SW948,11404337,1.0073661261070797,-0.48316124326920595
SU-DHL-6,5278396,3.0928075812605123,2.9853708187398
SW48,JQ-1-vorinostat (2-1 mol-mol),0.3555995079043024,1.0140256591546326
PaTu 8988t,24964624,3.238300662516523,2.6991753574908
Granta-519,135411,0.2246473977843227,-0.15844579436348677
LS411N,3025986,-2.0648766502168843,-1.1049434233103885
HEL,BRD-K58730230,4.651487565209977,3.467180392617522
K-562,148124,-7.41486725283878,-3.684774628349479
K-562,10302451,0.1323934402367818,2.482304475127133
K-562,1641662,2.591871767435193,3.0578201098931994
ML-1 [Human thyroid carcinoma],54618164,4.279062995535924,4.2054156698123935
Daudi,156422,2.1936092532092295,2.919878009371039
BFTC-909,44491742,4.0640318167931255,4.2950165752709815
PaTu 8988t,doxorubicin-navitoclax (2-1 mol-mol),-0.3664110079346409,-1.0653755842734123
MOLP-8,135398744,7.476327693514706,5.144987240827456
IGROV-1,54618164,4.2184521751950115,4.1710271863866115
HCC1500,selumetinib-vorinostat (8-1 mol-mol),2.561295167839282,2.4534650055527463
PaTu 8988t,4259181,-1.3402011211504403,0.010164957529105742
RCC10RGB,selumetinib-navitoclax (8-1 mol-mol),2.731385168920209,2.47176422950343
KU-19-19,31703,-0.69897788572983,-0.70053440553751
SK-HEP-1,5460769,6.10306620405049,2.547700718807808
K-562,11404337,1.5978316825317844,-1.1095272963482048
NCI-H2452,9840324,6.282829349463256,5.920984748870353
HEL,JQ-1-carboplatin (1-1 mol-mol),-0.4400207777249079,-0.17698293819530864
KU-19-19,11214940,3.3843502872937106,2.1183956072937633
MOLM-13,3815108,3.4784839929418343,2.166278919423226
IGROV-1,16065773,3.3717508464278585,2.5637831442992995
Daudi,6252,0.2227136884944618,-2.0552313693977293
SK-OV-3,1641662,4.382504296977698,3.662007260667388
MOLP-8,11238147,1.6731293567937424,2.2042051244329106
K-562,44462760,3.6560426907742896,3.368614981025152
RKO,9911463,3.963116579454927,3.3454223553710225
KU-19-19,387447,-3.0100561484626738,-4.07086709746503
LS180,219104,3.901138037988577,3.8321778433810603
SaOS-2,selumetinib-UNC0638 (4-1 mol-mol),4.750362941139615,3.2410663638372195
LS180,11609586,3.254650235567635,2.8710383678495037
RKO,3025944,4.391654014934833,4.014375516167112
ML-1 [Human thyroid carcinoma],16720766,0.621696324806819,0.8077786616076716
SW1573,11640390,3.5338327701281176,3.592662201764364
ML-1 [Human thyroid carcinoma],6917907,-7.443362541349426,-3.2413044434060705
NCI-H2452,navitoclax-pluripotin (1-1 mol-mol),-1.4411429928004444,-0.7611213085088779
LCLC-97TM1,2708,5.63991197078878,4.364634107059113
HuP-T3,262093,3.018266583248783,3.056708714656591
PaTu 8902,3503,3.0706473844938422,2.3874809022598513
HCC15,6918328,-0.0257689511183662,0.29579363077255894
COR-L105,24797083,1.0360227961267732,1.3981868562102726
P31/FUJ,9887053,2.876589254443052,2.42768427706512
WM115,446155,1.535185995815247,2.6025127066271834
COR-L105,613753,3.1601590793812,3.282697057794706
LCLC-97TM1,tanespimycin-bortezomib (250-1 mol-mol),-0.5611743356408021,-0.7948958898986601
IGROV-1,10385095,1.0670946713416192,1.232362619805574
NCI-H2452,6252,4.582294901932163,1.2922775674399938
MOLP-8,72193861,1.011292170776,0.34421134363331
LS411N,JQ-1-vorinostat (2-1 mol-mol),0.7731890132640523,0.04129740508402878
IGROV-1,26596,2.910298792762654,-0.9225547287840016
RERF-LC-MS,11640390,2.8932892314821927,3.884182901626202
SW1573,selumetinib-piperlongumine (8-1 mol-mol),4.823355107887568,3.189338167833924
ML-1 [Human thyroid carcinoma],9444,3.622178437751676,4.255380260810984
MOLP-8,carboplatin-etoposide (40-17 mol-mol),0.4522049028656168,0.9066697766893017
RKO,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7729264296394276,3.4049955336557813
SK-OV-3,168313047,2.892407732266751,2.5038186116189523
Daudi,9926054,1.7776420054693636,1.5794442545689464
COR-L105,2749,1.1758378373045044,2.2333379606520354
SK-CO-1,6918837,-2.3986996753086305,-2.6956453411540626
IGROV-1,12003241,-2.0122972114546904,-0.929001257652538
HCC15,9866186,0.9811967871114916,0.7912635236386898
MOLP-8,selumetinib-decitabine (4-1 mol-mol),-1.0628389373049278,0.6446854989003457
WM115,9887053,3.7520086754622657,4.287624732313083
COR-L105,9933475,1.7212192557919994,2.032689596579285
MDST8,9967941,4.864965348465847,3.6795396492881145
KU-19-19,5566,3.5813761109507154,3.107086095354073
MDST8,navitoclax-pluripotin (1-1 mol-mol),-0.7687489339577367,-0.7594570147036841
ALL-SIL,168313016,2.945013463521221,3.996979251679473
RKN,JQ-1-vorinostat (2-1 mol-mol),1.810431860868636,1.1613525209056932
LCLC-97TM1,216239,3.3274661005628636,1.9448741738284172
UACC-812,9935249,3.1921366544842,2.7163042514638875
KU-19-19,46398810,3.059016393641159,2.827935719580306
HCC15,selumetinib-vorinostat (8-1 mol-mol),1.4639379045779866,2.6140988711291397
Daudi,24901704,1.6931015271472445,2.1507626736005845
UACC-812,navitoclax-sorafenib (1-1 mol-mol),2.1784288698451473,1.6988694164628626
SU-DHL-1,135440466,0.4118800450630493,1.7301500092767381
IGROV-1,5311,1.0068816368200209,1.465700166332723
RERF-LC-MS,5329102,2.8374518121885637,1.9907111861756408
LS180,selumetinib-UNC0638 (4-1 mol-mol),1.869156071766359,2.5013418132862655
Granta-519,10302451,3.667767303482806,2.7314191136062624
HCC1500,alisertib-navitoclax (2-1 mol-mol),-1.6435253227103,0.4887862952832652
NCI-H1568,4096211,1.8643847121139272,2.0914918311121933
ML-1 [Human thyroid carcinoma],11612883,2.523942692100722,2.9680910655159307
LS180,44487872,4.564049669792266,4.3991972887339275
ALL-SIL,JQ-1-vorinostat (2-1 mol-mol),0.0034804556832889,-0.343120706475264
SW948,135411,1.551236240082995,0.4790659976339592
PaTu 8988t,216345,4.148994433618168,4.078233317294607
LS180,9935249,3.57280690269837,3.052262551378326
UACC-812,46926350,-4.425607795744521,-4.066443006624329
K-562,46224516,3.0237589268452396,2.261374869264234
SW948,16013152,4.211275799279611,3.3229962634503636
BICR 22,10074640,3.373223414806136,3.015246024684527
Granta-519,54618164,3.794628352719798,3.531737457885287
K-562,49793307,-5.346924391172112,-3.9931000470337734
IGROV-1,54678924,1.4704159748793169,1.9607782188634042
COR-L105,selumetinib-tretinoin (2-1 mol-mol),2.682328410307197,3.784858767983973
IA-LM,24785538,2.950939703376364,0.2266700197525249
HARA [Human squamous cell lung carcinoma],5278396,3.775794457804869,3.742041810324645
ALL-SIL,262093,0.6753795238054565,1.5594419859596258
SK-HEP-1,49793307,-1.6219654789172164,-2.12863780081714
UACC-812,9915743,-6.921665690083625,-0.07157168289413665
MOLP-8,24964624,0.5129160642166024,1.5312780295024624
SW48,16725315,4.089936042929296,4.206445616601275
P31/FUJ,25102847,1.6695774391929423,1.8179569085593121
MOLM-13,216468,0.0785275755512733,0.9747683569706973
HCC1500,135421197,1.2704457907642457,2.006097196006808
COR-L95,445643,4.015431140089913,3.6205283376316983
Granta-519,9826308,-1.279512827450026,-0.5592067043170823
HARA [Human squamous cell lung carcinoma],9549297,1.8946305959472185,2.610110302999439
HCC15,44589607,3.4730057914725005,3.1193199574535115
SK-CO-1,73707398,0.894037962240185,1.4951060920748223
RERF-LC-MS,46191454,1.934559197398404,1.9399588663391802
PaTu 8902,44491742,4.263402068757711,4.318443930466591
PaTu 8902,53481919,4.066569856261274,3.856345032797597
HCC1500,4521392,5.662319691471263,4.452896959686904
BICR 22,11364421,-5.708558910936986,-1.138633913179422
LCLC-97TM1,6610216,4.478615539127516,4.134603521701073
BICR 22,52912189,1.443997008169696,2.4559727348602705
SW1271,11404337,-3.6050810245472382,-0.26480168345482324
IGROV-1,969516,2.460805405371151,2.959542403331381
LS411N,25062766,1.7796504921777256,1.5959706978258819
IGROV-1,11977753,-2.2284230058029433,-1.0751157377032141
SW48,JQ-1-UNC0638 (2-1 mol-mol),0.4200169651809782,1.5171320498583736
IA-LM,54618164,4.43488746250501,4.018923000902869
SU-DHL-1,135398738,3.5570959576905983,3.877136868733637
HCC1500,23725625,5.012282150953445,5.077045230983261
SW948,56973724,2.5267361451247647,1.9806520661593974
COR-L105,2742550,3.8597521863519257,4.229123859371643
HCC1500,selumetinib-navitoclax (8-1 mol-mol),0.8768646792211049,1.5014754430243549
SW948,11485656,1.7814283284456571,1.9738577579432428
LS180,56963564,-0.4927248320174067,0.23746950765430072
RKO,9866186,0.3829002704071885,0.38864435756664334
Daudi,44202524,1.1056351253600936,1.3985760044833808
NCI-H1568,11964036,0.8982081488420575,1.3959113647685633
MOLM-13,9915743,0.7456385275428815,0.36718388969764193
Panc 02.03,4788,6.040807258084593,5.724791356515318
SU-DHL-1,10410894,1.885737679840171,3.1398108847120016
WM115,3062316,1.2654694678882143,1.7658056631294161
HuP-T3,148198,-3.5090934063696153,-3.096798356205499
HCC1500,24748573,2.217224851211772,2.3943476817236866
RKN,44185566,3.394049733904779,2.635795204350266
WM115,73707371,4.316198918387243,4.907799506831375
HARA [Human squamous cell lung carcinoma],2749,1.5155233624959286,2.1429551914191127
COR-L95,119607,5.444677320305195,4.9604515943670044
SW1271,3543504,5.279434126076659,4.510479314056267
RKN,613753,3.037549827357118,3.352622271924708
MOLP-8,9933475,1.6461417731910544,1.703853991761595
SU-DHL-1,374536,2.32669265560356,1.8130429301432187
NCI-H2452,11222830,1.0864314168284432,1.8980997511530637
BICR 31,16736978,1.5520316002325725,1.8975780715663852
BFTC-909,11656518,3.71751997684089,2.2126739002485003
SW48,49793307,-4.357023521296349,-3.05759043253024
HCC15,676352,2.734399334153108,2.2641394259674614
K-562,9933475,1.5582186007451084,1.741829603285272
COR-L105,1716436,2.5827881779858797,3.148558375936867
MOLP-8,71751553,4.257415338539138,3.886195025330186
MOLP-8,11427553,-1.470461076327197,1.6454943515730092
HARA [Human squamous cell lung carcinoma],5329102,2.385019760073336,2.1156857081219376
HCC1500,65064,3.4319990575629484,4.8594135502926115
BICR 22,54678924,2.835542995017498,2.236854673728795
SaOS-2,52947716,3.1327874038156636,0.2676363896421081
RERF-LC-MS,327653,4.17889189356682,3.337927628971641
RERF-LC-MS,216468,3.2358353560937267,3.5859334091114814
LS180,637858,2.1359320280537704,2.0450620358352185
ALL-SIL,navitoclax-PLX-4032 (1-1 mol-mol),-1.20714893159784,-0.7744536183715631
IGROV-1,erlotinib-PLX-4032 (2-1 mol-mol),3.0086678924768404,2.832251584673532
HCC15,25154868,4.699010678354358,4.465089598354386
BFTC-909,1716436,3.115342072857748,3.1534555130195354
WM115,208908,3.0871953707393662,2.029246716594958
COR-L95,5287969,-1.974656124599848,-2.135552250156981
MOLP-8,9907093,3.7363465424365567,3.355168360579331
RCC10RGB,5738263,4.593697299478501,3.6156892257312645
SU-DHL-1,446155,1.7989638936827528,2.233921584044687
Granta-519,51037431,4.032962229357369,2.945001692999073
BFTC-909,24771867,4.730369684143592,2.634109248758427
SW1271,9926054,1.9992649208496855,2.0409471238959953
IA-LM,46843906,4.034671652936036,2.044020003246741
PaTu 8902,3634881,3.736044150449037,3.2161604893118905
HARA [Human squamous cell lung carcinoma],5311281,2.4258881489706217,2.5021403582936648
COR-L105,89928392,1.7234999745886912,1.6579359729090961
Panc 02.03,6917907,-5.450554920776264,-4.638197244563574
ALL-SIL,216345,2.7239648031314108,3.0388731290688415
Granta-519,5311281,1.2060114833285496,1.9953482987407938
RKN,25150857,2.829513348324473,2.560460974772495
RERF-LC-MS,702558,6.005509402748126,5.475333590938352
Granta-519,44202524,0.8355806814666445,1.209954860088461
IGROV-1,65064,4.920352624378345,4.807518011418586
HCC15,82146,4.430619158397189,4.0036024235823495
IGROV-1,135984461,4.285945029851472,3.8689991336322858
SW1573,tretinoin-navitoclax (4-1 mol-mol),3.744579099862024,2.9918379074095713
RKN,25183872,-1.1518449365963386,-0.7573879617477352
SW1271,6450551,2.703162256598128,2.572569934610237
COR-L95,SNX-2112-bortezomib (250-1 mol-mol),-1.5926355912839212,-1.7620974483780438
RKN,656346,1.677354805367284,0.9099167718497935
MOLP-8,3503,1.781914224283778,2.1346438256910916
COR-L105,2828334,6.248355208389406,6.191537348088758
BFTC-909,docetaxel-tanespimycin (2-1 mol-mol),0.450361572300305,-3.3111371566262493
MOLP-8,135875424,3.0291075959050233,3.2794016287238805
HCC15,24748573,2.004363812639911,2.617791862953025
RERF-LC-MS,selumetinib-MK-2206 (8-1 mol-mol),2.1861340415515076,2.4542983896887134
HARA [Human squamous cell lung carcinoma],89928392,1.691456490518517,1.752166978761541
IGROV-1,56649450,0.515518984822669,3.2127099360498312
KU-19-19,9444,4.28834999434395,4.261513969685504
Granta-519,3552672,2.198733357723822,2.184890793719906
SW948,66577038,2.9537896679300655,2.8019988964149753
NCI-H2452,119607,5.591396796149955,5.531171808715441
RKN,selumetinib-tretinoin (2-1 mol-mol),7.09288474093864,3.5090708982697634
HuP-T3,2729026,2.9922624267509317,2.82589049060755
SK-HEP-1,71466578,6.341226391578653,4.753526948153926
Daudi,24785538,-0.3082535888445589,0.16585942557841643
IGROV-1,5280436,3.2616766817665086,3.3277931640803122
RERF-LC-MS,7251185,3.4578262740878976,2.705605555395664
HCC15,156414,2.365134958139565,1.5914091618099082
BICR 22,piperlongumine-MST-312 (1-1 mol-mol),1.342404351806,1.8209546856923802
BICR 31,10127622,3.719060323270891,3.629015358508876
SaOS-2,15547703,3.066966974063678,3.285151870728454
Daudi,decitabine-carboplatin (1-1 mol-mol),0.1639659484946293,0.07948590303451873
HCC15,alisertib-navitoclax (2-1 mol-mol),-2.6533611611755177,0.9052182403434793
SU-DHL-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.028973070586865,3.4394873610823793
SU-DHL-1,3689413,-2.511818154735677,-0.05769984827216604
COR-L105,56946209,-4.798718381888378,-3.705121974504999
IGROV-1,5978,-1.5618214380165825,-1.8390296877724637
BFTC-909,11222830,1.7098036316197358,1.6482118319134513
IGROV-1,216239,2.21703825410177,2.520195898682911
MDST8,135440466,3.3221976295713342,2.204150115248684
P31/FUJ,44632017,0.6534437162154956,0.4864105348318541
IGROV-1,219104,3.803083685328391,3.658673378772653
SaOS-2,637858,1.716758511666406,2.0521593465111385
WM115,crizotinib-PLX-4032 (2-1 mol-mol),-0.0688201401017855,1.5070344791832577
COR-L95,24753719,4.203119149122614,4.038344784198598
HCC1500,3025944,3.928139296588046,4.348796852951952
Panc 02.03,56946209,-4.513446270471167,-4.046879905521061
HuP-T3,25126798,3.926602492728053,3.7313323557366065
PaTu 8988t,3011155,4.341218756124128,4.195764488141433
SW48,20959075,-3.67297247887529,-2.5612382130471327
HCC1500,JQ-1-navitoclax (2-1 mol-mol),-0.2605650300766051,0.5726577124976725
BICR 22,44486219,3.936553836391045,4.346754544575643
RERF-LC-MS,6918736,-1.8242544668906209,-1.5965227297904678
NCI-H2452,selumetinib-PLX-4032 (8-1 mol-mol),3.036066268275686,3.708879182638616
RKO,44137675,4.282234128328841,2.8192027505842474
IA-LM,11626560,2.8197095065502515,1.1715523487610575
SW948,2746,1.2183078272507333,2.388890713445764
NCI-H1568,168313200,3.516432771095034,3.0985718716215986
IA-LM,262093,2.9896562434219627,2.3855062488095378
MOLP-8,4261,-0.435327551985223,0.209706947117671
HEL,2708,3.2519957529556716,3.2182830845222
BICR 31,selumetinib-tretinoin (2-1 mol-mol),0.9632535907950592,3.630672194811714
LCLC-97TM1,erlotinib-PLX-4032 (2-1 mol-mol),2.856806725221915,2.8669770929431366
MOLM-13,51039095,-0.7255439577713276,1.9579530567282148
IGROV-1,426756,6.142776526139055,4.3194317941047125
NCI-H2452,25154868,4.866167054223791,4.656017262471964
PaTu 8902,4705,3.6244040622068256,2.974207555288253
ML-1 [Human thyroid carcinoma],25105715,3.821272786179671,3.499917928235728
Daudi,135421197,0.2989842149032058,1.4008870998554377
IGROV-1,10427712,3.944243047938238,4.344426455563689
COR-L95,24978538,-1.547703636473998,0.042204924352563726
SaOS-2,52912189,2.036463757447864,2.5147525672756093
PaTu 8902,452548,0.9739796251952438,0.41984626355997084
IGROV-1,52912189,2.3966568144845666,2.586996607252429
SU-DHL-1,387447,-5.562438756444553,-4.859289492565162
HCC15,135398516,2.1695814103654696,2.113774028930785
SK-CO-1,6610216,4.838209270425191,4.187632252624034
MOLM-13,5351362,0.6925875902125201,0.9475105473809349
HCC15,46191454,1.8626809755345697,1.963729760919383
SW948,9825149,1.8114941973110277,1.908506032237203
Daudi,54639665,4.383406013207389,3.172201072153621
HEL,2828334,6.1216048061751795,5.741154909850695
BICR 22,71466445,3.433479198461154,3.831770972959228
ALL-SIL,9826308,-0.8056632694679019,-0.4740073721101966
NCI-H2452,57519531,1.3990882913061125,2.8687551687404715
BICR 22,54613361,0.4978505675466737,0.5780114342755039
SK-OV-3,135440466,2.5162908691834405,2.4120477992828118
SW48,JQ-1-MK-0752 (1-1 mol-mol),-0.7749163681319219,1.6573932426353124
SW48,6852167,2.2630322871527913,2.919272664528194
RKO,11404337,-0.3534280477619294,-0.680298443516076
ALL-SIL,5291,-1.9713425457655045,2.6455580477941028
K-562,salermide-PLX-4032 (12-1 mol-mol),5.074335009677914,4.652220468260815
IGROV-1,24771867,1.9944882740161016,2.247032045172989
MOLM-13,46224516,1.6904951862054391,1.68581808356471
SW48,119607,5.387394946551996,4.974723124880979
Panc 02.03,ISOX-bortezomib (250-1 mol-mol),1.22897027092613,0.7015717880257217
BICR 22,49836020,2.6142262300183305,2.1169372098125017
BICR 22,16720766,0.4876582946813295,0.8801928659857442
HARA [Human squamous cell lung carcinoma],159324,3.9851922367796937,3.2231900713939035
SK-CO-1,123631,1.846760097113305,2.3406469897026407
BFTC-909,36462,4.374665451212183,2.3711829294420967
LS180,vorinostat-carboplatin (1-1 mol-mol),3.0396864380779327,3.1934360336223637
RKO,5328940,1.7974237645790871,1.194559122458812
RCC10RGB,ISOX-bortezomib (250-1 mol-mol),1.8255695347909304,0.7844205641325306
ALL-SIL,5281321,-2.461016259028612,-2.644404355018297
P31/FUJ,568763,-0.9310646254211032,-0.1905867797816124
HuP-T3,selumetinib-UNC0638 (4-1 mol-mol),3.11768337000848,3.174590844883746
HCC15,crizotinib-PLX-4032 (2-1 mol-mol),0.980759868979001,1.9187820624588776
WM115,3081361,1.7542351340434374,2.3233186348582096
Panc 02.03,676352,3.0262590525496895,2.129875693744536
Panc 02.03,44462760,5.147948611944762,4.2727152483217585
COR-L95,11228183,-1.8408108773608771,1.5786477146226647
WM115,56973724,4.208743527700851,3.1800989896611753
KU-19-19,vorinostat-carboplatin (1-1 mol-mol),2.5196906513135913,3.3289934838495636
HEL,65628,4.10911337005638,3.0629608515463196
Daudi,11612883,1.1925703345745973,1.859877647111322
RCC10RGB,24856436,4.070420512574028,0.8533326279302451
COR-L105,46199207,3.6604959991625825,3.36223071413068
Granta-519,25195348,3.9328442274761217,2.2857326673808287
NCI-H1568,1750826,-3.116085482779225,-0.817533962990567
IA-LM,12001922,1.9531449792239188,1.6969404750314359
IGROV-1,19582717,6.764352444432722,4.225380737471511
HCC15,10113978,2.260363506948615,3.3136716818373366
SK-HEP-1,10074640,3.7857764861964935,3.2429242061772596
PaTu 8988t,6918328,1.905296387062238,0.04057024057559275
HuP-T3,24785538,1.540895569713237,1.7432051617926538
BICR 31,5281321,1.1837918014475457,-1.1087171838155636
MOLM-13,216345,0.0865178974102724,2.757604723715324
HCC15,448949,2.8674184346568414,2.215422592285563
K-562,44566777,1.311822236929868,-0.03891678867644257
HEL,452548,-1.769607447996444,-2.480365264454383
SU-DHL-1,11507802,0.9378608618407872,1.5466394753268842
SU-DHL-6,2113511,5.89050983447184,4.4610427369121375
SaOS-2,54613361,0.0035364978270003,0.10607714208009239
SaOS-2,24748573,1.7294478830476196,2.115759640814032
HARA [Human squamous cell lung carcinoma],9868037,3.8920643368101713,3.517418067918494
HuP-T3,49766530,1.2218451996302029,-0.33094689503797314
HEL,262093,2.3252232523203995,1.818985535955185
SaOS-2,tretinoin-navitoclax (4-1 mol-mol),2.244909484198112,2.393075935903532
MOLP-8,675434,3.835070621627746,4.114640545153992
RKN,16725315,3.256745916563384,4.099378283890956
RERF-LC-MS,5746,1.1068525081764873,1.515593962777233
SaOS-2,11964036,0.5086023979470407,1.2350706178831745
COR-L105,selumetinib-navitoclax (8-1 mol-mol),1.996235021345007,2.214389987975383
LCLC-97TM1,126941,-2.218385477362075,-2.510513956107027
HCC15,54618771,1.6567762934530044,1.3113017290863613
RKO,2113511,4.623772297498578,5.223745189710214
RKN,9929138,7.419607622812729,5.367668447385554
HCC1500,5460769,5.1304942195737935,2.470686682726498
COR-L95,31703,-3.0462560513884203,-1.5795288687856435
HCC1500,46224516,1.0534131743048871,2.507460346471429
Panc 02.03,5328940,2.397017671249583,1.7199212046368544
LCLC-97TM1,11404337,-1.4043223473519348,-0.45445041991846785
HCC1500,42642645,1.451455976812008,1.1366044138805576
IGROV-1,51037431,5.669320749085174,3.0676948197966
SW1573,107970,2.0608182724975266,2.546901059104839
SW948,46191454,4.338482378206047,1.1161508462442697
Granta-519,11455910,0.302072347623865,0.27187015174592144
COR-L105,2113511,6.080993735084838,5.7715200783368115
SW948,ISOX-bortezomib (250-1 mol-mol),0.2235113953706366,0.698005926557277
IGROV-1,448949,2.098499309472767,1.908937404324692
NCI-H1568,107970,1.680617581032042,2.3870420533992243
SK-OV-3,24797083,1.6169926593639932,1.445786746343512
ML-1 [Human thyroid carcinoma],vorinostat-navitoclax (4-1 mol-mol),0.5480043604957033,1.2838913069746822
SW948,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.798210383310514,3.179397082446629
IGROV-1,4259181,0.1937358171291443,0.2292410726093587
LS180,135875424,4.384751932486372,3.811138179140674
UACC-812,54765302,2.961863639252158,3.9735531628774408
SW1271,49867926,6.0238397416149345,4.4026641453201645
SU-DHL-1,3025944,3.851371371046294,3.883413796763689
SW48,9967941,4.423983829284398,3.8120719747365657
SW1573,11609586,3.686627979451031,3.2092461710806117
Panc 02.03,16065773,3.1661848504472023,2.563751739614867
RCC10RGB,135421197,4.393109316582631,2.432052596990515
IGROV-1,24785538,1.106246320450551,1.7794497909357887
HuP-T3,5278396,4.193223405360703,3.7132003658453128
IA-LM,24901704,3.940918836251392,2.7291424459007327
SK-HEP-1,11214940,1.8009666315936252,2.088048579306209
K-562,11364421,-5.792707438494169,-4.091133480170788
LS411N,3384730,4.573317632228089,2.0984813111972573
LCLC-97TM1,568763,-0.0784771886342085,0.36433467006296616
HCC1500,9936388,-2.5304598124234365,-0.8689175137323786
HCC15,5311,0.7792586953300233,1.563604825019541
SU-DHL-1,54686904,3.5039759810509676,2.7680346858700404
PaTu 8988t,11626560,2.010870886496287,2.0968841917742793
HuP-T3,2749,2.009482044490881,2.1051650571720644
RKO,60750,-2.2331483998906654,-2.6695967040459125
HCC15,5287620,-1.6098111318920385,-2.334768192569939
HEL,654092,-1.523294365181231,-0.9320389748224757
SK-HEP-1,71304818,1.6350171624170464,2.5775438039214187
SU-DHL-1,448949,1.2808073887625644,1.7817767991700055
K-562,5281321,0.5422415972342122,-2.094952169490416
NCI-H1568,selumetinib-JQ-1 (4-1 mol-mol),2.397330498930178,2.0428374612714095
LCLC-97TM1,5351362,1.316382729979947,1.4628157620509854
MOLP-8,5460769,1.8843864880791628,2.0680018227252743
SaOS-2,56963564,-0.1924881408966614,0.4759020364290575
RKN,446155,3.7628691651204234,2.426016320227161
HEL,doxorubicin-navitoclax (2-1 mol-mol),-1.6523771973343595,-2.538266931358608
NCI-H1568,16038120,0.8714631615296456,1.2812935844262616
Daudi,25102847,1.3031740879242997,1.9256692704185718
LS411N,25154868,4.929077040033465,4.329791204884385
SW1573,crizotinib-PLX-4032 (2-1 mol-mol),2.8041804107820796,2.044271896746055
ML-1 [Human thyroid carcinoma],54649381,4.324070376451948,3.943906835100778
LS411N,9915743,2.8294092926119028,0.5190613781782741
Panc 02.03,BRD-K55473186,4.513191364064351,4.116933674311181
SW1271,JQ-1-vorinostat (2-1 mol-mol),1.5175672893366323,1.1734686975167883
SK-HEP-1,selumetinib-navitoclax (8-1 mol-mol),3.029292695644022,2.043142317803783
SU-DHL-6,4917,2.9501994456287792,2.7443750759359244
Daudi,16741245,3.410771008602035,3.6030154288294227
MOLP-8,3062316,1.3489297980566397,0.9552258418865328
NCI-H2452,selumetinib-UNC0638 (4-1 mol-mol),4.804967854809725,3.324893747056322
RERF-LC-MS,25183872,-0.4545636564638026,-0.5594333499858896
HEL,JQ-1-UNC0638 (2-1 mol-mol),-0.0647820501822815,-0.2715188065985792
MOLP-8,60700,-2.8082015295780858,-1.368738060156518
NCI-H2452,637858,1.8545349692582156,2.235694691687436
LCLC-97TM1,11626560,0.938916298027116,1.4414191415583295
HuP-T3,136227924,2.888640375816574,3.1740180839308643
IA-LM,5284329,5.1954673618886655,2.482273917252723
RKO,104842,-2.5196749638548,-3.3276650013552413
SaOS-2,11494412,0.4895123820960489,1.584210086918381
IA-LM,9926054,3.212619063516659,1.852764285188892
MOLM-13,doxorubicin-navitoclax (2-1 mol-mol),-5.382475006616194,-2.407987341255174
MDST8,23635314,-2.200660522590374,-0.7413561975664414
SaOS-2,alisertib-navitoclax (2-1 mol-mol),-0.6198148244275179,-0.022360118401294975
RKN,4261,1.529955054772996,1.887602166180769
SW48,11396600,3.829401994456863,3.6004573982593255
LS411N,JQ-1-navitoclax (2-1 mol-mol),0.3997266798331875,0.7924757066755882
HCC1500,16659841,5.303826701580757,3.7896765455298382
HARA [Human squamous cell lung carcinoma],24901704,2.881552784728447,3.3461451965126754
BICR 31,JQ-1-vorinostat (2-1 mol-mol),1.378421076759701,1.1837471853856905
MOLP-8,10231331,1.2198029486879254,1.1419105416493387
COR-L95,16725315,5.004914745056217,3.9171548020277407
HEL,16115403,-4.756245139541522,-4.615190203785909
WM115,11717001,-1.1241138002933555,3.7114381359505133
SaOS-2,11626560,1.1465195781021866,1.8580610276039105
BFTC-909,9907093,4.635414583134371,4.290411731957343
HCC1500,66577038,2.9555971550997935,2.88513762877876
IA-LM,285033,0.5092837727748464,-1.5967912913652145
IA-LM,4917,4.737499942891754,2.8703193966562592
BICR 22,44632017,0.9263322393180023,1.3663841624558026
RKN,navitoclax-pluripotin (1-1 mol-mol),0.1191364332542713,-1.0895264937307088
HARA [Human squamous cell lung carcinoma],docetaxel-tanespimycin (2-1 mol-mol),-6.628155731353656,-3.209880476326343
SW1573,89928392,2.032641459256584,1.739145063322592
MOLP-8,119607,5.472499710124238,4.527700575399453
COR-L105,46398810,3.2483226376094194,2.729201072709156
HCC15,decitabine-navitoclax (2-1 mol-mol),0.0974547037094189,2.6652704505483715
HCC1500,135999136,4.086589117257826,3.5705840269931572
WM115,11497983,4.51521868458229,4.177974334328609
SK-HEP-1,46926350,-4.110479335135347,-3.9486613689419308
RKO,322968,3.8471310775605216,2.5786953004300113
LS180,25262965,-0.0916364033105869,-1.927363116380644
HCC1500,246676,4.424448695399937,3.933582406017759
COR-L105,104842,-0.9230389281504464,-1.8494657452650876
SK-HEP-1,navitoclax-piperlongumine (1-1 mol-mol),1.24584260367843,2.1213481853612466
SK-CO-1,6610355,4.767157937449789,4.432301043605101
IGROV-1,676352,2.310492141650647,2.185316034237696
SW48,262093,2.726859331273406,2.8538290828799955
HCC15,55508,3.481008151195261,3.5120870151697523
HCC1500,2126,3.801078614960916,4.749716825201193
PaTu 8988t,24951314,3.0808050806085188,1.283691379326988
RKN,11455910,3.815213247766997,1.1089544344024518
SW1573,3062316,2.075650426956439,1.3383209864000625
SK-HEP-1,5287620,-1.0463187584720948,-2.1593756332241223
HARA [Human squamous cell lung carcinoma],25102847,2.0322740825170555,2.567018300761668
MOLP-8,24779724,4.381900106399647,3.5082541003814414
Panc 02.03,107985,-4.238430695688479,-3.5982287160166124
IA-LM,322968,2.7570489193637018,2.745586247458104
K-562,448949,1.070656561881704,1.4921913325550435
LS180,54649381,3.823257143411622,3.6903343767018777
IGROV-1,5281321,-1.4962463697398798,-1.1570921533588192
NCI-H1568,42642645,1.4281976900349445,0.8672128086072648
SK-HEP-1,selumetinib-GDC-0941 (4-1 mol-mol),2.75141710768083,1.8484866972070262
K-562,44185566,1.8580861510177096,1.8825830366582965
SW48,637858,1.3097623359774897,2.014445896053188
SK-HEP-1,613753,3.3794099216210203,3.3319018709725525
ML-1 [Human thyroid carcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.412069402111766,3.2839732161272406
COR-L105,11234052,4.539846823478364,4.311075212842577
IGROV-1,72193861,2.0623829231433293,1.5194263716725789
SW1271,3503,3.0280256153278606,2.2530723115541296
NCI-H1568,57330099,4.373464200171548,4.3106265721844075
MOLM-13,1750826,-3.2515027143289728,-2.9190245600395825
SW1271,11222830,1.3106603955640226,1.6981960606355502
RERF-LC-MS,445091,4.218142840499499,4.477314236486384
BICR 31,3062316,-1.406162609577698,0.48282016885071444
HEL,25126798,0.3968700607761156,3.1786827844414596
COR-L95,5738263,2.419040765220329,2.9572692995894703
SK-CO-1,36462,0.7476665664464673,2.323892477524708
WM115,49766530,-0.6421157759153451,-0.14027310120929376
SW1271,ISOX-bortezomib (250-1 mol-mol),1.0601498198738095,0.44756228809612625
BFTC-909,46901937,4.445112058189045,3.228677993600337
SW1271,136227331,4.376300443457216,4.214260716348074
COR-L95,25262965,1.4716002732306153,-1.648017921571433
COR-L105,5281672,4.46136628199001,4.625130648348183
WM115,73707398,1.178086440828875,1.3884840446735698
Granta-519,6852167,2.2648312753409887,1.341189399525782
RERF-LC-MS,46174525,5.020740506928848,4.5649296130829216
SW48,navitoclax-PLX-4032 (1-1 mol-mol),2.4409762203438117,2.086029345599102
RCC10RGB,44202524,4.922768729279552,3.0049183812096625
BFTC-909,BRD-K27188169,5.152610673434624,4.007176150625635
ML-1 [Human thyroid carcinoma],44607530,1.6401891623478355,2.0357706641886253
IA-LM,439501,-4.16745845294267,-2.12644751749152
RKN,25262965,-0.5506090189051945,-1.4069826374998164
SW48,3385,1.919145280274203,3.60757253658746
RERF-LC-MS,12001922,2.43602915295576,1.9885851464593713
IGROV-1,568763,0.665047061839467,0.5048329413261234
P31/FUJ,10385095,1.5135865779060806,0.7878756437706673
HuP-T3,12001922,2.3367896101102907,2.0381312432359984
HCC1500,1641662,3.3816027924522487,3.640369806376893
HARA [Human squamous cell lung carcinoma],25195348,4.01900560130828,3.3671388760952516
P31/FUJ,1242560,3.8275456086274127,3.022427546966244
NCI-H1568,57519531,1.3161148530355309,2.6019283349587163
SW1271,42611257,4.308869978455437,3.395504259952643
Daudi,10184653,1.026270071695755,0.6620852445522726
K-562,2858523,2.745068324935018,2.897944160436189
IA-LM,crizotinib-PLX-4032 (2-1 mol-mol),2.5646441197957555,1.2525075741280514
HARA [Human squamous cell lung carcinoma],11152667,-1.8717886502550631,-0.2354767247635756
BICR 22,12001922,2.2523981699696165,1.9321802260967873
KU-19-19,tanespimycin-bortezomib (250-1 mol-mol),0.8089732350000719,-0.5945180902724784
UACC-812,5978,-2.554443854158195,-1.4462627196094038
MOLP-8,753704,3.0200894206550877,4.084970481607682
ALL-SIL,5394,4.4345454375843625,3.364637001687963
RCC10RGB,navitoclax-PLX-4032 (1-1 mol-mol),2.769034348653669,1.7478726161596867
WM115,selumetinib-navitoclax (8-1 mol-mol),-2.2824841087283954,2.2342473653671857
NCI-H2452,44137675,2.6709050374584846,3.818915164340349
BICR 31,52912189,2.5113420173615464,2.4990355817644248
WM115,72199292,4.562209520612744,0.6504523000681779
BICR 22,25154868,5.114547534217177,4.397857274209098
SW48,25262965,-0.5589271325062998,-1.7189969566563181
IGROV-1,4705,3.3098412390054603,3.2888610235200817
LS180,SNX-2112-bortezomib (250-1 mol-mol),-0.5067570232278682,-1.7989427361260601
COR-L95,11955716,-2.3894028875885778,-1.1272589438242846
BICR 31,241158,4.31214680273537,4.002601473203606
RCC10RGB,25062766,2.0619451400109265,2.1065141980979014
HCC1500,25262965,-5.244904140838402,-1.4878066727487496
PaTu 8988t,285033,-2.1993510069972215,-1.541457230628535
PaTu 8988t,44566777,-0.8532538772982161,0.5770294144575963
SW948,71466445,3.954398511848749,3.068674784874694
IGROV-1,6610216,4.310938387105607,4.267892092481897
PaTu 8902,11497983,4.394920409770125,4.264499265370782
SW48,11612883,0.3553002535249436,2.6523622210201974
SaOS-2,tanespimycin-bortezomib (250-1 mol-mol),-1.2470778221654188,-0.5647621907161533
HEL,9868037,2.50949616555346,1.8167547591780429
HEL,11178236,-0.8324730036537664,-3.664091904004047
RERF-LC-MS,60750,-4.1612389836176,-2.092828096411427
Granta-519,carboplatin-etoposide (40-17 mol-mol),-0.2598184919405968,0.4299775414112947
SaOS-2,24901704,3.518814077302041,3.3722421314898465
COR-L95,6914657,-4.192308975603822,-4.786934363777335
COR-L105,262093,2.940873643596252,3.095514335174098
LS180,44486219,4.325065743764261,4.1281963942366575
RKN,10074640,3.313081701902331,3.2935561502990356
BFTC-909,5746,0.5111824642409613,1.2397891072373746
K-562,8515,4.039482215632923,3.5489462749803082
PaTu 8988t,31703,0.1373281877500042,-0.7552113307133265
MDST8,135984461,4.124255066625015,3.683889240603079
WM115,107970,1.780812210779262,2.340240310718908
HARA [Human squamous cell lung carcinoma],44507138,3.9193587835112,2.646486452949221
IGROV-1,327653,3.667792542405671,3.1442631762226627
P31/FUJ,89183176,3.539325961528454,3.182314405042245
RCC10RGB,6438330,2.9900078425794385,2.4794675853645725
RKN,5280436,4.161667428331563,3.544499656425355
COR-L105,445455,4.3186388426275535,4.887654152773809
LS411N,24785538,0.7817075732213645,0.3107301457930569
Daudi,11152667,-2.9472151872913104,-1.9725225663650816
P31/FUJ,448949,2.0159916590055067,1.2648980457378336
Daudi,11609586,-0.3532025604686024,1.6543836846328184
SW948,46926350,-4.641976408237662,-3.846639515227515
SW1271,72193861,2.914678902909763,1.7238655063680823
PaTu 8902,25126798,4.210533326596683,3.8038187694760843
COR-L105,11955716,-2.257823880116287,-1.2093966119750648
HCC15,46224516,2.679221759698836,2.980507318785592
HCC15,135423438,2.37991378319322,2.3674656131445238
Daudi,421610,1.7509728437935097,2.4027715994618166
IGROV-1,selumetinib-MK-2206 (8-1 mol-mol),1.1145818568790276,2.3270393259080233
SaOS-2,11238147,2.85636627636287,2.7081640347457876
IGROV-1,374536,0.7022324251593053,2.6001797044254307
SU-DHL-1,51039095,1.7422871999086744,2.2075015132858735
IA-LM,72193861,3.820444995189443,0.4021489876264941
HEL,5738263,3.378820716395454,2.276224751338861
RCC10RGB,BRD9876-MK-1775 (4-1 mol-mol),3.486807022828034,0.9536156561058847
SW948,6852167,2.188206161672083,2.5148454426422866
K-562,71751553,5.367911183247371,3.9889325519927223
BFTC-909,71304818,3.116417285157316,2.700348528598583
SW948,25227462,-0.2382390684396511,0.008704351605794768
SK-OV-3,637858,3.830307013284548,2.2200735404728262
RKN,49766530,-3.8574490235665584,-0.5812229753853424
NCI-H1568,9933475,1.8521331470520848,1.8020796061162767
BFTC-909,decitabine-navitoclax (2-1 mol-mol),5.107856917496857,1.755201764224303
KU-19-19,17759555,3.7275461226555566,3.7618100751621895
LS411N,44589607,3.372730635507476,2.19014129210525
RKO,vorinostat-carboplatin (1-1 mol-mol),4.42147496708757,2.371368476382991
SW1271,5278396,3.101008990901291,3.6011366501945394
LCLC-97TM1,46398810,1.8633773855233131,2.517144782988693
SK-CO-1,6852167,2.111498553552754,2.783470080913748
SW1573,5479543,3.675213844165782,3.8058483939691543
COR-L95,12003241,2.921570030601445,-0.7214023809663612
Panc 02.03,9911463,4.953148943637795,3.916471941063267
P31/FUJ,crizotinib-PLX-4032 (2-1 mol-mol),0.7828925550397006,0.7985816040679505
RERF-LC-MS,3384730,3.247206310046507,2.9455924151899002
IGROV-1,51039095,1.7163430299301403,2.8854198320339504
KU-19-19,89928392,2.8864230284497747,1.5955427610163915
SK-CO-1,216468,0.6363757446548435,3.1909390179563752
LCLC-97TM1,3038522,2.979698040139259,3.119719995840603
BICR 22,6914657,-3.057028291966878,-2.948705793910262
MDST8,3815108,3.655140825789689,2.95144114275545
HEL,11364421,-3.0976744543470067,-4.383111917714851
SW1573,10074640,3.956421484938757,3.229814834412324
LS180,6610355,3.640469161520063,4.172843190410356
Daudi,2858523,2.224035136584194,2.687246885011482
BICR 22,135875424,4.925705128316808,4.0012894187776915
SK-OV-3,23582824,0.9299959314677436,0.7863661771804784
K-562,5282054,3.5952240521498062,2.88532916396386
NCI-H2452,44589607,3.0010828964799208,2.97174570705807
LS180,638278,3.5544678930796656,3.15293126407448
MOLP-8,426756,3.5390437920539117,4.238988757402146
HARA [Human squamous cell lung carcinoma],11964036,1.505983259630614,1.420747848259977
SaOS-2,selumetinib-MK-2206 (8-1 mol-mol),3.420103401204114,2.275876120219005
SK-HEP-1,selumetinib-PLX-4032 (8-1 mol-mol),4.995301598954557,3.072840175436896
BICR 31,71466380,5.422644788319504,4.549270621231727
PaTu 8988t,53392493,3.5279637137541524,2.922472864054389
UACC-812,6610216,4.947422623598504,4.077082476728754
SW1271,16038120,0.5203426502283315,1.1155239787490885
IGROV-1,67156097,0.1763939852409119,-0.6219122782993197
UACC-812,216239,2.3945159107119767,2.1204197878838107
HCC15,serdemetan-SCH-529074 (1-1 mol-mol),2.4880259252589543,2.1995808915260837
ALL-SIL,36462,-1.376242093473402,-0.4883978697060342
BICR 31,1750826,0.6511109819152475,-0.8957882849733891
IGROV-1,56649450,0.515518984822669,3.2127099360498312
HARA [Human squamous cell lung carcinoma],66577038,3.5726698245106445,3.1051257476626755
PaTu 8988t,6918837,-0.8891471976747255,-2.2674875572028172
ML-1 [Human thyroid carcinoma],9936388,-4.434207119356507,-0.5044781984218212
NCI-H1568,2828334,5.9155051642717,6.120155591268188
MOLP-8,56973724,1.5171827826362807,1.8791841313980309
MOLP-8,2729026,2.779201693602774,2.376589697660779
P31/FUJ,753704,3.2802738483106766,4.212197681486904
SaOS-2,25183872,-0.102413301755783,-0.8579161865970694
NCI-H2452,decitabine-navitoclax (2-1 mol-mol),4.538424362545292,2.400040540830484
LCLC-97TM1,9825149,1.404394440199107,2.226198925174449
WM115,9929138,6.7694003006369226,5.479721681253164
RERF-LC-MS,2746,3.2731211053052647,3.2982225213381935
COR-L95,5351362,0.837381680047442,1.0434334529210814
HCC15,ISOX-bortezomib (250-1 mol-mol),1.036560789961647,0.6057798687803918
RCC10RGB,3101542,4.48788654191394,3.028238158256083
BICR 31,44566777,1.4466588952743178,0.8625966198886846
WM115,5746,-0.962904812763719,1.4901730309429027
HEL,9903786,1.206049982415758,1.8945733867513064
NCI-H1568,44486219,3.435494584556288,4.378626340176888
SK-CO-1,124202324,2.795373404058925,2.5881697702287796
MOLM-13,5329102,-5.212236525427112,1.0952701941852765
SaOS-2,10427712,4.893681366378875,4.224847613498862
SW48,409805,3.4729287041870127,5.003019914494376
HCC15,216345,4.3772403070959705,3.925595386224215
NCI-H2452,46215462,2.291566037713401,1.9791220010632975
SU-DHL-1,55283,1.0511806970329092,2.601159368366218
SW48,navitoclax-birinapant (1-1 mol-mol),1.0401381719181744,1.9129560818425595
HARA [Human squamous cell lung carcinoma],56946209,-3.7436646215458182,-3.9027508761357286
MDST8,24821094,3.627663013095859,2.973331935435023
HCC15,9911463,3.642862209488471,3.9640974184215065
BICR 31,navitoclax-gemcitabine (1-1 mol-mol),3.844959889456845,-0.7863808389769575
SW948,11178236,-0.7120713487548671,-3.1185956577115364
HCC1500,5329102,1.6369795361395487,2.085506655466892
SU-DHL-1,11364421,-4.160715855029451,-2.1621452590519175
SU-DHL-1,176870,3.225718242496366,3.381365971845108
WM115,2742550,3.774256401917875,3.9395676791711236
SW48,12003241,-0.9746028071684796,-0.9993387172246402
NCI-H1568,11494412,0.631822071405162,1.866517508007864
WM115,25102847,1.9091464851380515,2.4218719541159994
COR-L105,23725625,5.8274909459435165,5.1262828196246835
Granta-519,9956119,4.186560294974692,2.4388921509107653
COR-L95,72193861,1.6807669427950571,0.8346080180643015
IA-LM,6917907,0.442667441503668,-4.580189790528099
SW1573,53232,-0.4627324496874346,2.6068973582528416
Panc 02.03,19582717,5.117031119305748,4.646061965499967
RCC10RGB,227681,3.758665689171896,3.496720935466226
WM115,24901704,3.629786211252992,3.5025625119519055
HARA [Human squamous cell lung carcinoma],4477,-0.0807211341972061,0.6119470499477487
K-562,637858,1.3097643671251342,1.1176123026575902
SW948,613753,3.0653891790249617,2.977719292430806
Granta-519,9926054,1.8135939424605243,1.6095615409900983
SK-CO-1,55508,3.57241133457179,3.328171879149583
HCC1500,5426,4.174536858194301,3.7701728323113706
IGROV-1,4521392,5.131794979216607,4.289033157048149
UACC-812,6918878,3.827620339158657,2.6016393903434194
SaOS-2,sirolimus-bortezomib (250-1 mol-mol),1.8011935542733906,0.5691167167306097
KU-19-19,72193861,2.401782330602402,2.0543760054597024
WM115,5281321,0.1495893125543727,-0.6838703299341072
ML-1 [Human thyroid carcinoma],3038522,3.665928761402901,3.0638321234993526
P31/FUJ,31703,-2.5575864334968976,-2.4567541742991867
HEL,decitabine-navitoclax (2-1 mol-mol),-1.4855622179945482,-1.0584108840817492
ALL-SIL,44589607,0.5481515481681011,1.6946164456036976
PaTu 8988t,11955716,-2.6731660557009267,-1.3743592023974045
IGROV-1,5738263,4.037832478240785,3.4363589432919066
HARA [Human squamous cell lung carcinoma],126941,-2.554285063423382,-2.8007976729319717
BFTC-909,650361,3.8112149600795706,3.6103866057363714
SW948,16725315,5.2631267850751335,3.8816565352421226
Panc 02.03,25102847,3.3458680072040603,2.287849570633368
BICR 31,216239,4.655547148927136,2.2534605808066615
SK-HEP-1,51039095,3.60670356936783,2.8585992000349645
IGROV-1,9907093,2.687959785702283,4.206066489676353
ML-1 [Human thyroid carcinoma],126941,-2.044263255039902,-2.219527566480944
LCLC-97TM1,49766530,0.6419783818490065,-0.5601219962226902
Granta-519,2113511,5.634502761977105,4.316289719399918
COR-L95,322968,2.331837213900703,3.021162083692202
RKO,ISOX-bortezomib (250-1 mol-mol),0.9877489052510549,0.44930441258857307
SW48,60700,-1.9747801062936423,-0.3988304786651245
SaOS-2,46907787,1.5905885991562354,2.4385436125852973
LS411N,5311,1.0830647686053458,0.7742728105355688
NCI-H1568,5278396,3.684546625455108,3.599706237932105
P31/FUJ,2858523,2.921593087757198,2.7828756235850256
MOLP-8,25102847,1.798391543473315,2.146868114108263
HCC15,57330099,4.175732386995395,4.219844497867108
LCLC-97TM1,16013152,5.423690206414697,3.832966309064616
SW1271,16065773,2.6188234772001886,2.460129068280436
RERF-LC-MS,52947716,-5.597592816818683,0.47326946283497284
MOLM-13,11167602,-1.7638454235436123,1.3303672022672504
NCI-H2452,vorinostat-carboplatin (1-1 mol-mol),3.5311802496777576,3.4960971565291583
Granta-519,3038522,1.8764454398289976,2.8169522680638823
SW1573,54626689,3.958399976383255,4.616516064425256
K-562,445455,4.202279962055385,3.7645430185330055
SK-CO-1,25262965,-3.291258197582341,-1.673437516792695
Granta-519,54618771,-0.1786557603441652,0.04952690820305747
ML-1 [Human thyroid carcinoma],216345,4.790115930225849,4.215372043699569
HuP-T3,42642645,1.566786855324099,1.0452501685459488
MOLM-13,44589607,2.917529465117915,1.8121878217065024
ML-1 [Human thyroid carcinoma],10385095,1.881738472046862,1.4778117936831814
SU-DHL-6,753704,4.418086475877281,4.267893766177272
SU-DHL-6,6918837,-4.716152603392634,-4.694031376666135
P31/FUJ,46199207,2.4446101047156215,2.6455376853670147
SaOS-2,156422,4.313289259132858,4.049879811650615
BFTC-909,5282054,4.21714099973987,3.764175056719468
RCC10RGB,9803433,4.221770064596342,4.625960521601336
Granta-519,UNC0638-navitoclax (1-1 mol-mol),-1.1089217343766455,-0.27876937674049435
RKN,89183176,6.327700475537756,4.732677162409058
BFTC-909,16038120,1.74161234898449,1.2829451987866995
HCC1500,71466445,3.970736335461394,3.8874049070874346
Granta-519,25062766,1.8322611726564384,1.2920230519053104
SK-OV-3,216345,4.761928129554225,4.168948792816453
Granta-519,11609586,-2.485330170292811,1.3140181972174667
SK-HEP-1,6918878,4.4325993547595655,3.100186454139713
P31/FUJ,676352,1.6175160353980318,1.9488062053026638
UACC-812,25227462,-0.2916299121927669,0.8132964675646577
RERF-LC-MS,54596558,4.400747096440468,4.539854813901143
Daudi,9911830,-0.0057102646081846,1.951417406113248
COR-L95,72376,-2.5853838467146493,-2.9169962530233904
LCLC-97TM1,135875424,3.9585615026829823,3.799317603243403
P31/FUJ,49850262,2.7073676452568427,2.605126062028962
HEL,10410894,1.686960620182283,2.681831663285589
LS180,10127622,1.4423864514133429,3.032759668565421
LS411N,16038120,1.458068935835204,0.5276139542163092
ML-1 [Human thyroid carcinoma],136227924,2.8741817701449506,3.120973820930221
IGROV-1,11214940,1.360660548899077,1.89163381162808
Panc 02.03,969516,3.806573436208542,3.005531481504602
BICR 22,JQ-1-navitoclax (2-1 mol-mol),1.0465005615278271,0.9252101141329462
SW48,656346,-0.2718986936332406,0.9422434052510452
SW948,285033,-0.875487938395224,-1.9711159675019334
Panc 02.03,4261,3.516583077320981,1.8038215435892795
SW48,49766530,3.606492941369466,-0.04694946324889727
SW48,16038120,-1.7922421690180796,0.9174137962098858
RKN,navitoclax-MST-312 (1-1 mol-mol),0.5631499209413128,0.9538174146175018
ML-1 [Human thyroid carcinoma],46199207,3.5690585114534024,3.4490726104002793
WM115,2945648,2.5851994154769025,2.9467439892325014
BFTC-909,vorinostat-carboplatin (1-1 mol-mol),0.6014624935477999,3.36606317290431
BICR 22,25227462,-3.180570489875023,-0.16582023717478717
IGROV-1,5460769,1.6083174601829917,2.5830547245527566
K-562,753704,4.7227938780788525,4.124089895481436
K-562,ISOX-bortezomib (250-1 mol-mol),0.3376370593793573,0.26919542912955985
HuP-T3,4788,5.894927949545096,5.744061291564123
SK-OV-3,42642645,1.640931292575566,1.178014369056716
PaTu 8988t,11222830,1.761666424308375,1.6087258201296137
BFTC-909,448949,2.818327130228084,2.243700622859664
HEL,serdemetan-SCH-529074 (1-1 mol-mol),2.278758279722759,1.4401800806882599
WM115,5281672,6.287836255113029,4.497460017075984
Daudi,3384730,1.441294292217556,1.745968142166305
SaOS-2,navitoclax-pluripotin (1-1 mol-mol),-0.5587106095561101,-1.0253966099445269
LS180,6252,-0.5438897009285958,1.0097416995455557
SaOS-2,3025944,4.435896212894107,4.267382888001634
SaOS-2,25161177,4.43427627730954,4.08326906060229
LS180,JQ-1-UNC0638 (2-1 mol-mol),0.673634242684319,1.3162190902131483
HARA [Human squamous cell lung carcinoma],6918328,1.494996835192892,0.3483086444437745
BFTC-909,11228183,3.298719229946038,2.506532852062957
Panc 02.03,navitoclax-sorafenib (1-1 mol-mol),3.063115591562286,1.8816085363139863
Granta-519,135659046,3.900512348834848,3.261486217919118
LS180,126941,-2.6871715133008385,-2.663590523782135
MOLM-13,3081361,0.9632978577503784,1.6928854486836615
WM115,9936388,-1.175666523167262,-0.5499060920077136
HARA [Human squamous cell lung carcinoma],119182,-1.5549760643936197,-0.5654504757447292
IGROV-1,15953870,2.712793598656007,3.559767641350228
RKN,10410894,1.511663597063748,3.2812873671397647
IA-LM,6918638,0.61198230609435,0.568837737011351
SW1271,56946209,-4.174123648346971,-3.5937706141613006
BICR 22,67156097,-1.5899611273150889,0.057492444182476364
SW1271,2749,2.846909316544141,2.132738925978411
KU-19-19,65628,4.405271017285275,4.407842084209402
MOLM-13,5566,2.591289759721003,2.7579835659186567
HCC1500,89928392,1.0051530188155344,1.5237153855856418
SW948,25102847,1.6816963863778185,2.313776501442652
ALL-SIL,10427712,3.5706749567785625,3.6527585545299774
IGROV-1,2749,2.0319044408234954,2.058794945926493
LS411N,selumetinib-piperlongumine (8-1 mol-mol),1.1466452951203283,2.112820897583752
HCC15,SNX-2112-bortezomib (250-1 mol-mol),-3.246727097806559,-1.421879918340361
SaOS-2,1242560,3.6046854082724034,3.6303331732586406
RCC10RGB,123631,3.672101761387351,2.572123733678255
SaOS-2,JQ-1-MK-0752 (1-1 mol-mol),2.214313979092396,1.7037903773901042
SW48,carboplatin-etoposide (40-17 mol-mol),-0.9429596789262168,2.808344195542557
ML-1 [Human thyroid carcinoma],400769,0.4240275581269139,-0.4525718361416828
MOLM-13,23725625,2.3173082013566204,3.328224453843859
SK-CO-1,15547703,3.920131639479481,3.156204899023166
SK-CO-1,navitoclax-pluripotin (1-1 mol-mol),-0.9841338872717872,-0.6318302859452374
SaOS-2,71729975,2.29546286795302,2.026085774129834
KU-19-19,12003241,-0.0608702413973226,-1.1983098843235909
SK-CO-1,568763,0.0338205510733868,0.6997146168869592
SU-DHL-1,984333,1.5848171755072842,-0.10152711468449548
RERF-LC-MS,49766530,0.7744144603938863,-0.2254881018471287
SU-DHL-6,11152667,-4.5064226702829,-1.8515326716007017
HCC15,2130404,2.6093174666871293,3.3953073707785295
RKN,11626560,2.593417875894138,1.9013219092033895
NCI-H1568,navitoclax-MST-312 (1-1 mol-mol),0.8258625122307741,1.093442383664458
Daudi,44137675,1.0044684727898117,2.7571841180800423
SW948,54619267,3.654776559833868,3.8805805569778493
MOLP-8,selumetinib-UNC0638 (4-1 mol-mol),0.7931432464838661,2.2424452693593193
RCC10RGB,4259181,1.719089746142662,0.6096907588961944
SU-DHL-1,9887053,2.0473441666614156,3.654021755479012
SK-OV-3,9911463,4.2249846626647125,4.03140095375839
HCC15,49766530,0.5190445493569186,-0.24479865403560022
Granta-519,3385,2.090684083959823,2.1978045486664386
RKO,54613361,0.2998145946125954,-0.09725792441616553
HEL,3384730,1.593743887858678,1.3836442200333208
NCI-H1568,11977753,-3.4091025242198696,-1.1746473789876806
SK-OV-3,285033,-0.1977879636486448,-1.942586129048995
Daudi,3385,1.70419989930712,2.5025777402626037
NCI-H1568,9825149,1.6639399446813206,2.481445562295152
IGROV-1,654092,-1.340387623873854,-0.2504128661705726
SW1271,126941,-2.215477966101826,-2.6798548388287906
IGROV-1,6852167,1.5305143027352028,3.032509029912688
HEL,11626560,1.0872099702081388,0.5224070214996621
SW948,126941,-3.436390914894009,-2.207445758872428
RKN,107985,-3.0900461086436404,-3.4149139315992376
P31/FUJ,12001922,1.6134382673725098,1.4738279511807957
Daudi,11404337,-3.064654238522792,-1.1290743862512043
SaOS-2,6438330,2.0981522234577064,2.1829564546696707
LS411N,126941,-2.790198017582557,-2.369154362509151
HCC1500,10302451,3.7658874637842135,3.2404295174180278
BICR 31,4259181,2.3774772051226685,0.5018590621380733
MOLM-13,11656518,1.5202718128538335,0.3323995012891002
COR-L95,148124,-0.3758104123213183,-2.2963835896716462
MOLP-8,53232,1.5052202963885184,2.5419694620551883
NCI-H2452,3038522,3.3601174997652725,3.202515128381957
HCC1500,erlotinib-PLX-4032 (2-1 mol-mol),3.588293308391856,2.842973928309608
SW948,16722836,1.2939108289094092,1.3879761301709375
HEL,439501,-2.350875236844296,-2.2699518858329286
NCI-H2452,445091,5.08182727911324,4.347244307740629
RKO,9840324,5.302067215897717,5.3890018881734285
SaOS-2,44489675,3.960447273667139,4.060131451527983
ML-1 [Human thyroid carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.479159740244691,2.294303232817961
BICR 22,46901937,4.667354689676901,3.161878297478523
LCLC-97TM1,2746,2.92478275020961,2.724654161945586
P31/FUJ,selumetinib-JQ-1 (4-1 mol-mol),-1.737174960648273,-0.32254601352209455
Daudi,44491742,3.5549145676591314,3.917660702527865
BICR 31,374536,2.383890315264743,2.590889043715728
NCI-H2452,17759555,4.398260875691204,3.8055608392504467
LS411N,25183872,0.0970121311419586,-0.7572968442580746
Panc 02.03,23725625,6.172373492037936,5.183207003496595
Granta-519,65064,2.9178387202883735,3.7354615070176376
COR-L105,11222830,1.704570553497338,1.7799364857931843
NCI-H1568,5394,4.198509108960074,4.058805612649091
P31/FUJ,135984461,4.1454221372139894,2.7159504309340194
K-562,49836020,4.414855158615189,3.115325290614495
HEL,4788,5.03605552733545,4.934042076503394
HEL,selumetinib-GDC-0941 (4-1 mol-mol),3.377819044796062,0.6376056839818909
LS411N,6610216,4.962940577428159,3.828630636068731
NCI-H1568,23635314,-3.8228905075414055,-1.6467523507078659
HCC1500,5328940,1.924598719414512,1.807441789875042
BFTC-909,44589607,3.3115887945185496,3.008911361013422
MOLM-13,5281321,-2.338854439084819,-2.7092446254396907
MOLP-8,71466380,3.4619880715079603,4.03126485101751
K-562,439501,-2.3563528898814905,-2.3965668355913823
LCLC-97TM1,44819697,0.4394946813834864,-0.38314700435703436
HCC1500,9956119,4.194319271525248,3.587926323072617
IGROV-1,JQ-1-UNC0638 (2-1 mol-mol),1.7292829396313356,1.6425714367240989
HCC1500,6505803,-1.3038553273576796,-0.38666114901023346
SK-CO-1,16038120,-1.5377645940979283,1.095889851743715
MOLP-8,46398810,1.7248083632166018,2.0723181068658896
RKN,73707386,3.296207724675486,2.7407377898470484
HuP-T3,6918638,1.0959798369911515,0.8782506661691264
SK-CO-1,72734382,5.327408257337546,4.778324534405486
P31/FUJ,alisertib-navitoclax (2-1 mol-mol),-2.72541188794455,-1.5661044435512101
SU-DHL-1,23725625,3.354193732931358,4.390595086653198
SW948,4378219,2.7444419460246716,1.8981006801790867
Granta-519,6610216,4.381057854502396,3.6921976710417193
SaOS-2,25126798,4.16568157244383,3.8469959639210027
MOLP-8,11719255,2.3085103352777057,2.348625311692827
SU-DHL-1,969516,2.44648475018104,2.695968141299788
HuP-T3,9884685,1.9355517940144655,0.9088888415225013
SU-DHL-1,54618164,3.660876980117255,3.8717201142883564
P31/FUJ,4788,5.1911977113578285,4.879090282717031
IGROV-1,10074640,3.2681490579824426,3.2011005848870036
LS180,46224516,3.8200366067107714,2.5252861333224255
K-562,24753719,4.107201496626299,3.5270343844513947
HCC1500,46926350,-3.99988450675712,-4.048957396655717
LS411N,11175137,2.6624545374598,2.2183519734695025
IGROV-1,71466578,4.017291197092763,4.606868667411447
Granta-519,10184653,0.998312657126817,0.7238984741277055
MDST8,selumetinib-MK-2206 (8-1 mol-mol),0.7033297936486181,2.448248095983427
MOLP-8,6918328,-3.583816044173495,-1.3363642215280596
SW948,56649450,1.940604714075546,2.6916201673141007
BFTC-909,374536,2.594742723017773,2.700757343935016
KU-19-19,44185566,3.361767971446376,2.7072498066429747
NCI-H2452,1750826,0.2631697114156899,-1.6792070131208723
LCLC-97TM1,24180719,3.1823264447338837,3.6523222481732205
SW1573,docetaxel-tanespimycin (2-1 mol-mol),2.3053158054818077,-2.201759653288753
KU-19-19,navitoclax-piperlongumine (1-1 mol-mol),2.9388781180521124,2.002355680113405
RKO,675434,4.252493680505022,4.185029892004281
RERF-LC-MS,vorinostat-navitoclax (4-1 mol-mol),1.7393887492524955,1.3429230103137193
HCC15,25105715,3.3758270019314147,3.420031356576788
HuP-T3,6610216,4.722811341582641,4.318307862468955
MOLP-8,156422,3.6985484587412394,3.0454502696308663
SK-HEP-1,6917907,-0.2672796642005143,-4.549528023295004
SW948,984333,0.954004982504914,0.8504261893442744
PaTu 8988t,51039095,3.672985699080835,2.8845577727022036
Granta-519,selumetinib-BRD-A02303741 (4-1 mol-mol),7.197937797796196,3.636724899425235
MOLM-13,10385095,0.2048351805935088,0.8594051839422581
WM115,2842253,4.366205978966029,5.626340604565795
NCI-H1568,navitoclax-birinapant (1-1 mol-mol),1.7942101393430023,1.6739057110267248
IGROV-1,135423438,0.764137689665023,2.603254828690989
RKO,16725315,5.119694523443236,3.6545747464727962
MDST8,11609586,4.829072296940778,3.071521008475772
COR-L95,7251185,1.1216187825494426,1.9126502088143593
RERF-LC-MS,51039095,3.2453184174795324,2.6905418931357676
P31/FUJ,17759555,3.626728737883383,3.2835130726830597
HCC1500,5113032,4.590685122922873,4.878033538923046
P31/FUJ,16741245,4.043144814115882,3.5140500831372323
HCC15,5746,0.6503914795852271,1.1730479482079583
RKO,10074640,2.8357111382750646,2.5840886170654107
WM115,10322450,3.651827454662003,3.639283176544522
LS180,11404337,-0.0678179476465551,-0.4574954998412915
Daudi,46191454,-0.8094751773550651,0.03179506823199461
P31/FUJ,selumetinib-tretinoin (2-1 mol-mol),-0.8330243559244562,2.2364988968252537
P31/FUJ,44202524,1.0280075167408849,1.213546036277804
ALL-SIL,44185566,1.0410692737439569,1.4835246671684967
PaTu 8902,54618164,4.284638344065584,4.209794626866725
COR-L95,46224516,1.2687748324677306,2.5056370133427377
COR-L105,56949517,4.666554440626914,4.144358735602999
BICR 31,piperlongumine-MST-312 (1-1 mol-mol),1.564015805040982,1.933467664349149
BICR 22,45279963,3.757910341256097,3.4321747099333515
HEL,9911463,3.4775133545177774,3.0052023637712004
HCC1500,navitoclax-PLX-4032 (1-1 mol-mol),-0.625964193644412,0.9774849788935246
BICR 22,JQ-1-MK-0752 (1-1 mol-mol),2.0389244155422577,1.2420268748450787
Granta-519,5287969,-2.420005986832857,-2.4830883678198163
IGROV-1,71466578,4.017291197092763,4.606868667411447
Daudi,1323703,3.9745876209629354,2.484587666171824
COR-L95,9956119,3.960527548011759,3.241569044955188
SW48,15953870,2.1672009909649415,3.397830609879564
SW48,5278396,2.530949009900888,3.3272706004702632
WM115,10296883,3.9273376390568138,3.9742066473501088
NCI-H2452,10302451,4.286596307748033,3.603646066108591
SW948,9915743,1.1952390119197474,0.6928536949363553
SW1271,9903786,4.005340236032604,2.9530774448005728
LS411N,49793307,-3.1894754739686455,-3.4134634777039468
Daudi,126941,-4.413815937813151,-3.093529040398488
SU-DHL-1,89183176,5.662525063156772,3.310487883466112
BICR 31,SNX-2112-bortezomib (250-1 mol-mol),-2.620347476140509,-1.220499638936535
SK-CO-1,216239,2.5779715954988656,2.3367344039750284
SaOS-2,24889392,3.914866726590468,4.033802778122968
LS180,3025944,4.8838055311701805,4.117542409024773
SW48,11626560,-0.4765255311776857,1.945061537493809
RKN,168313047,2.366456695786382,2.3320304963389176
NCI-H1568,4788,5.820003751306211,5.613451029592133
RKN,65628,4.337575078598336,4.317288284407826
LS411N,5311281,3.759327828108219,2.5191866455249126
RKN,23725625,4.172652901782409,5.030670667695941
BFTC-909,168312962,2.436518653578315,2.5054561973963523
K-562,56946209,-4.819463057676977,-4.693728350163448
K-562,navitoclax-piperlongumine (1-1 mol-mol),1.084720053726158,0.742484035484174
Daudi,11647372,-0.1839602824658907,0.2572642606370676
SW948,5479543,0.3482839273666757,2.899188096758248
SU-DHL-1,11626560,-1.697644171575415,1.2540528240055997
BICR 22,71466380,4.042212978424107,4.6233939590674025
HCC1500,selumetinib-UNC0638 (4-1 mol-mol),3.968035032331931,2.917891217876401
MOLP-8,BRD-A02303741-navitoclax (2-1 mol-mol),3.766843844868067,1.1949639871625595
MOLP-8,9967941,2.6295638429027206,3.167974835813128
SW1271,piperlongumine-MST-312 (1-1 mol-mol),2.322149279280664,1.6965216104317915
NCI-H2452,25183872,0.970145395005522,-0.6740251158357385
RCC10RGB,navitoclax-MST-312 (1-1 mol-mol),1.0881941253840328,1.159525232027724
RERF-LC-MS,sirolimus-bortezomib (250-1 mol-mol),0.955955259392996,0.7206798687057768
HCC15,8515,2.8931769079597767,3.9093137903099633
SK-HEP-1,7251185,3.0945137710223687,2.6139568647240066
HuP-T3,3689413,-1.422602865458103,0.295926247811856
HCC1500,2113511,4.626117550925971,5.365400314807697
HARA [Human squamous cell lung carcinoma],445091,4.978549366904043,4.312181971541961
SW1573,5351362,2.395315345585997,1.7225849198976317
SaOS-2,16725315,3.258166087647875,3.8879495797463774
SK-HEP-1,44566777,0.1035402456781041,0.8573645994136814
ML-1 [Human thyroid carcinoma],9887053,4.856845998315694,4.353918573619612
NCI-H2452,54618771,2.226699645078912,1.7021992960726018
RKN,5329102,3.127163305072316,2.0875343780038516
BFTC-909,JQ-1-vorinostat (2-1 mol-mol),1.4357033395957943,1.2949785748074196
IGROV-1,selumetinib-MK-2206 (8-1 mol-mol),1.1145818568790276,2.3270393259080233
NCI-H1568,5287620,-3.0605655272876104,-1.9063727829647568
IGROV-1,5329102,1.2794664511054334,1.9488652421415846
SU-DHL-1,71680916,6.473574001994787,4.6035390270935395
COR-L105,25262965,-4.3344847799771,-1.0650948444320152
SW48,3503,2.2068347221848605,2.2272720439567384
BICR 31,36462,3.088359748996336,2.442690563701817
SK-HEP-1,24753719,4.401042857593667,4.272965483875888
RCC10RGB,navitoclax-gemcitabine (1-1 mol-mol),-0.0681716439191075,-0.690255185111573
IA-LM,16659841,3.92216274325252,2.872260451165792
WM115,24771867,3.628628048718056,2.8713960989764313
SK-CO-1,67156097,0.6545128366700663,0.18415108885208362
RKN,selumetinib-vorinostat (8-1 mol-mol),2.829001792073934,2.6572777251307294
SaOS-2,navitoclax-sorafenib (1-1 mol-mol),2.1552340524690843,1.6816066759644894
IGROV-1,71466380,4.863636874274779,4.4710200884192215
HCC1500,selumetinib-piperlongumine (8-1 mol-mol),2.4825259194039173,3.2221146042339917
Daudi,5281321,-4.970506938945455,-2.5786137298535645
BFTC-909,12003241,-0.8371396827795129,-1.400702726002126
SaOS-2,44185566,3.018169617675811,2.6593356764402363
SW48,54619238,4.554849733994691,4.533223726085419
Granta-519,25227462,-6.0432717278136066,-2.5888513178790307
HCC1500,72376,-0.7270592073375387,-1.5392367824570194
SK-OV-3,3689413,0.6002437290843657,-0.4842437729603449
HARA [Human squamous cell lung carcinoma],122327,4.478573115200279,4.67477875744193
COR-L105,71466380,4.962997689396809,4.634899358165567
K-562,56649450,4.352548214039191,2.9986266812183064
ALL-SIL,2828334,5.780519190951295,5.67945527552826
MOLP-8,5746,-0.9490954024297016,-0.15475794948067903
LS411N,9935249,3.5378716054356927,1.6905937456433318
KU-19-19,148198,-3.572091199224797,-3.2784396410150607
Granta-519,navitoclax-piperlongumine (1-1 mol-mol),-0.8573381901716745,-0.6361913380954864
Granta-519,navitoclax-MST-312 (1-1 mol-mol),-0.2022371646874937,-0.37893361441142404
RERF-LC-MS,54619267,3.9836959677109354,4.139333018786174
RKO,piperlongumine-MST-312 (1-1 mol-mol),2.2495159802497864,1.4575467083081675
SK-CO-1,445455,4.388752059403359,4.663694942625275
ML-1 [Human thyroid carcinoma],42611257,2.85876832372032,3.447518840604942
BFTC-909,6914657,-4.61933610547547,-3.9459343172130357
IGROV-1,54619267,3.9701367924453455,4.205503480464525
NCI-H2452,6918289,-3.5458030779688277,2.8729077108108316
SW48,654092,0.3720639788768654,0.1328824233224627
LS180,10184653,1.1411409682713576,0.6956952319363439
SW1573,4259181,2.0061423198913766,0.2350659983509854
BICR 22,5978,-3.054007840707858,-1.4070946022344832
SK-CO-1,446155,2.509492168961503,3.2324201121573206
HuP-T3,piperlongumine-MST-312 (1-1 mol-mol),1.4346079723069378,1.7881689913371468
MOLP-8,6917907,-6.199761218038622,-5.208382482297448
WM115,6610216,3.675624927368402,4.15852323291028
BICR 22,11964036,1.4111698106068242,1.3068485635996354
IGROV-1,135440466,0.9791523710816318,2.416983707047748
SU-DHL-1,46224516,1.9664047258697153,2.356107433334934
ML-1 [Human thyroid carcinoma],656346,1.1399678324227185,0.8981532296893731
NCI-H2452,156422,4.888821376667332,4.129978142430127
BICR 22,446155,3.7361559304721106,2.7422175071832076
BFTC-909,3038522,3.685618431455981,3.2974180157941624
RKO,46907787,4.104881837237831,0.25589556431058463
IGROV-1,123631,1.7694522866439453,2.504102085151027
LS411N,5280436,4.183720769167266,2.97630484213355
HARA [Human squamous cell lung carcinoma],15983966,-4.087930187377121,-1.7999147941577933
HEL,5311,0.0816485968486221,0.5808886307442037
SU-DHL-1,327653,2.51842673185387,3.0585815137636634
MOLM-13,8515,0.8268618162227004,2.824816209281092
MOLP-8,25183872,-1.6811002192977054,-2.0069318514892625
Granta-519,11228183,-2.3490545548585335,0.03259318283704668
LS411N,sirolimus-bortezomib (250-1 mol-mol),1.8501035907850776,0.2884571676992937
SaOS-2,5470400,4.204063595869918,0.3030155753802446
BFTC-909,5738263,3.1091802601858185,3.5655458615123745
SK-CO-1,20959075,-3.269929661945314,-2.5338570713389332
SK-OV-3,9956119,5.08600620496794,3.8653571671578884
WM115,tretinoin-navitoclax (4-1 mol-mol),3.8155470378280008,2.6775716475344375
BICR 31,5978,2.6862960741960693,-1.4277077825723399
RERF-LC-MS,375860,-0.2896823379882159,-0.15681339197403868
SK-OV-3,selumetinib-piperlongumine (8-1 mol-mol),4.999927979817729,3.5123235064763865
COR-L105,44202524,4.8543272504702895,2.6014557997816046
MOLP-8,44137675,1.775364766844489,2.8070958892643953
IGROV-1,9907093,2.687959785702283,4.206066489676353
LCLC-97TM1,10385095,1.2595894653665305,1.3238811716129815
HCC1500,serdemetan-SCH-529074 (1-1 mol-mol),0.9549823890456136,2.0301127692481353
P31/FUJ,3038522,3.230912995410489,2.6252312206846518
PaTu 8988t,5281321,0.6032906637165831,-0.7021624831827127
HEL,9866186,-1.054303819018661,-0.1357075961796516
HCC15,carboplatin-etoposide (40-17 mol-mol),1.5999978710207647,2.6582236178822796
SW948,2708,5.7755473109613265,3.7773870232011086
PaTu 8988t,3025944,4.261130932115319,4.306881872421946
SK-HEP-1,3689413,-2.4602386660304143,0.0702398723460498
SU-DHL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.3225967046124065,2.8583002944596285
ML-1 [Human thyroid carcinoma],24771867,3.392643461506865,3.069729549966122
RKO,6252,0.5352436981906653,-0.5925461929594077
SU-DHL-1,4521392,5.192178694848648,4.1189918448651
Daudi,72376,-4.854665282210012,-3.695931517501188
RKN,4259181,0.9508926940780028,0.09724261618908059
ML-1 [Human thyroid carcinoma],4096211,3.147888642031647,2.385104477378473
HARA [Human squamous cell lung carcinoma],44819697,3.9048868362328264,-0.46829680089586867
SW1271,36314,-4.053350989931705,-1.7408129667387535
COR-L105,1750826,-1.9007119452090728,-1.0991773662993216
HuP-T3,salermide-PLX-4032 (12-1 mol-mol),5.718732466752557,4.908592320262061
Granta-519,46215462,0.9491023197189584,1.1379893569835415
SW1271,3676137,4.713113076263269,4.3519585318763205
IA-LM,5278396,3.9030690758091904,3.153109355280536
NCI-H2452,24775005,5.579264227156813,3.7070400725007304
K-562,23635314,-4.3400265171433725,-2.8540815461469875
COR-L105,6852167,2.71981320036177,2.856448263948712
Panc 02.03,16741245,4.354855972582246,4.095383405415997
SU-DHL-1,2733487,6.186604270067288,5.652890854358674
Granta-519,26596,-3.6955660538224784,-2.588197478106059
SW1271,JQ-1-UNC0638 (2-1 mol-mol),1.8151113798618133,1.5953643031625895
ALL-SIL,176870,2.444675771693443,2.4613924931419215
LCLC-97TM1,19582717,4.783105330370089,3.773196650603178
HuP-T3,119607,5.841541098284191,5.465334555071328
RKN,selumetinib-UNC0638 (4-1 mol-mol),3.946775123673676,3.7041861565921885
P31/FUJ,637858,0.7903103947120294,0.968753440122655
COR-L95,5329102,1.6379635813529434,2.041331558443041
BICR 31,5291,3.978522058600436,3.7398181494692837
LS180,6852167,2.255231171645259,2.703460817483437
IA-LM,89928392,1.436934436501384,0.904013911768802
RKO,docetaxel-tanespimycin (2-1 mol-mol),-5.095252166768177,-3.819972012381462
BICR 22,9903786,3.2901982519836213,2.9268245110786153
SK-CO-1,3384730,3.2619898650330272,2.9590999655295827
SW48,17755052,-0.4852421045975616,1.4920594488805807
COR-L105,568763,0.9810834095142736,0.7641130237726574
HCC1500,9866186,3.137309558941867,1.3030033502090503
HCC15,124202324,2.163317754038658,2.6546251181800424
HCC1500,6917907,-5.345696307345718,-4.491084848550926
HCC1500,23635314,-1.1425681705854864,-1.2186708782214632
Granta-519,126941,-4.311277898608593,-3.2755959683909355
SU-DHL-1,tretinoin-carboplatin (2-1 mol-mol),3.205630539300333,4.140944346465777
SW948,24771867,-2.1331828785420166,0.00381208462773595
HARA [Human squamous cell lung carcinoma],638278,3.613202989039307,3.3237037229127355
LCLC-97TM1,10410894,3.7243046596553344,3.2568759970008845
COR-L95,11609586,-0.6075050167057128,2.197557876694054
MOLM-13,9952709,2.652499766566874,2.20869421396431
HCC15,24951314,1.20775234306688,1.5119151244671571
BFTC-909,11175137,1.859642091823866,2.7347025006964354
PaTu 8988t,tanespimycin-bortezomib (250-1 mol-mol),-0.2002957463821567,-0.346763021128308
SaOS-2,9444,4.299296809659387,4.098687309891044
Daudi,71576739,4.751042411789338,3.3494805668355543
SU-DHL-1,6505803,-0.92520479323989,-0.9783006915896625
SU-DHL-1,11214940,-0.4959690036226346,1.8270591643950451
IA-LM,71466578,5.490140561499378,3.344705462873342
RERF-LC-MS,262093,3.104487938727744,3.1395418427293835
SW1271,71466380,4.990835020791986,4.429713173309238
Panc 02.03,135411,0.8368106867561712,0.8836706387333543
RERF-LC-MS,8515,3.770178660744851,4.156641913218553
HCC15,45100309,5.717971650422449,3.1771747503522936
COR-L95,54618771,1.9587299059916856,1.0281549340897245
LCLC-97TM1,16736978,1.4629436365964008,1.5164966487525715
IGROV-1,9825149,2.5588021380929553,2.3373954854021637
IGROV-1,227681,3.5439813498262347,3.349581816482457
RERF-LC-MS,44489675,3.7548789887197183,3.858110272065224
MOLP-8,3136844,3.797428854524256,3.750845172575967
COR-L95,5746,-1.1189080553056585,0.21924505717674275
BICR 22,135398516,2.7677082767193117,1.960620689590496
KU-19-19,tanespimycin-gemcitabine (1-1 mol-mol),1.208542786585586,-0.6716708568572143
ALL-SIL,57330099,4.126515702027515,3.8288033507647974
SW48,135398738,2.3509294796071454,4.394255559000481
WM115,2113511,5.303490143807845,5.516265512286204
Daudi,2729026,1.2833432455886875,2.2313621964913786
P31/FUJ,100016,5.4217002529902185,4.973658415366195
IGROV-1,71466445,2.3758001916617797,4.0089789708597205
ALL-SIL,6918878,-0.682122479171039,0.48928517136108085
Daudi,73707371,3.866210661620395,3.7413475980408406
ML-1 [Human thyroid carcinoma],60700,-3.146668380067059,0.44299080903435617
SW48,11364421,-4.967269122022574,-1.9371399379049625
HCC15,selumetinib-JQ-1 (4-1 mol-mol),1.0945511889039805,1.5039933168377828
LS411N,135411,0.7383506227122603,0.5031378954917755
K-562,3634881,3.4419902111623473,2.755966887271555
KU-19-19,969516,2.8919422545546043,2.9357540708767864
Daudi,135999136,4.063293138043838,2.4148676878364244
SU-DHL-1,12001922,1.0574025128990867,1.717073797326893
HCC15,carboplatin-UNC0638 (2-1 mol-mol),3.871381279129182,3.3919127181081654
MDST8,11427553,3.108888701151444,3.091278813757468
COR-L95,navitoclax-pluripotin (1-1 mol-mol),-0.7248049337705845,-1.2667604554321863
HuP-T3,9840324,6.187364891887578,5.8198469837359355
RERF-LC-MS,5281321,-2.2570738048063257,-1.254498483695032
UACC-812,16725315,4.601797708491857,3.955992464576234
WM115,53481919,3.625694730030069,3.9615818450481517
WM115,3136844,4.4781621433894925,4.483891098755793
SK-HEP-1,135999136,5.290710201924687,3.987815866005643
SK-OV-3,72734382,4.397767647147488,4.8993864312974065
SU-DHL-1,4096211,0.0680701310214702,1.5525768739325068
SK-CO-1,2749,0.8616454488616467,2.1071875821319814
COR-L105,4477,0.3499366832640422,0.7446580793838505
SW948,24785538,-1.2786696026485709,0.255825381335572
BICR 22,25161177,4.685384367036766,3.9932673765629794
Granta-519,11955716,-3.0537796337487064,-2.553323326672205
ALL-SIL,10127622,5.469150259822909,3.560238718926895
SK-CO-1,11238147,1.2924304468719774,2.7193304470628927
IGROV-1,11427553,2.926316692603687,2.9060946221137414
BICR 22,54618164,4.171441086739322,4.134869059952326
BFTC-909,57519531,3.2286550647211025,2.8680540890832167
SaOS-2,1750826,-1.0374385524430834,-1.523085713047972
SU-DHL-1,71466445,3.7763473385017994,2.6095081318524747
SW1271,6852167,3.737297660761554,2.880430575366903
SW948,9549297,1.722924191719054,2.35620961021146
BICR 31,72376,-0.802396523967939,-1.496138239642779
SK-HEP-1,56946209,-4.57873882670014,-3.8201629448765915
RKO,24964624,3.0430796891613903,1.512066382126013
NCI-H2452,54143018,0.9899128272921088,0.7047499324258404
SU-DHL-6,60750,-4.821248170588626,-3.7231488850451844
HEL,44259,1.31343744649104,0.39440562940156576
MDST8,3038522,4.546677862508445,2.935119006088162
Daudi,72193861,0.2314245956601211,0.27065781349903184
NCI-H2452,4096211,2.487981551988898,2.248741918817012
LCLC-97TM1,carboplatin-etoposide (40-17 mol-mol),1.252125961208134,2.3811680174175236
Daudi,208908,1.616008502166041,2.2059726963546815
LS411N,46191454,1.665967132338862,1.1693804896966034
Panc 02.03,262093,3.467425891303458,3.0740465016575182
COR-L95,462382,0.8255977399878551,0.9631421623827039
IGROV-1,16736978,0.1982875499977011,1.8368380524013042
MDST8,107985,-3.301997074358414,-3.514267562641588
COR-L105,navitoclax-gemcitabine (1-1 mol-mol),-0.9402734681791266,-0.5793798016028662
ML-1 [Human thyroid carcinoma],65064,4.907366569161651,5.101410039993528
RKO,54618164,4.0326978900214705,3.981126631592354
MOLP-8,5311,0.4432260076750803,0.4713033418428946
SK-HEP-1,5291,4.1108608913621545,3.7257334660817194
SaOS-2,107970,2.235066344736828,2.3466169161112718
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905,2.6103998565450537
Granta-519,6252,-5.172240666242431,-1.833800466181603
IGROV-1,285033,-1.3538783590767758,-1.8011463849982874
RKO,serdemetan-SCH-529074 (1-1 mol-mol),2.0344925203933006,1.5111723131326775
NCI-H1568,46191454,1.7726304550427152,1.8134443932930926
PaTu 8902,24856436,4.585148807200659,0.42331558620803017
WM115,5351362,0.9981168658111552,1.6391581246237814
IA-LM,387447,-4.406032561698067,-3.6604396255350826
MOLM-13,656346,-0.3431029585418202,0.4847245678127026
COR-L105,637858,2.3247583240908405,2.301587237712365
Daudi,448949,1.1283153338590814,1.351942891924448
SW948,42642645,-0.386998084672917,0.3829480292640545
BFTC-909,JQ-1-carboplatin (1-1 mol-mol),5.2410563732595845,2.4995964568638054
HCC1500,52947716,-7.376885049387286,-0.7813882751254401
MDST8,439501,-2.351670240427255,-1.912886817202849
RERF-LC-MS,25161177,4.303824118845859,4.371180794081938
SU-DHL-1,3634881,1.9377929493272257,2.821689988104274
RKO,46398810,2.934390735401444,1.9347381519924107
BFTC-909,carboplatin-etoposide (40-17 mol-mol),3.649517561488253,3.0379348923691754
HCC15,159324,2.6315252421023536,3.263831271060257
PaTu 8988t,serdemetan-SCH-529074 (1-1 mol-mol),3.002094874495684,2.1075052661046314
HARA [Human squamous cell lung carcinoma],11612883,2.0711773248440783,2.8424944071654936
Daudi,2949965,1.2926680931891954,2.1496300773915955
RKO,23725625,3.9986828157613616,3.8258808311378
HEL,16722836,0.561669465799647,0.8173150700433741
Panc 02.03,11175137,3.7353172411310696,2.7936196291212387
KU-19-19,6918878,0.8609723302141853,3.2420176708880537
Granta-519,docetaxel-tanespimycin (2-1 mol-mol),-8.26947994699302,-5.461907723785723
SW48,3854666,0.5343434371102147,1.8949990875569396
SK-HEP-1,11626560,2.7034566874481745,2.112765702024921
ML-1 [Human thyroid carcinoma],navitoclax-sorafenib (1-1 mol-mol),2.2930044306717954,1.9976197756254035
NCI-H2452,3825829,3.8827569930751937,4.298125012069915
BFTC-909,126941,-2.0975077483758415,-2.568909520744877
NCI-H2452,24951314,1.9717681393720747,1.7684215819230251
HCC15,54454,0.5186235809490349,2.7062252363936175
BICR 31,4096211,1.2121831781068038,2.170145406920873
SK-CO-1,6914657,-1.8836208914019363,-3.6188279947549615
SW48,44493528,3.8128145383765992,4.174410489912854
COR-L95,BRD-A02303741-navitoclax (2-1 mol-mol),0.0270607892224954,1.3456066059645824
SW1271,168312962,3.6054980890180746,1.7610417508287313
HARA [Human squamous cell lung carcinoma],5566,3.127581032716584,3.035820390694677
Panc 02.03,135440466,3.0724615257354153,2.2117965115587377
PaTu 8988t,navitoclax-piperlongumine (1-1 mol-mol),3.1694697801552025,1.8344602229292404
BFTC-909,11427553,2.7610941057010754,2.962954166441055
LS411N,ISOX-bortezomib (250-1 mol-mol),0.5408045393266885,0.613500310692223
SW1271,44493528,4.286060334293371,4.377541026352092
Granta-519,JQ-1-MK-0752 (1-1 mol-mol),-0.0004173872761687,-0.38509707833813345
LS180,49836020,0.6204023867713871,2.696244697738542
HEL,148198,-3.399100076616297,-3.9795178331161
ML-1 [Human thyroid carcinoma],19582717,3.041392892734857,4.532540196488009
Granta-519,3543504,5.0961511485487705,3.354339491348703
HCC1500,3038522,2.0060085934463108,3.0565343741494604
RKO,4917,3.097539294413192,2.9064840092891275
RCC10RGB,168312962,4.335962117924443,2.306087404462037
SaOS-2,104842,-4.966916923279438,-2.5542112193717275
Panc 02.03,753704,5.09544361232119,5.208219859774305
PaTu 8988t,439501,-3.4446792284706347,-2.081705814905023
LS180,5282054,4.115839158247494,3.8200666058986275
IA-LM,5287620,-0.8479822353163541,-2.052235583190071
RCC10RGB,6610216,4.531223922644925,4.3358387030858925
SK-OV-3,vorinostat-carboplatin (1-1 mol-mol),3.580838266034329,3.2781502314430337
HuP-T3,selumetinib-tretinoin (2-1 mol-mol),3.9566869559335585,3.048249588185074
SW1271,9911830,2.7072275961126997,2.5419663123004073
WM115,11719255,3.1992621528929166,3.6184727245143034
RCC10RGB,42642645,2.104174802814935,1.3312539901069433
K-562,72376,-2.627875463605781,-3.4544897202433127
KU-19-19,selumetinib-vorinostat (8-1 mol-mol),1.3262473417693337,2.516016276958348
HCC1500,9549297,1.8848953505663728,2.462272529559833
HCC1500,44241473,4.374636754710865,4.660759794383258
HuP-T3,2708,5.229598766149438,5.0774715857436705
P31/FUJ,9866186,-0.5408158091236333,0.10933165976309946
RERF-LC-MS,11657048,4.330866638894723,4.313280503853589
HEL,119182,-2.1951032337756935,-2.752935495542269
RCC10RGB,10296883,4.350673741830848,4.056862710162485
MDST8,10385095,1.2575537617816142,1.4433532309451984
SK-CO-1,23635314,-1.3218098525260824,-1.5285333985153124
BICR 22,72199289,4.441607504718354,3.3663175018594234
MOLP-8,9911830,1.992368688928045,1.944492355753968
SW48,24772860,-4.097111396936187,-1.8224501518458942
COR-L105,8515,4.561371818511258,4.111241790421363
IGROV-1,15547703,3.339928221860449,3.3183980775582658
SU-DHL-1,656346,-0.4085927723055031,0.8215514771335748
COR-L105,168313200,3.683873258385797,3.0516103512326085
Daudi,46224516,0.8162026590632436,2.0402644750669627
Granta-519,5287620,-2.8216901996678985,-2.4371997195153714
P31/FUJ,JQ-1-vorinostat (2-1 mol-mol),-0.2741289026450685,-0.6556327365650192
UACC-812,11640390,4.086462739167014,3.167237271751026
K-562,17755052,3.8994339695870326,1.224028389040146
BICR 31,selumetinib-GDC-0941 (4-1 mol-mol),-0.0760223515380139,1.5255793080422757
LS180,656346,-0.0089884994203474,0.6511206441507101
LS411N,selumetinib-UNC0638 (4-1 mol-mol),2.4499191002493315,2.817732047472973
SU-DHL-1,5311281,2.996662642824561,1.9303078789900048
RCC10RGB,25161177,5.612412997721579,4.109394056332185
K-562,3854666,0.2872946014041473,0.9830003599228732
P31/FUJ,9825149,2.400010374644864,1.7260034169204166
SW1271,11964036,1.1602803966527862,1.3176725041750168
LCLC-97TM1,176870,1.9757247403033509,2.827038632629764
K-562,168313016,4.482960220744853,4.034516650154481
BICR 22,selumetinib-PLX-4032 (8-1 mol-mol),3.113612897977895,2.437253909145625
SW1573,285033,-0.3175288260868649,-1.5716849013515626
BICR 31,4788,6.181654669045445,5.733230689426379
LS411N,11404337,-0.9351547419605356,-0.46522531222569424
RERF-LC-MS,9967941,1.5454786965180345,3.617210867104474
Granta-519,56973724,1.8473061894805545,1.6260600662787517
K-562,11507802,0.4095176942133114,0.6600712460950616
SW1271,1750826,-3.093550008900348,-1.7208088364278342
P31/FUJ,135398738,-0.0291234665218711,2.0349532569147595
WM115,5329102,1.7959886386080517,1.8986260725961186
MOLM-13,5470400,-0.3466627309634489,0.3386543024722644
WM115,navitoclax-PLX-4032 (1-1 mol-mol),-0.9695757520165332,1.9467985889044277
Granta-519,44607531,0.7355881041308102,0.9535994792343135
RCC10RGB,5566,3.997570642857795,3.0049513077834065
KU-19-19,24964624,3.8522438290321768,2.661606244763553
WM115,1641662,3.4019570651475557,3.691416913427081
BICR 22,5282054,4.223594396310054,3.5616857941552524
BICR 31,10231331,3.776464743887352,2.269435466828167
RKO,3825829,4.017808531984142,3.3688590989537506
Daudi,10322450,2.3131627402631905,2.9091963929814306
BICR 22,285033,-4.068757657270757,-1.480591596590522
SU-DHL-1,5281321,-1.7372628502658949,-0.8201676159890405
RKO,5287620,-1.9975210326345276,-2.011454386219733
Panc 02.03,53232,6.367991743549877,2.9718854470591776
SaOS-2,9826308,0.4955218987390744,0.6403301608502381
HuP-T3,10074640,3.8159838645365807,3.1533904227049936
SW948,4259181,0.2292867461834122,0.11948859390732737
HARA [Human squamous cell lung carcinoma],11222830,1.4006503885864872,1.6010636329071115
IGROV-1,568763,0.665047061839467,0.5048329413261234
ALL-SIL,decitabine-carboplatin (1-1 mol-mol),-0.0286812837112609,-0.45062691572552876
MOLM-13,322968,2.556875190594409,2.3257875720247565
ALL-SIL,9903786,1.532435199339551,1.7911509094981548
SW1573,409805,6.568626512075582,5.199808746027036
LS180,1750826,1.061711606063746,-0.3925609470484167
HuP-T3,46191454,1.9484889201022677,2.041056842263397
ML-1 [Human thyroid carcinoma],24901704,3.6288922396747743,3.488484867750642
HEL,216345,3.87635579429504,2.7305045977391686
BICR 31,2749,2.2358137088107033,2.1564473785842697
SaOS-2,3385,7.1536746080698395,3.981214916047329
WM115,11626560,1.643291568999912,1.7642970408279697
BFTC-909,selumetinib-GDC-0941 (4-1 mol-mol),1.742559417066922,1.7559853322109056
ML-1 [Human thyroid carcinoma],36462,0.3533243941090192,2.3665068445037805
Granta-519,24964624,2.975569692960617,1.3464430879398208
HARA [Human squamous cell lung carcinoma],16038120,0.7093520184689783,1.2615449016470546
COR-L105,6918638,0.8528151020185122,0.6995500846817341
RCC10RGB,9825149,2.634802111166888,2.6311140853823987
HCC1500,44493528,4.240662848371031,4.414798361148844
COR-L105,44489675,3.747818158649104,4.10383836577535
SK-CO-1,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1356145956067642,3.2308127996706095
P31/FUJ,selumetinib-piperlongumine (8-1 mol-mol),0.6855922532418997,1.6213963899851906
BICR 31,2746,4.041774334142006,3.373759630180918
MDST8,51037431,3.453193232905579,3.059365475363417
K-562,676352,1.515837042857868,1.84707115555793
LCLC-97TM1,73707386,3.587652793939767,2.664604925646022
SK-CO-1,54618164,4.180915062416914,4.0856285693762535
SaOS-2,5329102,1.942826181308244,2.051010351223349
SU-DHL-1,doxorubicin-navitoclax (2-1 mol-mol),-3.969153330724774,-1.9292345070490178
LCLC-97TM1,151289,0.9235530786043882,1.0258501526399306
BICR 22,400769,0.1100780529561809,-0.3980810106551521
Panc 02.03,docetaxel-tanespimycin (2-1 mol-mol),-0.6813802759264704,-2.4802266351557667
SK-CO-1,400769,-0.6897300489229926,-0.620521723822889
SW1271,56973724,2.58013716529859,3.1785561584144317
LCLC-97TM1,2945648,2.6479910997037934,2.8021241173801745
SU-DHL-1,439501,-2.3864560258185916,-2.07642575841579
NCI-H1568,148198,-4.9953315451672005,-3.342685194697251
RKO,11507802,1.7455765117352984,0.8775632617187409
Panc 02.03,216239,3.7763245170365183,2.3077646036221076
HCC1500,9825149,1.9829642871568696,2.1293630727817567
NCI-H2452,53232,3.5381177646863837,2.785527376578017
MOLP-8,11494412,0.4734092912657368,0.18190245158033203
Granta-519,9911463,3.5000933341892733,3.1152100900757813
SK-CO-1,10410894,3.775604170297083,3.268452020865456
Granta-519,navitoclax-pluripotin (1-1 mol-mol),-1.5381813072816537,-2.6966924668731247
MDST8,5328940,2.138158341424683,1.9830142367176788
SaOS-2,1716436,3.427239396926117,2.9460217459667253
HuP-T3,9887053,4.07990532641299,4.158678510153723
NCI-H1568,24772860,2.3104914540479324,-1.8719702945304078
LCLC-97TM1,135999136,4.356650968290631,3.5198827381289766
IGROV-1,4378219,2.016502068118561,2.6115568885069553
BICR 22,46199207,3.899734747403315,3.0772486638989647
BICR 31,9915743,-0.3251640044425866,0.5777670993434041
NCI-H2452,613753,2.817247196569438,3.3631350681707572
P31/FUJ,46174525,2.51911302821391,3.239569793856752
P31/FUJ,5335621,3.2282922271331613,4.043637945523307
IGROV-1,5278396,3.119031774261392,3.5605648712053206
HuP-T3,16038120,1.51216352382263,1.0680871411347765
LCLC-97TM1,17755052,0.1986775459223547,1.4561943923069942
PaTu 8988t,66577038,3.1818565141070625,3.1854590496331916
PaTu 8988t,54618771,0.599962301527202,1.5071279771287351
SK-CO-1,46191454,1.747962727561699,1.9305912087049508
SW48,46907787,-1.5740012638710297,2.404394617802188
ALL-SIL,11485656,1.390704841990788,1.6367578577856294
RERF-LC-MS,selumetinib-piperlongumine (8-1 mol-mol),3.579320132644808,3.4537174219872666
SK-CO-1,4788,5.843658659854095,5.72501661376376
IGROV-1,16725315,4.890680859998698,4.305274896672329
SW1271,24821094,3.627509655063773,2.9709685645684885
Daudi,navitoclax-pluripotin (1-1 mol-mol),-3.474702671481659,-1.9847792233643302
WM115,216468,3.848857711215856,3.5132316922193105
SaOS-2,24779724,4.377738848523283,4.1591573208416
HCC15,675434,4.852455641097197,4.532473958046843
SK-CO-1,46398810,2.9216967746168625,2.5955573096303706
LS180,JQ-1-vorinostat (2-1 mol-mol),0.4669519655203766,0.9962016869565887
Panc 02.03,123631,3.5560371664842325,2.5130630393119553
SK-CO-1,448949,1.9523830928265349,2.0661021729759286
RKO,285033,-2.0365968290915393,-2.391439650487114
SW48,2749,0.8385534684858028,1.8953735906858085
IA-LM,navitoclax-gemcitabine (1-1 mol-mol),-0.1598122581920494,-1.1477037208588825
HCC1500,54618164,3.7944844711277264,4.141768725679537
Panc 02.03,2858523,3.458791746781272,3.0378431517961686
PaTu 8902,piperlongumine-MST-312 (1-1 mol-mol),2.709357535529884,1.9559115975732084
COR-L95,4261,0.3666433774913241,1.1894189233739885
HEL,126941,-3.7945695708983664,-3.163113869113319
HCC1500,54596490,4.413271545106012,4.840810732325437
BFTC-909,375860,-1.1901103647211757,-0.09033592575189094
COR-L95,9866186,0.0204391385842873,0.7646234404398627
BICR 22,66577038,2.5300885228037813,2.675824037262903
SW948,9826308,0.2428169991227084,0.17240295263918606
MOLM-13,73707440,5.976327057082507,4.279351391204106
PaTu 8902,5291,3.72219732976082,3.577817155915162
RERF-LC-MS,5470400,2.5584942331402623,0.24373698634702617
SW1573,16725315,3.253832365815957,3.9969692475942127
SU-DHL-1,3552672,1.9257473882600096,2.769134877333355
HCC15,60750,0.68669542572171,-1.4238869368300044
SW48,5328940,0.1162920415883012,1.739855658729886
PaTu 8988t,4378219,1.99751885903338,2.7045452458250656
HEL,241158,3.370113308144609,2.7841300017500776
MOLP-8,53495165,-2.6639864548579535,-1.989792176450841
LS411N,46943432,5.879073426568822,1.4956155160510838
LS180,ISOX-bortezomib (250-1 mol-mol),0.5409757723847333,0.8040991674418255
SK-HEP-1,selumetinib-UNC0638 (4-1 mol-mol),4.697700742307761,3.2046252469956507
Panc 02.03,4521392,4.25988041093388,4.3469607079981
SW1271,5951923,6.143368489838077,4.222602146679791
IGROV-1,selumetinib-PLX-4032 (8-1 mol-mol),2.802309242721903,3.3283627110081677
HARA [Human squamous cell lung carcinoma],44185566,2.9912273208606552,2.516702143340827
RERF-LC-MS,11717001,4.567893424272946,4.256384419339512
NCI-H1568,25102847,1.8020479238639409,2.5602689182209923
MOLM-13,44137675,1.768154079183361,2.7162170760641366
RKO,10427712,4.823698606341804,3.7902792004410037
BICR 22,6852167,2.9570859917106533,2.7012795506614258
ALL-SIL,vorinostat-navitoclax (4-1 mol-mol),-1.3745471945547945,-0.7516813394033532
SW1271,124202324,3.327062905972079,2.7131974013584768
WM115,400769,0.2375153529743729,-0.4454551544409256
RKN,3038522,4.332475047921768,3.27332072713047
SW1271,4096211,3.040458805184357,2.112430040179348
BICR 31,60700,1.4006980690412227,0.0872312064030369
Granta-519,448949,1.64880276038625,1.2544395637296386
HEL,11964036,0.787171767074348,0.2584393436204747
HARA [Human squamous cell lung carcinoma],11485656,2.214748392282881,2.140539201804034
BICR 22,11485656,1.7887481250962165,2.414439032931923
HEL,44202524,1.7623585771552046,1.4521607035010127
COR-L105,3503,2.4932686195421625,2.4628985380457333
LS180,4788,5.917574515812926,5.674715811364512
IGROV-1,219104,3.803083685328391,3.658673378772653
IGROV-1,11152667,-1.4116509977729443,-0.4807995690827441
LCLC-97TM1,JQ-1-MK-0752 (1-1 mol-mol),0.5638595279312849,1.4468069681344842
HuP-T3,11485656,3.0565489144797224,2.3710362955619724
NCI-H1568,9907093,3.7800753982052697,4.143102311118603
LCLC-97TM1,10184653,1.174063194948861,1.1976283396760006
MDST8,16038120,1.9679009346440888,1.2532940447722611
MDST8,navitoclax-PLX-4032 (1-1 mol-mol),-1.0125849451326647,1.966000791047048
NCI-H1568,216239,1.54277692538335,2.3004425142217553
LCLC-97TM1,5280436,3.0011603005672804,3.1701081430390357
IGROV-1,selumetinib-UNC0638 (4-1 mol-mol),2.5141275878807563,3.496361764253738
Granta-519,5281321,-3.900138103622144,-2.596593711337201
NCI-H2452,6917907,-3.4621989648593696,-5.045700128661059
HCC1500,135659046,2.9858139057826905,3.7897225711037006
P31/FUJ,3825829,3.1586120375796516,3.2657215262940635
NCI-H1568,selumetinib-piperlongumine (8-1 mol-mol),3.9234194964704185,3.297052181763387
SW1271,JQ-1-navitoclax (2-1 mol-mol),1.3503657606474289,0.6602314133194527
SK-HEP-1,7326481,2.0213225214426505,3.035560380210113
PaTu 8988t,JQ-1-navitoclax (2-1 mol-mol),1.798415555135888,1.050699313516919
HCC1500,3634881,3.181593200231373,3.5476177468009427
HuP-T3,5311,2.274555641774389,1.5035237105117847
P31/FUJ,969516,2.490551298955204,2.165910552863981
LCLC-97TM1,25183872,-1.9138026924081315,-0.7302804442205623
WM115,54619267,3.5599503094850244,4.188629166742159
HARA [Human squamous cell lung carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),3.6972893846800545,3.14134501283297
SaOS-2,17755052,-0.5339241699834809,1.8559307457483947
SW948,decitabine-navitoclax (2-1 mol-mol),2.8681609289857155,1.3869839943863278
SaOS-2,19582717,4.316823865856345,4.012320672993634
COR-L105,25105715,3.731140483220641,3.4218398518589193
SK-HEP-1,5278396,4.037206436677834,3.7399429845703316
HCC15,erlotinib-PLX-4032 (2-1 mol-mol),4.047611661511117,3.0505053177056025
COR-L105,6918837,-2.1114263163326177,-2.236401442146022
IGROV-1,25262965,-3.18785020602057,-1.769235086629601
HuP-T3,6505803,1.3238670991795596,-0.5454766122266401
NCI-H1568,11214940,1.6761106979183067,2.2745032616258336
HCC15,44543605,4.452652862359365,3.961965454569624
SW48,46199207,2.9489751610364405,3.3337932363025984
P31/FUJ,104842,-4.465734156959207,-4.10905010337498
MOLM-13,24180719,3.226510234308061,2.990206482619237
HCC15,12003241,-1.0460858766179792,-1.1510556673969434
IGROV-1,10231331,1.9104831176724932,1.9562684504898138
IGROV-1,107970,2.287061680908213,2.450293041578794
LCLC-97TM1,46907787,1.8795083111860824,1.5279072929928645
IGROV-1,5278396,3.119031774261392,3.5605648712053206
SK-CO-1,5329102,2.034917542642271,2.003066053240407
SK-HEP-1,11152667,2.375581084403437,-0.37626767234626046
WM115,2126,3.806678244062894,4.812831702379844
SW1271,selumetinib-decitabine (4-1 mol-mol),1.699127774006886,4.044730244838089
K-562,6918736,-3.666344542032524,-2.3337414270390453
Granta-519,6450551,1.162651959279597,1.1490669655835533
NCI-H2452,5479543,3.804245584293823,3.749174632271426
Daudi,11497983,1.6119133198716458,-0.05101010797486505
WM115,4521392,4.32247006400087,4.167356731918618
MOLM-13,24901704,-2.733844077576574,2.0169422319914294
Daudi,56973724,1.9677776982823123,1.8628306173719085
HCC1500,613753,3.153964202511791,3.1356858387896596
Granta-519,5460769,2.1422187145203897,1.7590688169130444
RCC10RGB,53495165,3.554009618530711,1.2036923890825153
PaTu 8902,3854666,4.137852419807088,2.230353005044135
Granta-519,151289,0.2062194994497177,0.26968009870928233
MOLP-8,5479543,3.0970965636903327,2.914635792934845
LCLC-97TM1,4096211,1.6170661636178802,1.7301911384456152
LCLC-97TM1,SNX-2112-bortezomib (250-1 mol-mol),-1.5766290939625012,-1.4814456411572599
SW48,9907093,2.826389946725867,3.9251964383957985
MOLP-8,5281672,3.2641398124752063,4.2907501543133275
SW948,6610355,3.913576061403015,4.3685790641786255
SU-DHL-1,5746,-2.2023974745237815,0.030494343131464575
MOLM-13,10410894,3.311191932806664,2.466530683809735
SW1573,3384730,1.5192292760027193,3.129413114691007
IGROV-1,navitoclax-piperlongumine (1-1 mol-mol),2.320051681006032,2.072402223136384
NCI-H2452,54649381,5.966732082850981,3.967780234671343
COR-L105,JQ-1-navitoclax (2-1 mol-mol),0.1739680576486409,1.331063110595067
BFTC-909,9444,3.603329432205708,4.271488558907119
RERF-LC-MS,SNX-2112-bortezomib (250-1 mol-mol),-2.268317507970671,-1.1622414098097218
SW1271,9952709,3.6093754742197706,3.1967850417786208
IGROV-1,4788,5.801051990484709,5.600943865352735
K-562,3825829,2.9396673791475587,3.3584100368464194
COR-L105,53232,1.738169806280081,2.9614884222395976
Daudi,25195348,1.3194617548918357,2.493686651143071
NCI-H1568,46199207,1.8853593558521984,3.2619535376039757
RCC10RGB,135440466,4.497503570362309,2.2050439410522
SU-DHL-1,navitoclax-birinapant (1-1 mol-mol),1.3479254816656925,0.6705636057948048
NCI-H1568,3062316,1.133797551734723,1.268630159977713
Panc 02.03,56649450,3.905458120664549,3.503141364877408
RKN,44589607,3.09715941328701,2.9973871931678757
MOLM-13,568763,-0.9067431163570788,-0.1503645912848804
MOLP-8,444795,3.9342801961368417,3.346333575968105
RCC10RGB,navitoclax-piperlongumine (1-1 mol-mol),1.8990680206310235,1.510211764204389
COR-L95,selumetinib-piperlongumine (8-1 mol-mol),2.799372777395438,2.3591117971369413
COR-L105,vorinostat-navitoclax (4-1 mol-mol),0.9761778131002136,1.7220460711871195
IGROV-1,6918878,1.6706182189896102,2.8251442720745326
BFTC-909,piperlongumine-MST-312 (1-1 mol-mol),1.831832453388112,2.1342357069103874
BICR 22,5280436,0.2666608642372045,3.0379263456757912
BFTC-909,3081361,3.110656330811392,2.527370672375541
PaTu 8988t,45279963,4.21642269895433,3.5453307549302933
MDST8,613753,3.2461287764543085,3.213395572630629
LS411N,6917907,-5.419583860239815,-4.903269346043346
HCC15,5335621,5.428336568471036,4.82776515410578
SW48,71466380,4.3724837890251935,4.388618812924768
SK-OV-3,66577038,3.416512813520814,3.083432954496749
RCC10RGB,49766530,-1.6086406954404375,-0.4181926383750825
HuP-T3,16722836,1.72068374216493,1.9462011494654687
MOLM-13,168313016,3.5509192860421592,3.5995879496423924
SU-DHL-1,675434,3.83709506639581,4.322391098265396
P31/FUJ,9911463,3.6551866379259743,2.9629478902471487
P31/FUJ,445455,5.725867195241275,4.045009655135027
MOLP-8,285033,-4.447286141218139,-3.0651444212675534
RKN,107970,2.600341318615175,2.424483902269027
IA-LM,4788,5.899787929501101,5.685705701017872
RKO,71680916,5.910552922648844,3.9492873616345876
K-562,9825149,1.660902694463834,1.816761547349723
RCC10RGB,4261,3.441062261939301,1.9879540557607154
IGROV-1,387447,-3.9508602289798658,-4.222563559401191
WM115,54618164,3.776567993994872,4.195397614521104
LS180,44607531,1.744731406430345,1.4864034985953551
NCI-H2452,123631,2.1406097245383062,2.8156259375618653
K-562,262093,3.1056763935044813,2.0637727470407534
MDST8,24180719,2.4870372971011374,3.0793848495601144
WM115,66577038,2.911239385644133,3.0808778695739885
SU-DHL-1,6918328,-0.7249486298416586,-1.2814120302167171
NCI-H2452,135999136,4.5117873079445205,4.140300496214549
ML-1 [Human thyroid carcinoma],9823820,3.655965927562111,4.349510812785448
PaTu 8902,11609586,3.6092581559147185,2.8674668116932946
IGROV-1,11497983,4.37450324471555,3.930972573684747
RKN,387447,-2.9807645129134066,-4.18994839594319
LS180,6184667,4.288388758455988,2.8642809252084582
RKO,JQ-1-vorinostat (2-1 mol-mol),0.9623246898976432,0.10365459196915314
NCI-H1568,5460769,1.1324377767406906,2.9401919774114
ML-1 [Human thyroid carcinoma],374536,-3.4857090018028956,2.503904899391203
HuP-T3,3025986,0.0333046209415895,-0.7134786125711369
IGROV-1,11625818,2.877471533668122,4.50841022808998
SaOS-2,122327,5.211292969638739,4.783444800257165
BICR 31,46943432,4.176233154169203,2.6901342326243305
HCC1500,10427712,5.196976599700856,4.376392121472797
K-562,9866186,0.7861847855254385,0.2288379427766743
RKO,10231331,2.816804700080647,1.30225336489791
NCI-H1568,126941,-1.411149621431801,-2.672224556475442
HCC1500,9933475,1.9677534910437375,1.8694600903174985
ALL-SIL,53245473,2.8781179496967666,2.991526291313877
K-562,135423438,0.8826240773524879,1.2698817342126385
BFTC-909,9956119,4.255413767268681,3.74046163224561
HCC1500,9884685,1.9086372211674376,0.7736013968291401
P31/FUJ,71304818,2.235751993715144,1.9108577768658273
IGROV-1,tanespimycin-gemcitabine (1-1 mol-mol),-0.5447128478899342,-0.8477217853261126
MOLP-8,5470400,0.1664110443814662,0.25844435832006907
ML-1 [Human thyroid carcinoma],9967941,2.6659391926085183,3.9162727106043835
SW48,44819697,-2.186530212001632,-0.5483611334626355
SW48,12001922,1.4259296039497584,1.869492832484588
NCI-H1568,24951314,0.6613293075425478,1.7029270001724408
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057,2.7176867135552785
SW1573,51039095,4.568767182944777,2.7531408972296987
BFTC-909,46224516,1.8849058086882595,2.7970373836207933
SU-DHL-1,52947716,-4.8688827763192135,-2.010820800108167
IGROV-1,262093,3.169376516915595,2.9725385866170773
MOLM-13,selumetinib-PLX-4032 (8-1 mol-mol),2.341131850097057,2.5287537295625135
WM115,24821094,1.6911725066550027,3.307956790430656
COR-L105,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9364869385558905,3.954679887422148
SaOS-2,53325874,4.45514535643454,4.55871484198009
SaOS-2,4261,1.4562926555721387,1.6857879826512039
Daudi,selumetinib-BRD-A02303741 (4-1 mol-mol),4.766499662103581,3.8451337876096976
SK-CO-1,9907093,3.652313916117519,4.039626742708004
SaOS-2,613753,3.192322830330122,3.269290198913181
BFTC-909,148198,-2.03933057080943,-3.1958879358878236
MOLM-13,49793307,-4.691237884437231,-4.329590694710899
ML-1 [Human thyroid carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-2.7240522304333763,-0.8216963693508241
COR-L105,135411,0.974173137304268,0.7325268914556073
RERF-LC-MS,135411,0.496828330774242,0.7848199232243388
SK-OV-3,16725315,5.283554915030345,4.085690487220176
SK-CO-1,3854666,3.8596661393399927,2.402014673839708
LS180,51039095,2.999333495393298,2.981458808338005
RERF-LC-MS,135440466,2.007932851474071,2.4949739231143413
SW1271,SNX-2112-bortezomib (250-1 mol-mol),-1.3790138823522573,-1.2953548863678186
LS411N,446155,3.6642844723827266,3.176135471431915
HCC15,72193861,-0.2523453521741511,1.9523074874387558
BFTC-909,52947716,3.1995758728854224,0.45145586006478944
SK-HEP-1,9933475,2.440596541444364,2.031680963269662
MOLM-13,702558,4.671896667990455,3.7212145665188308
P31/FUJ,375860,-1.2092771030706315,-0.6166796036876783
Panc 02.03,57519531,5.330694472788803,2.7499068327068055
COR-L105,selumetinib-decitabine (4-1 mol-mol),2.222127008727221,4.1045575175981535
HCC1500,11238147,3.2515653100317023,2.864179695936305
RKO,11427553,3.456895276763714,1.5943407589306204
HARA [Human squamous cell lung carcinoma],24771867,-1.145662696893675,2.9493529110827152
HCC15,9927531,3.758901572486559,4.614728927229587
Panc 02.03,107970,3.0394503344184214,2.4242057975887037
BICR 22,6917907,-5.724798000333263,-2.713546817545189
P31/FUJ,219104,1.0946129740431632,2.5008569488917702
MOLP-8,selumetinib-BRD-A02303741 (4-1 mol-mol),0.9308410221976412,3.5906426376798652
ML-1 [Human thyroid carcinoma],421610,2.367130129227347,3.4017909537539577
P31/FUJ,SNX-2112-bortezomib (250-1 mol-mol),-3.0882098716957223,-2.5444815091692137
COR-L105,23582824,0.3539942370445449,0.8506256655680587
RERF-LC-MS,selumetinib-vorinostat (8-1 mol-mol),2.5829848762682865,2.5536478628369443
NCI-H1568,135999136,4.3721543597322405,4.165765559546101
HuP-T3,11404337,1.0495167124251128,-0.32178224079788265
MOLM-13,2729026,2.3347481789683564,2.2390909811429403
IGROV-1,9935249,3.330117761231163,3.199113830122317
IGROV-1,16038120,0.2864038103759729,1.3520562690437021
NCI-H2452,11167602,2.565240148317103,2.564652923396435
Granta-519,4788,5.939837006566146,5.007944225374145
HARA [Human squamous cell lung carcinoma],9935249,3.837366541191349,3.2231900713939035
Daudi,2842253,3.640131040983124,3.1730588851265473
PaTu 8988t,9911463,4.367264855700764,4.003667897004684
IA-LM,613753,3.1957676281974328,2.8266668337240435
HCC1500,168312962,0.9454061370050444,1.9154032590932835
Granta-519,52912189,-1.096728840522365,-0.05787942119746197
K-562,67291369,1.5957287334193675,0.7654323893317314
HuP-T3,1750826,-1.878047057258104,-0.7833903944197372
RCC10RGB,24180125,2.398663234613943,2.8511002646750727
SW1271,5566,3.0013167075914344,2.974764499100165
P31/FUJ,126941,-4.476387704672624,-2.8295147123296913
ML-1 [Human thyroid carcinoma],UNC0638-navitoclax (1-1 mol-mol),2.518264645027629,1.7553981752408818
HCC1500,44486219,3.883233561942222,4.439270152690646
SW1573,24964624,5.100144587499453,2.8086157550342055
LCLC-97TM1,crizotinib-PLX-4032 (2-1 mol-mol),1.007977471964547,1.5594940151903964
Daudi,42642645,-0.8700738631175318,0.18245021412538853
COR-L95,carboplatin-etoposide (40-17 mol-mol),-0.214243666427535,1.8407233527590159
HARA [Human squamous cell lung carcinoma],5746,1.191361240850758,0.8745745111691504
SW1271,969516,2.705669665349302,2.8251404378012013
COR-L95,6918837,-4.56092327324237,-3.36695046278886
SK-CO-1,25154868,4.619527339846263,4.32677633279998
RKO,159324,3.5523933893017583,1.406169444046545
HCC1500,168313200,1.6452616775244175,3.1205216789508925
IGROV-1,4788,5.801051990484709,5.600943865352735
KU-19-19,5746,1.6270456089520258,1.0739808473550836
RERF-LC-MS,46398810,3.3112335021243977,2.6956144187527116
IGROV-1,6438330,2.7487580937365683,2.3732182510767257
PaTu 8988t,123631,3.803217986992814,2.424927108932306
LCLC-97TM1,5278396,4.167561166456711,3.362240834073126
WM115,71680916,4.535911767348542,4.821462536070919
NCI-H2452,322968,3.869715934392993,3.9973323552673516
NCI-H1568,2708,3.449118605167301,5.130710317321917
Daudi,5470400,3.6690588756853706,0.12513437311448364
NCI-H1568,3038522,2.281352774411324,3.1628697887972357
K-562,24951314,0.9405452740645998,0.587166283271653
BICR 31,44137675,3.031084694210408,3.504400059204873
SaOS-2,82146,4.466197629976123,3.753118976513602
ALL-SIL,BRD-A02303741-navitoclax (2-1 mol-mol),-0.9236991288199824,0.13184324957754542
HuP-T3,5738263,4.055810266621769,3.5612034683486904
COR-L95,11494412,1.7619372096243109,1.1911634255637216
Granta-519,11507802,0.4974969144595386,0.6521230916263384
WM115,2949965,2.619280368742809,2.871252525768692
HCC15,613753,3.363668001401703,3.396050212511179
HCC1500,107985,-3.8501888791364034,-3.676934266018132
WM115,54678924,1.8194282087981308,2.32865705171202
Daudi,135398516,-0.2737475793919353,1.0239694048969603
PaTu 8902,5280436,5.000479378124589,3.323773208357713
RKN,439501,-1.5558449248177562,-2.213235276614839
RCC10RGB,5287620,-0.3857243809023412,-1.556455717994664
Daudi,5566,2.2518803351891616,2.7767295329614865
COR-L105,31703,0.0245204691354453,-0.5916611147865126
LS180,44507138,3.917968702075208,2.3747336330564486
Daudi,11964036,0.3747037141940179,0.28893008027205364
K-562,16659841,3.212428083743772,2.5444062866468298
MOLM-13,54618771,-0.6841479707721928,-0.015489781441316582
NCI-H1568,49793307,-3.5648882234860895,-2.464745270330882
SK-HEP-1,navitoclax-gemcitabine (1-1 mol-mol),-0.1291553978520299,-1.5134455250627163
BFTC-909,vorinostat-navitoclax (4-1 mol-mol),1.5579626952552863,1.4458083647652296
KU-19-19,selumetinib-decitabine (4-1 mol-mol),2.1660518976484853,4.2439194647170515
SW1271,107985,-2.924919788256343,-3.6701578279603755
COR-L95,2746,2.78697970441755,2.3201281669175864
IGROV-1,104842,-1.6690343627553987,-2.4680437747234056
COR-L95,16038120,0.5843691628917023,0.6950211174648789
HARA [Human squamous cell lung carcinoma],73707398,1.6371281450925783,1.4648642336260123
HCC1500,123631,1.5682585338280497,2.3072600819936704
PaTu 8902,322968,4.547287257097872,3.8788351801010306
HARA [Human squamous cell lung carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.4213259806317335,2.107737830567868
Daudi,11167602,1.0022899570414256,1.9797394392220595
ALL-SIL,10074640,-0.3353589360570669,2.4956139206989847
COR-L95,57519531,1.325264870307383,2.0259182552129587
LCLC-97TM1,46191454,0.3820919964810073,1.6093394255514752
ALL-SIL,439501,-2.349752310116714,-2.693154130207002
IGROV-1,25126798,3.9275606774720817,3.9472645153516153
WM115,24753719,4.6734048968266775,4.370076333754951
HCC15,36314,-6.084589216701663,-2.1264176934954677
HEL,16720766,-1.3120587580234824,-0.7863745061934179
SU-DHL-1,11222830,1.179409628644554,1.5378540912214351
HuP-T3,3634881,3.0028113890745707,3.344003032515409
K-562,5738263,2.3545721599917027,2.6899489313396874
SK-CO-1,16725315,3.5012946679092853,4.350816677123221
RKN,327653,3.2518035953304434,3.3327826246327548
RKO,24772860,-3.046302255649564,-2.5887135711030687
HARA [Human squamous cell lung carcinoma],1750826,2.2891380116234616,-0.7504614944057117
NCI-H1568,piperlongumine-MST-312 (1-1 mol-mol),1.2489252589958966,1.878700515543433
SK-CO-1,15953870,2.1343083972614725,3.5593751478581823
BICR 22,71751553,4.276876209585518,4.398966143634958
K-562,24964624,2.9615918690112717,1.664842247057431
RKO,11222830,1.6656419736189183,1.294216822894107
RCC10RGB,25105715,3.76392637454814,3.455536100359304
ALL-SIL,54618164,3.625474128679928,3.389673654389345
HARA [Human squamous cell lung carcinoma],25183872,-0.077265330214196,-0.4042965489014618
SU-DHL-1,49793307,-4.256389272054101,-3.948601385106333
SK-HEP-1,9915743,2.4580731883892293,1.6140385453878592
SaOS-2,10410894,2.56650375580144,3.5524561984909564
ML-1 [Human thyroid carcinoma],9926054,2.0491703403306056,2.0026978512333784
COR-L95,44491742,4.146782751375218,4.321722148817459
SK-OV-3,44137675,2.687297746540291,3.8195464795662675
SU-DHL-1,4477,-0.6876815909262691,0.43316596830595366
RKN,5311,1.8833679583763572,1.5520469624653745
COR-L105,11640390,3.408966388045623,3.804307339668378
RCC10RGB,637858,2.3286326267725084,2.4255420403138617
HARA [Human squamous cell lung carcinoma],16722836,2.4020375260133595,1.7159470364124987
ML-1 [Human thyroid carcinoma],54454,2.7684179569761422,2.813515939983582
NCI-H1568,serdemetan-SCH-529074 (1-1 mol-mol),1.1632168234026012,2.135092698660418
SU-DHL-1,6852167,2.266746993939426,2.3844165493521894
HARA [Human squamous cell lung carcinoma],2945648,3.3865607820212316,3.0915912558544894
HuP-T3,49793307,-5.3581383477853555,-2.3944527808224505
SK-CO-1,5282054,3.655593178279643,3.8352154888368997
RKO,2841722,4.522769482159767,4.019673568507658
Granta-519,65628,2.6603144373939154,3.1059018562239964
SU-DHL-1,637858,0.6782178889909583,1.7549178065607873
RKN,9911830,3.6623648245681744,2.658780226814437
ALL-SIL,tretinoin-navitoclax (4-1 mol-mol),0.1560826957318693,-0.4253463997473111
MDST8,ISOX-bortezomib (250-1 mol-mol),1.0361241685592786,0.5984337562682875
BICR 22,9884685,0.2149660223226223,0.8747099749525918
COR-L105,46907787,0.7742744471044445,2.6797672296805315
RCC10RGB,navitoclax-sorafenib (1-1 mol-mol),2.209619948834929,1.7118826504570228
RKO,54618771,2.3159310195777985,0.8824428250138895
HCC1500,6450551,2.2317386689521816,2.7032903362816607
BICR 22,10296883,3.888864516393213,3.820529475088912
Daudi,10302451,1.2926011902861492,2.825366365012605
Daudi,tanespimycin-gemcitabine (1-1 mol-mol),-4.635562978503933,-2.7381045261698573
SaOS-2,JQ-1-carboplatin (1-1 mol-mol),1.527244446829994,2.512562955315396
Granta-519,216239,2.502983600228736,1.7244671700341327
RERF-LC-MS,selumetinib-JQ-1 (4-1 mol-mol),1.7940148785234815,1.6356107423764172
NCI-H2452,4521392,4.554150979099382,4.375642189682001
IGROV-1,123631,1.7694522866439453,2.504102085151027
IGROV-1,5566,3.174346862827938,3.0608278143707066
MDST8,72193861,1.790495642839322,2.0483933432189967
COR-L95,400769,-0.6446482680437077,-0.7977575429692396
SaOS-2,5287620,-1.8033063725700844,-1.9037645490188757
COR-L95,6917907,-5.619348954097505,-4.992464329017069
WM115,9840324,5.544544164897635,5.892479699588532
COR-L105,selumetinib-UNC0638 (4-1 mol-mol),1.9595144972930605,3.38741438304407
SW948,10322450,3.138867511839475,3.4749894238153285
K-562,25126798,3.746183025237492,3.521316030792872
LS180,5335621,4.412574333730147,4.447108761057181
SK-CO-1,9911830,2.5560928673864676,2.454752897343457
BICR 31,selumetinib-vorinostat (8-1 mol-mol),3.0204654665417237,2.477612390345555
SK-CO-1,9825149,2.4273154495027147,2.026331440217476
HuP-T3,tretinoin-navitoclax (4-1 mol-mol),4.772875046445671,2.8970573916812485
KU-19-19,10074640,3.725362653690234,3.1343911499218877
NCI-H1568,24901704,3.012455129702266,3.302019651023154
PaTu 8902,216345,4.855612410794221,4.089519046747929
LCLC-97TM1,44202524,1.0559659544617075,2.1783112721617663
MOLP-8,9884685,-1.6145757941110517,-0.32343205458608976
SaOS-2,11656518,3.53164758658959,1.7952770259802315
ALL-SIL,5280436,2.610850174870569,2.6257547591651913
ML-1 [Human thyroid carcinoma],10231331,4.187669502210677,2.1132686341986746
HARA [Human squamous cell lung carcinoma],JQ-1-vorinostat (2-1 mol-mol),2.5839829159057848,1.2114511519066384
COR-L105,16659841,4.469572921203622,4.064927692516131
SW48,11625818,2.5740084903132914,4.468601636738865
COR-L95,135875424,3.0866900102445816,3.574342585703354
NCI-H2452,10074640,3.4255764700713685,3.2607868749760796
SK-CO-1,60750,-4.4937571478067495,-1.5155411676957649
BICR 22,374536,2.9550889228261386,2.3110740729378665
MOLP-8,2126,5.134995770793403,3.921942947425635
NCI-H2452,5566,2.960608772215372,3.0766359178472795
Daudi,54618771,-0.114332288085178,0.2614479588575784
NCI-H1568,44137675,2.485428235347338,3.490308073526212
BICR 31,24771867,6.325583215176513,2.7220568924500417
HCC1500,135875424,3.5744445956281483,3.771080327740736
K-562,vorinostat-carboplatin (1-1 mol-mol),2.490945525629646,2.3064082182903367
IGROV-1,753704,6.461140333581179,5.004819816134278
SW48,11497983,-4.007853458767396,4.095801334083676
MOLM-13,25195348,1.114215790958376,2.254203246736383
Daudi,441298,1.3514709590925575,2.2316075733120355
SK-OV-3,124202324,3.0713957973247186,2.4347648553498975
BFTC-909,23635314,-1.3241610546701814,-1.569240227428329
COR-L95,71304818,2.943301589855332,2.279028112594431
SW1271,44607530,2.17277245139498,1.8449709500728202
RERF-LC-MS,219104,4.628133490361187,3.9744513980613148
NCI-H2452,31703,-0.2834256058580119,-0.7619020649137149
Daudi,462382,-0.0525304302162242,0.24638155118693209
SU-DHL-1,25183872,-2.297532702486321,-2.1791988585815676
K-562,54618164,3.946994253297547,3.80770439811112
SK-HEP-1,568763,1.0235069184223942,0.5010761585162328
SW48,docetaxel-tanespimycin (2-1 mol-mol),-8.123886258687621,-2.911315742973354
Daudi,BRD-A02303741-navitoclax (2-1 mol-mol),3.127125631555358,0.765570854528733
Panc 02.03,2828334,6.385741192046609,6.258655794705388
HCC15,5702613,2.8473188935914835,2.9191266016410258
PaTu 8902,11625818,4.430115392870615,4.395715956179715
COR-L105,53392493,2.0389615313780256,2.6787087675677386
RKN,3062316,2.6330403907451863,0.791344370847536
UACC-812,6505803,-4.59801553223132,-0.4800280457604916
UACC-812,16736978,0.0217391388778129,1.754875629554771
BFTC-909,5278396,3.473037688340168,3.7059625241245118
SW948,73707398,1.7510146080607218,0.9765653941001635
BICR 22,107970,2.71438120007047,2.382843630309319
SW1271,984333,0.5174855517327741,0.659650455222491
IGROV-1,9967941,2.9735049794712545,3.7990311838607536
SW948,tanespimycin-bortezomib (250-1 mol-mol),-2.5529889563934693,-0.9059522901773456
SW948,135984461,4.375312800732864,3.2802048314127075
LS180,5280436,4.14000298943632,3.4802707566180975
MOLP-8,219104,2.0853040324344536,2.4297358488070278
MOLP-8,1716436,2.7387406442001287,2.7788658635103354
MOLM-13,171352865,4.594115651620468,2.045700154440618
KU-19-19,10127622,1.068304480617998,4.028397936895041
KU-19-19,5460769,4.3332822587900255,2.892245586531429
LS180,675434,4.417044491450032,4.33673490280946
RERF-LC-MS,vorinostat-carboplatin (1-1 mol-mol),3.78748525663286,3.4540019837794067
SK-HEP-1,66577038,3.45712203265648,3.0747977336643784
SW1271,3689413,-1.2412691685690602,-0.4793304147890257
COR-L95,10296883,4.074268886544182,3.6026357550295565
HCC1500,5287620,-3.8084705838741306,-2.091743353433968
RCC10RGB,JQ-1-navitoclax (2-1 mol-mol),1.088443536961304,1.1798978759513588
WM115,serdemetan-SCH-529074 (1-1 mol-mol),1.0432203411705916,2.0492166786731008
SW948,vorinostat-navitoclax (4-1 mol-mol),1.0335682598311662,0.7731165662929866
SW1271,46843906,3.0036733058278298,3.0573864695209996
SW1271,10184653,2.439662406391272,1.3298680231889224
SK-CO-1,31703,-2.259601900898513,-0.5826783118991261
COR-L105,10074640,3.626128603914542,3.2302267306372063
MOLP-8,11152667,-1.9226575172330305,-1.7429012068413974
SW948,56646779,5.261847054930003,2.6605034584456204
MOLP-8,9825149,0.6088991704164435,1.5400045924476897
ALL-SIL,piperlongumine-MST-312 (1-1 mol-mol),1.1188007214876046,1.2216360184476982
RKN,1641662,3.781184529562369,3.4962696368573787
Daudi,1750826,-5.008838903624334,-3.2660898062744956
RERF-LC-MS,24856436,0.2419222597799965,0.6616295793678572
COR-L105,6184667,3.4155069342084916,3.0732216601900064
HARA [Human squamous cell lung carcinoma],151289,0.6137813450564443,1.1270948302034078
MOLP-8,568763,-0.8505432933185847,-0.09280343213730123
Granta-519,piperlongumine-MST-312 (1-1 mol-mol),1.116794346695572,1.241586446051272
SK-OV-3,54618771,2.5849230632376923,1.624073431543409
SW1271,135398516,2.256973153183445,2.3751216825522103
MOLM-13,44819697,-1.7672663076184636,-1.9117182274869753
LCLC-97TM1,24748573,2.1629406196043894,1.854357487276848
NCI-H1568,10113978,1.8126489257310032,3.323593626412178
ALL-SIL,SNX-2112-bortezomib (250-1 mol-mol),-3.319111432428944,-2.7432605868744764
COR-L95,1566236,1.7351682171374878,2.2199500786736333
PaTu 8988t,54619267,4.243668204976347,4.108346631502289
BICR 31,73707398,2.635299985295534,1.4586720054867073
P31/FUJ,24978538,-1.1674360999825653,-0.718680602991099
HuP-T3,25227462,0.1487181406442073,0.7297601212735715
Daudi,439501,-2.973914496380735,-2.660546760258663
NCI-H1568,67156097,-1.7914617240991686,-0.4439586709839519
WM115,36314,3.85550299796777,-0.9809664740004103
MOLP-8,409805,3.552664043240888,3.7995484059601834
SW48,24753719,4.052743892866938,4.1948080206932365
SW48,3825829,3.1303188593692854,3.830770630789889
PaTu 8988t,54613361,0.5051194448617704,0.1883320189006411
SK-CO-1,44493528,4.973545843770428,4.343837900426239
MOLP-8,44202524,1.1617664844294235,1.4673975940767192
P31/FUJ,11656518,-0.8295634521320199,0.4551512018824386
HARA [Human squamous cell lung carcinoma],11625818,4.840804819194981,4.504273353564596
LS180,36314,2.4476112429633403,-1.5054396230163416
SK-CO-1,119182,-2.3548964470523974,-0.6938509810960278
LS411N,72376,-2.6969507034435236,-3.056371937472532
BICR 31,51037431,4.633533363663127,3.3970904905030244
ML-1 [Human thyroid carcinoma],72376,-3.175400377997246,-1.452356659891314
HCC1500,46907787,2.786329845885891,2.1455768983777213
MOLP-8,2708,2.5820066460748015,3.5395075722959035
HEL,10113978,2.6394190696879662,2.1228204366862324
HEL,1641662,3.192273244328466,2.819135472404862
LS411N,12001922,2.0246848718715604,1.7692586654472995
ALL-SIL,56963564,-1.2928564241979046,-0.32929105891768146
ALL-SIL,168313047,1.973173862571291,1.8873692147709267
COR-L95,3038522,2.051786867518871,2.94651627882695
LS411N,25102847,2.9606059837222767,2.23117530969446
SW48,5566,2.216391660090734,2.822125772140295
HARA [Human squamous cell lung carcinoma],637858,2.3831379320922728,2.1348870777860443
SW48,6917907,-5.957551707769467,-4.924304691745067
RKN,246676,4.414592383854902,4.280258201393461
IGROV-1,285033,-1.3538783590767758,-1.8011463849982874
PaTu 8988t,11609586,2.9135578891851233,3.1799298833815843
P31/FUJ,19582717,2.23583270668625,2.859210023979039
SK-OV-3,71304818,3.289226671933847,2.745584561996003
SW48,9903786,0.6824641791663469,2.5789873100704863
SW48,107985,-4.220376672084107,-3.539379430361165
ALL-SIL,49836020,-3.56746653346715,3.086807599337537
HARA [Human squamous cell lung carcinoma],24772860,-1.3203429479269333,-1.9838695182111932
MOLM-13,7326481,3.309466894819375,2.6371641560892187
PaTu 8988t,387447,-4.215036300164339,-3.8696556995340656
IGROV-1,10231331,1.9104831176724932,1.9562684504898138
NCI-H1568,salermide-PLX-4032 (12-1 mol-mol),5.036103452561945,4.9146119702385676
WM115,6852167,1.3860811523021286,3.12913727006086
SW48,11175137,0.8049020199472112,2.7614990105945707
NCI-H1568,6918837,-3.937828464321892,-2.9172194319912474
ALL-SIL,409805,3.511042482554543,3.6287814108673824
BFTC-909,11485656,2.882750602975944,2.5763280819947885
HCC1500,6610216,3.984830656845064,4.290538792135467
MDST8,46191454,-0.3052251724831438,1.871215797435123
NCI-H2452,52947716,2.3907771066336543,0.9361375928407222
COR-L95,135411,0.6709946332822974,0.5769327811756412
RERF-LC-MS,11497983,4.204546577264711,4.374438032196274
MDST8,3025986,-2.3601391308628368,-0.34772518944923925
K-562,10113978,1.9599198523990544,2.56087247060999
MDST8,66577038,3.4472401917824387,3.022413654340014
RCC10RGB,6917907,3.54732574828972,-3.4720205046909007
SU-DHL-1,54618305,4.34503505735179,3.370150824253478
RERF-LC-MS,selumetinib-navitoclax (8-1 mol-mol),2.77400767356552,2.3077716735608904
RERF-LC-MS,navitoclax-piperlongumine (1-1 mol-mol),3.552905574656644,2.089575946425255
WM115,448949,1.6539360415615445,2.1537914788671677
ALL-SIL,216239,1.0502640873271551,1.8087318161279184
HuP-T3,docetaxel-tanespimycin (2-1 mol-mol),1.3630986120545014,-3.127774300538947
IA-LM,53325874,6.131967715828746,3.8557799059285314
ML-1 [Human thyroid carcinoma],16219061,3.525142786131821,3.5348807860866946
P31/FUJ,119182,-2.8125390579467244,-2.845357679433444
SU-DHL-1,11717001,3.585470860794662,3.1760188798195217
MOLP-8,168313016,3.7646553629166304,3.842307371421459
ML-1 [Human thyroid carcinoma],11485656,3.567697107596816,2.5632641187195846
SW1271,9823820,4.369434873409536,4.248738150515632
SK-CO-1,51037431,2.025162533854422,3.003145007794136
SW48,11964036,-0.90016316876993,1.2861397768933054
Granta-519,702558,4.9740995052838874,3.7735756350465492
ALL-SIL,UNC0638-navitoclax (1-1 mol-mol),-1.2077799570565213,-0.22390700727754623
NCI-H1568,6918328,-2.169641972219076,0.282300543777413
Daudi,637858,0.7785119720749748,0.9769466436073708
SW948,53495165,0.2015090818079991,-1.2270258404110088
SW1573,46398810,3.5765453048302933,2.793580200957881
MOLP-8,637858,0.6022882265593398,1.0544429010820995
NCI-H1568,3825829,3.749474944576795,4.069466026810303
MOLM-13,4788,4.00969340257961,4.997919696394955
SU-DHL-1,135398516,1.716785738144405,1.8258035253059228
HCC1500,2945648,3.001490751925554,2.902186571070158
SaOS-2,SNX-2112-bortezomib (250-1 mol-mol),-2.769432838518552,-1.3319748094568942
HEL,46943432,0.8947528664895825,0.8919457929171989
RKN,3689413,-4.085525957083088,-0.3764294737271417
COR-L95,45279963,4.007720953160328,3.315585179314668
LS180,11364421,-2.9792456594346945,-1.7581906167935326
SW948,51039095,-2.1737453378627567,2.7886696111267253
HEL,135421197,2.810551353794614,1.3658977850041014
SK-OV-3,doxorubicin-navitoclax (2-1 mol-mol),-0.6082867931514424,-1.2334173907540749
HuP-T3,5351362,1.4959503226370765,1.6946958461883213
P31/FUJ,selumetinib-decitabine (4-1 mol-mol),-0.417260560947631,0.09934531900202634
SU-DHL-1,6623618,1.9512254956144048,2.0775095947073403
BICR 22,31703,-2.104947288409208,-0.7537207918817181
P31/FUJ,BRD-A02303741-navitoclax (2-1 mol-mol),0.458289206697817,0.18851695032827467
IA-LM,17755052,4.247702528352723,1.5635282383474263
IGROV-1,17755052,-1.0246415273055465,1.5188997187843807
WM115,navitoclax-birinapant (1-1 mol-mol),2.982568846631371,1.7525750309215815
IGROV-1,3503,2.453392942972796,2.4256007816649636
BICR 31,10302451,2.0763164615496232,2.7824686949772173
COR-L95,JQ-1-vorinostat (2-1 mol-mol),1.1858087423050925,0.5697028434349238
MOLM-13,2841722,4.084965304911922,3.706614179743153
COR-L105,9549297,5.541569761250669,2.6577313811377086
COR-L95,4705,3.007858501345706,3.107785294493709
SK-HEP-1,54626689,5.252317432323977,4.5777617650314095
BICR 22,24964624,2.8366894332481127,2.128466980131708
K-562,3384730,2.2830550335302555,1.6866095971042419
RKN,46224516,3.695788234754723,2.7352304395280966
Panc 02.03,44607531,1.9299895981807216,1.464539488712867
MOLM-13,11317348,-4.1893096196029465,1.1710221813215893
LS411N,60700,1.793788628592944,-0.6318604733174371
ALL-SIL,9967941,3.4348481015027628,3.0987642221624454
SK-HEP-1,46907787,5.1061569205326505,2.5542406100492228
RKN,5351362,2.529766574998156,1.5820868494042903
HuP-T3,31703,0.4675615226322689,-0.7393305001437173
SaOS-2,6610355,4.596244040557677,4.595125891125738
BICR 31,25195348,4.130650271984148,3.2716671537545188
MOLP-8,73707438,3.908454567487333,4.3594133950050935
MDST8,3503,3.3556251865549065,2.397248569636682
COR-L95,439501,-1.1523844892623298,-2.2267024615757776
HARA [Human squamous cell lung carcinoma],selumetinib-piperlongumine (8-1 mol-mol),4.925037100159097,3.2799331518971484
P31/FUJ,5281321,-2.503740446113486,-2.577690548876993
BICR 22,selumetinib-piperlongumine (8-1 mol-mol),3.0599254943264116,2.3799317169726
BICR 22,2729026,3.062923067871907,2.612057429410014
SW1573,51037431,1.8928004764191728,3.152598734650383
ML-1 [Human thyroid carcinoma],285033,-2.470992399828971,-1.2901969976481433
RERF-LC-MS,16741245,3.282184197465347,3.91618961409351
ML-1 [Human thyroid carcinoma],71466380,5.169213277707957,4.796748272397199
SK-HEP-1,11427553,3.604603983851784,3.0256129500158413
SW948,alisertib-navitoclax (2-1 mol-mol),-1.9206127672365017,0.48926325095386297
SaOS-2,36462,1.0480120523183942,1.6843392093075054
IGROV-1,124202324,2.2563058955522157,2.586915587219363
P31/FUJ,54618771,-0.1557090961755644,0.2825931155819321
HCC15,6918837,-3.491973763742546,-2.7835334089642982
RERF-LC-MS,10302451,4.085913110869725,3.3583003639147093
WM115,9866186,1.4274901944164853,1.116766723695839
RCC10RGB,3634881,4.1231622503065495,3.4321155813808404
MOLP-8,tretinoin-carboplatin (2-1 mol-mol),4.454701733266676,3.42144049815716
SK-OV-3,56946209,-2.3996417591607235,-3.92933519955943
Daudi,9907093,2.3595872536278977,3.2270624807772763
UACC-812,135421197,0.8848266315498433,1.9316333694124852
COR-L105,11707110,-2.3960237918310967,-0.18672662470517762
NCI-H2452,crizotinib-PLX-4032 (2-1 mol-mol),2.3217431804401607,2.081408852096644
RKN,selumetinib-GDC-0941 (4-1 mol-mol),1.8547441727402172,1.700435396325875
BICR 22,5287620,-2.2777736835755076,-2.174304877655148
HEL,135398738,1.3240045179008624,2.216550793364658
SK-CO-1,3825829,3.015639513793665,4.149450154915284
BFTC-909,135398516,3.047749913114312,2.3734880033147148
Granta-519,252682,6.242071482699392,6.333411758375125
RERF-LC-MS,piperlongumine-MST-312 (1-1 mol-mol),1.31949560405159,1.8369649342935803
SU-DHL-1,241158,1.6235055790866513,3.662333291734242
PaTu 8988t,8515,4.36808886077581,4.202531539498312
NCI-H1568,44489675,3.7863062268563064,4.022381447751724
MDST8,135875424,6.383148165610491,4.118556678262933
IA-LM,24771867,1.1290385026114922,0.11930368323057972
PaTu 8902,12001922,1.8953174279693872,1.825817400058711
HCC1500,8515,5.3989297102528715,3.9195758956435776
MDST8,4259181,0.8851574645315519,0.37303621098339496
SK-OV-3,16038120,1.745962946040546,1.1619201806702597
SK-CO-1,25126798,3.6561952188996503,3.7659336808714925
HCC1500,4261,0.9221319619811188,1.3550678105773002
WM115,613753,3.1291419252746877,3.2359842367923055
IGROV-1,6505803,-0.2382223795960626,-0.684667204166437
KU-19-19,49766530,0.1366302187334878,-0.5170142790718439
BICR 22,11494412,0.8036857209518554,1.8325685398114506
HCC1500,11955716,2.281516197797272,-0.9014330470476379
MOLP-8,71680916,4.479993680298279,4.0428580374422864
ML-1 [Human thyroid carcinoma],3025944,4.339456842576773,4.336395300956491
BICR 22,15983966,-4.391384426150851,-0.6977845697283044
SK-HEP-1,selumetinib-tretinoin (2-1 mol-mol),6.787404934084747,3.8021232177062463
RERF-LC-MS,9866186,0.0636323256725951,0.927071087919453
IGROV-1,54613361,1.0826132998561049,0.04411500100798021
K-562,4259181,-0.7813149193344907,-0.3554048333289071
SW48,6438330,1.214777505056659,2.071150864049068
LS180,54618305,4.3130332958468385,4.320790278494977
K-562,5746,1.9738407973257048,0.5990811105565123
COR-L95,3081361,3.577896308939448,2.233839494749622
KU-19-19,ISOX-bortezomib (250-1 mol-mol),0.6477518582997711,0.6787913906705174
MOLM-13,navitoclax-sorafenib (1-1 mol-mol),-4.200053856490793,0.44269298115846306
HARA [Human squamous cell lung carcinoma],2113511,5.545523050638764,5.658826652330574
NCI-H2452,alisertib-navitoclax (2-1 mol-mol),-1.045230676490147,0.913228651054339
K-562,53495165,-1.204911447319433,-1.6562650447748433
SK-CO-1,JQ-1-vorinostat (2-1 mol-mol),1.937629549480178,1.1402404919483975
HCC15,3676137,4.952150033317278,4.386668601044488
PaTu 8988t,46398810,3.220252132938068,2.7094194105630667
IA-LM,ISOX-bortezomib (250-1 mol-mol),0.3247346059672509,0.4508514240781533
BFTC-909,9927531,5.31835549136936,4.751433154316169
Panc 02.03,16722836,2.9028860212849565,2.015059603617198
NCI-H1568,doxorubicin-navitoclax (2-1 mol-mol),-2.631367093813306,-1.0940058425287464
Granta-519,3011155,5.044202810550695,1.9623740644193455
IGROV-1,3825829,4.144093606877803,4.251261360770304
HARA [Human squamous cell lung carcinoma],11404337,-1.2743672881567891,-0.26853075731808557
P31/FUJ,sirolimus-bortezomib (250-1 mol-mol),0.0617669843942014,-1.3445007313962076
WM115,11238147,1.7518250261640556,2.9765417803253587
HEL,6610355,4.700351008256091,4.030599463786271
COR-L105,10410894,5.46795970795096,3.4682049192852573
K-562,135421197,2.032823128578147,1.5702291739158278
HuP-T3,25105715,3.756943800954468,3.472901156847789
BICR 22,11717001,4.533318725499836,4.126928024237901
ML-1 [Human thyroid carcinoma],168313047,1.965548883908303,2.4235319913071707
BICR 22,176870,3.0604023761484154,2.4637520422868078
COR-L105,9823820,3.977631180290917,4.384043867078891
P31/FUJ,66577038,3.0536576112540916,2.658033794198767
HuP-T3,11612883,3.639610964764467,2.937865781868686
PaTu 8988t,12001922,2.536714978511883,1.905240622835976
P31/FUJ,24771867,-2.604308550432203,-1.070965840092791
P31/FUJ,3634881,2.159990781463395,2.5047731470681707
SW1271,11640390,3.706316930576478,3.5729388959348394
Granta-519,984333,0.7513060576966085,-0.8120310898919512
COR-L95,46398810,2.3153378536205036,2.2706548271101457
NCI-H2452,4259181,1.4154165902225178,0.3138875909391648
HCC15,docetaxel-tanespimycin (2-1 mol-mol),-6.454135481670954,-3.267323737314274
RERF-LC-MS,3503,1.2198018250646854,2.482333256934664
BFTC-909,168313047,1.967772312792883,2.409292500010374
NCI-H1568,49766530,-3.205306991379519,-0.27813252609981876
SW948,selumetinib-JQ-1 (4-1 mol-mol),-0.7293969321677569,0.623762768022027
IGROV-1,44491742,4.406671418311328,4.261557369742157
SaOS-2,54596490,5.687426160237218,4.580944293054774
Granta-519,46843906,0.846372381562089,1.2993205642087247
SK-OV-3,46398810,2.6339706660379205,2.6279086097821778
WM115,25154868,2.4497388117539773,4.628564577067015
K-562,navitoclax-gemcitabine (1-1 mol-mol),-0.2101297783462078,-2.020284432724782
BICR 31,123631,1.818021308876907,2.0930807436118912
HuP-T3,60750,3.212181181151216,-1.827651055108042
WM115,71304818,2.065667497969779,2.487827758810437
SU-DHL-1,11964036,1.0253922980362349,1.4523360967501189
SW1271,9444,4.046685913234064,4.436886614223771
IA-LM,1716436,3.827820678542469,2.8567634630580687
HARA [Human squamous cell lung carcinoma],3854666,0.7328632401261175,1.9804618120606845
Granta-519,selumetinib-decitabine (4-1 mol-mol),1.299817261369256,0.2388016157940043
SW48,44137675,1.8984167228990951,3.0714472417627143
IGROV-1,11364421,-2.1205062036040982,-1.8016648764064882
PaTu 8902,3465537,3.540732953494624,2.350407142518417
HCC1500,54618771,1.4039271563223086,1.2075323921772088
NCI-H1568,23725625,5.336887169251221,5.087734251043266
BICR 31,9936388,2.7244047649519074,-0.31347347204661735
IGROV-1,49850262,4.068828647042517,3.798528872146037
HCC15,5280436,4.320878094694944,3.619267805834977
COR-L95,46215462,1.6156782364555438,1.7365293924235636
SW948,25022340,4.946878477600784,1.2830236330347895
P31/FUJ,3025944,3.8644283212627895,3.7770050644535194
SK-CO-1,5978,-3.732613512446313,-1.7204787049649388
LS411N,19582717,5.192972758226466,3.106714517038711
SaOS-2,26596,-1.8442798913702467,-0.9393909442904504
MOLM-13,6610216,4.131122051839403,3.758145198287682
KU-19-19,3025944,4.41555498235696,4.263918748565839
HCC15,11497983,1.686538707374479,3.921641646959592
HCC1500,216468,3.3608861469702735,3.073220703449995
NCI-H2452,56649450,2.972344092085675,3.560662546841495
SK-OV-3,25262965,0.4953902890441227,-1.1595439214990333
HCC15,10184653,1.3258142209068642,1.7030136345430562
SU-DHL-1,3825829,2.249840075454991,3.8503962576319264
WM115,49867926,3.8689880289876446,4.332811158860729
K-562,285033,-3.792012978388577,-2.985403581419039
Granta-519,53495165,-2.785106410212646,-2.0241884370372722
SU-DHL-1,5335621,3.5965276677583846,4.093600338675791
NCI-H1568,1566236,1.6523344134899465,2.5824699848927684
HCC15,25195348,3.62058364960133,3.303387463578626
LCLC-97TM1,7326481,3.961997196958484,2.7927296477636383
SU-DHL-1,JQ-1-UNC0638 (2-1 mol-mol),2.5998168320155712,0.3232439386647831
LS411N,9887053,4.348393626170801,2.9444052375590264
LS180,208908,2.3350670945107783,1.4508718033844314
IA-LM,54454,3.681506421747591,2.490049304700555
RKN,4378219,1.9905206425028277,2.5267195061157808
WM115,selumetinib-tretinoin (2-1 mol-mol),-1.0607687385354925,2.708113557494414
ML-1 [Human thyroid carcinoma],2949965,3.680012286367402,2.9263426533078998
IGROV-1,216345,3.498629789107092,3.952276932102874
SW948,5282054,2.5738720751419746,2.9735476231153175
PaTu 8902,66577038,3.2739824602509304,3.090279718944935
COR-L105,1566236,2.352597865521479,2.504956863126934
MDST8,selumetinib-piperlongumine (8-1 mol-mol),2.2463644977006423,2.7911893391228215
MOLM-13,46191454,-2.5774836063329905,0.4348385424856653
HCC15,72734382,4.010055800269774,4.789349182596779
SU-DHL-1,navitoclax-MST-312 (1-1 mol-mol),0.7019716882253797,0.4623520145463172
SaOS-2,53232,1.3253237607162072,2.6096191677571143
KU-19-19,9936388,2.972521935644637,-0.7186581993128587
BFTC-909,selumetinib-JQ-1 (4-1 mol-mol),1.1253035869238386,1.6820373659766659
PaTu 8988t,selumetinib-PLX-4032 (8-1 mol-mol),6.546714585900996,3.7834682388523935
SU-DHL-6,445643,2.4790626422724107,3.4977716812969852
ML-1 [Human thyroid carcinoma],89183176,4.271882086089193,4.622968589905891
HCC1500,208908,1.6399748300125228,1.8049264926075599
P31/FUJ,4917,2.744589019426067,2.7552047960731887
HuP-T3,241158,3.8412641522091144,3.9074851730725864
SaOS-2,46224516,2.521923040225463,2.303192817573277
LS180,54618771,0.643112685351952,1.0405763816531801
Daudi,23725625,2.2816125857144978,3.381933763946642
Panc 02.03,25227462,-1.0518848939229315,0.747045367283206
WM115,462382,0.0353255606914336,0.7924638165008214
SaOS-2,135875424,3.0421388786055727,3.9143129580469873
Granta-519,10113978,3.360346958971763,2.1338579344241033
SU-DHL-1,51037431,2.2415500634191763,2.470227559128077
SW1271,135440466,1.7072517695379112,1.9802429751741177
BICR 31,208908,2.9880095911503983,1.6642442915206053
NCI-H1568,11719255,3.5544275615483087,3.4558979298531893
SU-DHL-1,4259181,-1.4222017445817885,0.1007753819154859
NCI-H1568,135984461,4.216726883570129,3.914952722953785
Daudi,navitoclax-piperlongumine (1-1 mol-mol),0.8768236288563281,0.4451497983270896
K-562,25195348,2.6278567451650394,2.823870936992846
SW948,6918638,-0.8188756331889222,0.04463690912882738
UACC-812,216345,3.8515167014354152,3.806165862436806
PaTu 8988t,446155,5.325372031764619,2.818896399654477
RERF-LC-MS,selumetinib-tretinoin (2-1 mol-mol),3.2790865080217397,3.9849561798789397
NCI-H1568,54618771,0.8004506686595156,1.3571879917396787
HCC15,9823820,3.975711917882334,4.272001494980469
RCC10RGB,9935249,3.9754060705766943,3.186214450037231
SK-OV-3,3854666,3.321518045263264,2.192574835583685
Daudi,135928012,2.6114481479622516,3.7991903350618257
RERF-LC-MS,selumetinib-UNC0638 (4-1 mol-mol),2.6397170445300433,3.375123925193045
HCC1500,44491742,3.6723474636183537,4.234488584843519
K-562,54626689,4.3954029102592145,4.315390884071467
SW948,11152667,-0.307089718187717,-0.9458571708993178
NCI-H1568,984333,0.7198134332239758,0.7698677132234044
Granta-519,selumetinib-tretinoin (2-1 mol-mol),5.148474908350203,2.389821625931216
IGROV-1,44507138,2.359177395411688,2.657257297026777
COR-L105,44566777,0.9614143121394376,0.788653194447194
HCC1500,25126798,3.9309577641895137,3.9135907878004947
LS411N,5470400,-0.4509258648896809,-0.15696737552686016
PaTu 8902,11427553,3.388107623793881,2.8916717706083817
BICR 31,JQ-1-carboplatin (1-1 mol-mol),2.1121797103281876,2.286215575627057
LS411N,11364421,-0.88941081068058,-3.3125807140509576
Panc 02.03,6918638,1.5939476449475074,0.7432002164310645
IA-LM,73707398,1.4255919606814562,0.6620641748124497
Granta-519,54613361,-0.5306815642640709,-0.8192257077841129
IGROV-1,176870,1.8349827429681411,3.3951507358346373
SK-OV-3,24821094,3.4952627197751744,2.8320971078755806
SaOS-2,5566,3.2892304449964125,2.8299687155992808
BFTC-909,44486219,4.380685277356905,4.317464893026252
SW1271,52947716,2.875834451056303,0.10981584318335963
LS180,20959075,-3.038194424999374,-3.0393262418383644
BICR 22,2708,5.160276397343071,4.744452408989262
LS411N,24856436,0.7977520405714393,0.5443695332215183
RKO,3062316,2.656751778030552,1.0492821378048425
IGROV-1,2841722,3.834853118277962,4.402824331350065
SW948,9967941,3.223093544556301,3.347689437533121
WM115,5291,3.6779708977342263,3.661807307967172
ML-1 [Human thyroid carcinoma],262093,3.5917492591420737,3.161487111676919
NCI-H2452,11152667,-1.2581393219211725,-0.28007979432002095
SK-HEP-1,54454,2.662573207119838,2.571364294643281
PaTu 8902,46398810,2.87785673961289,2.505521908934757
MOLM-13,4096211,0.3628379797080729,0.8519173010401908
SaOS-2,31703,-1.4545352226195103,-1.1634019854255588
NCI-H2452,89928392,1.3829077368930702,1.6368060131733153
PaTu 8902,sirolimus-bortezomib (250-1 mol-mol),1.4421927553258482,0.6664664007150963
SU-DHL-1,216468,2.865615091111303,2.649629656738445
BFTC-909,5335621,5.263558209813896,4.7328106437824395
IGROV-1,984333,0.6618578113050116,0.7757321655968299
SaOS-2,53393127,5.00574224434263,4.170108864490578
LS180,26596,-1.3053249122689552,-0.8795082649894489
PaTu 8902,216239,3.2515461693373946,2.2727799528263257
RERF-LC-MS,216239,1.5111459083459036,2.176974624631435
IGROV-1,327653,3.667792542405671,3.1442631762226627
MDST8,25062766,1.7641764997703038,2.230265949021268
COR-L105,tanespimycin-bortezomib (250-1 mol-mol),0.350179088814853,-0.45452698773774797
SW948,9911830,2.1163810502856344,2.2347623643889047
SW948,25262965,-4.786935998048743,-1.5268485446825653
Granta-519,17755052,3.698735089058188,0.4486917270569512
HARA [Human squamous cell lung carcinoma],969516,2.3775549977258836,3.0732478877164886
SW1271,navitoclax-MST-312 (1-1 mol-mol),1.6729617215063168,0.8425374225058374
BICR 31,65628,4.368112552275168,4.399355513285434
LS411N,1716436,3.6051806229528394,2.7591161296096054
HEL,31703,-1.5815868160580933,-2.3791721965513397
ALL-SIL,46191454,0.8221974593607395,-0.24554352509839245
IGROV-1,46843906,3.392503571349757,3.2108870149468163
MDST8,52912189,0.1558018738717314,2.1449808981968177
SK-HEP-1,73707398,1.730256970360003,1.381867115130777
NCI-H2452,969516,2.821538204226011,3.0088175451231525
Daudi,9825149,1.5190393381512124,1.7211231118843517
HEL,49766530,-2.395534265113236,-1.7297900877872967
SU-DHL-1,445643,3.1136870030048116,3.6771522997404515
Granta-519,25102847,2.235988678650905,1.8216374840222034
SU-DHL-1,8515,3.677486404661737,3.8100804464104856
SK-CO-1,decitabine-carboplatin (1-1 mol-mol),2.301340396249523,4.104685746416517
NCI-H1568,73707398,1.0000031751048108,1.4430132052619766
RKN,44607531,3.612700906890815,1.7492092223048177
RKO,448949,2.722052887717566,1.6794137323084368
SaOS-2,123631,3.143555798261004,2.3411814312084105
RERF-LC-MS,docetaxel-tanespimycin (2-1 mol-mol),-5.54075092456557,-3.0014634057772454
HCC15,445455,6.40486213649735,4.854572513930318
ML-1 [Human thyroid carcinoma],54639126,4.430736107428324,3.6485340821701966
MOLM-13,16720766,-3.0154852550238473,-0.924992710943342
SU-DHL-1,52912189,2.819399061651446,2.129762224419208
IGROV-1,6918328,-0.5330006254346346,0.14340166545995817
HARA [Human squamous cell lung carcinoma],67156097,-1.978765302962937,-0.6288759716829077
Granta-519,168312962,2.8455100129937447,0.15426909504953026
RCC10RGB,24748573,3.544482176439233,2.562969263397617
NCI-H1568,71576739,4.4464222538448075,3.944023353051342
IGROV-1,ISOX-bortezomib (250-1 mol-mol),0.8859012184952701,0.7598490112315838
MOLP-8,3025944,3.977744021049233,3.9143386076660254
MDST8,navitoclax-sorafenib (1-1 mol-mol),0.2125187849150193,1.525516050615584
SW48,3025944,3.8378875325919513,4.135290465279834
P31/FUJ,5460769,2.718083541162644,2.1707656981792183
PaTu 8902,56946209,-3.5225671286307585,-3.9642083200704676
IGROV-1,11964036,-0.1609353030421705,1.2179974141821919
HCC1500,327653,2.623652361439541,3.090621829541234
BICR 22,11640390,3.3009766271386014,3.49326974827342
IGROV-1,400769,-0.5589612210030486,-0.6656757902788744
HuP-T3,24821094,3.9398095537443023,2.9790577760127737
HuP-T3,BRD-A02303741-navitoclax (2-1 mol-mol),4.136817383870447,2.6112090499647564
RKN,54618771,1.93479648501244,1.5183759407284987
Daudi,BRD-A02303741-carboplatin (1-1 mol-mol),4.3065470056962765,4.151323307247276
PaTu 8988t,73707398,1.170719580837983,1.567466987438026
HARA [Human squamous cell lung carcinoma],10113978,3.460603354098383,3.435751469495805
Panc 02.03,10231331,3.962628244123872,2.146625641076019
HCC1500,387447,-5.435802195710178,-4.041984698743874
K-562,25150857,2.2256112733235978,1.8322538594171331
COR-L95,135398516,3.161482452438301,2.104655339361051
MOLP-8,46191454,-2.2442719810217984,0.5262732199175254
HEL,BRD-A02303741-navitoclax (2-1 mol-mol),-1.272488077546847,0.5937270388310076
BICR 22,4259181,0.3497439952553443,0.028415446565975406
SU-DHL-1,49836020,5.336381428124731,1.9151844609062585
P31/FUJ,246676,3.344572915959865,3.6588291064039202
MOLP-8,UNC0638-navitoclax (1-1 mol-mol),1.623066033495539,0.3788338152503017
WM115,JQ-1-MK-0752 (1-1 mol-mol),1.4273161009607245,1.8033267922950957
WM115,carboplatin-UNC0638 (2-1 mol-mol),3.608353626656174,3.1348609895764548
SK-CO-1,135875424,3.678629656731489,3.9295793800847303
SW948,3552672,1.903682389315955,2.229366819688602
NCI-H1568,selumetinib-BRD-A02303741 (4-1 mol-mol),5.032258587314436,4.153623856854069
NCI-H2452,JQ-1-navitoclax (2-1 mol-mol),0.3722844908497442,0.9700543932187429
HCC15,selumetinib-decitabine (4-1 mol-mol),4.297917027036863,4.115481943756851
P31/FUJ,6610355,3.438139996915945,4.0181670543042864
NCI-H1568,446155,2.3736727750277455,2.7584630172507354
HCC15,107985,-2.9906891972859415,-3.2409833705058175
Daudi,6918328,-3.006382851838594,-1.4502646338819696
Daudi,25161177,4.237474374185298,3.3044875839235086
LS180,selumetinib-navitoclax (8-1 mol-mol),0.5338849490491672,1.7917942330960446
RCC10RGB,vorinostat-carboplatin (1-1 mol-mol),4.3210323450827275,3.408623810480235
HCC1500,374536,2.8802619944250765,1.993637720131475
SU-DHL-1,400769,-1.357151076144479,-1.211827807861716
MOLP-8,16725315,4.20287759788283,3.796923614005087
K-562,SNX-2112-bortezomib (250-1 mol-mol),-3.0816368014715434,-2.3825655364688614
MDST8,24753719,4.799692184779076,4.3017500079567705
Panc 02.03,25195348,3.9334722209588735,3.383811118478682
IA-LM,5328940,2.67230513268953,1.6783367286776016
HARA [Human squamous cell lung carcinoma],387447,-4.146769649621688,-3.972283692128027
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905,2.6103998565450537
Granta-519,676352,1.633141874861156,1.7648959138597455
HCC15,49793307,-2.657858659953827,-2.648590834960124
K-562,16065773,1.923835638804153,1.9262637803184472
RERF-LC-MS,23582824,0.1470987082457378,0.8186701523924924
SW948,9907093,4.923675844906718,3.6516726200484015
HuP-T3,374536,4.193584653265312,2.760722895331203
WM115,11396600,2.8854117577089378,3.7329985471537914
IGROV-1,16722836,0.856484234547582,1.6578186067745204
LS411N,89183176,4.7846004508379085,3.2668890212690047
LS411N,selumetinib-MK-2206 (8-1 mol-mol),1.1332062725089502,2.021202794217359
HCC15,6917907,-3.7751611818797897,-4.254731809271225
NCI-H1568,637858,1.7833024505225796,2.119136750800092
PaTu 8902,5329102,2.5341846500240246,2.1094492376537612
Daudi,54765302,2.540510911033338,3.517034068082543
RERF-LC-MS,100016,6.56071523320666,6.279194756341414
NCI-H1568,387447,-3.95080818095812,-3.738536403521957
HARA [Human squamous cell lung carcinoma],168313047,3.4416690801744574,2.439842329728551
SaOS-2,11612883,2.0316436721768087,2.9049597132157485
SK-OV-3,135411,1.6318689765112546,0.8313584908704668
IGROV-1,208908,2.822483792004996,2.0980936230559535
RKN,51037431,2.467401650082352,2.9929922012972883
MOLM-13,3025944,3.8428716966726992,3.904822588639903
PaTu 8902,135421197,2.3024316473658004,1.9864775100247563
MDST8,969516,2.598297465814476,2.939685498066051
MOLM-13,60750,-4.5529472050787545,-3.175717649106468
SK-CO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.9815172513006872,1.0327619093199758
IGROV-1,9915743,-0.4757488934941289,0.9478037131254419
BICR 31,56946209,-4.213875977630207,-3.8701252023739614
MDST8,124202324,2.333625526818204,2.4413358592498753
BFTC-909,46907787,2.3649992203474515,2.370044787414743
Daudi,12003241,-4.903510386182724,-1.570033455267318
PaTu 8902,969516,4.108056616445131,2.9127106584366076
RKO,24951314,1.467797052763695,0.41020476435482117
SW48,439501,-2.266376314928653,-2.29317151049166
IGROV-1,5311281,3.3250623444804206,2.3525670297607557
BFTC-909,9825149,2.463033939289578,2.3165729070591903
LS180,2858523,3.002923184305197,2.902458706850607
HEL,decitabine-carboplatin (1-1 mol-mol),0.001071059904297,0.03803093325091463
ALL-SIL,selumetinib-navitoclax (8-1 mol-mol),-0.8393067870593486,-0.050401970193665296
PaTu 8902,10074640,3.6154267469790304,3.2144230504989797
LS180,135421197,1.2375553911833763,1.6434248014471848
ML-1 [Human thyroid carcinoma],3081361,2.035617561629102,2.738137829538987
HuP-T3,4259181,1.3598984416642497,0.53513737541339
MOLM-13,9840324,5.573129737038137,5.170990973917015
NCI-H2452,docetaxel-tanespimycin (2-1 mol-mol),0.4791468482228301,-2.999515817757325
RCC10RGB,7251185,2.312506998895348,2.6141733799591877
LCLC-97TM1,23725625,2.954034200595367,4.559910450239102
RKO,24797083,0.8657042008278414,1.1039209948143098
RKN,selumetinib-piperlongumine (8-1 mol-mol),3.808395082066658,3.7409083030605985
HARA [Human squamous cell lung carcinoma],45100309,5.833200435543825,2.9845298188190785
ALL-SIL,24951314,0.1921049921473096,0.20902003151025306
NCI-H1568,tretinoin-navitoclax (4-1 mol-mol),4.46686431300974,2.932517377695486
K-562,16725315,4.409558206085648,3.656082664743776
ML-1 [Human thyroid carcinoma],9825149,3.1128843906344117,2.613752967155735
SU-DHL-1,9915743,1.482861419138649,0.7124588979763924
SW1271,4917,2.7806051488376293,3.137070473186632
Granta-519,vorinostat-carboplatin (1-1 mol-mol),1.7690430171361815,1.8559357727377788
COR-L95,3062316,3.2830028596837217,1.3234301400940183
MDST8,10074640,3.541716125988611,3.143082891872949
IGROV-1,44185566,2.2104732991243248,2.6032061373338604
SU-DHL-6,57519531,1.2127003418717253,1.4485789684283816
SK-CO-1,241158,4.831010946536929,3.9546796920638907
SW948,46843906,2.6248020109336023,1.9917843432816382
RERF-LC-MS,6610216,4.063402980130349,4.243506879365089
RERF-LC-MS,46843906,4.323049782377064,3.253866179568821
NCI-H1568,selumetinib-UNC0638 (4-1 mol-mol),2.7760221243911016,3.4668826353492115
LCLC-97TM1,piperlongumine-MST-312 (1-1 mol-mol),1.3069230942291734,1.8625083317003566
RCC10RGB,selumetinib-vorinostat (8-1 mol-mol),3.237241333738756,2.6838515863713654
HCC15,24180719,4.303391195547382,3.56779875608081
RKO,selumetinib-navitoclax (8-1 mol-mol),2.1856811512057885,1.3060248737587623
MOLP-8,6505803,0.6382990348001342,-0.8496402023576298
Daudi,5278396,2.816567405543214,3.052712963821991
RKO,66577038,3.1469091340303637,2.822703945290012
MOLP-8,54143018,0.5860183196437395,-0.1292808583905657
SaOS-2,24856436,0.4386880001360848,0.278789482538085
BICR 31,9866186,1.254760755448308,1.13562180809906
RCC10RGB,11257553,3.6405008146732434,1.7926803170977736
SW48,JQ-1-navitoclax (2-1 mol-mol),-0.920123495664676,0.7714241121205552
RKO,57330099,4.8516025997257275,3.7749995193725305
P31/FUJ,54649500,4.423311343715707,3.095303129262664
SW948,10302451,4.082058519290096,2.956202300025089
WM115,2746,3.2273654457979957,3.4017264306310624
KU-19-19,654092,0.6096416345891582,-0.1845179392028192
PaTu 8988t,10296883,3.999790485906541,3.861810031419461
BICR 22,54143018,1.1733542553992964,0.8450850181619879
MDST8,71466445,2.0942740576673593,4.023298652610201
PaTu 8902,36462,3.471634301287976,2.2436786676433953
LS411N,44632017,5.0127460000138,1.1188498797793471
COR-L95,9911830,2.1813921058815553,2.233575451939744
ALL-SIL,9911830,-2.857836139869332,1.427319299253363
WM115,3465537,1.2344570371137795,2.3997374001616616
NCI-H2452,navitoclax-birinapant (1-1 mol-mol),2.13598555906201,1.7330225648788866
SU-DHL-1,54454,0.0220955119836291,2.3246752348811177
HARA [Human squamous cell lung carcinoma],9927531,4.552330692797245,4.8633002926831645
MOLP-8,24821094,3.654707766369703,2.598483823958312
MOLP-8,6852167,0.8455390099609336,1.6964378385950143
Panc 02.03,11222830,1.865607722872823,1.6549080870166455
MDST8,2746,2.514425635914287,3.142045857835055
Granta-519,1716436,2.7310795448836904,2.500250651115056
Daudi,selumetinib-tretinoin (2-1 mol-mol),4.819941209079035,2.6191205017138843
RERF-LC-MS,11625818,4.251014876931036,4.672508265850101
P31/FUJ,4378219,1.2412027933720209,1.690259833075698
HCC15,3062316,2.729530034687651,1.36083835418137
LS180,9903786,2.2166672873522857,2.585544231147032
PaTu 8902,16065773,3.37985868216597,2.427216520975133
LS411N,9911830,3.118029057589745,2.265921948330956
LCLC-97TM1,6438330,3.0238187505324885,2.4288895543714846
KU-19-19,25062766,2.9321374053838807,2.226486708850249
HCC1500,10074640,2.968051262406446,2.993410566420842
P31/FUJ,6505803,0.2535639265329721,-0.9612737794293891
NCI-H2452,387447,-3.2957708741809975,-4.093271132014137
MOLM-13,11228183,-2.7074565632423546,0.2861226950352631
SU-DHL-6,5566,0.7122829809928822,2.881397388540982
COR-L95,24785538,1.0654849938174582,0.7204614516772634
RERF-LC-MS,ISOX-bortezomib (250-1 mol-mol),0.403542566479009,0.8224578081173267
WM115,4578,4.221194502857287,4.639027098185583
COR-L105,4578,4.590840204947243,4.647903810626693
K-562,374536,0.780579010414565,1.1732194775036546
COR-L105,60700,0.1425021915553204,0.3850460211637501
K-562,46926350,-4.162486097405079,-4.21586635888308
SW1573,4705,3.887877577681455,3.2784934436051394
LCLC-97TM1,637858,1.4157632634757724,1.809316230021814
WM115,46926350,-4.284670953339827,-4.039686315204041
RERF-LC-MS,15547703,2.8085711207925015,3.440573256963974
NCI-H1568,11497983,3.872384435522252,4.419310307223435
MDST8,4788,5.889593740712007,5.747811764337216
IGROV-1,8515,2.1861539315976053,4.010335499622484
RKN,24772860,-0.333409077824626,-1.909990874332356
PaTu 8988t,322968,4.849886698333752,3.828019835571831
RERF-LC-MS,16720766,0.5604118097796991,0.9221953458937115
SW948,6505803,-1.4287073835677784,-1.050497104226784
BICR 22,462382,1.3729135623232431,0.6182253218676493
LS180,322968,4.435040308321651,3.6137032488715044
SaOS-2,11152667,-0.1732170298835725,-0.14802631985639217
ML-1 [Human thyroid carcinoma],49846579,3.632639122540709,1.8487104025692787
HCC1500,227681,1.895909952215359,3.4747659851692556
SU-DHL-1,57330099,3.736750567984075,3.9070900386007326
PaTu 8902,crizotinib-PLX-4032 (2-1 mol-mol),2.4716529657314252,1.8805603603240137
COR-L95,11977753,-0.4790698517891548,-1.4342955099929566
HARA [Human squamous cell lung carcinoma],6450551,1.1333007709837388,2.891072618052131
SW1573,11427553,4.057369297610019,2.7332122233596983
LS411N,selumetinib-decitabine (4-1 mol-mol),2.113542613262742,0.7161933340494245
LS180,12001922,1.7594619366424422,1.863933656989302
SaOS-2,12001922,2.1147367002170494,1.660470129510564
SU-DHL-1,3543504,3.7817510655567625,4.118830557039823
BICR 31,24901704,3.914024172074534,3.5565740085065713
MOLM-13,5287620,-2.884996470216499,-2.3396483436781494
BICR 31,25102847,2.842271629600241,2.708368327125163
COR-L95,10113978,3.7452762075447104,2.771270164442648
LS180,selumetinib-GDC-0941 (4-1 mol-mol),-1.227348326224306,1.103951382398977
MOLP-8,vorinostat-navitoclax (4-1 mol-mol),0.8660372331148116,0.4771708186013038
ML-1 [Human thyroid carcinoma],1750826,-1.3031865689994189,-1.336481331402933
MOLP-8,decitabine-carboplatin (1-1 mol-mol),0.1349258094123646,0.22015425028611013
COR-L105,168312962,3.0410731046381065,2.226450076306904
LCLC-97TM1,10322450,3.85878970197106,3.412016655315416
HCC1500,25161177,4.357780519617112,3.94885293250977
SK-CO-1,9967941,1.837567054996146,3.6836423709843866
COR-L95,5311,1.4789786210040632,1.0439418599915642
ML-1 [Human thyroid carcinoma],2733526,3.914729894927785,3.6959180462798673
LCLC-97TM1,72193861,0.688846554638978,1.071457138019257
SW48,4096211,0.1208358665406906,2.2450761919046203
LS411N,135875424,4.300305751936665,3.4475591010954854
SK-CO-1,42642645,0.466262192383588,1.0686865747264351
IGROV-1,1566236,2.765820903157784,2.3325147626756877
HCC15,10410894,4.508285516741203,3.3783562440273824
IGROV-1,6450551,2.579641476451469,2.7941304113048817
IGROV-1,452548,0.0422661560146271,0.49749531340117825
COR-L95,216345,3.729430833860697,3.42340518278946
Daudi,navitoclax-gemcitabine (1-1 mol-mol),-4.251556973738435,-2.4439715736555856
LS180,2945648,3.723684880750219,2.969764475630639
RKO,9936388,0.8183869926163714,-4.093114093530627
HuP-T3,10231331,2.6811135289001236,2.034947328815383
PaTu 8902,44493528,4.360494725244959,4.424793315793907
Panc 02.03,45279963,4.323488067826322,3.786346818714299
MDST8,BRD-K27188169-navitoclax (2-1 mol-mol),-1.2819787508049554,2.123229068973657
BFTC-909,44507138,2.8704731321552734,2.4296395712017245
ALL-SIL,49766530,-2.347000417785464,-2.391013400502712
SU-DHL-1,6918289,4.3249644726818275,0.6290330778104453
NCI-H2452,54626689,4.879011133008654,4.710424738246704
HCC1500,4917,1.9149154714535184,3.1308176780746693
LCLC-97TM1,15547703,3.011827246330581,3.1013096878500352
MOLM-13,71304818,2.1544936448447873,1.7857937842740972
SU-DHL-1,4917,2.4666047815714154,2.8992722187693745
NCI-H2452,56946209,-3.558178980562316,-3.8705201627766352
RKN,1750826,-6.055252220387113,-1.6469425267833488
RKO,25105715,3.388469834531371,3.3166280330419395
RCC10RGB,46191454,4.887818963424851,2.017782137265358
LS411N,3815108,3.549037613932863,2.4602818246685523
HEL,56946209,-4.040477533762366,-4.590030674073643
BICR 22,122327,5.571410232221064,4.5648523536792505
BFTC-909,969516,2.723005004244225,3.0287064177520984
KU-19-19,selumetinib-JQ-1 (4-1 mol-mol),-0.4288095691894706,1.6281851543229227
RKO,24856436,0.2423564692967549,-0.021670955454189365
SU-DHL-6,5746,-1.2123840023346684,-0.6639684728062238
SU-DHL-1,135411,-2.10627226052293,0.5825434654815529
SK-OV-3,1716436,3.636442167288748,3.1452292262568524
IGROV-1,44543605,3.88270235241076,4.025442537306717
K-562,6914657,-3.91828110768511,-4.963733205412279
HARA [Human squamous cell lung carcinoma],9866186,-0.525705997781229,0.8011620473931045
NCI-H2452,25262965,-3.6663688304344695,-1.6307125865284728
HARA [Human squamous cell lung carcinoma],navitoclax-MST-312 (1-1 mol-mol),0.8639589641874816,1.0712948636146435
MOLM-13,11404337,-1.791363376051536,-1.1912506454213045
RKO,36462,3.4370564574699185,1.400389522736176
IGROV-1,446155,3.750396425244744,2.6452400126125855
COR-L95,72734382,4.117898969233179,4.312566808187178
K-562,11396600,3.7562155275673415,3.023204605553728
LCLC-97TM1,4705,3.0319662392534057,2.919043549632326
Daudi,2130404,3.4806417402967993,2.4999945670439367
UACC-812,vorinostat-navitoclax (4-1 mol-mol),1.8866466886365112,0.6174567474082837
MDST8,327653,3.1544218347658375,3.2456523954603953
SK-CO-1,11656518,0.968890652064466,1.5969903699146153
K-562,5311281,3.9022564066083967,2.2754372629800197
ALL-SIL,carboplatin-etoposide (40-17 mol-mol),-0.158708138675103,-0.1418354246344017
MOLP-8,selumetinib-PLX-4032 (8-1 mol-mol),1.1163083218110827,3.6068036250480615
RKO,445091,4.342692134156949,3.933039807916262
MOLM-13,9935249,2.7939558009041283,0.9695767419511534
SK-CO-1,selumetinib-navitoclax (8-1 mol-mol),-1.2361376975305869,1.8439335433110546
RCC10RGB,selumetinib-JQ-1 (4-1 mol-mol),3.398592660488386,1.8353019088472922
SU-DHL-1,124202324,2.3695119203399906,2.1695597496930787
COR-L105,9884685,2.6443959528770167,0.9475714112192266
BICR 31,10113978,4.990782635230478,3.7176783330433727
HEL,crizotinib-PLX-4032 (2-1 mol-mol),1.5778515450818191,0.6098214294939437
MOLP-8,6610355,3.5622833697709178,3.9782586863165195
LCLC-97TM1,2749,2.4194398786749067,1.7878942811504321
Daudi,5311,0.1794409230409946,0.24502265311914834
HuP-T3,2113511,6.036487802507154,5.673163117046117
P31/FUJ,452548,-2.598049093653093,-2.54214606500389
SaOS-2,16065773,3.691866894593861,2.5030674044691668
RERF-LC-MS,65064,5.274588293813746,5.130998322659154
HuP-T3,89928392,1.747135585577409,1.6198345096872309
P31/FUJ,56963564,-0.6738396792941169,-0.4390538704362948
LS180,5746,0.8609008276830991,1.1860481215028518
BICR 22,11707110,-2.2145574606059912,-0.18372075777533645
Daudi,9952709,2.2307089742515713,2.4215191219417225
SW48,3543504,4.30466926238752,4.333219865865603
SW48,11427553,0.5193301330840923,2.387419056439702
WM115,56649450,1.7070260970326938,3.5370985486928737
IGROV-1,89928392,1.4824233552493276,1.3489737270283002
SW1271,72376,-1.909620961604672,-1.8920793001257865
SaOS-2,5278396,3.8495121754699686,3.4698579394020244
K-562,42642645,-0.9952706094252596,0.014132511392880553
Panc 02.03,446155,2.721578883226381,2.9427622553455834
RERF-LC-MS,44462760,4.251912039026111,4.104001902593518
BFTC-909,3503,3.411270469206907,2.224714160856413
MOLM-13,104842,-5.846939346357726,-3.962206258711682
K-562,11656518,1.1460195934444493,0.6682909538506688
HCC15,76446078,6.244123044550032,4.167855756771808
COR-L95,6438330,1.555078701387849,1.8006217281166519
COR-L95,9926054,2.0133423062539726,1.858059190784457
BICR 31,462382,1.217928478873545,0.5319938023297826
UACC-812,46199207,3.606176782545976,3.1698340067322412
SW1271,16725315,3.214819296898604,3.9239108080484284
BICR 22,3385,1.594485383262216,3.8819698178334967
HEL,11234052,1.6482548628813194,2.660643435443726
SW1271,49793307,-1.6735159246770874,-2.073121943194895
HEL,3025944,4.107185950107739,3.8249493238369237
SK-CO-1,1641662,2.678789461404506,3.5799688876342106
RKN,71680916,6.446363106372924,4.844401158982551
IA-LM,25183872,-0.4633226224219731,-0.6280892356095016
IGROV-1,6918837,-2.9804518885508635,-2.5312392789847498
HEL,252682,5.808471376099282,6.403992311593916
SU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),0.2178646036916351,-0.7359045398629953
MOLM-13,374536,0.9670025892080272,0.6845802105879577
NCI-H2452,168313047,2.588327036215806,2.551500477571379
Granta-519,4917,3.021022166883331,2.7596999830431064
ML-1 [Human thyroid carcinoma],JQ-1-UNC0638 (2-1 mol-mol),2.6444298637243167,1.8760266034285809
MOLM-13,selumetinib-GDC-0941 (4-1 mol-mol),-1.09695682780189,0.5078550335069942
BICR 31,262093,3.397835562493394,3.0291438651019997
LS411N,12003241,-0.0946051023392001,-0.6842597933679611
HCC1500,5282054,2.2651950194203323,3.612658307671831
HCC15,322968,4.854333863324092,4.112272363749419
RCC10RGB,9936388,2.3235560801623465,-0.22310342312461998
NCI-H2452,46199207,3.026577128215497,3.3039351078180617
Granta-519,9444,3.3091580955395146,3.363360016242238
IGROV-1,53392493,2.352084848618059,2.642870595906187
COR-L95,151289,3.0372683791028705,1.0283637593021062
NCI-H1568,216468,4.700562763036761,3.2700572177663223
WM115,25195348,4.859937697346287,3.5207011386753364
SaOS-2,2858523,3.094677154220442,2.8754640151874544
SW1271,421610,4.471416490511734,3.3429400492346155
BICR 31,637858,2.611871003184785,2.3307824326875473
SW948,11175137,1.686043515242534,2.3393374483772993
MDST8,11625818,2.7981930885976705,4.612633473230586
Panc 02.03,11609586,3.3931905350155915,3.0411283768175186
Granta-519,selumetinib-UNC0638 (4-1 mol-mol),2.20466638812085,2.4279970591720192
PaTu 8902,9825149,2.767587999144615,2.2114448582252537
HCC1500,6918837,-4.362896894201754,-2.7696632293160075
BFTC-909,navitoclax-PLX-4032 (1-1 mol-mol),3.5024450661652153,2.081745218008363
SaOS-2,5282054,3.07206551989859,3.566599551910605
SK-OV-3,navitoclax-birinapant (1-1 mol-mol),-5.0727238052406705,1.8230614328103685
SK-CO-1,72376,-3.2194985981528808,-2.1170393302702504
Panc 02.03,carboplatin-UNC0638 (2-1 mol-mol),5.105759320304772,3.467366578014631
WM115,10302451,3.6553280898048905,3.488787782085372
Granta-519,613000,2.2510291651452143,2.3583638766323007
SaOS-2,11222830,1.0878926350484104,1.4633974209780243
IA-LM,54678924,1.6007306497128662,1.6911224683144157
HEL,119607,4.922739390517752,4.311088325698885
HCC1500,6918328,-0.2689126411143879,-0.3714281763572218
HuP-T3,crizotinib-PLX-4032 (2-1 mol-mol),2.5650363225974315,1.9896512944538198
LS180,3062316,2.327440880417239,0.990874320190279
LCLC-97TM1,11317348,1.7152030009838672,2.392410030644915
SaOS-2,6918736,-1.8799034133096575,-1.9693365745051554
SaOS-2,12003241,-0.699813042979073,-1.007871538253468
LS180,10113978,3.7861477365363383,3.328230863884848
SW48,54618359,4.4319552735559,1.5990451464368878
PaTu 8902,ISOX-bortezomib (250-1 mol-mol),1.241492124971151,0.8634057386547928
HEL,387447,-4.961191552031455,-5.2099298070733155
RKN,6610216,4.220445612403551,4.302208413361282
P31/FUJ,656346,-0.3707458386499477,0.3873527994985821
Granta-519,selumetinib-JQ-1 (4-1 mol-mol),0.6993639444129659,0.034275165602261425
PaTu 8902,navitoclax-gemcitabine (1-1 mol-mol),4.2969329187245,-0.5981887918997179
MOLP-8,9952709,2.638563783306324,2.4315082023404013
SaOS-2,11455910,0.8777485884783317,1.0250516528532543
K-562,10184653,1.719293175029272,1.1047295103716015
Granta-519,4259181,-0.7648884727300508,-0.32138506417136337
BICR 22,4521392,3.4098909359208625,3.987677967043968
HCC15,2874250,4.519421691404506,4.384627318339097
SaOS-2,6918638,1.2055090485954645,0.5248389817085172
MOLM-13,9868037,0.9756233042827712,1.8227391776378798
HCC15,navitoclax-sorafenib (1-1 mol-mol),0.4047669070332462,1.9836142524621458
MOLP-8,16659841,2.203571056365997,2.4638929538093386
LS411N,656346,4.206497662771029,0.6397701448389889
RKO,5460769,5.660789679983863,2.001864361511272
BICR 31,6610355,4.797647038745592,4.71011394637905
ML-1 [Human thyroid carcinoma],17755052,4.154119256233629,2.166257883784866
RKO,11964036,1.8153618806471208,0.6670936242147778
NCI-H2452,7326481,3.286880233884326,2.813647378751013
RCC10RGB,44491742,5.1484686760969645,4.468611006020661
IGROV-1,50905018,6.092412272559071,4.170280575687789
BICR 31,9884685,0.303781088019613,0.7486797060429774
Panc 02.03,3081361,3.1546648300373357,2.33754378841704
BFTC-909,25126798,3.8219929141120166,3.8618113570552937
MOLM-13,66890843,1.9738756301734208,1.2638592966357896
HCC1500,24180125,3.164669305988548,3.125859714834708
SK-HEP-1,53392493,3.66906541895257,2.686574859962927
RERF-LC-MS,2945648,2.437954541344266,3.1810770832266213
HEL,25150857,2.447529551071105,1.6804376896437412
BICR 22,65064,5.333446499438452,4.990968801841357
PaTu 8988t,carboplatin-UNC0638 (2-1 mol-mol),3.665220724432894,3.5640802839199672
P31/FUJ,123631,2.0303759233077017,1.756594830224007
HCC1500,tanespimycin-gemcitabine (1-1 mol-mol),2.493780816473477,-0.7155140504817067
IGROV-1,11175137,1.8411496230681277,2.6241544688143255
KU-19-19,44241473,5.030815161961597,4.721952662775659
SW48,72193861,-0.4534629909928462,1.5169070707310661
NCI-H2452,selumetinib-vorinostat (8-1 mol-mol),3.054936641040398,2.7507529116331977
MOLM-13,5311281,1.6146001182421037,1.7670700916091375
HCC1500,9915743,1.9340540182592263,0.36248358785255147
SW1271,tanespimycin-bortezomib (250-1 mol-mol),1.119789259321392,-0.2737626405034066
SW1271,crizotinib-PLX-4032 (2-1 mol-mol),1.7792866548085249,1.7383371330500046
LS180,4096211,2.1975503712063604,2.1523141646288293
NCI-H2452,66577038,3.355972963473848,3.085847450885774
WM115,JQ-1-UNC0638 (2-1 mol-mol),1.9415560976310364,1.7707803410174907
HCC15,11175137,3.485795641541794,2.6634451281703404
K-562,navitoclax-pluripotin (1-1 mol-mol),-4.5842278555306395,-1.7479119380751436
HuP-T3,2945648,2.5475895191101197,3.0503350012958985
Panc 02.03,6450551,4.166761052507323,3.0596841965832766
K-562,2708,5.362475494708341,3.657173364675719
RKN,219104,3.4277527780329096,3.8646905384437726
RKO,16722836,2.0172870973895085,1.0549604130962695
UACC-812,439501,-1.4243957864326813,-2.0872741670536428
MOLP-8,11222830,0.9410853080031706,1.087824821546268
WM115,1239801,4.563824386797348,4.17402136968174
Daudi,11717001,4.763561920962392,3.5488043008508368
HARA [Human squamous cell lung carcinoma],24785538,-0.0579889747329333,1.8162896118196676
COR-L95,16736978,-0.5228132160938015,1.7279477970477777
IGROV-1,11213558,0.52356811652227,1.880143902805171
MDST8,44202524,1.4033794041893788,2.5213444359370416
SU-DHL-6,10113978,2.1190356124222194,2.213850163132214
SK-HEP-1,4917,3.764636353681369,3.2521971832904337
HCC15,452548,-2.1001752731425727,0.39942476026230517
SW48,46191454,-0.9829938197758128,1.6850508780442945
MOLM-13,4521392,4.5803067712490115,3.9518636680419634
HuP-T3,25062766,2.4453672011464023,2.0938602250443235
COR-L105,107985,-4.244896937866387,-3.2238801366298575
SU-DHL-1,89928392,0.4021872915525221,1.2985767988554537
BICR 22,55508,4.44611517999926,3.1764323828051473
ML-1 [Human thyroid carcinoma],135659046,3.731165476589243,3.8683230566790257
MOLM-13,675434,3.665195693175508,3.95910061114446
SK-HEP-1,6610216,4.694225049802747,4.368046397805634
IGROV-1,navitoclax-piperlongumine (1-1 mol-mol),2.320051681006032,2.072402223136384
SU-DHL-1,49766530,-4.824875359994143,-0.33452766369174186
HEL,12001922,1.658840092002429,1.5009469335046006
HCC15,46398810,2.6134237903958093,2.6293743908795735
NCI-H1568,3136844,4.658915015928919,4.4744968460147945
NCI-H2452,24821094,3.1123469452418537,3.2852213038085267
LS180,3543504,4.376890558116308,4.390667549059374
ALL-SIL,9927531,4.600523700119875,3.8981032127162702
BICR 31,11167602,4.451308398956488,2.452431747571215
SW1271,16219061,4.25548468975063,3.502949610255916
PaTu 8988t,448949,1.751499890417066,2.1840154649188572
WM115,2858523,2.9957579985597467,3.0057926346465895
RCC10RGB,11364421,1.2845393833467151,-0.3811853890132776
SK-CO-1,984333,1.8899562330111348,1.046441517420619
COR-L105,72376,-1.002534224494363,-1.0202640705681982
NCI-H1568,168312962,2.190321562510239,2.1633214374583893
SaOS-2,2746,3.4161371679978436,3.3116073232284493
Panc 02.03,51039095,3.661030142872421,3.0014542917598788
SK-CO-1,65628,3.554197618459022,4.167793632853982
COR-L105,16725315,5.297524124299076,4.4888611168629895
LCLC-97TM1,JQ-1-carboplatin (1-1 mol-mol),1.024195349701644,1.7049345556865179
RCC10RGB,46224516,2.231293839634299,2.884156624126535
RKN,9956119,4.4432647969313,3.5368308196113536
RKN,16065773,2.958619348149216,2.5859131188974267
WM115,17755052,0.4002517605741686,1.6514834620942807
WM115,168313200,2.1363369230808593,2.9644136219742063
BICR 31,ISOX-bortezomib (250-1 mol-mol),1.0654896454992784,0.741329128952601
WM115,navitoclax-MST-312 (1-1 mol-mol),0.1056862983661574,0.6442603591995153
LCLC-97TM1,9903786,1.8016114643921617,2.6537663559807623
SaOS-2,49867926,4.146129188416838,4.314081502696345
RKO,25126798,4.002843113400742,3.7163120734432447
ALL-SIL,219104,1.1543769867483644,2.065588705256395
Granta-519,tretinoin-navitoclax (4-1 mol-mol),0.0394078475475117,-0.30726705254447945
SK-OV-3,3062316,0.5292744016150154,1.1533189954219647
SK-OV-3,11178236,-2.424602318267421,-3.5122060952154457
LS180,9887053,3.1718141126704618,4.174838366334573
BFTC-909,25183872,0.7872065650622051,-0.9272592209052606
NCI-H1568,2945648,2.136721092573253,3.0686655453417804
RKO,1716436,3.795795915163565,2.796952384243822
SW948,65064,5.291153994733523,4.6818750410232886
PaTu 8988t,salermide-PLX-4032 (12-1 mol-mol),5.538923116384137,5.0888651089963535
SK-CO-1,16115403,-4.417233339728943,-3.8465108804624744
SaOS-2,400769,-0.6660591873157414,-0.704428338379373
SW1271,2733526,3.2893803459487594,3.7083222683933097
BICR 31,4521392,4.267019749412992,4.411188545683867
P31/FUJ,25154868,4.728907139536709,3.9161160659276413
HEL,676352,2.4086189638079643,1.758942748988918
PaTu 8902,BRD-K27188169,4.434214541500356,3.8708139100634686
KU-19-19,44607531,3.044914521934579,1.5664844356265482
RKO,selumetinib-tretinoin (2-1 mol-mol),2.520120690265609,2.9737833761417733
SK-CO-1,72193861,-0.1340038294528125,1.8557824419081463
HCC15,selumetinib-UNC0638 (4-1 mol-mol),3.167456472626372,3.2976374277921225
WM115,135423438,3.926483426744841,2.5093595524761163
RERF-LC-MS,135875424,2.839581382146162,3.9045091367905935
PaTu 8988t,46926350,-4.145321949318386,-4.05205652452585
Daudi,23582824,-0.638376916275564,0.7348082452824333
Panc 02.03,168313200,4.226618217059218,2.8884471743517732
NCI-H1568,11175137,2.3278621292073067,2.8654805115198085
COR-L105,11152667,-0.3968124554752262,-0.21000957330673364
IA-LM,5281672,4.428935042775787,4.629399789149264
IGROV-1,3062316,-2.2361832227909075,1.0538766918908529
SU-DHL-1,5281672,4.30860315799997,4.517914419684308
HuP-T3,tretinoin-carboplatin (2-1 mol-mol),5.021357813866161,4.8736546612476594
BICR 31,11625818,3.9395546041344858,4.691114730449494
ML-1 [Human thyroid carcinoma],5311281,2.103239185945236,2.4780806862270635
NCI-H1568,445643,3.6093957886383814,4.009253686682319
NCI-H1568,4477,0.3996701755478256,0.7592796421210762
RKO,36314,-4.63858923378885,-1.9210631473915136
Daudi,675434,3.694219652985114,3.9301814461875506
MDST8,60750,-4.217127024403589,-1.82148148332502
WM115,9903786,3.894434750277636,2.99691134708813
RCC10RGB,5282054,3.6705963985990993,3.6238764437605586
HCC1500,262093,2.85046563878574,2.8173005335204726
BFTC-909,4259181,-0.0277162117211437,0.24052687659132643
COR-L95,252682,6.347695054422412,6.38881788335053
LS180,9911463,3.681535048080384,3.836815157453156
SK-HEP-1,1566236,1.7725788045776691,2.362260336833298
LCLC-97TM1,6918736,-2.1743152466595626,-1.6212034373312136
SW948,10231331,-0.4116197219649379,1.340396942269859
COR-L105,selumetinib-vorinostat (8-1 mol-mol),2.277448874031188,2.7665617009787042
KU-19-19,52912189,3.155674258646967,2.6246227274657974
PaTu 8988t,44185566,3.1955818251601493,2.6479758245834097
ALL-SIL,31703,-2.84181702758724,-2.670970649896675
MOLP-8,67156097,-2.505693621695456,-2.302906834500157
P31/FUJ,12003241,-0.93015536828776,-1.5364012246267231
HARA [Human squamous cell lung carcinoma],44607531,1.5873617953354324,1.670764799732916
HuP-T3,72376,-1.771653200109272,-1.6793679524675114
COR-L95,vorinostat-carboplatin (1-1 mol-mol),3.640391778924097,2.4942526855919875
ML-1 [Human thyroid carcinoma],3062316,-4.511354956700351,1.1671100318446268
SK-CO-1,54649381,3.727346200170898,3.904788337814637
BICR 31,4578,4.306546690441069,4.543860585575998
HEL,24856436,0.2549549224561803,-0.6793632976155718
K-562,selumetinib-vorinostat (8-1 mol-mol),2.188537608414777,1.7818191234198417
Granta-519,selumetinib-vorinostat (8-1 mol-mol),1.614961732306094,1.8743299193735492
NCI-H1568,568763,0.1547040002068053,0.5908990596383261
SaOS-2,10184653,1.5674189620168135,1.4451202206933322
BICR 22,carboplatin-etoposide (40-17 mol-mol),1.4257688352427802,2.645746668589465
SK-CO-1,10127622,-1.7782095442547816,2.57695046939454
RKO,6450551,2.9764230599456782,1.6390312929148676
RCC10RGB,11222830,2.1708629162803654,1.8172013856834468
MOLM-13,439501,-2.531564352317227,-2.487076222587276
KU-19-19,5328940,2.592216165266187,1.761588594082994
SK-CO-1,BRD-A02303741-navitoclax (2-1 mol-mol),1.7439599678595026,2.237464009343684
KU-19-19,navitoclax-pluripotin (1-1 mol-mol),-0.1990402991745543,-0.8183346790546002
LS411N,46224516,2.772468105753273,2.5996146918927754
COR-L95,3465537,1.5360689669151406,2.2351322237182853
NCI-H2452,650361,3.725817753027947,3.7247960336359798
MOLP-8,135423438,1.7176055832456645,1.4703335556212764
Daudi,15953870,2.3174310256528017,3.0858075020572726
HEL,25062766,1.0860006913119025,1.3976286429375833
LS411N,9866186,0.9541786681011424,0.41804792359997445
NCI-H2452,72193861,1.1802568558602904,1.8390176058741008
SW1573,104842,-2.57352069349058,-1.867614927451889
SW48,1750826,1.3136286655933227,-0.5974948408226032
HCC15,25262965,-1.0400697166295236,-1.6938441469077887
SW948,156414,1.6424995325300082,1.0647521045397297
HEL,49793307,-3.822273429090704,-4.267121707543792
IGROV-1,JQ-1-MK-0752 (1-1 mol-mol),1.6911705649982345,1.637329210757965
KU-19-19,15983966,3.017543110767297,-0.5554754082055324
Granta-519,445643,4.101892829369416,3.4829644430461353
WM115,44462760,-6.607584862322745,2.5058881786115332
COR-L95,16722836,1.6737270586986386,1.4976795712607216
HuP-T3,19582717,-4.617931701404403,4.554062534332279
MOLP-8,135984461,3.690365922940533,3.0257453592090986
WM115,25105715,3.143290836206988,3.3307305912767946
SU-DHL-1,6610355,4.337111630655639,4.192839840593601
P31/FUJ,107970,2.0437014771117425,1.940994347894817
BICR 31,9903786,2.10396775229317,3.129833993332265
HCC15,119607,5.6213928119464285,5.256632169147872
K-562,53392493,1.9280012389180945,1.7757114373249139
Granta-519,erlotinib-PLX-4032 (2-1 mol-mol),4.2552857521313925,2.6137989317854378
ML-1 [Human thyroid carcinoma],4788,6.371899932480547,5.786758058727152
SaOS-2,6184667,2.75971928345779,2.9202216959192238
HCC1500,49867930,4.391361036771465,4.6567073741446965
HCC1500,156422,3.756088196252004,4.000097354113689
LS180,2729026,2.858515315971793,2.5577816707502534
UACC-812,9926054,1.7122964049751828,2.1256409064113835
BFTC-909,2945648,3.347829093032643,3.067336169994088
RCC10RGB,piperlongumine-MST-312 (1-1 mol-mol),2.4761046612469944,2.174204216806934
COR-L95,10427712,3.3507411292398315,3.964948121615691
HCC1500,73707371,6.057238887548947,4.8616485601049275
SU-DHL-1,5566,2.363543718324467,2.94058137777218
RCC10RGB,navitoclax-pluripotin (1-1 mol-mol),0.1501865832808995,-0.5848478485104639
SW1271,44137675,2.993655891868926,3.797112843801607
PaTu 8988t,10385095,1.1295524511895831,1.1669567772897436
IGROV-1,107970,2.287061680908213,2.450293041578794
LCLC-97TM1,3081361,3.200154540210029,2.344407657839064
MDST8,24797083,1.659668465713326,1.3795056708234572
MOLM-13,100016,3.967621300341963,4.8703262359833674
SW48,6914657,-5.582748420606011,-4.109549718667804
RKN,54454,2.1815674244706407,2.5311670104202597
SW1271,54686904,4.077781574312711,3.840712751382929
MDST8,tanespimycin-gemcitabine (1-1 mol-mol),1.2757210463641129,0.34067466297141075
LCLC-97TM1,11152667,-1.9849905525936635,-0.42906219226625725
RKO,6610355,5.147293026177706,3.999101502562117
HuP-T3,11234052,4.425621489915021,4.3383120515090035
BICR 31,11485656,2.9684140094972387,2.621110140775453
HCC15,445643,3.643779771767104,4.01004479246282
BFTC-909,alisertib-navitoclax (2-1 mol-mol),3.1464879320843635,0.7956810811283205
Granta-519,6918878,0.9437787040623058,0.17430843117702596
SU-DHL-1,16720766,-1.7997333167058054,0.7818802320498008
COR-L95,navitoclax-MST-312 (1-1 mol-mol),0.0334777259745642,0.10300823484475793
RKO,11626560,1.596896929931414,0.9468660283157867
IGROV-1,44589607,3.0909001492794377,2.6371328998482655
HEL,168313047,1.7739787927154282,2.0139219553738337
IGROV-1,11964036,-0.1609353030421705,1.2179974141821919
SK-HEP-1,969516,2.3030983588134917,2.9265604064166637
LS411N,68056272,3.648680202626129,2.998533120843553
WM115,navitoclax-piperlongumine (1-1 mol-mol),2.2126166903364037,1.6641580395226245
HEL,2749,1.5352641298417238,1.1260250088667103
MOLM-13,135398516,0.1807695197937267,1.1248829819500497
Daudi,176870,1.9898427065198672,2.500556174848211
HEL,10427712,4.076538081897971,3.713689725254829
SW948,24772860,-2.2115718578693495,-2.1462766599380716
Granta-519,2729026,1.8472912754822493,2.2074288849574417
COR-L95,5394,4.313147278509764,3.6384445007922857
LS411N,46907787,0.8939335106347707,0.16423546675715286
ML-1 [Human thyroid carcinoma],2841722,5.015074505803474,4.412648542598704
KU-19-19,11485656,2.7576201496249264,2.4723951129077837
IGROV-1,2858523,3.196384505087132,3.0856906019880785
SW948,702558,5.163408425848839,4.4997327881623965
RERF-LC-MS,72734382,4.885789692793362,4.757654369160355
NCI-H1568,JQ-1-navitoclax (2-1 mol-mol),1.9826778797664537,0.8957242462386666
RERF-LC-MS,11964036,1.6707185338079893,1.3188490777642863
ML-1 [Human thyroid carcinoma],25154868,4.839556149748317,4.631611836773833
SW48,3038522,2.575519148977434,3.037683225983977
IGROV-1,11364421,-2.1205062036040982,-1.8016648764064882
Daudi,24753719,1.7041863717102288,3.418550638535785
MOLM-13,selumetinib-BRD-A02303741 (4-1 mol-mol),2.2135360458532216,2.328543491976905
SW1271,73707438,3.2742940196229022,4.113509233770266
MOLM-13,44487061,4.373293273870424,3.0396314591750353
SaOS-2,568763,0.7449819257203903,0.5837187129133008
SaOS-2,168313200,1.7182390433527042,2.845403549253078
K-562,15547703,3.09098547046412,2.6996705157633887
BICR 22,24785538,-0.3286106781648999,1.9325383863703767
IGROV-1,9936388,2.10108466287406,-1.9459035272813119
BICR 22,4477,1.559722374810713,0.6055903803327092
LCLC-97TM1,navitoclax-birinapant (1-1 mol-mol),-0.5917483578052505,1.4868054589779076
BICR 22,16038120,1.2563245393113998,1.0527283843805104
PaTu 8988t,56649450,4.324867884259214,3.396234708930054
PaTu 8988t,135411,1.3050507330755643,0.7212695116249964
NCI-H2452,12001922,2.2907278374018296,2.107503812168166
RKO,44185566,2.4837284923488063,1.5990028634993465
K-562,9826308,0.1842141800186153,0.1389919130567706
RCC10RGB,5311281,4.058856975975892,2.4651965483574316
WM115,5460769,2.9023963298546507,2.7840194084884415
HCC15,119182,0.1055567812373319,-0.40971584697690333
BICR 22,44607531,1.5270609291983028,1.3513673625567284
HARA [Human squamous cell lung carcinoma],26596,-2.1080424946580245,-1.083285904550456
NCI-H1568,25262965,-4.225307409424958,-1.339826355449278
SW948,5328940,1.2304763256018572,1.4623715063529295
IA-LM,10296883,4.25848729020474,3.410855257918328
LCLC-97TM1,11964036,0.9095700511944136,0.9803852154855668
SK-OV-3,10074640,3.759507235638381,3.2306196016709667
BFTC-909,25062766,1.7422044094415416,2.0562886011564068
MOLM-13,44202524,0.8413416322030352,1.2858295139601053
P31/FUJ,44137675,3.225768708166513,2.7048599394668416
PaTu 8902,42642645,2.254917267204718,1.0484545032382797
RKO,53232,4.485666667988006,2.3322450647429314
MDST8,51039095,3.753808380930837,2.532216362358029
ALL-SIL,25150857,1.7729123360103365,1.5710764508027264
KU-19-19,136227924,3.1447471190609217,3.04209763826538
BICR 22,9911830,2.5765146499323497,2.633825665499291
SW48,26596,-2.356334812614481,-0.4862358730786861
WM115,8515,4.149615392892544,3.9152081800383725
SaOS-2,3025986,-1.3703894596366477,-0.5339053638204744
LS411N,6623618,2.410312404439064,2.2607451274213064
RKO,2749,1.3580925102381314,1.373156421431039
SW1271,9915743,1.6128868969613257,1.2551672570274404
SaOS-2,44589607,3.1014372869468736,2.8379275662806
BICR 31,9908783,4.390198834476992,5.112578039601941
RERF-LC-MS,1641662,3.403538628142178,3.5779868642960686
SW948,168313200,2.3052543991742933,3.168131923525641
BFTC-909,16720766,-0.0189955240044846,0.6105682885166599
HCC1500,46843906,3.5664723036358703,2.9590277785708796
BFTC-909,5291,3.495280995080932,3.6277902955098242
PaTu 8902,5287620,-1.817962379422155,-2.11485210858626
Granta-519,24772860,-2.616849709254195,-3.2105110142973
SW48,selumetinib-decitabine (4-1 mol-mol),-2.392622848847121,3.544395381859223
MOLM-13,2858523,2.990787770243497,2.308007257882396
MOLP-8,73707398,-1.5200522985211378,0.4447462678007875
WM115,4788,5.364989483250021,5.682703107290179
KU-19-19,11717001,1.9129980214779312,4.026381176710251
PaTu 8988t,3854666,2.839522644305469,2.2116225989236535
MOLM-13,vorinostat-navitoclax (4-1 mol-mol),-0.987195893966014,0.13832480675723832
RKN,11222830,1.5707482267531538,1.6559958181044487
SK-HEP-1,5978,1.689065603838291,-1.1525068064356767
LS180,374536,-1.6764778169414856,2.403916970130472
HuP-T3,sirolimus-bortezomib (250-1 mol-mol),0.6074306873304286,1.1019364736153114
RCC10RGB,46199207,3.760684270246491,3.2876584642783064
SW1271,49836020,-1.4027167140646708,2.3012165351265836
BFTC-909,2130404,3.366307483642889,3.38228551908887
SW1271,3384730,3.1846503121443144,3.0139036689704386
HARA [Human squamous cell lung carcinoma],selumetinib-MK-2206 (8-1 mol-mol),2.6906074312139676,2.467721012922135
SW1573,selumetinib-PLX-4032 (8-1 mol-mol),4.4065207246272005,3.582880566741532
SaOS-2,285033,-3.099559966451384,-2.061145851886163
LS180,71466578,4.68838045718991,4.317187566503389
LCLC-97TM1,2126,5.523539990092585,4.1908263990223595
NCI-H1568,9936388,-8.53108348301746,-1.3395482591814167
Panc 02.03,6505803,-1.93196111296706,-0.7330738166221222
BICR 22,9926054,1.8271931211135617,1.9990068476308485
SW1573,54618164,4.339091959582753,3.981977560771989
COR-L95,9907093,4.309721999642839,3.915921984448616
LCLC-97TM1,9911830,3.2250615193472085,2.1907423671972976
K-562,151289,0.3703020531314545,0.578568172570118
HCC1500,24821094,2.4557115965701257,2.603016457664743
ALL-SIL,11222830,0.8263932665864424,1.052706869164656
ALL-SIL,44490293,5.541636788423512,2.1584696761182176
BFTC-909,15547703,3.647732910564925,3.252378818187955
PaTu 8988t,11175137,3.61207596874577,2.662370976329048
COR-L95,44566777,1.612039010223373,0.8742911159364302
RKO,navitoclax-PLX-4032 (1-1 mol-mol),2.3429049321543083,1.5176047702060549
SW48,9444,3.3118033011757806,3.9883078749201393
COR-L105,52947716,1.1539739817838972,0.34834430656584536
HARA [Human squamous cell lung carcinoma],11228183,1.9492387662676105,2.710957525256824
SW1573,16013152,3.6979705228045354,4.1601541055027615
SW1573,17759555,4.342323370433329,3.721335547128057
SW1271,11609586,3.768986685585146,3.158342583750928
K-562,3552672,6.190745251508109,2.310455835983164
ML-1 [Human thyroid carcinoma],151289,2.136095657957592,1.2421567164918323
SW48,vorinostat-carboplatin (1-1 mol-mol),1.7573438485405597,3.238505663082561
COR-L95,selumetinib-BRD-A02303741 (4-1 mol-mol),6.0949369940274645,4.053627734449282
IGROV-1,57519531,2.639098862164858,2.62394357872308
IGROV-1,1716436,3.2816872421007375,2.9762840126337227
ML-1 [Human thyroid carcinoma],11222830,1.0897337620982457,1.6426957819802548
SW1573,tanespimycin-bortezomib (250-1 mol-mol),0.6931535757645308,-0.40244691598055515
IGROV-1,2828334,6.070696247039626,6.115429138645059
SW1271,53495165,2.774319130141937,0.2197646997781511
SW948,67291369,3.8063591597957593,1.6530188449265222
Daudi,11507802,0.3815953316544085,0.5030381511081652
RERF-LC-MS,2708,5.106155932743474,5.017800293903044
SW1573,52912189,3.9296893768173065,2.696539359029203
SU-DHL-1,25154868,3.5324679540942165,4.261374687977735
BICR 31,24772860,-2.497965982707089,-2.025815398147261
K-562,11719255,4.077642177046201,2.5514862886773892
WM115,5470400,-1.5377493662522326,0.41682490703516445
KU-19-19,44589607,3.6813877406069246,2.9830840109911674
LS180,11626560,1.7567799331145733,1.7864599362093014
Daudi,11427553,0.4642664556868584,1.184667382870358
HCC1500,44607531,1.3781074542184104,1.5162161197886557
COR-L95,sirolimus-bortezomib (250-1 mol-mol),0.1452212598896528,0.13383566749589965
PaTu 8902,4259181,0.9791956381618654,0.44270566907312253
SaOS-2,216345,4.363902597199754,3.7638870004587965
BFTC-909,100016,5.8134150302243865,6.241732113673189
BICR 22,56963564,0.2615280103832354,0.44415774928689444
COR-L95,selumetinib-MK-2206 (8-1 mol-mol),3.988992383923742,2.0611085132161735
LS180,613753,3.1711720082363337,3.2377408623169344
BICR 22,3825829,4.259881935728516,4.076215639111481
P31/FUJ,25262965,-1.897985536240049,-2.3605608705964705
RKO,15953870,3.3462063589818034,3.4354702824553023
ALL-SIL,26596,-3.0181503922951674,-2.736382451421851
SW1271,4788,5.888244914590778,5.540987200586094
COR-L105,25150857,2.68968810352953,2.6116330301961863
RKO,24753719,3.882573791668401,3.523122799081957
ML-1 [Human thyroid carcinoma],11719255,2.5461185366109453,3.5353316423627734
Granta-519,selumetinib-PLX-4032 (8-1 mol-mol),6.800610624755647,3.2889660404776935
P31/FUJ,selumetinib-PLX-4032 (8-1 mol-mol),0.7192847011043231,2.7922860163251375
PaTu 8902,613753,4.768885644214674,3.3822634909713387
PaTu 8902,44589607,3.762990171329796,3.1115646250825044
MOLP-8,176870,4.692998654081846,2.7481937883510996
MOLP-8,216468,0.300035377459394,1.1003552127755236
NCI-H1568,1641662,3.419317894706959,3.6704932118866544
HCC1500,11626560,1.5792444837322512,2.0708316278766135
HCC1500,3689413,-1.6712109221216571,0.12273818178058643
RKN,984333,1.094463938199557,0.6847938588929966
HARA [Human squamous cell lung carcinoma],9911463,4.1556235611039405,3.889612786932795
COR-L105,4788,5.897633886873905,5.766339316914034
HuP-T3,carboplatin-etoposide (40-17 mol-mol),4.278227331004969,2.888173865465332
PaTu 8988t,136227924,2.49705731140334,3.0559035539910724
LCLC-97TM1,3634881,2.947438100526324,3.2865221103840043
RCC10RGB,53392493,3.4706572822964072,2.8395983441018102
Panc 02.03,10385095,1.3097039910351371,1.3684106118786363
RERF-LC-MS,445455,4.41080153827665,4.789721863996777
PaTu 8988t,6918638,2.256433939948275,0.7605046058921162
KU-19-19,24951314,1.2793314486163916,1.4000325460810195
MDST8,25183872,-0.5549651899708961,-0.6260696720583525
COR-L95,JQ-1-MK-0752 (1-1 mol-mol),5.448110634286577,1.3546696038974684
WM115,navitoclax-sorafenib (1-1 mol-mol),1.4633730841087864,1.9749192594857123
COR-L95,9908783,4.358103020890871,4.585041623632529
COR-L105,3552672,2.0991572824292435,3.076010816261759
SK-CO-1,5566,2.706069596509063,3.0003493058159125
RERF-LC-MS,969516,2.2498421794663095,3.0332408269981688
HCC15,JQ-1-UNC0638 (2-1 mol-mol),2.9546017932515256,1.808362332851695
HARA [Human squamous cell lung carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.8572824243778725,2.3554452983411127
NCI-H2452,452548,0.0358025934468,0.5251009165606348
Daudi,409805,3.686040208403983,3.70401423775326
BFTC-909,5287620,-2.871557478653834,-1.9930248334685388
UACC-812,25183872,-0.2383295665292847,-0.4617573296494611
SW48,36462,-1.5563073788110886,2.0842168062742665
SK-CO-1,327653,3.1822308576162692,3.2961470331393357
MOLP-8,11507802,0.9747707839930404,0.8400120035210495
SW48,55508,1.9258231187784565,2.982085115663976
ML-1 [Human thyroid carcinoma],5329102,1.4103281602713895,2.084855811409015
COR-L105,16065773,2.993283969068687,2.4499478375407397
ML-1 [Human thyroid carcinoma],53495165,2.320007555236624,0.9783055799152847
LS180,451668,4.827094473942733,4.253970059777718
IGROV-1,36462,2.313632721410001,2.4205006734380525
RCC10RGB,selumetinib-piperlongumine (8-1 mol-mol),4.460336891472633,3.1228274542349657
COR-L95,navitoclax-piperlongumine (1-1 mol-mol),-0.3992176902442844,0.20646982056131674
MDST8,11719255,3.580824685094748,3.4926297665841166
BICR 22,135984461,4.376718251500639,3.6810258841491623
BFTC-909,selumetinib-MK-2206 (8-1 mol-mol),3.672772019831091,2.415547835157021
Granta-519,2871966,-2.0442685638601947,-0.6666970549182227
Panc 02.03,136227924,3.0839082623333387,3.3072342722300054
IA-LM,10074640,3.892343788144062,3.189240545268541
HuP-T3,navitoclax-piperlongumine (1-1 mol-mol),2.1493116178026157,1.9328658663900056
BICR 22,10231331,2.1949493731732095,2.3391947740436505
PaTu 8902,carboplatin-UNC0638 (2-1 mol-mol),3.7190209158995273,3.4131845952743993
NCI-H2452,10127622,4.466077980380041,3.954006160929998
PaTu 8902,11178236,-2.9840755573739943,-3.0162038081312033
MDST8,6918837,-2.3764765121755,-2.33572539328538
HCC15,1716436,2.8917896521916537,3.0054019663416973
Daudi,5351362,0.314899635949887,0.8728588038705009
IGROV-1,1750826,-3.124548162001242,-0.8863140199910039
SW1271,24779724,6.290779023739936,4.451841478568188
SW948,216468,0.513065020542466,1.7469016853868473
HCC15,5738263,4.375256926251463,3.451632311707053
Granta-519,25183872,-2.24080905771406,-1.9660029570932647
MOLM-13,selumetinib-navitoclax (8-1 mol-mol),-1.2398703731830696,0.2912709114106067
SaOS-2,46926350,-4.2820912559124995,-4.167044554084274
COR-L105,49766530,-0.5480688242609842,-0.06228161774323104
HEL,2874250,-2.245656223692803,3.9085366147589076
K-562,45279963,2.402740503794971,3.0610054995820595
SW1271,441298,2.7117876410913073,2.221750572061925
Daudi,46215462,1.1016280052611975,1.0636451237868256
BFTC-909,9915743,2.0959000942543025,1.2453515340004053
Granta-519,55508,1.5366901224911111,2.520975186489317
ML-1 [Human thyroid carcinoma],11507802,1.1504003941708354,1.8386373624300816
SU-DHL-1,445455,4.339452591135178,4.374359433878592
Granta-519,11222830,0.944926764715042,1.0709648972433696
SK-HEP-1,135421197,3.339831791709741,2.1827949420623245
COR-L105,11719255,5.177770829400177,3.705187186935541
SaOS-2,49793307,-3.0698778362667807,-2.5270667403499294
SU-DHL-1,54618771,0.3433661921186922,0.4456983683089674
SaOS-2,navitoclax-PLX-4032 (1-1 mol-mol),2.865443862493463,1.5417952223047564
IGROV-1,54618164,4.2184521751950115,4.1710271863866115
ML-1 [Human thyroid carcinoma],44507138,2.4759759240399206,2.6849194354158983
HCC15,4259181,-0.5021574884501439,0.35149944265805083
PaTu 8902,5311,1.4468060231693458,1.3638582846457792
SaOS-2,11609586,3.464015551213678,2.950228015989164
BFTC-909,26596,-1.7437210940555867,-0.7612193990622458
RKO,3385,4.410917651107157,2.986504514502852
SW48,5282054,3.4229655251352984,3.7046023964164148
HEL,3025986,1.4059985389197358,-1.5777920972989907
HCC15,2749,2.6993987110059456,2.117346223820119
RCC10RGB,serdemetan-SCH-529074 (1-1 mol-mol),2.3426493996230424,2.267603358128697
MOLM-13,2733526,3.3430267495988693,3.1951155698930127
HCC1500,71466380,5.203984730888507,4.479806390383066
SK-HEP-1,104842,-1.0887000355540395,-2.5796374404165237
SW948,5566,3.1149649258053107,2.793813481239103
Daudi,11234052,2.508646185471885,2.9327657188208502
WM115,tanespimycin-gemcitabine (1-1 mol-mol),-2.08510571323105,-0.6767528268812656
SW48,208908,0.7661322887377208,1.863766702043494
SW48,24978538,0.0148337391131729,1.4553878652147711
P31/FUJ,9926054,1.2698752833949425,1.673474571085465
Daudi,5287620,-2.5355659158885167,-2.420458799639536
BICR 31,53325874,4.467091056736401,4.783989405319724
LS411N,400769,-0.3072623933562745,-0.6944104084259753
HCC15,7326481,6.13295321500094,3.149793025796827
LS180,6610216,4.524725364990245,4.268266144879837
BICR 31,11609586,2.804864928293696,3.041399390514509
NCI-H1568,5351362,0.9370615420718584,1.6353380244403204
NCI-H1568,selumetinib-PLX-4032 (8-1 mol-mol),3.6289743773432463,3.6299775432829104
HCC1500,26596,-0.8174609850015592,-0.78944960010908
Daudi,JQ-1-UNC0638 (2-1 mol-mol),-1.821496210426365,0.28917181158579114
Granta-519,salermide-PLX-4032 (12-1 mol-mol),5.521121579042541,4.5242459624676465
BICR 31,5311281,1.899563489561116,2.557101812437384
HuP-T3,11964036,1.9148977928601396,1.6031144004367723
HuP-T3,6918328,0.6989696425214073,0.3537990647734833
IA-LM,56963564,0.8197284064300991,0.010688632591477867
K-562,25227462,-1.535473545694956,-1.2296648770751177
HARA [Human squamous cell lung carcinoma],68056272,4.667757023830857,3.2696536311508533
P31/FUJ,6438330,0.60015264799364,1.1510934438743907
NCI-H1568,54143018,1.7330311939537375,0.7772514858775945
MOLM-13,10184653,-1.0304513474260102,0.9705868521298278
COR-L105,3081361,0.7591954413754667,2.56953207425447
SW48,3465537,3.829258919586145,2.6754394581293974
SK-CO-1,135398516,1.0451560562277196,2.194424862225667
RKO,selumetinib-vorinostat (8-1 mol-mol),2.2625933360113826,1.8895289910062172
BICR 31,11222830,2.7999268343872603,1.5475317698952429
P31/FUJ,1750826,-3.787471607079622,-2.5737031110917665
MOLM-13,124202324,0.9453642044256088,1.1388276875528605
LS180,445091,4.461419397707798,4.442584726325251
K-562,4578,4.401657334703153,4.066632078423066
BFTC-909,31703,-0.9928331583982526,-0.8161983957748004
Daudi,54618164,3.154466747848232,3.5846054835252597
HCC1500,375860,0.1348683063529126,0.6422442737159656
MOLM-13,3385,-0.0516453787728095,2.52598521718212
Daudi,123631,1.6174763425926726,2.113774531171932
SW1573,6610355,4.129027118562099,4.575105295689033
K-562,44589607,2.662527895237601,1.869745620473673
SW948,24964624,1.7910099631647045,1.7322917563041
LS180,387447,-4.2321913932512185,-4.222608947068009
SW1271,445091,4.3767610709371025,4.596010103542516
LS411N,5328940,2.1913370268343324,1.3030612867770182
ALL-SIL,46199207,2.4207183231317826,2.70619760858404
BFTC-909,644241,3.062866082016443,2.2914657073986153
SK-CO-1,5738263,3.1381077819263954,3.6782206160031063
HCC1500,selumetinib-BRD-A02303741 (4-1 mol-mol),5.277663522211575,3.417029535385739
PaTu 8902,3385,6.504553614083827,4.331031735234362
SW1271,5328940,1.739297434861375,1.9278451379064148
Daudi,444795,4.05018196872557,2.987455118993607
SaOS-2,9887053,4.468769125876902,4.207980628401136
ML-1 [Human thyroid carcinoma],6610355,5.061552725322464,4.965781870752739
MOLP-8,9936388,3.4211096692910052,-4.312901312941147
SaOS-2,5746,3.648398890023908,1.2934843199702482
PaTu 8988t,135875424,4.8815767191826325,3.7892338173860565
SaOS-2,25195348,4.111342507306749,3.312892686322746
NCI-H1568,135398738,4.732110826035958,4.563365534252978
RKO,5329102,2.192208184281935,1.5905240972246582
ML-1 [Human thyroid carcinoma],122327,4.584045367066115,4.913158130070191
WM115,11612883,3.668907379861532,2.955357043081956
HCC1500,24785538,2.8337652504333817,1.756614454843355
ALL-SIL,3854666,-1.067048731148745,0.6301328889467741
WM115,11494412,2.975341542339242,2.1935307724933897
Granta-519,9884685,-0.5481626961732873,-0.6628126735268886
LS411N,selumetinib-vorinostat (8-1 mol-mol),0.590504538579532,1.6015364789169948
KU-19-19,5287620,-2.913600334543538,-2.036588401408319
HCC1500,25227462,-1.134185511373382,0.48445827115265133
SK-OV-3,9936388,2.038842599711319,-1.7124024152667225
HARA [Human squamous cell lung carcinoma],5113032,5.077717215414557,4.8262234121922765
HARA [Human squamous cell lung carcinoma],46191454,0.0255281814012309,1.8532449246433165
COR-L95,9840324,5.902997789616562,5.552723600239809
SK-OV-3,159324,5.082712026660022,3.4526642484458354
COR-L105,5426,4.419968019169297,3.641235689201681
HARA [Human squamous cell lung carcinoma],carboplatin-UNC0638 (2-1 mol-mol),4.127490867447662,3.2613823112450793
HuP-T3,44491742,4.372770131484514,4.237797065141595
HEL,navitoclax-gemcitabine (1-1 mol-mol),-3.418603962504733,-2.481810755172033
MOLM-13,5978,-4.923441638627742,-3.07197642751385
KU-19-19,9911463,4.338553857034003,3.9521255187197055
LS411N,SNX-2112-bortezomib (250-1 mol-mol),-2.160208901072175,-1.553172325060951
MDST8,9956119,3.20428794924567,3.3933596046356143
IGROV-1,44137675,1.8406125640672395,3.4274428126426426
NCI-H1568,24771867,2.7621066837370156,2.738584112227023
SW1573,3503,1.662872296112478,2.5762185862838423
ALL-SIL,54143018,-1.6646130342073118,-0.646419155590623
KU-19-19,9903786,4.470072542277405,2.9647365489987516
Granta-519,67291369,2.669151289874282,0.23622078900431717
HuP-T3,126941,-4.07371973001698,-2.6766725961875415
IGROV-1,11175137,1.8411496230681277,2.6241544688143255
LCLC-97TM1,3543504,4.4040963352609825,4.136885819908812
PaTu 8988t,10184653,1.9115764380070437,1.4086327835585786
BICR 31,10184653,-1.3652350776002238,0.3682816859295007
PaTu 8988t,4917,3.9515789700022728,3.085189156646285
LS411N,9967941,4.95978669187673,3.1505010707181924
SW948,6918837,-5.2716912634433815,-3.2938641998991174
Granta-519,19582717,3.2223711893143796,2.769543072080917
HuP-T3,753704,5.56041062328625,5.274875065675087
SW948,BRD-A02303741-navitoclax (2-1 mol-mol),3.1746461495638867,1.8165125331995549
HuP-T3,44819697,0.7007171788005963,-0.341680151045827
Daudi,49766530,-5.535187194073846,-1.9322650545234417
RKO,168313047,1.9322709085928884,2.0586918463885766
HEL,451668,-1.9900462993769088,-0.7736518142301838
BICR 22,selumetinib-tretinoin (2-1 mol-mol),2.504585066651982,2.832083517009325
ALL-SIL,637858,0.2842777242368783,0.8835030109515541
SW48,375860,-0.9823609780883206,0.1704019664875539
Granta-519,426756,3.1337304970475865,3.5918563789233144
LS411N,3038522,4.360410119835835,3.182519900857441
BICR 22,SNX-2112-bortezomib (250-1 mol-mol),-1.3459249311621435,-1.425738016861207
NCI-H2452,11626560,1.8431584922948163,2.146996461146868
SW48,135398516,1.3232406127849534,2.0359173027961255
SW48,5329102,0.4162536894409948,1.9513433653395602
ML-1 [Human thyroid carcinoma],322968,3.685498672876688,4.042669922030339
BICR 22,11427553,3.133254296040306,3.053108269118433
NCI-H2452,72376,-3.519434001557919,-1.4702907164005474
ML-1 [Human thyroid carcinoma],11238147,1.6119243998814434,3.0367296784525943
K-562,135984461,3.2548026411837787,2.967464486158372
SaOS-2,BRD-A02303741-navitoclax (2-1 mol-mol),3.697295369553163,2.20733809995502
Daudi,73707398,-0.7942959168982594,0.3451608680702478
NCI-H2452,46398810,2.3683678826725387,2.776086517390709
PaTu 8902,5738263,4.741832860910815,3.554351758115567
MOLP-8,10322450,4.082153801594249,3.166498288803544
HARA [Human squamous cell lung carcinoma],54618164,4.558968644978708,4.1470543987075015
SW48,5287620,-2.9796019172473747,-2.1816500186366015
COR-L95,navitoclax-birinapant (1-1 mol-mol),-1.5627413747354164,0.16799166400532925
MOLP-8,56963564,0.2564931281605764,-0.13621282345209873
Granta-519,375860,-0.9367901929922506,-0.43278343866549646
SK-CO-1,656346,-0.6691405855346803,1.0948079511396818
RCC10RGB,44607531,1.912198544747903,1.6949682565622153
RKO,9823820,5.913042612438718,2.131524969376372
SW1271,25262965,-0.6695626057691765,-1.4168745233746158
SaOS-2,2742550,4.001711578380083,3.9466509684988025
SW948,44491742,3.910317363967626,4.080700265481354
K-562,25105715,3.3934107563871088,3.1285161980627465
K-562,3689413,1.0071697658281389,-0.8782202753241262
NCI-H1568,9911830,1.3917537385715242,2.436969426479573
IGROV-1,42642645,0.3750175292659389,0.9821044308232436
MOLP-8,53392493,1.8438027475223988,1.5321096121750393
BICR 22,4788,5.9489186959823845,5.516611669043184
IGROV-1,5287620,-1.5394168430569777,-2.161262333371155
IGROV-1,446155,3.750396425244744,2.6452400126125855
LS180,15983966,-3.417830365026362,-1.7168629826324826
MDST8,5566,3.234550965497495,2.9659933775499514
K-562,644241,-4.86229706466587,1.2396807392295504
SU-DHL-1,135421197,1.1384736779813156,1.5247279694613158
KU-19-19,44507138,1.5611189443326865,2.6756522593421033
Panc 02.03,5281321,1.7682996743542674,-0.6688827095087991
SW948,44607531,1.464462944366021,1.2859610371023715
KU-19-19,54649381,3.8760376098429616,3.997980971485037
Daudi,25062766,1.1734245449662122,1.664340654257697
IGROV-1,56946209,-4.416985130578084,-3.845117093777393
ML-1 [Human thyroid carcinoma],49766530,-1.1158595986885904,-0.3199903186682878
NCI-H2452,11238147,5.37150149846425,3.038556684643751
HARA [Human squamous cell lung carcinoma],vorinostat-navitoclax (4-1 mol-mol),1.9090977342000552,1.335036740555351
HEL,3689413,-2.191477482826257,-1.6089597423571924
WM115,285033,-0.1832916587196474,-1.6824443684593455
SaOS-2,piperlongumine-MST-312 (1-1 mol-mol),1.0729634254150997,1.831243483253665
SU-DHL-1,426756,3.3694285311129777,4.0409259215576645
WM115,135999136,1.8466122948256136,3.7656271639151253
IA-LM,45279963,4.638115534107364,3.2160595892547423
MDST8,JQ-1-UNC0638 (2-1 mol-mol),2.369730621007783,1.8325927502799726
SW948,4917,3.7157271581620166,2.7745771502881884
Granta-519,119182,-4.107570420442856,-3.201514305385777
MDST8,56946209,-2.145438357732055,-3.556303602827856
HuP-T3,9927531,4.952379772704904,4.8542177897036085
RCC10RGB,72967,3.7162805539485775,3.5403567195768
P31/FUJ,vorinostat-carboplatin (1-1 mol-mol),1.4493920018144175,1.9799307949315317
COR-L105,25126798,3.974391104898093,3.965864255932122
IGROV-1,676352,2.310492141650647,2.185316034237696
MOLM-13,11640390,3.605079146985929,2.098495797271292
SW1271,10302451,1.5832525718610488,3.115148684796743
HEL,123631,2.2046071754004553,2.0123655007185834
Daudi,9887053,0.4273795924431001,2.624826363962118
HCC15,53232,1.2438342439906054,2.8751379320725707
KU-19-19,crizotinib-PLX-4032 (2-1 mol-mol),2.7637212964945745,2.0628301518147363
MOLP-8,107970,1.7976582890286323,1.7842936960550342
COR-L105,12003241,-1.8759508779616432,-1.0813138529761193
SW948,11222830,1.2602033369542562,1.3774899893805483
LS411N,60750,3.4958773713368725,-2.289026180640013
SK-HEP-1,selumetinib-decitabine (4-1 mol-mol),7.187577119098816,4.028908297881749
COR-L95,11152667,-1.0192155235937173,-0.7470562818750841
RCC10RGB,136227924,3.611686331312014,3.1828529775920402
Granta-519,46398810,1.929291860170987,1.9090412394310912
SW1271,135999136,4.614562085611917,3.8636345136852435
IGROV-1,53232,2.4872106086763393,2.945544598523988
SW1271,5329102,1.7502689549650896,2.1219818348391617
Granta-519,136227924,1.3333863896282263,2.3156666319375505
HCC15,11213558,1.313690011959325,1.6053994440917947
BICR 22,54619267,3.924840101579574,4.140759770801564
MDST8,9907093,2.778674083883115,4.237704192152314
P31/FUJ,11175137,-0.7372235608093404,1.5533478015674422
MDST8,36314,1.6029219233562175,-0.04461301106168092
PaTu 8902,2746,3.932313359375791,3.1700832583780296
P31/FUJ,3543504,4.167476980253382,3.8054293759551685
MOLM-13,selumetinib-decitabine (4-1 mol-mol),-2.0497039310535548,-0.9746349996873864
HCC1500,2749,1.6972528944159595,1.9424992646917647
HCC1500,2858523,2.9580940168196372,3.0207364554704945
P31/FUJ,241158,2.9181679480161997,2.473380596552118
IGROV-1,44202524,1.8303703172382677,2.5440727029340935
COR-L95,24856436,0.3013384579313291,0.2973540550778222
Daudi,15983966,-4.480185591931726,-4.467111657496977
MDST8,9903786,2.958137426904596,2.8160777957255245
SU-DHL-1,57519531,0.9649766396601452,2.667735127270256
IGROV-1,25262965,-3.18785020602057,-1.769235086629601
MOLM-13,135411,-0.7080955458923358,0.10031754436152805
HCC15,24901704,2.315976175325417,3.4225935993635073
SW1573,656346,0.5263129478884733,1.1520241585355573
SW1573,11238147,3.4967804964098517,3.059806948870311
MOLM-13,6918837,-5.322581124261525,-4.766062166592031
MOLM-13,444795,-0.8871401586886155,3.109292591994029
HARA [Human squamous cell lung carcinoma],2733526,3.2699742840947414,3.739211479748026
SW948,44486219,4.202726475674803,4.243493876474879
ML-1 [Human thyroid carcinoma],10302451,5.152653454280482,3.2398129200873798
SK-HEP-1,4259181,0.3926762831937545,0.46050379279821
MOLM-13,11152667,-8.249378694414048,-1.998949277203179
HCC15,46199207,3.454904957256138,3.1821149905226673
COR-L95,BRD-K55473186,4.076833088818027,3.9506990743221264
SK-HEP-1,11612883,3.763210558313423,3.1542076560270775
SW48,54619267,2.8192087316830587,3.8150263557682966
COR-L95,448949,2.666065821382702,1.6497129041533016
SW1271,31703,-2.541706035799043,-1.0141744612682002
SW48,374536,2.9137455711630365,2.0825466326113284
HuP-T3,25183872,-1.5149537087973208,-0.5597739186472254
BICR 31,71466578,6.11729815776394,4.452247494377231
PaTu 8902,JQ-1-UNC0638 (2-1 mol-mol),3.325968686418886,1.8043401784733215
SW48,135440466,-0.9616456131279733,2.226444833823696
Granta-519,322968,2.3569390760499234,2.0237598095379763
RCC10RGB,25227462,3.0929907596871646,1.008300409806837
P31/FUJ,6917907,-6.201167718101803,-5.829157341522344
PaTu 8988t,49793307,-2.0749757720441164,-2.3183217760982986
HARA [Human squamous cell lung carcinoma],9884685,2.402658407469787,0.9431392927769023
Granta-519,12001922,1.093482575381039,1.446073132749074
SaOS-2,54649381,4.670802712896813,4.004061884049931
BICR 31,11213558,1.307666782243681,1.5348468270608109
NCI-H1568,crizotinib-PLX-4032 (2-1 mol-mol),1.1920351291695386,2.183398605978633
RKO,selumetinib-UNC0638 (4-1 mol-mol),2.378322605916553,2.5167411013875927
P31/FUJ,tanespimycin-bortezomib (250-1 mol-mol),0.0118872693017982,-0.6153174935749625
SW1573,216468,2.7570678542174294,3.198939163614031
WM115,selumetinib-UNC0638 (4-1 mol-mol),-1.6649688708670054,2.4148673696193055
LCLC-97TM1,441298,2.906797889353979,2.3108460484695055
LS180,24753719,4.21554861148433,4.273670584802467
ALL-SIL,65064,2.797289094590348,3.716762811520433
BICR 22,67291369,2.228219380635809,2.708985924213414
RERF-LC-MS,168313200,3.896073258981905,3.180501551984969
SK-HEP-1,9444,4.343802313850578,4.31592091059707
PaTu 8988t,5328940,1.37213408852796,1.7805525184815325
BICR 22,5311,1.9321946929787237,1.6358201627127587
BICR 31,219104,4.339385963743166,4.056838757292399
IA-LM,navitoclax-birinapant (1-1 mol-mol),0.9661669112911666,1.2858505325717322
ALL-SIL,4477,0.1906678465210559,0.37895989527728985
K-562,25154868,2.7747166739598264,4.061916107608054
SK-HEP-1,16065773,3.000790971898234,2.486076267303638
PaTu 8902,11364421,1.1100050491651887,-1.4312219110515045
NCI-H1568,3081361,2.134244125445247,2.3930033619033004
HCC1500,11640390,3.4842141291887234,3.45356331651665
BFTC-909,11626560,2.2197507332783735,2.166101403999879
SW948,107970,1.650733689507072,2.1194485355065353
RKN,15983966,-2.847635435689191,-1.6220485236083448
P31/FUJ,11455910,0.7543092217738059,0.49258193034249137
MDST8,71466380,4.4925072325945825,4.219535331073353
HuP-T3,44185566,3.047929926499308,2.5728153016196695
WM115,24772860,-3.130789858430774,-1.7601090910684323
COR-L95,327653,2.664763845896721,2.9855553820574756
BICR 31,46398810,2.284799792972812,2.6861722085562407
MDST8,46199207,3.2831338438462545,3.168954745844353
P31/FUJ,54143018,-1.089453758548118,-0.5408431031815271
RKN,119607,5.106543735080002,5.481413111842056
COR-L105,5746,2.3338049438674933,1.6855239439904954
ALL-SIL,alisertib-navitoclax (2-1 mol-mol),-3.0899588817168286,-1.828348651735153
MOLM-13,5738263,2.9100103684660237,2.3443916106960283
RERF-LC-MS,216345,4.25766275770173,4.25486769640154
P31/FUJ,10322450,3.023071845081992,2.8805215616289126
BICR 22,16065773,3.2562595111068933,2.5475913726686543
HARA [Human squamous cell lung carcinoma],3136844,4.042885024123848,4.327217440836644
RCC10RGB,2858523,3.1824977664847833,3.066840495066445
HEL,3634881,2.3660153954756,2.6550349208966653
BICR 31,4705,2.7587837218207194,3.267077890496877
Daudi,16736978,-0.1290294552432643,1.145206494008544
HCC1500,409805,3.5957056987066407,4.877022449228412
COR-L95,11497983,3.7904455836505977,2.225727363489004
NCI-H1568,erlotinib-PLX-4032 (2-1 mol-mol),1.5802949352112503,3.1210146574646958
HuP-T3,123631,3.4682236131630213,2.361387340814525
MOLM-13,6918736,-1.7098661921605196,-2.523657972399163
MOLM-13,46943432,-0.154947866345158,0.9236021344594941
HCC1500,219104,2.0821347677363473,3.775301415048951
WM115,salermide-PLX-4032 (12-1 mol-mol),1.9364726172790967,4.588474689695229
NCI-H1568,65064,3.2204713254113373,4.949266807629103
SW1271,16720766,0.8044088826386648,0.6460183128811614
Daudi,119607,3.8512151262400978,4.26197808438718
HCC1500,72193861,2.243893882523798,2.0341544609487703
K-562,5328940,0.7651330448756731,1.243450553921623
SaOS-2,644241,2.5011234622868415,2.4011369202584696
HEL,60700,-1.2821695146150829,-1.9192939290413398
RERF-LC-MS,25227462,0.8140348385016122,0.8800151434014887
COR-L95,4521392,4.944619543772989,4.090127771747862
KU-19-19,16720766,1.6427063989874335,0.6296115412434046
SK-OV-3,3025944,4.375754256809385,4.360490222564932
P31/FUJ,36314,-5.221113398603202,-1.894809991482396
Panc 02.03,568763,0.7660787595735656,0.7051297150790274
PaTu 8988t,60700,1.4149082605005396,0.07735915332795308
BFTC-909,421610,2.763760389372973,3.3360773489293063
IGROV-1,selumetinib-piperlongumine (8-1 mol-mol),2.9206278268520163,3.265856932629969
RERF-LC-MS,123631,2.7610356359897104,2.664341841006505
IGROV-1,selumetinib-decitabine (4-1 mol-mol),3.5551285698551225,3.861051880010684
RKN,10385095,1.0188882527918253,1.2711949318218685
K-562,carboplatin-etoposide (40-17 mol-mol),2.706166377048538,1.1489476755317052
SW1271,selumetinib-vorinostat (8-1 mol-mol),1.620526536353516,2.1433938554454786
Daudi,44486219,3.679556481815833,3.6717973644483792
SK-CO-1,JQ-1-carboplatin (1-1 mol-mol),4.771818519750647,2.5137795028670427
P31/FUJ,159324,1.227532336429348,0.9552488941667285
SK-CO-1,6252,-1.3434891204218062,0.9749511289963729
LCLC-97TM1,656346,0.6605690440583806,0.8092097391413619
Panc 02.03,SNX-2112-bortezomib (250-1 mol-mol),-0.27502478347835,-1.084778716657203
RERF-LC-MS,675434,4.646232548137413,4.704404784868741
KU-19-19,123631,3.236221278135049,2.480870309090797
MOLM-13,15983966,-4.417403089755366,-4.361691136340256
HuP-T3,4917,3.663340719397695,3.106022930824596
LS180,44185566,1.7571027497277631,2.1899894904211963
P31/FUJ,11228183,-0.9086595542209992,0.1530001579074402
WM115,9933475,1.7795579913266513,1.8974286232726607
RCC10RGB,445643,3.986839371383198,4.024958900279696
LS180,11238147,1.5426585727528574,2.7248415173312663
SK-OV-3,6918328,0.3966751205296329,0.5643123027015826
SU-DHL-1,71466578,4.395132834723917,3.3703756000606586
ALL-SIL,135421197,0.8278001934093618,1.1744266932652978
BICR 31,2858523,3.440938149330432,3.057928123127917
NCI-H1568,72734382,4.159676082420196,4.732572858844482
BICR 31,10427712,4.26091650049326,4.345908099683126
K-562,5351362,1.2059406782397044,1.082212180235463
HEL,44589607,2.8579344181758164,1.8577693229748553
RERF-LC-MS,89928392,3.2509495975064193,1.7200520433664606
K-562,4705,3.481256778033869,2.930132905019491
SW948,400769,-0.4902020150535968,-0.7349136723206143
RKO,46199207,3.448070090368443,2.7943309606668527
HuP-T3,10410894,4.484643398072658,3.326250133119917
BICR 31,969516,3.644181632779252,2.7887102289270875
WM115,54618771,0.9043395114740442,1.2890704984678332
MDST8,2749,2.5181508528519365,1.9505984284333762
SW1271,4378219,1.9495591217614856,2.5103721047334715
RERF-LC-MS,12003241,-0.3897829713203344,-1.0243258320957538
ML-1 [Human thyroid carcinoma],11683005,4.957719989216769,3.028935178512041
PaTu 8902,44620216,3.796821774118314,3.9293828095170755
MOLP-8,4378219,3.751203523477959,1.7904804403740038
PaTu 8988t,11152667,-0.7220641758089987,-0.49522514183930527
SK-OV-3,navitoclax-gemcitabine (1-1 mol-mol),0.2321972175274424,-1.3154017186781775
SK-OV-3,60700,0.4435128165358443,0.32537802365290647
LS180,168313047,2.515878081381246,2.2305833355359654
K-562,400769,-0.7978860959413716,-1.3271003356063162
Panc 02.03,126941,-0.7071805078882285,-1.986043506325517
NCI-H1568,3634881,3.2529386900783024,3.6310654995569736
LCLC-97TM1,24821094,3.5658031163211996,2.9632475073760314
LS411N,11485656,1.6093796612349578,1.8484875077032656
HCC15,16736978,2.153897232237977,1.8980223117710586
LCLC-97TM1,6610355,3.6494140877324273,4.214766724549707
IA-LM,serdemetan-SCH-529074 (1-1 mol-mol),2.9054360397422387,1.7199139019976482
IGROV-1,9911830,1.9130562323799436,2.474737883098353
LS411N,159324,3.2133975478450005,1.6905937456433318
COR-L105,selumetinib-PLX-4032 (8-1 mol-mol),2.5098576733785705,3.572973588528746
SaOS-2,322968,3.970591848140582,3.639031306142013
BICR 31,216345,4.54975912567895,4.059535377792815
HEL,3825829,3.033394475732853,3.1777589039522938
COR-L105,46191454,3.4168297701439223,1.9623393062157868
K-562,5113032,4.649240406472478,4.443963964302208
BICR 22,156414,1.4774483319728589,0.25902668920497185
SW1573,135875424,1.8143158468632437,4.072051788945431
WM115,12003241,-3.303596686294694,-0.9067441138358541
RKN,11640390,3.613472996393559,3.75778271484278
HEL,23725625,2.914554844202699,3.5947392839879653
COR-L95,36462,-0.8944975018350346,1.070085784774183
HARA [Human squamous cell lung carcinoma],53232,3.05929528970331,2.886380868350687
HuP-T3,11977753,3.281021154274905,-1.2756240603752422
SK-HEP-1,400769,0.2777482831309371,-0.5516574067027066
IGROV-1,vorinostat-carboplatin (1-1 mol-mol),2.9918987847321645,3.3116198860222745
SU-DHL-1,246676,5.693727803678488,3.7440292280864416
HARA [Human squamous cell lung carcinoma],11626560,1.1307601374566012,2.0019870976379743
PaTu 8902,selumetinib-JQ-1 (4-1 mol-mol),5.2969208566894075,1.6173634847341023
RCC10RGB,44507138,4.147954700367582,3.005982208505984
LS411N,123631,3.048490743589503,1.8903388514334667
MOLM-13,11213558,-2.3442824820578347,0.7833673021151122
MOLP-8,selumetinib-tretinoin (2-1 mol-mol),3.5259628447658495,2.906947851090652
SW48,tanespimycin-bortezomib (250-1 mol-mol),-3.595985811968766,-0.8405094941249929
PaTu 8988t,444795,4.288290341819835,4.926657490947041
SK-CO-1,66577038,1.9378658470267984,3.0245907517514383
SW48,24771867,-3.897611921368264,2.509118904288525
NCI-H2452,9907093,3.826391051371518,4.336848473229284
SW1271,171352865,2.2565348875691624,2.9676547691128343
SU-DHL-1,11152667,-1.9410189761528236,-0.20368345691548911
SK-HEP-1,148124,3.734435411699081,-1.988970062228259
RERF-LC-MS,107985,-3.0933260647006215,-3.2217874716867403
HARA [Human squamous cell lung carcinoma],44589607,3.368220225067554,2.867298435606098
ML-1 [Human thyroid carcinoma],36314,-4.393977809452653,-0.9700505819562385
RCC10RGB,10184653,2.2305820416370965,1.5436369197427808
LS411N,17755052,2.4732315703899226,1.242900188543376
Granta-519,decitabine-navitoclax (2-1 mol-mol),-1.3661382782873654,-2.02338639506128
KU-19-19,24753719,4.40371401160258,4.305380240606224
PaTu 8902,72376,-1.694582331183855,-1.5537432492302403
HEL,72376,-3.0304513894944933,-3.5919225803627306
ML-1 [Human thyroid carcinoma],25150857,2.4072078224567486,2.561855589040478
SW948,9884685,3.1398548031465525,-0.1688569313860555
Daudi,24748573,1.578133478161721,1.2701300186001263
COR-L95,4917,3.3160135329409406,2.8197386989829045
SK-CO-1,2708,2.7526164010571152,4.816925616547001
Daudi,5479543,1.606221989903471,2.5085438641766213
PaTu 8902,vorinostat-navitoclax (4-1 mol-mol),1.8599454099065449,1.1164238453965352
MOLP-8,44632017,0.8356757219547752,0.6651704895184003
SW1271,9868037,2.9396003878324857,3.5381998541255566
COR-L95,11455910,1.0154509596480157,1.099819786004136
IGROV-1,445091,5.8777802446160825,4.388906584831391
IA-LM,107970,1.9308025720075177,2.254812084091702
BICR 31,15953870,5.115358479555731,3.6528119313306773
HEL,135984461,1.7610482730169696,2.999984841357549
HCC15,vorinostat-carboplatin (1-1 mol-mol),2.4228610420151853,3.1475468495758916
PaTu 8988t,5311,3.6038975682992422,1.4212329505724681
MOLP-8,navitoclax-pluripotin (1-1 mol-mol),-0.3360266341011599,-1.7100412840013883
RCC10RGB,BRD-A02303741-navitoclax (2-1 mol-mol),1.3031528560505037,2.3968122354260624
SK-CO-1,11228183,0.9546983133897222,2.6415628386611827
IGROV-1,JQ-1-MK-0752 (1-1 mol-mol),1.6911705649982345,1.637329210757965
NCI-H1568,selumetinib-vorinostat (8-1 mol-mol),2.593817270705759,2.6095924175492384
ML-1 [Human thyroid carcinoma],441298,2.939924630100921,2.480509116336245
BICR 22,42642645,1.569820729256039,1.269031679314992
RERF-LC-MS,387447,-4.351660250848144,-3.7803520081376267
SU-DHL-1,carboplatin-etoposide (40-17 mol-mol),-0.8202872264800385,1.3703524308759136
RKO,676352,2.3070338313311547,1.8710142199677013
HEL,66577038,3.4935326109734217,2.5021201972548623
RERF-LC-MS,25062766,1.7296886540377192,2.115497438519059
RKN,52947716,-5.912196482956353,0.597492310847231
SW48,56973724,0.919295357428288,3.0757909785865754
LS180,66577038,2.8527700320727725,3.0412945763715293
K-562,7251185,2.894408284149289,1.7821886539528853
ALL-SIL,sirolimus-bortezomib (250-1 mol-mol),0.3093926374933456,-0.9700090427079745
ML-1 [Human thyroid carcinoma],3025986,-0.9166044093803444,-0.20778062952015344
MOLM-13,6918878,-0.6248914400619264,0.559633949126262
IGROV-1,135421197,1.96820638017286,2.0521915627687775
RKN,11404337,0.6786980557761386,-0.23597392337456935
SU-DHL-1,6918878,1.5556600104975795,2.0064771706692266
MOLM-13,176870,1.4073018577806429,2.2986371757217237
SaOS-2,44566777,0.9896093397626105,0.4593446564039149
COR-L105,5470400,0.2171168006478052,0.1304494812645347
LS180,44632017,0.4358481157568056,1.0776091364039047
RCC10RGB,16065773,4.176477311044804,2.793230888308255
BICR 31,156414,0.5699919561712937,0.7439772153810157
SW1271,tanespimycin-gemcitabine (1-1 mol-mol),1.3087817847802907,0.021477149632219677
HCC15,JQ-1-navitoclax (2-1 mol-mol),-0.7343032708143507,1.3099754655234537
Daudi,54596490,4.948926549609605,4.432199399699773
NCI-H2452,11317348,1.7824301660124695,3.495331186674928
IGROV-1,60700,0.4424479122017752,-0.4537853201342644
IA-LM,135421197,2.370501142960713,1.688616764593888
NCI-H2452,135423438,1.816833708086427,2.380570051257156
NCI-H2452,6918837,-2.3246752526945413,-2.220558622623749
HuP-T3,409805,5.703463345532586,4.9742717678262345
Daudi,UNC0638-navitoclax (1-1 mol-mol),1.2047563677281543,0.160754514930316
WM115,3025944,4.015069634557516,4.268820309979037
BICR 22,10127622,2.812639951672956,3.3146833128450455
RCC10RGB,16741245,4.755009504271123,3.859926383650066
MOLM-13,selumetinib-JQ-1 (4-1 mol-mol),-6.008931443997215,-0.6830109871679738
BFTC-909,1641662,3.805506520632872,3.6540513815896873
SK-HEP-1,3136844,5.506062707172487,4.5243554159097314
MOLM-13,5335621,3.915836728943439,4.126809522618039
ALL-SIL,6918736,-2.784980550106597,-2.445064282311933
NCI-H2452,selumetinib-navitoclax (8-1 mol-mol),2.20402438215903,2.3399186753083296
SK-OV-3,5311,1.582209129738937,1.6441172728820501
NCI-H1568,4378219,1.8995328874154,2.5478301161656574
PaTu 8988t,135440466,2.5529183901912456,2.3867959394290414
P31/FUJ,208908,3.0114989034455415,2.1864357222766286
MOLM-13,55508,1.530825081139479,2.544722895276592
ALL-SIL,15983966,-4.919474478826657,-4.683511348006904
ALL-SIL,72193861,-0.8088702984298154,-0.0007585972220701715
Granta-519,135875424,2.983761714085865,2.9888695963456997
Panc 02.03,25062766,3.7424097220448207,2.200723588023698
LS411N,5282054,4.11513360382112,2.9095219929803586
WM115,9956119,3.8110537513046423,3.6151748262399197
Daudi,10077130,1.7104594990439606,2.7143704050749617
PaTu 8902,54618771,-1.3103145579416535,1.4033930013030054
LS411N,6610355,5.174673905344729,4.478754603607725
HARA [Human squamous cell lung carcinoma],446155,2.5576922800664006,2.7393834348718133
Daudi,11364421,-5.814557541528941,-4.811002442146335
SW48,10090485,5.377611493091081,3.7475506596261288
RERF-LC-MS,252682,6.464777279315186,6.469144298636532
RERF-LC-MS,25195348,2.310586589861769,3.524834799680732
LS411N,57330099,4.386912904802011,3.826196786598209
RERF-LC-MS,5351362,3.2669953777859493,1.7515544612043796
SaOS-2,5281321,-2.1045144226453134,-0.989104387313015
SW948,navitoclax-gemcitabine (1-1 mol-mol),0.2837649103664914,-0.2545128529466511
HCC1500,15953870,3.698430879415157,3.4359429777082964
BICR 31,107985,-2.559614665868775,-3.3312533387284575
SU-DHL-1,5978,-4.006589870739168,-3.170097145781433
SK-HEP-1,387447,-3.995016034956776,-3.948490533620185
HARA [Human squamous cell lung carcinoma],11609586,3.326388879496588,2.9734917648288364
BICR 22,44491742,3.912327775797625,4.344476918153077
NCI-H2452,10113978,2.1292579793865167,3.606212506303078
SW1271,selumetinib-MK-2206 (8-1 mol-mol),0.1264422257766406,2.3434659283056605
HCC1500,JQ-1-vorinostat (2-1 mol-mol),1.1801971963023554,0.8958240373420285
MDST8,JQ-1-vorinostat (2-1 mol-mol),0.5745237647612197,1.506955486373751
PaTu 8988t,10074640,3.912219918984309,3.261008017007149
RKO,25102847,3.0524897378806033,1.8718609030214766
K-562,446155,2.553560117982406,2.724516635113026
HuP-T3,3062316,-3.5835263694309862,0.8547331585035102
BICR 31,selumetinib-piperlongumine (8-1 mol-mol),5.193629730371027,3.400448068392255
HCC15,selumetinib-MK-2206 (8-1 mol-mol),0.2516850341197869,2.187569431452535
COR-L105,9915743,-1.8659407955600968,1.4166497265868545
SU-DHL-1,676352,1.6127382742380425,1.9359007804640427
SK-CO-1,15983966,-2.8914318783251733,-0.2903559061850307
BFTC-909,6450551,3.0302116860685886,2.936168195558497
HEL,salermide-PLX-4032 (12-1 mol-mol),3.70170985200322,4.285278166150537
LCLC-97TM1,6852167,1.822160840349085,2.67178852351104
K-562,1716436,3.607306146681396,2.610993964599174
ALL-SIL,6917907,-6.413711962559719,-5.284975682431657
SW48,44505237,4.455085659285412,2.57177426065657
MOLP-8,4788,5.509648062033256,5.053476291131981
KU-19-19,49793307,-2.3409308252506777,-2.24445033939858
IGROV-1,46843906,3.392503571349757,3.2108870149468163
LS411N,selumetinib-navitoclax (8-1 mol-mol),0.3933540744124401,1.6115937152274296
NCI-H1568,23582824,0.2708211860244319,0.850535566550944
P31/FUJ,156414,0.8249508749632878,0.6341803707601904
HCC1500,vorinostat-carboplatin (1-1 mol-mol),3.9041081325977616,2.968500925582566
Panc 02.03,24951314,2.3006835537528585,1.6479036114344974
RERF-LC-MS,46199207,3.61094494328213,3.147508235488368
MOLM-13,docetaxel-tanespimycin (2-1 mol-mol),-6.839014739935568,-4.6234616639517006
IGROV-1,25102847,1.7007012555618253,2.3788864193964825
COR-L95,9884685,1.274087436172542,0.47324336069374207
RKO,5738263,3.4166283525852523,2.81220462352641
BICR 31,446155,3.004688823756655,3.0287369092599064
MOLP-8,3081361,3.002632255231731,1.6976857228091184
KU-19-19,124202324,2.2262797687523266,2.829360350796259
COR-L95,241158,4.468160037389037,3.364575296404035
PaTu 8902,selumetinib-UNC0638 (4-1 mol-mol),4.723826632745484,3.047289170959116
SK-OV-3,9926054,2.1800400954819716,2.0164853399329954
NCI-H2452,285033,-1.1649166052412432,-1.5899938070425137
MDST8,SNX-2112-bortezomib (250-1 mol-mol),-1.5360671270430672,-0.8172574695215131
SaOS-2,3136844,3.967600163436525,4.326373648298769
Granta-519,36462,-1.2340392932323463,-0.13291308566139845
Granta-519,24785538,0.1958729752370936,-0.23416660776385378
WM115,5566,2.8846390038255127,2.771331906619538
IGROV-1,31703,-1.792518264692263,-0.76473317196135
HCC1500,3025986,-0.5847488606379614,-0.9615734326985097
K-562,2828334,5.968313970587813,5.69140253859883
HCC15,navitoclax-gemcitabine (1-1 mol-mol),-0.4507382221714274,-0.9569646285833199
LS411N,72193861,2.8187845663214848,0.5372340461034247
SU-DHL-6,11964036,-0.1529025297927845,0.4712094275186848
LS180,6918837,-2.789669873343886,-3.0435199917122704
Granta-519,445455,5.050402748491994,3.7363324581003705
LS411N,9926054,1.9376785020428349,1.9113701922664088
MOLM-13,135398738,2.371405234005272,1.999041833572037
BICR 22,53392493,3.288173891171126,2.6050504523000826
SU-DHL-1,crizotinib-PLX-4032 (2-1 mol-mol),-1.5954357785960134,1.3917015586372217
HARA [Human squamous cell lung carcinoma],2126,5.112984415511083,4.53337903102174
MOLP-8,9823820,3.862667538801475,3.0919719987586562
SW948,219104,3.4463785749905886,3.0144207210716143
Daudi,56649450,2.7731175257265757,2.6674327660648145
RKO,446155,4.170579555483674,2.6443232565152517
COR-L95,2708,4.088828930735336,4.229556843109093
HARA [Human squamous cell lung carcinoma],11427553,0.5044011516017802,2.9686980179666635
SW948,6610216,4.184431800680971,3.9844180564209832
SU-DHL-1,vorinostat-navitoclax (4-1 mol-mol),1.2163104495485748,0.42136835803435074
MDST8,24978538,-1.5034064763640302,1.0707231954078067
IGROV-1,navitoclax-pluripotin (1-1 mol-mol),-0.9669423716100508,-0.8005878421200114
Granta-519,vorinostat-navitoclax (4-1 mol-mol),-1.0034104350750142,-0.774880092748343
RERF-LC-MS,44607531,1.5104561529736475,1.6419300858614372
MDST8,16065773,2.461320056751215,2.4597986128892075
Daudi,11955716,-2.451420398730992,-2.2362428640461856
Daudi,44566777,-1.3909109996970672,-0.4015868563101717
WM115,53495165,2.3633352174150155,0.9217285798100118
MOLM-13,10077130,2.656845569256352,2.5005871985075485
LCLC-97TM1,11364421,-5.841421445385269,-2.4164462779862546
MOLM-13,9887053,0.5396890830211841,2.5875737102815193
IGROV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.258983073493191,2.1019894284006186
IGROV-1,46191454,1.3777495915525844,1.9806869903361553
Granta-519,5328940,0.7430401080732436,0.936543046793892
SW1271,54618305,4.440463475812739,4.6460819691018
COR-L95,23725625,3.551891881441416,4.3648826275017365
RCC10RGB,46843906,4.246883034106686,2.982077489755524
Granta-519,2945648,2.528276278220214,1.8109547421230807
Granta-519,11977753,-6.302388202708452,-2.7067418049373946
SU-DHL-6,15953870,2.4587311871536315,3.0163094193087985
MOLM-13,10322450,2.9930800125873045,3.1635979485355796
LCLC-97TM1,6505803,0.2281876141434561,-1.024060683316635
WM115,9967941,2.88500943866673,3.803482736409562
K-562,44202524,1.302888790519651,1.7035458804651062
K-562,252682,6.220409267483573,6.339402479744258
HCC15,49867926,4.259454552862098,4.234158971160672
BICR 22,25183872,-0.1596442578279089,-0.7844395730302729
RKO,17755052,3.988455753476612,1.5401085500567453
IA-LM,selumetinib-piperlongumine (8-1 mol-mol),4.519292467442182,2.1055183447289405
PaTu 8988t,5566,2.9380975134161553,3.0607158685429217
K-562,219104,3.3686951285077273,2.775024524995867
UACC-812,BRD-A02303741-carboplatin (1-1 mol-mol),6.034191295751065,3.804967154704913
WM115,100016,7.477930972064711,6.152238124791287
BICR 22,serdemetan-SCH-529074 (1-1 mol-mol),1.6325628481893268,1.896814614648346
SU-DHL-6,46191454,-0.3846699961999978,0.07764115397984371
LS180,124202324,2.088899784140079,2.431326446174745
KU-19-19,navitoclax-MST-312 (1-1 mol-mol),0.8014531944430209,1.1592138522680075
K-562,4261,1.1039684536741017,0.623449318939782
NCI-H2452,5282054,2.993265650723398,3.9830319574236763
MOLP-8,168312962,1.5743557083321402,0.8543393220024198
Granta-519,969516,1.9567849087702365,2.1959766130937357
NCI-H1568,25062766,1.9660972036535989,2.2308729659448225
MOLM-13,448949,-0.3738099635599754,1.118463413602796
SW48,11647372,-0.0986138935854908,1.4610946830658793
MOLP-8,selumetinib-piperlongumine (8-1 mol-mol),0.460809914604767,1.9162713973830643
SW1573,selumetinib-vorinostat (8-1 mol-mol),4.856763743237327,2.4911024199999336
RERF-LC-MS,11977753,-0.575574044510787,-1.5185879540806062
LS180,49793307,-3.6014942577594415,-3.159464293495398
SW948,3854666,3.050289300885683,1.618216744058059
HARA [Human squamous cell lung carcinoma],4917,3.022180747101803,3.0765688733934087
SW1271,navitoclax-PLX-4032 (1-1 mol-mol),5.386120495356167,2.1575374443083133
WM115,5278396,3.4301399168519153,3.6794137024518436
HCC1500,JQ-1-carboplatin (1-1 mol-mol),3.891416287519206,2.2780629886883914
HCC1500,11485656,2.6610961572019103,2.4222433762554183
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992,-0.07978751081200194
Daudi,2945648,2.1407869976239087,2.0430592746860445
MOLM-13,3689413,-2.8005667715254017,-1.8115629127236488
RKN,3543504,4.234888347098623,4.6025739491749
IGROV-1,24964624,0.5052308994941754,2.4866555393330456
PaTu 8988t,676352,1.787056590779638,1.9401238618963967
RERF-LC-MS,10385095,0.7812016081678173,1.3749791451627573
WM115,4259181,1.0090630393378868,0.3394772219901825
MOLP-8,navitoclax-gemcitabine (1-1 mol-mol),-4.985488409488958,-2.0426122392209285
SaOS-2,1239801,5.3522865443092575,4.132924090247126
Granta-519,44137675,2.975150065736677,2.690417306858389
Daudi,11455910,-1.173613913103254,0.34096593514120516
UACC-812,11152667,2.562952126743398,0.19383807871890693
SaOS-2,16219061,3.147835700454569,3.31996802836724
P31/FUJ,erlotinib-PLX-4032 (2-1 mol-mol),2.316286260335057,2.366143929473016
SaOS-2,71304818,3.198114510015862,2.303908227960499
IGROV-1,57330099,4.391385744785918,4.295238127934411
LCLC-97TM1,2729026,2.4668071198749555,2.7443500088781256
HCC1500,5281672,4.190998095776345,4.427689906027249
NCI-H1568,9884685,-0.6579514975056241,0.9423660621363571
ML-1 [Human thyroid carcinoma],53392493,2.260380394132801,2.782384453494935
LS411N,107985,-2.091782559178726,-3.522968893069719
COR-L95,42642645,0.7279572059378924,0.33854970637202625
LS180,5566,2.7460265721966897,2.915061998476109
COR-L95,104842,-6.859012992539376,-3.150425937571242
K-562,702558,5.364922414830515,3.9562028151185102
NCI-H2452,vorinostat-navitoclax (4-1 mol-mol),0.733087868835974,1.3376218862669338
LCLC-97TM1,9929138,5.774162864206733,5.5797246073409905
LS411N,31703,0.7183186901084707,-0.8839175074743022
WM115,23725625,4.964211357698685,5.376296797464566
HEL,piperlongumine-MST-312 (1-1 mol-mol),1.46077164854103,1.0341887416736928
SaOS-2,24978538,2.44958290959275,1.4637627507734752
HCC15,UNC0638-navitoclax (1-1 mol-mol),-0.269925552433359,1.7164367488221135
PaTu 8902,2858523,3.3217981805434196,3.0536380622727974
HARA [Human squamous cell lung carcinoma],135398516,1.8495805389969304,2.4077830385283376
SW48,65628,3.988389614478155,4.372614968984994
Granta-519,9903786,1.2937892753152922,2.0271840901641855
IGROV-1,71304818,2.4878074097553378,2.5520112760564713
COR-L95,25105715,3.673741872436949,3.3603734751359373
HuP-T3,6918837,-1.8626358392084263,-2.372396156642233
PaTu 8988t,72376,-1.956580109455481,-1.3682577614507436
NCI-H2452,46907787,3.091101876271566,2.6865771652646044
SW948,23725625,5.544404993552476,3.9838952937625294
K-562,25062766,2.5223735702376753,1.6412438468853572
SaOS-2,753704,5.53840358060444,5.002924546351003
NCI-H2452,56973724,2.8465784993073564,3.3159901055422005
Granta-519,71466578,4.383489061930637,2.4184059638485516
SW948,11609586,2.9863433458317714,2.27461478577396
HEL,71466445,1.5745300131733593,2.448259859580003
Daudi,5329102,1.2784768117884069,1.388403941156277
HCC15,409805,6.461768980239098,5.1351351805379055
Daudi,2871966,-2.2343916463272873,-0.5914914137477433
HCC15,selumetinib-piperlongumine (8-1 mol-mol),4.822467978355287,3.4650630442400585
RERF-LC-MS,135421197,1.554065103888189,2.0567610175316107
SW1271,selumetinib-tretinoin (2-1 mol-mol),2.7817516989696855,3.1719953654361586
RKN,serdemetan-SCH-529074 (1-1 mol-mol),2.47980812948558,2.0117800701478816
PaTu 8988t,25150857,2.5954794764360343,2.6695811239522143
P31/FUJ,11152667,-2.5755274762926095,-1.7405771912861363
BFTC-909,ISOX-bortezomib (250-1 mol-mol),1.0929987126714282,0.6650771699396487
BICR 31,2828334,6.263113325647995,6.258619452290888
MDST8,selumetinib-GDC-0941 (4-1 mol-mol),0.8218915121525238,1.6238035209084807
IGROV-1,11507802,1.5049911819213722,1.6593697740647066
Daudi,11485656,1.7254760898020216,1.6956879877737814
Granta-519,11152667,-3.975154363660797,-2.2921040024136476
SW48,11640390,-0.422464249163724,3.651660391288609
IA-LM,2828334,6.3387056990337705,5.795150334446381
HEL,36462,0.8349109175120154,0.1732403875076783
LS411N,4477,1.0450277541726452,0.3846038080025685
NCI-H2452,16219061,3.733701707144141,3.4656488655607127
RKO,16741245,1.399079485469943,3.4750287030616365
NCI-H1568,445455,4.330931204553833,4.778735148852991
K-562,15983966,-4.450185495623787,-3.9161435667606947
HCC1500,4096211,2.7054358198440345,2.4191531438658576
SU-DHL-1,46191454,-0.3713761809994262,0.7060395645876811
IGROV-1,387447,-3.9508602289798658,-4.222563559401191
NCI-H1568,71751553,3.6437596116554887,4.468211418206295
HARA [Human squamous cell lung carcinoma],selumetinib-vorinostat (8-1 mol-mol),4.369788913914824,2.470632758912733
WM115,46199207,3.650123600055899,3.2816693817082756
SaOS-2,71680916,4.865393442781168,4.912345384795865
COR-L95,9823820,4.611798945344124,3.6282866987909825
HuP-T3,44589607,2.433680498088492,3.024994140413077
SK-HEP-1,vorinostat-navitoclax (4-1 mol-mol),1.9601053638256545,1.401102758910382
IGROV-1,3634881,2.769147818550815,3.465113654355773
COR-L105,54626689,5.0742986339862926,4.688073433594607
HEL,176870,2.3693727744318887,2.5888205700973748
LCLC-97TM1,9549297,2.332709006301325,2.7175451786812372
COR-L105,24180125,3.5925931777332676,3.199892946361552
MOLP-8,89928392,0.1045876418070581,0.40640791473832377
BICR 22,3025986,-2.8899356497226756,-1.0957699081099839
ALL-SIL,400769,-0.758162988868875,-1.7607547883565986
BFTC-909,71466380,5.267829049221599,4.5760173287274775
MOLM-13,24951314,-0.2336633009541456,0.11689426539397348
MOLP-8,3038522,2.029025514425164,2.6011426865313365
RKN,16741245,1.555254881894904,3.895178107298415
COR-L105,71751553,4.255827287979035,4.527515687976678
MOLP-8,60750,-8.573260651984995,-2.7539680464796494
HCC15,navitoclax-birinapant (1-1 mol-mol),-0.4439511388855052,1.4624800181064495
BICR 22,24772860,-1.3590035600374548,-0.8414980042318345
LCLC-97TM1,5470400,0.2889153362640624,-0.08438333422825814
BICR 31,53232,3.653430995715962,2.873244753561544
BICR 31,8515,4.104799625743522,4.083010551319141
COR-L105,10127622,2.236200578684094,3.9738349494009886
NCI-H1568,5328940,0.3466597705312412,1.7886936850095778
MOLP-8,135421197,1.7506124789909805,1.3914244868230283
SW1573,54454,1.176648172779268,2.5768619607049597
NCI-H2452,11964036,2.1879069513719087,1.6513827640798524
MOLM-13,44493528,3.9608078939228175,4.066608497906089
SK-HEP-1,11396600,5.84824704867975,3.8583028622088955
WM115,46215462,1.6800224060395437,1.927754543798564
Granta-519,23939,5.101725753715152,3.3099777865971647
BICR 22,46907787,3.4905986586009843,2.2564372081553437
HEL,10184653,1.0835446596032057,0.43079150393955035
LS411N,9903786,3.6806866285220017,2.611674217567036
SW48,9840324,6.311735261945371,5.970756756154242
HCC15,24753719,5.171121417544096,4.395833141176434
SW948,11507802,1.163064588903486,1.1785146093485965
COR-L105,2733487,7.427108299628283,6.245671970218925
SaOS-2,439501,-2.8243657156627724,-2.2288166303644856
UACC-812,5287969,-2.4803922230812527,-1.8710680676304892
Granta-519,66577038,2.6663435544296346,2.5875363854014592
RERF-LC-MS,6918837,-3.051376318733669,-2.4835304372272256
NCI-H1568,11152667,-1.392140833696634,-0.2618358513184013
KU-19-19,49850262,4.263742487880845,3.6714314807200648
BICR 31,selumetinib-navitoclax (8-1 mol-mol),2.9853512378124023,2.128256394382169
SaOS-2,156414,1.509432711545826,1.5390254079799692
KU-19-19,navitoclax-gemcitabine (1-1 mol-mol),-0.4466146105667509,-0.4915040709736588
Granta-519,216468,0.2159572219264565,1.0801628579464395
P31/FUJ,3136844,4.357504973194935,3.633744653678238
MOLP-8,6918638,-1.572747132532541,-0.7413086174153808
LS411N,445643,4.311506480272609,3.941734681013708
MOLM-13,25126798,1.909946064109967,3.597793618862436
BICR 22,9927531,5.395078942533075,4.880024907420669
SU-DHL-6,3385,2.96945431954736,2.786584244175624
SW948,49766530,-0.6875988061214425,-1.5086010253758821
MOLP-8,5287620,-5.023262566828496,-2.174006765407765
SW48,selumetinib-JQ-1 (4-1 mol-mol),-4.010422232345994,1.5055062607188447
SW1271,5746,1.8306286254207629,1.0680673699256755
SU-DHL-1,4788,5.095368657375766,5.012255660464357
UACC-812,44607531,-0.3950460021726514,1.4455339992711067
SK-CO-1,10074640,3.0297361304753143,3.0747872291900875
IGROV-1,65064,4.920352624378345,4.807518011418586
P31/FUJ,9444,3.558733501871851,3.6350744252259575
MOLP-8,16722836,0.6223558214261112,1.0973197727216562
LCLC-97TM1,11647372,-0.3650454903758569,0.8587260245600155
COR-L95,9911463,4.18924595414168,3.414489612614883
MOLM-13,3634881,2.324290549736021,2.4265111319674557
IGROV-1,1242560,3.902441161940491,3.495812773537336
LS411N,702558,5.325144902608101,4.565856025891914
MOLM-13,969516,1.839627080728713,2.186813485522364
IGROV-1,50905018,6.092412272559071,4.170280575687789
SaOS-2,5311,1.6246857228566176,1.6202365166109465
ML-1 [Human thyroid carcinoma],5287620,-1.9113881956575816,-2.114723957057091
BICR 31,11178236,-3.7191700347439176,-3.196923048804964
IGROV-1,16736978,0.1982875499977011,1.8368380524013042
HEL,54613361,-1.063581606127445,-0.9662736133410745
LS411N,409805,5.900990799691521,3.8554565089191395
RKN,44819697,0.8547407464301948,-0.6316970915170986
SaOS-2,7326481,3.920515261577408,2.732521625533581
HCC15,135411,0.5020362424433897,0.6548317303416722
SW1271,135875424,3.8663800475620542,3.794251451445942
SW948,5281321,-2.986965028390854,-1.6212773175329656
ML-1 [Human thyroid carcinoma],52947716,-0.2471601623530622,0.671861925852955
ALL-SIL,16722836,0.4684239096852854,0.8060386746150366
BICR 22,3384730,2.588423009806214,2.9695802123150883
SU-DHL-1,5282054,2.781862093779865,3.5222349799170756
COR-L105,10385095,2.1444085139831643,1.4283192641176066
Panc 02.03,409805,5.9877775932277615,4.950445571094371
RERF-LC-MS,11707110,3.327368501952155,0.057441938027865715
Daudi,46199207,1.9328464692742409,2.711482175719549
SK-HEP-1,9907093,4.5474965014619455,4.308021507906713
NCI-H2452,6918736,-2.096990091914002,-1.7766980216134576
SW948,25062766,2.473025838261029,1.8961236778744384
SW1573,73707398,2.4757839790774123,1.5459182569010708
WM115,19582717,5.070140237856123,4.146743750034364
LCLC-97TM1,9926054,1.7367616025320842,1.7037580339852767
Granta-519,46907787,0.1510211143130647,-0.6381139278265877
HCC1500,JQ-1-MK-0752 (1-1 mol-mol),3.680434993229653,1.00857462924274
Daudi,9866186,0.2429325896096028,0.06627565504051926
HCC15,19582717,3.4575202036464665,4.260784439321278
BICR 22,3136844,4.306912771504561,4.258774117936176
PaTu 8988t,15983966,3.5024124287376477,-1.268530991523924
WM115,24964624,1.5810045411950775,2.559111071522153
Daudi,5335621,3.7832010435602568,3.8434311074340957
KU-19-19,selumetinib-PLX-4032 (8-1 mol-mol),2.356754737959246,3.4206901846299997
HCC1500,67156097,1.177976655162538,-0.22338427238420352
LS180,6918878,3.4964027843545775,2.6748870247543772
MOLP-8,4096211,1.580191863417666,1.008830042924208
P31/FUJ,6252,0.489412050489878,-1.6148309161847747
RERF-LC-MS,6505803,-0.6931241555509828,-0.3761071887641755
IGROV-1,24821094,1.720998716331183,3.215302732213308
BICR 31,5311,2.2783252682939876,1.4983476604721042
K-562,6438330,2.2742899368871123,1.6716371544117445
HCC15,71466578,3.4480874510133708,4.5815278424883354
RKO,5566,3.2270609816668308,2.6797417716791596
MOLM-13,BRD-A02303741-navitoclax (2-1 mol-mol),-0.0183785057987459,0.5351383611794536
Panc 02.03,24785538,2.724480470289088,1.6174181217318813
Granta-519,3025986,-4.58955813375105,-1.5197472577463784
BICR 22,6918837,-3.531862368916405,-2.286296154651554
MDST8,25262965,-2.668035259531665,-0.7162673163894224
IA-LM,5329102,2.7310604185474654,1.7063684151826197
SK-HEP-1,3385,5.476337571299632,4.353265043132361
LS180,16722836,2.063998190370722,1.6524010008222134
HuP-T3,tanespimycin-gemcitabine (1-1 mol-mol),2.6296169541858694,-0.7036670402348152
LS180,2749,2.025296960861402,1.9882834070093265
WM115,25262965,-0.2525217612691299,-1.318581158844912
PaTu 8988t,5287620,-2.232870102756846,-2.2303540547244687
BICR 22,1641662,3.554805763515046,3.1997479523982846
HEL,11152667,-1.5416892011653274,-1.719278475374925
COR-L105,doxorubicin-navitoclax (2-1 mol-mol),-0.4088475134066937,-0.6193341496297764
ML-1 [Human thyroid carcinoma],219104,3.7281299088831386,3.964194174008725
Granta-519,9907093,4.568904425758597,3.225173478390932
HuP-T3,56946209,-4.563482636842077,-3.9255615536375923
COR-L95,2126,5.99033959567007,4.136705928839639
WM115,216239,1.6966934324307903,2.529227704699203
HARA [Human squamous cell lung carcinoma],136227924,3.047223136335837,3.026307316768134
BICR 31,6918837,-2.993188010662521,-2.3918586513150557
WM115,3676137,5.1484929308777225,4.745676998588618
COR-L105,5113032,4.587192003158758,5.03586843270333
NCI-H2452,23635314,-2.1133256000938596,-1.6640945900363073
RKN,9887053,4.324470541002337,4.284005763177871
RCC10RGB,11427553,3.4421917630858387,3.1121572066692584
SK-HEP-1,3025944,4.243935374614092,4.265034922620417
HEL,613753,3.431831043675297,2.862580641537619
LS180,navitoclax-birinapant (1-1 mol-mol),0.3756173230443141,1.6485628515126904
ML-1 [Human thyroid carcinoma],135411,-0.343606028350642,1.0771217164291482
WM115,6450551,3.3231751041078086,2.783352478487091
LS180,11178236,-2.7486494175863703,-3.084103998435804
SU-DHL-1,53232,0.8595699071174782,2.7312519699399087
LCLC-97TM1,2742550,3.525188493197443,3.634633214680367
Daudi,1716436,1.8661291896859675,2.641360912814538
SK-OV-3,11964036,1.753508425012185,1.5733416558623263
LS411N,10385095,1.4098978051841675,1.3721914711326153
P31/FUJ,54613361,-1.6350280742113157,-0.9859939301767726
SU-DHL-1,638278,2.888532213305057,3.116622811648908
SW48,11228183,0.7765992306729816,2.5028530585303703
Daudi,54596558,3.73872893191344,4.044677453432368
IGROV-1,44543605,3.88270235241076,4.025442537306717
SK-OV-3,16722836,0.9083609759186712,1.7357394259992904
HARA [Human squamous cell lung carcinoma],tretinoin-navitoclax (4-1 mol-mol),0.6020182307201102,3.137549967595251
P31/FUJ,168313047,1.7496121138347704,1.8975325722347776
RCC10RGB,969516,5.025939213907113,3.0742440723237747
COR-L95,tanespimycin-gemcitabine (1-1 mol-mol),-2.183473735098961,-1.2403690501431008
Daudi,selumetinib-MK-2206 (8-1 mol-mol),2.382051987434729,1.4521776967420195
HCC1500,crizotinib-PLX-4032 (2-1 mol-mol),2.666541156679824,2.092069661578752
LS180,11507802,1.428529607587261,1.576035780416066
SW1271,2746,3.8382249001906814,3.4498869730473354
RERF-LC-MS,navitoclax-pluripotin (1-1 mol-mol),0.4193939180883417,-0.7250175514773636
SW48,6918328,-0.3603149144304291,0.010968811140827097
RKN,11214940,-1.342915177510304,1.8742617141627185
NCI-H1568,24180719,2.911739165396745,3.7060094340946366
BICR 22,selumetinib-JQ-1 (4-1 mol-mol),1.538481754600391,1.0604060365994592
K-562,11234052,2.2960989815513013,2.9399492512717416
SU-DHL-1,107970,1.234326472603969,2.0447411867198118
RERF-LC-MS,5280436,-0.2566098032119844,3.6464416253552225
HARA [Human squamous cell lung carcinoma],10074640,3.2082861236873814,3.1961706130714385
RERF-LC-MS,selumetinib-GDC-0941 (4-1 mol-mol),0.28876788592482,1.4862858177608402
WM115,6184667,1.9705044508079528,3.0616509759536505
P31/FUJ,26596,-2.2448149587984836,-2.6293060569110644
RCC10RGB,216345,4.504390062805713,3.981655353343011
WM115,3634881,2.5774509186458183,3.2245648116157586
COR-L105,5328940,1.3778120925573558,1.8530570813761804
NCI-H2452,135440466,3.051805385291023,2.2061578509799635
P31/FUJ,51039095,1.7212337572708742,1.9428909658850781
Daudi,135398738,3.444692827115736,2.196702538766576
MDST8,753704,4.923832713886697,4.9624815518798275
Granta-519,23725625,1.8582588361990624,3.186615987974503
IGROV-1,6438330,2.7487580937365683,2.3732182510767257
BFTC-909,51037431,4.63288955594681,3.10980503220719
LS411N,262093,3.2594677855419456,2.4053165651301076
Daudi,12001922,0.8334324910861088,1.5717824282252013
LS411N,10074640,3.3220574057236876,3.1707575854293193
COR-L105,6438330,3.2365890454650867,2.4116576887769923
LS180,3689413,1.3392854552239355,0.42351875804790845
IGROV-1,53495165,1.3981720287668329,0.7587144302660093
RKO,10296883,4.075814636405189,3.2818108087887823
MOLP-8,24951314,0.5243645664323562,0.34972944162172115
IGROV-1,25126798,3.9275606774720817,3.9472645153516153
BFTC-909,5281321,-1.6266730162675118,-1.3007406196227649
MOLP-8,123631,3.0356710048833446,2.037277988670816
LCLC-97TM1,selumetinib-MK-2206 (8-1 mol-mol),2.0492378318223508,2.273820028536498
PaTu 8988t,72193861,1.5880501840541692,2.0050377258692675
COR-L105,JQ-1-MK-0752 (1-1 mol-mol),0.9583306241234884,1.9252723421160127
MOLP-8,2742550,3.824247044326815,3.3629622047857555
BICR 31,10074640,3.67367044204876,3.176113019945632
UACC-812,1750826,-1.5614417963348088,-0.9633339193869588
LS180,9907093,4.718701288752834,4.11249558676131
BICR 22,25062766,1.615874512669176,2.255943221873947
NCI-H2452,6852167,1.5258165813873172,3.269713625605537
ML-1 [Human thyroid carcinoma],5328940,1.048806619411155,1.7595166204490393
PaTu 8988t,52912189,2.515835026596807,2.721567780273824
KU-19-19,9935249,4.318045076797651,3.329193437394025
KU-19-19,57330099,3.159149106170822,4.215760701501452
SK-OV-3,17755052,2.097752569372091,1.998273952903193
SK-OV-3,73707386,3.7899266428434233,2.991539943896407
HEL,navitoclax-PLX-4032 (1-1 mol-mol),-1.2293549578890797,-0.06828547502895062
SK-HEP-1,216239,1.5998975447874937,2.424599182833213
ML-1 [Human thyroid carcinoma],387447,-2.817858817217488,-3.7395012178231304
RKO,3689413,3.093382349703003,-1.3967965694660782
HARA [Human squamous cell lung carcinoma],11647372,1.8404588933860024,1.4657144675424996
K-562,44819697,-0.9868024060185686,-1.2879421261593358
LS411N,322968,4.732979049951269,2.7544845996660223
RCC10RGB,3689413,-2.0864832427963336,-0.2555766297572746
MOLM-13,BRD-A02303741-carboplatin (1-1 mol-mol),3.787495781999856,3.7395226754133177
COR-L105,409805,5.8843358134901775,5.231049439625614
ALL-SIL,11404337,-1.8413362349398936,-1.7203036104880836
Granta-519,135398738,2.4818536310203587,2.127944351281245
IGROV-1,10385095,1.0670946713416192,1.232362619805574
KU-19-19,5311,0.9327005340349652,1.6404045199882424
MOLP-8,6438330,1.5207659246126146,1.3408045823343935
SW948,5351362,1.282672018702937,1.4470597810481376
HuP-T3,54626689,4.821166418142214,4.633045240520863
HuP-T3,16013152,4.473149012747972,4.232407239200582
Panc 02.03,sirolimus-bortezomib (250-1 mol-mol),1.3966258084955054,0.7808600519069903
RKN,67156097,-0.5718675734992968,-0.6503491691754775
IA-LM,241158,3.7495123409873528,3.0277360880987385
LCLC-97TM1,644241,3.02487415997038,1.7721169010458453
NCI-H2452,9823820,3.552631474664052,4.3018492870455205
BFTC-909,2749,2.0212973698927184,2.2018940679557293
Daudi,9956119,3.1347708383856827,2.596540074652517
IGROV-1,alisertib-navitoclax (2-1 mol-mol),1.5599487267475047,0.33028678153687424
ALL-SIL,136227924,2.439460537978413,2.2966639742520742
HEL,44507138,3.4784823626806296,1.903708406436995
Panc 02.03,3634881,5.203302993958793,3.3440795025637584
HCC15,3038522,3.407637609998807,3.3980073113116167
RERF-LC-MS,JQ-1-vorinostat (2-1 mol-mol),1.4753675236489834,1.3055075293150629
SU-DHL-1,5311,0.6388765020007606,1.1957000088560503
RKN,16038120,2.2721636156695357,1.1401002386105812
Daudi,6917907,-7.619939635694887,-5.374693740138727
MOLP-8,3385,2.1758430637220334,2.679121760178774
COR-L95,2749,1.0184502693195283,1.5499559839941037
BICR 22,56946209,-6.158851096198738,-3.6522578693137073
SU-DHL-6,72193861,0.720057034069739,0.2877965276205312
RCC10RGB,122327,5.581829763733156,4.8351596842171904
Daudi,5284329,2.65655795986699,2.6282448714317588
WM115,72376,-0.2019485443349478,-1.6697785083631203
HCC1500,4378219,1.8377088226049565,2.313265364998127
SK-CO-1,246676,3.87632071272349,4.254197930875434
SK-HEP-1,docetaxel-tanespimycin (2-1 mol-mol),1.7150600920964667,-3.1829392001661403
IGROV-1,57519531,2.639098862164858,2.62394357872308
P31/FUJ,serdemetan-SCH-529074 (1-1 mol-mol),2.3029277371957884,1.3576451403567094
MOLM-13,1714884,4.557672503718371,2.5416869683150867
MOLM-13,JQ-1-vorinostat (2-1 mol-mol),-0.8524574918693427,-0.779309036354594
Granta-519,72193861,-0.9369484536210768,0.08688662713045021
RKO,5311,2.326095881991792,0.6597850451283804
SK-HEP-1,4521392,4.36382839215776,4.361624449369479
COR-L105,3062316,-0.8702764318143076,1.3299628715460985
COR-L95,387447,-4.370301659619954,-4.5162432267295545
COR-L105,10231331,1.4114577114599935,2.3401667441385916
SK-CO-1,637858,1.8597515079418403,2.1048102375982576
SW1573,5282054,2.2636648441362417,3.7745469787328387
K-562,66577038,2.461713560075674,2.7705750314305875
Panc 02.03,984333,0.8671961837803726,0.8070657514763775
HCC1500,9967941,2.192170342398577,3.588739924816931
NCI-H1568,5281672,4.0091617833462125,4.588668784208424
K-562,11640390,3.4084234644631244,2.7544236325159397
SW1271,60750,-2.442139934484719,-2.062439799054453
HARA [Human squamous cell lung carcinoma],5280436,4.238746998760762,3.4370500154818084
MOLM-13,24889392,-6.717782140097413,3.333165635145481
Granta-519,11364421,-8.40665244505035,-4.625558420665932
LCLC-97TM1,11612883,2.215690343731866,2.553873179151397
ALL-SIL,serdemetan-SCH-529074 (1-1 mol-mol),2.0214253699045392,1.3332294897677786
PaTu 8902,1566236,3.6887913704860535,2.2585877565841668
MOLM-13,16741245,4.189200129622084,3.31647380202426
SW48,6184667,4.015043076320991,2.9472407905739852
RERF-LC-MS,66577038,3.051572744120707,3.047237727063557
K-562,71304818,1.450074212827562,2.0481143244032642
RCC10RGB,44489675,4.041451654117508,4.361633960357638
LS411N,navitoclax-birinapant (1-1 mol-mol),3.012697957688565,1.3093657862212575
SW1271,10074640,2.938380325815859,3.232112731214603
RERF-LC-MS,11626560,1.1998891680987491,2.019406262182813
PaTu 8988t,81146,4.470184859000855,4.738767148149512
HCC15,11178236,-3.9629964965138584,-3.357144086001668
SW48,navitoclax-pluripotin (1-1 mol-mol),-1.096538281516441,-0.7061751172760808
HCC15,11317348,1.1767586352696475,3.0992529705485703
P31/FUJ,9903786,1.0734919883099745,2.088176048169201
IGROV-1,23582824,0.3287266354391525,0.857225844812434
Granta-519,3465537,1.1430845598370274,1.6829271771035814
PaTu 8988t,984333,0.9294993195358888,0.7444112990555487
HCC1500,11396600,2.707080690171913,3.8239926330792513
NCI-H1568,6252,-1.964470857288188,1.0257315560399178
NCI-H1568,7251185,1.379011815458227,2.6269738648512826
BFTC-909,UNC0638-navitoclax (1-1 mol-mol),2.418146384904106,2.134111184614323
LCLC-97TM1,55508,4.820744956173848,3.4520268904401847
PaTu 8902,9903786,4.041497343746548,2.9813853329036237
SW1271,12001922,2.1604198968714754,1.9601581831990114
HEL,6505803,1.212867497705534,-0.9240656754970835
SK-HEP-1,216345,4.108495190728752,4.014542100036161
WM115,4705,2.3860154683324897,3.095087422114958
NCI-H1568,JQ-1-vorinostat (2-1 mol-mol),1.325801474857881,1.2054350708094632
COR-L105,126941,-1.5036718028706904,-2.2563273326129716
PaTu 8988t,9926054,1.9241127892750265,2.0458270455058876
SW48,tretinoin-carboplatin (2-1 mol-mol),4.556026920056554,5.1107400122685975
NCI-H2452,navitoclax-MST-312 (1-1 mol-mol),2.3760907472780137,1.1550203950044944
SK-HEP-1,374536,4.396616434658188,2.3656837720537958
IGROV-1,carboplatin-etoposide (40-17 mol-mol),3.2860353297411256,2.5601997077949186
NCI-H2452,208908,2.397298909776284,1.9594991340606283
SW948,24821094,3.757524617053942,2.3632131059143675
K-562,44491742,3.373435641850853,3.933023643169717
RKO,24180719,5.308193040989237,3.333510109019827
MOLM-13,56946209,-5.150374128805616,-4.877493769554045
MDST8,54454,0.3151053774213321,2.3203779859017133
Daudi,969516,2.18084937908482,2.339889272287833
COR-L105,44607531,0.2442604090297878,1.6986928123199496
SaOS-2,54619267,4.116373312960232,4.235579248300962
MOLP-8,44607531,1.2227606502433142,1.2647094637830585
ALL-SIL,11427553,-0.6859128537837271,1.1385812957675532
NCI-H1568,11427553,2.9296384487881166,2.7619233878215734
SK-HEP-1,6918638,1.490993863020431,0.6500285059404863
K-562,11175137,2.6421325977097663,2.10899223710524
MOLP-8,25126798,3.554030345273679,3.449583201799014
MOLP-8,10427712,3.937375048887725,3.7345704263303117
BFTC-909,11404337,0.4468911705694049,-0.33655420274444503
Daudi,19582717,2.1579117268337975,2.898993273707701
SW1573,9936388,3.0507391751654698,-0.5495565046768853
SW1271,156414,2.097129180606755,1.443578457756615
Daudi,11213558,0.7122197709980888,1.0581821279815935
MOLM-13,135875424,3.721528356214304,2.939449138235539
LS411N,3062316,3.313525141236135,0.9981471255503171
Panc 02.03,6438330,3.381062774421129,2.387316293071139
MOLP-8,4705,2.7848528520877727,2.909310791972734
SW48,675434,5.164587034175743,4.413491531843027
NCI-H1568,46215462,1.5662565779678703,1.9707368804150536
BICR 22,23635314,-3.9149935419765423,0.028281440244803766
NCI-H1568,44607530,0.8979533446197012,1.7346853792161139
BFTC-909,89928392,2.1120581393996116,1.5018463759390082
NCI-H2452,8515,2.9816658051225344,4.2226848452463015
WM115,252682,5.883677253194902,6.52438622632532
SaOS-2,11507802,0.9759404440699744,1.4814727501921714
NCI-H1568,9935249,0.3822057580098375,3.293763779143867
SU-DHL-1,selumetinib-vorinostat (8-1 mol-mol),1.570079304001321,2.0247271591438794
SW1271,65628,4.408026608161547,4.549661054052098
MOLM-13,2742550,3.0943449980031845,3.014090591284446
HuP-T3,56973724,4.820716068374067,3.469151269801685
P31/FUJ,5328940,0.1000739186855886,1.0183096341925726
SW1573,sirolimus-bortezomib (250-1 mol-mol),1.011264687291747,0.9868232625159128
KU-19-19,9967941,2.4242338826427794,3.6438412685027033
COR-L95,selumetinib-decitabine (4-1 mol-mol),6.271791154986272,2.468725443904314
SK-CO-1,5328940,2.280320557186381,1.7954190652506445
HARA [Human squamous cell lung carcinoma],6184667,2.5882672266365128,3.1358784610143484
COR-L95,1716436,2.176954941746147,2.680681546320283
MDST8,46398810,3.011862004714757,2.538323990277554
SK-OV-3,654092,-0.1739817534251795,0.09466388234731836
SW948,54613361,-2.2535675944820084,-0.04873215863489919
HuP-T3,25154868,5.141210696949765,4.654358552616842
SK-CO-1,selumetinib-PLX-4032 (8-1 mol-mol),0.4034815942312452,2.769599026396018
RKO,124202324,3.4391315101947386,1.3943125392905715
RCC10RGB,9444,4.509247284467684,4.289197385062845
P31/FUJ,135421197,1.0144502005310674,1.2515204084938716
MOLP-8,44487872,4.385798937588512,4.118475870055115
PaTu 8902,448949,2.6032868845304606,2.2179054447573177
MOLM-13,11427553,-2.505370137631637,0.9010264716768432
IA-LM,60750,4.549488262081028,-2.235319824352423
MDST8,3825829,4.752817875520721,3.9811530804769295
SW1573,JQ-1-navitoclax (2-1 mol-mol),0.4708104580132937,1.2523974022498725
BICR 22,navitoclax-MST-312 (1-1 mol-mol),0.8152867092510746,0.9542892506447208
COR-L105,51037431,3.876010066295024,3.3276487260992567
RKO,31703,-1.8438289452025527,-1.221980080493747
HEL,5978,-0.5240559956879017,-3.2679286161602294
SW948,168312962,3.6749765666335903,1.4931670194571602
IGROV-1,72734382,4.633226130326536,4.706559262746967
SW48,216468,-0.1130169029097753,2.844997031682248
HuP-T3,216345,4.480282764347718,4.240094912600822
HCC15,439501,0.3030845703669018,-2.097803676296689
P31/FUJ,638278,2.9129004591727057,2.805124506079117
BFTC-909,676352,2.5282943369079818,2.131197777011895
SK-HEP-1,60750,5.759979022694095,-2.292479706876531
PaTu 8988t,4788,6.262210396704686,5.618423617786812
Panc 02.03,JQ-1-navitoclax (2-1 mol-mol),1.014156743517759,0.9804135455331909
NCI-H2452,doxorubicin-navitoclax (2-1 mol-mol),-1.0690798948484177,-0.8587592356580361
HEL,24951314,0.022330385445513,0.20628721288843402
MOLM-13,46907787,-1.536709398859376,-0.8994833671602518
SaOS-2,54626689,4.533352391847383,4.6638689488063445
RERF-LC-MS,10410894,3.034247655874134,3.417264107162058
RERF-LC-MS,9903786,2.6182355767545213,2.892500566428574
IGROV-1,107985,-2.8971910842184516,-3.6229283767492095
WM115,10231331,-3.458943295987183,1.5966013610857277
Daudi,71466578,1.924283792281082,2.6108914851402845
KU-19-19,6610216,4.876021689690227,4.415759378595437
COR-L95,6918736,-0.04136223528326,-1.9724101059835348
MOLM-13,11625818,3.232701320691832,3.1753493829003645
Granta-519,16038120,-0.1772437220791911,-0.051068956229282945
BICR 31,46907787,2.190433361645711,2.4991671399098676
Daudi,702558,3.2750017094913657,3.6941316588528834
MOLP-8,24856436,-0.8263886484359759,-0.47113601351720974
MOLP-8,135440466,1.6989907480456066,1.6457723810637335
SK-HEP-1,46843906,3.844316747572769,3.3380010935569944
RKO,54626689,4.750442055573677,4.247006283108253
HARA [Human squamous cell lung carcinoma],navitoclax-gemcitabine (1-1 mol-mol),-0.596107332987684,-0.9460013201643865
IGROV-1,11717001,4.394306548697183,4.091451272537581
Granta-519,5291,3.886616753428741,3.0737601282266933
HuP-T3,vorinostat-carboplatin (1-1 mol-mol),4.326832101925159,3.2196968345529124
SW1271,262093,2.7991981503454495,2.9333506795790214
Granta-519,1566236,1.1036082649410253,1.2598139275670677
BICR 22,24753719,4.1427183131543615,4.331311356473638
Panc 02.03,9926054,1.881153725115377,1.9464889321432564
HEL,selumetinib-UNC0638 (4-1 mol-mol),4.439373718009897,1.9548623201233857
HARA [Human squamous cell lung carcinoma],6918289,2.581505632245523,2.7008615992627876
LS180,54619267,4.074522434074431,3.9732204039889614
SK-OV-3,5281321,-0.7098099698865428,-1.1329159141478704
BICR 22,selumetinib-MK-2206 (8-1 mol-mol),1.8488971729777937,1.9262256986067812
SK-CO-1,2729026,2.8886798476744246,2.7296558878083523
Granta-519,23582824,0.9303240666722092,0.5161891463800822
HuP-T3,JQ-1-navitoclax (2-1 mol-mol),2.3872748820971217,1.2580089204943223
WM115,24978538,1.155471911978994,1.5690724748453704
BFTC-909,navitoclax-gemcitabine (1-1 mol-mol),0.1512584221412147,-1.3594860986961268
NCI-H1568,11238147,2.925799577076833,3.1698614479364733
ALL-SIL,135398516,1.5622324093538014,1.3104956520962334
COR-L95,135659046,3.614564650544248,3.5980339616507164
SW1271,1285940,4.280510054640018,3.545569681324401
SW1271,6505803,0.8186340021888412,0.021543930054222324
SK-OV-3,SNX-2112-bortezomib (250-1 mol-mol),0.4595025269763413,-0.9891442996198531
RCC10RGB,UNC0638-navitoclax (1-1 mol-mol),1.9805139183388023,1.9139361510346102
IGROV-1,11626560,1.7276653519578558,1.9710099371637753
ML-1 [Human thyroid carcinoma],24748573,2.352453339172467,2.3801501205140703
P31/FUJ,3552672,1.950832295752278,2.014882191965255
P31/FUJ,67291369,0.7371006748241407,0.444819017349328
LCLC-97TM1,107970,2.3018486004849907,2.2078419468710937
SK-OV-3,44607531,1.947967745365508,1.652597478180624
BFTC-909,9936388,1.702123766125507,-0.7918438741765239
ALL-SIL,8515,1.9161675301812888,3.123153185016684
LCLC-97TM1,25262965,-1.937189863749451,-1.509217580755863
HuP-T3,ISOX-bortezomib (250-1 mol-mol),0.144245152578182,0.5047994487255747
MDST8,6914657,-1.2463021469195388,-3.555717562900704
RKO,SNX-2112-bortezomib (250-1 mol-mol),-2.626179791835481,-1.8709187026526168
HCC1500,53392493,1.8683885031226253,2.4474329760363402
MDST8,135411,0.5541309628089411,0.7724452594139705
RERF-LC-MS,1750826,-0.5689233588179538,-0.8749290630598158
LCLC-97TM1,5328940,1.525932870405189,1.5506271697909184
NCI-H2452,25195348,3.541594611208225,3.279877947940289
ML-1 [Human thyroid carcinoma],71304818,3.0426605111728517,2.665695299083755
RKO,crizotinib-PLX-4032 (2-1 mol-mol),0.8147825419497507,1.290555662286006
SaOS-2,53495165,-0.9847313398251484,0.060381587400997805
SW948,11626560,1.2721393744446543,1.1884217662374699
LCLC-97TM1,tanespimycin-gemcitabine (1-1 mol-mol),-1.2417811136372243,-1.0995207157366085
HEL,25183872,-2.1054192111007657,-2.013804879408133
RCC10RGB,89928392,1.8749323034057075,1.9169094457616966
Panc 02.03,10074640,3.562403354758929,3.246860330301907
PaTu 8988t,57519531,4.351537289113079,2.8560154501875172
SK-CO-1,5281321,-2.128194299198524,-1.0014024799413341
RERF-LC-MS,5311,1.7201713868016182,1.4572144594500842
HuP-T3,11427553,3.1840600229712037,3.1117191382102756
ALL-SIL,4259181,-1.3200126273341632,-0.32059303555186025
HCC1500,11214940,3.550811671890936,2.349490153283996
NCI-H2452,navitoclax-PLX-4032 (1-1 mol-mol),2.336639386671478,2.5333647594114117
HCC1500,25195348,3.452030504957034,3.3778983039673935
SW1271,52912189,0.6284206808713965,2.64510469211057
MOLP-8,984333,1.0413549547234568,-0.0015534055858426902
SW948,72734382,3.6940713099503473,3.9987310503334976
IGROV-1,46943432,4.105714883822214,2.543944378732092
BICR 31,25227462,0.4256700478941367,0.7334100267042154
SaOS-2,2126,4.6809882623674905,4.58641782129944
SaOS-2,11427553,2.020035940690151,2.6222410476494855
MOLM-13,6914657,-6.22505002098335,-4.7569215329072225
NCI-H1568,24964624,2.125017418877952,2.540385732307459
HCC1500,11497983,4.502799578122533,4.209027561861651
K-562,23725625,5.2530061405843975,3.990574088530818
SaOS-2,salermide-PLX-4032 (12-1 mol-mol),4.26549663284579,4.600700465932677
RKO,136227924,3.256787131627037,2.516761885119447
IGROV-1,31703,-1.792518264692263,-0.76473317196135
HEL,6438330,1.7062913765539824,1.1098270802653647
RERF-LC-MS,25126798,3.475546322259903,3.8416790515271027
LCLC-97TM1,409805,4.11204743963536,4.359671853859172
Daudi,2708,2.1654486353587266,3.161464371293564
SK-HEP-1,6914657,-2.911576812343612,-3.5310682093975987
MOLM-13,36462,-3.0478349617512466,0.12548326295328338
COR-L105,208908,1.1794902635628597,2.154887849200424
MOLP-8,44491742,4.067907034019371,3.8919785156891544
Panc 02.03,89183176,4.957506748320777,4.661286337614538
Daudi,3025986,-1.684737909075286,-1.815630215541028
PaTu 8902,10302451,3.9687769441396608,2.632937989962906
PaTu 8988t,9933475,2.2874108911255693,1.9525679097729105
SW1573,5281321,-2.072955292880288,-1.0540226701519808
IA-LM,2733526,5.6911514373146135,3.812340029109891
Panc 02.03,6918837,-1.2317043962492993,-2.37667890961439
NCI-H1568,19582717,3.4209569673427342,4.263500940148937
WM115,55508,6.132181701054794,3.7753844892860355
MOLP-8,2871966,-0.632569947519592,-0.18459523763606434
ML-1 [Human thyroid carcinoma],decitabine-navitoclax (2-1 mol-mol),2.5515685650410216,2.5742265741863917
MOLP-8,decitabine-navitoclax (2-1 mol-mol),0.2255247501063145,-0.1532322333968995
HEL,6918837,-4.248380638359999,-4.543413591587872
RKN,alisertib-navitoclax (2-1 mol-mol),1.493636711316015,0.8212671659331912
BICR 22,136227924,2.105383482893856,2.957165416180531
SW48,135875424,3.469184081134181,3.5568689249019148
COR-L95,10127622,5.649647064343883,3.49310659256629
SU-DHL-1,60750,-4.603947913298721,-1.5171310870909989
ML-1 [Human thyroid carcinoma],16065773,2.2629168527060117,2.560874188894142
SaOS-2,446155,1.978878402700164,2.4569051075422155
Granta-519,tretinoin-carboplatin (2-1 mol-mol),6.438903911502162,2.9732474776955615
SK-CO-1,11625818,4.187860927408271,4.413008885287829
COR-L95,676352,2.06388279354012,1.837625588134153
RKO,11719255,3.406006587740275,2.516599872637263
NCI-H1568,135875424,3.0063280878885967,3.974428180144762
IGROV-1,25195348,3.0698662305180275,3.415717403813176
RERF-LC-MS,16659841,3.453543705685564,4.162738534459282
SW948,1641662,3.2658822910658905,3.4096015080182367
BFTC-909,5351362,0.3148685714677321,1.6538457460976566
COR-L95,24771867,5.320672645408192,0.8353948416728434
NCI-H2452,16725315,3.1677771909290184,4.300777668047787
WM115,9926054,3.0880179510914454,1.9252993922042412
IGROV-1,135875424,3.3275053166921347,3.5994810136651667
LS411N,4259181,-1.386635238211632,-0.04309672653490153
SK-HEP-1,24821094,3.809459846332286,3.197883363545836
P31/FUJ,tanespimycin-gemcitabine (1-1 mol-mol),-1.9905845316732809,-2.4094318550289167
ML-1 [Human thyroid carcinoma],17759555,4.838019485799326,3.8600157503262067
HCC1500,11364421,1.8102576985092016,-0.01921228909639803
WM115,11647372,-0.748702419415335,1.3799751153410398
IGROV-1,374536,0.7022324251593053,2.6001797044254307
K-562,5311,0.9288629076778604,0.615308272446391
LS180,navitoclax-piperlongumine (1-1 mol-mol),3.251687407924036,1.6423896376280558
HARA [Human squamous cell lung carcinoma],375860,-0.967052520231088,0.02411862652118655
Daudi,44607531,0.7322116783883826,1.2919981830522225
HARA [Human squamous cell lung carcinoma],9840324,5.741888919857564,5.8194903214421405
SW1271,448949,2.9810988383972084,2.1866461501010477
SU-DHL-1,42642645,0.6641769458510169,0.8958014866006887
ML-1 [Human thyroid carcinoma],168312962,4.623396193395582,2.483518386012882
SW48,53232,2.98078944705874,2.9421397000224023
K-562,4096211,1.5585244853649294,1.2149105911511702
LS180,89183176,4.9114720653238315,4.276658361331139
SW1271,10427712,4.007366682408904,4.457912263669021
BICR 31,JQ-1-UNC0638 (2-1 mol-mol),1.590211689658008,1.6757488125338984
SK-OV-3,72193861,3.227068856168802,1.9220737331689106
K-562,148198,-4.073315546446919,-4.002634922748777
ML-1 [Human thyroid carcinoma],25262965,-1.8922435286727564,-1.3106282684456292
K-562,tanespimycin-bortezomib (250-1 mol-mol),-0.7275623889359331,-0.5554738157719175
SW948,2729026,3.020599067804879,2.574284345365038
SaOS-2,3552672,2.445112397338648,2.512303294414981
K-562,6918638,0.0740833242167517,-0.29340982006961447
HCC15,67291369,1.6613409933263477,3.1653444055348343
LCLC-97TM1,11396600,3.6456493290211425,3.5279307382931897
HCC15,6438330,2.907250953014235,2.421040903713053
SW48,123631,-2.3971553119638553,2.3998171059850777
RERF-LC-MS,6918638,0.4520678244574614,0.7321222792709764
HCC15,54619238,5.509074276782743,5.020188112603966
HARA [Human squamous cell lung carcinoma],selumetinib-UNC0638 (4-1 mol-mol),6.072288250407716,3.044959324842006
Granta-519,5351362,0.2173676915670352,0.8654522846391027
SW1271,219104,3.9142621703193625,3.8328413975027114
WM115,selumetinib-JQ-1 (4-1 mol-mol),-1.8046253833707984,1.1943090868554709
SW948,11497983,1.2110688984787443,0.94874976273019
Panc 02.03,11404337,1.528571500956484,0.006151124082656654
SK-OV-3,107985,-2.353051363092625,-3.499843753966063
PaTu 8988t,selumetinib-GDC-0941 (4-1 mol-mol),1.0326932423441333,1.4484117812904285
HCC1500,56649450,4.199956636233384,3.1659222643178015
MDST8,54649381,4.2434412709491385,3.846549071027566
SK-CO-1,24772860,-2.764468608226056,-1.782764949698423
SW1271,2708,3.697662973501111,5.00498103370588
COR-L105,25062766,2.3512127388642865,2.3576045726154353
BICR 22,9826308,0.9832071992526458,0.38173237143251354
SW48,navitoclax-piperlongumine (1-1 mol-mol),1.2226780800612655,1.4039402957442666
KU-19-19,11404337,0.0275069311149896,-0.3688527774723069
LS411N,decitabine-navitoclax (2-1 mol-mol),1.6875581183367745,1.0061454953730453
LS411N,452548,1.178688753001054,-0.7964845458310524
COR-L105,3025986,2.299444367217184,-0.5359832535081689
IGROV-1,25102847,1.7007012555618253,2.3788864193964825
PaTu 8988t,24797083,1.3448554408655904,1.355629217917224
IGROV-1,46398810,2.003787621940583,2.6096694181773032
SaOS-2,2749,2.484303950908632,2.060893985913676
WM115,7251185,2.999080033015298,2.703178792593791
IA-LM,151289,3.753931026261757,0.8755564440113157
SW48,60168763,3.2354609354554924,2.670199063326014
IGROV-1,168313016,4.807199318661473,5.007223506561877
MDST8,5351362,2.4401541198795726,1.7432292265713576
RKO,5291,3.391339544898264,3.083108029711276
LCLC-97TM1,23582824,0.7435680585464137,0.8808793924800692
BICR 22,16725315,5.207801943730372,4.2531302121183145
HCC1500,44632017,4.723480031494906,1.4638221290146358
MOLM-13,219104,1.3929442819191806,2.4774309468274294
SaOS-2,44202524,1.4210473732360835,2.008470897847323
COR-L105,753704,5.105702577689745,5.154227105255197
BICR 22,216468,1.2752332856392885,2.7639990859504286
RERF-LC-MS,445643,4.345437949323675,3.9093887354153516
BICR 22,selumetinib-UNC0638 (4-1 mol-mol),2.123491609761504,2.68688141469089
HuP-T3,44607531,1.7591062122540748,1.3951406950879468
NCI-H1568,9915743,-0.8427224057935273,1.2472507985998522
ALL-SIL,126941,-2.455728969669062,-3.240201401312332
IGROV-1,168313047,1.93821625738322,2.5381340227240665
LS180,100016,6.005443229591697,6.100953045938907
SaOS-2,60700,-2.625519230364934,-0.18124392557590338
KU-19-19,9907093,4.38040739031281,4.271914726553465
SaOS-2,9935249,3.097116977919543,3.18396042454724
COR-L95,24821094,3.5692160345671335,2.679501698180276
Daudi,327653,2.694862581871668,2.536573045236329
SaOS-2,65628,4.208345318362158,4.19568604382001
SW1271,navitoclax-piperlongumine (1-1 mol-mol),2.304332277449707,1.7208201775715495
ML-1 [Human thyroid carcinoma],119182,-2.1546594526399647,-0.029511698307235212
LS411N,24772860,-2.6286287692739587,-2.347995323597988
HCC1500,15983966,1.4595203856942676,-0.2189101044225061
COR-L95,46907787,3.807595772412777,1.449464969527295
BICR 22,24821094,3.82687279949815,2.0028960834790146
RERF-LC-MS,56946209,-3.4945734927118552,-3.7818578339433877
IGROV-1,navitoclax-MST-312 (1-1 mol-mol),1.1838863893343448,1.2631477622809495
MDST8,49793307,-1.5088082080905487,-1.9371534565181223
RERF-LC-MS,tanespimycin-gemcitabine (1-1 mol-mol),-1.5952645398326415,-0.6991381759767199
SW1271,159324,2.241950485620868,3.2100279663775115
LS180,doxorubicin-navitoclax (2-1 mol-mol),-2.003067068648065,-0.7169898632572472
HCC1500,135398516,0.4161092034804287,1.829832285186847
Granta-519,46901937,3.6488183223471022,1.4643747529625204
RERF-LC-MS,5328940,2.240356815676024,1.6641474688908786
BFTC-909,navitoclax-sorafenib (1-1 mol-mol),2.944260401271062,1.902583835393346
Granta-519,400769,-1.7592122365530554,-1.382371145538471
BICR 22,135421197,2.0438055763788556,2.4003234161423705
BICR 31,9967941,4.3746614656618865,3.950271319550786
Daudi,89928392,0.010222000273875,0.07918273756259225
MOLM-13,151289,-0.2275053531847663,0.47152509741649196
IGROV-1,2874250,4.893662837169153,4.62690973769862
MOLM-13,4261,-0.2853779042398361,0.397939998643192
MOLP-8,5280436,2.785612173209183,2.6342764766972517
RKN,11427553,3.6372919842764424,2.8087884871082474
LCLC-97TM1,2828334,6.057082646440782,6.041296694072359
Daudi,11640390,2.7767455060282873,2.458051541100354
SW48,selumetinib-MK-2206 (8-1 mol-mol),-2.489387055809161,1.8286740976320681
RKN,51039095,3.7797830340785694,2.664984808890489
HuP-T3,46398810,2.968900053185397,2.524517690836107
SW948,60700,1.1260701186231294,-0.2295530064010353
LCLC-97TM1,168313047,1.50715487575417,2.276970682789306
Panc 02.03,46174525,6.272327915554807,4.557649138594008
SW948,72193861,0.8788999866892542,0.7016356496820687
HCC1500,6918638,0.5709126385335386,0.56009479902521
RERF-LC-MS,42642645,-0.4358765804877467,0.95633112610832
LCLC-97TM1,selumetinib-vorinostat (8-1 mol-mol),2.6249327644586153,1.7695316611049503
ALL-SIL,12001922,1.676377280214729,1.568741257809098
NCI-H2452,441298,2.247705741320954,2.3877449391214927
BICR 22,46191454,1.6809351488377804,1.4650187388663165
COR-L95,16013152,4.05038947229277,3.751673255613997
BFTC-909,72376,-1.4314875177558029,-1.5929569950152305
SU-DHL-6,15983966,-6.405792257227171,-4.278260136860826
K-562,11497983,3.839483588328175,0.9597965255875726
ML-1 [Human thyroid carcinoma],10184653,1.3933805894109417,1.8716884549043535
IGROV-1,4477,1.1767656777594142,0.4525080165862112
SK-CO-1,9444,4.465837668270579,4.074896493737458
SU-DHL-1,135999136,4.730243036337901,3.235362282418344
IGROV-1,54619267,3.9701367924453455,4.205503480464525
HARA [Human squamous cell lung carcinoma],6852167,2.790696024551457,2.995687671157961
SW948,31703,0.6983000463207195,-1.0048443265625582
HEL,sirolimus-bortezomib (250-1 mol-mol),0.9395189968578028,-0.6438895479322398
SU-DHL-1,BRD-K03911514,2.3803066372148742,3.5175534180002384
HCC1500,46398810,2.5427546617930905,2.7123083271031283
LS180,tanespimycin-gemcitabine (1-1 mol-mol),-3.220136839114834,-1.2113768746441413
WM115,51039095,2.786212621210589,2.8243698750026516
Granta-519,JQ-1-carboplatin (1-1 mol-mol),-0.0687085528306087,-0.26340942950684054
HCC1500,24772860,0.2838196702204312,-1.746536675879884
SU-DHL-1,71304818,1.6958772786188914,2.275000499160932
WM115,16736978,2.885535594388376,1.8206098649711058
NCI-H1568,54618305,4.1006341963066255,4.3970374488327995
RCC10RGB,11404337,1.763382313076518,0.4494859809837677
BICR 31,navitoclax-MST-312 (1-1 mol-mol),1.028775915948256,0.9789451575364175
HCC15,17755052,4.876160174226561,1.8924555525865765
COR-L95,6610216,4.601423414679649,4.011659534369649
LCLC-97TM1,10296883,3.762301074740285,3.625153408472508
Granta-519,753704,4.381381177541046,4.004278233486332
COR-L95,3825829,4.2210058836960265,3.8165052285182837
HCC15,51039095,2.370618956781999,2.736146708999032
IGROV-1,erlotinib-PLX-4032 (2-1 mol-mol),3.0086678924768404,2.832251584673532
SK-OV-3,crizotinib-PLX-4032 (2-1 mol-mol),2.8845128579100456,2.101454749498801
K-562,9915743,1.457381054045144,0.9019092900549178
Daudi,644241,1.4114598324864769,1.2408149471259708
COR-L105,6610355,4.615259996363044,4.790699293272112
NCI-H1568,400769,-0.2296701698466811,-0.7095065904796791
PaTu 8902,4096211,3.3878786245174917,2.1245789412231844
IGROV-1,6610355,3.969940996770339,4.587752442577103
NCI-H1568,15547703,3.0519937502167744,3.446401928416466
BICR 22,11609586,1.2076158919216122,2.8623448916627967
NCI-H1568,6918736,-3.5744965026463893,-1.4593453120639919
Panc 02.03,2729026,3.1511226959620715,2.757759973304618
RCC10RGB,73707438,4.14323951901879,3.908820273361755
SK-HEP-1,11609586,4.257559552037769,3.1351980455427424
KU-19-19,piperlongumine-MST-312 (1-1 mol-mol),2.2377116602988187,2.0989534604302724
WM115,9935249,2.3950107716018465,3.115711567863421
ALL-SIL,9929138,4.286241964174987,4.451409256550631
SU-DHL-1,452548,-2.7499107831448257,0.1844638117809739
ALL-SIL,JQ-1-MK-0752 (1-1 mol-mol),0.2899712696196563,-0.07251979222044101
COR-L95,262093,1.2094317801688714,2.4595832858418625
LCLC-97TM1,4788,5.877974617736734,5.7483532825949535
LCLC-97TM1,11455910,0.6647050862050086,1.0482335283512965
HARA [Human squamous cell lung carcinoma],5978,-4.046402058806829,-1.762799674152849
IGROV-1,3025944,3.9702787396819503,4.295235068720856
COR-L105,44486219,4.2268301570583,4.50879683391876
HEL,6852167,2.7971477189216207,1.7698280453352522
HARA [Human squamous cell lung carcinoma],6918837,-1.4537868658939308,-2.4662266337956877
BFTC-909,SNX-2112-bortezomib (250-1 mol-mol),0.3698834200349636,-1.1559019639392953
MOLP-8,24753719,3.861578571306771,3.4933927037231918
RKN,54649381,4.194319964969153,3.976663596800803
NCI-H2452,5738263,2.391583749104638,3.484362297306014
RERF-LC-MS,11612883,2.474683430971872,3.0289729292427476
LS180,67156097,-0.3004464994297747,-0.8500015256839528
ALL-SIL,638278,2.4844738615144797,2.8001000836443826
NCI-H2452,navitoclax-sorafenib (1-1 mol-mol),1.6826538344111892,2.1272503830025142
WM115,89928392,1.4475546317176564,1.554356791684572
NCI-H1568,4917,1.9457015565482707,3.1526795830873198
Daudi,2746,0.9195319579001202,1.855865610212674
RERF-LC-MS,136227924,4.560045704487339,3.0957297671284163
SK-OV-3,400769,-0.3757443057400228,-0.30745548765574254
Daudi,2742550,2.6022450411597764,3.2835680876605626
SU-DHL-1,1242560,3.2887270842989285,3.470383871944035
IGROV-1,1750826,-3.124548162001242,-0.8863140199910039
IGROV-1,3025986,-1.046010021597061,-0.728239843695637
SK-CO-1,serdemetan-SCH-529074 (1-1 mol-mol),2.3873903217982155,2.0157079480636417
COR-L95,11178236,-1.511835887926392,-2.9841590141454675
MDST8,15953870,3.886262261351445,3.8612098204848837
P31/FUJ,71466578,3.434376258750051,2.7253048236318405
SK-OV-3,navitoclax-pluripotin (1-1 mol-mol),-0.7992901012574275,-0.8269096503148201
HCC15,16038120,-0.3287102193479797,1.02003087313657
SU-DHL-1,selumetinib-JQ-1 (4-1 mol-mol),2.388331941434094,1.12112815355987
WM115,44607531,1.8052962391610108,1.6343942590976328
SK-CO-1,322968,3.708989182542924,3.6819131074624054
IGROV-1,1716436,3.2816872421007375,2.9762840126337227
IGROV-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1366391073371296,4.144256261524392
SK-HEP-1,15953870,5.227718988850451,3.86996485026038
SW1271,10231331,-0.1974856956768426,2.0461471945463763
HuP-T3,168312962,3.781886601468438,2.4798651660346978
Granta-519,11238147,3.49055902156802,1.9313332062086308
SW1271,54678924,4.1367056407476595,2.24331937717016
Panc 02.03,89928392,1.630028817710481,1.6845554039692965
BICR 31,148198,-3.2373882564770513,-2.9265726396370595
IGROV-1,104842,-1.6690343627553987,-2.4680437747234056
K-562,erlotinib-PLX-4032 (2-1 mol-mol),2.919036789421011,2.8939609338475565
HCC1500,10184653,1.0749855490236058,1.077602069658251
HCC15,44202524,2.021204517823952,2.4435698166206006
COR-L105,9866186,1.0648092573013754,0.8820575040257688
COR-L95,285033,-2.430535969260308,-2.7914445232764957
COR-L95,23635314,-1.8010937940640896,-2.2189157478488424
SaOS-2,11364421,-5.8107581348158,-2.0472117341806544
BFTC-909,122327,4.590877432942681,4.739750791623533
IGROV-1,54618771,1.2456991772210466,1.048952887103373
P31/FUJ,675434,4.075878142833804,4.1031706038972455
HEL,tretinoin-navitoclax (4-1 mol-mol),-0.5211961958831923,0.5704140458726713
NCI-H2452,5328940,1.966899609603824,1.892297057491811
RCC10RGB,72376,3.207429090732714,-1.0818026012375628
LS411N,selumetinib-tretinoin (2-1 mol-mol),1.6361357934026397,2.0659031597679873
NCI-H2452,4917,2.7944300449003907,3.261676273877636
BICR 31,1716436,3.7157300626912617,3.2309661954913564
MOLM-13,1239801,3.478439984806631,3.021946358013324
HuP-T3,10296883,4.266239948990751,3.9779128847147276
PaTu 8988t,107970,2.530920724052233,2.3689963395739535
ALL-SIL,675434,4.0400251875066715,4.090535294086444
PaTu 8988t,16736978,1.6582336139520693,1.8470251332929697
LS180,5460769,0.3293841533128088,2.375642124957433
MDST8,11612883,2.4942536836786635,2.906048768886929
COR-L95,46191454,2.009346014708409,1.2752928124214211
MOLM-13,451668,-3.798095624109847,-1.1429327589217773
Daudi,168313016,3.9002026806644734,3.8491918773160485
ALL-SIL,135411,-0.5620485907345016,-0.326397345847703
RCC10RGB,46215462,3.684591481140594,2.286401597987303
KU-19-19,4917,3.607977283390518,3.1662304625466606
Panc 02.03,71751553,4.925944110140211,4.560496961107326
HCC1500,5281321,-4.561246998431513,-0.48875585653037584
LS411N,44202524,4.412838675121289,1.9668100581240253
LS411N,637858,2.7012095970179635,1.412383779682281
ML-1 [Human thyroid carcinoma],46191454,1.5014607148772898,2.1877781768422495
SK-HEP-1,24797083,1.0035545042427043,1.252477758892253
ALL-SIL,navitoclax-gemcitabine (1-1 mol-mol),-4.146952784268296,-3.399259299825145
HARA [Human squamous cell lung carcinoma],24951314,2.561199492034659,1.6351370594347105
BICR 31,387447,-3.4745770631768553,-4.182932680363906
SK-CO-1,452548,-1.5551413224098238,0.9508507500543785
SW948,6914657,-4.288216532991124,-3.871981935617582
SK-HEP-1,216468,4.223762462623231,3.5163378136411523
ALL-SIL,71466380,3.7861137397034255,3.811627258795007
ALL-SIL,66577038,2.592918053791083,2.4718966427709197
K-562,46174525,4.631327159993839,3.2509410330529236
SK-HEP-1,11404337,1.0852289139958715,-0.20512848515280546
SW948,tanespimycin-gemcitabine (1-1 mol-mol),0.3148339676626304,-1.2572425043972089
COR-L105,156414,4.037454349539868,1.759458747705989
P31/FUJ,5351362,0.932451869978648,0.9812307978793701
BICR 22,57519531,2.122776388957543,2.884897290785887
HARA [Human squamous cell lung carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.0458249521104828,2.0402195736026947
SW48,156414,-3.5613148313114293,1.3211028417162933
BICR 31,24180719,3.9564262696237096,3.505476022350627
KU-19-19,11222830,1.7129831318158657,1.6544419709385432
HuP-T3,9911463,3.677427040789425,3.874874604476563
Granta-519,56649450,2.820913380280981,2.461937062945135
BICR 31,5328940,1.2878315189706533,1.575899805686767
HARA [Human squamous cell lung carcinoma],navitoclax-birinapant (1-1 mol-mol),1.3986072497708624,1.6275984491042
IGROV-1,19582717,6.764352444432722,4.225380737471511
IGROV-1,24951314,0.9075718706849548,1.347489049139528
Granta-519,9911830,2.3469616146388033,1.6243949108215283
RKO,3038522,3.342495330103654,2.7414045783440653
P31/FUJ,135440466,3.423250795887436,1.7223926695431246
IGROV-1,6918878,1.6706182189896102,2.8251442720745326
NCI-H2452,tanespimycin-bortezomib (250-1 mol-mol),1.699086924939448,-0.12897719151236905
SW1271,136227924,3.2074421772411372,3.13185252576166
IGROV-1,16722836,0.856484234547582,1.6578186067745204
WM115,piperlongumine-MST-312 (1-1 mol-mol),1.2080674757764085,1.9564584662260267
HARA [Human squamous cell lung carcinoma],3025986,-0.8541128463962537,-0.6752326380199221
IGROV-1,168313016,4.807199318661473,5.007223506561877
Panc 02.03,9935249,3.920507280118285,3.398991379852611
UACC-812,19582717,5.3439559865445245,3.9943239474127226
SK-CO-1,54619267,3.100073010472608,4.08803921756555
LCLC-97TM1,56973724,2.3842885859021985,2.504438767118227
P31/FUJ,44185566,1.65624467652309,1.3531235319409618
BICR 22,erlotinib-PLX-4032 (2-1 mol-mol),2.8586424250405784,1.9802358319333662
LS180,568763,0.2796957344404436,0.5904577292645004
HEL,5281321,0.1504430999261452,-2.301473521335434
COR-L95,168313200,1.9910859109269063,2.7311635694068452
NCI-H2452,100016,6.6405878618594985,6.28764748303683
SK-OV-3,vorinostat-navitoclax (4-1 mol-mol),1.2421133926861518,1.2461422248805278
SK-HEP-1,71751553,4.559763777433237,4.434777413197715
COR-L105,6450551,3.13458936271996,3.059532527509008
MOLP-8,227681,1.7901539797099055,2.749375206756844
LCLC-97TM1,24951314,1.6929873886763296,1.1033873775110004
LCLC-97TM1,20959075,-3.5903877814282836,-2.679847805260306
Panc 02.03,11964036,1.263021853424522,1.4758079740388461
Granta-519,54596558,4.099782953798094,4.073101321419891
IA-LM,navitoclax-PLX-4032 (1-1 mol-mol),1.0143857311372344,1.6392008754086995
P31/FUJ,navitoclax-gemcitabine (1-1 mol-mol),-2.2174176001996626,-2.4649488173154133
IGROV-1,246676,4.485924799339535,4.164745268848903
HCC15,25126798,3.760529318413009,3.9544551960542225
P31/FUJ,67156097,-2.27730723064269,-2.344528625339036
KU-19-19,4788,5.856744699338042,5.642199199354593
MOLM-13,44507138,0.4726740823031857,1.8001693028193113
COR-L95,5281672,3.930459616892441,4.2550344518568215
HEL,46191454,2.0114602406157487,0.01564169871451047
SaOS-2,25227462,1.0053365829052552,0.4357070237043094
NCI-H1568,327653,2.9538763640308403,3.3184562766833756
MOLM-13,126941,-4.1996343959718665,-3.5686222845353957
SW1573,23582824,0.5044187481506299,0.9176268734698044
SW1271,selumetinib-UNC0638 (4-1 mol-mol),0.1676161732677231,3.6885548676765727
RKN,46199207,3.372714950884571,3.09127657336906
MOLP-8,2113511,4.489524818659998,4.7111085372618025
K-562,selumetinib-decitabine (4-1 mol-mol),3.3977333997002215,0.6133636544423754
MOLM-13,9907093,2.467705892800055,3.2492666046631573
BICR 31,135398516,1.997761003126595,2.1424020120974507
SW1271,216345,3.992520329028928,4.061824986229194
SW1271,49766530,-1.8216621121390524,-0.9831209682441603
BFTC-909,44819697,-0.8003395289407239,-0.3119564118171807
COR-L105,tretinoin-navitoclax (4-1 mol-mol),2.190606174961121,2.953896285374898
COR-L95,24951314,1.2848618182948477,0.9712720150973447
Panc 02.03,11427553,3.85172253134883,3.0881265490671894
RERF-LC-MS,11955716,-2.426679724944883,-1.2314591385472786
LCLC-97TM1,168312962,4.14705930417905,1.6678477895696378
LCLC-97TM1,984333,1.7706091320352773,0.8915856684380931
RERF-LC-MS,3689413,0.4263782886644774,-0.06848722906462514
HARA [Human squamous cell lung carcinoma],613753,4.606319217012033,3.409781639144471
HEL,72734382,4.138558929268269,3.6343193354108196
Daudi,5281672,3.0556000328651267,3.7453064206306492
Granta-519,73707438,4.294812737502366,4.287195868672563
HARA [Human squamous cell lung carcinoma],23635314,-1.642514653884031,-1.9787943744371066
BFTC-909,3465537,1.8561429441463555,2.4047302823459744
MDST8,53232,0.2243602329572143,2.5539930345486024
PaTu 8988t,54618164,4.622822732421989,4.101157535307088
ALL-SIL,decitabine-navitoclax (2-1 mol-mol),-2.660613413513553,-2.3225550630181293
BICR 22,241158,4.423333712203234,3.486074256918382
IGROV-1,25150857,3.031865110078871,2.4976448648549052
MDST8,2729026,2.783400494590182,2.6525508630666064
IA-LM,56649450,5.159895082661475,2.924510073517071
RERF-LC-MS,44137675,3.373454428855253,3.638425940738
HCC1500,11612883,3.8728122953700113,2.886531906371002
COR-L105,44491742,4.003695029376484,4.336226957951536
SU-DHL-1,17759555,3.5507610454949177,3.52820478057851
PaTu 8988t,2828334,6.317024230854033,6.178795774970414
PaTu 8988t,168312962,3.961414669504744,1.879381892089837
NCI-H2452,15953870,1.9726746369071917,3.756861365743762
LCLC-97TM1,54626689,4.751501808909531,4.387954893397625
PaTu 8902,136227331,5.567107594748722,4.024550376963182
HARA [Human squamous cell lung carcinoma],445643,3.755641736641804,4.030679448012953
COR-L105,ISOX-bortezomib (250-1 mol-mol),0.2804376845822182,0.70552081471351
ML-1 [Human thyroid carcinoma],selumetinib-UNC0638 (4-1 mol-mol),-2.912510210684258,3.060092700079799
Daudi,11317348,0.8828508555827204,1.3409603226696938
IGROV-1,26596,2.910298792762654,-0.9225547287840016
K-562,2742550,1.8061055262772656,3.3309842417590985
IGROV-1,25062766,2.144848161581278,2.2146334694555136
ML-1 [Human thyroid carcinoma],439501,-1.5032891627146094,-2.151534350902605
IA-LM,navitoclax-MST-312 (1-1 mol-mol),0.5208691605540192,0.7515067495072683
SW948,123631,3.5700289871060327,1.8344131823402252
COR-L95,168312962,1.6965693753889812,1.4867418794343796
IGROV-1,9956119,3.7231415872817024,3.787686847770788
RKO,doxorubicin-navitoclax (2-1 mol-mol),-1.0579033502847706,-1.766637168395172
HCC15,23725625,4.984445415553906,5.1163018573914965
KU-19-19,JQ-1-vorinostat (2-1 mol-mol),1.2174768050309406,1.1727184791856544
RKO,2708,5.0364138660049935,3.6930825075079836
HARA [Human squamous cell lung carcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.215632811452015,2.059749666296776
IA-LM,148198,-11.384967135346804,-3.641603544004263
PaTu 8902,44202524,5.539571067533291,2.3471430022073454
SK-OV-3,10127622,6.3662035368843535,4.049514316529176
PaTu 8988t,16038120,1.6913300198770496,1.2706632320971607
HCC1500,6610355,5.5539350619643395,4.639250796918225
RKO,9956119,3.3077949428120195,3.094167251341808
MDST8,8515,5.547245054967808,3.8799357575261775
HCC1500,5978,-3.1049031694332183,-1.276434507879998
WM115,navitoclax-gemcitabine (1-1 mol-mol),-1.739473947075712,-1.323545441767297
BFTC-909,262093,3.5924629632259792,3.009116683790518
RKO,23635314,-2.140231911981244,-2.739969129224186
MDST8,11626560,2.2403804115384207,1.8136612616286325
COR-L95,UNC0638-navitoclax (1-1 mol-mol),-0.3776689942774316,0.9368906688194847
COR-L95,44819697,-0.3616253875757693,-0.9863935483753263
BICR 22,5351362,1.2051272382141311,1.8843927985324658
K-562,9967941,4.015535149970178,3.256230197722299
Panc 02.03,selumetinib-piperlongumine (8-1 mol-mol),3.9730948608994385,3.3329523498968143
HARA [Human squamous cell lung carcinoma],42642645,0.3266919515257925,0.9079970112580128
UACC-812,25102847,4.053875686762356,2.387640058492556
SK-OV-3,6610355,6.222226160480143,4.70550832899892
IA-LM,11152667,1.0642318645878492,-0.8223164009111159
BFTC-909,6918289,3.427790661189136,2.3336158615926603
Granta-519,11167602,4.36712443545526,1.665293117883091
BICR 22,60700,-0.4008092990404712,-0.14784374239191492
LS180,BRD-A02303741-carboplatin (1-1 mol-mol),4.457802595485306,4.009054846832861
RERF-LC-MS,241158,4.36087401910034,4.040137963381825
K-562,JQ-1-UNC0638 (2-1 mol-mol),0.4182690397422658,0.7374754406631895
HCC1500,24951314,1.2674136228128516,1.3791576857272956
K-562,65064,5.606410384518605,4.046881565582613
PaTu 8988t,6852167,4.186106645973286,3.1224069959194867
NCI-H1568,BRD-A02303741-navitoclax (2-1 mol-mol),5.689804602568574,2.599814420193782
RERF-LC-MS,25154868,3.293982375318642,4.4309914214269215
Daudi,11719255,1.9605498566152704,2.45813868469175
LCLC-97TM1,selumetinib-piperlongumine (8-1 mol-mol),3.449521534433945,2.4750765871252955
P31/FUJ,9907093,4.323796399268767,3.3729659737665028
SK-HEP-1,56649450,4.110961369423777,3.328275147534653
SW948,11238147,1.5812364597614252,2.4765641954760476
MOLM-13,60700,-3.6931560077615337,-1.579172231886747
SK-OV-3,54618164,4.236989567252486,3.975397984925327
WM115,53232,2.2909547616931243,2.934610598176627
Granta-519,11213558,2.214733921051264,0.8425506753712249
HCC1500,12001922,1.110118640671234,1.8752526608066307
MDST8,12003241,0.3559193403256231,-1.2503953944597535
ML-1 [Human thyroid carcinoma],452548,-2.1962617612927375,0.7180597455193168
MOLP-8,44819697,-0.0313402586892576,-1.5257158687876504
COR-L95,136227924,2.879022500990784,2.6548984556904647
Granta-519,135421197,0.2234065586927925,1.3226256776952057
MOLP-8,SNX-2112-bortezomib (250-1 mol-mol),-3.1816176018347018,-2.5151464544535984
SW48,6505803,-3.5264924347891897,-0.9322712232274291
IGROV-1,8515,2.1861539315976053,4.010335499622484
ML-1 [Human thyroid carcinoma],10410894,4.287937298613586,3.720640540695341
RCC10RGB,doxorubicin-navitoclax (2-1 mol-mol),1.2475465934468772,-0.22218831720674395
MOLM-13,25102847,-4.845176201807707,1.8629040508799974
SK-CO-1,selumetinib-JQ-1 (4-1 mol-mol),-1.696692082912101,0.8669970728981329
SW1271,53481919,3.611390941951582,3.9029134867733437
RERF-LC-MS,24964624,3.0594292113466515,2.5458197922555557
LCLC-97TM1,969516,2.175595213634207,2.655843122857288
WM115,JQ-1-carboplatin (1-1 mol-mol),1.8205622185822876,2.3403770471646492
RKN,49793307,-1.2643121180608,-2.5607957072135257
K-562,selumetinib-tretinoin (2-1 mol-mol),3.758766106216507,2.72460040670402
SU-DHL-1,15547703,1.7605543364675147,2.8810844198116587
COR-L95,11625818,4.182153411947424,4.024986245905158
BICR 22,12003241,-0.4808187565312439,-0.7630919936720417
LCLC-97TM1,124202324,2.4863882679536133,2.269736327443983
BICR 22,24797083,1.5794716057353129,1.3345883166672798
WM115,136227331,3.7917327546536983,4.122092997476519
MOLP-8,23725625,3.090240324780466,3.775681423902667
NCI-H1568,3552672,1.826953477138791,2.8448895072660267
SU-DHL-1,selumetinib-navitoclax (8-1 mol-mol),2.4518113927127754,1.1051122770435684
IA-LM,51039095,2.817946248906647,2.4322670204656847
K-562,11964036,1.6077176524784418,0.5353560739129188
HCC1500,5470400,-1.7385310235308598,-0.7839025678211158
SU-DHL-1,11396600,2.533401176626175,2.9218793812192483
BFTC-909,216345,4.226804426652683,4.22115624496235
Panc 02.03,71304818,4.256945507775637,2.5631139845981004
Panc 02.03,219104,4.2068478561753375,4.0346380442274725
SW948,23582824,0.2041553679799947,0.8158660999627293
NCI-H2452,5287620,-2.107035322199283,-1.9880524758876859
SW1271,15953870,2.918493523161381,3.5924935808899203
IGROV-1,119182,0.2112476135388779,-0.6514166435215911
SW1271,11656518,1.475105479065936,2.0044321316682705
Panc 02.03,49766530,0.9655059796360064,-0.2015062717342177
LS180,89928392,1.7442798189695845,1.4950535628064108
SW1573,53495165,2.229023421141798,1.1139385040167264
WM115,16659841,5.127619480623103,3.7976878901545685
SW1271,3552672,3.981050843991283,2.7402578876040025
SW948,9926054,1.8406028662949705,1.8873932420223891
MOLP-8,JQ-1-MK-0752 (1-1 mol-mol),-1.2157281413611027,0.25485749551218384
RCC10RGB,71466445,4.397911896340776,4.06510669840422
WM115,7326481,2.374260909001927,3.085537787770507
SW948,44202524,1.7116279237548724,2.3110818983747228
RCC10RGB,46907787,5.224507823938942,2.4925993396556345
LS411N,9936388,1.997277136132151,-4.142381822655088
SW1271,135423438,1.1699634662635283,2.221472833456843
SK-OV-3,ISOX-bortezomib (250-1 mol-mol),1.1042689402938264,0.7926192218377202
COR-L105,123631,-0.3749766708664047,2.4627277850188296
MOLM-13,52947716,-3.8827491455655694,-3.3982896227355557
HEL,36314,-3.7348038354216593,-2.2577961934295803
KU-19-19,54454,2.6957608866389866,2.607778489987958
Granta-519,BRD-A02303741-navitoclax (2-1 mol-mol),-0.3585433064620935,-0.11088887622285742
MOLM-13,71680916,4.890723285268907,3.7532962662095968
SW1573,65628,4.136448104244246,4.468189862286042
HuP-T3,11178236,-4.0067645508863174,-3.263659187622062
WM115,11364421,-5.628114250516673,-1.1125732108500768
K-562,613753,3.252228295501032,2.939698195347289
IGROV-1,24771867,1.9944882740161016,2.247032045172989
ALL-SIL,11152667,-2.075218964097288,-2.1897534947942194
BICR 31,3081361,0.7844567898788304,2.307870198642175
SK-HEP-1,piperlongumine-MST-312 (1-1 mol-mol),1.9419225552023804,1.9370147456328926
RCC10RGB,4788,6.17872638158586,5.778560692153276
Panc 02.03,11626560,2.1710424521283427,2.085073462856541
IA-LM,11175137,3.357915620650256,2.356825517323947
RCC10RGB,11626560,2.6825909392900376,2.2016911856645756
SW1573,168313200,1.7327341920391253,3.058959169436483
Granta-519,2828334,6.191507302277889,5.683559843030814
SK-CO-1,selumetinib-piperlongumine (8-1 mol-mol),0.2146036861774908,2.3537995734722874
MOLM-13,5460769,1.2989705913507943,1.922264100671049
SU-DHL-1,216345,3.4378126257341406,3.2452768571405732
WM115,vorinostat-navitoclax (4-1 mol-mol),2.428259860783612,1.3750177981083243
MDST8,9926054,1.8075400364112937,1.9931569459119958
WM115,676352,1.7628184284101875,1.9637362930334499
BFTC-909,55508,3.078625314561866,3.4782578436981635
RKO,100016,5.817852214634293,5.292420683111308
MDST8,46943432,3.6174081091701886,2.8126396420520434
SW48,5978,-4.7084088584036525,-1.429790191391764
ALL-SIL,44491742,3.700418914769662,3.8628903285894
ALL-SIL,navitoclax-piperlongumine (1-1 mol-mol),-1.3160613464557556,-0.8556395311539238
SU-DHL-1,11178236,-5.1175240313736845,-3.0830367666423144
BICR 31,11955716,-3.162575487986667,-1.2344750331570333
HARA [Human squamous cell lung carcinoma],11364421,-4.71423157944935,-1.9863495735540675
MOLP-8,374536,-0.3332412159105151,0.7103112215571484
BICR 31,66577038,3.1838871840280745,3.1366655553344436
MDST8,409805,3.941558883413243,4.908752902672047
K-562,6918878,0.8571724386049573,0.6067356428721165
ML-1 [Human thyroid carcinoma],56973724,3.438642865372283,3.4915197162928364
COR-L95,crizotinib-PLX-4032 (2-1 mol-mol),1.858262555354691,1.6218455926690978
NCI-H1568,5281321,-2.717480517336961,-0.9977286392296522
LCLC-97TM1,374536,2.574075324433214,1.880996652381321
HCC1500,docetaxel-tanespimycin (2-1 mol-mol),1.2750885769824285,-1.8115327469926357
HCC15,66577038,3.417660968254761,3.060467824910176
IA-LM,9911463,2.6703246121465436,3.2767857516460275
SW1271,1566236,1.9677070098040983,2.282605972975778
IGROV-1,11238147,2.1723642292765084,2.9638426560769027
SK-OV-3,11364421,-1.984047807336832,-1.5091888051173996
SU-DHL-1,54613361,-0.1121754666598921,-0.7071350494776797
COR-L105,119182,0.6226208228567816,-0.02583749916983976
WM115,3384730,6.229532895174781,3.0988429319361326
COR-L105,9967941,2.071649254258539,3.788701805719892
RKO,72193861,0.7735395045157347,0.31104885251709624
COR-L95,753704,4.781559661696253,4.643234163755691
IGROV-1,49766530,-0.195540678413639,-0.3473887637215129
BFTC-909,8515,4.73152093133166,4.079416990010939
Granta-519,31703,-4.611611754102639,-2.7487561649545147
SW48,19582717,4.381046957550593,4.108817685117966
P31/FUJ,selumetinib-GDC-0941 (4-1 mol-mol),0.2780140376369148,0.5889789502419105
HCC15,15547703,3.515422457694346,3.1960507572452825
HARA [Human squamous cell lung carcinoma],36314,-5.79294260923826,-1.5796501001769503
SU-DHL-1,BRD-K58730230,4.384837032763104,3.2268214579008183
HuP-T3,2858523,3.211348955084378,3.0744027870239474
LCLC-97TM1,24901704,3.846855123751057,3.1247870668200504
NCI-H2452,44607530,1.9759156929339727,1.9169844982227267
HCC15,9936388,-3.3305479025951783,-0.43425899972488474
RKO,46191454,0.9841477576830012,1.115531703171131
SW1271,3081361,2.248142117307072,2.3761364414011448
HEL,100016,4.260371486080393,5.060718730900298
Panc 02.03,327653,3.634511095206161,3.3001345278462337
NCI-H2452,25062766,2.439590704022921,2.1525072529116445
SaOS-2,44607530,1.05170222821091,1.8164636959822116
HEL,5335621,4.9483155198907225,4.024727702569985
BFTC-909,6852167,2.133526407129769,3.1971645710631176
MOLM-13,638278,1.880317910461832,2.6910411872501543
SW1573,selumetinib-GDC-0941 (4-1 mol-mol),3.5855850407433225,1.8382370062959306
SK-CO-1,387447,-5.86001644251988,-3.9979311556249355
MOLP-8,10113978,2.697897563265303,2.1980926435783967
MOLP-8,216239,2.6519870661660803,1.873410866479755
NCI-H1568,46174525,4.305444868539079,4.512326127391471
HCC15,navitoclax-pluripotin (1-1 mol-mol),-1.3512127688258049,-0.743578283216347
LCLC-97TM1,44607530,2.097748917507136,1.642148329191927
SaOS-2,9911463,4.168030006572111,3.9167298589782824
Daudi,24889392,0.6157424479011876,3.0668473826617197
PaTu 8902,51039095,3.3801139171258976,2.6977831048886305
Panc 02.03,navitoclax-piperlongumine (1-1 mol-mol),3.4917646743182216,1.8493976017656777
COR-L95,JQ-1-UNC0638 (2-1 mol-mol),1.8178477009164715,1.2359908112320313
Daudi,387447,-5.635352264179238,-5.343614339039838
IGROV-1,5702613,4.420745339537274,2.7967195987037288
LS180,375860,-0.0541765269880971,0.008603680471268544
HuP-T3,tanespimycin-bortezomib (250-1 mol-mol),0.6963202387947334,-0.3527843115685308
MOLP-8,241158,1.846975252387852,2.490535031953024
SW948,44819697,-1.5719383449848416,-0.9920659581346642
NCI-H2452,5951923,4.988154330604512,4.773892891337919
MOLM-13,54613361,-1.833470941599732,-1.0232683896809542
SW948,148198,-4.802987893737634,-3.145100098153004
BFTC-909,4261,3.835594401773327,1.7268615145431971
Daudi,45100481,4.914271492759253,2.618027794477774
MOLM-13,3384730,-1.9717967977442377,1.1825597882015364
IGROV-1,5566,3.174346862827938,3.0608278143707066
SU-DHL-1,10302451,2.2731723403274535,2.673464383249232
NCI-H1568,SNX-2112-bortezomib (250-1 mol-mol),1.539717951588267,-1.1369340712242417
RKN,24797083,0.944322820476056,1.5348039948945853
SK-HEP-1,148198,-3.434194259121147,-3.077475169830203
SW48,16736978,1.8227831775957584,1.6253548612057787
HCC15,2708,6.122532058448304,4.9000360365501585
SW48,5335621,4.0461877603353855,4.748659378630921
SW948,JQ-1-MK-0752 (1-1 mol-mol),3.431430026033012,1.283635740491108
NCI-H1568,71304818,2.2110745175145876,2.5517482728885676
COR-L105,5311,1.9211659995219237,1.6185558053635056
SK-OV-3,5328940,3.4311724872159903,1.872873033507306
RCC10RGB,1716436,3.489109378341682,3.1919605985605584
MDST8,6918878,1.145593411739036,3.1298397503856794
RKO,11364421,1.233720517884939,-3.961717410520919
P31/FUJ,65064,5.109694638799521,4.047395734781775
HARA [Human squamous cell lung carcinoma],BRD-K27188169-navitoclax (2-1 mol-mol),2.401020533417727,2.088138396752937
PaTu 8902,3025944,5.120505038776715,4.281544638920553
Panc 02.03,12001922,2.5444953584324193,2.0034806894689705
HARA [Human squamous cell lung carcinoma],135421197,2.918907943246249,1.8978905325788276
ALL-SIL,54454,2.130103786841792,2.4320696457874225
Daudi,11238147,1.1945947480643642,2.1225052187214346
WM115,148124,-1.9357807696466565,-1.967850285741817
PaTu 8988t,25262965,-2.4539636298097376,-1.2869400987304633
IA-LM,49766530,-3.412847117105243,-1.4764974030938678
Granta-519,44185566,0.7632366174102183,1.4993538042923413
MOLP-8,44607530,1.0628729381864028,1.3304025117216824
K-562,409805,3.7514940654800064,3.9263464013610383
BICR 31,89928392,2.942196417475874,1.8853531758203872
SW48,23725625,4.606874242451815,5.1488210137021255
RCC10RGB,16038120,1.536821218292656,1.343922041415089
MDST8,UNC0638-navitoclax (1-1 mol-mol),0.0251885834350385,1.9213819708510758
RKO,148198,-2.1467795088860875,-4.026636040043953
SK-CO-1,409805,5.790109243945559,4.926573421460932
HuP-T3,7251185,1.9415241444855404,2.757367037907421
LS180,11612883,2.759028826688456,2.6374877266979695
WM115,11507802,3.278245549501506,1.6829646421640032
IA-LM,168313016,4.257474229118996,4.200935381447566
ML-1 [Human thyroid carcinoma],5566,3.147714437598846,3.110394764453425
MOLM-13,crizotinib-PLX-4032 (2-1 mol-mol),0.492576617206884,0.951757214328627
SW48,10302451,2.1638159560649157,2.848222301076801
Daudi,65064,2.8809848507042095,3.699283260074178
LS411N,11612883,3.0472980958623705,2.001332423018792
NCI-H2452,11214940,1.2392722713501154,2.0327428222542423
ALL-SIL,984333,-1.3370961884574026,-0.8704069252251121
P31/FUJ,1641662,2.802136916275355,3.014927965743202
MOLM-13,25183872,-2.142456248879295,-2.2297091721166806
K-562,969516,2.7986550178028216,2.3758064848215024
Granta-519,54143018,0.4327684951223574,-0.546154925277031
SU-DHL-1,44819697,-0.3444138900100821,0.10202885530292241
HEL,selumetinib-vorinostat (8-1 mol-mol),2.406012225394231,1.536297945057251
Daudi,9933475,1.2993243126142855,1.5177534416547842
SK-CO-1,10427712,4.208191107568486,4.3625258756337
IGROV-1,selumetinib-decitabine (4-1 mol-mol),3.5551285698551225,3.861051880010684
HEL,2841722,4.805306475973069,3.8260360481128104
COR-L105,9926054,1.7310748902984938,2.1606497110506235
RCC10RGB,15983966,2.263334704673794,0.27685484388429316
COR-L105,JQ-1-carboplatin (1-1 mol-mol),-0.012244733852177,2.7609033198831976
IGROV-1,46174525,4.5083762186279595,4.6842433297580115
BICR 31,11175137,2.7548462189262817,2.700872473157883
COR-L105,11609586,4.426382611322312,3.074583458514712
COR-L105,tretinoin-carboplatin (2-1 mol-mol),4.8464312209914056,4.860175064779825
IGROV-1,107985,-2.8971910842184516,-3.6229283767492095
SW48,selumetinib-tretinoin (2-1 mol-mol),-3.039219122646087,3.0907957369020123
IA-LM,71466380,4.547922152882383,4.144958951743704
Granta-519,navitoclax-sorafenib (1-1 mol-mol),-1.03945044820541,-0.27449914191363195
K-562,11612883,3.292128537791773,1.9451527463439242
HuP-T3,15953870,4.533958601099395,3.602494327510006
NCI-H1568,219104,4.078417481216408,3.918565287608207
RKO,65064,4.5178366082525,4.420939478112231
NCI-H1568,9911463,2.564901149372131,3.947269027759012
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384,-0.5912558766204625
ALL-SIL,6852167,2.025737624061405,1.6013153647780458
Daudi,16065773,1.627011760718674,2.000058239259411
MOLP-8,10410894,2.1334782114390425,2.6114079660086924
RERF-LC-MS,73707371,5.9060077591992375,4.843824909455947
RKN,1566236,1.687441004968786,2.4041037680532007
IGROV-1,439501,-2.1510551928674557,-2.1202169343660575
MOLM-13,57519531,1.2030375936335158,1.4184761454328976
Granta-519,11625818,4.458439944218401,3.1030581403135096
WM115,JQ-1-navitoclax (2-1 mol-mol),1.0904660510926631,0.9549312397709034
MOLP-8,3689413,-2.303477592076259,-1.1835187395696365
SK-HEP-1,54596558,4.485352352092043,4.6040951853455585
SW1271,4705,3.86061099620112,3.333587397687341
Granta-519,9927531,4.885085469625254,4.121698512274509
SU-DHL-1,11427553,0.3775832797434548,2.233707556360542
ALL-SIL,15953870,2.429039509996585,2.871223006906402
COR-L105,4259181,2.2372065992854133,0.5093547047700534
HCC15,17759555,4.480266922784899,3.9222504014568402
COR-L105,10184653,-3.6529884694455608,1.668911300003669
RKO,72376,-2.4980018930037673,-3.025756877224603
RKN,vorinostat-carboplatin (1-1 mol-mol),3.833796397117187,3.4491542658275653
RKO,613753,3.427719504210608,2.822986590171874
LCLC-97TM1,10302451,3.3699574981481217,2.8863114880177005
PaTu 8988t,JQ-1-UNC0638 (2-1 mol-mol),3.720997870166264,1.914816043023847
MOLP-8,3634881,2.730356562919761,2.727010301348164
SW948,11612883,1.2539645440532456,2.168173346882494
HCC1500,carboplatin-etoposide (40-17 mol-mol),4.564857215457985,2.443963360638687
BFTC-909,10074640,3.0053798884123837,3.2653994493317766
LS411N,24901704,3.828527152917887,2.548570028915939
SW1271,51039095,2.010271277744507,2.9134909212829485
K-562,9935249,0.8993678101188762,1.6412368762402954
COR-L105,462382,1.111643181026989,0.7404014347267102
Granta-519,10385095,0.7144131323279258,0.6573551062898619
COR-L105,5281321,-2.635307184860664,-1.0102954160509645
KU-19-19,selumetinib-piperlongumine (8-1 mol-mol),2.2054937321135775,3.691195703647568
LS180,11234052,4.148077533652898,4.061991607935025
MOLM-13,sirolimus-bortezomib (250-1 mol-mol),0.2337551440217556,-0.8631358996135599
COR-L95,25154868,4.601001468087818,4.269843194808748
Daudi,3025944,3.5610963405625267,3.691793240398088
SW48,24180125,2.6937498240420457,3.011410176487948
SW948,navitoclax-birinapant (1-1 mol-mol),2.127959258569347,1.4461455917434423
PaTu 8902,168312962,5.583922762984923,1.7004529149237175
COR-L105,5280436,1.8180108392693488,3.7280413987424312
SU-DHL-1,44507138,1.5242294298964132,1.7210776461154251
MOLM-13,10302451,1.7245492330691454,2.4710366593229756
HARA [Human squamous cell lung carcinoma],72376,-2.3262904878865083,-1.8580885855362652
SK-HEP-1,44607531,1.6636821475505756,1.7114040302071862
IA-LM,15983966,2.169762444969255,-2.256834144375464
IGROV-1,56946209,-4.416985130578084,-3.845117093777393
P31/FUJ,25126798,3.55669651950966,3.2733314094708175
LS180,piperlongumine-MST-312 (1-1 mol-mol),1.6478111921038412,1.6525638724664047
BICR 31,15983966,1.7355748159582445,-0.3738961745900127
ML-1 [Human thyroid carcinoma],carboplatin-UNC0638 (2-1 mol-mol),3.254418532258765,3.4381034679841225
NCI-H1568,135421197,1.29303587511011,2.0233735891938998
HEL,374536,0.3200488785786777,0.9299204029137828
NCI-H1568,25161177,4.305259269080427,4.32653200088211
Granta-519,24951314,0.3336244464551668,0.1902244115258604
LS180,400769,-0.7559227838025858,-0.7326303598705627
MDST8,44607531,3.32682409463767,1.71048923298283
WM115,46843906,3.7194943725295992,3.0032100320716557
RKN,24771867,0.8860225124393014,2.727901099747598
HCC15,tanespimycin-gemcitabine (1-1 mol-mol),-1.7446538355575971,-1.1211377300589542
MDST8,72734382,4.130038178532864,4.736416955634459
SK-CO-1,1750826,-0.0283504159212216,-0.6099337615489835
MOLP-8,10184653,1.0374255182903005,0.8528599322301134
NCI-H1568,46398810,2.1853633940590966,2.7024066964069764
PaTu 8902,6438330,3.32865710338655,2.437192213367363
K-562,60700,0.041873955903415,-1.2906802897371799
KU-19-19,23725625,4.865374475902274,5.124728521080522
BFTC-909,6438330,3.0201113942824436,2.268526696445226
Panc 02.03,JQ-1-vorinostat (2-1 mol-mol),1.3831414404100788,1.1886783109592751
HCC15,65064,4.883028365063005,5.0572883991081525
HCC1500,285033,-0.4229420433590342,-1.6603970714416485
LCLC-97TM1,navitoclax-pluripotin (1-1 mol-mol),-0.4086079898924854,-0.7481561996878286
LCLC-97TM1,5479543,3.538440111241957,3.088418999930856
PaTu 8988t,613753,3.3970334474933495,3.448004941877506
SU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8883081844697346,-0.6867495146516398
SW1271,2949965,2.7362256869687895,2.939095799926219
SaOS-2,4705,3.668938036329027,3.178726650727443
KU-19-19,11364421,2.01242470272022,-0.9458401810654867
SW1271,676352,2.2943086949623885,2.0609466306062405
RKN,24856436,1.2279395925477072,0.49290121381315133
SW48,159324,-1.9628962598081805,2.8067391062444034
ALL-SIL,568763,-1.7129740739789223,-0.3676443468176982
ML-1 [Human thyroid carcinoma],73707398,0.9772448893034968,1.4986201792851148
WM115,9907093,3.0763750955907883,4.444929191802561
SW948,637858,1.5262532123254355,1.6040471243595327
PaTu 8988t,24901704,4.232615528659116,3.471602381126751
SU-DHL-1,11238147,0.4308170484254632,2.5999203352150264
BICR 22,alisertib-navitoclax (2-1 mol-mol),0.0230518675395602,0.6673356223985294
COR-L105,3634881,3.59150153069964,3.2773015196390145
BICR 31,49766530,2.6564815829329236,-0.3337145377728875
SU-DHL-6,439501,-2.4303946334698057,-2.8139090832730465
SK-CO-1,6438330,2.884853035173295,2.3174743942119154
RERF-LC-MS,tanespimycin-bortezomib (250-1 mol-mol),-0.8960063928147526,-0.5030036770321745
SW948,23635314,-3.685869994463448,-2.2257834066679156
ML-1 [Human thyroid carcinoma],24951314,0.9772476096511332,1.5670580279037418
RCC10RGB,24753719,5.18895385781671,4.434674232613461
RKN,tanespimycin-gemcitabine (1-1 mol-mol),2.340236610046533,-0.3778824571784014
HCC15,53481919,4.945944641956239,3.787285945192188
HARA [Human squamous cell lung carcinoma],52947716,4.13690029570622,-0.028754418006254435
BICR 31,11612883,2.9886930364048387,2.9726937616150337
HEL,20959075,-3.3486318540939535,-3.3356431709870433
SU-DHL-1,24964624,1.891650824203322,2.2348227250815715
K-562,11609586,2.0906528510972775,1.9146915334281982
KU-19-19,89183176,4.239044338938638,4.344327148002672
MOLM-13,9927531,3.44947203831576,3.995858146011209
COR-L95,10302451,3.773437494355592,2.910895065023807
SW1271,10385095,1.244878723840673,1.2418841231699642
SK-HEP-1,navitoclax-MST-312 (1-1 mol-mol),0.5798914619314417,0.9449122346408663
IGROV-1,17755052,-1.0246415273055465,1.5188997187843807
Daudi,3634881,1.264969339465191,2.5380995503108625
MDST8,46224516,2.508010817025431,2.4928008892208493
SK-OV-3,65064,5.055886881526936,4.896784376409474
IA-LM,11364421,2.389092199855664,-3.2087423810875735
P31/FUJ,6918878,-0.2487475841908946,0.6012361475778988
SaOS-2,426756,5.396474834861055,4.374488841876948
MOLP-8,25150857,0.9011737742745826,1.683419384744865
BFTC-909,11167602,2.8757137848929006,2.554716731925735
RKO,10302451,3.926970734642152,2.649008417642149
HCC15,6252,2.2097348223357396,1.2402016054056604
PaTu 8988t,135421197,1.788370067257354,1.9455733990885538
SW48,42642645,-1.378549292450493,0.8974193195691114
IGROV-1,docetaxel-tanespimycin (2-1 mol-mol),-1.5830865659631668,-2.6887974390705853
COR-L105,73707398,2.56355231698926,1.3077422966223458
Panc 02.03,3854666,5.373190444337423,2.654085490263207
WM115,11404337,-2.7813606850874595,-0.2332910725216014
MDST8,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9743607330604616,3.2427842540496323
K-562,9803433,4.389269041756261,4.408985390109134
LCLC-97TM1,JQ-1-vorinostat (2-1 mol-mol),0.588169137305971,0.6680901380847726
SW48,11152667,-1.5089069748808788,-0.4613631412625239
MOLP-8,BRD-K55473186,4.200306440270822,4.023519296094328
MOLP-8,3854666,0.8063321236158104,0.715057927968842
WM115,156422,4.742483160763306,4.094900004533316
BICR 22,10302451,3.218470138701286,2.389258158196005
P31/FUJ,3815108,3.712799909664185,2.3793881050336596
SK-CO-1,5280436,3.963354946284049,3.390914190515253
SaOS-2,11625818,4.3669462586555055,4.60288602007293
SaOS-2,serdemetan-SCH-529074 (1-1 mol-mol),2.337619260674083,1.8724643523806177
NCI-H1568,24856436,-0.7402646666066086,0.6493582351286572
MOLM-13,19582717,1.836192229041244,2.8460580768632138
SaOS-2,selumetinib-vorinostat (8-1 mol-mol),3.065255136374356,2.7808345202605436
LS411N,65064,5.143309491248943,4.794735703005001
HCC15,selumetinib-PLX-4032 (8-1 mol-mol),2.5653564815538075,3.686014000938779
SW948,1716436,3.337695569228523,2.695320460494599
HEL,60750,-4.342121097179363,-3.301361610911596
SW48,5738263,2.8832489904283207,3.5198591352541153
HARA [Human squamous cell lung carcinoma],216468,1.0737616041415703,3.0478170755592857
LS180,135984461,4.839780886141452,3.8618560206647747
ML-1 [Human thyroid carcinoma],123631,2.4078761561490025,2.6065965992758566
SW48,3634881,4.093042888484318,3.2641362803784273
WM115,82146,3.7974591517158,3.756409737022059
MOLP-8,24901704,2.731912612856625,2.251902855725282
SU-DHL-1,9826308,0.1808938529022712,0.45806271387088215
SK-HEP-1,60700,1.3088528574816594,0.1640711471495505
SW948,49793307,-5.1176222473357775,-3.1586883586727437
BICR 31,selumetinib-decitabine (4-1 mol-mol),4.509241156469813,3.747057556267313
P31/FUJ,15953870,2.7000087530897776,2.9149363996300663
SK-CO-1,24901704,3.265743022928408,3.458783306843263
K-562,selumetinib-UNC0638 (4-1 mol-mol),3.2530488329097698,2.51006262020373
Panc 02.03,100016,6.582809568040202,6.265697686887442
RKO,168312962,-2.5117583451491012,1.0542051210746848
RCC10RGB,25126798,4.759098567819552,3.8562194993681453
SW1271,24964624,2.7126751219569147,2.4654886057538543
ALL-SIL,9444,2.1167841583667277,3.6308730581166664
SW1271,1641662,3.842487885295187,3.6330740341122354
BICR 22,676352,2.452861704781308,2.0301617647556696
K-562,54596558,4.166105900128149,4.227938302605102
Panc 02.03,9933475,2.3025810529048205,2.0729758963264278
NCI-H2452,374536,-3.751500666928139,2.6357737974532216
SW48,9825149,0.0451584979105152,2.2569444546387127
MDST8,3634881,2.8722303311625006,2.9552559683550754
SW1573,24180125,4.83914798243841,3.1153887762377703
WM115,42642645,1.5932691238490415,0.9970010954272444
SaOS-2,24753719,4.762341084721446,4.33852424301429
SK-CO-1,25062766,1.7088187930933407,2.2568315610822784
Daudi,71466445,1.7957550148901065,2.1608723847406686
K-562,9903786,3.6050720376028105,2.4159485976398494
MDST8,5281321,-0.743993786053836,-0.6324872599936313
WM115,216345,2.152490626678771,3.8676269663688316
RKO,salermide-PLX-4032 (12-1 mol-mol),6.251314610722333,4.444879492522792
Panc 02.03,44566777,1.8066319547984584,0.3623113926964025
Daudi,carboplatin-etoposide (40-17 mol-mol),-0.43265013296543,0.7050698690686584
SW48,1716436,3.2732206570492512,2.8372655533505515
KU-19-19,serdemetan-SCH-529074 (1-1 mol-mol),2.9806718783116337,2.099551182672336
COR-L95,5281321,-5.086788267908354,-1.5474800892717147
ML-1 [Human thyroid carcinoma],2126,5.801287401499987,4.751102990995998
LS180,5287620,-2.159393408078438,-2.139350814252502
HCC15,24856436,0.7194572205096856,0.6217078978765298
HCC1500,JQ-1-UNC0638 (2-1 mol-mol),1.6511332544763542,1.2124463522189515
RKO,BRD-A02303741-carboplatin (1-1 mol-mol),3.1646455891745084,3.826479925905992
K-562,54613361,-1.429503199294265,-0.7780055175497307
PaTu 8988t,5311281,3.776140248734943,2.6415667848719324
HCC15,10090485,4.457627969814505,3.8024896575652694
LS411N,1242560,3.5784744482633526,3.379669557737364
P31/FUJ,JQ-1-carboplatin (1-1 mol-mol),-0.13727273351174,-0.2737623467858285
MDST8,3854666,1.4298592595361392,2.4887073632287637
HEL,carboplatin-etoposide (40-17 mol-mol),1.8930260059492108,0.7530977787380941
BICR 22,doxorubicin-navitoclax (2-1 mol-mol),-2.5908889748637467,-0.6189986265969908
SaOS-2,448949,2.4147534872316916,1.9924610771028635
K-562,44607531,1.5533391017282614,1.1957611004998674
RKO,656346,1.2468664563159324,0.3669885464293249
SW1271,54619267,4.215254166837184,4.171553507889389
PaTu 8988t,107985,-3.7439330143768106,-3.5850609821643733
Daudi,107985,-4.311158471957254,-3.965307994242879
K-562,89928392,1.1726799483120014,0.5642638255719405
BICR 22,2828334,6.182973514514405,6.242369377176971
PaTu 8988t,462382,0.0850922030405946,0.4705970620100258
COR-L95,54619267,4.025082196689936,3.782243465616426
SW48,44486219,4.521255071137468,4.344313061981913
MOLP-8,136227924,1.5113872866650588,2.311188929842028
SU-DHL-1,vorinostat-carboplatin (1-1 mol-mol),1.1997073903631768,2.8548218923461484
LS180,176870,3.0513508415646644,3.093076720395
ML-1 [Human thyroid carcinoma],409805,4.766723032315811,5.030731974405913
NCI-H2452,60700,-2.076184021255351,-0.1212301187993895
ML-1 [Human thyroid carcinoma],3465537,2.728802739434878,2.605216181017945
Daudi,2749,-0.7661278600765006,0.8843104767625753
SW1573,SNX-2112-bortezomib (250-1 mol-mol),0.5082376174745985,-0.8767948474959562
HCC15,11364421,-3.377820549130246,-1.3587004388058488
ALL-SIL,135984461,1.7193250250744925,2.4692949844479855
HCC1500,1750826,-2.1124887265082255,-1.3429438726256282
RKN,53392493,3.005817826052642,2.6753910677234405
P31/FUJ,JQ-1-UNC0638 (2-1 mol-mol),-0.0749230690326744,-0.28135964799294916
BICR 22,5287969,-2.619429839358568,-1.850857736587429
BFTC-909,24978538,2.589526114093726,1.718510387073843
SK-HEP-1,2828334,6.264472809398218,6.188674130740914
Daudi,4705,2.565440722309658,3.0167684615580863
HEL,11485656,1.96241131365886,1.4489818069948004
BICR 22,23582824,1.0399288647056628,0.9202932210306723
Daudi,doxorubicin-navitoclax (2-1 mol-mol),-4.527956590288398,-2.2162272056286025
HCC1500,navitoclax-gemcitabine (1-1 mol-mol),-1.5596806456791137,-0.12177689371849153
MOLP-8,11364421,-5.744944118703229,-4.139759858031076
COR-L105,374536,-3.312479831607182,1.9733083489384429
SK-CO-1,56973724,0.9140094173628892,3.206541265416228
HCC1500,135440466,3.12374064827048,2.441952638127199
COR-L105,24978538,1.189273057385404,1.944084404209099
SK-HEP-1,45279963,4.052806603396004,3.8742375278268275
K-562,11317348,0.8853213314815674,1.2452361194408101
RKN,6918837,-0.6134153399361431,-2.614827349787202
LCLC-97TM1,285033,-3.3608842191269104,-1.9802061115812748
HCC15,11455910,-0.3399110905288865,1.2998813262915028
SK-HEP-1,176870,5.630942733934813,3.6877418308061953
RKN,23635314,-1.997093039658799,-1.6091873596294217
HuP-T3,selumetinib-BRD-A02303741 (4-1 mol-mol),4.443167910893738,3.742115013464491
IGROV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.258983073493191,2.1019894284006186
SW948,969516,2.384481795832599,2.376541605525327
WM115,24180125,3.7433275341391057,3.062159464648807
SK-HEP-1,135440466,3.4774178685499324,2.2920667097373175
KU-19-19,11626560,2.7733848967135017,2.061501940298809
ML-1 [Human thyroid carcinoma],675434,4.374805668496918,4.715459653700328
LCLC-97TM1,44507138,1.7278080476353117,2.4421324415039583
SK-OV-3,25150857,2.8200349544845045,2.5773149757090774
HCC15,44491742,4.47716804785037,4.26062445775939
NCI-H2452,carboplatin-etoposide (40-17 mol-mol),4.403260682335101,3.103193563087226
LCLC-97TM1,25150857,2.1625900659079296,2.264198149759922
P31/FUJ,124202324,0.9428129005296164,1.1425967512260886
IA-LM,BRD-A02303741-navitoclax (2-1 mol-mol),1.2493454608743932,2.0350371214278313
COR-L95,6505803,0.0712785503404296,-0.6052761243280831
HCC15,24964624,3.0755429715166063,2.5010956044404464
MOLP-8,11647372,0.2904161448795228,0.04658465555993432
BICR 31,11977753,-1.0341786941527915,-1.0028931364840812
HARA [Human squamous cell lung carcinoma],216345,4.215325728716343,4.129318572509645
HuP-T3,5282054,2.779269170716028,3.9825029709479702
SW948,54618771,1.4567685239775812,1.1411811284240407
Granta-519,24797083,0.9051026865971544,1.0479413113550653
SW48,73707398,0.6331221198690845,1.4139154834489362
BFTC-909,135411,0.8518885281649031,0.8708558280121532
HCC1500,675434,3.977739266447536,4.465810519280005
SK-HEP-1,6918328,0.8938731782790444,0.3531512693545493
ML-1 [Human thyroid carcinoma],2113511,5.6174346670931286,5.438435958280076
LS180,159324,3.258862193159196,3.052262551378326
HEL,168312962,0.5016152377841688,0.5161983072451766
SaOS-2,44607531,1.4975746891341548,1.5667453610214053
IA-LM,vorinostat-navitoclax (4-1 mol-mol),2.163605213189375,0.9662666781550279
MOLP-8,6610216,4.187822370904977,3.8464709890985747
HCC1500,5278396,3.6802956879537856,3.7377883855390777
K-562,445643,4.07029800941494,3.6184115479773458
HARA [Human squamous cell lung carcinoma],11178236,-2.833191042701781,-3.0484999678008995
Panc 02.03,5351362,2.6810485074832,1.7564508936914347
BFTC-909,23725625,7.000464253417552,5.22855334132419
SK-OV-3,8515,5.143916520422132,4.073447124040122
RKO,24779724,5.847036108864024,3.227135120063569
MOLM-13,65064,3.286890258414819,4.272210068023325
P31/FUJ,9868037,1.2869642230829814,1.8384131453884283
MOLP-8,52912189,-0.8757353744499203,0.11847857240760337
HCC15,2113511,6.327015395869061,5.546132697993435
IGROV-1,25183872,-0.4560099928976716,-0.47504095999760115
MOLM-13,44259,-1.8425758706378912,0.4084177558675793
P31/FUJ,9911830,2.020541196825024,1.6902129928972778
NCI-H1568,11455910,-0.0792581795853734,1.1694265580646046
Granta-519,409805,2.9966967612339417,3.643090135693242
IA-LM,7251185,3.003277248553597,1.7384448490850444
LCLC-97TM1,24771867,-3.13973757551719,0.7354008704969766
SaOS-2,387447,-3.480142635313653,-4.215883245670237
SW1573,JQ-1-carboplatin (1-1 mol-mol),2.7673375122522,2.9503076053532387
HCC15,71466380,4.492977556176778,4.466707996201132
KU-19-19,11178236,-2.578122805273377,-3.205820122062363
SK-HEP-1,107970,2.7276242080982405,2.506449404818489
SW948,3503,2.019264798250741,2.426906082948536
MOLM-13,11455910,-0.3133362084586128,0.27758447535445513
COR-L95,216239,1.9606601522489808,2.110217866497397
MOLM-13,20959075,-3.627453597088981,-3.148615490575941
SW1573,3543504,3.864321270652805,4.556766471516178
NCI-H2452,16722836,1.367876124233394,1.7128415402547246
LCLC-97TM1,2949965,2.4577774402858203,2.777143284033227
HARA [Human squamous cell lung carcinoma],5479543,3.520150804916199,3.7849407959347805
SK-HEP-1,9911463,4.3683168964450125,4.0100855329088585
P31/FUJ,11404337,-0.879305702132212,-1.2186689588595383
RERF-LC-MS,23725625,5.011639185934848,5.206226190539968
LS411N,alisertib-navitoclax (2-1 mol-mol),1.9281713469171404,0.2586446032137719
SW48,126941,-4.535727103151088,-2.909239846663666
BFTC-909,6184667,3.207156937684644,3.122685445912828
KU-19-19,2945648,2.475372674219151,2.9820010156782346
HuP-T3,387447,-4.787053098216054,-4.0755111978851355
Panc 02.03,44493528,4.298055948100647,4.399959268693853
Daudi,4788,4.597613323137637,4.713106457490902
K-562,46907787,1.0881737362577,-0.19085158894535847
HCC15,6505803,-2.813846830430111,-0.8741101843355836
MOLM-13,3503,1.2246558483585983,1.8024133944193728
NCI-H1568,136227924,3.032081072579533,2.9853605454052126
RKO,9444,4.448790979485227,3.746619291781446
Daudi,107970,1.216737596928884,1.976809199604388
Daudi,5311037,3.4563783042396015,3.126095452603898
SW948,10184653,-0.1197105127119604,0.956132616880803
HEL,89928392,0.5480178499310975,0.39992910766535905
SK-HEP-1,5566,3.210365271342881,3.15609092480911
NCI-H2452,44493528,4.324080951064212,4.48768569237215
SW948,24753719,4.222068008445673,3.7250095258583324
K-562,11717001,4.3318290739670555,3.6152532683219816
HCC15,11647372,2.6612404016221824,1.2739039669379921
COR-L95,11214940,4.129361910595318,1.8954536155618802
P31/FUJ,57330099,4.216278217816623,3.736909002938894
COR-L95,24889392,4.336996294263524,3.9042647109405215
ALL-SIL,16725315,3.2612856597636064,3.520224702094718
SU-DHL-1,2749,0.1348057545057474,1.9386864843164786
IGROV-1,6918736,-0.950858733923241,-1.7286622919881407
HEL,46398810,0.908204113249262,1.7802723288702782
COR-L105,969516,2.680370673187369,2.981542299767713
MOLP-8,613000,0.7667530859484226,2.2348448105667624
HARA [Human squamous cell lung carcinoma],6252,0.9917938801151434,1.3273692152633871
SW948,375860,-0.5776308885037049,0.021312167330263643
Granta-519,6438330,1.446800550416973,1.0531160968247495
SaOS-2,3384730,0.9471099210722488,2.96700192072341
COR-L105,navitoclax-pluripotin (1-1 mol-mol),-0.739242899323645,-0.5067174315132901
SW948,10127622,1.0689347689119728,3.2357729242279953
SK-OV-3,104842,-0.359869843998673,-2.374138945059092
HCC15,2733526,3.237047771361035,3.761753470760523
ALL-SIL,9884685,1.523019065964201,-0.43624460344960236
HCC1500,31703,-0.1591983874970776,-0.6492200802082777
MOLP-8,24785538,-1.5077289265748457,-0.11132341621384091
COR-L95,6918328,0.296514622397876,-0.49094720737874037
LS180,24964624,2.8898766327054153,2.3279656964355437
PaTu 8902,2945648,2.947030382730425,3.1389411527606548
IA-LM,16038120,1.0865848932778794,0.6207970316157263
Daudi,54619267,3.035333918034676,3.6126822410328248
Daudi,5284373,1.725683673378691,2.212090903506278
SW948,56946209,-4.45606402023299,-4.160394357290647
SU-DHL-1,9956119,2.7884192993685666,3.3467009801469167
PaTu 8988t,3689413,2.4784022576221836,-0.18994642576448076
WM115,44241473,4.443917717257507,4.781196210342705
HEL,11507802,0.749942791895586,0.7034287915781933
LS180,25150857,2.6595729662678846,2.3755884976733905
ALL-SIL,11964036,0.9057184864624424,0.3072598872264776
SW1271,5351362,2.529410314371741,1.5695343000271236
KU-19-19,151289,4.45756440863607,1.1570808320345431
MDST8,24785538,2.8042557252914597,1.8852576266552767
LCLC-97TM1,11228183,2.6499520646531254,1.3442538556787182
NCI-H1568,10127622,5.078058454742808,4.229503430179647
RKN,676352,2.5860960344205175,2.1337189482316945
WM115,6505803,-4.475953396274594,-0.39050972514892274
MOLM-13,5278396,2.870927952465231,2.7831920776950003
SW48,1641662,2.4016053281737544,3.47839791887851
Panc 02.03,5329102,3.1751218779490404,2.133883057985257
P31/FUJ,136227924,2.3905530687579497,2.470295093298495
LCLC-97TM1,5281321,-1.0764177966981967,-1.2982416517904303
SU-DHL-1,23635314,-2.2508595154996844,-1.3543002276972536
SK-HEP-1,navitoclax-pluripotin (1-1 mol-mol),-0.7942291093316414,-0.5273095604607226
MOLM-13,44494015,-5.247330257185634,2.4771652772560997
SK-OV-3,carboplatin-UNC0638 (2-1 mol-mol),3.7911977444327034,3.487301511068834
HCC1500,46199207,3.053954841618667,3.1376231224937343
NCI-H1568,6610355,3.436001375430949,4.664896800033929
HCC15,54618164,4.329878027642837,4.191793655874553
RKN,969516,2.6409066030454804,2.834132482046727
COR-L105,71680916,4.738410817171978,4.828006540148161
SU-DHL-6,3634881,2.3700422517918653,2.675150453059707
Daudi,374536,1.069903440531545,1.2574533260227787
K-562,322968,4.0833948777840225,2.527992753118425
HCC15,tretinoin-navitoclax (4-1 mol-mol),0.5454082454604786,3.078554235175633
K-562,136227924,2.737847329779252,2.4767270600423417
HCC15,15953870,3.1000423449826275,3.8236872788940457
BICR 22,6505803,-0.8504421983690468,-0.48457900291193334
BICR 31,409805,3.7719372874267982,4.8587156782702845
MOLM-13,navitoclax-pluripotin (1-1 mol-mol),-3.59227040291678,-1.9670613715312428
KU-19-19,71304818,1.8280747292346609,2.631895610400336
SW1271,6917907,-6.616351101315701,-5.0136963993623915
SW48,44589607,2.4172125993075335,2.7537293411402572
KU-19-19,3854666,3.1161318305167995,2.2258785997364456
MOLP-8,11404337,-0.9705317414577028,-1.08621086621996
SK-OV-3,11152667,-0.6824217491873509,-0.06764785322952842
LCLC-97TM1,72199292,1.0139745528188595,0.6671195992380415
SK-OV-3,5566,3.179406871626594,3.0355691879548794
SU-DHL-1,11683005,2.624367478757415,2.360517613461504
PaTu 8902,71466380,4.078142681912824,4.512720570026745
Daudi,56963564,0.012925039709307,-0.15451506519834285
HARA [Human squamous cell lung carcinoma],656346,-0.3153592740671193,0.8492563199778325
SU-DHL-1,25195348,1.1859308431356896,2.5988872582274776
RERF-LC-MS,11494412,1.0302757077826894,2.000636032553306
IGROV-1,3634881,2.769147818550815,3.465113654355773
SW48,445643,3.7110082204631545,3.866822020006194
IGROV-1,3854666,2.3355254440561137,2.2929496706457795
BICR 31,tanespimycin-gemcitabine (1-1 mol-mol),0.6260798256664765,-0.2992526304944836
HARA [Human squamous cell lung carcinoma],49867926,4.231294833351195,4.439235215125546
PaTu 8902,387447,-3.44390255134181,-4.202174352461222
BICR 22,25150857,2.1797682691439233,2.349788185383574
SK-HEP-1,54618164,4.274964046269975,4.122330829356878
BICR 22,44493528,4.288893884195869,4.243163196752788
NCI-H1568,969516,2.3539842482072353,2.9365199412326386
HEL,52912189,-0.3930066433927971,-0.038836382479923236
BICR 31,53392493,3.0187901836288824,2.7934257749978415
Panc 02.03,6610216,4.56797737488032,4.338381654984132
PaTu 8988t,selumetinib-UNC0638 (4-1 mol-mol),4.596522805557342,3.71687121382462
SaOS-2,445643,3.906030165734591,3.962048226819844
SU-DHL-1,9967941,3.123701665105139,3.3577286972449047
P31/FUJ,10113978,2.718593007254544,1.8209653951142095
K-562,54618771,1.1969173800987956,0.4878258905055254
SW1271,445643,4.255849699563793,3.8812834911308873
SU-DHL-1,16741245,1.9818901112506189,3.7272763113772505
Granta-519,selumetinib-GDC-0941 (4-1 mol-mol),1.138104902542422,0.462914536219289
SU-DHL-1,9935249,2.376788737359572,2.613381771874222
HCC1500,doxorubicin-navitoclax (2-1 mol-mol),-1.8241267045237697,-0.8063860116526301
Daudi,11625818,2.088957631704298,3.1871503579924987
IGROV-1,11213558,0.52356811652227,1.880143902805171
HCC1500,selumetinib-MK-2206 (8-1 mol-mol),4.693148185456232,2.1616239923560197
SaOS-2,9907093,3.731287417721421,4.232984281198562
COR-L105,54618771,2.0419110046350135,1.6405324654322688
RKO,9935249,5.020114551473781,1.406169444046545
RCC10RGB,54649381,5.891551456540707,4.082621279930498
RCC10RGB,11228183,3.0224846047699288,2.520332098365999
BFTC-909,selumetinib-navitoclax (8-1 mol-mol),4.610305702630868,2.2678345783188423
ALL-SIL,11683005,2.0727325774258794,3.0530398006253625
RKN,9935249,4.428036529076262,3.177446616506953
SK-HEP-1,6918837,-2.2229066751457345,-2.2951786384469646
Panc 02.03,36462,3.4500230117265933,2.461790834554557
SU-DHL-1,9866186,-0.7631869517914462,0.7418812444082079
LCLC-97TM1,448949,2.0046135576158637,1.9996773673324781
SW1271,2858523,3.03244629786768,3.2165374345490223
SaOS-2,46398810,2.449640817433895,2.571122981804379
ML-1 [Human thyroid carcinoma],navitoclax-piperlongumine (1-1 mol-mol),1.771267146894677,2.13662490313056
COR-L105,16013152,4.074366111138725,4.210357987663515
SW1271,10127622,0.8769341404821704,3.7869357946456206
PaTu 8902,24951314,1.6215809376037376,1.402213538226674
P31/FUJ,navitoclax-birinapant (1-1 mol-mol),-0.4716815446348188,-0.29871241704383783
NCI-H2452,sirolimus-bortezomib (250-1 mol-mol),-3.2659140212788733,1.011010348330072
Daudi,72199292,0.1565760694605324,0.3805676352370969
PaTu 8902,409805,5.142449436796194,5.078961454983895
BFTC-909,16115403,-3.993091010962378,-4.2027151651233545
LS411N,serdemetan-SCH-529074 (1-1 mol-mol),2.4339981987212256,1.6573055386564457
NCI-H2452,6505803,0.3706171048891257,0.04715662576909892
K-562,123631,1.7867714727142892,2.118501863345935
SW948,selumetinib-vorinostat (8-1 mol-mol),-0.2109654118959779,1.7042371863692045
SW948,56963564,0.1376223024943695,0.03053977632701007
P31/FUJ,doxorubicin-navitoclax (2-1 mol-mol),-2.963925883799113,-2.560433569600765
KU-19-19,25183872,1.353604037781074,-0.6675921012634086
K-562,462382,0.6666012292356907,0.7243331837437799
BICR 22,216239,3.622359576149126,2.277145094706796
SW948,72376,-2.235310823117723,-3.016431443382449
SK-HEP-1,16736978,1.840110323821058,1.7016566083480518
LS411N,135440466,2.8415058675889,2.0601564166011443
BICR 31,2871966,0.8542621552894032,0.840583025578747
NCI-H2452,5311281,2.597680352332147,2.389134118361334
HEL,25195348,3.2451646073619416,2.358885653490184
MOLP-8,navitoclax-MST-312 (1-1 mol-mol),1.0636024254561756,0.34448830654231183
SW48,24856436,-0.3608375787119608,0.834711240929703
COR-L95,23582824,1.713723586402061,0.6853765564440971
NCI-H2452,400769,-0.2625889565980605,-0.3580965795060092
Granta-519,6610355,5.056177796240837,3.908319476960732
RKN,135984461,0.6080422026652917,3.7274012487944894
IGROV-1,9956119,3.7231415872817024,3.787686847770788
SU-DHL-1,24856436,-0.2626900450765423,-0.5688012823535133
BICR 31,9911463,4.617619725588035,3.9145712322218724
BICR 31,2742550,4.742856926113666,4.0693497624394395
Daudi,6450551,1.0042642679666238,0.9779229280060011
HEL,57519531,1.593967479342305,1.576730354108603
SW948,sirolimus-bortezomib (250-1 mol-mol),0.0443839489335638,0.38233327587451343
RKN,216345,4.602972623005823,4.105272225086015
SW48,46224516,2.362473255058207,2.4386892485054905
RKN,10184653,1.939164173873933,1.5582403804078881
MOLP-8,31703,-3.4249459011432912,-2.251554818527388
HCC15,9911830,1.9028880277746671,2.467999998255359
P31/FUJ,24180125,3.650250525491935,2.190784916694478
HCC1500,11427553,3.400784702269924,3.218917330707441
WM115,4378219,1.986798403927216,2.2658172710201008
MOLM-13,445643,3.334033231716822,3.4157681512878395
HuP-T3,135440466,1.565116417651368,2.358277667053816
ML-1 [Human thyroid carcinoma],44491742,4.3341380025681175,4.484767416495853
SaOS-2,5284616,3.138246393599145,2.3545477840215745
LCLC-97TM1,156422,4.251965697410575,3.5658099641428525
Granta-519,71680916,3.9040498639791226,3.506822101955757
SU-DHL-1,16725315,3.3729799888412257,3.7805158489552126
P31/FUJ,20959075,-3.3972839651855207,-3.045354562945889
K-562,16720766,1.059873963232806,-0.07505253828451669
WM115,9915743,2.6223908273409515,1.2578464034321561
COR-L105,11238147,3.8255779395664065,3.0222888067034854
HCC15,6918878,1.2461206152093485,3.219938260803257
SK-OV-3,11427553,3.3243369937323877,2.8305868639259666
RKN,6918736,-2.1202784612128416,-1.561329116827051
NCI-H1568,10385095,0.5241849666466598,1.3931801558323644
LS180,6623618,2.712323731600185,2.222003810404748
COR-L105,BRD-A02303741-navitoclax (2-1 mol-mol),1.6973601808682428,2.763481901459815
COR-L95,5287620,-3.7742892062529183,-1.7555337645349978
Daudi,11977753,-5.803293235753203,-2.554311652598383
NCI-H1568,375860,-0.3746562160702436,-0.13308118291224344
Daudi,1242560,2.7879344365615633,2.9603820192005537
RKN,2729026,3.0549768432694377,2.780213180372481
SU-DHL-1,56963564,-1.155496663147979,0.6992533407665852
SK-HEP-1,42642645,1.5394057036271682,1.2969292469198026
COR-L105,9935249,3.5389604716579175,3.3026308595857334
SK-CO-1,107970,2.4721550322855843,2.3884324334174525
RKO,5113032,5.90165838842917,4.314159618013164
SW1573,135411,2.599466343128946,0.9828612917982642
WM115,selumetinib-GDC-0941 (4-1 mol-mol),-1.581349987351192,1.1125304684677844
RCC10RGB,6610355,5.214940260192328,4.9475863722866835
BICR 31,5287620,-1.513974949921974,-1.8966280272085154
HARA [Human squamous cell lung carcinoma],10427712,4.036967432982734,4.384552598556341
RERF-LC-MS,72376,-2.3536044208150644,-1.4981011287592545
UACC-812,7326481,2.606201441290427,2.8583523583877257
MOLP-8,11717001,3.6554432811683824,3.8786262539800345
P31/FUJ,1317464,4.709019850634407,2.4920515426424625
HARA [Human squamous cell lung carcinoma],9956119,4.138225192842101,3.7202999793373808
HARA [Human squamous cell lung carcinoma],5328940,0.878974684606101,1.7589653866196124
SaOS-2,44507138,2.054017263478066,2.5330800355013263
IGROV-1,445091,5.8777802446160825,4.388906584831391
RERF-LC-MS,54613361,-1.445874788963763,0.05532781575632937
RERF-LC-MS,72193861,1.0218744083195843,1.69724098390271
RKN,vorinostat-navitoclax (4-1 mol-mol),2.458310168873828,1.3770583149398559
HEL,56963564,-0.4081404928481738,-0.29705942614546293
PaTu 8902,136227924,3.2072125986231117,3.0888424928203606
SW1271,25183872,-0.9123448839798644,-0.9320941196924398
LS411N,navitoclax-MST-312 (1-1 mol-mol),1.1524396159944978,0.7725598649015946
IGROV-1,25154868,4.833387840688245,4.615148866194814
LS180,107970,2.4480125060803077,2.1536315254794616
RERF-LC-MS,9840324,5.508232790936476,5.769866397963677
HARA [Human squamous cell lung carcinoma],55508,3.1590088041564752,3.3007954871334335
ML-1 [Human thyroid carcinoma],6918736,-3.4697519345619843,-1.6032578103199548
COR-L95,60700,-2.695152938475503,-1.4451972258100838
HCC15,24785538,0.0662714662573936,1.4583411181518138
IGROV-1,selumetinib-UNC0638 (4-1 mol-mol),2.5141275878807563,3.496361764253738
ALL-SIL,73707398,-0.324762560862376,0.2611062733966984
HuP-T3,23725625,5.187021863055133,5.079938498792872
IGROV-1,selumetinib-piperlongumine (8-1 mol-mol),2.9206278268520163,3.265856932629969
ML-1 [Human thyroid carcinoma],53481919,4.335778865313171,3.9286297743897127
MDST8,6505803,-0.0816923181525763,0.3630630234020582
SK-OV-3,5351362,2.7626479495985765,1.6448397081512827
IGROV-1,36462,2.313632721410001,2.4205006734380525
BICR 22,54618305,4.315554591509874,3.990097521241529
MDST8,5311281,0.3396864368094036,2.27570712209824
MDST8,9866186,0.4787443726889831,1.0418906897880265
COR-L105,9840324,5.89386509883338,5.891124089404481
SU-DHL-6,9887053,3.723065049771557,2.6538679939408105
SU-DHL-1,10113978,2.4232665022526154,2.970401145961839
K-562,6610216,3.734328570580528,3.880668315633878
MOLM-13,9936388,-7.059788369591511,-5.119167360176065
Panc 02.03,vorinostat-navitoclax (4-1 mol-mol),1.4480782846728824,1.2899785948351394
WM115,135659046,3.4373276092449667,3.506349675900114
HARA [Human squamous cell lung carcinoma],16736978,1.7495486591528322,1.8795189339562015
RCC10RGB,2708,5.228545547030361,5.014846234568601
MOLM-13,JQ-1-navitoclax (2-1 mol-mol),-1.828604943394028,-0.6006167606753298
HuP-T3,969516,2.913535439683091,3.016652365010001
P31/FUJ,135398744,5.7727848933678,4.828008302697043
SaOS-2,168312962,3.518591614256865,1.709694351401428
BICR 31,docetaxel-tanespimycin (2-1 mol-mol),0.9040464385667872,-2.7712083499187274
Panc 02.03,11364421,0.2085573081853932,-0.3901695359822836
SU-DHL-1,3385,0.1709309619587451,3.513088166996614
COR-L105,3854666,3.5309487733662923,2.581306053998405
K-562,3025986,-1.372296763308674,-1.0661921089455606
PaTu 8902,25183872,-0.4459453921876214,-0.6296880924144351
BICR 22,25022340,5.75714905141274,3.1654295684438187
SK-CO-1,71466445,5.862416915369376,3.920052538116039
HEL,159324,1.7687894675630291,1.2056721592357806
P31/FUJ,135411,-0.6620772647112111,0.12827529538693283
K-562,11455910,-0.068399521398108,0.6576932505429542
BICR 31,doxorubicin-navitoclax (2-1 mol-mol),-0.8834140125072127,-0.9551983092121303
SaOS-2,135421197,3.6760992974277817,1.8069226885731637
RKO,54678924,1.753529637740366,1.5282939253385015
LS180,9926054,2.059729849775666,1.6915107601834674
PaTu 8902,3081361,4.091517551590367,2.3247069566806084
HCC15,54618305,4.644823264977023,4.440703204457772
SK-CO-1,135421197,1.070123520764916,1.8995516467866715
MOLP-8,5282054,2.3704039128819603,2.9166523031556784
Granta-519,2874250,5.483813332492178,4.042971369393823
SW948,15547703,2.460178853059974,2.929638452856084
RKN,11175137,3.1657803092866224,2.7054930963867587
HCC1500,15547703,2.6330912213710693,3.0278959834537993
PaTu 8988t,3503,2.8268609009838706,2.3849169410118787
P31/FUJ,JQ-1-navitoclax (2-1 mol-mol),-0.8945725612384452,-0.5544836218403236
NCI-H2452,409805,5.262030999116563,5.113051252812916
ML-1 [Human thyroid carcinoma],9927531,5.643924198323062,4.958423763424912
K-562,107985,-3.1543528536618175,-3.822888533605531
RCC10RGB,6918837,-1.099435459858538,-1.9344735499380679
HuP-T3,2746,4.662800576379415,3.441661847829071
Granta-519,135928012,3.1328015926823065,3.6703310809978764
HEL,2733487,3.1527152778808794,5.450904526819086
RCC10RGB,11175137,3.603105896683611,2.7230659097968157
RKO,51039095,3.7257826703811014,2.3301568143508318
WM115,3689413,-0.1044392328624619,0.16971661657112727
SaOS-2,25154868,5.397428200613107,4.4283519730573975
RKO,25195348,3.4491832635970585,2.7512547838579082
BFTC-909,49850262,4.237463012213885,3.6454483348142026
SW48,168313047,2.500888470511616,2.2761058930629985
WM115,444795,4.375682835505768,4.928451816941177
IGROV-1,5738263,4.037832478240785,3.4363589432919066
MOLM-13,24748573,1.5626639761830592,1.4540971877855298
UACC-812,6917907,-5.293133909322777,-4.15645117129566
IGROV-1,168313200,3.9938362637732983,3.1711513354082497
PaTu 8988t,262093,3.2462588578894587,2.9847829802827524
KU-19-19,selumetinib-navitoclax (8-1 mol-mol),1.098074451823129,2.2407644594384233
WM115,3543504,4.159835009416132,4.620199508285497
Panc 02.03,selumetinib-MK-2206 (8-1 mol-mol),1.9117134680972272,2.0865380722180733
SU-DHL-1,9903786,2.5464454731205777,2.2409244191415736
ALL-SIL,6438330,0.5772640537372373,1.0430305539030216
SK-HEP-1,322968,4.726859452680793,4.116310050494562
ML-1 [Human thyroid carcinoma],1716436,2.512454049061402,3.1567502852817957
WM115,2874250,4.6839306454467975,3.7729522618934626
HEL,327653,2.969363674974165,2.683176856230328
SU-DHL-1,11625818,3.655247454502854,3.827804798634422
UACC-812,49766530,0.2629782697340875,0.0012058735383813502
SU-DHL-1,3815108,2.229733806447586,2.5094048860381655
IA-LM,71466445,4.189377103287156,3.0112108951183325
HuP-T3,1716436,3.1901993610711092,2.996660305019434
SW948,44566777,0.0218128389697893,0.6989868618252015
SaOS-2,24821094,3.1556587771151117,3.0221462785854603
Panc 02.03,135875424,4.996461687769912,4.207208483423257
COR-L95,3136844,6.4544258549997675,3.861437862112118
ML-1 [Human thyroid carcinoma],72193861,1.5092085092070135,1.9925569865979318
LCLC-97TM1,3385,2.7516430893834696,3.6316523049946414
K-562,135875424,2.7247406179323055,3.576588712825416
LS411N,5329102,2.797825403975713,1.7259728563243246
MDST8,24964624,1.7196440159479949,2.4812383903835133
KU-19-19,10090485,5.355458016675434,3.7199299379864925
HuP-T3,vorinostat-navitoclax (4-1 mol-mol),1.7749149652569187,1.2953391219776185
RKO,89183176,-5.254565057669901,3.342488083561163
WM115,decitabine-navitoclax (2-1 mol-mol),3.441832187102982,1.808644668441766
Daudi,24775005,2.5651956502981093,3.363924358774328
SW948,46215462,1.7533079238953375,1.8245804453033783
BICR 31,6610216,4.499990209090508,4.315719482357936
ALL-SIL,89928392,-0.8842785165403505,0.14972868308245585
MOLP-8,carboplatin-UNC0638 (2-1 mol-mol),1.5821453597747015,2.9803897309343017
SaOS-2,9933475,1.7767718055197024,2.0190216480454755
LCLC-97TM1,16722836,1.3652485758433368,1.5040556058033596
LCLC-97TM1,49793307,-2.6941720612695814,-3.0902877562028137
SW48,10127622,-3.686333454689576,3.181876959524587
Daudi,451668,-1.5751627659840317,-0.9339809182203714
NCI-H1568,135398516,0.1447365774963497,2.4081216556012737
MOLP-8,11178236,-5.22072808334844,-3.46661958000759
NCI-H1568,46907787,2.5747387573296425,2.801352515133153
PaTu 8988t,6914657,-5.535111189097384,-3.801939764285822
Daudi,vorinostat-navitoclax (4-1 mol-mol),0.7138664459313301,0.42518073784941207
SW948,3025986,-0.0730103520402185,-0.7938956943804526
IGROV-1,11612883,1.8715405446213529,2.898035216311469
RCC10RGB,3081361,3.5981013353753464,2.445509322601943
MOLM-13,73707398,-1.293008226929777,0.10645642096132843
RCC10RGB,9915743,0.9759946846108524,1.1858291074565444
HCC1500,24771867,4.066345817331682,2.9414246619200837
K-562,44137675,5.346911467461658,3.1662509903453833
BICR 22,89183176,4.4276408454646,4.2474229796902145
MOLP-8,tanespimycin-bortezomib (250-1 mol-mol),0.0565968388812305,-0.6412282230121535
BFTC-909,54619267,3.991913685478571,4.014770397982122
RKO,71304818,0.9175289508752972,2.2541072293478983
SW1271,selumetinib-navitoclax (8-1 mol-mol),0.9104447168636678,2.2282532802977952
BICR 31,25161177,4.144120396566418,4.240781860703223
SK-CO-1,6918328,0.4731277879927994,0.23833082504124728
RERF-LC-MS,6914657,-3.1593675222943896,-3.4159298084267893
NCI-H1568,44185566,2.743919877007031,2.7551313004093116
BICR 22,navitoclax-pluripotin (1-1 mol-mol),0.259222956634469,-0.9356381286140188
COR-L95,6852167,3.112371536345172,2.5609341421968588
P31/FUJ,5113032,4.875284905433655,4.446941333529768
BFTC-909,24180125,2.699370118217823,3.3432196616194063
SU-DHL-1,6252,0.3334498529847555,0.39253545118547284
K-562,tanespimycin-gemcitabine (1-1 mol-mol),-1.5492083628260829,-1.7407373850752714
LCLC-97TM1,322968,2.924684365208183,3.221595754556897
Daudi,60750,-4.624244800464318,-3.6629575899923044
NCI-H1568,3385,5.30334090203815,4.023945332059242
COR-L95,5978,-2.5997235685562026,-2.4367816378771114
Daudi,24856436,-0.3602858360333429,-0.44048896882421745
HARA [Human squamous cell lung carcinoma],54618771,1.4449475826214635,1.3871476782600376
MOLM-13,445455,3.1473640199222386,3.8016103519190723
SW1573,135421197,1.3915330004591782,2.0498065170076214
HCC1500,16065773,1.504426355167742,2.3085832352315405
HARA [Human squamous cell lung carcinoma],54454,2.560964814308564,2.78361665550442
K-562,piperlongumine-MST-312 (1-1 mol-mol),1.115742811823549,1.2096218089679474
Daudi,9826308,0.3207715704810925,-0.32225433119877145
RKN,17759555,4.047966260499275,3.421894266940945
RKO,navitoclax-piperlongumine (1-1 mol-mol),3.004924162452904,1.3129380777231907
PaTu 8902,9911463,4.390925153080421,3.889347380834208
LS180,54613361,-0.777399447336216,-0.3220834478602548
COR-L95,11396600,3.695258257335492,3.24591027955399
SU-DHL-1,9911463,3.067527187401269,3.3154534650734915
COR-L95,4477,0.8356196347588036,0.43776222047405555
SK-CO-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.065917743830426,3.8894961422190444
COR-L105,12001922,2.476912212032941,1.9900307728383912
NCI-H1568,25154868,2.392234118098981,4.3285140878380615
P31/FUJ,24964624,0.604485461730223,1.1985139086289678
RKN,11507802,1.1392194525963166,1.6656533334979167
Granta-519,2746,3.996696473436098,1.6020755567719704
BICR 22,6918736,-3.590209831667407,-0.41153454503878867
IGROV-1,135423438,0.764137689665023,2.603254828690989
SaOS-2,5460769,2.263492155098724,2.8153922007665306
MDST8,3025944,3.984610722170807,4.218205989977985
HuP-T3,9935249,3.692881062494191,3.0669396195708982
BICR 31,54618164,5.999146696375086,4.310639270861914
MOLM-13,3552672,1.8354180523958712,2.3381272418990178
ALL-SIL,24889392,1.2675997647257198,3.271147221532809
P31/FUJ,5470400,3.6840145170482383,0.2521713381274526
RCC10RGB,68056272,3.770230744947895,3.7852849595484446
K-562,135440466,2.878154323162211,2.0850956201221713
KU-19-19,16038120,2.2784541929956563,1.1707524012093224
IGROV-1,969516,2.460805405371151,2.959542403331381
RCC10RGB,54596490,4.957303932772775,4.9189329198471015
SW48,54618771,0.2213541125267267,1.1972825371165745
SK-CO-1,56963564,-1.3743653333208103,0.6488434583341716
HARA [Human squamous cell lung carcinoma],7326481,3.3732570103291657,2.9985513254759826
SaOS-2,4096211,1.593922478920674,2.1572614418622345
WM115,11317348,4.689716075377342,3.0774774594818446
LCLC-97TM1,ISOX-bortezomib (250-1 mol-mol),0.9661454802906008,0.7054906065664042
LS411N,387447,-3.952629374311597,-4.244246740282317
SK-CO-1,11396600,4.255124433433546,3.833712100794058
RKO,2828334,5.934464187728916,5.85144589624056
NCI-H2452,6184667,2.981030320075281,3.143594722441995
MDST8,119182,-3.087899770061731,-0.09408585053856822
NCI-H1568,5282054,2.3545727551586744,3.9579363748056227
SK-OV-3,selumetinib-UNC0638 (4-1 mol-mol),4.410799167981822,3.5241836059818525
HuP-T3,navitoclax-sorafenib (1-1 mol-mol),3.5500030348393667,1.84904443240152
HARA [Human squamous cell lung carcinoma],56963564,-0.1933628562955875,0.4981759789067069
MOLM-13,5311,-0.2452037316548625,0.310696323987885
Panc 02.03,119607,6.223236877281167,5.571192113323143
P31/FUJ,5566,2.621678413077409,2.8829128779565094
RKN,5311281,3.300248210659573,2.119368497077447
HARA [Human squamous cell lung carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),2.096379077317258,2.856921352903159
K-562,11152667,-1.0937594737206502,-1.429116571442645
WM115,241158,3.4880777915567496,4.057540944457237
HARA [Human squamous cell lung carcinoma],176870,3.342277724847585,3.1213046082134563
SW948,11707110,-5.12001559624384,1.9115309505097378
ML-1 [Human thyroid carcinoma],tanespimycin-bortezomib (250-1 mol-mol),-0.335060121238308,0.06542088251489149
RKO,3503,2.683687073265507,2.2167595670293867
SW48,tretinoin-navitoclax (4-1 mol-mol),1.442618908951043,2.261824969042806
HCC15,3081361,2.87617011057776,2.5743755874733627
SW1573,25102847,2.4268351657646874,2.6613871704905967
SW48,24785538,-2.175303706573729,1.418635493299416
NCI-H2452,5329102,1.9284891088724192,2.1161912674279066
NCI-H1568,56946209,-4.312547212322036,-3.6064304123634603
SU-DHL-1,23939,4.934189555353841,3.7743194527216053
IGROV-1,2708,4.438419625543199,4.8737039022119095
COR-L105,JQ-1-UNC0638 (2-1 mol-mol),-0.3865258904960421,1.6678351339935256
K-562,44489675,3.6585617881709585,3.6908898395916276
SaOS-2,23582824,0.6839328831098858,0.481451806880275
WM115,1242560,3.734530534800184,3.5333746785389364
BICR 22,89928392,1.801349914013067,1.455792709708586
MDST8,375860,-0.0509298762434446,-0.14099816403453047
WM115,387447,-5.543981096917634,-3.9529102415271757
PaTu 8988t,46215462,1.6929329300119484,2.006940700573822
SK-CO-1,25150857,2.4521914239487965,2.3334058974041323
RKO,46843906,3.289277038806309,1.902625400833137
SW48,sirolimus-bortezomib (250-1 mol-mol),0.5064948335670021,0.4455253194673668
SU-DHL-1,3062316,2.138301047480956,0.04043986497733241
LS180,31703,-0.5385699496513472,-0.9448392251132681
NCI-H1568,54619267,3.44714412714971,4.1237057137759
NCI-H2452,BRD-A02303741-navitoclax (2-1 mol-mol),3.2540850576086644,3.0092580145970027
SK-HEP-1,5351362,3.433378240202124,1.5680974552037372
Granta-519,119607,5.75770191278477,4.290423094251613
HCC15,2729026,2.745990777117554,2.7759914089681934
ML-1 [Human thyroid carcinoma],5746,-1.0436745341015816,1.5581658984415256
MOLP-8,24797083,1.4809895165463562,0.796351286990378
MDST8,446155,3.7715450651151854,2.636146101261702
SaOS-2,11317348,2.7618337203443377,3.3040643129667058
SW948,67156097,-1.6378764151549952,-1.3480978178170469
ALL-SIL,448949,0.3821166271144734,1.2241064796637682
SW948,5287620,-5.231918659547503,-2.0415932461099793
HCC1500,selumetinib-decitabine (4-1 mol-mol),6.513754829735322,3.6029997552092694
RKN,159324,4.081844329649501,3.177446616506953
SU-DHL-1,6917907,-5.829381256855267,-5.335764348687064
BFTC-909,3825829,4.25128930140834,4.204382235386555
SK-CO-1,119607,5.49560679798916,5.1413134709764385
LCLC-97TM1,6450551,2.230680139016655,2.1164261380297065
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404,0.41847899942055994
HARA [Human squamous cell lung carcinoma],644241,2.250939574369427,2.183669328359596
HCC1500,54626689,4.657243866783195,4.5583275232088365
IGROV-1,selumetinib-PLX-4032 (8-1 mol-mol),2.802309242721903,3.3283627110081677
IGROV-1,9866186,0.4571266497661056,0.7687581085210131
K-562,24772860,-2.920105669473321,-2.617195311662673
SW1573,9956119,4.0915863238100645,3.8080322444219967
BFTC-909,5280436,4.2143472852581025,3.486021289081097
SK-OV-3,5282054,5.04615494272688,3.8288143970931063
SW1271,24180125,2.511417012575286,3.1933838033113444
MDST8,doxorubicin-navitoclax (2-1 mol-mol),-1.1540260466133785,-0.7679085945722212
LS180,46398810,2.878388522539818,2.516381976591089
P31/FUJ,2749,0.384854271149864,0.9461644325203777
NCI-H2452,5281321,-2.0767365956379944,-1.289913284130953
SaOS-2,9927531,5.410264314347966,4.620585568606577
WM115,156414,1.595819692541897,1.5314109041587096
COR-L95,15983966,3.7167583960216897,-2.2650582479548653
SU-DHL-1,10322450,2.9485372728674473,3.1926129936731575
HuP-T3,66577038,3.287519898796673,3.063924681716323
Daudi,6505803,0.7229387165377155,-1.07415263839156
COR-L105,46926350,-4.1614749205792565,-3.958812636862582
HARA [Human squamous cell lung carcinoma],36462,1.692464431977034,1.8994285175376635
MOLM-13,tretinoin-carboplatin (2-1 mol-mol),-0.195663512171335,3.2365731176568704
MDST8,24901704,2.355370692316459,3.4398692534346584
IA-LM,navitoclax-piperlongumine (1-1 mol-mol),0.8087427714288938,1.2389245537834275
NCI-H2452,25126798,3.2665335299764298,3.984358538258056
ALL-SIL,107985,-3.6188373708521495,-4.028665844046481
P31/FUJ,5738263,2.6277017246063252,2.388394036690087
HCC1500,2742550,3.2494473825713026,4.074891270780697
LCLC-97TM1,54618771,0.7707104681824843,0.9301503243988349
MDST8,3062316,2.63216781392049,1.1242983201680308
K-562,100016,4.034095210213227,5.090776856869371
NCI-H2452,136227924,3.4253193575490695,3.1916921458831498
IGROV-1,3025986,-1.046010021597061,-0.728239843695637
IGROV-1,135875424,3.3275053166921347,3.5994810136651667
RCC10RGB,400769,0.8506758933165035,-0.373173283283678
HCC15,44241473,5.510013950441446,4.919272776059081
SK-CO-1,26596,-2.200264316257102,-0.8421196269815405
HCC15,613000,1.6197134073445976,2.642596749424345
Granta-519,10427712,3.8202730219655496,3.6316596543006865
HCC15,5479543,3.813478020040636,3.7328193873239983
PaTu 8902,135423438,1.708930423466824,2.917017468657707
Panc 02.03,24964624,3.328827283539013,2.559625840193438
LCLC-97TM1,25154868,4.98783448400422,4.341978895424239
RERF-LC-MS,5113032,4.48589538963195,5.075445773053882
SK-CO-1,168313016,6.229837204453753,4.968992684918929
SW1573,9926054,3.1618263718643513,2.1272861267993424
MOLP-8,451668,-1.0880279758209197,-0.3837463271853553
Granta-519,doxorubicin-navitoclax (2-1 mol-mol),-4.791758111451553,-2.7813249649078875
SW1271,46191454,0.8015154670027128,1.7311895788132865
IGROV-1,156414,1.4212019235656712,1.5312627368550193
IA-LM,vorinostat-carboplatin (1-1 mol-mol),4.059193114117947,2.456016778450664
NCI-H1568,11647372,0.9090690740398496,1.703823335367395
ALL-SIL,JQ-1-carboplatin (1-1 mol-mol),0.1765424524035188,-0.0009565199608048125
HEL,5394,4.33544579006292,3.1092320149833403
Daudi,23635314,-4.750280690911186,-3.233026261185099
SK-OV-3,3543504,4.529917197725731,4.737440018951791
NCI-H1568,51037431,4.33384460889792,3.1813679826472088
SU-DHL-1,2708,2.612747958759665,4.519093988040004
SW48,151289,-0.0884278513227002,0.9089571733572572
SW1271,24772860,-2.1080107772753607,-2.037176066021708
SW1271,675434,4.352597318848774,4.4201034192908955
Granta-519,44632017,0.2326960109936577,0.6313092730344533
SaOS-2,11955716,-1.373693500458253,-0.6944665550692126
KU-19-19,159324,4.255883770522122,3.329193437394025
SU-DHL-1,4261,-0.6665613942828803,0.8866090845240676
COR-L105,10302451,1.2881684147693646,3.2549568087435676
IGROV-1,navitoclax-MST-312 (1-1 mol-mol),1.1838863893343448,1.2631477622809495
ALL-SIL,4096211,-0.2650943934034739,1.0617927075047222
IGROV-1,216468,0.5330864756407336,3.0599210903105187
Daudi,46907787,-0.707382985228944,-0.5189139770876412
ALL-SIL,11175137,2.2895463411974597,1.8563784474532907
HuP-T3,7326481,3.4338903427833674,2.9021775193303125
SK-OV-3,11626560,2.736987670099794,2.0062335981445463
NCI-H1568,5978,-3.194054905017319,-1.4039181974163037
P31/FUJ,25062766,0.5108470478058419,1.5716259494046625
LS180,4261,0.8191216854939201,1.4894258117038255
HEL,71304818,2.1837189642761645,1.788150995385022
NCI-H1568,71466445,4.632148673172368,4.175517345854292
PaTu 8988t,5282054,4.412677005920707,3.736135709921281
SW1573,54686904,4.039437320121271,3.8368291943599924
RKO,53392493,2.7606647137416616,1.713144156341517
PaTu 8902,156422,4.606541116596145,4.133086974018845
COR-L105,54454,1.772071227552003,2.72268134248656
KU-19-19,9926054,2.3371072555508445,2.0095283241988593
IA-LM,3136844,4.47285753340146,3.791044044108801
Daudi,3854666,0.3283534306514684,0.74798355217457
MDST8,tanespimycin-bortezomib (250-1 mol-mol),-0.1010970299548422,-0.036372337475965175
SU-DHL-1,72193861,-0.6645199564816581,1.607341597412061
SW1573,navitoclax-gemcitabine (1-1 mol-mol),-2.643981149214972,-1.2940918772256789
SK-CO-1,44202524,0.5946445627983161,2.327038912900703
K-562,1750826,1.7671131923879069,-2.382312881499671
LCLC-97TM1,3854666,0.8191923722369518,2.055602188986042
SK-HEP-1,4477,0.3599343153867445,0.5457962218629919
BICR 31,5282054,4.622453961920413,3.878364305848554
ALL-SIL,3025986,-1.187507928097146,-1.7613557502036183
BFTC-909,3062316,2.03384364484094,0.8583686006086801
ML-1 [Human thyroid carcinoma],135875424,5.514442636506433,4.036658083681267
Granta-519,444795,4.599812836973149,2.927881411693859
UACC-812,piperlongumine-MST-312 (1-1 mol-mol),1.224354228260847,1.9482717025014356
COR-L95,selumetinib-JQ-1 (4-1 mol-mol),4.793493423716469,1.1169270886820888
RKO,1566236,3.4833841973625725,1.8933726368069295
BICR 31,navitoclax-piperlongumine (1-1 mol-mol),2.358684882853314,1.797797715496855
LS411N,carboplatin-UNC0638 (2-1 mol-mol),3.912215714956053,3.349869166836042
ML-1 [Human thyroid carcinoma],JQ-1-carboplatin (1-1 mol-mol),0.7562453345428342,2.3957445964517525
NCI-H1568,8515,2.0721444777555327,4.159906984224194
MOLM-13,24978538,-1.2743594434772367,-0.15262088131589988
SW1573,23725625,4.357604161446221,5.03296033783228
HEL,15953870,2.2428109686656295,2.7393640576233134
Daudi,52947716,0.9938257746380776,-3.009408179739287
BFTC-909,44259,1.3269924163099676,0.898464868303362
MDST8,selumetinib-UNC0638 (4-1 mol-mol),2.2725517612456416,2.9151659151123623
SaOS-2,6918328,0.1895131607356872,0.26286919807980197
HARA [Human squamous cell lung carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),5.192132134204876,3.7811302194468204
NCI-H1568,3503,1.1278876480867208,2.3487591268149473
IGROV-1,72376,-2.111352545322758,-1.9602596944051651
SaOS-2,selumetinib-piperlongumine (8-1 mol-mol),3.928507120342424,3.4154250998898994
SK-CO-1,654092,0.6285789884023978,-0.07707042421351364
SU-DHL-1,44589607,1.246014317818898,2.7066938165540484
PaTu 8988t,3552672,2.097731757890035,3.0375552082613813
HCC15,5282054,3.6050373222028815,4.0229349145039075
HARA [Human squamous cell lung carcinoma],1641662,3.0207416829742058,3.555005975909482
WM115,16013152,3.8161355323039,4.031106690432684
ALL-SIL,54618305,4.365324809283883,3.1704192882691835
SK-CO-1,25195348,3.743308569883415,3.429541254365369
BFTC-909,123631,2.8792987518934403,2.5964707239189604
NCI-H2452,25022340,5.0430378131248785,3.0339292329271803
BICR 31,11719255,5.311316415457661,3.59309102075578
BICR 22,JQ-1-vorinostat (2-1 mol-mol),0.486661425618767,1.0687428614624226
HuP-T3,568763,0.3762081962980199,0.5137344756314343
Panc 02.03,71680916,5.6819891784443595,4.907770349406273
SK-CO-1,44484440,3.788843022204708,3.257154013350734
HCC1500,60750,4.75355506285403,-1.8863910865494933
SK-CO-1,44607531,1.475264767684201,1.3078601318723024
MOLP-8,1317464,4.425962710369034,3.102461862957842
BFTC-909,107985,-3.700699007813787,-3.353831417780549
SK-CO-1,3025986,-0.6416687634539443,-0.7165094254985348
BFTC-909,44493528,4.370300807083883,4.375537784071937
SW48,49850262,3.202043440642355,3.5549227129885193
HCC15,sirolimus-bortezomib (250-1 mol-mol),2.085701918672026,0.7000908524333255
MOLM-13,5746,-2.6320399073484633,-0.1284520115573355
NCI-H1568,36462,0.6787379731584755,2.1350664637335033
SW48,vorinostat-navitoclax (4-1 mol-mol),1.1280429303528072,1.6209772987649789
LCLC-97TM1,31703,-1.7062756219896058,-0.7504502429004016
BFTC-909,54454,2.6967031082973527,2.5956325347565814
BICR 31,5351362,2.0722735669158876,1.56156163674833
ML-1 [Human thyroid carcinoma],20959075,-2.269435131540743,-2.451172130428401
HEL,3543504,3.6690825601144064,3.5625759505330508
IGROV-1,11178236,-2.8618715106425725,-3.389782851629859
SW48,176870,1.305545107688616,3.104406334781148
LCLC-97TM1,3062316,0.5973926668956511,0.9841391936276546
HCC1500,6852167,3.541859976914812,2.7897828104033304
MOLM-13,54626689,4.673711949381485,3.92088340153894
RKO,11175137,2.9264569639519906,2.272023091046812
SK-OV-3,carboplatin-etoposide (40-17 mol-mol),4.59219202218907,2.913522168086916
BFTC-909,73707398,1.325657316242966,1.3910155891562244
SK-HEP-1,11485656,3.3898088020096324,2.6800314700771963
SW1271,637858,1.8302889918552376,2.0491034332986287
P31/FUJ,151289,0.3376751835645198,0.534273588575478
MOLM-13,6918289,0.5846893448973186,-0.45251359870331653
RKO,4096211,2.0568907070726397,1.136145925669092
HCC15,42611257,3.545791426903468,3.3707037323073634
RKO,51037431,1.443783779144223,2.952821523634619
RKN,1716436,3.648262431092988,3.1031517661530996
RKO,216345,4.0768365061219525,3.10110589023607
MOLP-8,54454,2.3030156333842533,2.36681036619123
HuP-T3,JQ-1-carboplatin (1-1 mol-mol),1.982980925186552,2.5167799785554426
SW1271,11719255,2.0964009449704335,3.505315121370431
SK-HEP-1,5328940,3.1706915881362097,1.8247848025398319
HEL,6914657,-6.908409772348001,-5.54671362095097
LCLC-97TM1,6918878,3.384977217975284,1.8377567734519191
HuP-T3,46943432,3.2592232125577665,2.6665329789877052
KU-19-19,11152667,0.8748891502312,-0.51273674316812
MOLP-8,5278396,3.6007551773478093,3.0274523733045346
MOLP-8,71304818,1.8062780808091792,1.8919311319487917
BICR 22,selumetinib-navitoclax (8-1 mol-mol),1.8614529515345275,2.344501518419952
SaOS-2,5280436,3.62212536353362,3.5325495661439823
IA-LM,71751553,4.579394980470846,4.041791983614026
COR-L95,374536,2.031472802797221,1.8272133497135434
HCC1500,1716436,1.6304357372897462,3.0605158338999696
HARA [Human squamous cell lung carcinoma],10385095,1.0837341672046903,1.2803620970442406
SW1271,9967941,4.951865473173475,3.7716149938273715
KU-19-19,6918837,-3.3861016705907203,-2.4717865905060386
LCLC-97TM1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.91566117969414,3.112054056334054
RCC10RGB,54626689,5.11978438920743,4.7147694754442115
COR-L105,24964624,2.7213287093015848,2.562428088673369
RERF-LC-MS,10184653,1.661334722418144,1.7048557262362258
COR-L105,9907093,4.049740181744662,4.355827662004428
WM115,4917,1.7802954819592542,2.822912640149766
Daudi,25262965,-3.918146889356354,-2.5883269554302477
RKN,9926054,2.8101544562472056,1.9896102818905381
COR-L95,969516,2.641832541585458,2.536130368765157
ML-1 [Human thyroid carcinoma],9868037,3.639883526106939,3.525206879076487
LS180,60700,-0.831384616867798,-0.4200300694733891
HCC1500,25062766,2.7449885477672136,2.5128887998027998
COR-L95,11640390,2.478695805138082,3.0770594495382984
HuP-T3,54618164,3.3933985234085755,4.124289317883052
SaOS-2,25105715,3.6317688538247968,3.3738335390186425
SW1271,5335621,2.365445027841909,4.725202455739854
NCI-H1568,72193861,1.9818580959671683,1.8898095858521629
HuP-T3,JQ-1-UNC0638 (2-1 mol-mol),1.1921000919454006,1.623234928688905
SW1573,10385095,0.5068001344623563,1.3300559913444392
ALL-SIL,2841722,3.706104916487932,3.785851697424477
P31/FUJ,71466445,3.0287439983851225,2.5307088436593728
IA-LM,JQ-1-UNC0638 (2-1 mol-mol),3.2694867389724744,1.4193170753517035
COR-L105,4917,3.658916006838,3.1717997722928972
RCC10RGB,9903786,5.708919982977709,3.172327381620278
HuP-T3,25161177,3.646148401953212,4.31625724557148
K-562,71466445,2.3693775657442373,2.7266849226493513
K-562,11977753,-1.2336845020581693,-2.2674991301556746
LS180,16725315,4.563180557999628,4.346505618483098
NCI-H1568,66577038,1.9593359628641709,3.3352981760327607
SaOS-2,3465537,1.5281169625539155,2.558247614382331
ML-1 [Human thyroid carcinoma],11640390,3.608850000621235,3.9490904552924326
MOLM-13,17755052,0.2343645648969551,0.6375879981128758
RERF-LC-MS,67156097,-1.006688958645714,-0.43628188958933917
SW948,5470400,-3.941225454290086,-0.4140360359590506
HEL,44185566,1.408371464536178,1.4980655730180343
RCC10RGB,3503,3.522457107356278,2.470833577082862
BICR 22,9866186,0.6641273098552615,1.0896114668740904
K-562,52947716,-5.609155633475852,-1.812434333752063
SaOS-2,1641662,3.0320316508312883,3.6335420213964933
SW48,5460769,-0.8804369809799648,2.5953076175233747
MOLP-8,11625818,3.354870459420626,3.4895114814231323
KU-19-19,3025986,-0.2897675094370045,-0.6961645868091125
K-562,9444,4.095192274458736,3.530628676514708
IGROV-1,5329102,1.2794664511054334,1.9488652421415846
LS411N,11427553,2.839596649209722,1.7970644344368674
SU-DHL-1,10385095,0.4695713178913991,1.2534361728301684
SW1573,124202324,3.209850220678193,2.8427738377064546
BFTC-909,2949965,3.0294119536880197,2.997865359104722
Panc 02.03,44589607,4.606435993835204,3.0995319178289877
LS411N,25126798,4.124739072985443,3.678487327031687
RKN,24785538,4.869460471506453,1.9256341497283562
SU-DHL-1,31703,-2.5255735182995203,-2.322841917954135
KU-19-19,6505803,0.0199416611110358,-0.6001460468326989
MDST8,5281672,5.754114909876849,4.642223496678291
PaTu 8988t,9903786,4.140175125497243,3.0234641456362334
SK-CO-1,11717001,2.027201802005241,3.811441878697902
K-562,navitoclax-sorafenib (1-1 mol-mol),1.3368563864105187,1.1880084531698492
HuP-T3,54454,3.567661200928428,2.7038886108816684
MOLP-8,262093,0.615798330418347,1.7867146541037602
SW1573,6918328,0.8267852089643692,0.24367816684406
LCLC-97TM1,73707398,0.638027637531153,1.170781526085503
SaOS-2,11719255,3.097989779485228,3.4926183231679677
SU-DHL-1,73707386,2.8817783064824773,2.3579133579500775
HARA [Human squamous cell lung carcinoma],2841722,4.596341456340547,4.3398960074541115
LS180,9915743,2.834892961755663,0.5233234184253434
ML-1 [Human thyroid carcinoma],54143018,-0.4485048931823356,0.5095782204527292
BICR 22,4578,4.285603675470092,4.374052105343181
SaOS-2,24951314,1.4499530102948022,1.4851038947070534
RKN,6918328,0.5495182279950256,-0.006748486745383443
IGROV-1,66577038,3.2148239132520455,2.9135445220316942
COR-L105,15547703,4.316721747481802,3.1186118742831557
HCC1500,753704,5.032412058463686,5.0895245099426765
RKO,44819697,-0.2126149769206573,-1.7075186710449766
HCC1500,16013152,3.952751911590144,4.161107647725802
SW948,89183176,3.757757719513151,3.471823864241216
IGROV-1,JQ-1-navitoclax (2-1 mol-mol),1.1306356566784013,1.0934121522923557
ML-1 [Human thyroid carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),3.3397252964004593,2.9268254863116043
ML-1 [Human thyroid carcinoma],11427553,2.643507576643823,2.976461554420328
IA-LM,44819697,3.529669119404179,-0.9995425188947261
PaTu 8988t,148198,-4.283282973565046,-3.5484950200793217
HCC1500,5287969,-0.1960949732639439,-1.5263064427182127
RERF-LC-MS,5460769,5.094680634820597,2.519018443448459
BICR 22,10113978,3.5652875556244923,3.5223695396807875
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681,1.2208608800777077
LCLC-97TM1,6184667,3.4160200622822736,2.764535042385842
SK-OV-3,44507138,1.930427516054787,2.732869289359211
SW1271,54626689,4.884226988721356,4.622492140887002
COR-L105,25195348,2.918205578273492,3.5565985884335305
MOLM-13,49850262,2.0503909100702873,2.2725083354572813
LS180,104842,-3.608354535822108,-2.8157981743097213
Granta-519,6184667,3.6411271735359207,1.9564045843574427
IGROV-1,49836020,5.658436828096057,2.9664372037760165
HuP-T3,54619267,3.893027602521098,4.104720819500853
SW1271,409805,4.993473873943069,5.070629574914825
NCI-H2452,2749,1.5209092727807076,2.218664840404414
MOLP-8,JQ-1-carboplatin (1-1 mol-mol),-0.7588683882378918,-0.46097121880361747
SK-OV-3,119607,5.6958068077620405,5.359771913133227
Granta-519,JQ-1-navitoclax (2-1 mol-mol),-0.9470910727061151,-0.9582491336133557
SU-DHL-1,6184667,2.253300303827536,2.8319596637332256
WM115,2871966,2.231269661110087,0.8017056609474271
SK-HEP-1,219104,4.349330089087446,3.882506069274892
SW948,selumetinib-piperlongumine (8-1 mol-mol),0.6665506156446188,1.961794870930843
SW48,8515,2.6507036204950256,3.9094586920571777
MOLM-13,241158,1.7093626682651633,2.3489996524278136
RCC10RGB,71576739,5.1028364410536735,3.9165679410653023
LS411N,54619267,4.196494516067777,3.762767312200556
Panc 02.03,637858,2.766769284687194,2.4246943917509665
P31/FUJ,25150857,2.053516150415863,1.5116707447994608
P31/FUJ,24951314,0.294555023880993,0.3161879877345297
SU-DHL-6,16736978,-0.092754907722646,0.5501206387163645
RKO,151289,1.190219151105647,0.5061832918905347
NCI-H1568,1716436,2.664872339798973,2.914784568452713
SK-CO-1,doxorubicin-navitoclax (2-1 mol-mol),-2.167378618505947,-0.4955476462542283
LCLC-97TM1,49836020,1.9924259842665932,2.6955671588961736
HARA [Human squamous cell lung carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),1.441529788664552,2.4232698031955833
HARA [Human squamous cell lung carcinoma],44137675,4.310894105428011,3.771452954218718
SW948,11647372,1.3621251009964823,0.34283350436304566
LCLC-97TM1,selumetinib-UNC0638 (4-1 mol-mol),3.547341579124928,2.6133323396355075
LCLC-97TM1,56963564,-0.6229750501206363,0.37077117818141514
IGROV-1,11427553,2.926316692603687,2.9060946221137414
HARA [Human squamous cell lung carcinoma],54618305,5.079823174852019,4.181643817702489
SW48,24951314,0.6660870475429757,1.2502042633108816
RCC10RGB,46398810,2.467266718263722,2.7185809444819524
NCI-H1568,16720766,0.7309820541773976,1.150240407159754
K-562,decitabine-carboplatin (1-1 mol-mol),4.43725246072026,0.04969217702399579
HCC1500,6918878,3.8452122267855544,2.7030492302886215
MDST8,JQ-1-navitoclax (2-1 mol-mol),0.0958031568177067,0.6479327350246795
BFTC-909,BRD-K27188169-navitoclax (2-1 mol-mol),3.3946327784578245,2.124291268230725
NCI-H1568,9840324,5.648333485386012,5.749058492045107
SaOS-2,24772860,-2.2454069761524416,-2.0034962462666552
NCI-H1568,12003241,-1.4870303892505918,-0.7229973200659299
IGROV-1,135411,0.626702113064729,0.5476186778903702
SU-DHL-1,123631,2.2104669936854817,2.266403920286407
BICR 31,676352,2.5344425849235472,2.1494749255648404
WM115,2828334,5.840169576442124,6.1302119492575
BICR 31,16722836,0.993439631718574,1.647441057234143
LS180,71304818,2.5144465721497573,2.257818057659008
HCC15,176870,4.3801450304989835,3.6291875599444383
SaOS-2,44137675,2.8908105588075537,3.651539000078847
SW48,57519531,1.1891467216952898,2.794637363769234
LCLC-97TM1,46943432,0.977611384475134,2.223773430732199
LCLC-97TM1,selumetinib-tretinoin (2-1 mol-mol),4.0009002077883755,2.868227444692652
MOLM-13,alisertib-navitoclax (2-1 mol-mol),-6.0299100304654365,-1.427713040708623
UACC-812,52912189,-0.0403441295384107,2.5615137226265947
HEL,638278,3.1804055556137394,2.814483001731924
ML-1 [Human thyroid carcinoma],135440466,2.0685655954708824,2.3054492428329776
UACC-812,45279963,4.1756281682233185,3.3271731818967156
MDST8,12001922,2.1068751805520423,1.8487639717882294
HuP-T3,11626560,2.4663043755994094,1.9052676248130567
HCC15,9884685,1.2743229964902805,0.9672611466953437
Daudi,82146,3.751797413920901,2.6930380295195047
IGROV-1,vorinostat-carboplatin (1-1 mol-mol),2.9918987847321645,3.3116198860222745
BICR 22,969516,2.807563254821311,2.6568306470188885
RKO,6917907,-7.36544436443182,-4.903862703833496
LCLC-97TM1,BRD-A02303741-carboplatin (1-1 mol-mol),3.5226633114065407,3.7522035416514967
P31/FUJ,54649381,3.661627004097492,3.116602196375757
P31/FUJ,15983966,-4.570279214878008,-4.10275587631771
COR-L105,49793307,-0.7736136433109717,-2.0778949672035854
HARA [Human squamous cell lung carcinoma],107970,2.425047737070786,2.405959638287982
SK-CO-1,57330099,5.774767561552264,4.196670188838641
SW48,navitoclax-gemcitabine (1-1 mol-mol),-2.8390563906078543,-1.1082874787342845
Daudi,36462,-1.782907247885185,0.32488307486362555
SW1271,10077130,5.262255440725952,3.3818404862900353
PaTu 8902,124202324,2.5191853508509823,2.6303522423010337
SW1271,4261,2.1417567232825157,1.8139260652129272
SW1271,568763,-0.4148311333850545,0.4220562825246882
IGROV-1,44185566,2.2104732991243248,2.6032061373338604
PaTu 8988t,piperlongumine-MST-312 (1-1 mol-mol),1.7723365960000816,1.875276269848986
RERF-LC-MS,54678924,1.4734481784853186,2.327343286001356
SW1271,17759555,2.4829827438054104,3.5719733500697233
HCC1500,2871966,-1.8945265193529464,0.3363949889624544
RCC10RGB,119607,6.074674808773517,5.330093718500353
MOLP-8,5566,2.8349074996791295,2.89488679809556
K-562,24901704,1.0460453676907424,2.3666679382739773
SK-OV-3,44607530,2.4027946355264507,1.9042426378948358
IGROV-1,44589607,3.0909001492794377,2.6371328998482655
SU-DHL-1,44185566,1.07324922266726,2.354229706966738
MOLM-13,navitoclax-gemcitabine (1-1 mol-mol),-4.310291489660192,-2.576410551060426
SaOS-2,42642645,-0.01972406793895,0.5560681380897252
SaOS-2,327653,4.165382989627235,3.259548786677905
RERF-LC-MS,44491742,4.380479941679622,4.280977103225964
Granta-519,navitoclax-gemcitabine (1-1 mol-mol),-5.4729921992931665,-3.0310844641986545
K-562,3038522,1.918387146447148,2.8427563034724947
HuP-T3,702558,5.633624519144866,5.431571543208346
ALL-SIL,2858523,2.9846374491002376,2.7257248986720573
WM115,44589607,3.0632481185375933,2.8107556625900725
LCLC-97TM1,11977753,-2.2409153175434953,-1.4614956665827574
Granta-519,7251185,1.138949301849667,1.2941390381363904
MOLM-13,446155,1.5984418257641329,2.2143041405924246
SW1271,11455910,0.4702460968788743,1.1874839721006842
WM115,10184653,1.7306018843706388,1.4598024572702857
SW1271,12003241,-1.4062779923685875,-0.9318324998363404
SU-DHL-1,3038522,3.3518104703058467,2.530950670033626
RERF-LC-MS,44819697,-0.3406635094896507,0.05341887071184157
SW948,tretinoin-navitoclax (4-1 mol-mol),4.012168549649723,1.6808434475107907
SK-OV-3,piperlongumine-MST-312 (1-1 mol-mol),2.5779047815349627,1.8499707770978302
RERF-LC-MS,3825829,3.876424055067748,4.054813809286817
SU-DHL-1,208908,2.168834483257838,1.8756995940585157
COR-L105,4378219,1.9356703916494296,2.7588866659600138
SU-DHL-1,44489675,4.002710700308593,3.561569618735723
BICR 31,5329102,1.5123342757929257,2.076670194657527
BICR 22,72193861,1.1787223619968317,1.7985095788015635
SK-CO-1,4259181,-0.2853622975740302,0.5417625672623358
RKN,5278396,4.050807510430523,3.512084460290154
LS411N,3543504,6.407278726964401,3.8839215379390506
Granta-519,2749,-0.6711865738648753,0.8590922737527694
LCLC-97TM1,11222830,0.9756157307321038,1.4516106360837657
HCC1500,49766530,0.4188049276678212,-0.0111562627952565
BICR 31,24821094,2.272776200428542,2.6909817856312177
LS411N,15953870,3.79326986504028,3.324325933140013
KU-19-19,15547703,3.5460273004695364,3.1749780294085004
IGROV-1,10410894,3.2660402181528263,3.340238906212299
SK-HEP-1,9936388,2.725726666175631,-0.24763112787045366
SU-DHL-1,68056272,2.8441937668208297,2.539147745205624
BICR 31,107970,2.625018410874988,2.4203932532496735
RCC10RGB,24978538,2.2083570886635258,1.516390090536728
MOLP-8,42642645,0.4027543307161444,0.09219614388620095
IA-LM,6438330,0.5920782597943414,1.8510604751804005
HCC1500,25102847,3.871994319987046,2.5309690456486185
SK-CO-1,9903786,1.8148473241522671,2.9289396441706246
SK-HEP-1,51037431,1.9503987957256583,2.9014044175908085
SU-DHL-6,15547703,1.663295720719241,2.6409526782968915
PaTu 8988t,42642645,1.5127014290808742,1.0563978156534888
Daudi,4578,4.14840859618435,3.676580729336788
HEL,73707398,1.0006953763352662,0.3276839399723105
RERF-LC-MS,3634881,4.923247717838372,3.340199911432726
HCC15,9907093,4.55737056946543,4.24483881953387
IGROV-1,16725315,4.890680859998698,4.305274896672329
COR-L105,navitoclax-PLX-4032 (1-1 mol-mol),0.9673135251369994,2.1748372282974318
COR-L105,107970,2.936160881286492,2.399117451562894
PaTu 8902,11485656,3.4031855994132663,2.2219268050867798
BICR 31,5287969,-2.0848564793948423,-1.7259458632155054
SU-DHL-1,3503,1.2104794697541517,1.9547524871882647
WM115,selumetinib-MK-2206 (8-1 mol-mol),-1.676879875544035,2.105009884521391
RCC10RGB,107970,3.009214725762471,2.465779392295058
KU-19-19,51039095,3.4730458815699743,2.8317063354142196
KU-19-19,selumetinib-MK-2206 (8-1 mol-mol),2.230752575212941,2.381096711180497
IGROV-1,16038120,0.2864038103759729,1.3520562690437021
P31/FUJ,selumetinib-UNC0638 (4-1 mol-mol),1.8703414483738705,2.4970397886383506
SK-OV-3,1323703,3.751791158325908,1.3687828507171016
K-562,JQ-1-MK-0752 (1-1 mol-mol),2.296423482837328,0.329866503561966
LS180,56946209,-4.291807545115399,-4.063403056998236
BICR 22,16741245,4.124711805224883,3.576049083121508
Granta-519,11396600,3.399615682634249,2.1144589965175014
LCLC-97TM1,4378219,2.0431586025336332,2.291233371764669
COR-L95,piperlongumine-MST-312 (1-1 mol-mol),1.3307800151979865,1.487202475530414
PaTu 8902,3062316,3.1999770976977966,0.7524686418730075
MOLM-13,9825149,-0.4975121245832732,1.738608992214865
PaTu 8988t,36462,2.8739750906545263,2.21770192593845
WM115,4261,1.0617223830766982,1.7148291444373884
BICR 31,54618771,0.3365869204450262,1.3945952571813425
IGROV-1,6918837,-2.9804518885508635,-2.5312392789847498
SK-CO-1,49850262,4.729060483840123,3.6456533409942273
NCI-H1568,selumetinib-MK-2206 (8-1 mol-mol),2.137801357231392,2.209855848594959
SK-CO-1,49793307,-2.625714785229563,-2.657287349937818
ALL-SIL,159324,0.7144692186053382,0.7540547961799359
BICR 22,tanespimycin-bortezomib (250-1 mol-mol),-0.7202446559484896,-0.32550652012235404
RERF-LC-MS,24821094,3.899392046553833,3.1549457232601075
NCI-H1568,selumetinib-decitabine (4-1 mol-mol),4.70224066359239,3.8517327635105265
ALL-SIL,54613361,-1.2150310590443698,-0.9350778326032594
MDST8,54618771,1.2096098448968695,1.45861107301995
MOLP-8,26596,-2.4791577040777812,-2.585536155044844
RKO,4788,5.372325515812119,5.399632640006604
P31/FUJ,44589607,2.3901798108348533,1.6938533986113888
SK-OV-3,613753,3.56222269809742,3.2659566888568348
SW1271,navitoclax-sorafenib (1-1 mol-mol),2.5597569107989457,1.919348019237327
SW1573,2858523,3.1892649395611556,3.039918608728468
LS180,72193861,-0.0461725132802377,1.865515906956749
RKN,25126798,3.956068538327861,3.7816707144878494
MOLM-13,6917907,-6.412365954060792,-5.438675386465959
WM115,50905018,4.954075896774319,4.516023041164971
HCC1500,54619267,3.954111090910006,4.147381234377982
IGROV-1,6252,1.1284141516966473,0.9238180936102215
Granta-519,49766530,-2.591856607816134,-2.205736375493046
RKO,400769,-0.364727826621167,-0.6249452429175433
SaOS-2,5113032,4.015669070835574,4.753208573744804
MOLM-13,JQ-1-carboplatin (1-1 mol-mol),-1.1937671788026978,-0.5689661585633764
BICR 31,400769,0.3553213589698107,-0.3347211294842264
HARA [Human squamous cell lung carcinoma],16720766,-0.0810608938508249,0.8646566883664901
MOLP-8,JQ-1-navitoclax (2-1 mol-mol),-1.8736660374722776,-0.3885985899798612
RKO,24901704,3.90150667551114,2.5030202466327434
K-562,675434,4.134192231732703,4.143509567339837
PaTu 8902,vorinostat-carboplatin (1-1 mol-mol),3.3056109148195936,2.918634916193828
IGROV-1,60700,0.4424479122017752,-0.4537853201342644
RERF-LC-MS,439501,-1.3704502050640626,-1.9948329101516584
PaTu 8988t,3081361,3.3861147832051004,2.590259608848642
PaTu 8988t,11507802,1.1782523393568187,1.599486780962615
RKN,25154868,3.091821445991922,4.526042415513962
SK-HEP-1,3384730,4.617019540739567,3.045039199797034
IGROV-1,135411,0.626702113064729,0.5476186778903702
RKN,44202524,1.6880658914716755,2.1923141692826333
MDST8,10127622,1.4568360900186117,3.3255501811950445
ALL-SIL,5978,-4.2912860791141725,-3.3883501222978407
LCLC-97TM1,25195348,3.14182472834864,3.228119155584774
MDST8,navitoclax-piperlongumine (1-1 mol-mol),-0.5700737020348542,1.6474626081241945
MOLP-8,2949965,2.304667717892232,2.3612928646482985
IGROV-1,alisertib-navitoclax (2-1 mol-mol),1.5599487267475047,0.33028678153687424
NCI-H2452,11485656,2.991875358712002,2.653763053934106
Panc 02.03,2708,5.654354843286421,5.052115875399791
SaOS-2,15953870,3.7774839542606617,3.664252611169323
LS411N,11238147,4.220683195687341,2.4618609486243828
WM115,selumetinib-vorinostat (8-1 mol-mol),-1.5219389321344234,1.9414159041217078
COR-L105,11404337,0.9270352493146456,0.13887009973431835
RKO,20959075,-2.9107192765247536,-2.6769654910521394
IGROV-1,452548,0.0422661560146271,0.49749531340117825
SW1271,25062766,1.8071163488926476,1.9581885266897836
SK-OV-3,24180719,3.148638094054939,3.8665677946825037
IA-LM,doxorubicin-navitoclax (2-1 mol-mol),-0.2967430289420483,-0.8531367897604042
MDST8,sirolimus-bortezomib (250-1 mol-mol),1.3453299631576727,0.8581752345713619
Daudi,selumetinib-PLX-4032 (8-1 mol-mol),4.542051250808824,3.3438620435237927
NCI-H2452,25150857,3.315566378385427,2.6414673510392
P31/FUJ,carboplatin-UNC0638 (2-1 mol-mol),3.2617545834686155,2.884589822976382
LS411N,216239,2.6090534487015953,2.1657634356689153
SW948,2828334,6.27053385486612,5.870112875527671
HEL,25262965,-1.9607005706581808,-2.4419548137348985
SK-HEP-1,46398810,3.2056962377986333,2.6818151485567374
P31/FUJ,46191454,0.7861082656977861,-0.254545515291533
SaOS-2,11404337,-0.7935370479535776,-0.2830305305499712
LS411N,6918878,3.507421995092854,1.0257501266619007
COR-L95,5566,3.0030322186541754,2.8787024705920228
NCI-H1568,2729026,2.4592472427928795,2.848919138770768
Granta-519,5566,3.1418180472473023,2.9266981878902856
SW948,15953870,3.980690301912255,3.4338209723950235
IA-LM,selumetinib-navitoclax (8-1 mol-mol),1.3709865001695822,1.7757269013026198
SaOS-2,tanespimycin-gemcitabine (1-1 mol-mol),-1.7775872222613356,-0.6611320107152069
COR-L105,decitabine-navitoclax (2-1 mol-mol),1.4499610580472069,2.220109621687927
PaTu 8988t,4096211,4.042256121680771,2.348182657828333
HCC15,638278,3.5096393014384346,3.132424786555891
LS411N,44185566,2.59688005994845,1.8326503937139362
WM115,15547703,2.53174585982074,3.15135888780215
RERF-LC-MS,46907787,3.883745984979501,2.280043086074346
RERF-LC-MS,49793307,-1.4864117200972382,-2.481730387880159
LS411N,6918837,-3.511331359252859,-3.2472762068807572
HEL,2729026,2.9938268289747394,2.132908659465493
SU-DHL-1,9911830,2.4926956672938543,2.247359547851812
RKO,6505803,-0.9276151073099124,-0.7900399997733955
HEL,5351362,1.012542471793317,1.0155345312204949
SW48,448949,2.118847083295334,1.8953850801113663
LS411N,3854666,3.592971008902542,1.311480380681198
Daudi,55283,2.1333092426313143,2.6181029558964486
WM115,568763,0.4176363376103466,0.6789007198212476
ALL-SIL,JQ-1-navitoclax (2-1 mol-mol),-1.241318632460125,-1.0636775323919008
K-562,54143018,0.8143265967368298,-0.3210604298823039
WM115,6914657,-1.139050920215431,-3.504797339410842
BICR 31,JQ-1-navitoclax (2-1 mol-mol),1.1041257622460865,0.955175420646426
ML-1 [Human thyroid carcinoma],24821094,3.2142530929148982,3.1252335748626336
Daudi,57519531,1.0816397392331083,1.5952880533249691
MDST8,9840324,7.1320098113776185,5.895415692218948
ML-1 [Human thyroid carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.127776457092234,2.5831038394909016
NCI-H2452,67156097,-0.4931697978204585,-0.7187590600758067
ALL-SIL,11507802,-0.6218585688390301,0.33860667915051323
MOLM-13,9926054,0.378361077880871,1.5317735058583066
LCLC-97TM1,676352,2.332754642745106,1.9467052729288405
SW48,6450551,-0.0066484474606689,2.6266046372560456
LS411N,tanespimycin-bortezomib (250-1 mol-mol),-0.7094268710043169,-0.980739287275567
MDST8,vorinostat-carboplatin (1-1 mol-mol),3.0562610561977004,3.2594600003537657
ML-1 [Human thyroid carcinoma],53232,3.218931075380609,3.0622466044236747
KU-19-19,46191454,1.4474607873871597,1.6776292473814922
BICR 31,135440466,1.3506373291640237,2.102890927126449
SW948,44632017,0.8619787858061628,1.3912849388394684
NCI-H2452,159324,4.677055932941875,3.503612975146014
WM115,60700,0.0008203329731028,-0.5089785512968809
HuP-T3,selumetinib-navitoclax (8-1 mol-mol),3.027921751084016,2.131631536987563
RKN,9936388,2.306220468641662,-1.0881871289720881
MOLM-13,2945648,3.0282797197343374,2.1265354791274205
P31/FUJ,135875424,3.622681212031297,2.8703112427558146
LS180,navitoclax-gemcitabine (1-1 mol-mol),-2.7206195218400007,-0.7705004623687094
BFTC-909,24964624,2.4776408698208003,2.4530657016905018
HCC1500,3825829,4.205963950909598,4.16839009896009
P31/FUJ,selumetinib-MK-2206 (8-1 mol-mol),-0.6510792771612892,1.1948639257318239
SU-DHL-1,135984461,1.9491307161872016,3.2531111931780816
NCI-H1568,409805,3.8387714265583592,4.94818605960125
COR-L95,2945648,2.3261820103406183,2.3334122968649336
LS180,selumetinib-tretinoin (2-1 mol-mol),1.4682365811163622,2.338623190314207
IGROV-1,5746,1.9055212643377857,0.9876999046106951
BICR 22,selumetinib-decitabine (4-1 mol-mol),2.485402962452582,2.913079013398618
HCC1500,104842,-2.1208898309536073,-2.1349126285805804
IGROV-1,148198,-2.659972993252853,-3.5352534439174246
ML-1 [Human thyroid carcinoma],4259181,0.3770562232502641,0.4831145305101552
K-562,crizotinib-PLX-4032 (2-1 mol-mol),0.2702262717922032,1.1550664060540894
IA-LM,5746,4.310443233142937,1.2481716481233744
WM115,10427712,3.357641117907952,4.485821076790128
WM115,31703,-1.493876478932265,-0.9479987251059961
K-562,10296883,3.719487542859837,3.4731820357810053
UACC-812,JQ-1-navitoclax (2-1 mol-mol),2.277260275544626,1.0900422322548327
SW1271,selumetinib-BRD-A02303741 (4-1 mol-mol),1.6288124556214316,3.7969998304155355
IGROV-1,10184653,0.79276129336756,1.359206657765272
K-562,5287969,-0.8630520858269013,-2.0316444790226353
MOLP-8,148198,-4.437033387624053,-3.9136133821805346
BICR 22,navitoclax-gemcitabine (1-1 mol-mol),-3.257857035264034,-1.1237431996966236
BICR 31,24951314,2.26082148142024,1.4879854183350176
COR-L95,9887053,2.0711365362831193,3.073464907780048
SK-CO-1,2841722,4.495379043063509,4.351582619364579
COR-L95,54618164,3.8157010413732406,3.805682705296314
ML-1 [Human thyroid carcinoma],107970,2.5074769228196025,2.410038800226039
SaOS-2,25262965,1.6840235781335875,-1.3869079842874419
MDST8,25150857,2.921484336528134,2.5609721173078013
SK-HEP-1,984333,0.8474815446030621,0.7451785865804957
COR-L105,5311037,4.270584574919318,3.984112597423646
P31/FUJ,selumetinib-navitoclax (8-1 mol-mol),-1.1281624183387444,0.23756918609960478
LCLC-97TM1,3825829,3.858617243526108,3.680236215751266
SK-OV-3,24951314,1.413681041410239,1.5886528927277528
NCI-H2452,9903786,2.1501841215173396,2.826317222093051
PaTu 8902,56963564,4.5637436248697565,0.5125579887486534
SaOS-2,262093,2.7398792490382244,2.880814180303621
HARA [Human squamous cell lung carcinoma],4788,5.847017929418924,5.619575626014693
BICR 31,3854666,2.26793763186435,2.217696088167603
SK-OV-3,15953870,4.452396287203901,3.6869492380192845
HuP-T3,serdemetan-SCH-529074 (1-1 mol-mol),2.447475280373413,2.2316935734409533
BICR 31,24785538,2.8976650742045127,1.6835386995575081
HuP-T3,9903786,4.0743016574038915,2.9715378826217504
Granta-519,11175137,2.0306520437568767,1.570618657596463
Granta-519,25105715,3.663648488967505,3.1820124913222823
NCI-H1568,49867930,4.553956635433513,4.602901304213336
HCC1500,16038120,1.5738549040879308,1.0897701793339334
LCLC-97TM1,227681,3.759896348853487,3.0612104873867008
BFTC-909,49867926,6.076136735210805,4.406805776424972
ALL-SIL,5278396,3.0589186731365814,3.068036468074997
HCC15,2742550,3.2685764522673972,3.9717519873298146
RERF-LC-MS,44486219,4.018485879154908,4.4033108087574195
RERF-LC-MS,462382,0.9319597157341816,0.932975995097844
SK-CO-1,selumetinib-UNC0638 (4-1 mol-mol),-0.0758878647184332,2.4987465872609427
SW1573,3854666,2.927116287337192,2.3972260532928384
Daudi,9935249,-0.0031627785077317,0.9185158109475722
MOLM-13,10231331,1.9024628033326092,0.3332282240181836
SaOS-2,6918837,-2.9214939411920593,-2.3064123269115893
HCC1500,11507802,0.960722132601806,1.9276723111212686
WM115,doxorubicin-navitoclax (2-1 mol-mol),-1.5072575260972283,-1.2567372201263993
BFTC-909,navitoclax-birinapant (1-1 mol-mol),3.573845080821179,1.5474604247431714
LS180,9911830,2.83226076921101,2.4310091900385413
RERF-LC-MS,11222830,1.7620759794741472,1.630864104908519
MOLP-8,6252,-2.041702184925406,-1.5269596596599875
SW1271,5978,4.916909360273371,-1.851070380530823
MOLM-13,5479543,2.5400848053862264,2.411216250783973
NCI-H2452,11612883,2.7546488169018963,3.1319241248611123
NCI-H1568,44493528,4.1542795967274175,4.272348111021552
RKN,46398810,3.1612721401313792,2.6637478424545105
ML-1 [Human thyroid carcinoma],676352,2.608959843452948,2.246467741506116
MOLM-13,ISOX-bortezomib (250-1 mol-mol),-0.222539624438373,0.06030192510214505
ML-1 [Human thyroid carcinoma],31703,-3.706133682115605,-0.27521502390226593
SW1573,31703,0.7694714266266048,-0.9780613547313095
BFTC-909,11238147,5.503103761619835,2.867682362128256
SK-HEP-1,637858,2.866868896175592,2.0287638769089056
HARA [Human squamous cell lung carcinoma],12001922,1.8002757111950325,1.958099227158652
KU-19-19,2828334,6.071698785304069,6.182648610410083
SW48,JQ-1-carboplatin (1-1 mol-mol),0.1401684728057108,2.5542773973540434
RERF-LC-MS,2828334,5.9123201087220325,6.150683410067029
SK-HEP-1,vorinostat-carboplatin (1-1 mol-mol),4.117273876837617,3.3829784018008313
PaTu 8902,54649381,5.340946431274584,3.936214696588503
RCC10RGB,11214940,1.429625683961422,1.977957435663336
NCI-H1568,25195348,2.211268152441431,3.7171099696780345
COR-L95,10184653,1.5221413196357014,0.9572727837073636
BFTC-909,3634881,3.6308731463535704,3.34633815269015
IGROV-1,navitoclax-pluripotin (1-1 mol-mol),-0.9669423716100508,-0.8005878421200114
SaOS-2,24785538,-0.4134197784310965,1.6712948047297673
RERF-LC-MS,4705,3.292681011259135,3.323550239990388
MOLP-8,10127622,1.9499981558353492,3.621972537172407
Daudi,11626560,0.3779689739853294,0.6833289520510565
MDST8,168312962,1.677679532849221,1.790638934952139
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057,2.7176867135552785
MOLM-13,10113978,0.7724135376915046,1.809834428500214
PaTu 8902,selumetinib-MK-2206 (8-1 mol-mol),3.282015538774474,2.2472658878640797
HCC1500,216239,1.4805608336728902,2.4515176354935333
RKN,5281321,-0.4803497212669658,-1.3155119774857116
PaTu 8902,11175137,3.538788964844938,2.6944649581810944
Daudi,10113978,1.6179427120332186,2.225456847436563
K-562,26596,-3.6076758496321832,-2.723565312106566
UACC-812,tanespimycin-bortezomib (250-1 mol-mol),-2.245399368845158,-0.3126151108563909
Daudi,5291,1.8632614405000685,3.1597199439757175
NCI-H1568,2874250,4.364133169191667,4.546611095473448
LS411N,984333,1.2324204412799928,0.7440407519384296
PaTu 8902,11222830,2.39915227633331,1.631940293215012
MOLP-8,54678924,1.6307832002497362,1.4627704638926904
COR-L95,49793307,-5.549400502924621,-3.3955230895760065
HCC1500,45279963,3.5713917460093434,3.6360167699277497
WM115,54765302,3.574934655958074,4.366523824338446
SaOS-2,136227924,4.496792726095474,2.9244272704975316
NCI-H2452,107970,2.3345640718356364,2.3979951887906372
LS411N,16720766,1.2713952174238143,0.35840619484211766
MOLM-13,navitoclax-PLX-4032 (1-1 mol-mol),-1.1656285238385289,0.02902511443029873
MOLM-13,216239,-5.069803023561943,1.2682105201922291
RERF-LC-MS,44241473,4.536869636330491,4.816951722657861
LCLC-97TM1,10074640,3.2021543880531156,2.957333878347289
Panc 02.03,10296883,4.297264305827386,4.061272555748089
IA-LM,3689413,-4.432004355370191,-0.9392328218739229
RKO,375860,-0.2095842697906711,-0.3965128099612205
HuP-T3,676352,1.9029965224961456,2.19147605848478
SW1271,5470400,4.349220092525355,-0.042885971545663384
NCI-H2452,656346,1.056906556032961,1.1325273549339727
BICR 31,56649450,1.7574149169243078,3.3067378724110377
RERF-LC-MS,24785538,0.8057743011820994,1.931945149670953
SaOS-2,9825149,0.8893885919981879,2.185045617015166
HARA [Human squamous cell lung carcinoma],51039095,3.2872110498619573,2.9573776216811223
PaTu 8988t,carboplatin-etoposide (40-17 mol-mol),3.874190963823487,2.753853164230727
SK-CO-1,638278,3.4780853527987854,3.439708840632764
WM115,4096211,3.685037910266886,2.2099939793745786
RKO,126941,-5.081226966265268,-2.917040979030603
RERF-LC-MS,54618771,0.9955970244631366,1.267113259471199
Daudi,50905018,3.9297282000687312,3.6931405125506522
WM115,11609586,3.058244435077658,3.013433119414916
BICR 31,9926054,1.721382648019371,2.0861810432819397
RKO,24821094,3.7157598247146977,2.394774619918692
IGROV-1,135440466,0.9791523710816318,2.416983707047748
NCI-H1568,44202524,1.0522971592210668,2.3567252128988985
HuP-T3,9933475,3.0776536859408807,1.9970409264595568
COR-L105,carboplatin-UNC0638 (2-1 mol-mol),4.035332544942737,3.485265290337653
BICR 22,11612883,2.729453217725868,2.8310829498787418
MDST8,25154868,3.4078840547236333,4.640356307603526
WM115,12001922,1.1273981641266086,1.8758582947646931
SW48,2742550,3.28553671385033,3.9715151474374926
WM115,445091,3.8598878691820886,4.3857574232883225
RKN,135875424,3.6230459419726526,3.8586770763006393
BFTC-909,2708,5.254338200716292,4.82233543020907
SaOS-2,2871966,1.7918423486815835,0.2712624080620431
SW1271,serdemetan-SCH-529074 (1-1 mol-mol),2.3446355759055684,2.0737392078883063
HCC15,44632017,0.3758817607479284,1.4365730175727456
COR-L95,2729026,2.664378744829576,2.441610431269706
SaOS-2,1566236,1.7620742085681662,2.229321619229122
BICR 22,11955716,-1.4294009955010087,-0.8684383434385636
BICR 31,2729026,2.966794528433677,2.702056557669975
COR-L95,119182,-1.6347192148686482,-1.0594568527760275
LS180,5328940,1.742567210928755,1.4254845157258023
Panc 02.03,46398810,3.420081587494409,2.6510761433778613
RCC10RGB,60700,3.171193268028763,0.3791532970227914
SU-DHL-6,451668,-1.4332734905345434,-0.10197942851714656
Granta-519,16219061,2.116318709414125,1.9957460301311303
ML-1 [Human thyroid carcinoma],42642645,0.1882919364816784,1.0422378230154257
HEL,53232,2.5038982548529747,2.6071944406331244
RKO,44507138,3.480554434186059,2.2497004938986023
NCI-H2452,3081361,2.98247650375621,2.5564978564582064
RERF-LC-MS,44202524,1.2785968032229695,1.836479929380163
RERF-LC-MS,16722836,2.4162442447682193,1.7093907669075896
HCC15,637858,3.032734575357801,2.2403665119005653
IGROV-1,11396600,3.99372654279783,3.7225258561310515
BICR 22,44202524,1.658152527320416,2.5360472951392747
MOLP-8,54618771,0.2679151571300236,0.45159853407048095
NCI-H2452,navitoclax-gemcitabine (1-1 mol-mol),1.5021089136928458,-1.4877788774676253
LCLC-97TM1,54678924,1.535359034662644,1.7712334571079595
BFTC-909,49793307,-2.946331542038894,-2.5264872655432904
KU-19-19,5738263,3.812580710038467,3.618301064635127
PaTu 8988t,24821094,3.93253598055128,3.2069938362869563
LS180,148198,-2.644013472885731,-3.430127195790301
HEL,409805,5.92709656224454,3.8116728591268703
RKO,11612883,3.106052261550285,2.020145394257727
SW1271,122327,4.37632222345113,4.646425793555098
MOLM-13,44241473,6.124350775268443,3.6752044005611126
HuP-T3,2126,5.715410620657667,4.8223687800358865
K-562,5291,-1.1872539047134878,2.0050826035726352
RKN,5282054,3.624299707956654,3.742633243464447
BICR 22,613000,2.6534426018316277,2.6679134819075294
HCC15,49850262,3.6300454046422774,3.8618086135609078
SW948,613000,2.5939391420023212,2.55477727160749
COR-L95,135440466,3.0574476104836914,2.056187095788874
SK-HEP-1,262093,3.158620019748703,2.991613664202792
UACC-812,sirolimus-bortezomib (250-1 mol-mol),-0.7676605385666967,0.7867964146852223
MOLM-13,123631,1.0914116119684203,1.7923074352914097
BICR 31,4378219,2.049792351388142,2.653669428989629
LS411N,16722836,1.825979837410603,1.3290169205115463
SU-DHL-1,10074640,2.3568880289385654,2.6065240869444466
ALL-SIL,6918328,-1.7903684912223865,-1.6159405033427503
SU-DHL-6,3384730,1.0298608560692932,1.5556688786748452
SU-DHL-6,11485656,1.7981230616770194,1.7192970358572597
ML-1 [Human thyroid carcinoma],24785538,0.9232201957937346,1.8775665547109417
NCI-H1568,176870,1.641159934282528,3.6377259975960334
HEL,5280436,3.9989145330348896,2.6113554110541344
BFTC-909,5328940,1.2290524134113243,1.8383436392907466
SK-CO-1,151289,0.7492352886663923,1.080619774874164
RERF-LC-MS,104842,-3.024577047260716,-2.6752404866655355
PaTu 8988t,46843906,4.444995617536364,3.3353004925460787
BICR 22,24856436,-0.0251718817877118,0.7428936548283928
HARA [Human squamous cell lung carcinoma],208908,3.016531266929929,1.8687363402521038
IA-LM,67156097,4.3159050642226,-1.6700032981576696
HuP-T3,6438330,2.3942211080747837,2.3743368497271113
HCC1500,10296883,3.843895309810077,3.95602171683888
HARA [Human squamous cell lung carcinoma],3062316,1.9438846554207736,1.2171121340971895
SK-CO-1,56946209,-3.7989193199280016,-3.962285466818359
Granta-519,148198,-4.763660659469611,-4.318974435426989
HEL,4917,2.9031193377759603,2.747928857764778
RCC10RGB,66577038,3.312011612499516,2.97691427035121
Panc 02.03,3689413,0.2165954212360822,0.16339530043796696
ML-1 [Human thyroid carcinoma],89928392,0.0943028098974214,1.5255602682601472
SW48,241158,3.5185545260205364,3.933658396794318
COR-L105,selumetinib-GDC-0941 (4-1 mol-mol),0.702191872416662,1.6840793207777949
HCC1500,navitoclax-birinapant (1-1 mol-mol),-3.387149505683513,1.4815872836875357
K-562,11167602,1.4540526159902811,1.7868917801308326
HEL,9911830,3.2406370139452134,1.3953929230437856
SW948,25150857,2.687963392787196,1.9180973112524429
WM115,44137675,0.4260207876885596,3.651942452442553
SaOS-2,4917,3.064827494863108,2.969111011985553
SaOS-2,3503,1.987605483793098,2.2034038134038227
LCLC-97TM1,9840324,5.858053248657865,5.610217339309511
RKN,11178236,-3.061903912386503,-3.3865787224159987
COR-L95,46843906,2.16387123849571,2.283163028072262
K-562,46191454,1.7723208241237427,0.6504281732414134
LCLC-97TM1,5746,2.627938158922912,0.9021956170167065
RERF-LC-MS,613753,3.34976336152667,3.287117938160004
HCC1500,9823820,4.617789125102065,3.9704092112801557
PaTu 8902,49793307,-1.5016152541437175,-2.7607943287794736
LS411N,24964624,2.837560916730962,1.512401906341627
Granta-519,42642645,-0.7384711962533689,-0.039044939314780404
Daudi,156414,0.7854974484116999,0.5802178672938126
HCC1500,9840324,5.570797833564005,5.863951961942408
HuP-T3,6914657,-2.995276103152913,-3.782076370515203
SW48,11178236,-2.976969958039468,-3.1153956592010474
Granta-519,11214940,1.149911870185247,1.0169290709004806
Granta-519,72734382,4.317814968690637,3.4025830041996774
SK-HEP-1,selumetinib-JQ-1 (4-1 mol-mol),3.7826975046986697,1.8736327356546416
SK-HEP-1,15983966,0.8278271069258164,-0.8355694311156483
BICR 22,6610355,3.5129220888937622,4.446409571638971
HCC1500,44489675,3.6836892776405854,4.088868200072827
IA-LM,3634881,3.385658224323674,2.855428494908135
SaOS-2,JQ-1-vorinostat (2-1 mol-mol),0.950161902916163,0.9654864592922872
COR-L95,4788,5.892645370038274,5.420947461180943
NCI-H1568,11717001,4.19629869858104,3.9584493786837633
RKO,46224516,2.430810450928805,2.425829025544555
LS411N,6505803,-0.6536233604701492,-0.9872742634760943
HARA [Human squamous cell lung carcinoma],135423438,3.0787654328489986,2.535383709241498
HCC1500,16725315,3.090868252599208,4.14268090889528
Panc 02.03,5287620,-2.132468814908427,-2.0064030759378286
ML-1 [Human thyroid carcinoma],5470400,0.2567315670041485,0.19916027423990165
LS411N,5351362,1.130738510814583,1.3422528696367204
IA-LM,168312962,3.008218706470952,1.4281165119739712
SW48,9887053,1.6385742110161594,3.8914570089294966
HCC15,2945648,3.8992008266513305,3.0605170046356047
WM115,10385095,0.3137764342063494,1.3139235857555773
SW48,11213558,0.38171338020492,1.8417601663406913
IGROV-1,9911830,1.9130562323799436,2.474737883098353
HARA [Human squamous cell lung carcinoma],6918736,-1.65788247009277,-2.0610678001371325
LCLC-97TM1,5284616,3.038958191933125,2.4576584024107047
SW948,5311,0.5245292911924586,0.894716508947341
PaTu 8902,2949965,3.498586647815041,2.9698354442331354
PaTu 8988t,53232,5.050646647161413,2.7844034728829516
ML-1 [Human thyroid carcinoma],navitoclax-pluripotin (1-1 mol-mol),-1.2739160400163367,-0.623832953874791
P31/FUJ,2729026,1.895106624580685,2.327230443622065
SW48,568763,-0.0201118962331156,0.46800573772389065
SW48,selumetinib-GDC-0941 (4-1 mol-mol),-3.255152499343646,1.3859160534972492
SK-CO-1,docetaxel-tanespimycin (2-1 mol-mol),-5.721099284006835,-2.6663813778826824
SK-CO-1,54454,2.352526453014332,2.879049782603231
MOLP-8,tretinoin-navitoclax (4-1 mol-mol),4.347252260304068,1.2545814699817657
SW948,151289,0.9927868711009586,0.90364738244913
RCC10RGB,676352,2.417271143726191,2.3277158807255454
LCLC-97TM1,15953870,3.316413299321368,3.490354808982704
HCC1500,252682,6.335850466863892,6.47937963414142
LS411N,doxorubicin-navitoclax (2-1 mol-mol),-0.6349980356208603,-1.0501692859655616
SW1271,702558,5.67814751001827,5.26868494199556
HEL,3503,1.2339935625044716,1.7520847207903074
SW948,6918328,0.2458443826474451,-0.03314191878544172
ALL-SIL,124202324,0.3755400921280209,1.204124337760372
SW1573,2729026,2.4001203305493397,2.845826778581351
SW948,57330099,4.403961221202979,3.889179392013682
UACC-812,42642645,2.375397400257474,0.9902076420587275
LS411N,tanespimycin-gemcitabine (1-1 mol-mol),-0.1859317712708109,-1.2295796700144277
PaTu 8902,984333,1.3011106079808883,0.7584060692651979
P31/FUJ,135398516,1.7387657861081838,1.2373749171978303
WM115,46224516,3.0669076127990276,2.5190991291323375
SW1271,24771867,3.777194428597206,2.168115680062058
HEL,73707438,4.0836720937600175,4.314625275488582
MOLM-13,16038120,-1.7825288578452578,-0.036755276622523356
IGROV-1,10427712,3.944243047938238,4.344426455563689
LS180,3815108,3.93048377981505,3.0348219872174456
HCC15,1750826,-0.4775912601104041,-1.0934467577204152
IGROV-1,selumetinib-tretinoin (2-1 mol-mol),4.176281087704045,3.5060811077276726
P31/FUJ,42642645,-1.1469220315427042,-0.06943820272917059
HEL,1750826,-3.7677259179114047,-2.6617075506826122
NCI-H1568,25183872,-0.3156837582718859,-0.43223943552524036
SW48,54143018,-1.2192841502688678,0.5258596161749103
SaOS-2,441298,1.6833347099113902,2.4536167077510758
SU-DHL-1,119607,3.7964753700545546,5.093083733526624
LS180,654092,0.275565618798522,0.06401835269431115
RKO,6918736,-1.762610939534952,-2.180214402331676
ML-1 [Human thyroid carcinoma],6918837,-4.218663166819277,-2.1212581198844678
SK-OV-3,168312962,4.003119281373622,2.0367393185985274
PaTu 8988t,3062316,1.6786738127042626,1.135594043822279
P31/FUJ,5746,-1.0128835373821496,-0.09382167288307683
ALL-SIL,46943432,1.7359798293614472,0.9879035648382885
IGROV-1,119607,5.004384040905396,5.231508030316479
LS180,135440466,2.758543039731734,2.164456384390051
HEL,15983966,-4.130179752932702,-3.671824124826713
SW948,11228183,2.319596035574442,1.0152296853645304
SK-CO-1,navitoclax-birinapant (1-1 mol-mol),0.739134837908099,1.8010534613820661
NCI-H2452,219104,4.089454197150707,4.049588994509897
LCLC-97TM1,24856436,-0.9719468010392746,0.2732081080949029
WM115,1716436,2.084402062067542,2.898338590153097
WM115,54596558,3.929397107249587,4.514868066728355
HCC15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1827234466059498,1.6034110063214235
SW48,2828334,6.103861625006206,6.173556554095008
Granta-519,5335621,4.386788840750005,3.9848965180321483
NCI-H2452,25105715,3.487348959516136,3.517236181095116
LS411N,11152667,-0.1489697958567156,-1.0471644485597198
HCC1500,4259181,0.9827468065480526,0.4475843468539572
SW1271,1716436,3.164329770032204,3.072707538528324
PaTu 8902,tanespimycin-bortezomib (250-1 mol-mol),1.9395223164568671,-0.6919805804683117
KU-19-19,637858,2.3404288739792314,2.0255308803039354
SK-OV-3,3081361,2.5908903164469317,2.4312954499191104
BICR 22,10322450,4.612637955736889,3.6064357779116865
ALL-SIL,44819697,-2.9345943950607136,-1.8728205667877078
LS180,4259181,0.5796574720850999,0.4256539425731773
IGROV-1,6918328,-0.5330006254346346,0.14340166545995817
RERF-LC-MS,11178236,-5.98494163410248,-3.001664254515841
SK-HEP-1,SNX-2112-bortezomib (250-1 mol-mol),0.9629137048911888,-0.8933575286555812
IGROV-1,11485656,1.900409616013456,2.405844444552459
HARA [Human squamous cell lung carcinoma],5281321,-1.682952924947167,-0.6633250237684746
BICR 31,16065773,3.973194001978765,2.499431245347875
IGROV-1,6252,1.1284141516966473,0.9238180936102215
SaOS-2,135398516,5.990406168261382,2.1383309933902983
RCC10RGB,11485656,3.364959979667133,2.86513249257945
NCI-H1568,46926350,-5.085925204635643,-3.8579207059820133
LCLC-97TM1,123631,2.4246211789463445,2.0427957382270203
BFTC-909,44185566,2.75887016136311,2.760998937214419
BFTC-909,124202324,2.9321657702899295,2.774777790908426
LS411N,4917,3.429074291339912,2.837971306167954
BICR 22,135440466,2.8663984884678513,2.1772369792124295
HCC1500,10127622,5.201205269222406,3.8297757861910697
WM115,24748573,1.2650334763374356,2.2245419350212488
LS180,17755052,1.7669119525953814,1.2598312583481621
HEL,5278396,2.941082820113368,2.9988388433364594
K-562,6917907,-5.621792844351372,-5.598290532532662
WM115,11175137,1.8074191527620995,2.5126703819421166
ALL-SIL,6610216,3.679901693613009,3.6516810579788253
IGROV-1,3815108,1.915722485757852,3.075155589269578
IGROV-1,44491742,4.406671418311328,4.261557369742157
NCI-H2452,11647372,3.7610160121318055,1.408694305639289
Granta-519,25262965,-5.6090339200635375,-2.7287675815436967
HuP-T3,5287969,-2.0305885584054693,-1.6990549864699778
Panc 02.03,4578,4.394890119629889,4.6633309093193205
PaTu 8902,46199207,3.581196343990194,3.226496005352773
MOLP-8,5329102,1.1360795478534944,1.3626504792758172
SW1573,24797083,0.9725439959134782,1.4347729003781524
COR-L105,11507802,4.378208095645504,1.9896634476269741
SK-HEP-1,10385095,2.0924930980552148,1.2774918862665445
ML-1 [Human thyroid carcinoma],44185566,2.5450411112530475,2.79493702722909
MOLM-13,54618164,3.841266236609366,3.4238502151527177
SW1573,5287620,-0.7347028317725576,-1.9738047607472096
Panc 02.03,24821094,4.183998590604807,3.284209385597443
NCI-H2452,11977753,-3.0535753971711617,-1.7655530974136324
MDST8,selumetinib-tretinoin (2-1 mol-mol),2.2380074013059086,2.828513612864815
K-562,5278396,3.2143611477277325,3.2316905278629395
MDST8,46907787,1.4338285439483007,2.413562905917735
MOLM-13,16219061,2.363003680724254,2.47331902858247
IGROV-1,3854666,2.3355254440561137,2.2929496706457795
LS180,11175137,3.0855574956004506,2.6571150967561556
PaTu 8902,24180125,3.5735575491444505,2.9971829192005246
Granta-519,135440466,3.2501433765769097,1.8416539663931166
Granta-519,3634881,2.8250958488191533,2.579241270962912
BFTC-909,24785538,3.0409365635840433,1.7031713516110139
Daudi,9903786,1.3988461789185107,2.070388941936071
IGROV-1,126941,-2.246216453812328,-2.537892910089535
HuP-T3,327653,2.4979616286385573,3.3129123235884737
KU-19-19,24785538,4.6207321752497545,1.8093535615627458
PaTu 8902,11238147,5.651020754323713,2.9331259902882723
P31/FUJ,24772860,-2.926152167827307,-2.998446484288252
SW48,969516,2.6010409472277303,2.76273185666845
NCI-H2452,11656518,-0.3763326461825258,2.071159363690181
LS180,156422,4.137124258725139,3.988326060949394
K-562,16038120,0.8140588279430221,0.18412094610585403
HEL,9956119,2.2634866876643924,2.817136995447661
MOLP-8,16013152,3.9032026583920656,3.223902841179456
SaOS-2,7251185,2.1177882155213488,2.2316726361762225
SW1271,16722836,1.1489272284540188,1.6445350259357188
SW1573,1750826,-4.895155026964416,-1.559415361589434
COR-L105,6918878,5.053406021852451,3.156252351240617
HuP-T3,44566777,1.596285673654969,0.519398738150963
RCC10RGB,11167602,3.5267453541831695,2.680117301743739
KU-19-19,3689413,0.155027117273248,0.14228971312969765
LS180,262093,3.1953995116592826,3.0583289568475585
HEL,168313016,4.358661125075543,3.984175562676001
LS411N,448949,2.5849168666236273,1.7133382456954351
RERF-LC-MS,11507802,1.168612691302407,1.6575755474363867
RKN,3025986,-0.1432368238740909,-0.562053127579121
LS411N,5566,3.1552423609786153,2.8238401362693732
MOLM-13,168312962,1.173226591058953,0.3407240441152596
KU-19-19,16741245,1.8623441782077492,4.1349097967293
BICR 31,5746,2.9612823230829592,1.4289686751132171
RERF-LC-MS,448949,1.7883798522328354,2.0082267408039285
Panc 02.03,piperlongumine-MST-312 (1-1 mol-mol),2.606918356339114,2.0132792176924816
K-562,135411,0.731253239019591,0.22616245128408505
WM115,3825829,3.803690072721518,4.170368810533612
PaTu 8988t,1566236,2.792784501487116,2.4054234379187465
SK-HEP-1,25102847,3.375423501622406,2.6136050954923458
RCC10RGB,4378219,3.5112219508307017,2.931019909087841
IGROV-1,46907787,2.182756719431072,2.1834689700260004
ML-1 [Human thyroid carcinoma],176870,3.163449715300446,3.639891965402397
COR-L105,9903786,2.948812050867326,2.9897530090122717
SK-HEP-1,5287969,-1.6185163943497696,-1.8441420409711111
LS411N,66577038,3.114674219164565,2.8682204435427248
LS180,11152667,-1.0678137233062412,-0.40557360493233346
SW1573,10322450,3.835483834832597,4.095117601782943
ALL-SIL,4369359,5.632204520937589,2.154610221626153
P31/FUJ,6918289,5.395091759648689,-0.5385516330507183
NCI-H1568,carboplatin-etoposide (40-17 mol-mol),1.7182211320205656,2.7431826977437335
BICR 22,54626689,4.975060177279609,4.625418335666737
RKO,11455910,0.1271196393609195,0.4785208250170405
NCI-H1568,2749,1.8950065449811435,2.2486371615424265
SK-HEP-1,2858523,3.173409588420467,3.0739133473855613
HARA [Human squamous cell lung carcinoma],46907787,3.600628557962214,2.422072490437123
NCI-H1568,16736978,1.0202421307584555,2.1137196112405348
NCI-H1568,11640390,2.883529605834316,3.649365162527991
SaOS-2,375860,-0.2844076074043694,0.0663947476098962
Granta-519,9549297,1.4990763156673828,1.692133846349234
ML-1 [Human thyroid carcinoma],24772860,0.5673209260643837,-1.4803062487248342
MDST8,9915743,3.1722151191536607,0.8413059226863194
HCC1500,7251185,1.592161448601532,2.5215637701602183
PaTu 8902,654092,0.4014878659730266,-0.268634022540683
HCC15,36462,0.276886424919507,2.0220115264268905
HEL,11222830,1.7664464656365049,1.039303615199202
LCLC-97TM1,6918328,0.5489211755624944,0.15818371856081895
SW1271,11427553,2.280233400826346,2.716275970908395
MOLM-13,tanespimycin-bortezomib (250-1 mol-mol),-1.8317105130308673,-0.5354996501942808
SW1271,216239,2.3992651597700805,2.2595226608938863
LS411N,52912189,2.124177170278397,0.7936914016422155
RKO,262093,2.7220373961576834,2.20663894838811
RKO,selumetinib-piperlongumine (8-1 mol-mol),2.2390647410806306,1.9115449973167693
SU-DHL-1,24180125,2.3898229933344193,2.783242888000629
P31/FUJ,10231331,0.360402840185862,0.8976817932791856
COR-L95,navitoclax-PLX-4032 (1-1 mol-mol),-1.058390181093963,0.7301941891216859
HCC1500,4705,3.1720127097688073,3.085763327729008
ML-1 [Human thyroid carcinoma],16722836,0.1571893320134409,1.9024882539440804
ALL-SIL,49793307,-3.5976005593324607,-4.408743765599342
LS180,decitabine-carboplatin (1-1 mol-mol),4.499129095785504,4.367234052168438
BICR 31,selumetinib-PLX-4032 (8-1 mol-mol),3.623780948669338,3.5965855816961585
HARA [Human squamous cell lung carcinoma],409805,4.942295126142001,5.129388212356325
ALL-SIL,44489675,3.868517697091687,3.6810010865698035
COR-L95,9825149,1.4009706639997015,2.0255866358838377
SK-CO-1,25102847,2.4259034566713087,2.34409784690926
COR-L95,36314,-2.5383774872687743,-1.2260554937029517
IGROV-1,1641662,3.5854177848263675,3.643618354670236
BICR 31,16720766,0.8786813091838682,0.6280272271722747
BICR 22,51037431,2.6213243445689254,3.002823653143979
BICR 22,2742550,3.9616050819266326,4.0407057383261265
Panc 02.03,46843906,3.852893526574364,3.402982472975995
NCI-H2452,2708,3.4614923437122704,5.050829092134634
RCC10RGB,15547703,6.556615668020641,3.406970995642307
RCC10RGB,5311,2.218274000934613,1.8381420722555317
ALL-SIL,erlotinib-PLX-4032 (2-1 mol-mol),2.6221278423473446,3.0684788513822125
LCLC-97TM1,24964624,2.5877637900313384,2.1990481391899794
KU-19-19,107985,-2.420790531142743,-3.2908431591488845
PaTu 8902,67156097,4.866613623772486,-0.20693924258560392
KU-19-19,676352,2.681008284282423,2.099098660075349
NCI-H1568,67291369,4.628091486396258,3.0609673154562733
BFTC-909,54143018,0.6300785047889099,0.7950119394967325
BICR 22,5329102,1.9183442886017033,2.0716967125102643
LS180,JQ-1-carboplatin (1-1 mol-mol),1.5137098822728978,2.1476088408827096
SU-DHL-1,1641662,2.0867851207635044,3.2150838376665316
SU-DHL-1,54143018,-1.2287450259829942,0.77453005351799
WM115,3552672,1.460151745141153,2.9670954498147655
Granta-519,6505803,0.3707466177802866,-0.8923952097792036
BFTC-909,2733526,3.41724914482818,3.911923587104886
COR-L105,445643,5.447871607768224,4.159161899027279
SW1573,BRD-A02303741-navitoclax (2-1 mol-mol),1.994158389176884,2.855105009016077
COR-L95,135421197,1.4504202802892363,1.6616441949956147
BICR 22,4096211,1.2113689067872688,2.510444731287717
Daudi,241158,1.9180708700138325,2.2994805086429273
RKN,docetaxel-tanespimycin (2-1 mol-mol),1.659975764237714,-3.2131937668026263
COR-L105,44543605,3.798835657012519,3.9635336378488466
NCI-H2452,1641662,5.47511848960003,3.7505669904311594
IGROV-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6574753619864233,-1.249883240287894
HARA [Human squamous cell lung carcinoma],9826308,0.352829852370258,0.5674045183551117
MOLM-13,44489367,5.70063080501961,4.376146171383371
MDST8,9936388,-2.5080849755955485,-0.4847645205883693
Panc 02.03,5311281,4.827416145020449,2.546349670539492
MOLM-13,carboplatin-etoposide (40-17 mol-mol),-1.2909434999313618,0.7849500343815464
Panc 02.03,71466380,5.929652601038649,4.533342834507283
BICR 22,148198,-3.168643556299537,-2.944300443860061
LS411N,salermide-PLX-4032 (12-1 mol-mol),5.97516001818146,4.6265007875390545
SK-HEP-1,serdemetan-SCH-529074 (1-1 mol-mol),2.785522004432589,2.2417506319262057
MOLP-8,36462,-1.3356090090333852,0.6376315057008063
RKO,168313200,3.1169425006108455,2.9342405654831327
SK-HEP-1,24951314,2.4991128927954063,1.5236877308657908
HARA [Human squamous cell lung carcinoma],654092,0.0602204093244996,0.12207117659254309
COR-L105,71304818,2.509036292239667,2.610947388764724
LS180,11485656,2.0322073649322716,2.0507067971549926
SW1271,44185566,2.531281599529394,2.6211034153999497
P31/FUJ,49836020,4.674155414221834,2.668562548327328
UACC-812,carboplatin-etoposide (40-17 mol-mol),1.4623710182991412,2.1602098881756797
SW48,selumetinib-piperlongumine (8-1 mol-mol),-1.6389231751651676,2.6594662908403253
RERF-LC-MS,9933475,2.253072026550434,1.8541543727607197
SK-CO-1,24964624,3.1718881088721735,2.3172296263097034
Daudi,serdemetan-SCH-529074 (1-1 mol-mol),0.5315798853273473,1.287325443766462
LCLC-97TM1,54619267,4.094508182091097,3.9087310501582846
SW1271,53232,2.609582991635379,2.7655581791336514
COR-L95,5282054,2.7623794331923293,3.276274610403192
LS180,navitoclax-MST-312 (1-1 mol-mol),2.264329466995316,1.1077580146607429
ALL-SIL,2749,0.4174204822378836,0.6681628397513113
MOLP-8,11455910,0.4759456923848041,0.3522888322549686
SK-OV-3,5329102,2.1848030817162427,2.093673106902658
IGROV-1,5978,-1.5618214380165825,-1.8390296877724637
BICR 22,135411,0.5903998872112299,1.0374147977660664
NCI-H1568,6610216,3.52063980115584,4.335658806968255
SK-CO-1,176870,3.965368978694832,2.9818163321317503
BICR 22,selumetinib-GDC-0941 (4-1 mol-mol),0.9236459983080146,1.2282714687967173
BFTC-909,doxorubicin-navitoclax (2-1 mol-mol),-1.537563048544383,-0.7295998527272447
IA-LM,9936388,2.150111055311291,-3.3933685797941564
ALL-SIL,selumetinib-BRD-A02303741 (4-1 mol-mol),5.278969536899067,3.7682372471325607
ML-1 [Human thyroid carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),-0.2880991888537167,3.5231556149598173
SW1573,navitoclax-MST-312 (1-1 mol-mol),-1.0459858342436132,1.1091439961596454
P31/FUJ,11214940,0.6332731592867608,1.3442963068115044
WM115,421610,3.513747492259629,3.2508572355532146
SaOS-2,227681,4.210698048028356,3.432333887185608
BICR 22,25102847,3.5270600092516444,2.623085121882152
BFTC-909,46199207,3.2760821272908753,3.3023423071140368
IA-LM,25154868,2.8804249714329537,4.354938062086041
SaOS-2,5738263,2.656867973667437,3.3330090461467266
BICR 22,5738263,3.828959854789421,3.368776563524136
IGROV-1,navitoclax-sorafenib (1-1 mol-mol),2.116164500809202,1.8613346241419115
SW48,SNX-2112-bortezomib (250-1 mol-mol),-3.704667477676808,-1.2933592392490019
Daudi,24771867,-1.2539165255857252,-1.1163524681455557
Daudi,446155,1.8075236258569949,2.533599219626299
LCLC-97TM1,56946209,-4.83981355951691,-4.011320750980605
BFTC-909,702558,5.601571619782522,5.438797859541177
LCLC-97TM1,24797083,1.6672233423539589,1.305537161378862
IA-LM,2945648,2.6647419367463794,2.054338271568648
LS180,11717001,4.39666521822979,3.8751469007724135
LS411N,42642645,1.4293896003043414,0.1682975132443176
SaOS-2,16038120,-0.4228492368909831,0.8305017101221078
HCC15,387447,-3.5284625014182556,-3.8977546987102203
K-562,24785538,3.0712560410264436,0.4095887011728099
PaTu 8902,6918289,3.1585202712855196,2.8267870572096196
BICR 31,11404337,-0.6318210319309021,0.1054902980506685
Daudi,navitoclax-PLX-4032 (1-1 mol-mol),2.817343533206949,0.7333740331154087
LCLC-97TM1,5460769,-2.8089441547625067,2.018847567675187
IA-LM,25150857,2.846024040084871,2.0329624890436975
HCC15,56973724,1.575466068691269,3.3262468044647857
ALL-SIL,3384730,0.9130815120154347,1.3911522819148803
Daudi,426756,2.2442144831253383,3.741972885560638
NCI-H2452,6918328,0.3371182351616307,0.43421491761113384
SW1271,11364421,-1.228057709924225,-2.1978087902159946
HCC1500,9911830,2.253316240952314,2.5691616015508596
COR-L95,60750,-4.239654973449372,-2.5226678857024565
COR-L105,675434,4.897128449999278,4.604886640669026
RKN,5978,-1.5379865785523688,-1.644614683036312
BICR 31,1641662,4.3069637553272715,3.653803972297395
SW48,5281321,-2.141746406212142,-0.8704403631737293
SaOS-2,navitoclax-gemcitabine (1-1 mol-mol),-3.208051277471344,-1.84286910674387
SW1271,vorinostat-navitoclax (4-1 mol-mol),2.219898250998274,1.1083560351418038
K-562,12003241,-5.632155645383806,-1.0870864570596113
IGROV-1,11455910,-0.2792640061206097,1.170949703546458
COR-L95,10410894,3.9632969340699735,3.071269750275045
SW48,5351362,1.0988845715277948,1.4229572044999488
HuP-T3,9907093,4.467626530245781,4.35692273995409
IGROV-1,16065773,3.3717508464278585,2.5637831442992995
Panc 02.03,439501,0.4668648826805023,-2.087790524676772
COR-L105,11427553,3.315123926488956,3.097114809317529
IGROV-1,119607,5.004384040905396,5.231508030316479
BICR 31,151289,1.9519908762907336,1.1318315355719974
SK-CO-1,60700,-2.5556595153787915,-0.27895529944035036
ML-1 [Human thyroid carcinoma],2828334,6.601742138030732,6.147861183007378
BICR 31,3825829,4.543850483279072,4.094404629859381
SK-CO-1,65064,5.377201033407044,5.094095897402664
HuP-T3,613753,3.2946831222357233,3.4372345007600273
SK-HEP-1,89928392,1.6602086186634375,1.544969284001465
NCI-H2452,5291,3.747673065274588,3.784473741981413
NCI-H2452,24964624,2.8171716992687967,2.5481429991686384
SU-DHL-1,654092,-1.6609972231677514,-0.11834983991783579
LCLC-97TM1,327653,3.202975625508304,3.1150000823962363
LCLC-97TM1,11507802,1.3666879232460134,1.3152040947166845
SK-HEP-1,sirolimus-bortezomib (250-1 mol-mol),1.4424973508492578,0.9353184110079913
BICR 31,selumetinib-UNC0638 (4-1 mol-mol),2.7430116861345977,3.2971096005118814
SK-CO-1,11222830,1.7982943188317977,1.5863232743290478
WM115,24951314,1.781657055553587,1.4656251311909916
WM115,135421197,2.9135607351561883,2.0384628281727633
LCLC-97TM1,136227331,4.3740550996774745,4.0929802475725054
BICR 22,24951314,1.8959621159637303,1.5661696518824217
HCC15,15983966,-4.250826265389746,-1.2666049150894079
Daudi,24964624,0.5895170730703193,1.254518072089266
SaOS-2,11257553,0.2323229130258903,1.5147519080670397
RKN,doxorubicin-navitoclax (2-1 mol-mol),-0.6554911641899885,-0.8840477723793431
RKN,46191454,2.1430961760764897,1.7617813012024381
ALL-SIL,navitoclax-sorafenib (1-1 mol-mol),-0.9804805399961952,-0.3915961051141508
HARA [Human squamous cell lung carcinoma],24180125,3.640570848683534,3.198636238733607
BICR 22,10410894,2.962619033825151,3.194011656138162
NCI-H2452,168312962,2.634597095527088,2.4834656537859074
MOLM-13,452548,-4.1979459883625045,-2.826239407509037
HARA [Human squamous cell lung carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-1.5170547368842298,-0.7645390730091153
SW1573,44185566,2.872643000979188,2.7810956838655763
SK-CO-1,5470400,-5.490738264790885,-0.8724057039134548
BICR 22,9933475,1.970614134756263,1.694790964361781
BICR 31,24753719,4.233476426959058,4.133486427281303
HuP-T3,4261,3.8165819220848767,1.6004223821247683
COR-L105,7251185,3.034502689275401,2.681768914076623
ALL-SIL,selumetinib-MK-2206 (8-1 mol-mol),1.6757681784854677,1.4943341452687886
SW948,crizotinib-PLX-4032 (2-1 mol-mol),1.0252435682890393,1.329992094802582
SK-OV-3,49793307,0.1269396758315965,-2.62855844140154
ML-1 [Human thyroid carcinoma],11647372,1.3935699525801049,1.3724380771914726
KU-19-19,216345,3.688803948438149,4.033562935100943
LS411N,638278,3.5631537252490917,3.221058035948643
SK-CO-1,374536,2.850215581982446,2.3615895211560596
ML-1 [Human thyroid carcinoma],25126798,4.037868296097697,3.8833310929824902
P31/FUJ,11178236,-2.454576103037029,-3.4993874905609648
SW948,439501,-2.1692174321648174,-1.8949942529060328
NCI-H2452,9911830,3.1691750432917645,2.8746287045506755
IGROV-1,9911463,4.195269991960018,3.944117300033468
PaTu 8988t,JQ-1-vorinostat (2-1 mol-mol),2.250446694675845,1.3528333670474981
KU-19-19,46199207,3.5920417522591723,3.2434042392184783
IA-LM,25102847,3.5065737869109017,2.0139832841138743
SaOS-2,10385095,0.9171223668306429,1.1657028857422553
SK-HEP-1,285033,-0.6546577384402199,-1.4313747748686456
WM115,1566236,3.8332358430398847,2.365746108462679
LS180,3025986,-0.3657173630682503,-0.8849457957987508
HCC1500,11625818,4.269459310239442,4.355507947814222
HCC15,44259,1.006506996100477,0.9654183916058499
RERF-LC-MS,285033,-2.0574538896256587,-1.651896870999718
IGROV-1,241158,3.288496474515495,3.972968391235794
BFTC-909,6917907,-4.2174557642594035,-4.979732405538252
BICR 22,375860,-0.6251605141105395,0.19171609294405514
BICR 22,119607,5.438520616053313,5.1182567338595115
RERF-LC-MS,676352,1.6328584527608256,2.1721031768580965
HCC15,6918289,2.816502870816243,2.555402600867959
RKN,241158,3.8611150596916577,3.932333540945764
COR-L95,3634881,3.005165393659793,2.8141397920961406
IGROV-1,11626560,1.7276653519578558,1.9710099371637753
LS180,3385,1.8718372753364907,3.4976041440120826
SU-DHL-1,56946209,-5.3778659012875325,-4.5176177194318266
Panc 02.03,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1370964450490924,3.527773990439804
NCI-H2452,448949,2.771204919609998,2.1228826671724392
SW1573,5113032,6.532830278238065,4.807595935464817
SK-OV-3,11485656,3.3782074628341894,2.6177628131515225
BICR 22,81146,6.036644504914818,4.637598964125858
P31/FUJ,76446078,4.256026108364254,3.1405837919197284
Daudi,2113511,3.606563716227827,4.313538292906859
HuP-T3,5328940,2.3682781464336147,1.597064205912808
RKO,6852167,3.601912647929868,2.2400660368319345
SK-HEP-1,1750826,-4.478019715406424,-1.2414958760722445
SU-DHL-1,25102847,1.7846654255237482,2.168211056360217
KU-19-19,2749,1.0704171129437314,2.2142115122015085
COR-L105,136227924,2.729950058152846,3.0315224349221457
RERF-LC-MS,crizotinib-PLX-4032 (2-1 mol-mol),1.247076899545937,2.094647180117687
RKO,25154868,3.654559992823761,4.064836216236382
HCC15,5113032,5.023051877119823,5.009862046454257
LCLC-97TM1,3815108,3.2576294300862867,2.8810041365617782
SU-DHL-1,6610216,4.061950863639378,3.743298837929388
LS411N,136227924,3.1900427132689724,2.545504736702625
BFTC-909,selumetinib-piperlongumine (8-1 mol-mol),4.839600666891057,3.4776259315211155
KU-19-19,51037431,1.6044173216619535,3.3046302332979076
MOLM-13,637858,0.5048034575879493,0.77866554295103
SW948,5329102,1.476566645762777,1.7878398530634434
NCI-H1568,tretinoin-carboplatin (2-1 mol-mol),4.637834792559274,5.049166216718678
K-562,serdemetan-SCH-529074 (1-1 mol-mol),0.9314801413999184,1.6825485089211731
SW1573,1566236,3.3872191513469025,2.5335391481189085
IGROV-1,46174525,4.5083762186279595,4.6842433297580115
SW948,9956119,4.230492181635778,2.97861140589791
SaOS-2,100016,6.565789067704999,5.866262199744271
WM115,11152667,0.9737214532192616,-0.339075486832352
HCC1500,439501,-1.4156205398968564,-2.155462768453229
SU-DHL-1,selumetinib-UNC0638 (4-1 mol-mol),2.6727434521528894,2.1780398516652024
NCI-H2452,49793307,-1.217787389832333,-2.170870290668714
BICR 22,208908,1.938925459708866,1.4330575148263387
KU-19-19,675434,4.307992798559183,4.575649804891731
SU-DHL-6,168312962,-0.817402334599034,0.7822468541912357
RKO,4705,3.750134101835121,2.931464102234545
MOLM-13,72193861,-0.3301410770598842,0.070107825547518
SU-DHL-6,11497983,-4.838706392617486,-0.1886845864123809
IA-LM,6610355,7.432350505906943,4.42426008633477
SU-DHL-1,100016,4.0163007651424945,5.579409772748496
SW48,tanespimycin-gemcitabine (1-1 mol-mol),-4.429955017650206,-1.3849016989828948
BICR 31,11717001,4.942461846011657,4.065769034849553
MDST8,452548,1.517979290481689,0.7001535371171107
SaOS-2,vorinostat-carboplatin (1-1 mol-mol),3.1714498028608573,3.1638827076594196
ML-1 [Human thyroid carcinoma],tretinoin-navitoclax (4-1 mol-mol),3.335416129341979,2.9388492879170887
HCC15,216239,2.699139377969599,2.592159220735104
SW948,54143018,1.1269042701713536,0.27799715039997336
PaTu 8988t,2871966,0.7913795837456433,0.3282544450640784
HARA [Human squamous cell lung carcinoma],24889392,3.022552356394008,4.329514767110557
MOLP-8,702558,5.64086941386953,4.246052661862298
SK-CO-1,9926054,2.0008566323964576,2.1020593141032196
NCI-H1568,208908,1.6425276108518176,2.0994714156236003
BICR 31,11364421,0.6668909809197356,-0.8562517515662676
RKO,6438330,2.4839059464581785,1.851459207075863
HCC1500,11717001,5.16685929391629,3.961784309457412
NCI-H2452,5335621,2.361346054519045,4.873943152332611
SK-HEP-1,168313200,3.8713243832650335,3.0605233458438437
MOLP-8,5281321,-3.090542457479921,-2.337928699534582
LS411N,5287620,-2.7795044954925423,-2.2142944698182028
BFTC-909,42611257,4.384387627976705,3.5959677196878856
MDST8,135421197,2.23565927197073,2.1691376513095197
LCLC-97TM1,navitoclax-MST-312 (1-1 mol-mol),1.32635815912294,1.181041581432676
ML-1 [Human thyroid carcinoma],4261,2.09291450929782,2.12230373076438
SU-DHL-1,136227924,2.1802521862386395,2.272310466498179
HEL,9929138,6.278460484472286,4.892877812076284
BICR 22,100016,6.157225392196351,6.195388624681167
BFTC-909,6610216,4.898578232775107,4.324701811021054
ML-1 [Human thyroid carcinoma],327653,3.144384021244803,3.4100896481164704
P31/FUJ,2708,3.1798246734444535,3.1736575645659624
SK-HEP-1,11222830,2.864448489509693,1.60555365353618
SW948,6450551,1.190778779915613,1.7997148918311938
P31/FUJ,3503,1.1912257572322915,1.774968479583225
SU-DHL-6,11214940,-0.480666123434414,1.5959356250936845
Granta-519,3101542,4.848909880356854,2.0310961393191067
COR-L105,JQ-1-vorinostat (2-1 mol-mol),0.2989866544918393,1.1967756196153665
SK-OV-3,54613361,2.1799599530092597,0.3884160285257826
SaOS-2,navitoclax-MST-312 (1-1 mol-mol),0.5918912917357866,0.8267729638288748
PaTu 8902,9866186,4.760639543290191,0.9038284537260115
BFTC-909,selumetinib-UNC0638 (4-1 mol-mol),3.893293421232559,3.447728001041983
MOLP-8,445455,4.348825488954634,3.912359940239629
LS180,327653,3.1909584751660973,3.225155109034284
LS180,selumetinib-JQ-1 (4-1 mol-mol),-1.4901017430136672,0.9373484297217749
WM115,24889392,3.868386170167097,4.433177311100524
SK-CO-1,54618771,-0.118181134306818,0.8691555823404858
SaOS-2,9868037,3.691858985861763,3.319726226117181
Granta-519,navitoclax-PLX-4032 (1-1 mol-mol),-1.627997667174391,-0.6867936044175665
HCC15,10385095,2.335943691067567,1.3868229862556947
MOLP-8,2874250,4.289349020932475,3.901093594130373
IA-LM,selumetinib-PLX-4032 (8-1 mol-mol),3.550842721167267,3.270316704610068
SU-DHL-1,44137675,2.905771721153928,3.4398516799976937
SW948,16038120,-0.173493225813213,0.6978209204814034
SW1271,387447,-4.431171658059158,-4.196822656901957
HCC15,71304818,2.608087345638841,2.6546841667423826
HuP-T3,navitoclax-pluripotin (1-1 mol-mol),0.368847097693027,-0.6013131575855888
SW48,44259,-0.1330653223053438,0.901870119457678
SK-CO-1,selumetinib-tretinoin (2-1 mol-mol),0.0609322450258742,2.0252134059208178
BFTC-909,216239,2.6603594422751136,2.342104927217942
MDST8,9825149,2.535214047656483,2.2881431935937773
BICR 22,11625818,4.758067302616356,4.248844308292301
LS411N,6852167,3.3651093558735035,2.6038051560312634
BICR 31,7251185,3.1852875333924415,2.738917353129188
ALL-SIL,25195348,0.8279476297727174,2.235341813843342
SaOS-2,73707438,3.8840228628110336,3.8162575518458484
Granta-519,selumetinib-MK-2206 (8-1 mol-mol),2.927373885066516,1.4200386364234328
BFTC-909,17755052,1.7621152527207813,1.8709623452119846
MOLP-8,vorinostat-carboplatin (1-1 mol-mol),1.858459936032215,2.083042929884213
SK-CO-1,3815108,2.810447278858876,3.084649693040559
COR-L95,3025944,4.2211844332657344,4.096516702204187
RERF-LC-MS,9825149,2.3136516136403595,2.263291372968586
KU-19-19,72376,-1.7461965003174784,-1.5927012677790842
K-562,568763,0.3044566284292496,-0.23718322799895775
ML-1 [Human thyroid carcinoma],4521392,4.335063435629941,4.318744647407709
Granta-519,6917907,-6.07944377191165,-5.5265115650467
SK-OV-3,4788,6.178998906779571,5.755375418061395
HARA [Human squamous cell lung carcinoma],3081361,3.3764732224556533,2.281187590679678
RERF-LC-MS,6852167,1.8897499878184068,2.9862628691224278
RCC10RGB,2746,4.042085650474663,3.4623519005487293
SaOS-2,54143018,-0.9786223984268784,0.5171098706977317
HCC15,451668,4.7728580097586635,4.343564345996523
RKN,135999136,4.319110081529012,3.85250680004709
ALL-SIL,11228183,-1.4217334963731665,0.08292224754822124
RKO,568763,0.6942409100068829,0.19053401666652178
SK-CO-1,71304818,2.179260281615582,2.2554252737630036
SaOS-2,151289,0.9278405880660672,1.1431102747923756
BICR 22,tanespimycin-gemcitabine (1-1 mol-mol),-1.0672550933922087,-0.8505604586784342
MDST8,241158,1.799926141571129,4.151256169369673
BICR 22,11214940,1.8032425349242045,2.4064625966003903
BICR 22,navitoclax-birinapant (1-1 mol-mol),0.9663061977057198,1.0703192420627732
LS411N,9825149,1.7370452341191267,1.8880540877073364
K-562,72193861,0.1570904811456113,0.28338499813424617
RKN,89928392,1.2442310560485252,1.5604470609929693
HARA [Human squamous cell lung carcinoma],25150857,2.860855820493058,2.6642077919347575
RERF-LC-MS,44493528,4.358183394704722,4.431361958760603
COR-L105,5738263,4.054674337055045,3.6598964222647288
P31/FUJ,5280436,3.1830796623136832,2.427512038170959
Daudi,JQ-1-navitoclax (2-1 mol-mol),-0.7335137922261505,-0.5308582379154663
LCLC-97TM1,135398516,2.1563049020997593,1.9271442485500256
COR-L95,25102847,2.826830714185171,2.3906400065030073
BICR 31,11427553,1.8414471938085448,3.1187832651682106
P31/FUJ,navitoclax-MST-312 (1-1 mol-mol),-0.1859808943498902,-0.2112795006467229
IGROV-1,15547703,3.339928221860449,3.3183980775582658
LS411N,navitoclax-PLX-4032 (1-1 mol-mol),1.1305163231038025,1.4565755596795384
LS411N,6918328,-0.170211770014818,-0.06543937093210976
Daudi,3136844,3.4483363469146098,3.4534554263538246
MOLP-8,10302451,3.559537910744256,2.797000819147625
LCLC-97TM1,24772860,-2.203105978452304,-2.104790880245057
SK-OV-3,selumetinib-GDC-0941 (4-1 mol-mol),2.556628673081414,1.6194420504635263
ML-1 [Human thyroid carcinoma],637858,1.1825057393141218,2.275663500010261
SW1271,119182,-0.4023310904747799,-0.24386955868537208
RERF-LC-MS,135398516,2.452363199699896,2.127978177974173
SK-CO-1,44495899,4.504236306700641,3.4477447747438656
IGROV-1,10127622,3.2581804056600165,3.875227432905807
SK-CO-1,44491742,5.1736211152382285,4.299257753994386
MOLM-13,4477,0.1750371811238646,0.595585849863395
WM115,25183872,-1.8696572442850008,-0.8400144222644579
BFTC-909,JQ-1-navitoclax (2-1 mol-mol),1.710597904541152,1.0230124318787805
LS180,JQ-1-MK-0752 (1-1 mol-mol),0.6783898145505391,1.3594769526317072
HCC1500,5335621,4.362965892261437,4.427543646724827
P31/FUJ,1716436,3.053886593694114,2.5598758567426954
Daudi,9915743,0.3665260221427978,0.30281814037415944
UACC-812,selumetinib-MK-2206 (8-1 mol-mol),1.487616505543695,1.869385856384445
SK-CO-1,5311281,1.7217135985324663,2.5909436018604817
IGROV-1,3503,2.453392942972796,2.4256007816649636
SW948,17755052,0.6738246482480579,1.1932353183240865
Granta-519,5329102,1.3717145166802862,1.5020450037887132
HCC15,25183872,1.7330298559310635,-0.3741971388246451
IGROV-1,23635314,-0.611739968448912,-1.678385308243569
HuP-T3,46174525,5.4457837824532245,4.620771949616959
IGROV-1,46199207,3.293579955374855,3.198525099770563
NCI-H1568,11656518,0.902462789439692,1.8055515366786352
SW1573,12001922,2.294011710402099,2.0132471045981886
HCC1500,navitoclax-sorafenib (1-1 mol-mol),-0.1825981932609776,1.0368493942616552
ML-1 [Human thyroid carcinoma],6918289,2.565001109569917,2.902855346938026
SW948,2871966,1.833559506117821,-0.08640175982807531
RKO,42642645,1.3055497818976145,0.1551048002998755
NCI-H2452,6450551,2.947106204512916,3.0562956849828056
P31/FUJ,10302451,4.186780329312711,2.8194524959281746
P31/FUJ,6918837,-4.676526715032863,-4.425947227032782
HuP-T3,3552672,1.4793505278318,3.331396731031541
BFTC-909,25105715,3.3944682152224455,3.591967862758713
HEL,44197249,3.8651368484410056,2.0958600799067404
HCC15,JQ-1-MK-0752 (1-1 mol-mol),3.1823820949476564,1.8493418757015316
BICR 31,46215462,1.6669957894505008,2.138680344321467
HuP-T3,9866186,1.729562359157257,0.874855471074362
HuP-T3,11717001,4.25253085122872,4.104771396727082
NCI-H1568,54618164,3.652866089784218,4.143873286022476
WM115,441298,3.225500618866892,2.5389486510369146
LS411N,71304818,3.0616651991102697,2.0214814317399514
NCI-H1568,navitoclax-sorafenib (1-1 mol-mol),1.4784994486098395,2.0302453093897803
SK-HEP-1,10184653,3.249474772070569,1.7717354079549088
BICR 31,12003241,-1.4237270953299652,-0.8738242198047002
RERF-LC-MS,25150857,3.1332692975488934,2.5169835622981918
COR-L95,24964624,2.1587115359420994,2.0652894337287973
SU-DHL-1,44241473,4.633491620971472,4.311860217840034
HARA [Human squamous cell lung carcinoma],72193861,-0.0489023079435419,1.7832278269923063
ML-1 [Human thyroid carcinoma],11152667,-4.726499990059393,-0.3381648175915468
MOLP-8,6918878,0.495059053850733,0.6734461989359878
RCC10RGB,448949,3.406339167429426,2.137842321459089
HCC1500,148124,1.3380754252474834,-0.30227799992584925
HCC1500,5280436,1.8565158203383687,3.2695825794694064
IGROV-1,10302451,0.4135234554742116,2.920703036367115
Granta-519,285033,-4.09305161448312,-3.460889418280585
HEL,JQ-1-navitoclax (2-1 mol-mol),-0.660921199279695,-0.43579725746059245
Granta-519,71304818,1.7993370678919798,1.7901770107104127
NCI-H2452,3689413,1.184555113675537,-0.2806202177934963
IGROV-1,2708,4.438419625543199,4.8737039022119095
SW1271,49850262,4.063818012025616,3.734139894498609
LS180,6918736,-2.1262365465987907,-1.1663856164501036
PaTu 8902,10127622,6.3250626499292295,3.2494871349244945
SW1271,57519531,1.4534695216386555,2.7526292158002197
HCC15,57519531,1.9577451103636032,2.488984431089806
SK-HEP-1,navitoclax-PLX-4032 (1-1 mol-mol),2.657614017988428,1.9882161307889288
SW48,44185566,0.7812235367324193,2.511270197582368
Granta-519,navitoclax-birinapant (1-1 mol-mol),-1.2889388818955343,-0.35819441447031836
KU-19-19,241158,4.34083218708613,4.041296706840412
NCI-H1568,11404337,-0.63897934294681,-0.2670185699248885
Granta-519,219104,2.15431657191886,2.0887648272751007
SK-CO-1,5746,-2.8271360432483035,0.9609860006586217
WM115,6918837,-2.450050091846588,-2.342342665712364
SK-CO-1,11152667,-1.1935109806009474,-0.13988092579105008
SW1271,9825149,2.2012182796133084,2.332507541922933
SaOS-2,208908,2.5337103611164893,1.7274666011360662
SW48,5470400,-1.7303817372543355,-0.8299443505544987
NCI-H1568,JQ-1-UNC0638 (2-1 mol-mol),1.923479920407172,1.7624565201318894
SW48,15547703,3.0370188863847414,3.052165827670089
SW948,46907787,2.3709287142369555,0.5281528239685909
Daudi,5113032,4.739966647777949,4.4613361405772025
SaOS-2,135984461,4.8186429168984475,3.476936088189741
MDST8,168313047,3.800021027786958,2.343320985062344
RCC10RGB,11964036,2.4986740771219673,1.7173215524521492
SW1271,24785538,1.505278847517323,1.756383575858837
BFTC-909,3676137,5.055523871435828,4.554727314994805
SW48,9868037,2.459515994210572,3.257911063451848
KU-19-19,10231331,0.2937024112037242,1.9901348590125907
ALL-SIL,54619267,3.6744484896003713,3.4308096096528806
BICR 22,selumetinib-BRD-A02303741 (4-1 mol-mol),2.600469012399248,3.007910604977084
RCC10RGB,24951314,2.138755705452886,1.5689541045566833
SU-DHL-6,26596,-1.882707371112463,-2.691190130623387
COR-L105,46843906,1.9821208299636863,3.2493342171224397
RERF-LC-MS,4477,-0.1141702320643991,0.612750944337087
MOLM-13,49766530,-2.4914272268054107,-2.172966018292971
SK-CO-1,4917,2.9299888563447163,3.1531223336488625
Daudi,72734382,3.17690285998388,3.4837826920072157
LCLC-97TM1,11625818,5.063433550011292,4.036141697625333
LS411N,vorinostat-navitoclax (4-1 mol-mol),1.2590657469614004,0.9888954091763675
ALL-SIL,451668,-1.1904263441284522,-1.0521144443464834
SK-CO-1,219104,3.537047767593632,3.8105869982519693
NCI-H2452,65064,5.258935158123576,5.033572904510973
BICR 31,25062766,2.0025728701089904,2.1915786636266965
LCLC-97TM1,4261,1.8883571230172835,1.6324169082589424
BFTC-909,54618164,4.281231487810877,4.039741900293469
NCI-H2452,16736978,0.9447398024439234,1.9590914976240796
NCI-H2452,selumetinib-BRD-A02303741 (4-1 mol-mol),6.449127799684226,4.132384877614802
ML-1 [Human thyroid carcinoma],selumetinib-decitabine (4-1 mol-mol),4.367801531941202,4.013199511282384
WM115,6917907,-5.049795628811172,-4.2453637815146275
HuP-T3,5746,1.6464242063318688,1.3948849904089107
MOLP-8,327653,2.384727852533787,2.762392118388654
SW48,72376,-3.1415011638088144,-2.39413833166456
SK-HEP-1,23582824,1.0257570544783106,0.9435104627454807
K-562,12001922,1.1213264373636214,1.6332192554571716
WM115,10410894,3.2188686198907743,3.340001835454421
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681,1.2208608800777077
ML-1 [Human thyroid carcinoma],49850262,3.5297334075235245,3.986980543121341
KU-19-19,44819697,-2.543386759740491,-0.64614379350168
LS180,46199207,2.9384583216685023,3.1415298328814094
LS411N,56946209,-3.80128700519076,-4.097341004676116
LCLC-97TM1,6918289,3.014261251605047,2.3711773653513797
KU-19-19,107970,3.004209688555129,2.4486230337370323
MOLP-8,72376,-3.958595065171294,-3.1953190029599097
IGROV-1,5291,3.6852809555447985,3.7385579399574174
Granta-519,46191454,0.5060764897707477,-0.39886603909505686
COR-L105,24901704,3.8942422617258714,3.369626266054085
NCI-H2452,24797083,2.030715286150645,1.4878505468669452
NCI-H2452,124202324,3.032884210730814,2.849939447082315
LCLC-97TM1,4259181,-0.2611730486969081,0.10149482304248691
KU-19-19,73707440,5.592820593626321,3.671129711050065
RKN,5460769,5.79272629497122,2.7455621463365336
RKO,10184653,1.6814092199651305,1.2466222206914646
PaTu 8988t,24180125,3.300808715406375,2.939813870199675
COR-L105,2858523,3.082532365215724,3.0420367478912205
BICR 22,decitabine-navitoclax (2-1 mol-mol),1.4331437420597166,1.9408153275504463
LCLC-97TM1,16065773,3.044024356255971,2.242662952745492
MOLM-13,16115403,-5.622868208190141,-4.712228880678476
Daudi,104842,-7.567274671559235,-4.213985504335178
PaTu 8988t,3825829,4.270364787448243,3.873682508966488
HuP-T3,227681,2.514870644267688,3.591828337986592
ML-1 [Human thyroid carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.142388159439524,1.5875687373129883
COR-L105,11964036,1.2117851204645589,1.5353256486369191
SW1271,135659046,3.922158232881772,3.804138874226226
IGROV-1,4917,2.985904350427039,3.1841674630064296
HCC15,9826308,1.2579647962340863,0.8626024620253159
SK-OV-3,46199207,3.479599233509405,3.2654384826931926
KU-19-19,2729026,3.069520174525383,2.795919325699546
COR-L105,25102847,1.810865395215699,2.4944966359152394
SW1573,9935249,2.8664920450292852,3.433869639184147
COR-L95,1714884,3.7968274989469992,3.0691230833816787
PaTu 8988t,7251185,3.286029674356028,2.713034521697228
SK-CO-1,24856436,0.7128954142297991,0.3984383362893119
HCC1500,5738263,2.955373895930653,3.6075449981460292
SU-DHL-1,6914657,-4.020831804674196,-4.631711841128112
SW48,638278,3.16751315896482,3.013868540032384
LCLC-97TM1,135421197,1.517750954289076,1.779248822787421
ML-1 [Human thyroid carcinoma],11404337,0.3501599152959295,0.03275719158902345
RERF-LC-MS,selumetinib-decitabine (4-1 mol-mol),3.240984973519631,4.38499391882978
NCI-H1568,6914657,-5.120590256929669,-3.6762942046823315
NCI-H2452,3676137,5.703513737309888,4.547294749468914
PaTu 8988t,11238147,3.9795465318298526,3.067133596522964
RCC10RGB,5113032,2.807854627845623,5.187166798635344
IA-LM,44607531,1.5934898700442923,1.5896323621529962
MOLP-8,BRD-A02303741-carboplatin (1-1 mol-mol),5.885720002784475,3.9775306906463017
SW1271,docetaxel-tanespimycin (2-1 mol-mol),1.954654024202385,-3.1977991999821995
RKN,3815108,2.827407220517517,2.939278985731039
IGROV-1,448949,2.098499309472767,1.908937404324692
BICR 31,5426,4.483861121335425,3.7522088169358367
SK-OV-3,322968,3.987773865251791,3.8418016467545413
BFTC-909,15953870,3.192835350037467,3.692387569124891
BFTC-909,4378219,4.497242068417329,2.4849469287202024
COR-L95,54143018,1.379812266453913,0.22411107279616066
SU-DHL-1,11612883,2.467580560997241,2.6206652480105324
COR-L105,alisertib-navitoclax (2-1 mol-mol),1.2187125492955395,0.8285334108891503
LS180,5978,-1.0800938866172374,-1.7150574164778256
NCI-H1568,44566777,1.438409258191859,0.8751398024013587
BICR 31,42642645,1.5553576315566706,1.0301631911762188
MOLM-13,654092,-2.113392174262404,-1.252345169589055
LS411N,124202324,2.3656166654970137,1.5110257669303382
SU-DHL-1,5329102,0.4187283879213827,1.8407415168290393
Daudi,51037431,1.7669670215364446,3.046855049000353
RERF-LC-MS,45279963,3.7797867340420215,3.8652100205199087
IGROV-1,49850262,4.068828647042517,3.798528872146037
BICR 31,12001922,2.662375748901725,1.9455673602359553
IGROV-1,49793307,-2.5291790820063538,-2.5602916201086976
PaTu 8902,2828334,6.440933390339598,6.197789525970465
SU-DHL-1,24951314,0.6018835624310062,0.9124870277647035
MDST8,676352,2.6149374435458643,2.0562741597415455
HARA [Human squamous cell lung carcinoma],3503,1.5305596721968624,2.4115574311052566
MOLP-8,44185566,2.3020252385384747,1.6991057712435826
RKN,44137675,5.459450119186335,3.6908239620781775
SU-DHL-1,216239,2.4334915471860064,1.9957023271962167
RCC10RGB,5328940,2.5920229504771264,1.8334174189121284
MOLP-8,5351362,0.578803181676615,1.0550173738951096
KU-19-19,4521392,6.281175440463305,4.474464985260277
HuP-T3,219104,4.090562015064086,3.935247362210801
BICR 22,16722836,2.37465920140225,1.7039579257999602
Granta-519,54678924,3.4908303220152512,1.2969360961140213
SW948,5738263,3.889172676108031,2.7195114268749436
SW1271,9549297,2.1335240165820606,2.684255743379387
MOLM-13,5280436,3.611781786093365,2.6247786100108503
BICR 22,3062316,1.4778056821676904,-0.11589435555400071
HCC1500,46191454,2.281809335685502,1.4598889315196224
HARA [Human squamous cell lung carcinoma],445455,6.075035505832661,4.660748062342467
SW48,9549297,0.4487326680785643,2.414947451128003
SK-OV-3,46843906,3.785109660734252,3.1530185572632767
NCI-H2452,5351362,1.571040634520482,1.7232206101072793
RKO,56946209,-3.445993729976747,-4.156547669362585
SaOS-2,56649450,2.657103116813459,3.643052896011631
KU-19-19,doxorubicin-navitoclax (2-1 mol-mol),-0.7241135755509572,-0.9000703138282184
LS411N,23725625,5.218761480016774,3.9493028991747394
RERF-LC-MS,4578,4.625372786711685,4.587280749855807
MOLM-13,11507802,1.0337656748409854,0.7626899211466142
SW48,65064,5.106206142410259,4.8633828328957485
HCC15,2828334,6.579413009448801,6.190219102457217
SaOS-2,4378219,3.572923749570723,2.3755899971188157
BFTC-909,23939,4.493588141952023,4.177483676164626
RCC10RGB,439501,-2.548266242367821,-1.7348801808860244
SW1271,3815108,3.2377532103389832,2.836684656934685
P31/FUJ,5287620,-2.889875327880449,-2.195630478147822
HARA [Human squamous cell lung carcinoma],448949,2.536052822584039,2.197826391488086
LS411N,5281321,2.872375461605106,-2.052308820210141
ML-1 [Human thyroid carcinoma],4917,3.4875612389510184,3.1406990113051263
MOLM-13,16736978,-0.7178102164081313,0.7822858767581903
HuP-T3,24964624,2.5347495437600753,2.3533656312283977
SW1271,3038522,2.6397404309625574,3.3993345654826777
SK-OV-3,6852167,3.0870556066687076,3.0349933582912234
PaTu 8902,25262965,1.559985123462204,-1.4852683821709265
PaTu 8988t,89928392,1.7442497788257625,1.5464284798095735
RCC10RGB,5494449,5.764110819730859,3.1904680007129453
LS411N,JQ-1-carboplatin (1-1 mol-mol),1.929098606006951,0.5989965132892319
Daudi,5282054,2.334684985175564,2.6481787178296283
SW1573,9866186,2.2605214925080035,1.2801764961124484
SK-HEP-1,16013152,4.2454363352103925,4.018647576953016
IGROV-1,11647372,-0.6595372928368528,1.317194176365466
RKO,60700,-0.2024014556335324,-0.7816824886364071
SaOS-2,66577038,3.461550546017496,2.9397698672131494
BICR 22,6918638,0.0558003797401064,0.6773347255734715
NCI-H1568,6918878,3.5715267618547832,3.251745812328374
RKN,17755052,4.615024850417848,2.1379339619379216
RKO,10385095,1.2981289243482117,0.8838024157691728
NCI-H1568,25227462,1.3523005990409367,0.6127607969263575
IGROV-1,168313200,3.9938362637732983,3.1711513354082497
LS180,52912189,2.5201251776162454,1.7771838421182955
SK-OV-3,446155,4.068831864004445,2.759909928645485
SaOS-2,2729026,3.0079080963172573,2.6630032150661096
COR-L105,24785538,1.9787344511962284,1.9775132215947753
WM115,9549297,1.875565618317202,2.475971436504099
COR-L95,53392493,1.7864953470488698,2.2150555522258735
SaOS-2,219104,3.933074432676362,3.752370723836918
WM115,3854666,2.6196721416111024,2.1965053526727245
PaTu 8902,11626560,1.9806688551606229,1.8840608893737953
P31/FUJ,24901704,1.8625310117446785,2.2002917985223673
IGROV-1,9911463,4.195269991960018,3.944117300033468
LCLC-97TM1,216468,0.7418366776466117,2.1926581331000925
MOLP-8,387447,-5.214034261316855,-4.843564423255673
RCC10RGB,16722836,2.017391543442539,2.057689812731359
IGROV-1,JQ-1-vorinostat (2-1 mol-mol),0.7179438393808574,0.9619361753564235
SW48,5311281,1.5627745937535438,2.199000928098342
MOLM-13,11497983,-4.003769607545663,-1.3228028951916402
KU-19-19,2858523,2.990442019675252,3.019573952943883
COR-L95,11626560,1.5180153972734145,1.5223806721832558
WM115,123631,1.7981952102566006,2.457900167097735
RERF-LC-MS,2874250,4.628157945253743,4.49759871309276
MOLP-8,65064,3.020382379730844,4.194695604585003
RERF-LC-MS,3854666,0.8294073497518095,2.3261418298134675
HCC15,3689413,0.3467742153458734,-0.04106587505144268
HCC15,25150857,2.8177810894811786,2.5065605206232764
LCLC-97TM1,46174525,4.403281113181967,4.118733080236321
SK-HEP-1,31703,0.3185055118054912,-0.6972241636991208
BICR 22,123631,2.0553358195001383,1.9484728286422195
Panc 02.03,selumetinib-PLX-4032 (8-1 mol-mol),3.6013795626113163,3.502543841596365
ML-1 [Human thyroid carcinoma],JQ-1-vorinostat (2-1 mol-mol),1.0159563388217403,1.2103979203330573
COR-L105,11213558,1.6245415685033464,1.9534418363118204
COR-L105,3689413,-2.1605707630353708,0.17775669941851427
MOLP-8,4917,1.932746630984224,2.7686525741088497
HEL,11238147,1.9261110470981635,1.9137685818045722
HCC15,46907787,1.7788170946404287,2.3066403288669908
HCC1500,3062316,2.994925150114549,1.4725941538203875
MOLP-8,9935249,-5.983061984872936,1.6446736204610999
IA-LM,135398516,1.3190430503048431,1.696316971167301
NCI-H1568,6917907,-6.013699668749745,-3.8548460188443174
PaTu 8988t,25062766,2.121196656552597,2.028768883795564
HARA [Human squamous cell lung carcinoma],49793307,-3.043253960744797,-2.482338024902136
BICR 22,JQ-1-carboplatin (1-1 mol-mol),2.1312623877062125,2.3676437623163844
HCC15,3825829,3.261310602619802,4.165700044470278
SaOS-2,36314,-6.649536011740597,-1.1604714671510374
BFTC-909,54613361,0.5481358040879688,0.13742081753909824
HCC1500,navitoclax-MST-312 (1-1 mol-mol),-1.0378024218006647,0.9523599267922294
KU-19-19,135999136,4.912207411852192,4.032378684528706
HCC15,126941,-2.714458984381298,-2.8328622250078297
K-562,387447,-4.172741798582805,-4.9698577805079545
BFTC-909,400769,-0.3884900564724624,-0.7028739501586666
SW948,serdemetan-SCH-529074 (1-1 mol-mol),2.314613339768124,1.812623827036921
K-562,19582717,3.29667086675107,3.069070860293412
LS180,676352,2.815097827506973,2.132387526644057
SK-CO-1,5278396,2.886619996042885,3.578921370941121
SW1271,654092,-0.6724961197062129,-0.015080381192026347
BICR 31,984333,1.688597902845401,0.7867791679677958
ML-1 [Human thyroid carcinoma],3854666,0.5957604923029644,2.5331288785671813
PaTu 8902,6918328,0.0837665640709721,0.03376186445802612
KU-19-19,25126798,3.8528221502524262,3.796609196229414
SW48,BRD-K27188169-navitoclax (2-1 mol-mol),2.506636688150973,2.131686410414812
K-562,984333,1.160515473081413,0.045058010167535516
BICR 22,4261,1.6582900308021409,1.5114165210014383
P31/FUJ,24753719,3.279397605233023,3.2935569206401265
RKO,89928392,1.6264666324972337,0.8145721813189144
ML-1 [Human thyroid carcinoma],11364421,-5.159158552339723,-0.9409389150309445
MOLP-8,2746,0.9128995235322724,1.802459434232408
PaTu 8988t,44589607,3.069724280166482,3.016014808533767
Daudi,55508,3.074140286884227,2.8452663715155584
IGROV-1,53232,2.4872106086763393,2.945544598523988
HCC1500,11178236,-0.8618797474299623,-3.262000341740202
SW1573,11228183,1.3544411199442492,2.88197434496779
ALL-SIL,docetaxel-tanespimycin (2-1 mol-mol),-8.351495985477111,-5.223844512105249
HCC15,151289,0.5818248951012718,1.1168995538639401
RKN,navitoclax-sorafenib (1-1 mol-mol),2.725354143371073,1.949855079519125
LCLC-97TM1,9956119,3.701469228999412,3.426955529967338
LS180,65064,5.333283055182179,4.887468919695063
Panc 02.03,1566236,1.9322803720882225,2.3129490314436385
WM115,UNC0638-navitoclax (1-1 mol-mol),2.6292832027586783,1.7830926223826447
COR-L105,5311281,2.5909348271223833,2.4656990680134503
COR-L105,4261,1.037866526492344,1.8545158949664668
MOLM-13,6505803,-3.0527041000310255,-0.7663714893496124
SaOS-2,24797083,1.1743557883271736,1.253533466456565
NCI-H1568,selumetinib-GDC-0941 (4-1 mol-mol),1.6241640738587435,1.7558911506602677
PaTu 8988t,44819697,-1.4855632158782932,-0.4689551148676147
IGROV-1,JQ-1-vorinostat (2-1 mol-mol),0.7179438393808574,0.9619361753564235
MOLM-13,136227924,1.704251401840426,2.230724133269379
K-562,11955716,-2.44804051648688,-2.4059524280069056
PaTu 8988t,119607,6.161307312166748,5.2867343849310915
COR-L95,71466380,4.385390307812106,4.29543019345559
SW48,400769,-1.161678790289576,-0.5468485056048749
SK-HEP-1,54618771,0.9570801540222316,1.1773380719485063
Daudi,10410894,2.7348964142664096,2.3436770635669344
P31/FUJ,8515,2.4023085754769133,2.930823590674255
MOLP-8,12001922,1.340541943266141,1.7109050012855005
SaOS-2,24180125,2.5037581025896896,2.962797508761125
LCLC-97TM1,11497983,-3.4928977535107872,2.217793577604135
KU-19-19,54618771,0.4920305765445359,1.3224942465278569
BFTC-909,9826308,0.9467806471528852,0.5485222596257755
HEL,6252,-2.3526628041976547,-1.561139997815561
PaTu 8902,1750826,3.002378182351502,-0.790563418390899
HEL,375860,-0.4243086466742362,-0.4406689910171234
SK-CO-1,erlotinib-PLX-4032 (2-1 mol-mol),3.6761827416716737,2.3685727552286835
LCLC-97TM1,44137675,2.6535109564984403,3.322840526078153
BFTC-909,4096211,2.208598833058293,2.296910017132477
SW948,piperlongumine-MST-312 (1-1 mol-mol),2.3670131047839496,1.583982462330519
MDST8,serdemetan-SCH-529074 (1-1 mol-mol),2.3277787595180417,2.0016523192301388
ML-1 [Human thyroid carcinoma],46215462,1.6577528274030604,2.0873986595146503
SK-CO-1,10231331,-0.7210930575000714,1.8648358754941627
RERF-LC-MS,9908783,5.63449812951243,5.018245856817435
SW48,BRD-A02303741-navitoclax (2-1 mol-mol),2.3907101942881392,2.5099413985469092
SaOS-2,navitoclax-birinapant (1-1 mol-mol),2.783475564423097,1.361446255484509
SaOS-2,54618795,3.185724709117328,1.476451684901012
PaTu 8988t,637858,2.5993481939897314,2.1794265418330045
HEL,984333,-1.1600295079037413,-0.618547789426397
HCC15,2841722,4.4106331963661285,4.388740551212561
SW948,676352,1.6772543111300298,1.976596057087969
BICR 31,24964624,2.1782924417506235,2.465069495069775
MDST8,984333,1.6302493723588198,0.9825414037239697
SaOS-2,25102847,2.0054521503393956,2.497029846578111
NCI-H1568,11396600,3.496587037401377,3.8453793409123698
SU-DHL-1,25126798,1.813712960287442,3.6511030847050154
MOLM-13,445091,4.269392983422825,3.5724086299977382
IA-LM,6918328,0.468629569752011,0.24001688416973793
RKO,16038120,2.1201165412688385,0.462154630549515
Daudi,3689413,-4.376822515219121,-1.8118635236585272
LS411N,1750826,2.0365622567800985,-1.8445678827953265
SU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),2.071258944893258,0.6070755867848141
LS411N,11640390,3.2208706785393972,2.741198019655363
SK-OV-3,2729026,2.529477515357917,2.8085190383276943
BICR 22,1317464,3.72634745746102,2.9970648218757394
PaTu 8988t,6917907,-5.027469783550181,-4.18868709859141
BICR 22,168313200,4.032164885313491,2.926978981072529
WM115,24180719,-0.1236916700903925,2.873560835606572
WM115,2708,4.839353437835411,5.017889605701264
Daudi,erlotinib-PLX-4032 (2-1 mol-mol),2.269531504347571,2.7764376803483537
SW948,135398516,1.5329637117305952,1.9298205572714946
SK-HEP-1,15547703,3.182423809990023,3.4494829196891987
HARA [Human squamous cell lung carcinoma],17755052,1.9898088824831797,1.6745320391931955
SW1271,400769,-0.393739366900267,-0.681708457866023
COR-L95,11657048,4.451680892653422,3.4309237095707994
KU-19-19,5470400,0.4514058362673593,-0.0713482542122148
SU-DHL-1,46199207,2.2603615990150803,2.980493218633909
LCLC-97TM1,452548,-0.620032222833134,-0.24796099626309145
COR-L105,216345,3.681753487249753,4.0411195405306355
SK-CO-1,6918736,-2.135863333000623,-1.1607224571447279
SK-CO-1,5351362,1.1244803572081656,1.4936647871276219
Granta-519,451668,1.0102660805443675,-0.32651396114700804
RCC10RGB,71751553,5.18764953581067,4.5255920143121555
SW948,44137675,3.8395253943289553,3.3040793501690757
SaOS-2,JQ-1-navitoclax (2-1 mol-mol),0.6153479757572562,0.7564754026211784
LS411N,654092,0.6196619744838121,-0.7373116786257549
HCC15,11222830,1.5967166138936082,1.7894616433826824
RERF-LC-MS,54143018,1.1379926617289184,0.4011943674865318
HuP-T3,107970,2.2315719384591133,2.4067063595023224
MOLP-8,462382,0.932516774133838,0.39485279727930506
ML-1 [Human thyroid carcinoma],24889392,3.5627585346619712,4.437111138140833
COR-L105,448949,1.923777772079977,1.9977409887301016
SU-DHL-6,5311,0.0847535344452709,0.3736411953670457
COR-L105,65064,5.250674314711081,5.2497537071468745
RKO,9908783,5.5436232623995805,4.398418722292576
BICR 22,1566236,3.7080344976190434,2.55204270017093
SK-OV-3,2708,5.531711784720637,5.032235641939791
RERF-LC-MS,148198,-3.5927713028936834,-2.9845298033250613
K-562,10127622,4.587499993681003,2.8540664100153874
MDST8,3543504,4.366917593553272,4.623528346227698
NCI-H2452,675434,4.57874791360699,4.587673942149568
BICR 22,vorinostat-carboplatin (1-1 mol-mol),3.8807496375646937,3.0573755501848523
K-562,73707398,1.1020172598138147,0.5796212758412135
BICR 22,11178236,-2.3138277354389176,-2.608427895451391
KU-19-19,53232,3.650570649303299,2.7860368599436662
COR-L105,2126,5.6436039579971045,4.688635659497275
MOLP-8,alisertib-navitoclax (2-1 mol-mol),-4.498852011390448,-0.9661123172518797
WM115,984333,1.7219326558446977,0.9289746528304436
Daudi,6918878,-0.3078198284611306,0.2778336965224157
HCC15,16725315,4.804384009366738,4.4315950561242
Panc 02.03,tanespimycin-bortezomib (250-1 mol-mol),-0.3690940442428398,-0.5902759284019404
ALL-SIL,56946209,-4.755076906810128,-5.010017694892896
P31/FUJ,25195348,1.3039046822632598,2.3540243616258945
NCI-H1568,4261,1.7177455985107426,1.7309985509008763
BICR 22,11238147,2.160553784520482,2.6675983219649657
SW48,decitabine-navitoclax (2-1 mol-mol),-0.1693110303669234,2.2842568002833135
LCLC-97TM1,25126798,4.007107372760091,3.7387003750055796
PaTu 8988t,11612883,3.2937262662044424,2.933213948534871
SW48,44507138,1.5733509414979852,2.5836030791137112
SU-DHL-1,66577038,2.452346655400699,2.9271110138088856
ALL-SIL,60168763,4.204461937910143,2.1835408028347443
Daudi,25227462,-5.495402710114509,-2.3721351293245165
LCLC-97TM1,613000,2.0466318432711708,2.4646535835536914
LS411N,2828334,6.327786282136184,5.773793998339483
IGROV-1,9866186,0.4571266497661056,0.7687581085210131
SU-DHL-6,72376,-4.568822946856545,-3.7639267860234615
P31/FUJ,984333,-0.8646677641211812,-0.4820427980903422
COR-L95,123631,2.8240072692867915,2.175791912525066
IGROV-1,11497983,4.37450324471555,3.930972573684747
BFTC-909,5281672,4.401358042981416,4.65935468643462
PaTu 8902,44607530,2.9609228636650826,1.6203602191685877
HuP-T3,5566,3.0002994658008935,2.9907239638835152
NCI-H2452,JQ-1-UNC0638 (2-1 mol-mol),2.3308008637008837,1.9051064052236912
IGROV-1,2729026,2.3541792737160296,2.7004088930875123
COR-L95,11222830,1.53452681839189,1.3945784640888135
LCLC-97TM1,66577038,1.6013450181273698,2.9007038619403853
IGROV-1,24772860,-3.2892316801587835,-1.8789103289424602
IGROV-1,navitoclax-gemcitabine (1-1 mol-mol),-2.4690208522715005,-1.1783761571028573
HCC1500,navitoclax-pluripotin (1-1 mol-mol),-1.6377620908642292,-0.6793462580075605
NCI-H1568,54678924,1.274078635657008,2.500198958058426
ML-1 [Human thyroid carcinoma],navitoclax-MST-312 (1-1 mol-mol),1.8932386957075495,1.2230781645961288
RCC10RGB,9908783,5.908182650801537,5.109117331746165
IA-LM,66577038,3.3956332242260765,2.7398601579037716
LCLC-97TM1,selumetinib-JQ-1 (4-1 mol-mol),1.553276046289172,0.9848756374028659
COR-L95,9935249,2.976260244275784,2.2128790181805664
SU-DHL-6,9868037,3.231553190440303,1.9670033664701614
RCC10RGB,11640390,5.2605770793622275,3.883992813111196
Daudi,285033,-6.062056136351362,-2.9933462689223473
BICR 22,11626560,2.057582050988773,1.8943682947719755
NCI-H1568,60750,-4.838669884752028,-1.8855136127262808
MOLM-13,2708,1.6215518677504634,3.014537413397866
LS411N,crizotinib-PLX-4032 (2-1 mol-mol),1.3060638395576354,1.3326033523019403
K-562,10385095,0.5975872383647969,0.7262367467988051
P31/FUJ,tretinoin-navitoclax (4-1 mol-mol),0.2737114955755992,0.20499690418434402
ALL-SIL,9887053,2.3955838154567703,2.6887007359648787
RERF-LC-MS,151289,1.06337646711186,1.1428342233300586
LCLC-97TM1,71466445,2.7974721848465025,3.3983320946343873
RKO,15983966,1.976330033309676,-3.2720929862148433
SU-DHL-6,54143018,-0.9166021499884252,-0.23943316362227507
WM115,sirolimus-bortezomib (250-1 mol-mol),-0.1340053181182992,0.7287984333373818
MOLM-13,vorinostat-carboplatin (1-1 mol-mol),0.7090489644750352,2.0095582637610105
IGROV-1,49793307,-2.5291790820063538,-2.5602916201086976
COR-L105,crizotinib-PLX-4032 (2-1 mol-mol),2.1629523176516248,2.0516699926811515
SW48,9866186,-0.0602537260044697,1.040793825190264
ALL-SIL,24753719,3.3195109491118635,3.3144889632469194
PaTu 8988t,409805,3.676693079768219,5.076677936546822
BICR 22,11175137,1.6412636442827269,2.6947220786829797
PaTu 8988t,vorinostat-navitoclax (4-1 mol-mol),3.0451026382172732,1.169865013797292
MOLP-8,9887053,1.3364969406129874,2.8061746261499905
Daudi,81146,4.468898659357518,3.6770170934203876
NCI-H2452,6438330,4.066979701794873,2.4932045252990163
SU-DHL-6,73707438,4.161722925172636,4.1263553654080685
SU-DHL-1,9825149,2.3972801394012415,1.7503176161910239
LCLC-97TM1,1242560,3.1698209685240832,3.5099652262189482
RKO,44632017,0.9673312213076444,0.9802128682496314
ALL-SIL,10184653,0.3156525087572682,0.7774785586530174
MOLM-13,15953870,2.45012914744678,2.7424000772651236
WM115,docetaxel-tanespimycin (2-1 mol-mol),-3.9058848396527464,-2.9808072177600344
HARA [Human squamous cell lung carcinoma],3038522,4.1452744027346045,3.2128299227503887
Daudi,9908783,4.64363842559646,4.209287461005699
BICR 22,2746,3.5358057095338404,3.4615030450695046
SK-OV-3,9903786,2.611217845094376,2.8216339766312046
Granta-519,446155,3.3236756015859266,2.529713798850037
HuP-T3,46843906,1.6260119885378777,3.342707434909654
RCC10RGB,25102847,4.4790627708666255,2.651701735665589
SW1573,119607,3.675967979424282,5.288831782408798
NCI-H2452,36462,2.3648017756260327,2.4754870326970937
RKO,9926054,1.883626680074333,1.8635540862282864
UACC-812,11396600,4.679415745859403,3.490208170093796
LCLC-97TM1,67291369,2.1623476689900527,2.0348993768822825
SaOS-2,9926054,1.5065280757428428,2.0450789021676647
SW1271,11485656,2.5257448561020053,2.4586988139446624
SU-DHL-1,65628,3.0805404655500843,3.890804102020668
RERF-LC-MS,24889392,5.73600211591012,4.19024275286221
IGROV-1,16720766,-0.0562020789376145,0.7225276642330394
SaOS-2,53392493,1.7453499080757628,2.3606940281568933
BICR 31,JQ-1-MK-0752 (1-1 mol-mol),2.163474213011291,1.4893323412612423
LCLC-97TM1,71466578,4.4967812415195025,3.8686470038933156
MOLM-13,135440466,-1.1165614244178856,1.7101873785664756
IA-LM,1566236,2.064855820915055,2.298646790060319
SW948,3825829,4.076553662425885,3.6868152473401348
HARA [Human squamous cell lung carcinoma],44491742,4.175098575791361,4.2018052692413095
WM115,322968,4.566671406107956,3.98733762932268
RKN,637858,2.0099352926359533,1.9673749550838775
COR-L105,135398516,1.4567379833558207,2.5156543474740882
LS411N,15547703,3.407600768992332,2.717683921375339
SW948,6918878,-0.2941800388813576,1.6445126277180335
SK-OV-3,31703,-0.6007067740148971,-0.6822575616614643
BICR 31,16038120,0.7865824758597759,1.1525761210647851
SW1271,46943432,0.8939870827443378,2.4015477141733235
Daudi,67291369,0.2775886597323658,0.4424095402718307
WM115,SNX-2112-bortezomib (250-1 mol-mol),-3.3081919953178507,-0.8826827788585083
BICR 31,11455910,2.0785566961581186,1.366228097987472
MOLM-13,25150857,2.0975264071969075,1.5916097859839329
COR-L105,46174525,5.553907170062061,4.563567531364836
COR-L105,piperlongumine-MST-312 (1-1 mol-mol),2.3163882961547086,1.9931559962831518
SW48,serdemetan-SCH-529074 (1-1 mol-mol),1.5320240627835209,2.104204814868501
IGROV-1,135398516,1.9751898057484376,1.972987049213949
PaTu 8902,3689413,3.662647678116459,-0.12147895938974973
Daudi,31703,-5.42156315939604,-2.3084299489774818
IGROV-1,24785538,1.106246320450551,1.7794497909357887
Daudi,navitoclax-MST-312 (1-1 mol-mol),0.6762626360352524,0.2740805297047966
PaTu 8902,676352,2.5672836386659625,2.102446498741376
MOLM-13,426756,3.5583078181784504,4.100398560939275
WM115,64971,1.594754361798162,2.669505408315101
SW1271,4521392,3.9428497415690713,4.344648017349478
HCC1500,19582717,3.689290387765622,4.002438394797849
BICR 22,71680916,5.5411632888305755,4.668239604179719
IA-LM,462382,0.6444148679919928,0.5832436135207013
P31/FUJ,24856436,-2.072993507389728,-0.5539397023316363
LS180,135411,0.2951252953722391,0.45710114939846747
MOLM-13,72376,-3.7215877343251456,-3.4332267076102183
RKO,6610216,3.958403220086871,3.8426481956767713
RKN,452548,0.7515073582009456,0.15063696521280623
P31/FUJ,navitoclax-sorafenib (1-1 mol-mol),0.3998417690889591,0.08016698418390795
SaOS-2,3038522,3.0360203721983257,3.013697768776019
SK-HEP-1,409805,5.808157500863876,5.477340926224056
BFTC-909,44137675,3.23817368119839,3.692736298603141
SW1573,25183872,-2.56928333929943,-0.6359563935845173
HCC1500,23582824,1.5666293035108128,0.8110845469972184
MOLM-13,11612883,-1.8374573083034769,1.6910786201251087
MOLP-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1535423507469189,0.7830305010248473
ML-1 [Human thyroid carcinoma],445643,4.241689590807037,4.046477178197012
KU-19-19,135421197,1.2163789616721166,2.061360340398448
SK-HEP-1,49766530,-2.8567737760804324,-0.54815021271383
Daudi,46843906,1.1534141628569738,1.434921031303749
HARA [Human squamous cell lung carcinoma],322968,4.828098936758316,3.99519795195335
IA-LM,11494412,5.732457488131999,0.7958952945496383
RKN,sirolimus-bortezomib (250-1 mol-mol),0.997863897964826,0.8309111854543498
Granta-519,selumetinib-piperlongumine (8-1 mol-mol),3.4654025033242712,1.985109881049779
Granta-519,46943432,2.0409318821812477,0.7364765828889116
MOLP-8,46174525,3.423634821116614,3.4831081655185665
RCC10RGB,19582717,5.580606305911862,4.344441251166476
NCI-H1568,71680916,4.3779497666633915,4.944687666736616
SW948,3689413,-2.2648112033429824,-0.718595199374829
RCC10RGB,252682,6.528801566934436,6.523804781374577
Daudi,135875424,2.734623655159311,3.183527312048501
K-562,4788,4.09681667300412,5.208526368672181
BFTC-909,66577038,2.856590203747272,3.061590416435261
BICR 22,56649450,1.894872176339528,2.705131064800201
LCLC-97TM1,23635314,-2.2617116518456792,-1.8692884810383756
SaOS-2,16013152,4.240825830990255,3.8532533361217243
MOLP-8,5738263,2.3540234006064424,2.6439476536036204
IGROV-1,3552672,2.134472496867482,3.1161889649456254
BFTC-909,6505803,-2.7076869289136147,-0.23158853443029914
NCI-H2452,9952709,3.912471204941481,3.198994139628411
SW48,4477,0.2937974315698831,0.8775947843754571
IGROV-1,10113978,2.874171865860951,3.376082455229595
Daudi,3465537,3.6729414318228697,2.0668314945058284
HARA [Human squamous cell lung carcinoma],400769,-0.3643318812201842,-0.6186668777964262
WM115,60750,-0.3155979924811316,-2.1147342516343666
LCLC-97TM1,3552672,1.9872160910848609,2.5581140994278333
P31/FUJ,16720766,-1.2973124396101832,-0.48515249638096636
PaTu 8988t,16722836,1.7927006401716397,1.7568870504965526
RCC10RGB,24785538,4.443576486987547,2.0171992016065996
LCLC-97TM1,54454,2.264936650655555,2.6185751052890436
BFTC-909,44202524,2.4582417316930916,2.4328750285829663
NCI-H2452,9956119,4.089312834038711,3.8485571973576067
LCLC-97TM1,44589607,2.470818031732135,2.6118158561699407
K-562,9911463,2.5078915917546336,3.263677310001404
RKO,12003241,-0.2410566552434749,-0.9683686419139405
SK-CO-1,9887053,2.665990529661509,4.006008480838661
HEL,9444,3.6260707724362113,3.5898528765667947
RERF-LC-MS,54618164,3.9158352593779377,4.112766567101151
SW1271,vorinostat-carboplatin (1-1 mol-mol),3.5487525185295774,3.1342417184426914
MOLM-13,400769,-1.4398892181534526,-1.3025692657656975
RKO,54454,4.6965621210229225,2.554842954554785
HEL,3815108,1.7280464955300685,2.201187124587473
HuP-T3,400769,-0.02490432142157,-0.46795571917659584
COR-L105,439501,-1.395093001857319,-1.8698085267082607
P31/FUJ,11717001,4.27266863837082,3.3932092541700762
WM115,44566777,1.1755609042254629,0.913305451119242
Daudi,9823820,1.816535221490948,2.838337004783991
K-562,selumetinib-BRD-A02303741 (4-1 mol-mol),3.9452785747148233,3.571209483465611
SaOS-2,11178236,-4.192404287761835,-3.352043828904823
RKO,107970,2.3673735748138265,2.1688145389382583
Granta-519,3384730,1.8851059301538475,1.3748374641123384
Daudi,3081361,1.2348545680767924,1.9902670194523526
COR-L105,11656518,2.8708923278875846,2.1187057717857134
SK-HEP-1,4261,2.0689452694586596,1.9195304708740037
IA-LM,4261,0.3595729013120086,1.5960053285925135
SW1271,5282054,4.135247135343962,3.9491371897063603
NCI-H1568,44491742,3.692908194165655,4.279067049122554
K-562,10074640,1.329135681779355,1.9212250161782216
IGROV-1,9908783,5.873270433212515,4.898196436608434
MDST8,24951314,1.0921901869172437,1.4514008280392008
ALL-SIL,3081361,0.1962192778787347,1.673454057833837
SaOS-2,4578,4.61303870633514,4.425208970577656
HARA [Human squamous cell lung carcinoma],3689413,3.203435099189031,-0.08857358533385178
SW1573,selumetinib-navitoclax (8-1 mol-mol),2.299465388888248,2.30604197913265
IA-LM,25227462,1.9658589227885097,0.47012902707445287
MOLP-8,71466578,1.6771539715617054,2.4387540010171107
HCC1500,11977753,-0.4307765862265268,-1.1247779165712382
BICR 31,vorinostat-carboplatin (1-1 mol-mol),4.357832771492993,3.1454036339322164
BFTC-909,568763,0.745825262149274,0.5266318480471526
HARA [Human squamous cell lung carcinoma],16741245,4.4624437574750955,3.8635161519151753
RCC10RGB,613753,3.3201179844199498,3.299276308266012
BICR 22,421610,1.881248812005912,3.295951474335891
COR-L95,55508,1.7090560645840305,3.1333462337834366
SaOS-2,2945648,3.259308629519986,2.8353086917023633
LCLC-97TM1,selumetinib-GDC-0941 (4-1 mol-mol),1.4589950943419845,1.1773106543120568
RKO,409805,3.580644131410829,3.7682695863067632
COR-L95,53495165,-2.3377393798516395,-0.36539879587278273
SK-HEP-1,25154868,3.1824362497542182,4.586616742964985
NCI-H2452,tanespimycin-gemcitabine (1-1 mol-mol),1.9681737644651764,-0.09688986906172109
SaOS-2,5978,-3.9287237947590494,-2.322809898628
COR-L105,4096211,2.67395928769434,2.376440002593068
LS180,15953870,3.325208983942858,3.2033519194443367
Daudi,66577038,1.2731684674623205,2.540245911342784
HARA [Human squamous cell lung carcinoma],carboplatin-etoposide (40-17 mol-mol),3.125998778003278,2.641716326422347
RKO,6918328,0.803085247134139,-0.49456189340443657
SW48,4259181,-1.8199657809061969,0.13747762364766083
SK-CO-1,44185566,2.2410285456889176,2.4278702011773965
K-562,5978,-3.1400031562505393,-2.9300761515772007
SaOS-2,613000,1.0847199338514617,2.859018909196444
LCLC-97TM1,9826308,0.172966057550933,0.2981809414875091
Granta-519,5311,0.5114694341413046,0.3164971439964407
SaOS-2,carboplatin-etoposide (40-17 mol-mol),1.667562518729443,2.582655132638003
SW1573,4788,4.2029613497215195,5.636377431859524
PaTu 8988t,vorinostat-carboplatin (1-1 mol-mol),4.263432325084182,3.300428790087056
WM115,2729026,3.0250773642114175,2.6311985703941176
IGROV-1,23725625,5.712368491237602,4.826829899326003
ML-1 [Human thyroid carcinoma],8515,2.907082200923046,4.276715053399518
SK-OV-3,24964624,2.562140083880341,2.4908842559701925
HCC15,navitoclax-PLX-4032 (1-1 mol-mol),0.321962590188161,2.3052033788806594
MDST8,5278396,3.853168516309647,3.239209494470839
RKO,119607,4.75876667689532,4.559868576584412
MDST8,65064,4.754326425577863,4.790493090167856
MOLP-8,54596558,5.109397009340411,4.299491584983995
WM115,9911830,1.4636751787761997,2.640171738543197
SK-HEP-1,44486219,4.3977685724309215,4.48431148728972
BFTC-909,15983966,-4.834157449814871,-0.7640115498568673
SU-DHL-1,24901704,2.0463171426909086,3.037636551476169
NCI-H1568,3025944,3.938114410703908,4.341646925974612
LS180,selumetinib-PLX-4032 (8-1 mol-mol),2.448756445045049,2.9260810365440637
ML-1 [Human thyroid carcinoma],4477,0.6808915512553289,0.5863026982436506
RCC10RGB,16725315,5.2458056955252275,4.309528735224837
RKO,53495165,0.8925500623489324,-1.4441427795791824
HCC1500,71304818,1.489157695167493,2.4578991254256035
COR-L95,135398738,4.3251787986630195,3.680622291173737
HARA [Human squamous cell lung carcinoma],9903786,2.5216559880194263,2.77660108427502
SaOS-2,56949517,5.721423210410403,4.161249252470486
ALL-SIL,644241,-6.056766449232899,0.8445552415117215
MOLM-13,42642645,-6.876168570605093,0.007063739983851425
RCC10RGB,51039095,3.636696049778912,2.9936588137832505
ALL-SIL,60700,-4.240130526526249,-2.374042120118681
PaTu 8902,15547703,4.581249636071297,3.018382814498145
BFTC-909,11609586,2.9417391320909134,3.001613040757245
SW48,11455910,-0.1633281652990052,1.1202052958837794
LS180,selumetinib-MK-2206 (8-1 mol-mol),1.4028786728536926,1.8093400519752831
HARA [Human squamous cell lung carcinoma],JQ-1-navitoclax (2-1 mol-mol),2.200588179814963,1.3442174788462415
MDST8,11364421,1.2673702676732186,-0.8671489200996406
BFTC-909,navitoclax-piperlongumine (1-1 mol-mol),2.723586959528991,1.812003779653534
IGROV-1,23939,4.412541857664819,3.939569037532609
HCC15,11626560,0.3588759938830249,2.013118680733179
MOLP-8,1750826,-2.6273703880538166,-3.0282880473539637
RKN,crizotinib-PLX-4032 (2-1 mol-mol),3.0048201060690314,1.903516886847408
SaOS-2,3634881,3.4478485283346454,3.1476078253867383
KU-19-19,65064,5.4276979548790285,5.012712386445353
SK-OV-3,53392493,2.9853646548342767,2.744922813486151
BFTC-909,44607531,1.7004331217528663,1.6086955671856296
RKO,9915743,2.8851858618766957,0.4019607957793787
WM115,969516,2.5733075045080405,2.928597769680231
MOLM-13,navitoclax-MST-312 (1-1 mol-mol),-0.7732876947237494,-0.09961083306536404
HCC15,1641662,2.7903081608832743,3.6457841038875047
PaTu 8988t,24856436,-1.0780184146975675,0.7682414376507493
BICR 22,151289,1.1052603945032196,1.1998780921353627
RKN,10302451,3.971829298943927,3.1358954429398973
Daudi,9840324,5.326423492349393,5.282944414101955
Granta-519,24978538,-1.4483375486726318,-0.9623894481790778
IA-LM,969516,4.593397144463051,2.5695125116571744
LS411N,16741245,4.421981695824733,3.601620400271433
SaOS-2,241158,3.6917409878316136,3.7613909432007557
HCC1500,49846579,-4.075833194843517,0.9023243793239031
LS411N,11626560,1.8283516183370416,1.1820807001813456
NCI-H1568,2746,2.7741418395417163,3.4135346101863013
PaTu 8988t,375860,0.0559535091713014,0.09189691924580319
BICR 22,613753,3.418897622092284,3.051786852684907
ALL-SIL,52912189,0.8155728349845486,0.07282285509321001
BICR 31,erlotinib-PLX-4032 (2-1 mol-mol),1.9143994783784697,3.1306166953988384
BICR 22,3634881,3.8771660288779457,3.2671465829967534
RKO,3543504,4.836700902585943,3.603049836700391
Granta-519,6918837,-5.331886820340028,-4.746853345654699
SW48,56963564,-0.9893979738252238,0.785893572904615
Daudi,4259181,-0.0890599021012781,-0.3624113457404853
Granta-519,7326481,2.8185757173328927,2.662554573649928
SK-OV-3,4096211,3.632564776557465,2.3108159720619925
HARA [Human squamous cell lung carcinoma],11317348,1.2268055094863417,3.3098079906959974
SK-OV-3,24856436,1.946601057004947,0.6510786769444078
Daudi,613753,2.7401651571031618,2.797839761007828
ALL-SIL,navitoclax-pluripotin (1-1 mol-mol),-6.100095381264916,-2.2966835379356123
BFTC-909,452548,0.7682850038212578,0.32786915954811735
P31/FUJ,409805,3.653161003579303,3.5491525701802145
IGROV-1,11404337,-0.7659238947812715,-0.42994840461573886
SU-DHL-1,24753719,3.670729792524347,4.088950130270964
BICR 22,24901704,3.9299918475898408,3.2849605581583
ML-1 [Human thyroid carcinoma],9911463,4.5829335325836436,3.9205462580583803
NCI-H1568,135411,0.4069452326541798,0.7181413951435751
ML-1 [Human thyroid carcinoma],SNX-2112-bortezomib (250-1 mol-mol),0.4585620616557309,-0.715892469211997
K-562,126941,-4.461586339574126,-3.180394255587367
Panc 02.03,2113511,6.868929428825361,5.579364780603445
NCI-H2452,44241473,5.273016525632626,4.807812202237015
RERF-LC-MS,135984461,4.284403636339015,4.055708808190408
KU-19-19,5329102,2.6076401407195355,2.2123171447256524
SaOS-2,49867930,4.412008076102657,4.632602024785948
HARA [Human squamous cell lung carcinoma],9926054,1.843677597683555,1.921338272292835
IGROV-1,54618771,1.2456991772210466,1.048952887103373
BICR 22,7251185,3.2802016727508105,2.5831260163314487
WM115,11178236,-3.130587173648645,-3.0291547732275497
BICR 31,168312962,4.404506435623785,2.396775809322094
BICR 31,135421197,2.236076370585341,1.9434873574539224
K-562,72734382,4.39493075447737,3.765689892031209
Daudi,4521392,3.754955104648716,3.959300253538177
NCI-H1568,9903786,2.4011050725962115,3.1394615328457522
Panc 02.03,1242560,3.876690059869664,3.63605167542231
SaOS-2,24771867,1.911103494547597,2.046666470456129
NCI-H1568,46224516,1.8217130718981496,2.876222624262588
HuP-T3,637858,1.096014734488476,2.199432051556043
HARA [Human squamous cell lung carcinoma],10184653,0.92256613856931,1.0743975107686663
HCC15,9825149,1.99442718669858,2.418511873096301
ML-1 [Human thyroid carcinoma],1285940,4.2577484489413004,3.6055539784654345
LS180,9967941,3.3265068520356227,3.5675338795158744
BICR 22,15953870,4.283514914534557,3.675281827272313
ML-1 [Human thyroid carcinoma],124202324,2.283804161098842,2.710023582336189
P31/FUJ,49766530,-2.577046245506879,-1.8158490452357632
COR-L95,erlotinib-PLX-4032 (2-1 mol-mol),3.78665088959685,2.837755778681896
IGROV-1,5470400,-0.2457809435208252,-0.25996288766363285
K-562,3025944,3.938999685525622,3.9449706972143503
ML-1 [Human thyroid carcinoma],5282054,2.990899024296238,4.137650442118667
Panc 02.03,1641662,3.717230762709902,3.633710953197031
UACC-812,selumetinib-JQ-1 (4-1 mol-mol),2.304813012505874,1.2192503637839784
WM115,tanespimycin-bortezomib (250-1 mol-mol),-3.082960536086858,-0.39672416231571034
SK-CO-1,613753,3.569116813952151,3.265533587133425
RKO,navitoclax-gemcitabine (1-1 mol-mol),-2.8709534482220196,-1.7830056294393708
LS411N,73707398,1.3643081745247092,0.7996731767358198
RKN,60700,0.8209474049972991,-0.4091807483329435
P31/FUJ,52912189,-0.0654684439378525,0.06702742351136415
Granta-519,49793307,-5.0235824363471675,-4.531822670403638
LS180,439501,-1.9142457865624176,-1.967671690644707
BICR 22,19582717,3.5857042125142247,4.343371946066716
P31/FUJ,11612883,1.4537759753270971,1.8417906308342038
RCC10RGB,135423438,4.4299924289236055,2.627496874851396
HCC1500,piperlongumine-MST-312 (1-1 mol-mol),1.4293216638390454,1.8877840196620446
IGROV-1,24797083,1.5319862293819655,1.2043321730741277
WM115,11657048,4.298694485616108,4.299064001637891
SaOS-2,5328940,1.8581375817896455,1.857402298934006
K-562,11427553,0.716330793964625,1.4373470874971477
BFTC-909,60700,0.4554202898414442,-0.016112483206076406
HARA [Human squamous cell lung carcinoma],24964624,2.781169175627229,2.697747342360994
HARA [Human squamous cell lung carcinoma],44259,0.8184068416156438,0.8890939685712884
HEL,656346,0.4971755704716853,0.21805872497839499
ML-1 [Human thyroid carcinoma],3384730,3.994618489141425,3.1552720892900394
SK-HEP-1,25126798,3.9918710327668503,3.9508407019698892
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933,0.983107216194821
HCC1500,568763,-0.919346546730658,0.5327710631615394
SW948,selumetinib-tretinoin (2-1 mol-mol),-0.8554904901249896,2.833763208016214
NCI-H2452,71466578,5.120149615089657,4.895164094464973
COR-L105,2871966,0.4959639880090196,0.6313647185915594
SW948,5746,1.511438037719251,1.098003876895787
WM115,10172275,3.759074377781229,3.464788744364333
PaTu 8988t,11964036,2.992263460840089,1.4783618683105786
SW948,16219061,3.499504842183279,2.686911894902818
LCLC-97TM1,53495165,-0.6427926162361222,-0.31460114465716993
UACC-812,3081361,1.9829916627298712,2.3371720521434924
SaOS-2,5287969,-1.655987163162804,-1.9054316283621744
IGROV-1,25183872,-0.4560099928976716,-0.47504095999760115
IGROV-1,44607530,1.2936443589937894,1.8202582922331754
BICR 31,salermide-PLX-4032 (12-1 mol-mol),5.564689341846323,5.058513925729176
SK-HEP-1,57519531,4.12625544642691,2.6310088306484425
BICR 22,119182,-2.736639797021525,-0.08332946455690352
PaTu 8902,4521392,4.129468839379376,4.420039081252523
LCLC-97TM1,60700,-0.7670870439402468,-0.7525388976462257
ALL-SIL,44607531,0.7892287314343482,1.1912216499364832
SW48,16720766,-1.213948450866439,0.7226058329949784
LCLC-97TM1,9911463,3.937478558519083,3.612459096044992
SW1271,6918289,2.985913038733717,2.7874690079236926
SK-HEP-1,25183872,-0.6604608842788147,-0.585097456893534
P31/FUJ,5311281,0.8046363155731003,1.713692492958193
MOLM-13,107970,2.204740997332017,1.8315059024031752
PaTu 8902,44607531,2.4953979740561136,1.511496320788614
BFTC-909,5978,-2.385180460490498,-1.7942078272540374
IGROV-1,9926054,1.8111808945519428,2.061281477065468
MOLM-13,JQ-1-UNC0638 (2-1 mol-mol),-0.7004023711482303,0.04030717296104422
SaOS-2,44632017,0.980304929421305,1.337362964600486
WM115,23582824,-1.5173797182891284,0.7985519724212778
RKO,5746,2.147448518007633,0.8066619785347301
SU-DHL-1,docetaxel-tanespimycin (2-1 mol-mol),-2.528242404368283,-3.955376763674353
COR-L95,11234052,4.796206825131301,3.6310796641876015
HuP-T3,navitoclax-gemcitabine (1-1 mol-mol),2.4880623143443965,-0.5659079011729431
MOLM-13,46199207,1.8343479247638497,2.853175796846133
SK-CO-1,216345,2.2578794962248403,3.9271680556624955
LS180,24951314,1.284825385865239,1.3764216722194578
SW1573,71680916,4.0865163925225385,4.594327541983275
LS180,11427553,3.214146965067504,2.9160171441423084
HuP-T3,17755052,3.4304742988115366,1.7579470732900075
IGROV-1,44607530,1.2936443589937894,1.8202582922331754
HCC1500,11964036,2.769497384705972,1.3219154920908287
LS180,446155,1.950458971830876,2.8188899905942453
SK-OV-3,10385095,3.0219456492917485,1.2945721994836739
BFTC-909,serdemetan-SCH-529074 (1-1 mol-mol),2.384231187993096,2.2140942809936575
LS180,23635314,-2.728761007932067,-1.8429019878882966
ALL-SIL,25262965,-0.0785584741633136,-2.2636059401818884
MOLM-13,9956119,3.465056755214706,2.835679533395594
Panc 02.03,54619267,4.6873070757127335,4.180976223005061
MDST8,45100481,5.670163105184411,4.485825439748818
P31/FUJ,11427553,0.2126015278922564,1.2603755261262888
RKO,navitoclax-sorafenib (1-1 mol-mol),2.2009176263452983,1.6051445825933657
SW1271,123631,1.9601206845091983,2.5780026647922063
HARA [Human squamous cell lung carcinoma],5738263,3.6004475982525825,3.4905406635041487
SW1573,11626560,2.096503053081923,1.9643565838516404
COR-L105,11717001,4.401406695561914,4.062551129099914
COR-L95,JQ-1-carboplatin (1-1 mol-mol),1.8062318254958765,1.6739757493462357
IGROV-1,135984461,4.285945029851472,3.8689991336322858
HuP-T3,16725315,3.145396972494799,4.430633358997845
SK-OV-3,5278396,4.0115131897954175,3.672603651803225
HARA [Human squamous cell lung carcinoma],9907093,5.03391680027973,4.24039035979703
RKN,piperlongumine-MST-312 (1-1 mol-mol),1.5374075036414252,1.759334012958569
HCC1500,7326481,2.1911838281348897,2.9427605670552457
ML-1 [Human thyroid carcinoma],6918328,-0.1732040518011542,0.30363129391025867
RKO,11485656,2.16906736756012,1.86282429053567
HCC1500,17755052,3.708779056995352,1.3315402916022043
RKN,16720766,0.5941206863048918,0.7016346971621675
SK-OV-3,49766530,0.1985460846164677,-0.3101786230480936
NCI-H1568,11178236,-4.756412327662482,-3.043431895251565
K-562,613000,2.5009117496842292,2.3562465198249285
SK-HEP-1,doxorubicin-navitoclax (2-1 mol-mol),-0.2519782158989084,-0.7339837840984115
Daudi,49867930,3.141108082189553,3.7867852761463663
P31/FUJ,451668,0.4769801026955246,-0.48589033005044596
SU-DHL-6,2708,3.434249932793118,3.2479034358354215
RKN,11497983,4.544575984994342,4.388208543591192
IGROV-1,23582824,0.3287266354391525,0.857225844812434
HCC15,2858523,2.7763462118547833,3.106978743877793
RERF-LC-MS,3025986,-0.71270364092759,-0.6762518922081836
LS180,984333,1.4840791700280882,0.5776090164183826
COR-L95,24901704,3.9540534266274183,2.8666506730783903
NCI-H2452,selumetinib-JQ-1 (4-1 mol-mol),2.500134928300083,1.5895789893181074
MOLM-13,piperlongumine-MST-312 (1-1 mol-mol),1.1119295359137316,1.2180320313965836
COR-L95,409805,3.71634228772174,4.321664669649676
PaTu 8902,9823820,4.420414335239228,4.079778978764088
Granta-519,24821094,2.4908648032560183,2.4101359672635
SU-DHL-1,26596,-2.3613305357908625,-0.9245985130077855
RKN,285033,-0.0275118271199953,-1.9451531001432725
BICR 22,sirolimus-bortezomib (250-1 mol-mol),4.6715609696805505,0.8536656942396802
WM115,ISOX-bortezomib (250-1 mol-mol),0.2831832229570691,0.6183484925956302
NCI-H2452,9936388,2.1806204942966803,-0.8688891738778304
LS411N,54618771,1.0517408544895162,0.9155964816451442
RKN,72193861,2.3331130274465313,1.9184078967245577
MDST8,46843906,2.4704071908178844,3.10484966711467
HCC15,11485656,2.480533785053976,2.39923575462358
MDST8,11977753,-2.9914432786855305,-1.5964893302550585
PaTu 8902,168313047,2.1566405666580963,2.4958541696305954
MOLP-8,135928012,3.056644501758044,3.9219069732425793
ML-1 [Human thyroid carcinoma],25062766,2.2645177949682775,2.32508732305259
MOLP-8,10074640,3.1436066614625173,2.9008935336288357
HCC15,12001922,1.9087360775911748,2.1161326345415072
LCLC-97TM1,3025986,-2.553955076787079,-0.8767409994128282
BFTC-909,2842253,5.585220688564769,5.397151837316895
RKO,216239,1.9979551619375524,1.8597670412008955
HARA [Human squamous cell lung carcinoma],241158,4.240217877475157,4.059878504824227
RERF-LC-MS,JQ-1-carboplatin (1-1 mol-mol),4.276053499927872,2.474052755586077
Granta-519,135398516,2.1425852334349575,1.139738577211028
KU-19-19,10385095,1.1563887024661463,1.4002197283558973
LS411N,navitoclax-gemcitabine (1-1 mol-mol),0.4425335439188313,-1.0033016209238894
SU-DHL-1,9803433,4.734138876460479,4.587554059719094
HCC15,135999136,4.472611779685761,4.1083411432271655
SW48,11238147,3.1100916590750045,2.665601676304622
HCC15,tanespimycin-bortezomib (250-1 mol-mol),-2.289156821264784,-0.5800086507661006
BICR 22,409805,3.8456212820768214,4.920153962833774
SW948,selumetinib-GDC-0941 (4-1 mol-mol),-3.896690328067956,0.7095495177729677
P31/FUJ,24785538,-0.2737810661065927,0.167192072643554
Panc 02.03,176870,4.923826321280428,3.7145405640017883
RCC10RGB,322968,3.1449149812629877,3.3685401255502496
HCC15,107970,2.678547076190946,2.2472822982377747
SW1271,71304818,2.7682192858067385,2.5829966021036483
LS180,3634881,3.5372782333734696,2.967549857390553
COR-L105,11214940,1.6414587299435788,2.0380989343832043
SW1271,5287620,-1.7165830209074355,-1.9182953902217657
HCC1500,navitoclax-piperlongumine (1-1 mol-mol),-1.489158158277352,0.75448030399393
COR-L95,49766530,-0.268325836176492,-0.4377245418270077
P31/FUJ,6450551,0.3392586382091512,1.212212656101674
PaTu 8902,5566,3.0665407385312182,2.9965559132236654
SW1271,6610216,4.395476769861187,4.430005107019542
IA-LM,4477,0.1872236957364025,0.6020052807546877
BICR 31,6917907,-2.0849244140580683,-4.789642282147032
Daudi,56949517,3.615784656128556,3.730884645077632
SW948,selumetinib-navitoclax (8-1 mol-mol),-0.0800083599001994,1.1221610929492625
Granta-519,156414,1.3767921664113123,0.7213199669182684
SW1573,60700,0.5293530759970745,-0.11697227407053865
PaTu 8902,11404337,0.5155229173062875,-0.31212991972917903
BICR 22,52947716,-3.710960782083666,-1.134438877507748
HARA [Human squamous cell lung carcinoma],5311,2.3146371221244184,1.5735589514101607
ML-1 [Human thyroid carcinoma],135398516,0.6909808613935852,2.123427078898957
SW48,216239,2.7420558854204105,2.35459194865617
HCC15,136227924,3.0147456858017923,3.1515718461736975
MDST8,400769,0.2052239388954162,-0.5327959586684933
IA-LM,navitoclax-sorafenib (1-1 mol-mol),0.7106711881893861,1.5862781548940164
RCC10RGB,4917,3.4531775579708044,3.037196763281758
RERF-LC-MS,73707398,2.0319367406190483,1.5181631683176062
LS180,4917,2.9590600733191272,2.9422488845975563
Granta-519,46926350,-4.5411361861126,-4.604998104158193
BICR 22,1716436,3.778329286476686,2.95289009463925
LCLC-97TM1,55283,2.725406070596606,2.765709125556322
LS411N,BRD-K27188169-navitoclax (2-1 mol-mol),3.592750133273901,1.6031146025618093
RKN,168312962,-2.199105388969794,2.2500694272858994
MOLM-13,54619267,3.3881439662249657,3.26314603044179
Granta-519,sirolimus-bortezomib (250-1 mol-mol),-0.0602153873263711,-1.8231318903051656
COR-L95,1239801,5.40725658561935,3.667749344201889
IGROV-1,10184653,0.79276129336756,1.359206657765272
HCC1500,16741245,3.4170657459529865,4.058735696173875
LS411N,44491742,5.693616041532359,4.25003356851669
HARA [Human squamous cell lung carcinoma],5282054,3.837128949835148,3.880866084820361
Granta-519,24753719,3.151565571990212,3.1113139962080067
MDST8,decitabine-navitoclax (2-1 mol-mol),-0.200661322464638,1.8492443147422726
RKO,107985,-4.24085601271806,-3.676689394516066
HEL,322968,3.0393820993226535,2.17999757209798
Granta-519,46224516,0.9242838162777752,2.309053059743092
LCLC-97TM1,9823820,4.2474508710721315,3.689311026092962
MOLP-8,23582824,0.4015956903029024,0.7086295465594245
NCI-H2452,60750,1.245026450810127,-2.0637927194472883
NCI-H2452,piperlongumine-MST-312 (1-1 mol-mol),2.5229701837483263,1.9839589404926101
COR-L95,54596558,4.049100773357865,4.3147231179627665
SW948,135398738,3.916695667859345,3.1258876031519494
SK-CO-1,9936388,-6.4137542305703015,-1.0999563077984968
Daudi,60700,-3.752408099295295,-1.916300209986479
COR-L105,11612883,3.356288934915157,3.0649685918687943
PaTu 8988t,10302451,4.044762571435361,3.2024277033710247
SK-CO-1,44507138,1.8454813707467936,2.5570359347253704
COR-L95,44486219,4.398500193784116,4.316882250126911
LS180,1242560,3.670855291471482,3.4446086969895147
PaTu 8988t,25102847,3.84691315859083,2.613319147152928
SU-DHL-1,1750826,-3.9186889861650713,-1.0017463492061907
IGROV-1,4261,1.934016649932683,1.749295064961824
IGROV-1,9903786,1.7387584479757865,2.940397437684869
IGROV-1,9935249,3.330117761231163,3.199113830122317
COR-L95,446155,4.383849487789403,2.8139580774622157
COR-L95,9967941,2.195306027237361,3.3597622938807996
BICR 31,49793307,-0.900639036765476,-2.3444230469232235
Daudi,52912189,-0.5619081020202099,0.0644610451296659
MOLP-8,9911463,4.2009596294807245,3.165086221306636
LS180,44589607,3.154958497437342,2.8430963399427043
Daudi,24821094,0.7293316215174883,2.4250225262311957
RKN,12003241,-0.3350096455718494,-1.4544438463131386
LS411N,148198,-2.2204558676981576,-3.595367287352618
RERF-LC-MS,446155,1.000000375050646,2.897330854105474
MOLM-13,10127622,2.24693559354045,1.865135214782912
SU-DHL-1,decitabine-carboplatin (1-1 mol-mol),1.7663528844174463,3.726734582620785
P31/FUJ,72734382,3.508076038929844,3.6840372612132053
SU-DHL-1,568763,-0.4525318049600722,0.5955905272462715
SaOS-2,11977753,-0.3684170228919589,-1.3777386687246485
SaOS-2,969516,2.4754458532868067,2.851998741646903
SU-DHL-1,54619238,4.649416356939895,4.007954133213656
SK-OV-3,6623618,3.404966669354166,2.438552284106398
WM115,9952709,2.366340614566085,3.161488569297903
Panc 02.03,10184653,2.526680989613479,1.131521389155559
SW1271,3634881,2.897813479014186,3.199381117764992
P31/FUJ,72376,-3.3088434861533704,-3.462265030949327
P31/FUJ,46907787,-0.8407426122417735,-0.51163406980032
IA-LM,5351362,3.020488284300014,1.3003421968910047
NCI-H2452,676352,2.443862996701222,2.2454483238743204
SU-DHL-1,56973724,1.0008411647005613,2.949602817301336
PaTu 8902,1716436,3.3992265902353425,3.0314057168168125
ML-1 [Human thyroid carcinoma],10074640,3.5607250325369812,3.240489591837276
MOLM-13,11717001,3.6418982852877457,3.1709493407157017
MOLP-8,613753,2.6774354597179,2.7596862115410947
IGROV-1,44137675,1.8406125640672395,3.4274428126426426
P31/FUJ,6914657,-6.361388893160888,-5.283502890779925
LS180,60750,-4.478139976515186,-1.244548366504606
SW1271,3062316,-1.9256219632112692,0.7946479468348555
RCC10RGB,219104,3.453227771477981,3.7945825696563134
HuP-T3,6917907,-1.7519392074642692,-4.691452785069942
SU-DHL-1,11656518,1.4392799669460994,1.091703924428024
MDST8,54626689,6.955475194588027,4.385215203402834
SW48,10410894,3.4061289364485794,3.2986522102341196
HEL,72193861,0.4910118925931417,-0.006807520912936498
Panc 02.03,65064,5.367712415574159,5.206578954168347
BFTC-909,984333,1.0937084793466407,0.7405519752103461
IGROV-1,426756,6.142776526139055,4.3194317941047125
RKN,11152667,0.0617927102225113,-0.49319003366336295
BICR 22,3025944,4.210034761741456,4.18055235386802
SU-DHL-1,11640390,4.597120644825806,2.7194881538463083
RKO,44589607,3.597229089573096,1.8591947422826076
IGROV-1,56963564,1.8260986108097368,0.7602628846689794
Daudi,24180719,3.437659555986817,3.4658182400517243
BICR 31,45279963,4.353781648061694,3.750307573715137
KU-19-19,445455,4.442962740031222,4.733853954501322
Panc 02.03,5281672,4.500820026656837,4.801111857670633
Granta-519,675434,3.9057117034292976,4.045876616452657
WM115,46398810,3.009678027858605,2.510306970880466
BICR 31,119607,5.814089022953436,5.312864080309978
IGROV-1,23635314,-0.611739968448912,-1.678385308243569
HEL,44819697,-3.010940469478465,-1.855328733571216
ALL-SIL,5282054,2.788902246408387,2.608005659736676
WM115,5328940,2.031963430852867,1.8995244031526892
BICR 22,11455910,2.0554057071158303,1.5768650988037516
COR-L105,serdemetan-SCH-529074 (1-1 mol-mol),2.960742836944571,2.227484425329033
P31/FUJ,4259181,-1.476581151251805,-0.2684765303653825
MOLP-8,54619267,3.766514987830834,3.747882226816057
P31/FUJ,44489367,5.126164790260484,4.226600111438717
RKN,11625818,5.974552631000589,4.550699201648704
SK-CO-1,alisertib-navitoclax (2-1 mol-mol),-2.923852550533504,0.7567706798436936
BICR 31,5470400,2.045329114611378,-0.4647568648472401
LCLC-97TM1,5738263,3.894572665100205,3.048700615459118
SW48,2729026,2.3283979545053155,2.566840709562267
HARA [Human squamous cell lung carcinoma],123631,2.9564926917309635,2.2583156398897746
COR-L105,11167602,4.878993593502554,2.6205387687407637
HCC15,9549297,1.5760835884765407,2.9114384428191933
HuP-T3,448949,2.1685596620814565,1.9457068001076678
Granta-519,9915743,0.9460784198503543,0.012036246376691215
MOLP-8,51039095,1.4019996450160122,2.1351276845058673
COR-L105,56649450,3.0558986692826595,3.3631207122824884
WM115,16038120,1.6321211746217177,1.2085494996535653
K-562,31703,-1.219746708928784,-2.061778630205404
ML-1 [Human thyroid carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),1.7858982688933729,2.2643631838249214
SU-DHL-1,11609586,1.5538406664396571,2.5798144604732793
BICR 31,3025944,4.108701914406302,4.403537271876105
SW48,66577038,3.1598846844687545,3.0640681065050996
Daudi,24180125,1.1000611971852634,2.268845910081847
SK-CO-1,6184667,4.676967004326267,2.805326517697951
Daudi,SNX-2112-bortezomib (250-1 mol-mol),-4.343389130323972,-2.463761092082211
SU-DHL-1,67291369,2.039504043535649,2.336774430993921
IGROV-1,3815108,1.915722485757852,3.075155589269578
ML-1 [Human thyroid carcinoma],2708,2.4589573831191633,5.057413515949319
SW1271,selumetinib-GDC-0941 (4-1 mol-mol),0.8746912096343703,1.89811311540935
LCLC-97TM1,68056272,3.7652459105524585,3.5501841286086
NCI-H1568,9926054,1.8156743035592564,1.9733067761298924
SU-DHL-1,2113511,3.6581551041454823,4.94403693341397
HCC15,3503,1.8764785687467953,2.2507942979584716
SaOS-2,3062316,2.2990980703822115,1.4261614371793112
K-562,16736978,2.075477087199636,0.9413733973931331
SU-DHL-1,selumetinib-decitabine (4-1 mol-mol),2.598187269312087,2.9296264085621475
RKN,135440466,3.1815161125023033,2.2480372382580747
SK-CO-1,89928392,1.2451759556756246,1.5630741222851836
NCI-H1568,54596558,4.146513733670967,4.371025103579422
LCLC-97TM1,4477,1.1810793422928998,0.7503848670210624
LS180,16741245,4.152630132762677,3.83344097831102
SK-CO-1,decitabine-navitoclax (2-1 mol-mol),-0.6610169057545121,1.631670775471603
BFTC-909,159324,4.114702101808939,3.178878783991187
PaTu 8988t,2113511,6.37119394515457,5.560636528645856
ML-1 [Human thyroid carcinoma],alisertib-navitoclax (2-1 mol-mol),-1.2100779480376045,0.7821008047332855
IGROV-1,5291,3.6852809555447985,3.7385579399574174
PaTu 8902,16038120,1.215016097060631,1.0280851011520262
ALL-SIL,10302451,-1.1728976190372558,2.7780227516678537
UACC-812,tretinoin-navitoclax (4-1 mol-mol),2.4411364981876043,2.236253345905971
LS180,vorinostat-navitoclax (4-1 mol-mol),1.6395407762655403,1.326241646153012
IGROV-1,docetaxel-tanespimycin (2-1 mol-mol),-1.5830865659631668,-2.6887974390705853
P31/FUJ,vorinostat-navitoclax (4-1 mol-mol),-0.3847698718995038,-0.4904119405496647
ML-1 [Human thyroid carcinoma],7251185,4.28899372473645,2.749815729930571
SW948,7326481,3.486606738365962,3.003276255940971
HCC15,44507138,1.6295786006094204,2.8485512033130793
RERF-LC-MS,16725315,4.583339442818838,4.469652318833995
P31/FUJ,148198,-3.664233852608881,-4.134640601681135
HEL,49850262,3.2265871136708997,2.6273448918731237
HARA [Human squamous cell lung carcinoma],25126798,3.0348047735223935,3.909095327437076
BFTC-909,60750,-1.7298046099952136,-1.9462106672661912
SW48,doxorubicin-navitoclax (2-1 mol-mol),-4.619867397585904,-1.2825927144167617
NCI-H1568,675434,4.067969537829177,4.6559160156466355
COR-L95,19582717,3.635233206850296,3.490995171969879
COR-L95,148198,-4.800055382400855,-3.844417127462644
BICR 22,44819697,0.2156040754176,0.06700970678822685
SK-OV-3,46224516,3.444215787907748,2.8367266560365807
HCC15,5281672,5.6563329698974965,4.611870877713905
HEL,6918328,-0.4966077251990671,-1.3312540771036823
NCI-H1568,24785538,0.5698046292147018,1.750112232222896
RKN,23582824,1.7370647325872666,0.7944636675767345
PaTu 8988t,navitoclax-gemcitabine (1-1 mol-mol),-0.4570432900108468,-1.054213848457496
SU-DHL-1,322968,2.585334286015635,3.26213959508241
BICR 31,24797083,1.8361324304615187,1.6000246447807074
SK-HEP-1,3062316,3.432714145613195,1.3648353481597189
PaTu 8902,2729026,2.7803221257085884,2.6591940348022014
SK-OV-3,11609586,4.251063762376387,2.9427791153488387
HARA [Human squamous cell lung carcinoma],3025944,5.227932597847333,4.275024592647713
ML-1 [Human thyroid carcinoma],156414,1.0547615836858202,2.0262823885281507
Granta-519,44607530,1.7224857333943702,1.2767298363550672
NCI-H1568,15953870,3.42403550557497,3.6107843338081382
RCC10RGB,carboplatin-UNC0638 (2-1 mol-mol),3.3801418218563337,3.554408629667628
MOLM-13,erlotinib-PLX-4032 (2-1 mol-mol),1.7877509525982431,2.749687903892118
MOLP-8,252682,6.161004481234046,6.365002504621673
SW1573,126941,-1.0305779796426808,-2.777284935930743
BICR 31,9927531,5.661036072082279,4.860977513986467
RCC10RGB,441298,3.7731685554529384,2.6495758721877065
MOLM-13,387447,-5.119095777855545,-4.7073218314805905
Granta-519,216345,1.0997896286755158,2.4056011553200305
LCLC-97TM1,107985,-4.222636663811031,-3.6173118429649787
LS180,3384730,2.894746509752001,2.6890831244235964
HARA [Human squamous cell lung carcinoma],9936388,-6.286258703982233,-1.693241492259618
ML-1 [Human thyroid carcinoma],2746,-1.478438692576885,3.488985945402811
KU-19-19,44493528,4.383684457454455,4.407380244347058
LS411N,53232,4.5193815700089655,2.866050162075333
ML-1 [Human thyroid carcinoma],46907787,2.3673247902218804,2.2150930502376713
LS411N,6438330,3.3380693145982816,1.9960210806569756
HARA [Human squamous cell lung carcinoma],5284616,3.060508834181737,2.6797211251965845
NCI-H1568,JQ-1-carboplatin (1-1 mol-mol),3.4150339974619457,2.8412214984497903
BFTC-909,16725315,4.495652912061774,4.125659466183934
RKN,124202324,3.704376342602573,2.742531022638096
LCLC-97TM1,10127622,3.458194652659875,3.1479195016343864
SW948,vorinostat-carboplatin (1-1 mol-mol),1.7834644899516086,2.393436723280575
SaOS-2,5494449,1.7356769079300427,2.716789140750292
HEL,702558,3.166026376934585,3.6106775615187883
KU-19-19,11612883,2.975593545287462,2.8875753361895455
BICR 31,6914657,-2.1990076047646703,-3.8100549499517
PaTu 8988t,2858523,3.414247843041017,3.078706946165261
SW48,9911830,1.5953282800372102,2.559790839505301
Daudi,11178236,-7.583909031047052,-4.353504095618124
Granta-519,44819697,-1.094231558387569,-2.0375918915749445
MDST8,2828334,6.077771510152207,6.283656819565109
RKN,9911463,4.114615883902867,3.8371990830057556
RCC10RGB,JQ-1-vorinostat (2-1 mol-mol),1.4034358595851535,1.2416228605232533
SaOS-2,9903786,2.3206358959344264,2.6632113044355736
RKO,44607530,2.6096687798301677,1.6877675971206594
SK-CO-1,11455910,1.152685438196598,1.018039223814964
SK-OV-3,25183872,-0.070614613180641,-0.6171337613326547
WM115,25227462,1.5125525407178182,0.4324724150138452
HCC15,2126,5.047391044285817,4.777703989151322
HARA [Human squamous cell lung carcinoma],9823820,4.297752192216693,4.188594780961079
HuP-T3,11238147,3.6375005285241033,2.9178721829794814
SU-DHL-1,168313047,2.0629090722275945,2.22743835190854
BICR 22,5335621,5.24838502551373,4.5022952140775585
SK-OV-3,135398516,2.140261030425796,2.2533115173375204
ML-1 [Human thyroid carcinoma],6852167,2.7131700239928316,3.0399215325125835
RKO,11214940,1.6564081526645635,1.4775426412178725
SW948,9935249,-1.8483271913214137,1.6789508497422898
NCI-H1568,2871966,-1.5477941874243064,0.5576913116911032
WM115,54626689,3.4845925362433,4.6240421434336
IGROV-1,46398810,2.003787621940583,2.6096694181773032
NCI-H1568,alisertib-navitoclax (2-1 mol-mol),0.1984676648447771,0.37285601949665015
RCC10RGB,selumetinib-UNC0638 (4-1 mol-mol),4.208062457345683,3.432007864890425
SW1271,selumetinib-PLX-4032 (8-1 mol-mol),0.5021040652093107,3.225245699722326
BFTC-909,3025944,6.464154930724253,4.242572071403466
BFTC-909,10113978,3.8739618499623094,3.446022984948399
LS180,docetaxel-tanespimycin (2-1 mol-mol),-5.0888233311005795,-3.061347611707766
BFTC-909,24748573,2.672786285704278,2.2218621805428076
MDST8,23582824,0.3553467044538872,0.8663311269635919
MDST8,navitoclax-MST-312 (1-1 mol-mol),0.0883996467230522,0.4947678007197813
SW948,53392493,1.921137473015096,1.942119924962955
LCLC-97TM1,5287620,-2.537847801025228,-2.1212638718900583
HCC1500,3552672,1.623977684405255,2.931913396214254
SW1271,2113511,4.856200971437617,5.477290760552672
RKO,11238147,3.3996395604326977,2.3654547862347473
MDST8,56963564,1.9609696235744132,0.49591543433390706
HEL,JQ-1-vorinostat (2-1 mol-mol),-0.5678151706430512,-0.4925982768906932
MDST8,73707398,0.930898424190815,1.4187671492267253
SaOS-2,selumetinib-GDC-0941 (4-1 mol-mol),1.0166144741288403,1.4896252658692213
COR-L95,serdemetan-SCH-529074 (1-1 mol-mol),-0.7704324455951623,1.680135747125342
HCC1500,107970,1.6380228058856745,2.2867489355927133
HARA [Human squamous cell lung carcinoma],262093,3.694607099499911,3.1147187426448575
ML-1 [Human thyroid carcinoma],5335621,2.3456257872682933,4.742779271581992
MDST8,11222830,1.739834123793711,1.6815055999883384
MOLM-13,11364421,-4.614262921489179,-4.632058536328138
MDST8,89928392,1.3331112546959425,1.5675396496700005
SW1271,doxorubicin-navitoclax (2-1 mol-mol),-1.1619625703073235,-1.047650015491096
RERF-LC-MS,148124,-5.592640359076286,-1.9351937319074006
PaTu 8988t,219104,4.30352428274638,4.005991872823075
SaOS-2,16659841,3.6368059645085737,3.645153966542381
HuP-T3,selumetinib-vorinostat (8-1 mol-mol),2.242647534898157,2.185622829594656
ALL-SIL,25183872,-1.1896517316661384,-2.3089678542812786
HuP-T3,3503,2.6961085729175465,2.4118845319340987
SaOS-2,148124,-5.379251304292956,-2.1361031885702078
SW48,25102847,1.5289459974072863,2.34600506593361
PaTu 8902,6852167,4.282216220168943,2.8609968074604537
ALL-SIL,11396600,2.960335319566646,2.4345726410189688
LS411N,54649381,4.0879656113234315,3.3319846781760463
LCLC-97TM1,56649450,1.9268896253969057,2.7821766351603365
Panc 02.03,42642645,1.4849485241267697,1.1050684613054234
PaTu 8902,5328940,2.100447742300893,1.4949741942464392
Daudi,10127622,5.05479511248997,3.3750483364296717
SaOS-2,15983966,-4.612114381732812,-2.210208728433155
SK-CO-1,selumetinib-decitabine (4-1 mol-mol),0.410871863589865,2.761803584011939
MOLP-8,11214940,2.188017762346292,1.7725585587870785
SW48,44607531,-0.0703962424187993,1.5094744798686617
IA-LM,637858,2.795809218533269,1.3576216413753794
LS180,119182,-2.2864715680735603,-0.8146463284853291
SK-CO-1,135411,-1.9906675184189948,0.8975550545819092
SW1271,15983966,-1.9627382742922743,-1.2879464108518428
LCLC-97TM1,11485656,2.4293249862604913,2.054466729384119
Daudi,135984461,3.9990978127252728,2.7831889289669385
HARA [Human squamous cell lung carcinoma],11455910,0.2072973533181662,1.093904272439458
SW1271,24180719,4.447587763279296,3.532911958099027
RERF-LC-MS,4917,3.617944790726347,3.181459198272058
HARA [Human squamous cell lung carcinoma],1242560,4.08747373250943,3.6661112003234844
COR-L105,44185566,3.03526972595121,2.6888352021222217
MOLP-8,8515,3.727464051425151,3.525461777434095
Daudi,11656518,1.0836561052202376,0.7384784838376514
MDST8,10302451,4.267643132743765,3.2567205378765203
Panc 02.03,tretinoin-navitoclax (4-1 mol-mol),6.083694650761559,2.830492901081582
MOLP-8,135398738,4.11621412508813,2.3619442167633284
RCC10RGB,568763,0.4218853975706897,0.6968504693636633
SW1271,285033,0.340737243750418,-2.0096583263304293
Granta-519,67156097,-3.3327998752636483,-2.5925631852243436
WM115,11964036,0.4423113132234746,1.6735868271611567
SK-CO-1,156414,0.1991331726980137,0.7136430332768728
BICR 22,568763,1.1340411223212885,0.7889849389088016
P31/FUJ,176870,1.9707243184949097,2.480164544724348
SW1271,24748573,2.5868513601661336,2.412813153286559
MOLP-8,72199292,1.2541603744267094,0.5240424331663318
RKO,5282054,3.8735499096789856,2.8576260763749644
RKO,selumetinib-decitabine (4-1 mol-mol),2.541552473841643,1.1220602377417943
HCC1500,16722836,2.402902940836366,1.792319381544691
Panc 02.03,46199207,3.8452319744534886,3.1556876052207854
PaTu 8988t,71304818,2.8353343090304257,2.5823041359649896
IGROV-1,241158,3.288496474515495,3.972968391235794
Daudi,71751553,3.830487233171358,3.9181685888699764
COR-L95,46174525,3.763282126483136,3.905991248790739
NCI-H2452,2126,4.762499509878762,4.715336998049877
HCC15,11228183,0.6025691709173914,2.826637747306045
HCC1500,11404337,-1.1638452247583002,0.03594267764890891
PaTu 8988t,16725315,5.4103858057829095,3.976464144096818
MDST8,4378219,1.9480435949418269,2.471929243205264
IGROV-1,5351362,1.961059142684053,1.504268883775559
HuP-T3,44489675,3.6946366435409352,3.989744606471187
SW1271,4259181,0.7411137136724786,0.38313403722727024
RKO,5978,-3.7617282032773582,-2.3110328494837655
MOLM-13,11485656,-3.968420003132376,1.525987464636306
K-562,24821094,1.908113699718487,2.7537965932577877
SW1573,89183176,3.862510153781557,4.550356007990747
K-562,24180719,3.2747438118023533,3.25762107452816
LS411N,4788,5.997281207159956,5.538389646954498
IGROV-1,66577038,3.2148239132520455,2.9135445220316942
SaOS-2,selumetinib-BRD-A02303741 (4-1 mol-mol),7.165298435960504,3.7835007108256957
Daudi,9549297,1.403366421117492,1.6532011421497816
UACC-812,11427553,3.574449796486334,3.0796296638243614
MOLM-13,52912189,-1.0667663091505395,-0.27379493098315133
HCC1500,selumetinib-JQ-1 (4-1 mol-mol),2.938993597127826,1.5144438935904854
SW948,erlotinib-PLX-4032 (2-1 mol-mol),3.457135081619971,2.7035141032787013
PaTu 8988t,selumetinib-JQ-1 (4-1 mol-mol),1.6621315506186802,2.1597786770212277
IGROV-1,24821094,1.720998716331183,3.215302732213308
Granta-519,11427553,-0.9723301484726812,1.2374845300535116
MOLM-13,208908,2.7636340376000317,2.1881710383049966
IGROV-1,9915743,-0.4757488934941289,0.9478037131254419
Panc 02.03,241158,4.402915180139186,4.12373208677409
IGROV-1,24748573,-1.0654275876710166,2.192874029067236
COR-L105,5287969,-1.8496230723467,-1.6129826770931095
MOLP-8,10296883,2.725727750190508,3.1449982713733844
SW948,241158,4.5321951743877005,3.4093643349124148
ML-1 [Human thyroid carcinoma],216239,2.965937740464059,2.3184478339603127
MOLM-13,navitoclax-piperlongumine (1-1 mol-mol),-1.0908841522604569,0.015438989620770123
SU-DHL-6,10302451,3.370117636140473,2.876468623327864
IGROV-1,9936388,2.10108466287406,-1.9459035272813119
HCC15,72376,-1.512462057486854,-1.7810463259551677
COR-L95,6450551,2.8920154707175776,1.9330053087858914
NCI-H1568,5738263,3.2402226460817323,3.596987782541687
RKO,54619267,4.028311361432676,3.9209078178402854
RERF-LC-MS,4261,2.068565192175152,1.8859173645739826
K-562,73707371,5.645446798773975,3.807687537907966
SK-HEP-1,carboplatin-etoposide (40-17 mol-mol),5.6878657292744075,3.0370661060225657
P31/FUJ,ISOX-bortezomib (250-1 mol-mol),-0.0400156428773503,-0.20415917890661484
WM115,122327,3.780637240577924,4.86856204349482
WM115,25150857,2.4679229997528394,2.436823814318553
SK-CO-1,11178236,-3.2010052407962215,-2.7755045558884692
RKN,753704,4.966407297087677,5.2537222584723136
BFTC-909,selumetinib-PLX-4032 (8-1 mol-mol),5.555922755682714,3.8222531959302533
SW1271,227681,3.2917347097405725,3.6734212068288827
MDST8,568763,0.1407924711645573,0.7108591539739595
BICR 31,5566,3.2898773587253096,3.1306705913629718
HARA [Human squamous cell lung carcinoma],3385,4.962584280578164,4.023860286245773
RERF-LC-MS,6450551,1.967154760545028,3.016682356788459
IGROV-1,2874250,4.893662837169153,4.62690973769862
ML-1 [Human thyroid carcinoma],ISOX-bortezomib (250-1 mol-mol),0.9716953544539896,0.8436832145225414
HCC15,56946209,-3.385198311974778,-3.83762371178428
BFTC-909,136227924,2.3418993883842134,3.1998878280099787
Granta-519,1750826,-3.7858867937492984,-3.210503943928346
P31/FUJ,11625818,3.2136174191857174,3.445895260612123
COR-L105,10322450,4.112392966182136,3.9040252065168515
HCC1500,5566,2.905130044911903,2.991070199642729
SW48,51039095,1.7096770563148074,2.8006199737704587
SW1271,8515,5.208985199998064,3.9842065613265225
KU-19-19,73707398,1.7453733414385195,1.4551477613193804
K-562,11707110,1.6681367726124623,1.0780788116007984
COR-L95,16065773,1.8842547212847705,2.1669849331824222
LS411N,docetaxel-tanespimycin (2-1 mol-mol),0.1660438979420715,-3.3591674669093345
IA-LM,11178236,-6.720771550362321,-3.2940316241951444
MOLP-8,54596490,4.413151323823571,4.264017624459485
ALL-SIL,44202524,-0.4119558263455749,1.2587304217300535
WM115,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.6716900719045018,3.019306689756192
MDST8,6918328,-0.3527629143091293,0.11817634440745223
BICR 31,104842,-0.0442586507462943,-2.610562979052665
BICR 31,6852167,2.001013365002547,2.9218204776511834
MDST8,vorinostat-navitoclax (4-1 mol-mol),-0.0959848783200281,0.944784859361991
IA-LM,24821094,3.0699000024292293,2.5684263650691737
IGROV-1,73707398,0.8848064516600974,1.2346201404199644
SaOS-2,46191454,1.8159544721998524,1.6896956581273883
NCI-H2452,selumetinib-GDC-0941 (4-1 mol-mol),2.2378905262634343,1.9170883835254133
LS411N,25150857,2.959758413524705,1.9177785076332032
HuP-T3,11175137,3.603877049706456,2.7579354487170993
LS411N,135984461,5.061110843141604,3.331573014999638
IGROV-1,4261,1.934016649932683,1.749295064961824
SK-CO-1,BRD-K27188169-navitoclax (2-1 mol-mol),1.3228586557967312,2.3086433759148166
HCC1500,9952709,2.298703589628035,3.2870205267652226
SK-OV-3,176870,3.5610869734905255,3.787984683555339
PaTu 8902,9952709,4.3707417693645745,3.350084278782061
P31/FUJ,56973724,0.796880831995934,1.7914234320840807
RKO,2729026,2.3662843020346753,2.4767199509071
RKO,387447,-4.452540898932811,-4.042366099840375
SK-CO-1,135398738,3.5773200936681584,4.551916075171851
BFTC-909,3552672,4.498195948808332,3.041304277853412
Panc 02.03,7251185,3.0530850004567767,2.694354706691601
K-562,sirolimus-bortezomib (250-1 mol-mol),0.4974638580928024,-0.6115278540931324
RERF-LC-MS,serdemetan-SCH-529074 (1-1 mol-mol),2.886633168137992,2.253407404022895
Panc 02.03,53392493,3.617637281515077,2.83928719644409
LCLC-97TM1,446155,3.780165105352184,2.9398341542107698
BICR 31,23725625,6.004496967521932,5.347109752935486
RCC10RGB,11612883,4.41570881394896,2.9887890205125096
WM115,5280436,2.216411919293008,3.6453549361576982
RKO,selumetinib-JQ-1 (4-1 mol-mol),0.7539248953092096,0.41442276608677703
NCI-H1568,10184653,1.3826991243685076,1.0278204555666943
LS180,10427712,4.740953715848998,4.199464838304333
SU-DHL-1,JQ-1-carboplatin (1-1 mol-mol),3.662871226226577,1.791678894864689
ML-1 [Human thyroid carcinoma],56963564,0.9868520726565888,0.7468024740211053
HuP-T3,12003241,-0.2833744856936582,-0.9484823188461478
Daudi,9884685,-1.7998414591903729,-0.5345392983902609
SK-CO-1,44259,0.6005082969424771,1.2583650039236816
MDST8,10231331,0.2022855962524302,1.7791243829897194
SK-CO-1,4261,0.7789911540114764,1.3047460687322734
P31/FUJ,10074640,2.9862675466657764,2.7751123151657975
SK-CO-1,12001922,1.782153173177779,1.8914496002329966
SaOS-2,16720766,-1.9505026731708328,0.2399402536979784
RCC10RGB,216239,3.3222265979679375,2.4318460882236357
BICR 31,navitoclax-pluripotin (1-1 mol-mol),-0.5418229135264367,-0.8599345333413296
KU-19-19,sirolimus-bortezomib (250-1 mol-mol),2.2113915758762133,0.7815590065143744
COR-L105,72734382,5.425179503032161,4.989480568970642
LS180,11640390,3.36619781023128,3.6366345615457925
K-562,25262965,-1.232298297425116,-2.435196411917724
IA-LM,piperlongumine-MST-312 (1-1 mol-mol),2.1673101171047513,1.5316490087755756
LCLC-97TM1,135411,0.5874500365845237,0.6146265645531896
SU-DHL-1,46398810,1.696894130738712,2.1822609572021086
P31/FUJ,6610216,4.336076332167018,3.747709518772957
BICR 22,5291,3.723640910280853,3.711580430433259
HEL,44632017,1.0842639602191189,0.6584095063217765
Granta-519,4261,1.1412453306659267,0.14732862686470174
Granta-519,56963564,-0.5609340564012296,-0.23793896733472641
MDST8,53392493,2.9375507482716334,2.6250815752671213
LS411N,44819697,-0.923326266781905,-1.0528049913158968
NCI-H2452,selumetinib-decitabine (4-1 mol-mol),5.979248786857892,4.253227840029621
NCI-H1568,5291,3.770643134542437,3.881467096663502
BFTC-909,11612883,3.5324782187628827,2.98325259198152
RCC10RGB,11955716,4.4260489213830425,-0.15204073108306113
SW1271,11626560,1.376954486231794,1.872558290295514
SW48,46943432,0.8743166493146273,2.6662902910117987
HEL,3062316,2.2727573444408633,-0.2812656715352771
MDST8,JQ-1-carboplatin (1-1 mol-mol),1.720719180230483,2.626299649867471
RCC10RGB,5329102,2.357265375302505,2.301572249273642
ALL-SIL,9866186,-0.4181259896802407,-0.42851382476944444
NCI-H1568,selumetinib-navitoclax (8-1 mol-mol),2.553812274921004,2.2896165558906967
HEL,23635314,-2.6594801266287154,-2.7962068984597024
Daudi,10074640,1.7373836938395748,2.6247409061172107
RKO,26596,-1.341584325458414,-2.4571712025425465
WM115,11167602,1.5239005360441813,2.7587733101721335
IGROV-1,2746,2.8413672686351212,3.4115604594893005
Daudi,24978538,2.467871482925033,0.12475754172463746
RKO,2858523,3.1569923390566332,2.592263727701958
LS411N,15983966,2.6804451752833978,-3.128995947470849
SK-OV-3,452548,0.7579906967862455,0.3722226048798476
MOLP-8,25262965,-4.805551534468427,-2.5263748403081565
LCLC-97TM1,46215462,1.4949685345148778,1.6924394771963347
BICR 22,439501,-2.4052901035443,-2.1087071593994207
SW48,10184653,-2.0074491437034094,1.2192449586040788
P31/FUJ,168313016,4.690131242833582,3.925927040413543
NCI-H1568,selumetinib-tretinoin (2-1 mol-mol),5.145646184067631,3.5770933787962202
SK-OV-3,selumetinib-JQ-1 (4-1 mol-mol),5.055306733015199,1.9065475644055365
LS411N,54613361,3.867376577775082,0.08611521648105912
COR-L105,24772860,-1.435746068442861,-1.6997691440595342
K-562,11222830,1.892206265748428,1.2260839792460003
Daudi,10385095,0.347773175212431,0.7741272978213716
HCC1500,44137675,4.199849963716895,3.2326725025898266
SW1573,11404337,-1.3449252751203844,0.043337524364376295
SK-HEP-1,46191454,1.8876467264614776,1.9529575313519376
P31/FUJ,135999136,4.068676884464422,2.6598116395775544
RCC10RGB,25150857,2.370598483016253,2.4554671151695344
NCI-H2452,57330099,4.302779847582817,4.285908127478276
IGROV-1,10127622,3.2581804056600165,3.875227432905807
COR-L105,5282054,3.9571885951378505,4.14696231402386
LCLC-97TM1,53481919,3.8027519676947232,3.7341231660163485
NCI-H2452,3025986,-0.5496531660815697,-0.36207604281619404
WM115,11955716,-2.4505472507691013,-0.9787371505171013
BFTC-909,637858,2.264716830291231,2.1667795067955837
COR-L105,selumetinib-JQ-1 (4-1 mol-mol),0.4359614379036839,1.2218412601932283
Daudi,1641662,2.995591169153073,2.823149004172519
MOLP-8,446155,0.367312642153156,2.429341333342396
RERF-LC-MS,135999136,4.400683337930441,4.276757226773663
WM115,5738263,3.851280366828244,3.6791159547412957
MOLM-13,65628,2.9573007313246924,3.086090453257171
HEL,9936388,-3.337900467930123,-4.9845721361786275
SW48,104842,-4.777281812432541,-2.711540561921156
MOLP-8,ISOX-bortezomib (250-1 mol-mol),0.0006851036189058,0.15467914758223908
Granta-519,11626560,0.2073830225530282,0.4558597254893073
SK-CO-1,969516,2.7975557975376035,3.0802161932453016
SW948,11640390,3.051257470103826,2.626429367300797
HCC15,10302451,3.767869991537956,3.1851957154390824
MDST8,crizotinib-PLX-4032 (2-1 mol-mol),1.604281792595084,1.7955218940182833
PaTu 8988t,46943432,6.478561461465468,2.826678476962507
K-562,208908,1.7214906675478436,2.2425940814972583
NCI-H1568,11612883,2.467781963295413,3.0511505230447518
LCLC-97TM1,9884685,-0.6945268748645868,0.5361246896772962
Granta-519,6918328,-2.2526378564537355,-1.9210613078643337
Granta-519,5470400,-3.2597420844446163,0.11432396496310197
LS180,10231331,0.7625893939503741,1.912924343279653
SW1271,46199207,3.134892747913181,3.2361475945845286
HEL,11404337,-0.835651629585067,-1.342606301449347
Daudi,216345,1.872370108624604,2.645485361331063
MOLM-13,decitabine-navitoclax (2-1 mol-mol),-5.337552823003331,-0.8309419142216656
RKN,54613361,0.2026815444056028,-0.06548376199671757
LS180,452548,0.7544699085550369,0.7931119058907544
RKN,44493528,4.408823872302737,4.482168576978742
SK-HEP-1,11238147,2.1467729161342524,2.9495222654106614
MOLP-8,tanespimycin-gemcitabine (1-1 mol-mol),-4.944533339092102,-1.7515320071002756
COR-L95,11364421,1.7062947816433405,-2.136371150475316
KU-19-19,452548,1.4010535434747853,0.562157286799071
COR-L95,tretinoin-carboplatin (2-1 mol-mol),4.531796019532578,4.198872761027465
IGROV-1,44819697,-0.8326420176056434,-0.3008163036319238
MOLM-13,salermide-PLX-4032 (12-1 mol-mol),4.733891503361179,4.3365073918616215
RERF-LC-MS,2729026,3.1361811776879644,2.787112736899106
RKN,4788,5.902938799554125,5.594103798672446
K-562,216239,1.6121414929675577,1.7317642677631937
HARA [Human squamous cell lung carcinoma],2729026,2.992927693558788,2.8507488621216446
IGROV-1,2746,2.8413672686351212,3.4115604594893005
IGROV-1,637858,1.814476597989254,1.985554296772254
HuP-T3,11214940,1.8541641961456377,1.911894956955757
IGROV-1,46907787,2.182756719431072,2.1834689700260004
P31/FUJ,445643,6.117258311867223,3.4890667858217888
Granta-519,3854666,0.1662242620713641,0.721942807012971
MOLM-13,tretinoin-navitoclax (4-1 mol-mol),-1.997886556177749,0.18709860021393115
LCLC-97TM1,135440466,1.105929023295497,2.2146208959369473
RERF-LC-MS,56649450,3.38813984116235,3.430227107113623
SK-CO-1,11612883,2.4661452350243493,2.822931813719945
SK-HEP-1,44137675,4.549525792934436,3.72810243448488
HCC15,72193870,4.3690783386047025,2.3218402885715275
HCC1500,2746,2.6069735713089006,3.0414434549352625
MOLM-13,decitabine-carboplatin (1-1 mol-mol),-2.1020710624228833,-0.48095392989610153
Daudi,11222830,0.8543881776084605,0.9315754460919191
WM115,2749,6.3303951951253445,2.1359390228963413
K-562,9840324,5.675524269237515,5.387796475941247
MDST8,10113978,3.624916965791189,3.0895644518213197
NCI-H2452,44507138,2.753685109279225,2.6157711377172927
MOLM-13,5282054,3.1361279245897857,2.791742765197702
BICR 31,9911830,2.2138272662609064,2.8264281476353994
HEL,6917907,-5.38656193144065,-5.423827636884721
IGROV-1,2858523,3.196384505087132,3.0856906019880785
MOLP-8,322968,-1.2094679469942695,1.9842329347920993
BICR 22,3503,2.960513829073252,2.202833908551233
ALL-SIL,10113978,1.6173510565910796,1.9813999616461384
HARA [Human squamous cell lung carcinoma],navitoclax-sorafenib (1-1 mol-mol),1.2625473684238606,1.8046967596585495
RERF-LC-MS,119182,-0.645974794966856,-0.05230664822904091
LS411N,4261,1.591263829932159,1.2158215554356393
SW948,4096211,1.12279899109382,1.528900793128532
K-562,11485656,1.7795111963017332,1.7262896448194396
MOLM-13,53232,2.182263698942312,2.470380639690695
ML-1 [Human thyroid carcinoma],44819697,3.711954604060423,-0.27717132941110023
IGROV-1,3689413,-0.3633634632064185,-0.19535332220703427
RCC10RGB,12001922,2.277970650057297,2.153010951694156
RERF-LC-MS,246676,4.480243243269967,4.4263372550097335
HCC15,374536,0.7951987879889547,2.516444148654562
MOLP-8,11977753,-4.876868381891939,-2.7515994241835715
Panc 02.03,2874250,4.438896474206821,4.762454344557956
COR-L95,613753,3.031049367391043,2.8810248136722083
SW1573,9840324,5.095993559480237,5.865322007149182
SW48,24901704,1.780712261537264,3.265465168361883
BICR 22,6918328,0.5113628660513942,-0.008309930626720191
Daudi,54613361,-0.5183638298018372,-0.8363196602821003
LCLC-97TM1,25102847,2.141917897082315,2.126748896701642
HuP-T3,3081361,3.872954779649628,2.4469411206923883
LS180,969516,2.6818241036299275,2.7306131291298295
SW1271,2945648,2.4921907486938646,3.06373417890056
BICR 31,25126798,3.691910729857057,3.967895083006037
KU-19-19,SNX-2112-bortezomib (250-1 mol-mol),-1.0111363937138018,-1.2873197951789996
Daudi,262093,0.7533038243356376,1.684187512825458
RKN,20959075,-2.033811748726601,-2.5009701826403274
KU-19-19,702558,5.449368171937104,5.313949730470414
SaOS-2,2842253,6.143936300195383,5.49319572383695
RERF-LC-MS,26596,-1.2372341703529914,-1.183757548034576
PaTu 8988t,5329102,3.3339986936080717,2.2483678465238546
ML-1 [Human thyroid carcinoma],44607531,1.8496707927685447,1.6194760928634908
SaOS-2,73707398,0.8491853151273433,1.0245320974938519
K-562,JQ-1-carboplatin (1-1 mol-mol),0.3966707315482991,0.19504412281978017
SaOS-2,984333,4.259432573695519,0.4638533227389876
LCLC-97TM1,53232,3.007779101776312,2.9904860355391407
KU-19-19,3503,3.0769201112014803,2.3226002153915912
WM115,57330099,5.984461482923693,4.2338691647176
HARA [Human squamous cell lung carcinoma],82146,4.619283658647928,3.7644535439333886
LCLC-97TM1,44491742,4.237702230509644,4.023173038449571
SK-CO-1,9915743,2.0474134916136184,0.8151504475477754
HCC15,73707398,1.6988346513711203,1.788485709103961
HCC15,4477,-0.3802251277588812,0.7548789957455555
BICR 22,26596,-1.8883514509946957,-1.0474863981018754
SaOS-2,445091,4.479630914494518,4.459048049235703
HCC1500,3503,2.0705498046235817,2.4192293794674296
SK-CO-1,salermide-PLX-4032 (12-1 mol-mol),5.553578625312618,4.718828165293179
RCC10RGB,71304818,3.488257335656729,2.715371176848746
RKO,241158,4.5302703569847305,3.057267457302585
SW1271,168313016,5.582938604018868,4.980327573372342
SW948,10385095,1.3660359707166476,1.5512343392941583
RERF-LC-MS,3543504,3.1700226881436193,4.489257180631346
LS180,5311,1.1738972820475675,1.4762130106701783
RERF-LC-MS,5291,3.9873816513243785,3.8855364174506946
RCC10RGB,53481919,4.9196370953200805,4.155342678275534
Daudi,44241473,5.233980827552566,4.126712678498389
Panc 02.03,10127622,3.4148938287456776,3.578722359860638
BICR 31,49836020,4.313223650735915,2.537366401502017
Daudi,54618305,3.9105424608095847,3.437357614014918
SK-HEP-1,5746,3.319924463812582,1.2436457676283035
ALL-SIL,67156097,-2.3407546390754037,-2.1932611863241704
ML-1 [Human thyroid carcinoma],24797083,1.931228349809168,1.483841248438035
P31/FUJ,613753,2.9305719806169432,2.844991756477546
PaTu 8988t,1641662,3.634680635371761,3.5700321265065424
SU-DHL-1,15953870,1.992339234699044,3.0392848783970385
COR-L95,decitabine-navitoclax (2-1 mol-mol),-0.2234984214129892,0.7638848981048391
SW1573,JQ-1-UNC0638 (2-1 mol-mol),2.8948762578833667,1.9274617487912844
P31/FUJ,navitoclax-PLX-4032 (1-1 mol-mol),0.0164871875305551,-0.3731070218049502
Daudi,vorinostat-carboplatin (1-1 mol-mol),1.6612162447966572,2.033405000220303
SK-CO-1,11364421,1.7180407971266538,-0.4755959797393271
COR-L105,16722836,1.79329711252707,1.9630905717386462
IGROV-1,439501,-2.1510551928674557,-2.1202169343660575
ALL-SIL,50905018,3.9646846974495418,3.716350830050542
SW48,25126798,2.5731969050098993,3.675628213082784
PaTu 8988t,10113978,4.3652834043747335,3.3543634908108606
SK-OV-3,12003241,-1.2313805329375749,-1.1603902867194826
Daudi,1317464,3.6966432302020817,2.7634199141573488
WM115,5978,4.185238310426041,-1.5030065502519832
RKN,carboplatin-etoposide (40-17 mol-mol),3.53893718453625,2.909683724788613
ALL-SIL,24785538,-0.5874123218373029,-0.012440568105048583
COR-L105,sirolimus-bortezomib (250-1 mol-mol),-3.794916830429034,0.8730542800842251
IGROV-1,9967941,2.9735049794712545,3.7990311838607536
SK-HEP-1,11977753,-1.1270659898133608,-1.364277344678737
COR-L105,676352,1.9469411585028615,2.091427308490317
MDST8,11485656,2.867381561993162,2.4648699843403534
SW1271,selumetinib-piperlongumine (8-1 mol-mol),2.3808052258502705,3.5413090789188995
SW48,6918736,-2.164113269607571,-1.1911500493676634
SK-HEP-1,445455,4.37046727572682,4.686646315217522
Daudi,4096211,1.4831417361144643,1.1319046908314467
LCLC-97TM1,16038120,-0.9192372639718316,0.6053793709294287
BFTC-909,3384730,4.46542670181497,3.0606392301616414
K-562,36462,1.3855340321895664,0.5274016426120501
SK-HEP-1,5329102,2.506246240472525,2.048171821253795
WM115,25161177,2.874219730459086,4.001887696364516
HCC1500,119607,4.730010050453825,5.2144350597083635
IGROV-1,24964624,0.5052308994941754,2.4866555393330456
HCC15,421610,3.960173561996767,3.3275984041568996
ALL-SIL,4788,4.920956242868583,4.666380914699345
IGROV-1,49766530,-0.195540678413639,-0.3473887637215129
SK-HEP-1,11175137,3.0126176485486114,2.7595704077809837
MOLM-13,selumetinib-piperlongumine (8-1 mol-mol),2.118239948342191,1.5773663355847147
K-562,54678924,1.7343444538293111,1.3173420263988147
ML-1 [Human thyroid carcinoma],5281321,-2.300928121678764,-1.1726794778458376
ML-1 [Human thyroid carcinoma],11167602,2.9640815113410923,2.6053405819612334
COR-L105,6505803,1.059348129706536,-0.12301501461688001
P31/FUJ,25183872,-2.108478877482417,-2.1209443209116374
Daudi,navitoclax-birinapant (1-1 mol-mol),2.1928151248147194,0.5248888913371086
NCI-H1568,9444,4.259676436179719,4.240327831050147
NCI-H2452,selumetinib-MK-2206 (8-1 mol-mol),2.148853035614541,2.5415727455094608
KU-19-19,19582717,2.992815973528006,4.415785799249677
RKN,36462,2.460575122343829,2.4598237959520355
P31/FUJ,3062316,2.2346133515561415,0.5984754832097974
MOLM-13,36314,-7.769941141611737,-1.2592408928411338
HEL,44484440,3.2564839193688524,2.751756503311307
RERF-LC-MS,168313016,4.277512101574917,4.957138173235207
HCC1500,637858,1.1010846881251866,1.9470075381628942
COR-L105,11178236,-3.064044900311784,-3.2546826391765267
IGROV-1,44202524,1.8303703172382677,2.5440727029340935
LS180,alisertib-navitoclax (2-1 mol-mol),1.1962644272537857,0.749839476396444
MOLP-8,11175137,1.914718066408171,2.0424149039118875
LCLC-97TM1,1641662,3.5570250788057187,3.375338322883851
SK-HEP-1,46199207,3.772137058295689,3.231013309214475
SW1573,6917907,-6.296104468024424,-4.76314720168687
HEL,89183176,1.9576500820122449,3.2086679764563417
SU-DHL-6,49793307,-4.306431914357451,-4.295642030182646
K-562,6918837,-4.262812875828109,-3.9788226142785765
Daudi,44493528,3.680262260756896,3.90023804705383
RERF-LC-MS,5311281,3.366561586065275,2.448728065155607
IGROV-1,675434,4.336225379212549,4.493507228414784
NCI-H1568,216345,3.8344110950672823,4.094967371660222
SU-DHL-1,9926054,1.6936537424309908,1.5389928372222024
Panc 02.03,9911830,3.8856260346392903,2.6662415593092463
HCC1500,2729026,1.749867272011919,2.5372432736034325
ALL-SIL,42642645,-2.33031271995146,-0.17241890754525124
Daudi,9911463,2.4252044126403915,3.0029668343813385
NCI-H1568,45279963,3.534456091536717,3.677317570827969
RKO,135999136,6.045591123054076,2.917604483599446
SW948,JQ-1-UNC0638 (2-1 mol-mol),0.5184819522178918,1.174695410567771
SW948,9903786,1.6902329933335576,2.7107021231523554
RCC10RGB,9956119,4.44093701823858,3.613868857087346
SW1271,25154868,5.0403607075499375,4.384779937986838
K-562,65628,4.517417686157834,3.4581515349967447
SU-DHL-1,613753,2.797885663964736,2.6367441939130343
SW48,ISOX-bortezomib (250-1 mol-mol),0.0957852828937709,0.751729033508106
HCC1500,44566777,0.0909506116020526,0.9082784016595272
NCI-H1568,54454,3.61375646412465,2.687885956245942
SW948,44507138,2.949706410080911,2.5886492756778443
SK-CO-1,17759555,4.047587343089958,3.5033525876855287
HEL,568763,0.2288469977463405,-0.34284095662588626
BFTC-909,3815108,3.5118939741133075,3.0272749974141027
ALL-SIL,24901704,-0.1489296834412312,2.0937535528742415
MOLP-8,piperlongumine-MST-312 (1-1 mol-mol),0.7424689739493265,1.2817122980754934
KU-19-19,24772860,-1.0696999794461075,-1.6953400326739492
MOLP-8,9866186,-0.5209158528959533,0.12638997036661861
NCI-H1568,JQ-1-MK-0752 (1-1 mol-mol),3.5105249308751363,1.9513553971505098
HuP-T3,71304818,3.5647709327393287,2.5557656436348637
MOLM-13,11683005,2.7238157220539345,3.066021245866842
HEL,54618771,0.7283869495698151,0.050916619496412456
RKO,selumetinib-PLX-4032 (8-1 mol-mol),1.8013466074828854,3.5189256189879137
WM115,selumetinib-PLX-4032 (8-1 mol-mol),-2.130332393585934,1.9578893589576263
NCI-H1568,25150857,2.4294918673251416,2.615549266501931
RKN,6438330,1.1013294242613172,2.428638533940172
HCC15,644241,2.326085716096255,2.4279364010388536
LS180,2708,3.937371430907984,4.813358760991937
LS180,51037431,3.4786862718788747,2.9413831604370433
K-562,16741245,3.9224206604880583,3.507271739874545
RERF-LC-MS,44185566,3.014427147988128,2.7850310233169506
SW48,navitoclax-MST-312 (1-1 mol-mol),0.8806321220589545,1.0556336820511218
RKN,5566,3.4992110401170944,3.1319450545161005
LS411N,navitoclax-piperlongumine (1-1 mol-mol),2.36008373550467,1.3567284320855535
MOLP-8,216345,2.155670358283386,2.9561002387626947
HCC1500,BRD-A02303741-navitoclax (2-1 mol-mol),0.0071603230581946,1.6771603136402788
HARA [Human squamous cell lung carcinoma],alisertib-navitoclax (2-1 mol-mol),-2.092897901371494,1.1641151358835702
PaTu 8902,46224516,2.4477060426075723,2.7645630152473215
RCC10RGB,241158,4.984223152954295,4.0181297334108645
HCC15,11612883,1.9950389922708311,2.835467729881663
HCC15,969516,3.14053560758236,3.1108926749895636
LS180,9866186,-0.1716689837079009,0.7985003907522945
Granta-519,decitabine-carboplatin (1-1 mol-mol),2.1725621434549582,0.3235261887606704
RCC10RGB,24964624,2.93015987785669,2.6615040073071374
MDST8,216345,3.5638732818875094,3.8066874481771946
RCC10RGB,10302451,3.839480938635774,2.7589793208982383
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084,6.254266241307152
WM115,44491742,3.78432787650886,4.157050296295914
SU-DHL-1,selumetinib-piperlongumine (8-1 mol-mol),2.378072265787347,1.9061077717308532
KU-19-19,262093,2.7281718696395303,2.921707288626858
ML-1 [Human thyroid carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),2.7869393467132344,3.2280760850969488
COR-L105,1242560,3.3237423881291233,3.688750515392589
MDST8,16736978,0.980275670291684,1.7858065145475082
NCI-H1568,16722836,1.2045551605263336,1.823253596907228
WM115,5282054,2.577591804396212,3.885322655113226
IGROV-1,25195348,3.0698662305180275,3.415717403813176
PaTu 8902,148198,-2.774580136562139,-3.3282716180477077
HEL,26596,-1.8679385890512872,-2.527847549981712
Daudi,25126798,3.548189682848153,3.3206949704992077
PaTu 8902,selumetinib-piperlongumine (8-1 mol-mol),5.497989392681889,3.111884379512212
SaOS-2,decitabine-navitoclax (2-1 mol-mol),2.350842092351968,1.7370287166187537
PaTu 8988t,56946209,-4.946927234389905,-3.936110412980385
SK-CO-1,2945648,3.4071568821077993,3.0394081578057808
SK-CO-1,JQ-1-navitoclax (2-1 mol-mol),0.4682346666935782,0.6751412748327559
BFTC-909,3136844,3.2427360302120403,4.4072056412187814
IA-LM,71304818,3.3887828048220094,2.267766613363338
NCI-H2452,122327,4.606448802646307,4.785190668521074
LS180,12003241,-0.6460664270988897,-0.8687412519819055
SK-HEP-1,16741245,3.65273757252914,3.9270267942678765
RCC10RGB,6918638,2.235907203261483,0.7989330258472137
WM115,16065773,1.4979025411384967,2.4327989863249426
HARA [Human squamous cell lung carcinoma],9825149,2.481612932411,2.297243520709043
Daudi,54678924,0.8831010429483725,1.3371687889650996
MOLP-8,9903786,1.299688823902182,2.0102450998132597
ML-1 [Human thyroid carcinoma],24180719,3.042356764984187,3.5415749579258784
WM115,219104,4.514482202684108,3.9990597914494264
Daudi,25150857,0.8259987709661276,1.6293941902291584
KU-19-19,selumetinib-BRD-A02303741 (4-1 mol-mol),2.399823528664379,4.056923502662405
BICR 22,25262965,-4.220207088048826,-1.408196320645935
BICR 22,25126798,3.759096897040898,3.6071408223847694
HCC15,11717001,5.339668805105819,4.119992337885923
Panc 02.03,JQ-1-MK-0752 (1-1 mol-mol),2.226829891800918,1.3122083671345066
BICR 31,6918328,1.2499033439512497,0.43023151905599155
COR-L95,25150857,1.208080540357677,1.9072763544873244
ALL-SIL,104842,-6.679847729141338,-4.999227736271499
ML-1 [Human thyroid carcinoma],6450551,2.5869852554462622,3.1461247601849993
MOLP-8,crizotinib-PLX-4032 (2-1 mol-mol),0.0452912472141007,1.2659846667493593
IGROV-1,11612883,1.8715405446213529,2.898035216311469
HEL,9926054,1.596813412273358,1.5410321303107901
HCC15,11404337,-0.219975280966356,-0.19248810770367636
LS411N,168313047,3.2811764574410893,2.29331942716651
HuP-T3,168313200,4.289513738947004,2.8600010213891642
RKO,216468,3.08027711257304,1.1289204896927394
HCC15,5566,3.133848096057735,3.0683841121738884
SaOS-2,2130404,2.752105467907615,3.1701305924864953
PaTu 8902,6623618,2.257974787323956,2.4694046046246663
Granta-519,45279963,2.8131243875516097,2.480368777347497
BICR 31,6918638,1.4401869695378149,0.7600775873488128
IGROV-1,2729026,2.3541792737160296,2.7004088930875123
SaOS-2,decitabine-carboplatin (1-1 mol-mol),4.9062736540715735,4.20280202801488
PaTu 8988t,126941,-4.347732149803542,-2.7961734879610303
BICR 31,44607531,1.4420456412349776,1.4407242621288336
RKO,227681,3.9032876810461814,2.8285042541095016
Granta-519,5278396,3.331153353007608,2.941054622279189
MOLM-13,11214940,0.2452206847669268,1.3663523306427998
Granta-519,6914657,-5.464946920891912,-5.367484904270714
SW1271,72199292,4.741032264194907,0.6293383646064002
LCLC-97TM1,3676137,5.47833794075875,4.425956651574499
BICR 31,6505803,0.2507928346620714,-0.4014360997686356
NCI-H2452,9927531,4.529523169776047,4.903442729283803
HEL,107970,2.2652057864285893,1.9719045467712502
P31/FUJ,73707398,-0.9687174770786582,0.3495529578620106
SK-CO-1,3634881,3.2176217097393867,3.4624591032492003
ALL-SIL,71680916,4.0231197218666015,3.726697545228083
IA-LM,carboplatin-etoposide (40-17 mol-mol),4.857587432381165,2.4939465771918874
NCI-H2452,54678924,3.78052585603054,2.4329448005744156
HARA [Human squamous cell lung carcinoma],20959075,-3.3968163713216657,-2.6840894642531015
RKN,9840324,5.059199694090175,5.747666087046066
LS411N,25195348,3.7393125277208608,3.487902865650747
ML-1 [Human thyroid carcinoma],171352865,2.7298814774275435,3.4276781933024902
BICR 31,11497983,4.106423080888053,4.382756740081763
RKN,3825829,4.2934517576030276,4.0854599373037885
Panc 02.03,104842,-1.6275579890051994,-2.506171069835548
SK-HEP-1,4378219,1.9889575503272792,2.5226346646860454
NCI-H1568,11609586,2.169671625299293,2.8626956022276984
NCI-H2452,24772860,-2.067021978185303,-1.8669438423328943
HCC1500,2828334,6.090675120485649,6.035387465026433
ML-1 [Human thyroid carcinoma],15983966,-5.2151360937473,-0.6008195965523624
HCC15,selumetinib-navitoclax (8-1 mol-mol),-1.9070047094364015,2.3719802888593686
ML-1 [Human thyroid carcinoma],5291,4.042812106600411,3.7392020998921414
SK-CO-1,426756,3.753929508081783,4.3771481053160155
SaOS-2,46215462,2.3169135098646483,1.640712366178215
IGROV-1,216468,0.5330864756407336,3.0599210903105187
RERF-LC-MS,25262965,-1.1343637554659964,-1.5569643503045127
NCI-H1568,53392493,1.829675716879907,2.8206643061447
WM115,6438330,2.009543324889134,2.323726011783934
P31/FUJ,9908783,6.361014450142155,4.466738992574424
HCC1500,5291,3.388112901698238,3.6803690258488087
HCC1500,216345,2.2086555393223293,3.6955280946350255
SK-CO-1,16722836,1.1930735523198912,1.9687748916123784
MDST8,2858523,3.149165485885388,2.879551438108176
IA-LM,44486219,4.346993548383093,4.227900187062402
P31/FUJ,10427712,4.089067276268696,3.585772097823768
K-562,24771867,1.7261535062160185,-0.8442717324860359
SW948,2742550,2.6149964231270166,3.2511809900897477
COR-L95,2113511,4.880906118348224,4.983873829981473
BFTC-909,82146,3.493415453952883,3.738559515806074
BICR 31,4261,2.904745052497421,1.6383285086985742
BFTC-909,119607,6.015893315993201,5.474778339031484
MDST8,JQ-1-MK-0752 (1-1 mol-mol),1.445543393100169,1.3983656486115725
Granta-519,262093,1.5974758737964725,1.5249648236583044
COR-L105,4521392,4.261553030698096,4.3255339143553115
HuP-T3,52912189,2.4400429797195065,2.3594422158231096
HCC15,168313016,4.627209757330862,5.104088328780927
MDST8,15983966,1.9809932367095728,-0.33919176477705326
Granta-519,9866186,-0.14818829969678,-0.139702089305677
SK-HEP-1,462382,1.018219313736715,0.5562808490757937
Daudi,7251185,0.6493905196982933,1.4840790260475938
HEL,3385,2.274300648457042,2.7304163535540034
NCI-H2452,44185566,2.4757676958398824,2.7750486260294065
SW1573,9884685,-1.2788581073527363,0.9372527789181178
RKN,6505803,1.4092626649390017,-0.3096604967729007
COR-L105,selumetinib-piperlongumine (8-1 mol-mol),1.184006147072735,3.441763069513147
RERF-LC-MS,11427553,2.91041132641442,2.9463475352194153
SW948,107985,-3.1361927230844255,-3.293440417738813
IGROV-1,24951314,0.9075718706849548,1.347489049139528
IGROV-1,753704,6.461140333581179,5.004819816134278
LCLC-97TM1,54143018,-1.232378656007133,0.25475312214205376
SU-DHL-1,16038120,-4.191759239414132,0.40188310475472727
SK-HEP-1,65064,5.472205201006758,5.08842515382639
COR-L105,2733526,5.6711261994322,3.7886635365162777
HuP-T3,56649450,4.499318873015619,3.2296806569564716
SW48,16741245,3.865069024996995,4.0967846746082355
HCC15,89183176,3.7013914070621903,4.367677267499207
SU-DHL-1,135928012,2.7237506411412427,3.7212030910397225
HCC1500,24901704,3.772063812557438,3.3293079586407144
K-562,6505803,-1.797722788015983,-0.992710579931717
P31/FUJ,docetaxel-tanespimycin (2-1 mol-mol),-5.9377835284500895,-4.652961691615068
ALL-SIL,9936388,-6.364749169872344,-5.572476784059919
P31/FUJ,5284616,2.141886646431612,-0.924876185793003
RKN,654092,-2.299209260296745,-0.059003826887468455
SW48,piperlongumine-MST-312 (1-1 mol-mol),1.3077982167208542,1.7800356839219225
Panc 02.03,462382,1.1832417961450334,0.7662690642222951
P31/FUJ,11609586,2.709581392176905,1.626036049893885
COR-L105,322968,4.452130073523545,4.06738006778269
RKO,135398516,4.318914396092429,1.2868952667245077
Panc 02.03,44185566,3.1312758482446976,2.5923459145444157
NCI-H1568,72376,-1.5373297187690371,-1.7286986536785478
Daudi,11494412,-0.3802447608890573,0.4862825393926184
SW48,erlotinib-PLX-4032 (2-1 mol-mol),3.2399078814474924,2.675659700355141
SW1271,2126,5.27764055734565,4.569784679421617
RERF-LC-MS,10296883,4.230661493555322,4.0721199773986605
SK-CO-1,53232,1.9491581074450712,3.085633054340811
HCC1500,11222830,1.0956735100670385,1.5783646021354871
SK-CO-1,vorinostat-navitoclax (4-1 mol-mol),1.5116374119241311,1.2025877314447735
LCLC-97TM1,16219061,3.747043694071086,2.971672674869104
HCC15,3543504,4.297283358198234,4.636423812148763
SW1271,6918837,-1.9255423784418917,-2.4688790490155252
SaOS-2,53301938,5.583232766578932,3.139614234667225
UACC-812,9866186,1.6792636289805696,1.246123477952439
RKO,5278396,3.510721289362286,3.0870309894614683
K-562,16722836,1.308803334400655,0.9539219118483522
HEL,selumetinib-tretinoin (2-1 mol-mol),7.234386750467808,2.2569619614608087
P31/FUJ,9935249,2.700947453739227,0.9552488941667285
IGROV-1,5351362,1.961059142684053,1.504268883775559
IGROV-1,44819697,-0.8326420176056434,-0.3008163036319238
HCC1500,5746,0.8617369744590151,0.9510287004102252
BICR 31,15547703,3.2095649219178006,3.109703263881649
P31/FUJ,72193861,-0.3659416399435479,0.2791212876873176
PaTu 8902,24964624,3.11499425545507,2.7151069163319757
BICR 31,vorinostat-navitoclax (4-1 mol-mol),1.4356739307232549,1.049984876883489
SK-OV-3,24901704,3.989938255280614,3.522944241974342
LCLC-97TM1,2113511,6.012866888022406,5.741331241394887
SaOS-2,3081361,3.085781742119062,2.336895707910943
IGROV-1,15983966,1.7101486625531308,-1.0802482622533212
MDST8,6852167,1.3374988720553735,2.891230726288652
MOLM-13,67291369,-0.0488061328139809,0.6863592350116876
K-562,JQ-1-vorinostat (2-1 mol-mol),0.1257253367868581,-0.28842695839530547
MOLP-8,9926054,1.7939353525170396,1.6356236706403535
SU-DHL-1,168312962,-2.257405592485961,0.7553915126111868
LCLC-97TM1,219104,3.650486733954163,3.433057874082309
HuP-T3,984333,1.5721860041126483,0.9978891865192625
Panc 02.03,4477,0.984097917718396,0.6421618129178942
Daudi,selumetinib-piperlongumine (8-1 mol-mol),2.587128104626929,2.034550934725499
IGROV-1,9929138,6.483056540257463,5.448450079437211
SaOS-2,11175137,1.9690729540796783,2.5763502467094934
LCLC-97TM1,9915743,-0.0836077976930932,0.5556732435288955
PaTu 8988t,9907093,4.39010034793255,4.281756834638393
LS180,73707398,1.191690395470446,1.4224613483996407
ML-1 [Human thyroid carcinoma],25102847,2.935986325205898,2.857216633718411
Daudi,11960529,3.700971671461623,3.284200508050042
RKO,4259181,-0.4049041326260317,0.054237851703235564
MOLM-13,31703,-4.683228669920675,-2.6515055982745173
SW1271,4477,0.3648589081307944,0.682849127278248
HuP-T3,216239,2.9976543037230665,2.452641831704619
HCC15,9903786,1.5576741113339283,2.8990447517049165
IA-LM,selumetinib-JQ-1 (4-1 mol-mol),2.5487957947561544,0.7994637008642943
Daudi,1239801,3.0112900662314717,3.1568052979321517
PaTu 8988t,25126798,4.088623680113087,3.893720093439269
RKN,227681,3.7901732699912585,3.4962642562626467
K-562,216468,1.7844503846326911,1.1595849219237688
NCI-H1568,11234052,4.07711650557102,4.093233032095299
RERF-LC-MS,17755052,1.8057357372617977,2.0182382179746923
HEL,135999136,1.6019096984193502,2.3903642946468495
HEL,9887053,3.0781159437380974,2.788614405000547
RKO,11625818,4.5581118700811105,3.7618764429096374
HuP-T3,322968,2.6241189840020787,4.023306425154272
BFTC-909,11317348,4.568727931072339,3.4666974624876046
SW48,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.5460315373913385,3.3906132947212986
MDST8,1716436,1.1500764778734351,2.822853510788646
ALL-SIL,16741245,1.8101156107911176,3.687225176683508
Granta-519,16722836,1.0937584859115594,0.6400719393897681
PaTu 8902,10385095,2.391345219233966,1.3009539495735458
WM115,3038522,1.9104775831242309,2.8680719628373534
HCC15,decitabine-carboplatin (1-1 mol-mol),4.946381859305088,4.552473243923698
RKO,11497983,5.954072388877685,0.3747674141752315
BICR 31,46174525,4.37434163277974,4.1658597235310015
IGROV-1,JQ-1-UNC0638 (2-1 mol-mol),1.7292829396313356,1.6425714367240989
PaTu 8902,73707398,2.5949502925816397,1.472404001597718
MOLP-8,1641662,3.485304007232308,2.9220640506394107
HuP-T3,11640390,3.629059315953643,3.6682601963125547
HARA [Human squamous cell lung carcinoma],53481919,4.643044937502802,3.9480276381054615
LS411N,49850262,4.021647044836445,3.1175642268715
HARA [Human squamous cell lung carcinoma],9952709,3.695976506837269,3.0968662142629273
SW1573,24951314,1.273840217876839,1.514510047392888
RKO,441298,2.3183923582018107,2.311761124411408
COR-L95,5335621,4.389010810876702,4.232008111033802
MOLM-13,selumetinib-UNC0638 (4-1 mol-mol),2.1826018630699746,1.8508331174321973
MOLM-13,24785538,0.0261170120397283,-0.05117076800245046
Granta-519,374536,-1.3755413186728007,0.7760473331880593
HuP-T3,9911830,2.533690069517969,2.7929795323626703
HCC15,11640390,4.25082988279064,3.8348072456004845
Daudi,375860,-0.7416229308895455,-0.54787185233718
BFTC-909,16722836,1.424017650466323,1.7495041495242867
BICR 31,selumetinib-JQ-1 (4-1 mol-mol),1.6620620003816966,1.5840373274284303
BICR 31,crizotinib-PLX-4032 (2-1 mol-mol),1.5274046089824267,1.9925127307570614
LS411N,46398810,3.253541487295017,2.252894542523371
SW948,carboplatin-etoposide (40-17 mol-mol),4.008054530018911,2.935513035308526
HARA [Human squamous cell lung carcinoma],24748573,1.9169510591730587,2.441532544914279
BICR 31,136227924,2.8140968842668923,3.0921834802102586
SK-CO-1,24753719,4.51149350773187,4.166611555697247
LS411N,JQ-1-MK-0752 (1-1 mol-mol),1.615286960946078,1.0838427554791314
SW1271,57330099,4.656552081384507,4.159020325380539
ALL-SIL,60750,-4.149254188873004,-3.9141628943867057
MDST8,42642645,1.1052716804296012,1.2198255970992837
ALL-SIL,25062766,1.575972356073685,1.4365630616914915
LCLC-97TM1,salermide-PLX-4032 (12-1 mol-mol),6.666218718302321,4.806028772634846
SW948,11455910,0.6774609071475187,0.9663822679670555
SK-CO-1,11485656,2.076616779710352,2.413247137760871
P31/FUJ,387447,-5.269499156732966,-5.090609556034491
SaOS-2,54765302,6.138432086002101,4.172878033784475
KU-19-19,3384730,2.4463371108200995,3.172778885488741
SW48,56946209,-4.8342224094221455,-3.8759931891923878
RERF-LC-MS,71304818,2.1402027844306986,2.5567981810854503
SaOS-2,5351362,1.054118918695375,1.5047485575633797
SW1271,60700,-2.0966401571631805,-0.005769519152897267
SK-OV-3,12001922,2.3689117655248197,2.014570841802547
BICR 22,11222830,2.7513096778080293,1.576016385436022
HEL,637858,1.821308587756956,0.8450628038781693
LS411N,11609586,3.7769222068832384,1.9292320595065664
PaTu 8988t,crizotinib-PLX-4032 (2-1 mol-mol),2.4555083865109197,1.9951446379268334
SW1573,53392493,3.256582971351183,2.733032016239071
IGROV-1,71466380,4.863636874274779,4.4710200884192215
SK-HEP-1,119607,5.888068080296772,5.387802412651577
K-562,5329102,1.5928854941533903,1.6013755985494202
RERF-LC-MS,24901704,2.6292316786888295,3.3211957268566636
RKO,54649381,4.449908747747005,3.2060906983953092
KU-19-19,6438330,3.038685724131264,2.364174889530679
RERF-LC-MS,6917907,-5.461995819879327,-4.711945068724177
Daudi,6852167,0.8630196090584432,1.6046687146966945
RKN,2708,5.19327789915259,4.915219026033724
SK-CO-1,51039095,2.6345691844177006,2.8851165772678
HEL,9935249,3.1121102066484827,1.2056721592357806
Daudi,6184667,1.7615544136572183,1.9656914714408498
ML-1 [Human thyroid carcinoma],24964624,3.117302997790913,2.5192474202616117
SK-HEP-1,selumetinib-vorinostat (8-1 mol-mol),2.40344777828312,2.5576728598261274
LCLC-97TM1,5978,-5.540378308178224,-1.5567329859513452
SaOS-2,135999136,4.306712196094447,3.721303068286839
IGROV-1,5311,1.0068816368200209,1.465700166332723
PaTu 8902,10184653,3.3664490630517023,1.1351567313905315
IGROV-1,54678924,1.4704159748793169,1.9607782188634042
HARA [Human squamous cell lung carcinoma],54613361,-1.6613115011598742,-0.20379200338551826
IGROV-1,16720766,-0.0562020789376145,0.7225276642330394
RCC10RGB,31703,2.24368059098483,-0.4201386121914919
SW48,4261,1.3708847234833408,1.6524924301459563
LCLC-97TM1,navitoclax-gemcitabine (1-1 mol-mol),-2.1258188281402757,-0.9011768671545884
Granta-519,11494412,-1.422706675432074,0.3665888366191386
BFTC-909,10302451,3.622269240471498,3.2310337561488565
HARA [Human squamous cell lung carcinoma],452548,-0.3270885928487969,0.28260755828722944
SU-DHL-1,11497983,5.985793176782232,3.389633579034278
HEL,44486219,4.241945120616936,3.8816272876010127
HuP-T3,9926054,1.9266750805140576,1.9631370987822587
Granta-519,5281672,3.715092894597705,3.9568710205248965
NCI-H2452,568763,0.2251625503779925,0.49351122422900934
Daudi,15547703,2.9729250708388815,2.436274546609774
RERF-LC-MS,1566236,3.687566928717542,2.849991640080524
SW48,3689413,2.066117060158584,-0.11142146063838032
RKN,11396600,3.670395083293249,3.7193708796364326
COR-L95,25227462,1.0954609187473372,0.2548127131032546
P31/FUJ,11497983,-3.9754433923569295,-0.1829373780791174
COR-L105,11977753,-3.381629820862821,-1.1980962909738702
SaOS-2,10302451,5.268852772808677,3.235984365677427
WM115,25126798,4.207732195436686,3.9546115935916233
HEL,6918736,-2.4872933380365483,-2.62877303365513
ALL-SIL,vorinostat-carboplatin (1-1 mol-mol),1.2348853562201922,1.729420658375611
MDST8,selumetinib-JQ-1 (4-1 mol-mol),-0.5732607032642526,1.5941029550443273
BICR 31,11626560,1.5769037831027732,1.8387262057550058
SaOS-2,53481919,3.9662352208904,3.6971211177832726
NCI-H2452,4378219,4.095695943124218,2.5286188404428334
RKO,135440466,3.093117295091816,2.1197737303793205
ALL-SIL,selumetinib-decitabine (4-1 mol-mol),-0.1840409792284095,0.37260440550013546
IGROV-1,4521392,5.131794979216607,4.289033157048149
WM115,6610355,3.646348527159068,4.665321408074752
IA-LM,46199207,3.643614442277753,3.1141383184696343
RERF-LC-MS,navitoclax-MST-312 (1-1 mol-mol),2.0546989000241367,1.1703620422125958
RERF-LC-MS,4259181,-1.273108977623296,0.2673109564696826
COR-L95,selumetinib-PLX-4032 (8-1 mol-mol),5.035796466628604,3.682715308795346
LCLC-97TM1,9866186,0.636434294421894,0.6061601735827927
LS180,selumetinib-BRD-A02303741 (4-1 mol-mol),2.497004756461055,3.290727679620698
BICR 31,285033,-1.6333817403557132,-1.5257733944586773
SW1573,24821094,3.391149888356164,3.2583513153673818
RERF-LC-MS,984333,0.876742343627688,0.7781754244287618
SW1573,2828334,5.538488922798482,6.2037286074736855
BFTC-909,11214940,1.666026285351028,2.0152286802246127
MOLM-13,SNX-2112-bortezomib (250-1 mol-mol),-3.9385993868290665,-2.7038078581650358
ML-1 [Human thyroid carcinoma],55508,1.8303716396385248,3.6265815751358184
MOLM-13,16722836,-1.8349401857846608,0.8222791758347612
MOLP-8,135398516,0.6877200142840878,1.2435876426727643
NCI-H1568,56649450,2.3390116545362956,3.015787994734251
COR-L105,5329102,2.9490674090485007,2.3005271478979954
BICR 22,104842,-5.460039616101889,-2.416440039184861
ALL-SIL,44507138,0.0905903694215729,1.35539704365607
COR-L105,navitoclax-piperlongumine (1-1 mol-mol),1.1506089120324992,2.220958256998326
Daudi,252682,5.82526834825694,6.309113037161924
SK-CO-1,24785538,-2.301834394825824,1.7029026215456853
HCC15,4788,6.208189927463216,5.670933873471788
HARA [Human squamous cell lung carcinoma],54686904,4.432396143260886,3.8181752454517204
SK-HEP-1,5282054,5.2464488654660935,3.959631184305022
K-562,2729026,2.90327889883348,2.4990676177020106
HEL,docetaxel-tanespimycin (2-1 mol-mol),-3.324993936619335,-4.421087465430699
IGROV-1,135398744,6.402844237905131,6.421571172017375
Panc 02.03,44819697,-0.6097657869730747,-0.027612042942925373
COR-L95,6252,1.2572884944075156,-0.23900020360457946
HARA [Human squamous cell lung carcinoma],613000,1.7145271439199108,2.8514735492925136
HARA [Human squamous cell lung carcinoma],54143018,-1.1176720961651934,0.3205850319067
RKO,135411,0.3039750611139232,0.2606312795448137
SW1271,5284616,3.4240840801047825,2.8111342967602413
Daudi,9803433,4.921870042846492,4.036853871055199
HuP-T3,1566236,2.433067651410228,2.2715355315619274
NCI-H1568,11364421,1.3511041801335055,-1.0942240387036912
SaOS-2,54678924,2.353285364311993,2.000389392955356
NCI-H1568,6438330,1.052967118553252,2.4479700535609896
SaOS-2,56946209,-2.927880316628738,-3.614783345369145
MDST8,71304818,3.102141708789901,2.4452182324209684
MDST8,16722836,1.8236379945665244,1.725044937581754
COR-L95,5460769,3.3963309413836815,2.620912157561173
SW1573,5328940,2.8151731448483424,1.8544773718062961
P31/FUJ,44486219,4.066329818545256,3.8917739996123437
SK-CO-1,44819697,-0.0659450585917303,0.193415070354938
NCI-H1568,3689413,-2.0602171008804935,-0.17295723664214813
SW48,4788,5.795432827385499,5.449554966821804
IGROV-1,11625818,2.877471533668122,4.50841022808998
HEL,5282054,3.8014373831294073,2.7833166071991036
Granta-519,2858523,3.0573334835342725,2.783654550481553
Granta-519,2708,2.6467102550113357,3.12924071073684
SaOS-2,10074640,3.1546787022314264,3.1403981232639255
Granta-519,alisertib-navitoclax (2-1 mol-mol),-1.8552810437041576,-1.8145066052032135
NCI-H1568,462382,0.4864277786958156,0.7697543207581006
PaTu 8902,6450551,4.419968438595772,2.8859317183853754
NCI-H1568,89183176,4.755399227223714,4.4370971396220815
SK-HEP-1,89183176,6.199387598364303,4.708360923126555
COR-L95,3689413,-1.01311028513846,-0.39909794712651475
SW48,322968,2.620984302451229,3.551529462160653
NCI-H1568,2113511,4.994259934049027,5.414273143485734
RERF-LC-MS,10074640,3.277461458690314,3.28012750855796
P31/FUJ,11485656,1.9746673234827223,1.517493345958354
NCI-H2452,24978538,1.4440845227299357,1.60411427939298
SW948,46398810,1.81837356763434,2.474010268081626
SW948,navitoclax-pluripotin (1-1 mol-mol),-1.6002032912556945,-0.7338602237756199
SW48,5280436,3.9386259808510737,3.3999007454120314
NCI-H1568,16013152,3.794215458313736,4.143533604935074
K-562,JQ-1-navitoclax (2-1 mol-mol),0.4672607120603991,-0.12110091293089262
SaOS-2,72193861,0.3662001709486771,1.308991122991812
SW1271,6623618,2.240401111492455,2.596435811175975
BICR 31,11964036,0.7129684858082154,1.4096079793603093
MOLM-13,71466445,2.28410988708537,2.117054815779089
SW1271,5280436,5.166796757102748,3.5142518754569716
Daudi,crizotinib-PLX-4032 (2-1 mol-mol),0.8611087114550048,1.129115187193885
SK-HEP-1,5470400,0.5577708849126581,0.6160841563291387
SW1271,73707398,1.637161284255629,1.207524936198192
Panc 02.03,24771867,4.320948526904658,2.9466831162275775
K-562,11494412,-0.907204058397288,0.42494962953491233
HuP-T3,4477,0.7500067469313434,0.4992459581262853
WM115,44489675,3.6522428576041888,4.027158397054004
IGROV-1,10074640,3.2681490579824426,3.2011005848870036
LCLC-97TM1,387447,-4.752686001320434,-4.194683039991158
NCI-H2452,136227331,4.192235498443636,4.165748514021697
BICR 22,44566777,0.9464577594296588,1.1306024220884192
Daudi,44462760,2.2846011846998184,2.757036602386892
HuP-T3,11222830,1.7699584455080513,1.622973920652477
BFTC-909,10184653,1.6906150005550105,1.6546882093967605
COR-L105,navitoclax-sorafenib (1-1 mol-mol),1.5234919165461795,2.063172854999585
SK-CO-1,5460769,-0.7722931098274061,2.599349838849109
IGROV-1,9884685,-0.088911709267569,0.5773181567430125
SW948,10074640,3.6458957710098927,3.0696303017509052
RCC10RGB,2729026,3.187414345119047,2.7893880826769624
SU-DHL-1,25105715,2.6102250612439857,3.2407178513560577
SaOS-2,2708,4.307882235107384,4.7293080305573145
SW48,11485656,-1.6768123952056315,2.2390264935506057
LS411N,5738263,3.6843208102291127,2.868479285849529
LCLC-97TM1,89928392,0.9843618500255806,1.2033371273471531
IGROV-1,5328940,0.347812751869877,1.7834206777630226
BFTC-909,carboplatin-UNC0638 (2-1 mol-mol),3.28125381181505,3.6057992227337343
MOLP-8,6184667,3.7618917164892296,2.3939553894558574
HEL,9907093,4.271492923268933,3.479536769113804
SU-DHL-1,409805,5.150132871505728,4.706972738557187
IGROV-1,5287620,-1.5394168430569777,-2.161262333371155
HCC15,6184667,2.403880665872793,3.0362558925856664
ML-1 [Human thyroid carcinoma],119607,6.010030667993389,5.501522807725524
BFTC-909,11152667,-0.3524603871752078,-0.37860493295929937
BICR 22,10427712,4.255154443676342,4.232676098965424
RCC10RGB,73707398,3.9170227295506304,1.6296985722026478
SK-HEP-1,4788,5.857315027837397,5.730407756677765
SaOS-2,11167602,3.026359974607451,2.5539829441036686
IGROV-1,3825829,4.144093606877803,4.251261360770304
Daudi,53232,2.2893399383043116,2.476858567118077
HARA [Human squamous cell lung carcinoma],2828334,6.6956020196427115,6.165511784052049
LS180,5470400,-3.6342626980574657,-1.2946156184313091
NCI-H1568,322968,3.6220797151302673,3.9337508957713525
SU-DHL-1,25150857,1.7165355924738273,2.5198696907816536
NCI-H2452,9926054,2.7849990975548726,2.0794812140757255
RKO,5280436,4.655813696583822,2.8442020950829954
Panc 02.03,25126798,4.246913180768056,3.839181859240439
BICR 22,5460769,-1.4539525700949456,2.13841825977113
RERF-LC-MS,4521392,4.229663793191115,4.364820362446889
COR-L95,65628,4.016533332946612,3.9902706621442627
ML-1 [Human thyroid carcinoma],72199292,2.652505906746634,0.501210080649063
BFTC-909,11507802,1.7199271215311116,1.7366511037983998
HCC15,16115403,-5.315255617661217,-4.055070683934901
Panc 02.03,24797083,1.7288458125332262,1.4177081308765893
Granta-519,16065773,1.8580334509866892,1.9065382194055172
MOLP-8,67291369,0.6739245689833524,0.6253643357009189
LCLC-97TM1,71304818,2.70820846116735,2.340199329210455
COR-L105,10113978,3.5062120769458907,3.291004657791098
IA-LM,selumetinib-GDC-0941 (4-1 mol-mol),3.6293192218894017,1.2381716229398465
ALL-SIL,5460769,0.8731159867521163,1.7346461189471567
MOLM-13,89928392,-0.0278317389216686,0.3455476001919117
ALL-SIL,selumetinib-PLX-4032 (8-1 mol-mol),4.528203505983491,3.4899039321707575
SaOS-2,6852167,2.181246544986129,2.949518827024363
SK-CO-1,135999136,4.853872243910513,4.20015710081009
LCLC-97TM1,5329102,1.5800226001590805,1.9926064925769686
RCC10RGB,3825829,4.92777419243283,4.365385729105147
WM115,16722836,2.5522609953991577,1.8595264840945598
KU-19-19,6610355,5.477302473020379,4.636078608323832
HCC15,5311281,-0.1593612251340344,2.5592515799502022
WM115,11656518,-0.7680829336702796,1.7370075711972857
IGROV-1,675434,4.336225379212549,4.493507228414784
BICR 31,322968,4.229982613329669,4.07097295417821
LCLC-97TM1,serdemetan-SCH-529074 (1-1 mol-mol),1.7773916595129422,1.9804019383385452
MOLM-13,409805,3.504188648592109,3.7238559580516357
NCI-H2452,68056272,5.088176766324353,3.696652853183773
HuP-T3,JQ-1-vorinostat (2-1 mol-mol),0.3185506624165122,1.1332935260885086
RERF-LC-MS,25102847,0.6953191965745218,2.4401351665854674
SU-DHL-1,5278396,2.36959409949266,3.304701241307057
HCC1500,9935249,2.2800833668468266,3.1306945229997054
HEL,46907787,-1.2802643066913908,-0.6228882671503925
Daudi,64971,1.9256728094608813,2.0757188073339297
KU-19-19,168313047,3.3084179069540696,2.51415078533649
HCC1500,9903786,4.21203406645071,3.074999794679116
BFTC-909,3689413,0.9841636034152118,-0.1738786184095961
MDST8,9911830,3.786562744766562,2.49027571934743
WM115,262093,2.5199436905866905,3.042347937415645
IGROV-1,5311281,3.3250623444804206,2.3525670297607557
ALL-SIL,4261,-0.4593745111072439,0.1456697124083821
ML-1 [Human thyroid carcinoma],25183872,1.7816002858265556,-0.4234585669068495
NCI-H1568,25105715,3.512540774448481,3.5135685649484687
COR-L95,12001922,1.5177554079359803,1.690292376691094
Granta-519,25154868,5.041568583050757,3.816972061271512
MOLP-8,navitoclax-piperlongumine (1-1 mol-mol),0.7236562214911971,0.7795481489162179
SK-HEP-1,3503,1.99172511033101,2.4477137038782386
BICR 22,2749,1.4483580801045477,2.1524647123842158
SU-DHL-1,10231331,2.149159497852676,0.9904029184241172
SU-DHL-1,132496,3.861580575323874,3.7743397353698147
NCI-H1568,11955716,5.84501437277453,-1.0844417763595215
COR-L105,11647372,1.8386560750541856,1.2581830501151803
PaTu 8988t,702558,5.248840045640507,5.266961980830177
RKO,219104,3.7756995047121658,2.8284561767800254
RERF-LC-MS,119607,4.38818595494476,5.342369625178899
SK-OV-3,969516,2.624811361400939,2.884350644907446
SU-DHL-1,67156097,-2.1897423830418155,-0.6580657330909212
HARA [Human squamous cell lung carcinoma],25262965,-0.7160848382234604,-1.5881211605103658
MDST8,10296883,3.644541291105843,3.9404280159730702
BICR 31,135411,1.1842135795155395,0.8818992039531605
NCI-H1568,17755052,1.5920713080731803,1.8046123694229155
K-562,selumetinib-JQ-1 (4-1 mol-mol),0.1487830644360653,-0.014613532419097797
Granta-519,3062316,1.222650334372554,-0.006363996041539686
MOLM-13,11609586,0.2693262849825738,1.628637179620197
MDST8,65628,4.39024768664476,4.499070183341738
LS411N,11222830,1.85641131377126,1.3162761077023182
P31/FUJ,5278396,3.2564464707559786,2.8748584655829976
NCI-H2452,selumetinib-piperlongumine (8-1 mol-mol),3.871574708601934,3.4969596705070995
HCC1500,11228183,-3.1075364778620544,2.20221635442783
Panc 02.03,3503,2.8594786206641514,2.467806751790974
MOLM-13,12001922,1.648284949914827,1.5608156687128119
Daudi,decitabine-navitoclax (2-1 mol-mol),0.1880854613737136,-0.9925953762626236
HEL,tanespimycin-bortezomib (250-1 mol-mol),0.901321339562179,-0.6342707146752945
KU-19-19,selumetinib-UNC0638 (4-1 mol-mol),2.3716952230277313,3.2276708515736874
RCC10RGB,135875424,5.859031260595621,4.197196703159389
LS180,44491742,4.531352051294965,3.9925398745688976
Daudi,salermide-PLX-4032 (12-1 mol-mol),4.83725960729828,4.401676030863075
SW948,5460769,-0.6640669541383749,2.4006305577778075
BFTC-909,9866186,1.150003196853964,0.8340649983508774
KU-19-19,docetaxel-tanespimycin (2-1 mol-mol),1.4200175787881737,-3.2483772518457115
Daudi,322968,1.8489038189519929,2.264981878030382
LS180,135999136,4.321194581518088,4.073785762298206
MOLP-8,4259181,0.2540996075245788,-0.3129184683101179
SaOS-2,UNC0638-navitoclax (1-1 mol-mol),2.2506963685809676,1.565749460131305
BICR 31,17755052,0.616652074058669,1.655227019883709
Daudi,10427712,3.475831712716563,3.7614680806670195
ALL-SIL,6252,-2.462384672511242,-2.2609129750199575
IGROV-1,57330099,4.391385744785918,4.295238127934411
ML-1 [Human thyroid carcinoma],5311,0.3887425314777955,1.6567138444850285
LS411N,5746,2.615146419652584,0.9674798268431783
WM115,11625818,2.666283825244439,4.562539281579048
SK-CO-1,17755052,1.6143754050867285,1.5022465589658143
BFTC-909,4788,5.986704833543041,5.663820307151346
BFTC-909,613000,3.1980696015333137,3.1139189279308517
RCC10RGB,9933475,1.608288384582936,2.0681289755432184
COR-L95,11964036,1.1862097811542611,1.0387305012198074
IGROV-1,12003241,-2.0122972114546904,-0.929001257652538
ML-1 [Human thyroid carcinoma],67156097,-0.9782117982072136,0.11622666267991014
SK-CO-1,navitoclax-PLX-4032 (1-1 mol-mol),0.9904814430420492,1.695522450862896
LS411N,676352,3.0047981548436873,1.88082063157997
NCI-H1568,6918638,-0.3782949656582497,0.5867684489252694
HCC15,654092,-0.5163256778254894,0.07588281382617419
MOLM-13,72193870,3.075841334601934,1.5722701432205923
ML-1 [Human thyroid carcinoma],24180125,2.9342502769836263,3.1244393820856318
SK-HEP-1,1716436,3.791424957504218,3.046365304784304
IGROV-1,637858,1.814476597989254,1.985554296772254
IA-LM,44137675,5.685431340913792,3.224870646775104
RKO,49793307,-1.4433237106321422,-3.187870567798279
Panc 02.03,1750826,-0.0877771412327358,-0.6106403234595852
P31/FUJ,216239,3.114152508734425,1.9270430019872504
BICR 22,9911463,4.403388511465592,4.000701976593243
LS180,3503,2.1233569957286673,2.1431163388186367
NCI-H1568,135440466,1.9451121966001212,2.2886912885377284
LS180,6917907,-5.898955627831861,-5.729872203373033
NCI-H2452,3503,2.8949427881039367,2.3497811602747127
LCLC-97TM1,9952709,3.284131025623194,3.0457219356276255
MOLM-13,168313047,1.872191765635252,1.9429931860451615
RKN,65064,4.855719732775604,4.792229026247572
SK-CO-1,1716436,3.109025551437123,2.9469949441215557
Panc 02.03,322968,4.613737356937267,4.1754570365654615
SU-DHL-1,16115403,-5.307217729681928,-4.253116626260946
Daudi,5738263,2.220866513982768,2.5935422760485944
SW48,10074640,2.891302128524984,3.1070269652819498
SW48,3552672,5.820012420560967,3.085218826541714
Daudi,568763,-0.9358982895655849,-0.09880957879343033
HCC1500,11234052,4.300499145525321,4.039172950299918
WM115,16741245,4.109793610684897,3.8411475788790743
SK-CO-1,6917907,-6.103253673111458,-5.353748531952059
SW48,100016,6.031440310304127,6.168496515005924
SW948,12003241,-1.7903806895013192,-0.540333439577354
SK-HEP-1,9840324,5.848573782723059,5.823363809653613
ALL-SIL,5328940,-0.9694628184696558,0.9657207820195556
BICR 22,2858523,3.373464702278958,3.000602487322039
NCI-H2452,17755052,2.4746667711045514,2.3312001232487716
HEL,tanespimycin-gemcitabine (1-1 mol-mol),-4.465092392275179,-2.2464946224696067
P31/FUJ,654092,-2.277731190350674,-1.1269261287101922
HCC15,selumetinib-BRD-A02303741 (4-1 mol-mol),4.266961603535723,3.9243337287167113
BICR 22,16736978,1.4452527998079976,1.9322977824114906
HARA [Human squamous cell lung carcinoma],107985,-4.031127583701494,-3.535003033948403
RKN,SNX-2112-bortezomib (250-1 mol-mol),-0.3229299326159797,-1.4131362403374084
ALL-SIL,9843750,4.4328493438561845,3.038226112514028
IGROV-1,168313047,1.93821625738322,2.5381340227240665
Panc 02.03,selumetinib-navitoclax (8-1 mol-mol),2.257139592520967,1.7505698484485637
RCC10RGB,24797083,3.688734393817597,1.3501087218593821
IGROV-1,67291369,1.8066430555976296,2.741763800081531
SK-HEP-1,135875424,4.97106166770821,3.9742735670102642
SK-OV-3,676352,2.4999853996447423,2.127336759211404
IGROV-1,3689413,-0.3633634632064185,-0.19535332220703427
MOLM-13,2126,3.944929409626795,3.6804193338068787
SW1271,25150857,2.216244024484901,2.510932895502325
P31/FUJ,piperlongumine-MST-312 (1-1 mol-mol),1.5235846843184453,1.2999996753246856
Granta-519,3689413,-2.6080640580656977,-1.9813354568163033
UACC-812,11955716,-3.4049141440551765,-0.6151951396065602
WM115,6918638,1.2765614986990457,0.8180569440067127
MOLM-13,119182,-3.013346002661584,-3.2259352660585767
HuP-T3,25150857,2.779922499061356,2.656740213083302
RKN,400769,-0.3685197718994141,-0.6528885665544147
RCC10RGB,navitoclax-birinapant (1-1 mol-mol),2.5525116990099015,1.8783748854500868
COR-L95,9927531,5.207677506691081,4.398391758655598
RKO,439501,-1.8401322759847645,-2.189906268531959
COR-L105,135875424,4.584511127602178,4.058971607677312
MDST8,67156097,-2.036194319435593,0.6779978540119594
SK-CO-1,11640390,3.1287755311468715,3.5176773407341835
NCI-H2452,9915743,1.4140850498548845,1.4106947745590543
COR-L95,54626689,4.626807564914302,4.556315129650878
NCI-H1568,sirolimus-bortezomib (250-1 mol-mol),0.676282688891887,1.0193194176092968
SW48,15983966,-4.810478602921179,-1.594893830361197
RERF-LC-MS,53495165,1.4938275665549956,1.2944365021929523
SW1573,10026128,4.237670104162456,3.9355085036878172
BICR 22,5328940,1.2238467278980267,1.5486205378134945
IGROV-1,25150857,3.031865110078871,2.4976448648549052
SW48,54649381,3.6753624817280706,3.8785076305956006
RKN,11485656,2.343665915939472,2.2454650509755636
IGROV-1,216239,2.21703825410177,2.520195898682911
ALL-SIL,selumetinib-JQ-1 (4-1 mol-mol),0.7996490760807272,-0.20049684132541465
SaOS-2,675434,4.709862103920263,4.575450402733416
WM115,439501,-0.2667789802830004,-1.3484649510505642
RKO,11152667,-2.010180339323448,-1.2113412512487465
BICR 22,702558,5.841545864846151,5.331816135522636
SW948,navitoclax-piperlongumine (1-1 mol-mol),1.2480624926894286,1.2203425419722036
IGROV-1,52912189,2.3966568144845666,2.586996607252429
SU-DHL-1,219104,2.7039031158758395,3.385907262127003
SW1271,19582717,5.373754052547774,4.311905687811326
IGROV-1,119182,0.2112476135388779,-0.6514166435215911
SW1573,25150857,3.3863948467965717,2.549324495609668
LCLC-97TM1,1566236,1.804143498427706,2.0988114835741882
SW48,6252,-1.782590172996294,0.6092213620958633
MOLP-8,168313200,3.062868142984741,2.8559508026692457
SU-DHL-6,969516,2.321858620209541,2.200109242352901
K-562,44632017,0.5936262556123562,0.9195825280409227
BFTC-909,56973724,3.22598802973391,3.1820155552477924
NCI-H1568,24180125,3.319632294157453,3.1023282664855274
HCC15,JQ-1-vorinostat (2-1 mol-mol),0.768732947542672,1.1751779389963088
RKO,15547703,3.988071110220001,2.59202814672805
COR-L105,446155,1.2274898824574871,2.7849729011440956
WM115,25062766,1.993857010637035,1.8763710613245366
HCC15,42642645,-0.8684016042996798,0.8376264398812494
IGROV-1,3136844,5.214591389089975,4.508852158835291
COR-L95,16659841,4.2643844802603725,3.1848033214889746
NCI-H1568,107985,-3.6136890416333665,-3.480347430926745
HEL,9967941,3.646907071964301,3.1920281650576907
NCI-H1568,5311,0.289477139532769,1.8048821480312258
HCC1500,24964624,2.92457410282952,2.3039321874449636
LCLC-97TM1,44185566,1.2712415312804253,2.1652391551227175
HARA [Human squamous cell lung carcinoma],4259181,-0.0825087225465529,0.31517257706291574
RKO,135421197,1.472175761257966,1.5421252110642985
BICR 22,UNC0638-navitoclax (1-1 mol-mol),4.356226198213725,1.6427709723679431
WM115,vorinostat-carboplatin (1-1 mol-mol),3.7982137973374104,3.306469431129542
K-562,docetaxel-tanespimycin (2-1 mol-mol),-6.155798984221324,-4.283799053342093
P31/FUJ,119607,5.165578068786105,4.5466518028728835
SW1271,44507138,3.04083255973368,2.498821354632001
MOLP-8,72734382,2.92105223846654,3.5817208703540344
COR-L95,selumetinib-tretinoin (2-1 mol-mol),5.25273224867287,3.3009989430504474
RKN,12001922,2.582060834791438,1.8874759030605037
MOLM-13,3025986,-2.268401268397509,-1.6511820030497497
ML-1 [Human thyroid carcinoma],54613361,1.1529799235720395,0.3548453635602311
HARA [Human squamous cell lung carcinoma],65064,5.174523602274789,4.921686603532411
BICR 22,387447,-3.632542993789297,-3.3395882158114576
SU-DHL-1,navitoclax-pluripotin (1-1 mol-mol),0.447892144567538,-1.8926391187591585
BFTC-909,selumetinib-vorinostat (8-1 mol-mol),1.99531584260594,2.9868851559629785
MDST8,44819697,0.5968481057166135,0.05199040187204231
COR-L95,54613361,1.8571878459944453,-0.3401785600279302
PaTu 8988t,25183872,-1.065851307698322,-0.6752251612158962
HCC1500,969516,2.5012208253247374,2.917449681179233
LS411N,51039095,3.380080993968732,2.8661085878287778
IA-LM,10385095,1.8174613436578264,1.1720725961458074
Daudi,JQ-1-vorinostat (2-1 mol-mol),-1.994208072819334,-0.6645353360424021
MOLP-8,44589607,1.928632926439859,1.8208911535509786
UACC-812,JQ-1-UNC0638 (2-1 mol-mol),0.7883661966359787,1.747746400500359
SK-HEP-1,5311,2.3418360503567386,1.5842076145745259
NCI-H2452,24889392,3.037712354939189,4.281058643562213
SU-DHL-1,4378219,1.8683369375684944,2.0847170404466575
NCI-H2452,2858523,2.6943426896823284,3.0131477779510423
ML-1 [Human thyroid carcinoma],decitabine-carboplatin (1-1 mol-mol),4.481069697343496,4.566108070413995
IA-LM,119607,5.918153428689206,4.630418399016578
ML-1 [Human thyroid carcinoma],11214940,1.6315509593699482,1.9619469807049803
COR-L105,46224516,3.053099263199949,2.729503528186978
SW948,3062316,3.151526592835161,1.0285787633769234
BICR 22,6610216,4.672862717569176,4.193588213405364
SW948,16736978,1.371465793072688,1.446981941757999
IGROV-1,2828334,6.070696247039626,6.115429138645059
RCC10RGB,44185566,3.1564704709707856,2.794412843468283
Granta-519,135999136,4.28714374371566,2.3344465442219358
BFTC-909,654092,0.6323398211983356,-0.2152357844592667
SW48,selumetinib-PLX-4032 (8-1 mol-mol),-2.238777477327049,3.1895953838950946
P31/FUJ,17755052,1.7010190253681206,0.5462228369720615
SU-DHL-1,2945648,2.120687124348465,2.6270194307427848
LCLC-97TM1,16720766,-2.0806199642234704,0.2654383399314239
HCC15,3025944,3.8616867083103648,4.212133995118853
LCLC-97TM1,53392493,1.9813066602409652,2.517264809279962
WM115,selumetinib-piperlongumine (8-1 mol-mol),-2.154986024806584,2.683677996575806
COR-L95,675434,4.0325297307826125,4.472082805300994
SaOS-2,11213558,1.0641156085827448,1.7975852854700924
Daudi,JQ-1-carboplatin (1-1 mol-mol),-0.7509851402821236,-0.17106646583317034
KU-19-19,1716436,3.531012736022478,3.087464353408651
SU-DHL-1,11485656,1.6397040363022437,2.1550702586423527
SK-CO-1,16736978,2.1510378918389415,1.4535255199600374
SW1573,selumetinib-JQ-1 (4-1 mol-mol),1.6562897469951037,1.9529966055793222
HCC1500,136227924,2.675203690625814,3.049546223507985
LCLC-97TM1,sirolimus-bortezomib (250-1 mol-mol),0.527232919113557,0.7310913990297181
RKN,BRD-A02303741-carboplatin (1-1 mol-mol),5.528038962892509,4.2105084734203295
PaTu 8902,selumetinib-PLX-4032 (8-1 mol-mol),5.82901614817581,3.2776460990805614
Daudi,219104,1.6178665476553538,2.393719699732385
WM115,5284373,2.6004259651165644,3.0339663694158765
SU-DHL-6,216345,3.116690602340157,3.1532179653461787
HuP-T3,5460769,4.291069487745317,2.4715205802171285
HARA [Human squamous cell lung carcinoma],54619238,4.4726064543510144,4.7859120138292335
Daudi,8515,3.193004700442435,3.209714322383013
HCC15,3815108,3.1337581441750277,3.0950380132228155
IGROV-1,5280436,3.2616766817665086,3.3277931640803122
COR-L95,107970,2.0048060228155333,2.101061235872426
BICR 31,25150857,2.3687059872087217,2.42861951064372
IA-LM,6918837,-2.975709639111599,-2.952083669077359
WM115,3025986,-1.3268545497049868,-0.6922014892106033
WM115,BRD-A02303741-navitoclax (2-1 mol-mol),3.3998938295257632,2.222662209516132
SW48,17759555,2.861947497664063,3.497435052772553
SK-CO-1,selumetinib-vorinostat (8-1 mol-mol),-0.8201042282991368,2.2439648839466035
SW1271,9956119,4.3828310926576375,3.784543760219923
ML-1 [Human thyroid carcinoma],piperlongumine-MST-312 (1-1 mol-mol),2.022291985496103,2.0023705716412934
MDST8,24772860,-2.900176299695688,-1.2006546876993347
SaOS-2,4259181,-0.1317601722396107,0.08435219747957304
PaTu 8988t,5746,3.0775825889142543,1.3528490679309895
SaOS-2,4521392,4.5837419847316845,4.244113315572953
SaOS-2,445455,5.662681927298568,4.645581928818518
IGROV-1,148198,-2.659972993252853,-3.5352534439174246
SK-CO-1,11404337,-0.5084033800481932,-0.2896550109714094
Granta-519,4578,4.680400709321271,3.6937908344283237
RKO,4261,2.924548439505643,1.1103519350100037
MOLP-8,54618164,3.908946135671936,3.765325826457379
HCC15,24978538,-1.0517559532383662,1.8642895591516855
COR-L105,2945648,3.0602962908492386,3.125446120846606
RCC10RGB,salermide-PLX-4032 (12-1 mol-mol),5.5053951487435775,5.018664807713567
NCI-H2452,4705,3.641149380662554,3.2347236764757707
SK-CO-1,54143018,-0.6826828748975821,0.6112687148294321
MDST8,26596,-1.25574590011264,-0.6595933614922768
NCI-H2452,54454,2.511734775409603,2.5500872842086784
HARA [Human squamous cell lung carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.088944743887487,1.56783038450803
RERF-LC-MS,16038120,1.5599846769821624,1.0753876819315398
SK-OV-3,44185566,3.1295797630764266,2.801894763903343
BICR 31,148124,2.7085675831815292,-1.7310222980622803
P31/FUJ,439501,-2.3575947617146475,-2.3107010668702626
BICR 22,11152667,-1.8276171650012312,-0.1474198895796813
COR-L95,56973724,4.268430703602559,2.3034133070380887
RERF-LC-MS,54626689,4.221264321270605,4.642094993479255
IGROV-1,1641662,3.5854177848263675,3.643618354670236
MOLM-13,613753,2.871004682812888,2.725625029720269
IGROV-1,11404337,-0.7659238947812715,-0.42994840461573886
SW48,219104,2.280685064057957,3.684407188745171
Panc 02.03,crizotinib-PLX-4032 (2-1 mol-mol),2.31663341207245,2.0276565168093432
Granta-519,9935249,0.0212855082517002,0.6604949644600029
MOLM-13,2749,0.3899767988765278,0.8717147088635591
WM115,1750826,-0.9273267035114736,-1.259801740794315
SK-OV-3,2858523,3.2787147644650716,3.10966398509882
COR-L95,selumetinib-GDC-0941 (4-1 mol-mol),2.521789990361809,1.449766105733493
ML-1 [Human thyroid carcinoma],969516,2.8184901812435923,3.0596246464193193
SW948,25183872,-1.604238480901096,-0.7947926924598029
HARA [Human squamous cell lung carcinoma],decitabine-navitoclax (2-1 mol-mol),1.7884131125603568,2.4106644599245897
IGROV-1,6914657,-4.141311308759326,-4.202549605651811
SW1573,salermide-PLX-4032 (12-1 mol-mol),4.9189296859442315,4.93220852176935
HCC15,6610216,4.23435184261858,4.272549670241593
NCI-H1568,10074640,3.1711026687004855,3.283815913116582
SW48,4917,2.351047632498956,3.017257773917894
MOLP-8,46215462,1.266580776259001,1.0048707084336583
WM115,erlotinib-PLX-4032 (2-1 mol-mol),0.1999561238865428,2.9115054655374424
COR-L105,387447,-4.5302496546864885,-3.970587925965045
MOLP-8,44462760,3.111101001788515,3.013126898339398
BICR 31,44819697,0.4590360698509347,-0.18479244291735256
HuP-T3,9956119,4.370077084995815,3.7283136804648427
PaTu 8988t,sirolimus-bortezomib (250-1 mol-mol),0.5843474412149585,0.5433630845109747
KU-19-19,66577038,3.864819378735941,3.041495422993161
BICR 22,5746,-1.0393569299451335,0.9195057595765956
HARA [Human squamous cell lung carcinoma],6438330,2.871193568039211,2.3014240738386014
SW48,67156097,-2.150931452918296,-0.3793794476388279
SaOS-2,25150857,2.491525195617086,2.160125674868895
NCI-H1568,613753,3.056586098825006,3.376716562392949
LS180,44137675,2.850653785387247,3.4410392984179627
RKN,11364421,-3.590581417405073,-1.943077397514201
HuP-T3,23582824,1.5911146583975455,0.8073411022201056
SW48,446155,2.2181780639059907,2.6842415233424943
SU-DHL-1,44202524,0.8334918459072751,1.6413442476191287
RERF-LC-MS,11404337,1.609147033115388,-0.10248580859592586
K-562,44486219,4.057183894108205,4.051089977464734
PaTu 8902,serdemetan-SCH-529074 (1-1 mol-mol),2.396607903766339,1.902573610602839
PaTu 8988t,46199207,3.796589685342678,3.2071354676394255
LS180,11964036,0.9251272605785624,1.2573782806627825
SW948,8515,3.759025323790885,3.4973722571629047
SaOS-2,374536,3.743747938767685,2.6048114340344206
SW948,135875424,4.663257041681152,3.50429863642952
SK-HEP-1,72376,-0.6035227354554765,-1.6426995586806135
SK-CO-1,1242560,3.64748499205759,3.5907836870202856
SW48,selumetinib-vorinostat (8-1 mol-mol),-2.7312432821532724,2.2012584518013485
MOLP-8,3025986,-4.599162344151263,-1.5523165288065537
SW48,25150857,2.2099211562472125,2.1945888898390855
ML-1 [Human thyroid carcinoma],10127622,2.646237824428173,3.7254520164009737
LCLC-97TM1,3465537,1.1142431298706064,2.1864203059577134
NCI-H1568,9887053,3.9549233487650666,4.264937719029203
SW48,5746,-2.6538895977275745,1.2799719983275357
LS180,44484440,3.4848015178596343,2.955443772661512
Daudi,25183872,-3.2629659020313393,-1.8118765339237268
IGROV-1,984333,0.6618578113050116,0.7757321655968299
COR-L95,135999136,4.28146486500778,3.075096191656379
RERF-LC-MS,4788,5.0822281264538365,5.778804040680401
HuP-T3,2828334,6.159425491986346,6.183376875980168
RKN,3854666,2.132003481112045,2.2144039936687485
HARA [Human squamous cell lung carcinoma],676352,2.7556636695973515,2.1225180516029654
PaTu 8902,54639665,4.483683562011812,3.2234244753678927
ALL-SIL,24180125,1.6553840753953686,2.1121254556634086
SK-CO-1,12003241,-0.9578793579943758,-0.8644964005958989
BFTC-909,104842,-1.584917163766509,-2.720932000603386
HARA [Human squamous cell lung carcinoma],60750,0.0702005032300629,-2.1387413102575814
MOLP-8,24772860,-3.493237790177901,-2.9554499528607328
SK-OV-3,49836020,-5.2191550029019025,2.6784243633020584
K-562,46199207,1.8646546122938352,2.9211216193269296
SaOS-2,BRD9876-MK-1775 (4-1 mol-mol),1.220945840769529,0.4181480132227637
MOLM-13,6450551,0.4092106163446157,1.3228846920586066
BICR 31,1566236,4.637821170940002,2.4179986083735674
SW1271,54454,2.1914366041236204,2.6233884341069644
HCC1500,selumetinib-PLX-4032 (8-1 mol-mol),4.771751115117369,3.0999766577954673
SaOS-2,9952709,3.1448975558697545,3.2519220182501165
HuP-T3,54618771,0.8132197250487964,1.2788345403472778
IGROV-1,6918736,-0.950858733923241,-1.7286622919881407
ML-1 [Human thyroid carcinoma],654092,0.5372247724983673,0.0143795179527582
Granta-519,53392493,1.7904738197895116,1.4763438168570349
NCI-H2452,445643,4.078319116283011,3.828813708958449
HuP-T3,5281321,0.1098786391841839,-1.0304420207437106
NCI-H2452,654092,0.1220899319284023,-0.18880692765678844
ML-1 [Human thyroid carcinoma],135423438,1.332992654992983,2.4711780168894473
MOLM-13,56973724,0.5307136138302019,1.5156879368938443
BICR 31,439501,-2.4499261286992007,-2.064026109974441
MOLP-8,44495899,4.403173191891281,2.991877076177181
Daudi,44632017,0.5148090574579154,0.7453502099984952
SaOS-2,selumetinib-JQ-1 (4-1 mol-mol),2.075892545487755,1.9341682769576687
SU-DHL-1,10077130,2.6641926349973875,2.8744743674803437
SaOS-2,9549297,2.000544043325996,2.598627476458581
LCLC-97TM1,24785538,-0.7280489014481334,0.9371723969715369
HuP-T3,10302451,3.3244038223924868,3.0023508552674967
Panc 02.03,73707398,1.687012904299387,1.2669809545008484
SW948,25161177,4.032512886861284,3.583635283575426
COR-L105,17755052,1.2153053156846572,2.0888531644552737
HCC1500,11719255,2.4435237001116685,3.5741302834337048
RERF-LC-MS,5287620,-3.2415128958876123,-2.037989775578228
WM115,72193861,3.0084505907765795,1.8843601717944307
K-562,2113511,5.3605896450220785,5.234060596036626
RERF-LC-MS,24772860,-2.3078196081029136,-1.7662017095369316
SK-CO-1,navitoclax-gemcitabine (1-1 mol-mol),-3.3609230620799595,0.20966787176113844
HCC15,piperlongumine-MST-312 (1-1 mol-mol),2.732022929511258,1.9998770713086924
MOLP-8,15547703,2.3372930335131663,2.701577689544337
LS180,4378219,2.066313424484697,2.25730393195776
SW1271,168313047,1.8206519834924395,2.582251928476465
RKO,123631,2.6120370559458155,1.7920252832485488
NCI-H2452,3011155,5.255477653901917,4.368107146532795
Daudi,16722836,0.8830828668869325,0.9556292314701055
PaTu 8988t,6505803,-0.6279165545759258,-0.3694309978842752
SW1573,5280436,3.0542460563059253,3.5525169391791063
MOLM-13,262093,0.9014616367149992,1.4495576315659835
IGROV-1,BRD-K55473186,4.387806234483854,4.14752716839065
SU-DHL-1,selumetinib-MK-2206 (8-1 mol-mol),2.1944562589821226,1.996574895119482
SW948,5287969,-2.4513180825948515,-1.7651990207347041
P31/FUJ,54619267,3.5260071244925575,3.614088382098265
IGROV-1,navitoclax-sorafenib (1-1 mol-mol),2.116164500809202,1.8613346241419115
SW1271,11396600,3.626770708484224,3.600136729909424
IA-LM,676352,2.5463710414635696,2.0871727421301958
SW48,148198,-2.7635683141359277,-3.4879350725153544
K-562,6918328,-1.3297822316036851,-0.6391694524913805
HARA [Human squamous cell lung carcinoma],25105715,3.4880191589222966,3.590732051589092
Daudi,135423438,1.6157885595086947,0.8549712849565135
Daudi,6438330,0.2626238759101729,1.1439979365774948
Daudi,44543605,5.193449926403497,3.7367368442904962
SaOS-2,71751553,4.337892909522829,4.5197853234484535
MOLP-8,23939,4.352572888875192,3.398576929377148
SW48,2858523,2.8468158768410965,3.0119991265008133
SK-HEP-1,selumetinib-piperlongumine (8-1 mol-mol),4.719630045140052,3.5688825189755384
COR-L105,9911463,4.222864246171191,3.932271517548468
SW1271,11167602,2.369450835450289,2.3992665856376316
SW48,135928012,3.696922095661256,4.134443341429134
Granta-519,53232,4.0944047749373915,2.4620401330728847
COR-L95,2871966,-0.8178907803151099,0.19475224997425866
MOLM-13,17759555,3.648246486561575,3.2230251301634314
COR-L95,tretinoin-navitoclax (4-1 mol-mol),0.626714074175952,1.0281200089609108
SK-OV-3,44589607,4.1377534493712265,3.071554934060532
RERF-LC-MS,44543605,4.169252612552019,3.8915250176442515
Granta-519,49836020,3.8229564713378057,2.6789127389251997
SW948,5278396,3.777624651516773,3.0886096017335403
HCC15,400769,-0.8695567043490428,-0.49109184504738096
ALL-SIL,3038522,2.34327176020718,2.53647853054421
SW948,135440466,1.4177296224023617,2.377016409772847
PaTu 8902,400769,0.6580342998730634,-0.35584548531250876
IGROV-1,5746,1.9055212643377857,0.9876999046106951
COR-L95,25195348,4.044301101066811,3.223026977921698
BICR 22,24180125,3.296229177015365,3.2905948297688785
SW1271,carboplatin-UNC0638 (2-1 mol-mol),2.98870654666586,3.5274922042089623
RKO,73707398,0.9128481241529548,0.6974298689422506
BICR 22,selumetinib-vorinostat (8-1 mol-mol),2.1163342168700936,2.5789159299063313
HCC1500,decitabine-navitoclax (2-1 mol-mol),-0.2719438923490784,1.2337464737865425
IGROV-1,15953870,2.712793598656007,3.559767641350228
WM115,71466445,4.303064097958205,4.012794203824015
COR-L105,9956119,4.279642090153805,3.8166285684023302
BICR 22,168312962,0.5954564951508424,1.0254511138142397
SK-OV-3,navitoclax-piperlongumine (1-1 mol-mol),3.1171344026711147,1.6667103342063745
LCLC-97TM1,46843906,2.6060669508648675,2.607353117378651
HCC15,9840324,6.2076616503129,5.898952556622463
RKN,24964624,2.2448388370498704,2.662312165835951
IGROV-1,selumetinib-navitoclax (8-1 mol-mol),2.4437934407587907,2.2916338222218724
K-562,10410894,3.650757753763785,2.759774888997821
SW48,124202324,1.4616392816877528,2.6023041491807275
IA-LM,15547703,3.104636726250569,2.900997036868767
SU-DHL-1,decitabine-navitoclax (2-1 mol-mol),1.6803027957585963,0.3264103212755348
ML-1 [Human thyroid carcinoma],15547703,3.133536230544004,3.45440939040812
MDST8,49850262,3.692937134795778,3.5445937945213486
UACC-812,52947716,-6.767186414102593,-0.35873557672067463
ML-1 [Human thyroid carcinoma],9911830,3.383108057822615,2.7716281309888275
HEL,11427553,2.263048189869726,1.3443633420476562
IGROV-1,5281321,-1.4962463697398798,-1.1570921533588192
IGROV-1,135421197,1.96820638017286,2.0521915627687775
LCLC-97TM1,104842,-3.469971777740615,-2.567498186964851
RCC10RGB,374536,3.743226525407361,2.160076427433265
COR-L95,107985,-2.989419812710682,-3.5708936667122826
RCC10RGB,72199289,4.762339751475906,3.2001777843275914
NCI-H1568,11485656,1.8106242285910237,2.5306222594971133
MOLP-8,9549297,1.4376511571672042,1.6977019522809564
Daudi,24951314,0.2263717121921743,0.186075184788943
BFTC-909,7326481,3.4905195575106527,3.032784789892434
BFTC-909,6623618,2.802037410677928,2.4369649317732014
HuP-T3,5287620,-3.5836939395445913,-2.0835779339702647
COR-L95,568763,-0.4949329271490838,0.22703064779952814
SaOS-2,216239,3.028726771334262,2.3563993514089265
RKN,navitoclax-piperlongumine (1-1 mol-mol),2.28018118974292,1.7643614665197913
Daudi,5311281,1.0302556341787754,1.910004536830984
LS411N,3503,3.033347172376105,2.2567777476137105
BICR 22,4705,3.4365696424802477,2.4502194908712713
Granta-519,6918638,-1.0102021398050984,-0.936014435880904
HARA [Human squamous cell lung carcinoma],11175137,1.814800704414418,2.7283915781498047
SW48,54618164,3.7830586534540616,3.9937634321503963
MOLM-13,25105715,3.5182090361281326,3.0341228770283464
Daudi,11175137,1.084300991963852,1.9530106146078723
SW1573,42642645,1.1024283721976142,1.0068585618227048
P31/FUJ,11364421,-5.080526011220062,-4.264142422775316
MOLP-8,12003241,-1.4499361325619826,-1.4661078145796358
Granta-519,10410894,1.4137063553430784,2.5681425414140784
RCC10RGB,57519531,5.003664553369681,2.916669979413022
HEL,11625818,4.404342627749774,3.4529556294137844
SK-HEP-1,1242560,3.752923936287399,3.6901320220874334
SW48,3062316,-0.5038339303633423,1.0349046014216312
HEL,219104,3.0071408108258253,2.4044325038724623
SK-CO-1,3025944,4.807689572392986,4.207853169709744
SK-OV-3,52912189,0.2062426244094619,2.3481323612033123
COR-L105,51039095,3.4251018662752073,2.9382057599482105
HEL,65064,3.1933308972510113,3.966396644392288
Daudi,9929138,3.458684768924583,4.277034654328406
SK-OV-3,11404337,1.4011927232423718,0.11004363971001908
ML-1 [Human thyroid carcinoma],7326481,3.5221044039257037,3.079571104448307
MDST8,11178236,-3.494725666780331,-3.0143921254762045
HCC1500,ISOX-bortezomib (250-1 mol-mol),0.4566996929358766,0.9262997549240828
WM115,119182,-0.4924283039006125,-0.2614210744060279
COR-L95,56649450,4.0191520211736895,2.8420978501853904
HCC15,5278396,3.283293724206623,3.561440839811832
LS180,54143018,-0.5111931850291043,0.34323336676309696
MOLM-13,10427712,3.427914513597021,3.7107080217660187
NCI-H2452,1566236,3.5735792412039022,2.257283277743441
ALL-SIL,452548,-3.3771532504793194,-3.024345451666664
KU-19-19,409805,5.730069773001202,4.9886236218964335
SK-CO-1,sirolimus-bortezomib (250-1 mol-mol),-0.6660837723392407,0.7439014949854739
HARA [Human squamous cell lung carcinoma],17759555,3.7036804092868847,3.6250828226076464
SW948,11955716,-2.1355637415890323,-1.7559590634676574
RERF-LC-MS,11609586,3.546222239883878,3.0295326223072774
IGROV-1,selumetinib-tretinoin (2-1 mol-mol),4.176281087704045,3.5060811077276726
WM115,5311,1.988201906885666,1.5271752597152113
HCC1500,5311,1.250436307916732,1.4148791269332477
KU-19-19,5282054,4.451216911386669,3.8141146660701617
PaTu 8902,4788,6.453607861068675,5.571111126516197
PaTu 8902,4261,2.3507697687761224,1.467101408552508
SW48,68056272,2.992212540747962,3.5740012309176334
HCC1500,56963564,1.3630245510511625,0.581154455780137
Panc 02.03,25183872,-0.079390979301081,-0.7696508844496971
LS411N,11964036,1.3999141622104765,0.780167563207402
BFTC-909,135440466,2.535274686795805,1.9460125858884578
SW48,selumetinib-UNC0638 (4-1 mol-mol),-2.2763178570350857,2.6545107825049787
ML-1 [Human thyroid carcinoma],54619267,4.278122085164484,4.195508008573783
LS180,25183872,-0.6080839156226316,-0.6013978183134482
PaTu 8902,71304818,2.9919229428361263,2.3787427411633857
BICR 22,216345,4.525930969601246,4.104767951143583
NCI-H1568,374536,1.2941902477204823,2.0473391604930757
LCLC-97TM1,135423438,1.8911988038183152,2.158722446197682
NCI-H1568,56963564,0.2273202395709376,0.3257516868564444
K-562,9927531,3.3022164605184763,4.3177940849848335
SW948,2858523,3.1308292618704905,3.0844126695344447
COR-L95,ISOX-bortezomib (250-1 mol-mol),0.3297770164947888,0.10931721971300215
SK-OV-3,5287620,-0.5544150043477152,-1.7137727818845208
ML-1 [Human thyroid carcinoma],3676137,5.53606210778591,4.581907526717983
NCI-H1568,5311037,3.1621369524545155,3.905316875977909
WM115,15953870,3.7155207356015207,3.723470644694643
Daudi,445643,2.8458589584694307,3.671449035694634
BICR 22,navitoclax-piperlongumine (1-1 mol-mol),2.368049525679639,1.3265892577587093
HARA [Human squamous cell lung carcinoma],49766530,5.57937649881164,-0.25815698174693863
NCI-H2452,156414,1.7996451609117237,1.6654264794271136
Daudi,53301938,4.372641532954565,0.24594513156528677
PaTu 8902,9907093,4.385383441203628,4.280503939145152
SW48,136227924,1.7122170056378203,2.7988747297551457
P31/FUJ,4096211,0.7441609883240002,0.883045384319906
IGROV-1,6610355,3.969940996770339,4.587752442577103
PaTu 8902,4917,3.0649190232675525,3.145995862676736
IGROV-1,613753,3.483244781428779,3.2854533997103594
SU-DHL-1,3136844,3.883215489826005,4.16963451598225
HEL,446155,2.11086977892158,2.230617416158204
HuP-T3,46907787,1.2763139172323097,2.3761344798279764
ALL-SIL,2729026,2.163276094007301,2.1562284320257405
NCI-H2452,54613361,3.2620625907056744,0.23956600310370837
BICR 22,448949,3.2035793217055124,1.9483128710903745
SW948,5280436,1.724516723779293,3.13996066463592
BICR 31,25154868,5.458998944130281,4.560445529081716
LCLC-97TM1,44632017,0.6758650901814578,1.3656868348887667
PaTu 8988t,docetaxel-tanespimycin (2-1 mol-mol),-5.646992799561264,-2.54027864576709
SK-HEP-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.819431075997551,4.01723533019336
HARA [Human squamous cell lung carcinoma],4261,3.400371454492322,1.83884122932463
HARA [Human squamous cell lung carcinoma],salermide-PLX-4032 (12-1 mol-mol),5.233652502193764,4.894543458495649
ML-1 [Human thyroid carcinoma],9866186,0.3108629746931657,1.2833241413411054
SW948,409805,5.995103866916248,4.189488674249695
P31/FUJ,16736978,2.2012912480094444,0.7839764534540218
SK-CO-1,crizotinib-PLX-4032 (2-1 mol-mol),1.4696043946454187,1.8814101210294323
PaTu 8902,19582717,4.67665303596855,4.5522234747552455
SaOS-2,24775005,3.5680490412807555,3.532347902069662
Granta-519,327653,2.833903719231272,2.4730965690420565
ALL-SIL,446155,2.369103686447931,2.0699666001815884
HCC1500,445643,3.796669497386567,3.9799262213614726
COR-L95,7326481,3.0640813007839105,2.6970936878153267
Granta-519,selumetinib-navitoclax (8-1 mol-mol),0.4649117531552323,0.20585940757871146
LS180,53232,2.536426383073758,3.048851876037666
P31/FUJ,10127622,1.4388313131004449,2.6964319441791975
HARA [Human squamous cell lung carcinoma],vorinostat-carboplatin (1-1 mol-mol),4.151404263307493,3.2792579274858555
WM115,alisertib-navitoclax (2-1 mol-mol),1.935725956121268,0.48496571626921176
SaOS-2,11214940,4.2656495802712735,2.117954865232988
RKO,637858,2.400395947377078,1.3256724843061098
NCI-H2452,3552672,4.527548939486843,3.097942289383562
Daudi,168312962,0.2834059413422853,0.624169541568465
P31/FUJ,216468,2.1049028903625673,1.1769597530929077
MOLP-8,11656518,1.844531268869525,0.6602248845824639
MOLP-8,5426,4.334733303826167,2.444861653393356
SW48,54454,2.31662951125423,2.761216202472264
K-562,4521392,4.220123235241678,3.86413409266775
SU-DHL-1,selumetinib-PLX-4032 (8-1 mol-mol),2.801448892460394,2.660669690619497
RKO,1641662,3.3091455873155367,3.0433092778028934
BICR 31,135875424,5.0736941678127945,4.059407241183727
SW1573,BRD-K27188169-navitoclax (2-1 mol-mol),1.518643472033959,2.487788522427842
Daudi,44607530,0.9746569917988196,1.5463323416270043
SK-HEP-1,25150857,3.0587845310763297,2.478971914000976
COR-L105,tanespimycin-gemcitabine (1-1 mol-mol),0.318019061549867,-0.26429756861641995
Granta-519,23635314,-4.977140911540282,-3.0387941189346552
LCLC-97TM1,24753719,4.6973214087473405,3.923345897938221
P31/FUJ,11640390,3.1324724534083277,2.4007785637011945
HCC15,navitoclax-MST-312 (1-1 mol-mol),-0.227842438558318,1.0918196904245037
K-562,6450551,-0.0734681627771844,1.2277144473964299
Daudi,56946209,-7.191237665956405,-4.9584720785620915
Panc 02.03,25154868,5.464083731960118,4.496977606540278
P31/FUJ,5311,0.3390662723443479,0.6639191537777187
SaOS-2,11485656,2.155652122560971,2.5009132523656596
IGROV-1,3025944,3.9702787396819503,4.295235068720856
COR-L95,docetaxel-tanespimycin (2-1 mol-mol),-3.340788273550256,-3.589916572709303
PaTu 8988t,11494412,2.1257430484232525,2.0614390087395233
IGROV-1,53495165,1.3981720287668329,0.7587144302660093
LCLC-97TM1,42642645,0.0997949580151915,0.6212400009004508
HCC1500,36314,3.7134374865247017,-0.0038429875952099212
NCI-H2452,3815108,3.5712952235347455,3.1264646723278355
WM115,11214940,3.8761690772861126,2.0695998990661706
SW48,676352,1.4830170410483523,2.1126476780206143
MOLM-13,25262965,-3.0495150612642465,-2.1241370149120997
ALL-SIL,tanespimycin-gemcitabine (1-1 mol-mol),-4.457360880270642,-2.9096324743728683
Panc 02.03,148198,-4.053337817942692,-3.4062034966487276
SW1573,71466380,3.629171273590213,4.50690025756136
SU-DHL-1,151289,-1.0536473601541108,0.71639549726831
SK-OV-3,JQ-1-vorinostat (2-1 mol-mol),1.4863340037373012,1.1224201329810075
COR-L105,285033,-1.0049053408998423,-1.2829611333356008
SU-DHL-1,SNX-2112-bortezomib (250-1 mol-mol),-2.738100295775396,-2.6117019390749774
Daudi,135440466,1.490781603812653,1.755846394179719
NCI-H2452,6918878,3.5446658281374277,3.3805065062492377
PaTu 8902,123631,3.453096327622384,2.004387399640379
COR-L95,15547703,3.222652754514603,2.875240143291832
NCI-H1568,123631,1.2596294102093508,2.32278471107309
P31/FUJ,216345,2.9363986514954203,2.6587186469221677
HEL,4261,0.4865008011530605,0.2841245141241324
SK-HEP-1,5280436,-0.1709015599208282,3.544452054072795
SaOS-2,25062766,1.5016836694759386,1.9317461264945626
RERF-LC-MS,51037431,2.0455212647735364,3.0887872329629498
HCC15,11656518,2.9308462534519024,1.8997067902098073
RKO,10127622,3.209405126939437,3.4395215824654475
COR-L105,9927531,5.197941564874311,4.940041347287984
NCI-H2452,6623618,2.534886377212576,2.550781362149716
SK-HEP-1,16725315,5.326615386804391,4.193898871434619
SW1271,11152667,-1.5987482479879582,-0.34545203442298605
PaTu 8902,selumetinib-GDC-0941 (4-1 mol-mol),3.4038309056959424,1.1547010798615347
SU-DHL-6,3825829,3.5283611337160155,3.3226205936188817
RCC10RGB,11656518,3.9855029209510215,2.01917434388259
SaOS-2,67156097,-1.585481519484996,-1.0801975740067442
BFTC-909,5566,2.8568699448622263,3.2209496449654127
SW948,4788,6.033471365822279,5.7787697707376005
LCLC-97TM1,1750826,-2.0890062190589544,-1.8640233109778475
MDST8,3689413,-1.6812703512916511,-0.059146594154521635
SW48,9926054,0.5681768331785455,1.8019839695215072
MOLP-8,selumetinib-JQ-1 (4-1 mol-mol),-0.4981022967817401,-0.1442124360575698
SU-DHL-1,262093,1.7952973078733698,2.4354993762201205
BFTC-909,439501,-2.4866456286351095,-2.240623147138413
HCC15,123631,2.7523193051058974,2.5966067720605097
P31/FUJ,60750,-3.4241008025920396,-3.254868973963148
Daudi,9927531,3.2507934675389447,3.7984442355864583
MOLM-13,5281672,4.456656164404507,4.323213343116332
IGROV-1,11222830,1.5703285223102077,1.6121445311307228
SK-CO-1,5311,2.0479844637297617,1.6139632322182442
COR-L105,15953870,3.0827686267342957,3.7983960734720017
PaTu 8988t,9866186,1.4965239773376473,0.9668508374180417
IGROV-1,124202324,2.2563058955522157,2.586915587219363
PaTu 8988t,9936388,-7.900053622036252,-0.296554603588169
HCC1500,11152667,3.4439033763408644,1.0510623392569614
MDST8,54618305,4.422279328619345,4.289543266659413
MOLM-13,3825829,3.189823245525434,3.3718994478758173
BICR 22,3081361,1.798482521796042,1.5883696939392369
SW1271,3854666,4.252835819462087,1.9604622688763973
HuP-T3,285033,-3.1273004056463916,-1.6098650051342829
COR-L105,navitoclax-birinapant (1-1 mol-mol),1.1502985438361142,1.6867328226561986
SK-OV-3,6610216,4.5015440272840275,4.152069898438347
ML-1 [Human thyroid carcinoma],56946209,-4.214217670545523,-3.5525204908654326
SU-DHL-1,10090485,4.45721233802345,2.944821539093645
COR-L105,54765302,4.547071050564395,4.102791826521548
SaOS-2,44491742,4.263847553999534,4.447411355880201
RCC10RGB,BRD-K55473186,4.42890698658841,4.189990272001693
SW1271,2742550,3.530952260660614,4.095860805346538
Daudi,148198,-7.679285276133229,-4.266956546311044
RKN,104842,-2.3241286690000265,-2.536094274854641
SK-CO-1,3689413,1.2567954519757167,0.30001237026769756
Panc 02.03,24180719,3.694319415808187,3.7457377491566053
MDST8,637858,1.7716899628344815,1.8598711729986002
BICR 22,11404337,-1.5250786338229352,-0.49510741263353625
NCI-H1568,82146,4.486561599154294,3.740403192069339
LCLC-97TM1,52912189,1.3140510236946998,1.4243493395581754
BFTC-909,6918328,0.6354681535452512,-0.06367436133242699
IGROV-1,selumetinib-navitoclax (8-1 mol-mol),2.4437934407587907,2.2916338222218724
SW48,10385095,0.7767009249070084,1.3040448786767016
RKO,56649450,4.8662264096692684,3.0247550712477818
SW948,45279963,3.8052773477912782,3.277610158984845
RCC10RGB,3038522,2.595581097335362,3.277930147574441
BICR 31,3689413,0.760898743899782,0.20320045880856327
RERF-LC-MS,5282054,4.065617468844444,3.969684190793294
K-562,selumetinib-PLX-4032 (8-1 mol-mol),4.219594820991848,3.3420879671786463
K-562,25161177,2.405708421255354,3.5016468697558207
ALL-SIL,11497983,-4.396279985993102,-1.5369136757458939
SW1271,446155,1.3369653200346725,2.407063260813435
HARA [Human squamous cell lung carcinoma],568763,1.3363257274557196,0.38532113100611176
Daudi,10296883,2.545577320776033,3.228401041147219
COR-L105,52912189,0.1952406080619365,2.3948493881859716
RERF-LC-MS,36314,3.6884025033565897,-1.370941759138632
SU-DHL-1,25062766,2.372674975426994,1.8196936629989553
BICR 22,126941,-2.054722221433598,-2.011833536268448
P31/FUJ,46398810,1.6622931867453647,1.6323068201702609
K-562,15953870,3.5143251027161613,3.148839846549444
MOLP-8,89183176,2.6780353354925706,2.8777866365804736
MOLM-13,9967941,3.903949930542719,3.0208176104019735
ML-1 [Human thyroid carcinoma],57519531,1.467564757525082,2.4719566130923742
SW1271,5291,3.239071539524422,3.748329796137451
K-562,56963564,-0.0263606087054764,-0.21394439446084632
LCLC-97TM1,54613361,-0.0023609252607709,0.06780830575000416
Granta-519,24771867,-1.6352261980607803,-1.3233819697810525
RERF-LC-MS,5287969,-2.0564845219287555,-1.8112903479715718
SW48,alisertib-navitoclax (2-1 mol-mol),-4.705705243079418,0.6343835788534194
IGROV-1,168312962,3.022863957843741,1.71023733404168
SaOS-2,6505803,-1.001039194104569,-0.4297652520509985
Panc 02.03,5460769,1.6540560754425335,2.7469768024211123
RCC10RGB,vorinostat-navitoclax (4-1 mol-mol),1.2015093799520282,1.2633485710362329
ML-1 [Human thyroid carcinoma],11175137,2.0792526924223735,2.6771107921276176
Granta-519,crizotinib-PLX-4032 (2-1 mol-mol),0.3086247100875356,0.8469335124686029
HCC15,135440466,1.473766152733558,2.135715279331658
Panc 02.03,448949,3.46549633046868,2.1738326362547205
SW48,119182,-2.1563748503052103,-0.5146485933572884
SK-OV-3,36462,2.5052417836250496,2.3715928628093037
LS411N,46199207,3.2917214979820506,3.1570561499944474
Daudi,71466380,2.956949879575845,3.723165181470462
RCC10RGB,44566777,1.0790521939265936,1.0524407499335375
P31/FUJ,446155,2.867326521256313,2.291359816220414
SW948,navitoclax-PLX-4032 (1-1 mol-mol),3.63435849770784,1.1792914303456854
SW1271,sirolimus-bortezomib (250-1 mol-mol),1.1899864031488736,0.9677761055366821
BICR 31,71576739,4.400142576070014,4.058821954558742
SW1573,6623618,2.3278245092002936,2.4730425520806065
ALL-SIL,969516,2.19071597716798,2.231262866274431
COR-L105,241158,4.618729119434587,4.125652649688109
Daudi,24797083,-0.0937737057199073,0.78754772430727
HEL,5566,2.9283259495001133,2.8260917161864985
BICR 22,44137675,4.05989667865121,3.203463311126317
Granta-519,3503,1.8528122642218805,1.901746818303636
WM115,5287969,-2.3112325385791093,-1.4920285880588748
NCI-H2452,3062316,-0.5574526988915461,1.0760657745309405
PaTu 8988t,12003241,-0.7673639150441187,-1.01847451771918
SK-CO-1,44589607,2.7511810771029213,2.9197332730175414
RKN,23939,4.640348748177221,4.079384831821864
IGROV-1,72734382,4.633226130326536,4.706559262746967
BICR 22,46215462,1.5294433170369757,2.157407608453227
MOLM-13,2949965,3.7040534246432624,2.2457943699917817
HCC1500,46215462,1.5254849350202837,1.9317278635728805
K-562,25183872,-1.1768480549542706,-1.6447323791840591
HARA [Human squamous cell lung carcinoma],5470400,2.3733756266777037,-0.3762783429335166
IGROV-1,3081361,0.99973562532788,2.4002194488001196
NCI-H1568,9908783,4.863315848037401,4.981424408773264
HEL,vorinostat-carboplatin (1-1 mol-mol),1.771793472925216,2.0109422363278866
SW48,25195348,3.355247289110599,3.3371970823085104
HCC1500,135411,2.801194317933856,0.8176579603833838
BFTC-909,10410894,3.671861694905457,3.602676533855948
COR-L105,2708,5.5167338716905885,5.053598866744828
SW1271,9927531,4.558020454092029,4.789692936796403
NCI-H1568,44462760,4.02669785413772,3.924337357077883
COR-L95,11612883,2.9601999054336106,2.2400187661746966
KU-19-19,selumetinib-tretinoin (2-1 mol-mol),2.7257099010203047,3.717542991595759
SaOS-2,46199207,3.779046434903352,3.0698727819351905
MDST8,15547703,1.8320295844693912,3.383719876998254
SK-HEP-1,23725625,4.972795252846745,5.297932896949619
HuP-T3,JQ-1-MK-0752 (1-1 mol-mol),1.9324342474715044,1.330667675661657
SaOS-2,doxorubicin-navitoclax (2-1 mol-mol),-1.9339656168793864,-1.630914952081213
HCC1500,24797083,1.1358144177435396,1.293610564053867
MOLM-13,11647372,-0.8512376057901615,-0.02911780213616147
Daudi,navitoclax-sorafenib (1-1 mol-mol),1.4462190868370148,0.49812104293198495
K-562,5335621,4.97915810125604,4.090191552821983
COR-L95,2858523,3.028185885315027,2.9495349888373776
HCC1500,9911463,3.4774936591741703,3.8795401207638243
RKO,452548,0.942587279069954,-1.3612571287928217
MOLP-8,126941,4.086011311839599,-2.7787774822728566
P31/FUJ,3384730,-0.5934712638177775,1.2603861869760242
LCLC-97TM1,16725315,3.732120983026874,3.972819669420793
HuP-T3,60700,1.2793809884126126,-0.07650009712857085
SaOS-2,9956119,4.053594307296879,3.3706556118904505
HEL,alisertib-navitoclax (2-1 mol-mol),-1.6663288612486489,-1.4261667140938514
SK-CO-1,46199207,2.9466484543003197,3.2893781567335743
SK-OV-3,11175137,3.182781765506491,2.768657024911863
LS180,11222830,1.8684195070218452,1.6030344949108095
SW1573,selumetinib-MK-2206 (8-1 mol-mol),4.390623431255029,2.5050454247017226
K-562,23582824,1.4169931108164455,0.6750437612818242
COR-L95,3025986,-1.3264557881304966,-1.183195866225229
NCI-H2452,16065773,1.9140766169124153,2.5739679319691913
MOLM-13,54454,1.7928295036604598,2.0795833099268717
LS180,119607,5.442141379439383,5.042409142519796
Granta-519,644241,4.377614733152813,0.8727639449529369
IGROV-1,46199207,3.293579955374855,3.198525099770563
IGROV-1,3038522,3.6829378423722416,3.2822085495821267
HuP-T3,135875424,4.261865095251217,4.115814978916749
IGROV-1,89928392,1.4824233552493276,1.3489737270283002
KU-19-19,5280436,3.7375704611092657,3.473171013474679
SW1573,54678924,1.9184875438403524,2.189256781507544
K-562,selumetinib-MK-2206 (8-1 mol-mol),2.367030654184624,1.7298127925677502
SK-HEP-1,11364421,3.0648019303900624,-1.541485169277262
P31/FUJ,11507802,-0.4015560413947272,0.888253110987244
MDST8,selumetinib-PLX-4032 (8-1 mol-mol),6.148002129111475,3.0349246542858026
NCI-H1568,89928392,1.1949851991515912,1.594371000603649
WM115,11222830,1.2308018153574234,1.7079037359035107
SU-DHL-6,9908783,5.938767725153886,4.302925081724822
HCC1500,25150857,1.1801270031504156,2.3423247669771583
ML-1 [Human thyroid carcinoma],9915743,-0.6180546405493912,1.2953724871576775
NCI-H1568,4521392,3.7910777113602303,4.297843642115344
COR-L95,25183872,0.0728708482253017,-1.0727802357644898
IGROV-1,227681,3.5439813498262347,3.349581816482457
PaTu 8902,6918878,3.691618711508776,3.178336517065083
K-562,1242560,3.4884556471232293,3.232387003802647
BICR 31,53495165,2.344314514368125,0.43776978276457323
BFTC-909,tretinoin-navitoclax (4-1 mol-mol),5.193173988671874,2.536843797744158
BICR 22,17755052,1.4011116930942769,1.3379084236194807
Daudi,17755052,0.1512024273398794,0.517261329927649
HEL,67156097,-1.6398778776875675,-2.245634571543921
BICR 31,44486219,4.3544536670303025,4.4615257176938465
SU-DHL-1,119182,-1.9070320733957784,-0.3599256625838182
WM115,135440466,3.0586385090162085,2.3772612120725025
IGROV-1,11152667,-1.4116509977729443,-0.4807995690827441
BICR 31,10385095,1.3759128494100044,1.5462469107885495
RKO,969516,2.537841036798478,2.2547165761788035
Granta-519,123631,2.886011281362197,1.8458480351881366
HEL,4477,0.140225607998234,0.4687783094418734
HCC15,568763,0.562622735167329,0.5270815102881485
HCC1500,9926054,1.7367797854287812,2.0567600676427085
HCC15,vorinostat-navitoclax (4-1 mol-mol),-0.4329287763165494,1.5756696534646972
SW948,444795,4.960330673315111,3.607600669433145
SW948,119607,5.410714093672246,4.664080091201624
RERF-LC-MS,9936388,-8.273067767637817,0.1514275034299968
SW1271,alisertib-navitoclax (2-1 mol-mol),1.9083065334137317,0.4750982295723351
KU-19-19,4261,0.7367611445661113,1.9024236037699853
SU-DHL-6,387447,-5.553627026103078,-5.023620169025594
SK-HEP-1,3825829,4.395950359013269,4.133686197229074
COR-L95,9903786,3.7357721387912513,2.772347155783253
SK-HEP-1,44185566,3.236949395761265,2.869934792945579
COR-L95,73707398,1.0347493154641954,0.9110653894120468
SW1271,66577038,2.7134536861777807,3.0577086934256554
RERF-LC-MS,36462,1.1230283698314445,2.2573951442203017
LS180,5278396,3.460947025625347,3.460601634295865
Daudi,3062316,-6.775500959037878,0.4032340423925126
K-562,107970,1.9304513771469212,2.1832325800547427
HCC1500,3854666,1.4433352503078565,2.2127886637482495
LCLC-97TM1,JQ-1-navitoclax (2-1 mol-mol),0.3092105032557149,0.9221870426528409
HCC1500,11455910,0.2448151005088887,1.1548697124697107
MOLP-8,46907787,-2.434163875600539,-0.7083683387073714
LS180,crizotinib-PLX-4032 (2-1 mol-mol),2.1034358212812867,1.8891205507759148
RERF-LC-MS,53392493,1.949934555719578,2.775631021834584
MDST8,6610216,4.3863838734153,4.113682512063921
COR-L105,navitoclax-MST-312 (1-1 mol-mol),1.0518954464197996,1.2403230577885205
LS411N,216345,4.369072592416217,3.317196407372847
SW948,JQ-1-carboplatin (1-1 mol-mol),1.423261364200352,0.8265166593982782
SW48,2841722,4.762546821441249,4.145641329004562
SW48,9956119,3.393025538441131,3.408202457249973
PaTu 8988t,44607531,1.764787957031886,1.871856233975881
HCC15,16741245,4.574628343563009,3.952035427829683
SW948,89928392,1.4444572178844948,1.1149082384218645
SK-OV-3,25126798,3.9960730178767,3.9495897488945326
RKN,54143018,1.3184566027416504,0.755029418047953
NCI-H2452,24180719,2.8480667171601852,3.8948933321424164
COR-L95,9915743,0.942320604231091,0.3919893594936775
LCLC-97TM1,decitabine-navitoclax (2-1 mol-mol),2.9245922441873717,1.778452251993852
LS411N,selumetinib-PLX-4032 (8-1 mol-mol),1.7092095935664802,3.1936346450362083
ALL-SIL,387447,-4.904935645240703,-5.059076874691763
SW1271,54649381,4.56488530045006,3.8939048327232477
KU-19-19,4259181,2.3072251676522835,0.4042125808675427
SW948,25105715,3.628389782970242,3.2939058425505574
SK-CO-1,tanespimycin-gemcitabine (1-1 mol-mol),-4.470227169685732,-1.047904273401864
LS180,19582717,2.9052461851112565,4.270887017742024
Daudi,676352,1.3635905677607614,1.8226418890226384
SW948,SNX-2112-bortezomib (250-1 mol-mol),-2.424265268462928,-1.4939611188906567
ML-1 [Human thyroid carcinoma],375860,0.003862862725961,0.05861512577580932
SW48,9915743,2.691515978939234,1.2217599527322118
MDST8,BRD-A02303741-navitoclax (2-1 mol-mol),1.0671280155352338,2.457013787027347
P31/FUJ,navitoclax-piperlongumine (1-1 mol-mol),-0.4738069202441977,-0.1666354524085646
SK-CO-1,navitoclax-piperlongumine (1-1 mol-mol),0.7177098692298883,1.5883204457909728
Granta-519,3025944,4.149663954634143,3.737728377803158
ML-1 [Human thyroid carcinoma],46174525,4.296155307906125,4.486403920414714
SW1271,2841722,4.036476035404804,4.340108300086927
SW948,53232,2.3961531254319466,3.067901084971681
SK-CO-1,25183872,-2.2315902989777725,-0.5099582988126826
KU-19-19,vorinostat-navitoclax (4-1 mol-mol),1.414230786423441,1.2330103035150486
SK-CO-1,selumetinib-MK-2206 (8-1 mol-mol),-0.5781899978856783,1.6733302560777534
P31/FUJ,6918328,-1.424420935100909,-1.3817177389597421
HuP-T3,71680916,4.329506074723249,4.827048063427962
P31/FUJ,262093,1.035147161622815,1.739287216891197
SaOS-2,11228183,2.7080984165628754,2.289914616104356
NCI-H1568,6852167,2.376266672184036,3.0410090756255115
RKO,4477,1.7070595719756474,0.35345527456697895
Granta-519,46199207,2.493616790778817,2.711361342818404
IGROV-1,5470400,-0.2457809435208252,-0.25996288766363285
IGROV-1,409805,5.990596261907717,5.16137303049135
PaTu 8902,15983966,2.4191743534269463,-0.8572566471844794
RERF-LC-MS,31703,0.0184985959907658,-0.7490452337487337
NCI-H2452,SNX-2112-bortezomib (250-1 mol-mol),-1.5822620251622193,-1.258151469674398
P31/FUJ,46224516,2.421293495972869,2.1584779677685466
BFTC-909,10127622,5.216996592058982,4.25132397684658
HuP-T3,55508,4.397520768584908,3.62912359675502
HuP-T3,10385095,0.7178899916931367,1.373408819647626
RKO,16013152,4.038378204585466,3.4798123424344194
RCC10RGB,6918328,1.0053978601828475,0.46671163590314835
SW948,9444,4.221430823371368,3.847866051974783
WM115,53392493,1.845382538513501,2.705267758892032
HCC15,44185566,3.08334642122707,2.6682311251054576
LS180,JQ-1-navitoclax (2-1 mol-mol),0.8160001924760493,0.7584724853579365
UACC-812,25262965,-4.249514707304517,-1.5835308225386322
WM115,51037431,2.6247692404465868,3.375837729158833
SW948,5311281,0.0185560472432188,2.564899926236751
HCC15,44607531,1.6724658843452191,1.6162448857561478
MOLP-8,6450551,1.973885798572914,1.4735686727877297
MOLP-8,7251185,0.7855879803762651,1.4126624349895789
SaOS-2,5479543,4.655800274360292,3.8133161385674597
IGROV-1,4917,2.985904350427039,3.1841674630064296
Daudi,3825829,3.2006002080342544,3.380195812129926
UACC-812,148198,-2.7739066615342236,-3.2256578068949624
Granta-519,1242560,3.55554960326222,3.010630347933284
HARA [Human squamous cell lung carcinoma],60700,-1.6734694813518207,-0.04351381418781795
HEL,17759555,4.966386069896687,3.3994740772260292
SW1271,119607,6.141140067390372,5.20356908720184
Daudi,3038522,1.648170780235362,2.596683958521737
PaTu 8988t,969516,4.442820223092304,3.019656521082943
HuP-T3,4521392,4.351966444408677,4.287852902375222
BFTC-909,2113511,5.65564772398506,5.442082319380701
ML-1 [Human thyroid carcinoma],9903786,1.6234934744716731,3.0883734929779987
SW1271,24856436,1.0602186643720275,0.4060805866552585
HEL,24180125,3.3188099636510495,2.2185955325408844
WM115,10077130,4.784184630126653,3.6368561344556083
SK-HEP-1,5281321,-2.075735756673856,-1.2240281153964911
UACC-812,10184653,-4.111635019949291,0.19236943787483296
BICR 31,55283,4.60336009153674,2.987239088292183
MOLM-13,11178236,-3.317575610691226,-3.8747247084129426
COR-L105,57519531,4.553300256365288,2.944701896350564
ML-1 [Human thyroid carcinoma],3815108,2.9979183689426723,3.0906290149938336
ML-1 [Human thyroid carcinoma],sirolimus-bortezomib (250-1 mol-mol),0.5199068018007997,1.0008452764379772
ML-1 [Human thyroid carcinoma],vorinostat-carboplatin (1-1 mol-mol),2.0705525470951587,3.2601070653663116
ALL-SIL,11317348,-1.373590167325895,0.9136924410084659
LS411N,6914657,-4.299110458286086,-3.89740436558307
ML-1 [Human thyroid carcinoma],12003241,-1.866080903179476,-1.1355148427681632
HARA [Human squamous cell lung carcinoma],1716436,3.773793106717324,3.173606945607272
LS180,57519531,1.9809210286085912,2.493215886520155
LCLC-97TM1,60750,-0.9490237417659374,-2.170768298963968
SU-DHL-1,49850262,3.2383746822480384,3.3388363571921404
SK-OV-3,9911830,2.8997016876614863,2.6229908574305383
PaTu 8988t,alisertib-navitoclax (2-1 mol-mol),4.265397677389301,1.057819258746352
RERF-LC-MS,15983966,-4.090154567310139,-1.3284494250844374
SK-HEP-1,selumetinib-MK-2206 (8-1 mol-mol),4.11054762578972,2.5726566955363213
RERF-LC-MS,24951314,1.4075693116182684,1.607043946859968
SK-HEP-1,11494412,3.332434654266433,1.916858836016558
BICR 31,51039095,3.0794813668201546,2.9684441622885527
Panc 02.03,11178236,-2.8028080099743624,-3.0998789298272116
SU-DHL-1,24772860,-2.736237819232434,-1.3748502982607989
Daudi,6610216,3.2134188501838494,3.7977540246210366
NCI-H2452,53392493,2.782389188766079,2.7908621462489576
NCI-H1568,445091,4.097432324473231,4.507475882817434
K-562,9926054,1.8612748023096723,1.6606303612815463
HCC1500,24978538,-1.6021545775061432,0.6845630788521316
COR-L95,25126798,4.203058281978897,3.7238715117731944
LS180,44819697,-0.9723932292423276,-0.3557399824828572
BICR 22,5281321,-1.7077192732848236,-0.5399052196397244
PaTu 8902,656346,4.145274855759625,0.8339625815512755
BFTC-909,42642645,1.561027146692027,1.0923117022861242
IGROV-1,49836020,5.658436828096057,2.9664372037760165
Daudi,168313200,1.4988300519601074,2.6573128703431377
MOLM-13,24779724,4.7751629548446894,3.4455451353101125
IA-LM,docetaxel-tanespimycin (2-1 mol-mol),3.5360773084497494,-3.198561145354639
K-562,doxorubicin-navitoclax (2-1 mol-mol),-1.4702798280033291,-1.8501202837929847
RKN,2828334,5.965623907482328,6.131657551219889
NCI-H2452,5280436,4.838161671645799,3.4660031638394218
HARA [Human squamous cell lung carcinoma],25062766,2.285935640348263,2.1662299069306683
BICR 22,637858,2.779101364791116,1.9753829361762456
RERF-LC-MS,56963564,0.3267097404636779,0.5192930309906907
RCC10RGB,2949965,2.9970768068045577,3.1038499988666466
WM115,10074640,2.7921613557017473,3.0714685825323507
KU-19-19,25154868,3.204596310046931,4.405643514385733
BICR 22,49793307,-5.020228152199773,-2.2148301807979567
SU-DHL-1,5460769,-0.475427190707336,1.85637939326255
NCI-H2452,9868037,3.199558399493599,3.553690953219615
SaOS-2,9823820,4.1201217228566565,3.9737401445639455
SU-DHL-1,9444,2.825333870881758,3.852733952503863
HCC1500,53495165,1.6495193303321407,0.6438588728828466
RCC10RGB,9952709,4.37754893062567,3.2827986319746527
Granta-519,73707398,-0.348610297970246,0.31110133756139746
HARA [Human squamous cell lung carcinoma],44632017,0.7187380309890276,1.4035550747101306
MOLM-13,26596,-2.2068545341754295,-2.479898906250661
K-562,52912189,0.5484446218637569,0.4751272876231238
MOLP-8,doxorubicin-navitoclax (2-1 mol-mol),-3.5664947897809207,-2.0721718296165865
IGROV-1,375860,0.7731558163124775,-0.26571234880109557
IA-LM,11964036,4.998383188027045,0.8808525435826438
MDST8,387447,-2.914953377887094,-3.590175200823948
IA-LM,9915743,1.455667571666015,1.1775483844678625
LS180,6918328,-0.1069758097146191,0.006486423864713511
PaTu 8988t,6610216,5.064895456595333,4.351908599719581
SU-DHL-1,104842,-6.410970225096146,-3.312357730984627
P31/FUJ,56946209,-4.67609529352027,-4.608647757087706
SW948,6917907,-5.884345700630281,-4.977190367853951
BICR 22,53232,4.030024483575548,2.8929806163916636
PaTu 8902,568763,1.8312011651342244,0.5681064244834532
ALL-SIL,6505803,0.7073572306495796,-1.0639784584903773
SW1271,selumetinib-JQ-1 (4-1 mol-mol),-0.3516238001186607,1.3693847529142837
LS411N,10302451,4.220534629483678,2.948000600773907
RKN,11238147,3.9265768628415487,2.8227097136723818
PaTu 8902,135440466,3.176809791892748,2.14764096605192
MOLM-13,119607,3.836878131829583,4.377805944625427
HEL,11612883,1.9962168488272864,1.9409999707454373
COR-L95,11485656,1.8696119642586884,2.0151072971589277
MDST8,675434,4.4652962141660595,4.341676293779834
IGROV-1,11507802,1.5049911819213722,1.6593697740647066
SK-HEP-1,2708,5.260013220141412,4.863941505500568
LCLC-97TM1,BRD-K27188169-navitoclax (2-1 mol-mol),5.367919613117806,2.259564055379771
SU-DHL-1,5738263,2.757121948334044,3.2292068246585375
Granta-519,54626689,4.523537450364534,3.726159946799763
SW948,135421197,1.7477185084776832,1.6795944726956251
SW1573,ISOX-bortezomib (250-1 mol-mol),0.8486273919193054,0.7672036834811439
BFTC-909,tanespimycin-gemcitabine (1-1 mol-mol),0.2587370636739561,-0.10611161016462914
BICR 22,4917,3.6655313291566327,2.7622271213670144
HARA [Human squamous cell lung carcinoma],2130404,2.6459509712703246,3.2845756329913973
MOLP-8,16736978,0.6033273838828506,0.8328751275710701
SW948,11396600,3.556168564723583,2.8775850497203583
IGROV-1,2113511,5.982902824257526,5.620563129665174
Panc 02.03,16725315,5.289216895099664,4.53724051745215
K-562,9549297,1.810271401171294,1.6431094336254333
SU-DHL-1,60700,-3.861884777487788,-1.550040044273151
MDST8,89183176,5.515733421140453,4.183613185231684
PaTu 8988t,selumetinib-decitabine (4-1 mol-mol),5.718429611668687,4.091640971048614
WM115,10113978,3.3670712397266698,3.163763175213493
SW48,25154868,5.084018259884556,4.21348576125693
Granta-519,107985,-5.079154139769343,-4.152706771145356
IA-LM,15953870,4.160803294534019,3.4756694818129628
RKO,19582717,4.345992572306107,2.986399837776381
WM115,selumetinib-decitabine (4-1 mol-mol),-1.8184529973078083,3.1215352710810276
ALL-SIL,2742550,3.1857763586562577,3.285153471214989
COR-L95,375860,0.21091681928276,0.0720115906994065
Daudi,JQ-1-MK-0752 (1-1 mol-mol),-0.2875395851345496,0.30020280180186093
COR-L95,702558,5.203109308170341,4.576429941972859
ALL-SIL,5329102,0.5818325089631969,1.1057426295684347
MDST8,9911463,4.372295154952754,3.828773277736801
LS411N,44607531,1.9881484499388475,1.3227302792309052
Daudi,68056272,2.8001037652797818,2.960643105462913
MOLP-8,4521392,3.737637773211522,3.8978452269642414
MDST8,20959075,-2.855250986095604,-2.296893796099571
IA-LM,400769,-0.2498086542393983,-0.5340408456797661
IA-LM,16722836,2.5380745713557893,1.3983950715161588
HCC15,445091,5.451686926059382,4.36172962676956
HCC15,11507802,1.1916077520331714,1.7907221174204986
MOLM-13,9903786,0.7109980532390177,1.8204113798295591
SW948,24901704,3.213341299668661,2.624627149830107
ML-1 [Human thyroid carcinoma],46224516,1.5473988782080883,2.733109202343141
SU-DHL-1,10427712,3.576020229714379,4.1017418488897235
ML-1 [Human thyroid carcinoma],107985,-3.3059977696559204,-3.105994409567143
SK-CO-1,piperlongumine-MST-312 (1-1 mol-mol),2.091052840490691,1.9637388743901483
Granta-519,51039095,1.7779321154646133,1.8932266847808108
RERF-LC-MS,65628,5.693639897620667,4.315160393458425
SaOS-2,2828334,6.074749772556143,6.017144104189331
SW48,3815108,2.5063295630391806,2.813513782203001
SK-CO-1,11626560,0.3943389380121196,1.9068141619802819
HEL,107985,-3.965696416470184,-3.833990130688122
KU-19-19,60700,0.8700483452505813,0.13987546871764944
Daudi,5280436,1.0789231424034973,2.5859343279160827
MOLP-8,54613361,-0.8734170036218252,-0.635538964269819
HARA [Human squamous cell lung carcinoma],439501,-2.358364257130844,-1.9505496407874383
SK-CO-1,24978538,-0.5683899539074425,1.4333539727781723
SU-DHL-1,54649381,3.644517842316546,3.3176963582024337
SU-DHL-1,44493528,3.922242735424854,4.218024959613032
P31/FUJ,5282054,2.945149434876345,2.73848225437885
SK-OV-3,49850262,4.3958011115665006,3.8340021791981855
IA-LM,10184653,0.8510906912410041,1.3830550854315595
NCI-H1568,36314,4.092621701538515,-1.214558459689703
BICR 22,46843906,2.889476079217857,3.293405756826751
SU-DHL-6,9444,3.111459322097769,3.6541092686120065
ALL-SIL,10410894,2.969142576372873,2.3516082799599904
ALL-SIL,9549297,0.2429486516660708,1.544153182324373
Daudi,46926350,-6.041265180126537,-4.627522071143519
RKO,1750826,1.760307875609834,-2.7277416423801126
PaTu 8988t,4477,0.4312443696129938,0.6626743871008034
Granta-519,5282054,2.5814189459390957,2.586002937303432
SaOS-2,carboplatin-UNC0638 (2-1 mol-mol),3.570952437368873,3.157400128589779
IA-LM,16065773,2.795317455347302,2.342718873803711
RCC10RGB,156422,4.423389512885201,4.06749832759041
IGROV-1,11214940,1.360660548899077,1.89163381162808
Panc 02.03,16720766,4.473005389666903,0.9196157912802455
Granta-519,3081361,1.7559432073327723,1.5203501088577849
MOLP-8,52947716,-7.872176911001468,-2.3974805712358673
KU-19-19,5281321,2.871465791170073,-0.7675995192325015
IGROV-1,5282054,3.614574021382022,3.728084570775175
MDST8,4261,1.8348924416255383,1.9561172347778426
MOLP-8,100016,7.090961588333011,4.96507046396505
Granta-519,168313200,2.290121636997186,2.896487904587722
HCC1500,462382,0.0787876699821948,0.8077838738049654
IGROV-1,10113978,2.874171865860951,3.376082455229595
IGROV-1,BRD-K55473186,4.387806234483854,4.14752716839065
HARA [Human squamous cell lung carcinoma],5291,4.037970789679042,3.8386393648558212
P31/FUJ,10410894,5.368264014178215,2.4986173093273134
BFTC-909,3025986,-2.0399601309440336,-0.3531361014462806
MOLP-8,24771867,-5.187641849515016,-1.2345963395999777
BICR 31,11214940,4.966543096658616,2.206916033814093
Panc 02.03,selumetinib-JQ-1 (4-1 mol-mol),2.589155616289617,1.3445936632112998
UACC-812,9936388,-5.022392750910281,-0.88996334241792
ALL-SIL,24772860,-3.38763553354356,-3.1714704589094374
MOLP-8,11626560,-0.689912231097504,0.8611778864317173
HARA [Human squamous cell lung carcinoma],selumetinib-JQ-1 (4-1 mol-mol),3.6659251122276015,1.993712904291978
BICR 22,navitoclax-PLX-4032 (1-1 mol-mol),4.097608134933257,1.654170371960532
SW948,262093,3.1804911198162036,2.448359619543386
SW948,216239,1.8650010893863176,2.1716407051591635
SW948,11364421,-5.809742751249139,-2.738182913675885
HEL,10302451,3.814274659252608,2.2918719910341254
K-562,46398810,1.812730009869126,1.9684204367152855
Daudi,216239,1.5780166370194677,1.9634748378782936
LS411N,10231331,0.2083934704449227,1.0633428188991
MOLP-8,46926350,-5.986975596425451,-4.370190199087889
SK-HEP-1,11964036,3.325100881793091,1.7343089377158416
Granta-519,11485656,1.6660529916447626,1.5627623346710078
K-562,2871966,0.96376622724181,-0.26217336995412294
P31/FUJ,54454,2.7341923640247123,2.408559190735899
SW48,54613361,-1.8010952783890095,0.05523555173403082
NCI-H2452,46843906,4.012061875028764,3.0900940838501127
HEL,135875424,2.9448279330391927,2.9302215603846156
HARA [Human squamous cell lung carcinoma],16725315,4.551171651287005,4.3495592997814905
SW1573,serdemetan-SCH-529074 (1-1 mol-mol),2.68378670703322,2.2350508849616935
ML-1 [Human thyroid carcinoma],51039095,1.326261900002616,2.9725231974216877
P31/FUJ,decitabine-navitoclax (2-1 mol-mol),-1.2834649241305407,-1.292944809263287
HCC1500,54678924,1.846277418486191,2.2370818996475235
SU-DHL-1,UNC0638-navitoclax (1-1 mol-mol),-6.722227351020971,0.7381548996853035
MOLP-8,9927531,5.438833274000949,4.158116654118774
PaTu 8902,selumetinib-vorinostat (8-1 mol-mol),2.5580221704247403,2.252633926049962
HCC15,9952709,3.084010703088348,3.025437611537816
K-562,3503,1.244026999465694,1.9667532035631914
SaOS-2,3689413,0.0712794264513353,-0.39362978928370707
MDST8,10427712,3.921886084986449,4.20732645256748
HARA [Human squamous cell lung carcinoma],11238147,2.905443405294126,2.921329246367985
SU-DHL-1,1716436,3.093009546519781,2.4279081888102905
PaTu 8902,25105715,3.5553172149604375,3.444692041584737
HuP-T3,24771867,4.228511460696379,2.9075685723864875
RKN,31703,-0.7196573309741882,-0.7772637075430624
MDST8,60700,1.1908209554887386,0.34501158028760137
SW948,carboplatin-UNC0638 (2-1 mol-mol),3.7515115045005913,3.4473544529162634
HEL,54454,2.1583735480761437,2.3548117882477344
NCI-H1568,UNC0638-navitoclax (1-1 mol-mol),3.297813275168301,1.972387583460045
BICR 31,alisertib-navitoclax (2-1 mol-mol),3.3923193563221257,0.6704347884559155
SU-DHL-1,135875424,2.8587183873170847,3.843789358600195
SU-DHL-1,36462,-1.6063137198477124,0.7875581797701714
MOLM-13,73707386,2.881964792667641,2.410403725823522
P31/FUJ,3854666,0.6136756098719494,0.823835668082536
ML-1 [Human thyroid carcinoma],6505803,-0.5261965004955029,0.49397375337477406
MOLM-13,159324,-0.2587959593058327,0.9695767419511534
SW948,19582717,2.742329976582949,3.153494305806803
SK-CO-1,444795,5.109688629113172,4.636301607390652
Daudi,400769,-1.3686052359334673,-1.4242502371376011
SK-HEP-1,10296883,4.4971190241998835,4.049149445383099
HARA [Human squamous cell lung carcinoma],12003241,-0.2443339656532688,-1.3246519773580392
LS180,17759555,2.746757712453425,3.5207156720658053
MOLM-13,156414,-0.1970532812518614,0.952979573633917
ALL-SIL,72376,-2.2514410459425043,-3.832258893498882
BICR 31,selumetinib-MK-2206 (8-1 mol-mol),1.335551689205146,2.165974875254132
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683,-0.3761189675837376
HCC1500,51039095,2.9997605815390935,2.929554480343112
WM115,44185566,3.0030021210520794,2.6544013851687667
COR-L105,4705,0.5312031062005766,3.362978098135218
Granta-519,8515,3.731909716775835,3.012667663005203
ALL-SIL,11234052,3.5011978223530926,2.7755776735738955
COR-L95,tanespimycin-bortezomib (250-1 mol-mol),-0.3690826099539636,-0.36601025818644034
ML-1 [Human thyroid carcinoma],44632017,3.256506939906626,1.6329687961281207
Granta-519,613753,3.0344429390603493,2.7817711300602697
HuP-T3,5329102,2.4996480668272527,2.251445500363868
SU-DHL-1,2828334,5.462697908299577,5.936496966288311
SK-OV-3,51039095,2.3576173335626147,2.9027435560403476
UACC-812,5470400,-2.2578344499942418,0.05406468613655635
HCC15,9935249,4.091947122155354,3.263831271060257
UACC-812,JQ-1-vorinostat (2-1 mol-mol),-0.5213031534169104,0.878817340752901
SW1271,322968,3.7653444240208263,3.832435073179472
COR-L105,54678924,1.4327429630461548,2.338051696189451
Panc 02.03,31703,0.91391851070637,-0.598043325567001
NCI-H1568,5329102,1.5348278867114138,2.321332171356987
Granta-519,9887053,0.035640336798207,2.3985442089209
IA-LM,6610216,4.173583896241699,4.000048487732219
NCI-H1568,119182,-0.8732650634834633,-0.03554026779734377
IGROV-1,159324,2.8766947154825044,3.199113830122317
NCI-H1568,5566,2.911706555521376,3.218482775909356
Granta-519,ISOX-bortezomib (250-1 mol-mol),-0.0076351128807997,-0.43718336331477947
NCI-H2452,10385095,2.425738192808243,1.3625823135266364
HuP-T3,16065773,2.155269900494742,2.548265801299671
SW948,448949,1.5714288146717783,1.7381555864995435
NCI-H2452,107985,-2.625758680845612,-3.2962888986343093
RCC10RGB,1750826,-3.277944046627699,-1.9822604878362455
Granta-519,16736978,1.0160166250823044,0.7078984626876678
HEL,104842,-4.135712202151618,-3.9867298383167182
MOLP-8,71466445,1.892906464336944,2.310934831447867
MDST8,262093,2.389063867163299,2.973239396317821
COR-L95,4259181,0.8580425806970188,-0.014633910390976395
Daudi,45279963,2.6753649589319854,2.7976692617144976
IGROV-1,656346,1.6285470744333117,1.0057567422649532
SK-HEP-1,10427712,4.527720982072863,4.586473486551293
SaOS-2,11647372,0.6261520317366223,1.2699092964122984
COR-L105,53495165,0.9627099148057476,1.1736036616934646
Granta-519,11404337,-2.8078628280004048,-1.4421964802989748
SW1573,25154868,3.281093993360062,4.5546077231890365
RCC10RGB,crizotinib-PLX-4032 (2-1 mol-mol),2.89623675646366,2.060171655372388
BICR 31,3503,3.4488620791118993,2.4172251180080533
SK-CO-1,3062316,0.5910144260309655,1.1580650793650389
RKN,6917907,-6.438038185084336,-4.873906298233298
LS411N,23635314,4.011909681168236,-2.0470970741422163
WM115,11234052,4.1182935305671435,4.106144151680016
Granta-519,tanespimycin-gemcitabine (1-1 mol-mol),-7.490554088908799,-2.7772305692358272
SW948,JQ-1-navitoclax (2-1 mol-mol),0.5901277786092829,0.9079418515157603
RERF-LC-MS,11485656,1.5190166417661397,2.606441439267164
PaTu 8988t,46224516,2.924922546378164,2.8620848013133333
Granta-519,JQ-1-vorinostat (2-1 mol-mol),0.0738956362017292,-0.7610786782378531
SK-CO-1,5287620,-2.837552470898679,-1.8329588338698763
PaTu 8988t,24772860,-1.5593380796956875,-2.091893285371765
PaTu 8988t,6184667,3.5063575702163345,3.0745981286556496
BICR 22,36462,0.4717839486114671,2.104921691600472
RKN,16722836,2.340122812915413,1.7399458158132617
Panc 02.03,54618164,4.482290203520866,4.1716352517868485
BFTC-909,2841722,4.3094465275997536,4.39261180986087
COR-L105,2746,3.1035280268076217,3.508621172701351
IGROV-1,9929138,6.483056540257463,5.448450079437211
HCC1500,2708,5.151987441269929,5.013574486948036
MOLM-13,11238147,1.4582306649534449,1.8631102608187802
RERF-LC-MS,11364421,-3.8493036468537265,-1.5449388986107533
ML-1 [Human thyroid carcinoma],100016,6.6260589736745015,6.336435400115362
RERF-LC-MS,16736978,2.30801467798398,2.23144412289461
LS180,44241473,4.435457667187811,4.645838512462891
SW48,16722836,0.2197322523934369,1.6225008564702197
NCI-H2452,9444,3.5242093703527697,4.295286634334334
SU-DHL-1,5284616,2.4488241799592143,0.15493120270588226
K-562,54454,3.689215856042272,2.5396597100963727
HEL,2945648,2.719646445320408,2.0582477620103647
ML-1 [Human thyroid carcinoma],selumetinib-JQ-1 (4-1 mol-mol),1.6383064835611996,1.5094483414722526
HuP-T3,9936388,0.6940852338085793,-0.3832471160517732
LCLC-97TM1,10427712,4.124790087544491,3.962984624800157
SK-CO-1,navitoclax-sorafenib (1-1 mol-mol),1.5561836215711824,1.749771521040671
SW1271,135398738,5.657599080768866,4.617902201199431
RKN,216468,4.351451769225332,3.263247555247906
SW1271,46224516,1.263100640010589,2.7673802481334633
SK-OV-3,60750,-4.210978436614257,-2.259921477987856
SU-DHL-1,11455910,0.1271925880707346,1.139200059606347
Granta-519,25161177,3.429453868131532,3.084151283161461
PaTu 8902,SNX-2112-bortezomib (250-1 mol-mol),1.6303309640570394,-1.1850146532717496
COR-L105,erlotinib-PLX-4032 (2-1 mol-mol),-0.0740461614956173,3.0854507894748
UACC-812,16065773,1.9582746458630844,2.364820892419401
MOLP-8,2858523,3.112163707938977,2.7194534915107558
ML-1 [Human thyroid carcinoma],6252,2.036085666454029,1.340699299932133
IGROV-1,6505803,-0.2382223795960626,-0.684667204166437
HEL,24772860,-2.0205510075596425,-2.7614952099561845
HCC15,4917,3.2753021602409267,3.171035717618399
HEL,ISOX-bortezomib (250-1 mol-mol),0.0125517502363375,0.10196756910208644
P31/FUJ,6184667,2.9500590386465393,2.1105428274908142
MOLP-8,46843906,0.174682801852784,1.4503405752534346
NCI-H2452,54618305,4.302077073898344,4.746968918534055
BICR 22,8515,4.348804794701894,3.8232741439372147
COR-L105,24821094,-1.121187296223131,3.01946384772984
HCC1500,4788,5.676843976237076,5.423112210278214
SK-HEP-1,2746,4.04921422913523,3.5083552118117094
Granta-519,tanespimycin-bortezomib (250-1 mol-mol),-0.1680583743842791,-0.7862973873091409
COR-L95,46199207,3.11604668311128,3.179074763753369
MOLM-13,1641662,2.418131669664625,2.848061541072962
WM115,135984461,4.094268409164816,3.9798640939136787
LS411N,10127622,0.4126946340819594,3.119371728161624
HARA [Human squamous cell lung carcinoma],11497983,-2.5330413808054333,3.9929471776712444
ALL-SIL,11364421,-5.245070547120315,-5.0358510373617085
NCI-H1568,44607531,1.2688225542701184,1.5092000565869552
SW1573,navitoclax-pluripotin (1-1 mol-mol),-0.8972243214684317,-0.7337966575360262
SW948,104842,-0.6555530305877334,-2.4690345211397458
SK-CO-1,46907787,4.316773762169295,2.374635980879446
HuP-T3,104842,-2.1883971380944054,-2.468448476837209
IGROV-1,11178236,-2.8618715106425725,-3.389782851629859
HCC1500,71751553,4.671922723370954,4.686221584448312
SW1271,54618771,-0.1319273231055389,1.6389421621443356
ML-1 [Human thyroid carcinoma],9952709,4.669340472029816,3.3294767273001455
IGROV-1,654092,-1.340387623873854,-0.2504128661705726
HCC1500,44819697,2.691999336982048,-0.12291129415053367
HEL,44137675,4.224171499328968,2.9928269444922018
MOLM-13,tanespimycin-gemcitabine (1-1 mol-mol),-4.499081483016427,-2.122556376929802
COR-L95,5328940,2.113977806947162,1.6834925252865134
SK-OV-3,3825829,4.139200001280225,4.15023977785865
Panc 02.03,216468,3.8655539989600176,3.491909541196209
SW948,25195348,3.534636067330416,3.372044115003242
MOLM-13,9444,3.2439366633039426,3.151258363859351
NCI-H1568,24821094,1.7576462865100984,3.020289565569102
MOLP-8,1566236,0.7132031003128095,1.3329920059801632
HuP-T3,11455910,1.0919804440303738,1.2544591805501193
MDST8,44185566,3.0590843033834116,2.5332723924076435
NCI-H2452,216345,4.1608899350266615,4.1523605001901265
SaOS-2,23635314,-2.530968731721941,-2.227325032479743
MOLP-8,selumetinib-MK-2206 (8-1 mol-mol),0.6863734484808788,1.930853874129052
LS180,168312962,-1.039638615515642,1.404760291948728
BFTC-909,crizotinib-PLX-4032 (2-1 mol-mol),2.7598509436067906,2.047431110601172
BICR 22,322968,4.6496227244818416,3.594543432320582
NCI-H1568,vorinostat-carboplatin (1-1 mol-mol),1.5719417416558872,3.3650366584136373
RKO,6918837,-1.4612228483082623,-3.704053675130733
MDST8,selumetinib-navitoclax (8-1 mol-mol),0.5901837965573531,1.9823477821342614
SW48,613753,3.5910736246612323,3.0173775993756013
IGROV-1,44507138,2.359177395411688,2.657257297026777
WM115,52947716,-6.8465929822900815,0.4028611256584139
RKN,73707398,1.136221501718042,1.2129141383298485
HCC1500,4477,0.2789780560390432,0.7489992411525506
Granta-519,11719255,2.4006867045586953,2.2895984052677574
HCC1500,6918736,0.2919336581768246,-0.9687802426531477
IGROV-1,4477,1.1767656777594142,0.4525080165862112
IA-LM,11609586,4.073174168632335,2.3189008426677025
NCI-H2452,11404337,-0.3859535574072682,0.02942594942213572
Daudi,136227924,1.3476403322374937,2.3049282329538445
SK-OV-3,387447,-3.0618968905277164,-4.285045284697523
MOLM-13,3854666,0.5101644656521153,0.8941121789553185
RKN,46843906,3.906010302389018,2.8625664291166144
ALL-SIL,1641662,2.105441320822025,2.86908909769084
MOLP-8,46199207,3.622115707782432,2.736135080848911
HEL,17755052,2.5427584711612554,0.5049802731779617
MOLP-8,9915743,0.5160575940701332,0.3122742537277956
NCI-H2452,135398516,0.2354885350790482,2.5909243639337154
NCI-H2452,JQ-1-vorinostat (2-1 mol-mol),1.361868366541758,1.3296467849194855
SW1573,9911463,3.734935340044018,3.95877881755472
P31/FUJ,selumetinib-vorinostat (8-1 mol-mol),0.1511350548351421,1.3318999002925653
IGROV-1,23725625,5.712368491237602,4.826829899326003
IGROV-1,54143018,0.8385018685685798,0.5645110124959853
WM115,135875424,2.968517855352779,3.913475524548981
SW948,16659841,2.968981271202921,2.920377171080781
SW48,25183872,-1.521332471338628,-0.808590585379237
ALL-SIL,selumetinib-GDC-0941 (4-1 mol-mol),1.4850584156304236,0.6715560855178417
RKN,selumetinib-JQ-1 (4-1 mol-mol),2.2117221190324323,1.8814846641434044
COR-L105,UNC0638-navitoclax (1-1 mol-mol),1.0855753959105363,2.102991529087543
WM115,5284616,2.9108529677003565,2.5116816266838433
SW948,4705,1.720002028261835,2.831212787800812
HCC1500,71680916,4.362866442203444,4.935591763429456
PaTu 8902,17755052,3.1533076581920936,1.6901092749387348
COR-L95,11427553,2.745819698220539,2.158660342530185
MOLP-8,11707110,-0.9708482925672104,1.4530533806804797
HCC15,5351362,1.1207822529279785,1.6509811825140404
SaOS-2,11234052,4.364959006359101,3.828375150139706
SK-OV-3,6918837,-1.7709381590236568,-2.5369948879947186
RKN,10113978,4.430129932581481,3.404177202619368
Panc 02.03,5566,2.8367562997211815,3.089569868506654
IGROV-1,crizotinib-PLX-4032 (2-1 mol-mol),2.0296160065449858,2.027106144327899
Granta-519,4096211,0.4087245803445845,0.9178837400238696
SK-HEP-1,72193861,3.0367238048594603,2.118198045106021
SW948,9933475,1.7222383900333498,1.8589024169466808
SW48,9936388,-6.68623848822316,-2.332986812950559
NCI-H1568,11222830,1.5738139714037271,1.6539632761511351
IGROV-1,24856436,0.4840146383282276,0.5618135300104937
SW1271,25105715,2.9104912505007143,3.5056663228473015
IA-LM,11238147,3.064975348903814,2.3321099041856863
PaTu 8988t,23635314,0.3317794086663004,-1.7590827706169807
Granta-519,3136844,3.153984140395424,3.427852310647759
COR-L105,24951314,2.139685821030411,1.5929240815725627
IGROV-1,135398744,6.402844237905131,6.421571172017375
LCLC-97TM1,156414,1.5907536031970133,1.1137566505166474
BICR 22,46926350,-6.042960620867506,-3.9659102428271327
Granta-519,387447,-5.4996124066637435,-4.9200287423288325
BFTC-909,51039095,2.7594177275421403,2.831078058287089
Panc 02.03,5746,2.615751109567445,1.2182915758457686
SW948,71466380,3.8629020707603914,4.169775198861759
SW1573,tanespimycin-gemcitabine (1-1 mol-mol),5.2364436023498815,-0.38300449510136386
COR-L105,24856436,1.5602990639828938,0.7160882400017925
K-562,327653,3.3038748071855175,2.7362002371177936
Daudi,16725315,3.035985748437892,3.5898584419497372
LCLC-97TM1,6917907,-8.098980466082804,-5.434244527662254
NCI-H2452,4261,1.8682088943565944,2.1317244966775526
SU-DHL-6,241158,1.5794519300851928,2.5413187128440877
IGROV-1,9840324,5.720969888694302,5.746629450287327
COR-L95,10074640,3.0551355702246292,2.969937983164446
ALL-SIL,navitoclax-birinapant (1-1 mol-mol),-2.9890180212020265,-0.9284596676150207
BICR 31,5460769,3.9433617709959696,2.5524510844995087
WM115,navitoclax-pluripotin (1-1 mol-mol),-1.858334672155358,-0.8422074680587383
ALL-SIL,171352865,4.1926931777749346,1.7605441211166584
PaTu 8988t,5351362,2.286773409161727,1.5269406956265434
COR-L105,54618164,4.149947168538197,4.086781560917847
K-562,168312962,1.3008721680360658,0.886468511872841
NCI-H2452,3634881,3.1517111283550854,3.3310211863088
SW48,crizotinib-PLX-4032 (2-1 mol-mol),0.8715368349247399,1.838899454888373
LS411N,2858523,3.1062955336512603,3.1079225345637473
NCI-H1568,65628,3.926137474064237,4.420939784531289
SW1573,25126798,4.147065453172024,4.008631169476465
SU-DHL-1,9868037,1.568771805047012,2.977870087110365
HCC15,46174525,4.292402667650191,4.645807333043106
HCC15,54626689,4.436341034968849,4.491416871867095
K-562,241158,3.183928650435804,2.8492175935615
HEL,400769,-1.0010167847558078,-1.6184400944145587
MOLP-8,24180125,2.8280981087253605,2.4386463805975787
LCLC-97TM1,6918837,-2.241539398034031,-3.0311204561681633
SW948,52947716,2.6983492764143984,-0.7260919230137037
HuP-T3,11609586,3.0975126346448056,3.0197309739223113
ML-1 [Human thyroid carcinoma],44589607,3.064794245292079,3.1432971998353043
K-562,9911830,-1.954559593888618,1.5868843591612523
Panc 02.03,54454,5.027619058009229,2.871933152734655
Daudi,9967941,1.9498714635628245,2.9934386122858756
SK-CO-1,46224516,2.9108482414820833,2.635747502113196
IGROV-1,56963564,1.8260986108097368,0.7602628846689794
PaTu 8902,119607,6.110313748168657,5.327011727383906
SK-OV-3,1750826,-0.3132155362058529,-1.6915697835066807
NCI-H1568,11507802,1.223292685938289,1.6327047569036546
SU-DHL-1,6918736,-2.1290482192432396,-0.9684136070918251
MOLM-13,6252,-1.803091878000868,-1.7246376099836414
HuP-T3,16659841,4.694527425679891,4.230859161088585
COR-L105,135440466,2.282908830244017,2.280189465287851
COR-L105,36462,5.237060103367249,2.3103333520738207
LS180,16038120,0.768362963165676,1.087767832222595
COR-L95,11719255,2.8113582651389684,2.6918674463870014
K-562,71466380,4.109476883218819,4.01077393454316
LS411N,selumetinib-GDC-0941 (4-1 mol-mol),0.0319239505994205,0.9765369193550352
LCLC-97TM1,65064,4.239331302053654,5.078359070329428
ALL-SIL,11626560,-1.2475078800938888,0.5297396340579911
IGROV-1,9903786,1.7387584479757865,2.940397437684869
HARA [Human squamous cell lung carcinoma],119607,5.240910567943734,5.266028390301079
UACC-812,3025944,3.7003704595595894,4.307123824335098
HCC15,52912189,2.9796194932949875,2.4325816563511666
SK-CO-1,24951314,2.193758155281627,1.5170593806661479
IGROV-1,208908,2.822483792004996,2.0980936230559535
BICR 31,2945648,3.0787524499283023,3.138921200391487
WM115,11485656,3.738489726762909,2.5501021095300103
IGROV-1,126941,-2.246216453812328,-2.537892910089535
KU-19-19,135411,0.3258457054887789,0.9379847443159395
PaTu 8988t,tanespimycin-gemcitabine (1-1 mol-mol),0.132721029617077,-0.5929811667512466
P31/FUJ,BRD-K27188169-navitoclax (2-1 mol-mol),0.0086353275600694,0.6506442265559342
MOLP-8,25105715,3.7016775455761968,3.0268678475991506
IGROV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0361645465839266,-1.0970599541983097
NCI-H1568,25126798,3.633705991567496,3.83970356820981
LCLC-97TM1,3689413,0.1289764847745495,-0.42726828195315514
SW48,5311,0.4861581581750583,1.235798959030373
LS180,409805,6.164182483443964,5.1301174169237065
ALL-SIL,17759555,3.7861470032844418,3.351486144154245
K-562,7326481,2.6072018104551824,2.8356131055616407
SK-CO-1,8515,5.207883928071115,3.9801158591541332
NCI-H1568,439501,-2.6831567396736022,-1.9140395082214738
BICR 31,3634881,3.594506321194918,3.454545911694363
KU-19-19,656346,4.826208082880011,0.9989946782865732
SW1271,10410894,3.9794007270318903,3.2463870894592777
ML-1 [Human thyroid carcinoma],3689413,0.6725245747839163,-0.12271167373469588
SK-HEP-1,16722836,2.576451725849178,1.8905092008883893
RERF-LC-MS,10113978,3.210216765519601,3.4206241597891305
LS180,54454,2.0147485365690945,2.809708981595965
NCI-H1568,9866186,-0.23967308205821,1.1103994145604168
IGROV-1,10302451,0.4135234554742116,2.920703036367115
PaTu 8988t,9935249,3.4642640806067897,3.1246656970876883
HuP-T3,65064,5.168937665689206,5.065551758596471
UACC-812,JQ-1-carboplatin (1-1 mol-mol),1.7132070182589942,2.64660361674561
LCLC-97TM1,44543605,5.020704141539917,3.7809425223599376
KU-19-19,3062316,3.300727237006398,1.3451922701536219
IA-LM,54143018,6.360653223606267,0.26559727847043246
HCC15,JQ-1-carboplatin (1-1 mol-mol),2.0328384477438477,2.595002772397291
PaTu 8988t,11497983,4.771256524847766,4.724214515283504
IA-LM,7326481,3.2597510497719964,2.8729876588966112
MOLP-8,57519531,1.794840771759573,1.668875713535648
Panc 02.03,387447,-4.21908064053878,-4.152581473360214
Panc 02.03,9866186,1.4364847380387245,1.0012133420397518
BFTC-909,56946209,-2.8280109825858943,-3.998998433721053
K-562,46843906,1.6079735978006011,1.5726775959632635
IGROV-1,3038522,3.6829378423722416,3.2822085495821267
COR-L95,9933475,1.8209744616881691,1.944322204009819
NCI-H1568,54613361,-1.9115789745186575,0.20279336105482937
PaTu 8988t,11178236,-5.843883599227575,-3.8456198754843482
IGROV-1,24856436,0.4840146383282276,0.5618135300104937
HEL,5746,-1.0378501544368317,-0.3438468774595148
LS180,216345,2.343571728213523,3.942437897446386
MOLM-13,11234052,1.8885372726820036,2.8948031936699676
IGROV-1,656346,1.6285470744333117,1.0057567422649532
IGROV-1,613753,3.483244781428779,3.2854533997103594
RERF-LC-MS,44632017,0.7768655843829712,1.3641666571409377
LCLC-97TM1,10113978,4.598206277837053,2.9666768748866175
LS180,136227924,2.415770069388299,2.903798867737835
Granta-519,5978,-7.678617575463935,-3.2154324395090015
MOLM-13,2828334,5.861258184508348,5.666655955498033
ALL-SIL,3815108,1.81429533281988,1.9783135316171663
NCI-H2452,serdemetan-SCH-529074 (1-1 mol-mol),2.3569369644908535,2.272900456114594
LS180,10385095,1.937933801431244,1.311254045652985
SW1271,7326481,3.1173859417421985,2.954111049245958
COR-L105,176870,-0.2151307909405896,3.6135290160344002
IGROV-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1366391073371296,4.144256261524392
HEL,6918878,-0.4197772532459504,0.39014846814053267
RCC10RGB,44589607,3.0966280095343777,3.0555987279554895
RKN,ISOX-bortezomib (250-1 mol-mol),1.0286936108605995,0.7860370837233058
SW48,89183176,5.513741245898386,4.161113268721945
KU-19-19,168312962,-2.211081322704064,2.232118885455589
LCLC-97TM1,11656518,-4.424964199082896,1.756267361483103
ML-1 [Human thyroid carcinoma],426756,5.157831333984941,4.526231606710164
SW48,decitabine-carboplatin (1-1 mol-mol),4.347409294464919,4.250374615947014
WM115,6918328,0.4200257259119496,0.1637371198234596
RKO,44491742,4.905526099010324,3.8631553159763894
SU-DHL-1,5280436,3.4353188558540895,2.986804851344968
SW1271,BRD-K27188169-navitoclax (2-1 mol-mol),3.98136464619854,2.0182893631484418
P31/FUJ,702558,3.294053878414949,4.065779997967723
MDST8,322968,3.292336134337166,3.909416591320905
MOLP-8,66577038,2.4807994544381997,2.790888377576467
NCI-H2452,216239,2.289885444542123,2.341107950833104
LS411N,24951314,1.1768436480242177,0.5422744339426986
HCC15,5291,3.948819619575577,3.7504709181832667
RERF-LC-MS,11152667,0.0782441689403026,-0.2665048946005404
NCI-H1568,285033,-1.965656578387781,-1.7986568458747754
K-562,119607,4.708269214175102,4.578005143417693
MOLM-13,6918328,-1.6668605659600593,-1.3229540843147485
HuP-T3,51039095,3.318948357155543,2.888096646553024
COR-L105,3025944,3.915005293474353,4.3383765235621405
SK-CO-1,carboplatin-UNC0638 (2-1 mol-mol),2.9632424574107157,3.425122642503287
NCI-H2452,42642645,0.8357005775142816,1.083857335404589
PaTu 8988t,67156097,0.822255948885768,-0.26987520695636996
P31/FUJ,44507138,1.0120664141515707,1.8778464354214577
SK-OV-3,sirolimus-bortezomib (250-1 mol-mol),1.4473324892897623,0.7265420054536375
COR-L95,vorinostat-navitoclax (4-1 mol-mol),-0.3281165082224372,-0.009745370589020058
HCC15,10074640,3.1199478074334106,3.2872802513038484
IGROV-1,53392493,2.352084848618059,2.642870595906187
SK-HEP-1,135398516,1.8011759760648425,2.2292915471407873
HCC1500,tretinoin-navitoclax (4-1 mol-mol),-0.6846797821009611,1.5476015072927058
IGROV-1,1242560,3.902441161940491,3.495812773537336
IGROV-1,24901704,3.0789156375765936,3.2189541140905016
RERF-LC-MS,23635314,-3.639251677232653,-1.8239765294365162
KU-19-19,56946209,-3.434845070293707,-3.836523935161495
SK-CO-1,11427553,2.3636745936222177,3.010655964283564
SU-DHL-1,erlotinib-PLX-4032 (2-1 mol-mol),3.622151043319632,2.742892985097306
Panc 02.03,6852167,4.143336119644561,3.0599312027001355
NCI-H1568,26596,-1.690126811671561,-0.9064635583453373
ALL-SIL,100016,4.099229681419155,5.095171974624643
SW1271,navitoclax-pluripotin (1-1 mol-mol),-0.6532328489926583,-1.0800404134219375
BICR 22,219104,4.618531153522784,3.523916786882268
HuP-T3,4378219,2.0668857590794767,2.5351275000417446
IGROV-1,11647372,-0.6595372928368528,1.317194176365466
BICR 31,46843906,2.802485697538939,3.2727083441053626
SW1573,navitoclax-piperlongumine (1-1 mol-mol),1.792577527221854,2.053089011261873
HARA [Human squamous cell lung carcinoma],44202524,1.300312464104863,2.2365918006086005
PaTu 8902,65064,4.553320484088526,4.904493411254229
NCI-H1568,10410894,1.924104691976128,3.3388799342712816
SU-DHL-1,72376,-3.386078956410557,-2.2659361175556993
BFTC-909,JQ-1-UNC0638 (2-1 mol-mol),2.2684379316791112,1.9180750630575312
NCI-H1568,16659841,3.88074746768202,3.976089550614383
LS180,selumetinib-vorinostat (8-1 mol-mol),0.5678514609289822,2.15669916984106
LS411N,54618164,4.167426775220608,3.825624369293
MOLP-8,5287969,-2.4943575090146903,-2.1112266277599674
Granta-519,24856436,-2.399051702227432,-0.9414794260528582
SK-OV-3,JQ-1-navitoclax (2-1 mol-mol),0.6239682404577798,0.9009108093857189
BICR 22,3689413,1.1307119933583345,-0.10841414943673096
SW948,11494412,0.3616963479580831,1.0117192732668838
RCC10RGB,3552672,3.073432883089278,2.9797425426362776
LCLC-97TM1,72376,-4.375427192181232,-2.156027504121642
SW948,11234052,4.776317924055416,3.293228216123814
P31/FUJ,89928392,-0.2575535361410093,0.20082343425890373
SK-HEP-1,ISOX-bortezomib (250-1 mol-mol),0.2987916672751671,0.7292260181361158
MDST8,piperlongumine-MST-312 (1-1 mol-mol),2.167739236118489,2.0383362061027306
HuP-T3,selumetinib-JQ-1 (4-1 mol-mol),1.2883856318712232,1.3997055877191065
NCI-H2452,2742550,5.209305166760603,4.0745117249284295
SW48,9884685,-1.5395746259931604,1.0120968570036988
SU-DHL-1,16722836,1.4294085247204618,1.7883251740416313
MOLP-8,11640390,2.6566405323234057,2.272208840434006
RKN,5113032,5.131058822839954,4.935759585264021
Panc 02.03,5311,2.7910052639268415,1.6721322459398533
HuP-T3,36462,3.380707637397105,2.3133978629639733
IGROV-1,tanespimycin-gemcitabine (1-1 mol-mol),-0.5447128478899342,-0.8477217853261126
K-562,6852167,3.2696177089982807,2.1802382911695743
KU-19-19,16725315,4.810213458660102,4.238017061322685
Daudi,44819697,-3.048561633253287,-1.7483433111755822
NCI-H2452,73707398,1.4673083704761625,1.2347086567724161
SU-DHL-1,6438330,0.8462618394668467,1.615874325429584
PaTu 8902,carboplatin-etoposide (40-17 mol-mol),6.0931927841576385,2.88450152174743
IGROV-1,400769,-0.5589612210030486,-0.6656757902788744
PaTu 8988t,6918736,-0.015847459349983,-1.5517732820226628
NCI-H2452,12003241,-1.7557808561862691,-1.3591343542239698
SW48,89928392,0.7467993581529679,1.324733333315023
HARA [Human squamous cell lung carcinoma],135875424,5.177992671051203,3.8477525556175154
NCI-H2452,71466380,5.164331301376758,4.571796956463658
Panc 02.03,4917,3.7856869354758342,3.1642904533633494
SW48,25062766,1.0755009410821956,1.9990451230311392
IGROV-1,4259181,0.1937358171291443,0.2292410726093587
BICR 31,46926350,-4.294934659479777,-3.8116203720234245
Granta-519,72199292,2.8103945289975623,0.5518594963619184
HARA [Human squamous cell lung carcinoma],216239,2.4828561148565256,2.2584173377659624
MOLM-13,11222830,0.9845802392597008,1.2313576913110755
SK-HEP-1,676352,1.798347685811885,2.120448924965797
SK-CO-1,36314,-5.371942323616045,-0.8473423812434302
P31/FUJ,71466380,4.574945433624961,3.9004196862973486
PaTu 8988t,11427553,3.005069211450264,2.8503827039264893
ML-1 [Human thyroid carcinoma],1566236,3.1920996771286783,2.7187883717101147
NCI-H1568,151289,0.8908355813530987,1.198539782990273
SW48,216345,1.323366684487305,3.871258577247894
SK-HEP-1,44819697,-0.1381867301228731,0.11029552298650667
BFTC-909,24951314,2.3445794180209565,1.6378113860824468
SK-CO-1,107985,-2.728069079888901,-3.3911254710521614
BICR 22,168313016,4.910867780923905,4.630096787298828
SW48,3025986,-2.1875732043663048,-1.1779842589912226
HEL,SNX-2112-bortezomib (250-1 mol-mol),-2.046606544409741,-2.935430424003629
UACC-812,erlotinib-PLX-4032 (2-1 mol-mol),1.674253271447935,2.435449763978486
HCC15,446155,0.1844871361320988,2.87414800155529
LS180,sirolimus-bortezomib (250-1 mol-mol),1.3360442889009512,0.785824118681695
BFTC-909,56963564,-0.1720168824982637,0.5937348793881503
MOLP-8,151289,0.9447515089929442,0.64051491706364
HEL,11609586,2.7821230127549663,1.7607028918755978
ML-1 [Human thyroid carcinoma],66577038,3.490614785347513,3.115174331085589
SW948,46174525,3.747184504681747,3.5356236820569196
HCC15,11964036,0.8100768326008368,1.4453212194028668
SK-OV-3,53232,3.610813443380856,2.686423563728836
NCI-H2452,9884685,3.2183676658345868,1.083144990459834
RKO,navitoclax-MST-312 (1-1 mol-mol),1.4157691797100402,0.565385712745301
K-562,44241473,4.342180714885996,4.37538052280562
HCC1500,65628,4.452955395596753,4.4920450095376605
MOLM-13,24771867,-2.755307399303063,-1.4057787836537086
RERF-LC-MS,168312962,0.3496483928324376,2.330344876189059
SU-DHL-1,carboplatin-UNC0638 (2-1 mol-mol),2.541711165237938,3.10949014299886
NCI-H1568,44589607,2.521775448277625,3.07112600554302
ALL-SIL,selumetinib-UNC0638 (4-1 mol-mol),2.881146238835363,2.136519140588937
Granta-519,5280436,1.7342596657129103,2.572194017054126
NCI-H1568,72199292,0.3941551729128716,0.5574336337172502
SK-CO-1,439501,-2.410857533331093,-1.927441587769919
Daudi,selumetinib-decitabine (4-1 mol-mol),-0.4974612156096017,-0.041936851708356176
PaTu 8902,3038522,3.855914834510199,3.1430387562867654
SU-DHL-1,159324,0.2044468524757833,2.613381771874222
BFTC-909,46398810,2.674147192871529,2.7062906458645317
LCLC-97TM1,148198,-1.8422045751990368,-3.3429430139826217
MOLM-13,selumetinib-MK-2206 (8-1 mol-mol),0.4118015123896347,0.943442767941773
LS180,5351362,1.0497784443121565,1.3468880985583878
NCI-H1568,5311281,2.6261557759532974,2.5118455710142813
SW1271,44589607,3.6432775089048888,3.0593125077637855
RKO,54143018,-0.3751060369564643,0.04391223838702003
COR-L105,44607530,0.5885750535327339,1.8129246977263822
RKO,navitoclax-pluripotin (1-1 mol-mol),0.0128409422156563,-1.4592900251314382
Granta-519,serdemetan-SCH-529074 (1-1 mol-mol),-1.751418488769959,1.208310226558025
SW948,387447,-4.931777613053621,-4.199589823597311
BICR 31,168313016,4.3680397842259095,4.943297289184976
LS411N,36314,3.823716751686664,-2.02383013088234
IA-LM,JQ-1-vorinostat (2-1 mol-mol),1.5927237168826456,0.1888946960635943
MDST8,67291369,1.5579520311273356,2.84314966849996
RERF-LC-MS,3062316,3.070306969339253,1.267717596444171
COR-L95,doxorubicin-navitoclax (2-1 mol-mol),-3.6271325367233977,-1.5855177110028325
ML-1 [Human thyroid carcinoma],navitoclax-gemcitabine (1-1 mol-mol),0.4874661343054459,-0.8517001838224258
WM115,JQ-1-vorinostat (2-1 mol-mol),1.1090035526940631,1.0690122177292911
MOLP-8,11964036,0.2292639686830329,0.46965233989360294
RKN,66577038,3.4891743358782104,3.083212687176504
PaTu 8988t,5978,-2.779195325360685,-1.5763226404364625
RKO,8515,4.32265921632429,3.4826961192080312
SU-DHL-1,46907787,0.92481130470373,1.8523362221253072
COR-L95,216468,4.837628080392179,1.9155539390134946
SW948,462382,0.505941174695894,0.7048987577385799
NCI-H1568,448949,1.6827994040181535,2.0727287084181922
ML-1 [Human thyroid carcinoma],11626560,2.2482240841306123,1.994415648682144
NCI-H2452,10184653,1.4868368660739673,1.666301116303953
NCI-H2452,1285940,4.318373702463549,3.585692433161335
SW48,52912189,0.0060801339095902,2.2082992627005495
RERF-LC-MS,46926350,-4.177207395055215,-3.925791861525696
P31/FUJ,5978,-3.805650321394954,-3.2543505121646614
Daudi,4917,1.6956741153412938,2.7254710468514554
LS411N,44507138,1.8249335905604152,2.102019305233917
RERF-LC-MS,10231331,0.9954911948227504,2.3199991467442307
HCC15,4261,-0.2961876318733478,1.7181937231939315
P31/FUJ,16722836,0.3472605187822769,0.9565521230687541
MOLP-8,45279963,3.839697844480557,2.7005014802255505
NCI-H2452,446155,1.665772886963468,2.463009691356253
NCI-H2452,11609586,3.752552997604344,3.1336877046312437
ML-1 [Human thyroid carcinoma],54618771,2.3801125351223105,1.4887226121362864
IA-LM,9933475,1.89794527933904,1.8414966663802486
MOLP-8,4477,0.6768027916096236,0.6371341266904507
IGROV-1,42642645,0.3750175292659389,0.9821044308232436
IGROV-1,6852167,1.5305143027352028,3.032509029912688
Daudi,5287969,-2.32062356362434,-2.2133044927735877
WM115,44607530,1.3586937130527126,1.828990934137758
SU-DHL-6,5291,3.0098231219330422,3.0621453349092906
IA-LM,53392493,3.818463276064527,1.9576133315140976
MOLP-8,5328940,1.3442597724286955,1.2182677767780938
NCI-H1568,11626560,1.7284579168385834,2.0839904071985993
NCI-H1568,9967941,2.084939505363619,3.7437846066881586
BICR 31,24856436,1.9770307243044476,0.6054125268887257
LS411N,6918289,4.168112514533401,2.018914970234596
SK-CO-1,49766530,2.416603727276247,0.41658937163488524
LS180,15547703,3.0095925001469577,3.1019435454632327
SK-CO-1,24771867,2.6665073598645086,3.138162108854483
MOLP-8,17755052,-0.3093261728985458,0.7264570859356146
HARA [Human squamous cell lung carcinoma],SNX-2112-bortezomib (250-1 mol-mol),-1.7614271905544292,-1.3911168857179126
NCI-H2452,6610216,4.12804282735119,4.369860355548425
RERF-LC-MS,16065773,2.958049600168222,2.50103839353194
SaOS-2,6610216,4.351676798413151,4.197394555096999
RERF-LC-MS,navitoclax-sorafenib (1-1 mol-mol),1.552996311194731,2.014070457802305
COR-L95,BRD-A02303741-carboplatin (1-1 mol-mol),4.777626447761979,3.810866217469762
NCI-H1568,3854666,0.7326561551321923,1.9594910975325897
SU-DHL-1,11404337,-0.9851913382580488,-1.0597718465919213
HARA [Human squamous cell lung carcinoma],2708,4.268843127757034,5.0515311328828645
K-562,2746,2.4328857060914797,1.9665479059878297
Daudi,16038120,0.2901991168563289,0.07935624143693726
MOLM-13,71466380,3.777949844495899,3.6324065713962232
Panc 02.03,11955716,-1.8470517927785437,-1.349026720341858
LCLC-97TM1,2858523,3.382646598163124,2.945499728591414
SK-HEP-1,11234052,4.66363668535284,4.204585988484919
HCC1500,322968,2.559368987278369,3.598423452537224
COR-L95,24772860,-0.7858558168975444,-2.0144673225018384
RKN,selumetinib-navitoclax (8-1 mol-mol),4.166323835760914,2.2138111066516992
SW1271,89928392,3.428275427880058,1.3087769999271865
RCC10RGB,24821094,3.8097926200280225,3.135257448638293
HEL,24753719,3.7144242054355985,3.1707117107493286
K-562,445091,4.14956176193418,3.9166162227717454
HEL,136227924,2.725456875957553,2.500035882859084
IGROV-1,carboplatin-etoposide (40-17 mol-mol),3.2860353297411256,2.5601997077949186
LCLC-97TM1,159324,3.194316902825419,2.3264956286498424
RERF-LC-MS,57519531,1.5399611647939,2.6377767722654277
RKO,JQ-1-navitoclax (2-1 mol-mol),1.6431758808285295,0.3111759320331881
SW1573,navitoclax-birinapant (1-1 mol-mol),1.5026164736180645,1.7927165585225695
HCC1500,51037431,2.242858518427135,3.0436069615933707
ALL-SIL,12003241,-5.746631994241774,-1.5322719150779525
P31/FUJ,44819697,-1.8374306821299025,-1.9149275258562488
SU-DHL-1,tanespimycin-gemcitabine (1-1 mol-mol),-4.4382165085850405,-1.7978632837317183
MDST8,107970,2.8941750874079744,2.273252842859449
SK-OV-3,3503,3.0304882575129497,2.349164112361207
HuP-T3,selumetinib-piperlongumine (8-1 mol-mol),4.093853736240695,3.080162150131116
HCC1500,9927531,5.051014893697188,4.55732340568705
NCI-H2452,selumetinib-tretinoin (2-1 mol-mol),6.004763322543325,3.6645230156768456
HCC15,5328940,2.162982624771584,1.82893480065542
Panc 02.03,11626927,4.481877662185247,2.9549482784349856
SU-DHL-1,navitoclax-gemcitabine (1-1 mol-mol),-3.283553666087357,-2.3138481175021437
SU-DHL-6,2749,-0.5951367082815587,0.9739659786907423
HARA [Human squamous cell lung carcinoma],15547703,3.5023955614710633,3.2020500895508817
MDST8,135398516,1.8788362071916904,2.2545790361034967
MOLM-13,5328940,0.1532905912336842,0.9159245775942054
WM115,4477,-0.2872762876800434,0.48960382133138347
ALL-SIL,5746,-1.6673474530311534,-0.4995730390821425
PaTu 8902,25150857,2.644837375624729,2.6751568573381155
MDST8,219104,3.7181204954875864,3.550264224526888
Daudi,11228183,2.4864875823277557,0.5206599650000557
ML-1 [Human thyroid carcinoma],613753,2.773006926215127,3.2962418981807557
Daudi,984333,-2.2486456844128333,-0.15035097494769453
Granta-519,12003241,-2.1147517064841925,-2.2587072669513804
Granta-519,BRD-A02303741-carboplatin (1-1 mol-mol),4.5159158584764745,3.89169437074916
SW48,387447,-4.885505238560258,-4.013489659590617
COR-L105,36314,4.185071185075879,-0.26246687388812245
HuP-T3,4705,2.7233440783632608,3.210874229383362
Panc 02.03,54678924,2.4878586568917536,2.353949827786615
SW1573,16065773,3.287625611468905,2.545894116125462
ML-1 [Human thyroid carcinoma],15953870,3.8046885468141016,3.7644771916779303
COR-L95,10385095,1.3959867651371194,1.1140035623973683
P31/FUJ,2945648,2.3869646223252365,2.0406667386612445
PaTu 8902,55283,3.4956890773009097,2.932331865042219
COR-L105,89183176,5.033590250009003,4.42729688219439
HEL,navitoclax-MST-312 (1-1 mol-mol),-0.4450786060493964,-0.01409785225328103
HCC1500,445091,4.393350110080019,4.387966965156453
SK-CO-1,11175137,2.477148698701912,2.655773476806244
SK-CO-1,navitoclax-MST-312 (1-1 mol-mol),0.863563965470539,1.1982025117989255
BFTC-909,54618771,2.8225313881877545,1.539126524704979
HCC1500,73707398,0.9868057798362108,1.421923971603368
WM115,135398516,0.1940094116062491,2.4501766819531796
SW948,11977753,-4.015233583581633,-2.0747807305031727
KU-19-19,446155,2.785852834205258,2.7530741277416073
BFTC-909,3854666,1.1654585644167257,1.9803651630286847
ALL-SIL,327653,2.0915878780614623,2.2549036779824805
RERF-LC-MS,2749,2.1448012118135176,2.2659876103188115
SK-CO-1,3503,2.662166466999906,2.461779414567747
IA-LM,60700,0.8821511316384938,-0.25313914321179526
Panc 02.03,10302451,3.706546166543765,3.083855694968406
SaOS-2,45279963,3.893370234288743,3.65619067627647
HARA [Human squamous cell lung carcinoma],2858523,2.980861882613042,2.9994984172309223
RKO,tanespimycin-gemcitabine (1-1 mol-mol),-1.448163850865836,-1.361032443527155
K-562,11626560,-0.7477726232652755,0.9524376636387479
PaTu 8902,252682,7.782026892174048,6.684424548246507
HARA [Human squamous cell lung carcinoma],24856436,-1.2762108597510684,0.6229678916298118
HCC1500,9887053,4.8738692747205175,3.819110117174051
IGROV-1,11717001,4.394306548697183,4.091451272537581
NCI-H2452,9911463,3.657985193851277,4.047153279449283
HuP-T3,11707110,2.782188957571083,0.20117689558142896
COR-L105,5287620,-2.2558017577268665,-1.8347998044491052
K-562,9907093,4.115761716505682,3.60396047732813
SW1573,53245473,3.5468633352222287,3.501393594133715
COR-L95,100016,6.620829555802918,5.604530531769158
Granta-519,11178236,-5.517610268531398,-4.3008937090494
IA-LM,3503,2.293282991199797,2.206729567136181
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943,-0.059520534313722555
IGROV-1,navitoclax-gemcitabine (1-1 mol-mol),-2.4690208522715005,-1.1783761571028573
MOLM-13,23635314,-2.1464398793300408,-3.0999685252540075
WM115,45100481,5.666571363096329,4.556903889323658
ALL-SIL,doxorubicin-navitoclax (2-1 mol-mol),-2.2880067679034526,-2.940025224011854
COR-L105,5351362,1.5942690709113274,1.6516164905766688
IGROV-1,6610216,4.310938387105607,4.267892092481897
SK-CO-1,4521392,4.292734672993078,4.258992637881842
RERF-LC-MS,53232,1.207294902086358,2.7470759018811703
NCI-H2452,16038120,1.767482091574877,1.0236977092796709
LS180,107985,-4.080313435814333,-3.4580536962387525
SU-DHL-1,24785538,0.8988368126388477,1.3151809828166336
IGROV-1,11977753,-2.2284230058029433,-1.0751157377032141
ML-1 [Human thyroid carcinoma],6623618,2.7004595127938686,2.3735993528613357
SW48,24964624,1.8073600797801577,2.244763987323225
RKO,9911830,2.9376280530386123,1.8779636149187136
SU-DHL-1,navitoclax-PLX-4032 (1-1 mol-mol),4.469831301175806,0.7750305757643448
Panc 02.03,navitoclax-pluripotin (1-1 mol-mol),3.190516365419919,-0.7056543472315309
HEL,5287620,-1.51108604946339,-2.108597298580707
MDST8,11964036,-0.5107320494490124,1.5844091925793817
HCC1500,10385095,0.8648832931247582,1.4777430670119234
SW48,702558,4.851481027043998,5.091116685398866
BICR 22,15547703,3.054989624104991,3.250835632863533
LCLC-97TM1,375860,-0.9613247940016756,0.17443876049873622
BICR 22,5566,3.0896765386345244,2.690621767458438
SW948,36462,2.9711779559511604,2.193589278626302
SaOS-2,135411,0.7043200334589346,0.6772554569047168
SW1271,24889392,3.729104653817525,4.139908212645693
K-562,4917,1.7461656699737091,2.8670356496672746
MOLM-13,11964036,-0.3903680086882432,0.009250869927918095
SU-DHL-1,9907093,3.802209526559384,4.029975320968802
MOLP-8,44507138,3.0437239609683515,1.804980488762422
HCC15,441298,2.404091830829315,2.469576469838176
IGROV-1,246676,4.485924799339535,4.164745268848903
IGROV-1,3136844,5.214591389089975,4.508852158835291
Daudi,119182,-1.0022442636317743,-3.27594008169
SK-CO-1,2742550,3.074063089907043,3.957570854831222
COR-L95,5291,3.794551144961864,3.548848442578925
ML-1 [Human thyroid carcinoma],6184667,3.426764234055379,3.2249099638819594
WM115,16219061,2.9198343751130036,3.585960136672215
RERF-LC-MS,2871966,0.0193381278585586,0.7855682061342057
SW1271,44607531,2.0262821909932964,1.7161716151324946
NCI-H2452,53495165,2.6100799702143824,0.734077741163202
SaOS-2,3825829,3.573326366415088,4.04332705498077
HEL,1242560,2.170830105823081,3.105199038675985
SU-DHL-1,selumetinib-tretinoin (2-1 mol-mol),1.6823534410792318,2.255262707381271
MOLM-13,135423438,-5.2048777869707035,1.0018608063036885
RKO,3815108,2.4813915623878264,2.3826195587123347
SK-CO-1,57519531,1.3464743023672243,2.616570452079463
SU-DHL-1,2729026,1.1961155288156848,2.4290753409969095
MOLP-8,57330099,4.408814311331857,3.790463306306921
SK-HEP-1,25262965,-1.9202339310426983,-1.2191148385115496
HCC15,71466445,3.952377160133232,3.821743314622394
Daudi,49793307,-5.375388093698208,-4.238116429218312
RCC10RGB,52947716,3.397847809230189,0.8973994837534062
COR-L95,selumetinib-vorinostat (8-1 mol-mol),2.598334256861724,2.078497934711639
MOLM-13,10074640,2.6694741782411975,1.8208143685179294
HCC1500,16736978,0.2362509616809698,1.3228623201422745
WM115,11228183,1.7654096487865938,2.6767694148876116
Granta-519,25150857,0.8022216450857215,1.51362665447017
RERF-LC-MS,2858523,3.0171071482923826,3.146148783951631
K-562,71466578,3.85538032532176,2.9267759533790865
RKO,135875424,3.829354185480349,3.4362828256605824
HEL,4096211,2.9626104821001524,0.8026200413148008
LCLC-97TM1,67156097,-2.339870774569048,-0.9480688655883825
COR-L95,3503,2.5200783295079834,2.1924916368242418
SW48,11609586,2.634017068041322,2.911201793437544
SU-DHL-1,375860,-0.8487932986720208,0.05691327917676261
SU-DHL-1,5351362,0.9282229173955964,1.3903280756500316
SK-OV-3,6917907,1.1533351492785058,-4.98945432686944
PaTu 8988t,65064,5.1728218990125,4.77872989379084
RKN,3503,2.6546301780010144,2.3744293884526724
IA-LM,23582824,0.7235929041173603,0.8205230899600922
IGROV-1,54143018,0.8385018685685798,0.5645110124959853
Daudi,11214940,1.5157277988308535,1.0752798033971598
SW948,4261,0.2066749270482282,1.1676992649982012
HuP-T3,15547703,4.355520728687953,3.003592490297429
NCI-H2452,24748573,1.1942514329138498,2.441287538882675
IGROV-1,159324,2.8766947154825044,3.199113830122317
MOLP-8,JQ-1-vorinostat (2-1 mol-mol),-1.65297675500665,-0.6955991209026609
MOLP-8,navitoclax-birinapant (1-1 mol-mol),3.3062400198752195,0.47189449082197477
SU-DHL-1,3465537,3.713885766889003,2.048531243391843
NCI-H1568,60700,-0.8736945480852499,0.013243361195148535
P31/FUJ,3689413,-2.495432751898851,-1.3336292630602353
PaTu 8902,16722836,2.3982166809874768,1.5886806672945035
SW1271,452548,-0.0979853591066759,0.3685607172811809
HCC1500,9444,4.370086947523025,4.031078558416582
IA-LM,navitoclax-pluripotin (1-1 mol-mol),-1.626939018948189,-0.9006595735142012
MDST8,44137675,1.8173250203578384,3.6117753433388713
IGROV-1,5460769,1.6083174601829917,2.5830547245527566
SK-CO-1,10302451,2.4520332675877605,2.799689468478231
IA-LM,sirolimus-bortezomib (250-1 mol-mol),1.6120597722062386,0.770535277665012
SU-DHL-1,3384730,1.173741268518712,2.623596713083865
LS411N,11178236,-2.533537215148808,-3.0676040760682133
COR-L105,216239,2.81147830727615,2.504026615608908
MDST8,1750826,-3.2078848487443716,-1.6828714781585976
HARA [Human squamous cell lung carcinoma],tanespimycin-gemcitabine (1-1 mol-mol),0.469334809183726,-0.5549637053484062
SW1573,3025986,2.659291536752942,-0.33024874717690933
SK-OV-3,73707398,1.4890038437616029,1.3957502414737524
LCLC-97TM1,12003241,-0.8351557307101188,-0.8886894801660382
BFTC-909,1750826,-0.1726466566192349,-1.9750089943256512
WM115,44819697,0.4217395821242636,-0.5633159803874134
Daudi,57330099,4.348234162675926,3.770901852592463
HCC15,6852167,3.485797740848402,2.902020531458871
IGROV-1,23939,4.412541857664819,3.939569037532609
Daudi,carboplatin-UNC0638 (2-1 mol-mol),1.637238274504332,2.601334906981182
MDST8,159324,4.143261975826356,2.9169125572534678
IGROV-1,9840324,5.720969888694302,5.746629450287327
LCLC-97TM1,36314,-6.600382606146434,-1.3997374678816292
UACC-812,11494412,1.976870257251046,1.896557697873669
LS180,24785538,2.36344296814186,1.2662616927461132
SW1271,46398810,2.1181317502001864,2.6223482022513567
COR-L95,8515,4.297389552329342,3.587971829927081
HEL,67291369,-0.0398574366947598,0.22074731267642245
WM115,65064,5.519507799834776,4.6326733550701285
K-562,11178236,-5.937287665657859,-3.7035670569549577
MOLM-13,46398810,-0.3461491770759903,1.5940954925649018
Daudi,49836020,3.49644839546437,2.880818609101525
SaOS-2,135659046,3.828911922642458,3.9227432439503347
MOLM-13,156422,2.6570896066322054,2.515261136828931
IGROV-1,11222830,1.5703285223102077,1.6121445311307228
MOLM-13,3062316,-0.5121609334560062,0.39444044143860807
RCC10RGB,24775005,3.7293513155953737,3.8806289387944783
Daudi,135411,0.411387979123234,-0.1830580430542753
HEL,6623618,1.8836955043929509,2.0269288918547015
IGROV-1,5702613,4.420745339537274,2.7967195987037288
BICR 31,3025986,-1.7152493432112506,-0.6298414893635896
ALL-SIL,crizotinib-PLX-4032 (2-1 mol-mol),-0.8453908934030238,1.0524985679100358
HuP-T3,46926350,-3.9956296104835447,-3.916301553443615
SW948,11964036,0.9329377934210036,0.6456420068115871
HEL,navitoclax-pluripotin (1-1 mol-mol),-0.6457207254934652,-2.2948203832009786
BICR 31,168313200,4.293337148285007,2.9886846749246048
LCLC-97TM1,613753,3.2994086878019693,3.0686850081124732
NCI-H1568,2858523,2.9099207435493306,3.0610144418777456
K-562,selumetinib-piperlongumine (8-1 mol-mol),3.695022326832345,1.9935159479704143
WM115,168312962,-0.8720769549309708,2.3022852098815623
COR-L105,3136844,4.323289843330604,4.471156725181905
SaOS-2,24964624,2.194529135867758,2.492587546785562
IGROV-1,322968,4.140599241163106,3.877148528872593
SU-DHL-1,44259,0.9870469643742532,0.8999340753352221
HuP-T3,erlotinib-PLX-4032 (2-1 mol-mol),4.371591161861475,2.7815201442498556
Daudi,7326481,2.37278983949268,2.692672525869154
HCC1500,5284616,3.2143502285360395,1.7013722369063993
Granta-519,6918736,-3.0470654964091346,-2.504747928861308
K-562,53232,2.317344808959498,2.574063383571292
KU-19-19,6914657,-4.990300196809823,-3.8611164267363516
Granta-519,72376,-3.0273971733074463,-3.424939583535246
SW948,54678924,1.3690911042909353,1.6392989856006763
HARA [Human squamous cell lung carcinoma],135999136,4.433628677785179,4.106850416733314
SU-DHL-1,2858523,2.096941494706986,2.9959382720943766
HCC15,11427553,0.4296382841284133,2.858416770898659
HCC1500,UNC0638-navitoclax (1-1 mol-mol),-0.3841073877308503,1.486724263156823
PaTu 8902,9444,4.223556509018044,4.2093495444915305
Granta-519,10074640,3.4462174196318864,2.606826375796416
NCI-H2452,11213558,2.927858740250081,1.7815225217863722
HARA [Human squamous cell lung carcinoma],10302451,4.803964333247322,3.3326393144373814
SU-DHL-1,17755052,1.573040093702568,0.862845588371018
HCC1500,44185566,2.7833515387265435,2.3670630090225715
BFTC-909,107970,2.2861723254681774,2.5145352334707285
WM115,46191454,1.770414974730312,1.763164702360865
Panc 02.03,selumetinib-decitabine (4-1 mol-mol),4.111945447475948,3.346105123570723
SW948,JQ-1-vorinostat (2-1 mol-mol),0.5761489017255973,0.21804663570770985
SW48,984333,0.702746968378095,0.6038550860416548
MOLM-13,4378219,1.3750720877022855,1.8168683435130912
SK-CO-1,104842,-6.47047720162668,-2.2895737829574583
HARA [Human squamous cell lung carcinoma],135440466,2.4398826683273165,2.4237586591672753
SU-DHL-1,753704,3.8222320630358344,4.770768318390465
NCI-H2452,11640390,3.686004280320225,3.840930536504793
IA-LM,44185566,3.1900951690600596,1.8976319565996798
SW948,24748573,3.0928652753553685,1.909182669130591
HCC15,16722836,0.9313515315756092,1.723345029171395
SK-CO-1,2858523,3.0692168261278345,3.043703591104201
BICR 22,984333,1.5288435331300914,0.6411120678788429
WM115,46907787,1.8634039559333693,2.5376567288108673
K-562,135398516,2.1877631842117315,1.453860171355351
PaTu 8988t,navitoclax-pluripotin (1-1 mol-mol),-0.085365931635351,-0.6226537292389254
SW1271,56649450,5.123918884487689,3.5566076485246776
MOLM-13,73707438,4.222752629567675,4.096782127599641
BICR 31,navitoclax-PLX-4032 (1-1 mol-mol),3.597223758742863,2.0799757747066154
IGROV-1,9908783,5.873270433212515,4.898196436608434
COR-L105,100016,7.1590039780101895,6.3220810170632795
MOLP-8,2733487,6.371854996101937,5.527857371042285
HuP-T3,40482356,5.071639396405957,4.343145610290085
Daudi,10231331,6.134507235467236,0.809340777152356
IGROV-1,JQ-1-navitoclax (2-1 mol-mol),1.1306356566784013,1.0934121522923557
ALL-SIL,135398738,2.8388897343309214,2.1171725357072853
Granta-519,15953870,3.078322892664931,2.970152619473552
SW1573,16722836,2.4665820842388606,1.6552587497699247
RKN,262093,2.5285063130840344,3.039169539163021
COR-L105,16736978,0.0668136597141226,1.9444982878477932
SU-DHL-1,3854666,0.5155348387571919,1.743644493067758
SaOS-2,docetaxel-tanespimycin (2-1 mol-mol),-4.954749121249774,-3.2388462760001384
HCC15,1242560,4.141842055686159,3.480837564113573
Daudi,227681,2.3413610492173533,2.4779106555679355
BICR 22,9825149,1.9632507246672848,2.1706830754919157
KU-19-19,57519531,2.7709295903751987,2.6669242963349236
HEL,675434,4.82305615478698,4.085911279807476
LCLC-97TM1,9927531,5.703886109604247,4.839287242045575
HCC1500,60700,0.3261825799377537,-0.2693585673878404
SK-HEP-1,3025986,-0.7748266135658505,-0.6162572988160061
LS180,5281321,-2.3743222213125703,-0.9758467360299461
RERF-LC-MS,11234052,4.094456859515875,4.294729873454566
COR-L95,JQ-1-navitoclax (2-1 mol-mol),-0.0986281743436248,0.30500338822363715
RERF-LC-MS,753704,5.128075002459309,5.215992991012619
ALL-SIL,71304818,1.8469641946240791,1.8300852479320946
LCLC-97TM1,2733526,4.142341185184233,3.692633177662359
SW1271,6918328,0.5991052607451842,-0.08350113714215095
SW1271,24901704,3.681572165465946,3.3351251680948106
Granta-519,11656518,1.6452745070498538,0.2144046406156204
NCI-H2452,3025944,3.797054601848671,4.305622675838871
COR-L95,navitoclax-sorafenib (1-1 mol-mol),-0.3721439158461418,0.6782856374205513
RKN,24951314,1.3743916622304369,1.6392940895958736
SW1271,25126798,3.686543071113652,3.91264851672154
IGROV-1,6450551,2.579641476451469,2.7941304113048817
IGROV-1,54454,2.453541831966438,2.8424551272422875
COR-L95,9936388,1.0197606854481494,-3.193932809112097
Daudi,42611257,3.0497080994784307,3.095611042254559
BICR 22,54618771,-1.5156377594303725,1.0303310633354352
LCLC-97TM1,23939,4.339779460008714,3.924796869891265
NCI-H2452,46191454,2.4313233431346366,1.8124726067517813
COR-L105,42642645,1.1549939076973508,1.10064543334192
MOLP-8,11609586,0.3617141221652126,1.7442572511519123
BICR 31,613753,3.1747241586791772,3.3211751915078738
SU-DHL-1,5328940,1.3431964509037,1.6873922536970196
HARA [Human squamous cell lung carcinoma],5287620,-1.762699468398793,-2.001746497178048
SW48,carboplatin-UNC0638 (2-1 mol-mol),2.888292790339682,3.309847072413076
BFTC-909,11455910,1.958059547603208,1.5841645693083217
RERF-LC-MS,322968,4.758979615786181,4.16776473203085
KU-19-19,5351362,1.814646406429004,1.4652588372182382
MOLM-13,54649381,3.864277780400009,3.1885696012775075
RKO,selumetinib-MK-2206 (8-1 mol-mol),2.0156387563640337,1.7990313040457537
NCI-H2452,72199292,1.1345413256627164,0.5950580234307828
MOLP-8,676352,1.5936675202889017,1.787770886787798
HCC1500,676352,1.5631676801704226,2.015829633365805
COR-L95,51037431,4.395819234826154,3.096299982202333
Daudi,5328940,0.4604914818199462,1.093379082626513
SU-DHL-1,ISOX-bortezomib (250-1 mol-mol),0.1782734065105105,0.11647512856557447
IA-LM,168313200,3.804941602819176,2.9717603454299315
RERF-LC-MS,navitoclax-gemcitabine (1-1 mol-mol),-4.0027913936317026,-1.2825893025292914
RKO,119182,-2.4803685643523,-1.2612822480405053
Panc 02.03,selumetinib-vorinostat (8-1 mol-mol),2.158693436679715,2.857450275413303
PaTu 8988t,25227462,0.2940996568558364,0.27093029278525704
SU-DHL-1,9929138,3.6810672504095385,4.639476430699494
SU-DHL-1,12003241,0.0778318253848937,-1.1461082167703793
RKN,15547703,3.1395613683678287,3.2132050069100386
MDST8,selumetinib-vorinostat (8-1 mol-mol),1.0590621941896752,2.459250297012014
MOLP-8,375860,-0.9263291950812266,-0.4317931664102025
PaTu 8988t,11234052,5.58672838892775,4.378599955232877
LS411N,piperlongumine-MST-312 (1-1 mol-mol),2.10220496247882,1.489694815279656
SK-CO-1,126941,-2.257482818819106,-2.0435137819234335
KU-19-19,selumetinib-GDC-0941 (4-1 mol-mol),1.3867335606828617,1.544006899246432
LS180,3038522,3.8311766422201727,3.0609099413244967
SW948,1566236,2.0550116218076235,1.8746630201088428
Granta-519,89928392,0.2978525114312038,-0.0346527018970715
MOLP-8,19582717,2.2376953494036624,2.802094510033919
HCC1500,vorinostat-navitoclax (4-1 mol-mol),-0.8820209164506474,0.7606012871029777
K-562,2874250,4.395305106833161,4.2852430490966285
SU-DHL-1,11234052,1.0073590907004168,3.7753228957202656
BICR 22,73707398,1.4183060149157571,1.4715241207297558
COR-L95,46926350,-4.41571269577794,-4.077125139879971
Daudi,25154868,2.925803317483448,3.728482900163004
HEL,16725315,4.4825385691379145,3.5280663082559136
IGROV-1,67291369,1.8066430555976296,2.741763800081531
PaTu 8988t,11404337,-0.5897258437911538,-0.37112089079059873
SK-CO-1,9911463,3.850014047184169,3.878523677201841
LS411N,89928392,2.6081309937571655,1.009407732565817
SW948,374536,1.478775672326772,1.301159796486172
Daudi,3543504,2.1992036346279997,3.399742554003871
NCI-H2452,5746,2.2152642195731818,1.4910892192035903
K-562,451668,2.928523807666895,-0.5208929764638305
RERF-LC-MS,71680916,4.2559060280924665,4.686038112044382
BFTC-909,5311281,3.2468587214362175,2.073416732053996
HCC15,54649381,3.779002151510325,3.917559901356822
SaOS-2,6252,5.899001284083339,1.2423444945578788
SK-CO-1,2828334,6.603893313093487,6.073138428797765
HARA [Human squamous cell lung carcinoma],8515,3.1956320485149265,4.0666913721833735
RKN,56946209,-4.407104587623599,-3.7140113229799296
P31/FUJ,54618164,3.783909273991047,3.7687147460479564
P31/FUJ,46943432,0.8368365469264624,1.0697211884451618
SU-DHL-1,24180719,4.350105317542874,3.154239049465342
SK-CO-1,10113978,3.831664495659769,2.9895334562971896
Granta-519,16659841,3.0104726191973756,2.618438938970881
HCC15,5329102,1.9423862085433257,2.155870910180904
RKO,9903786,4.184024439899693,2.3788678733784407
Daudi,76446078,6.274042769130843,3.3530424113967623
SU-DHL-1,5113032,6.615586057729586,4.771887609673009
ML-1 [Human thyroid carcinoma],carboplatin-etoposide (40-17 mol-mol),0.3624432437862623,3.066359173342002
IA-LM,219104,4.299166533144503,2.7148883535850867
P31/FUJ,5329102,0.6917422477571054,1.3538405270162237
PaTu 8988t,5278396,4.086122365965545,3.5229188055374534
LCLC-97TM1,8515,3.105500626842055,3.8003401651475865
ALL-SIL,36314,-6.574209880787115,-2.885935565192174
HEL,JQ-1-MK-0752 (1-1 mol-mol),-0.9106796249442436,0.019423187088489807
SU-DHL-1,252682,6.908372017357921,6.294579188217912
MOLM-13,24753719,4.086009941734247,3.1694705678599298
LS411N,119607,5.818355117504778,4.507066017624291
MOLM-13,66577038,2.3893764671204853,2.4361781820357797
HCC1500,25183872,-1.4621663438631347,-0.7056398209809842
KU-19-19,6917907,-4.52253618895935,-5.516476816102116
MOLM-13,11396600,-0.7885098330267027,2.4447119782789466
SW1271,25195348,2.4923805554625407,3.37783866699469
NCI-H2452,15983966,-3.826639310361129,-1.008803962245716
BICR 22,6184667,3.547514920621151,2.87868645862082
IGROV-1,11396600,3.99372654279783,3.7225258561310515
PaTu 8902,24748573,3.607230896648149,2.3452784077083657
MDST8,54613361,0.3905773320508885,0.541638411153292
SW948,136227924,2.9576701343794145,2.4626958373868453
HEL,135411,-2.1892340188273836,-0.15702717205486347
RKN,322968,3.2277505791227776,3.939123073709476
HARA [Human squamous cell lung carcinoma],15953870,3.428154571209005,3.6346575842169484
RCC10RGB,alisertib-navitoclax (2-1 mol-mol),1.3902469753656497,1.0868869354614967
COR-L105,444795,5.02091820523187,4.825786911642814
RERF-LC-MS,11175137,3.6286013190581503,2.745593646808916
RKN,54619267,4.894700718514424,4.23209720000141
MDST8,54143018,0.2489025697900608,0.8433660089244788
LCLC-97TM1,4917,2.8423920861921803,3.0254682275794154
Granta-519,60700,-4.015034522335836,-2.3967385045081464
MOLP-8,56649450,1.2499213171679169,2.646375404180765
RERF-LC-MS,11719255,3.775646564562419,3.6220641212448617
BFTC-909,12001922,1.803559970478093,2.043007837706886
MOLP-8,3384730,1.892166165987978,1.7387804931333721
RKO,176870,5.862868084879783,2.826047434983772
HCC1500,SNX-2112-bortezomib (250-1 mol-mol),0.5561082321817433,-1.2629306496758692
PaTu 8988t,navitoclax-MST-312 (1-1 mol-mol),1.1129030049458837,0.9919317983327203
IGROV-1,24772860,-3.2892316801587835,-1.8789103289424602
IA-LM,6450551,2.2909353415785403,1.84758234003562
HARA [Human squamous cell lung carcinoma],441298,0.3301976976056055,2.4554385650841466
BFTC-909,6252,5.031852570794812,1.3883614299234566
BICR 31,9907093,4.585915925811977,4.107819956268485
MDST8,285033,-1.9150900594470792,-1.637354071384078
MOLM-13,375860,-1.005106987112833,-0.5692842552994777
P31/FUJ,16725315,4.109597365862544,3.5748695733141007
IGROV-1,216345,3.498629789107092,3.952276932102874
SW1271,208908,1.7498569635536685,2.0300674324078383
COR-L95,11507802,0.9381723124038672,1.1717175495131074
RERF-LC-MS,6918328,0.3946668064090056,0.2277996713945938
NCI-H1568,426756,4.294080241318686,4.325940433454058
K-562,67156097,-2.769244311294464,-2.052581801139024
LS411N,2729026,2.9791300415919646,2.5423810221198884
SK-HEP-1,2729026,3.094345392685322,2.8340615451611915
Panc 02.03,54618771,1.0884531427161812,1.0919127522190082
MDST8,5282054,3.0885738072945776,3.560339706804846
HARA [Human squamous cell lung carcinoma],31703,-1.5277652674394486,-0.47800524174031045
HEL,54143018,-0.2807045945993052,-0.4008256954492061
COR-L105,5278396,3.038896363429305,3.6923896737765394
SU-DHL-6,6450551,1.9173550036200224,1.3263174910311764
LCLC-97TM1,1716436,2.9898763561132276,2.9564191388834886
K-562,54619267,3.679496217482672,3.7882125275738696
Granta-519,1641662,2.857235389717828,2.960058424526387
PaTu 8902,219104,4.25826825351418,3.9123611759805383
NCI-H2452,24779724,6.409137734448782,4.604868398501926
RCC10RGB,2126,5.809199309072596,4.921426095821327
HuP-T3,24753719,4.122061219367772,4.368858463494355
RKN,44197249,3.9607888926275217,4.144999520527568
SU-DHL-1,44543605,4.013392575246718,3.294576412174881
HEL,11455910,0.7002369428142345,0.32876261020093517
SK-HEP-1,5281672,4.68841423543723,4.610218895464838
SW1271,navitoclax-gemcitabine (1-1 mol-mol),-0.9038417813496232,-1.5418038768971172
BICR 31,23582824,0.6119811525421108,0.7680613657770168
SW48,57330099,4.121753491452113,4.199580392230215
MOLP-8,3825829,4.0673932001437,3.4628379739377384
Granta-519,5746,-3.467826904777232,-0.6439566140280023
K-562,46215462,1.6076592131491731,1.3947869172337823
Daudi,alisertib-navitoclax (2-1 mol-mol),-1.1022910082635888,-1.067030290142631
MOLM-13,6852167,0.0474303723036755,1.401187130691919
PaTu 8902,44819697,-0.6077719001286086,-0.4069328966953896
P31/FUJ,selumetinib-BRD-A02303741 (4-1 mol-mol),2.927335699972257,3.1922898004103875
HCC15,135875424,4.57405525423842,4.026907436745639
BFTC-909,6918736,-1.9066217610366931,-1.7528646491030468
MOLP-8,25195348,2.8158250690550215,2.591393155956344
KU-19-19,11175137,2.6409229524549858,2.793070790517402
MOLP-8,selumetinib-vorinostat (8-1 mol-mol),0.5192774432453199,1.8202499740653086
SU-DHL-1,15983966,-4.109397573586815,-1.5183580362678806
Granta-519,4705,3.4024179319436483,2.904675455190705
SaOS-2,6450551,2.5324870379200113,2.596313451508341
SU-DHL-1,6918837,-2.995399398295858,-3.7643551464661256
RKN,selumetinib-BRD-A02303741 (4-1 mol-mol),7.036223119013143,3.8644927636131685
SW1573,159324,2.9705070550476274,3.433869639184147
LS180,11625818,4.457813695022962,4.227999764843423
Granta-519,10296883,3.749738066673353,3.1697953035419095
Panc 02.03,285033,-1.023489563814438,-1.5576372281568631
SU-DHL-1,11175137,1.828860424721981,2.3280336338983294
HEL,124202324,1.0355607531680788,1.0787012173994281
NCI-H1568,702558,5.469457182473135,5.24508407507734
IGROV-1,46191454,1.3777495915525844,1.9806869903361553
WM115,55283,3.7426713954425415,2.800366952540364
SW948,7251185,1.827873481109932,1.8437596223896398
MDST8,4521392,4.294685623216763,4.2644686004754915
HuP-T3,selumetinib-GDC-0941 (4-1 mol-mol),0.9673243203252392,1.4401796202826713
LS180,11455910,2.088798844266998,1.1048742177635704
NCI-H2452,151289,3.721937933525537,1.209352174010877
LCLC-97TM1,11214940,1.4536772193180694,1.9570079252311803
RKO,25062766,2.7314931301361476,1.7530605147204974
SU-DHL-1,navitoclax-piperlongumine (1-1 mol-mol),1.5701555779120346,0.6474910136713318
COR-L105,3385,6.244906352702261,4.327559756739383
IGROV-1,375860,0.7731558163124775,-0.26571234880109557
SU-DHL-1,9936388,0.846879508636978,-3.0510029147609687
MOLP-8,11955716,-2.2423093620343666,-2.2253772513751375
IGROV-1,11455910,-0.2792640061206097,1.170949703546458
HEL,216468,1.594172428774628,0.9926236870709935
K-562,216345,3.9110155346915088,3.320827840091019
SK-HEP-1,6450551,3.663777137244395,3.0816746117426237
Daudi,5460769,0.2326576177581661,2.152475215163431
BICR 22,1750826,0.8880077925102622,-0.8894330007507238
RERF-LC-MS,11238147,2.4729298726299147,3.1379552846257974
BFTC-909,54649381,4.487285574329416,3.9963559270636386
RERF-LC-MS,9926054,1.8051014319834384,2.0318838015594283
IA-LM,1750826,-4.675530321169698,-2.504277581388169
BICR 22,46398810,2.733805979632988,2.5823138227379214
WM115,445643,3.76443753653658,3.9887107149775285
LS411N,3689413,2.701640891749041,-0.8254995966826277
SW48,71304818,2.1411626536950323,2.346415503992061
HuP-T3,5291,4.150853397708747,3.8080604889290197
SW48,9911463,3.374803590447597,3.8556077215440006
Daudi,16219061,1.2860438148144782,2.247549362841416
SaOS-2,9911830,2.995519789289086,2.4438183848206334
BFTC-909,5329102,1.9658448878596055,2.2973262352245185
NCI-H1568,53495165,-0.6133813456223128,0.8451976268490149
BICR 22,6918878,1.3704913724877863,2.6945859450776406
SK-OV-3,4259181,0.9080230343390464,0.47419445668309107
HCC15,BRD-A02303741-navitoclax (2-1 mol-mol),0.3796712498058268,2.865669448740497
BFTC-909,445091,4.3207806819680625,4.5442612169984935
WM115,2130404,3.451007656106494,3.391418762968039
RCC10RGB,11152667,2.8531679730856268,-0.1383740238178888
HEL,5460769,3.63888115942649,1.8066024185695755
HEL,969516,2.4495484774391296,2.204696820714299
MDST8,11152667,-1.6082048518025778,-0.21714903570344884
WM115,54596490,4.400808012137458,4.36241506237647
NCI-H2452,1716436,2.783046357832639,3.1567642418912176
MOLM-13,4917,2.9272389210025955,2.5795331723039174
ALL-SIL,119182,-4.503247338331098,-3.122815862210136
MDST8,3552672,1.9687663546279843,2.792314337144232
HCC15,16720766,-0.3160262480808965,0.6774714406474845
ML-1 [Human thyroid carcinoma],12001922,2.2640831281012916,2.071691972461613
MOLM-13,12003241,-3.578107028375036,-1.737428347126317
SW948,24856436,-0.402936098482521,0.4082985037579138
HCC1500,44202524,3.676243999694772,2.1341639389901594
Daudi,4261,-0.6156785773872924,0.26039029755913146
MDST8,11507802,0.9258202338292296,2.0596537329323574
BFTC-909,54626689,4.365294423210906,4.671428130700481
NCI-H1568,16741245,4.262204040009308,4.047547418667424
HCC1500,25154868,1.8923567203600569,4.412140013849862
HCC15,navitoclax-piperlongumine (1-1 mol-mol),-0.4364560874228035,2.076916477186258
COR-L105,3825829,4.424164708702568,4.248614841228798
HEL,10074640,3.098757234686198,1.5677497220343535
RKO,44202524,1.4476976505001866,1.8285716328680843
SK-HEP-1,6852167,5.53454213252302,3.0155687143597594
